From 11:00 pm to 12:00 pm EST ( 8:00 pm to 9:00 pm PST ) on January 6th, the website will be under maintenance. We are sorry for the inconvenience. Please arrange your schedule properly.
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer .
Quilizumab (Anti-Human IGHE Recombinant Antibody) is a humanized IgG1κ monoclonal antibody targeting immunoglobulin epsilon (also konwn as: IGHE, IgE). Quilizumab targets the M1-prime fragment of membrane-expressed IGHE/IgE, leading to IGHE/IgE switching and memory B cell depletion. Quilizumab has potential in asthma research .
Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gammaantibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease .
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .
Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine .
PLAUR Human Pre-designed siRNA Set A contains three designed siRNAs for PLAUR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis . Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease) .
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research .
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .
Inclacumab (Anti-Human selectin P Recombinant Antibody) is a human monoclonal IgG4 antibody selectively targets P-selectin with a Kd value of 9.9 nM. Inclacumab inhibits P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide bind with P-selectin with an IC50 value of 1.9 μg/mL and strongly inhibits cell adhesion .
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen and blocks CD80–CD28 binding. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma .
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .
Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research .
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer .
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a humanized recombinant anti-CD6 monoclonal antibody (MAb) targeting the extracellular SRCR distal domain 1 of CD6. Itolizumab reduces T-cell proliferation and inhibits the production of pro-inflammatory cytokines, such as INF-γ, TNFα and IL-6. Itolizumab can be used in the research of psoriasis, rheumatoid arthritis (RA), COVID-19 .
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .
Opucolimab is an anti-PD-L1 recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors .
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis .
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN) .
IPR-803 is a potent inhibitor of the uPAR·uPA protein-protein interaction (PPI). IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activity .
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research .
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid .
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research .
Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin .
Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2 .
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell activation. Lirentelimab can be used for the research of eosinophilic gastritis and duodenitis .
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin .
Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL) .
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma .
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody that can be used for the research of cancer .
Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research .
AC Antibody affinity resin is AC commonly used packing. AC Antibody affinity resin has highly cross-linked agarose matrix with 85 μm of average particle size. AC Antibody affinity resin has alkali-resistant protein A derivative (E. coli) ligand. AC Antibody affinity resin can be used for antibody affinity chromatography .
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin (Disitamab vedotin (HY-P9985)) .
Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC antibody) of antibody-drug conjugates to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia .
Brentuximab is a monoclonal antibody targeting CD30. Brentuximab is conjugated with monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107), which can induce apoptosis in primary effusion lymphoma cells. Brentuximab vedotin exhibits antitumor activity with an IC50 of 10 nM against human CD30+ cancer cells .
Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases .
Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia .
Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection .
Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b .
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis .
Enfortumab is a humanized derived anti-Nectin-4antibody that can be conjugated with the highly efficient microtubule disruptor MMAE (HY-15162) to generate the antibody drug conjugate (ADC) Enfortumab vedotin (HY-P99016A). Enfortumab can be used for the study of locally advanced and metastatic urothelial carcinoma .
Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody that can be used for the research of atopic dermatitis (AD) in dogs .
Ocrelizumab (Ocrevus) is a humanized anti-CD20 monoclonal antibody. Ocrelizumab can induce B cell depletion and inhibit multiple sclerosis lesions in mice through antibody dependent cytotoxicity (ADCC) .
Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer .
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) .
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity .
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein .
Elsilimomab (B-E8) is a IgG1 monoclonal antibody against interleukin-6 (IL-6), with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab can be used for the research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA) .
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells .
Anti-α-Tubulin Antibody, AF555 conjugate is a conjugate of mouse anti-α-tubulin monoclonal antibody and the red fluorescent dye Alexa Fluor 555. Anti-α-Tubulin Antibody, AF555 conjugate can be used for the detection of tubulin (Ex/Em: 554/567 nm) .
Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells, thereby preventing CD40 signaling. Toralizumab, a immunosuppressive agent, has the potential for active systemic lupus erythematosus (SLE) research .
Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection .
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment .
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) is a neutralizing antibody of IFNAR1. Anti-Mouse IFNAR1 Antibody (MAR1-5A3) reacts with IFNAR1 and inhibits IFNAR1 signaling in vitro and in vivo. Mouse IgG1 kappa, Isotype Control (HY-P99977) is the isotype control of Anti-Mouse IFNAR1 Antibody (MAR1-5A3) .
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions .
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .
Anti-Human/Mouse denatured collagen type-I Antibody (XL313) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to human/mouse denatured collagen type-I.
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness .
Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAPantibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity .
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA) .
Licaminlimab (OCS-02) is a single-chain anti-TNF alphaantibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation .
Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells.
Anti-MERS-3A1 mAb bocks the binding of MERS-CoV spike protein to DPP4 receptor .
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively .
Gantenerumab is a fully human anti-amyloid-β (Aβ) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-β binding. Gantenerumab can be used for Alzheimer's disease research .
Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma .
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity .
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine . Rovalpituzumab has activity against small cell lung cancer (SCLC) .
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes .
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors .
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research .
Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM)antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is the anti-DLL3 arm of the bispecific T-cell engager (BiTE) antibody-Tarlatamab (AMG-757) (HY-P99575). Tarlatamab targets both DLL3 and CD3.
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults .
Ongericimab (JS002) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab has lipid-lowering efficacy. Ongericimab can be used in research of hypercholesteremia and hyperlipidemia .
Efungumab is a monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab can be used for research on invasive candidiasis (IC) .
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor .
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .
Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may be helpful in inhibiting the cytokine response to SARS-CoV-2 in COVID-19. Clazakizumab can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection .
Livmoniplimab (ABBV-151) is a monoclonal antibody against GARP/TGF-β1 that can inhibit the release of active TGF-β1. Livmoniplimab has anti-tumor activity in colon cancer mice. Livmoniplimab can be used for the study of locally advanced or metastatic solid tumors .
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) .
Anti-Mouse 4-1BB/CD137 Antibody (3H3) is an IgG2a antibody agonist against mouse 4-1BB, derived from a rat host, capable of stimulating 4-1BB signaling in vivo.
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease .
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer .
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules .
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research .
Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody. Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM respectively, has anti-tumor activity .
Palivizumab (MEDI 493) is a humanized monoclonal antibody against respiratory syncytial virus (RSV). Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM. Palivizumab can prevent respiratory syncytial virus infection in cotton mice .
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .
Recaticimab (SHR-1209) is a humanized monoclonal antibody that inhibits PCSK9. Recaticimab can bind to PCSK9 and mediate its degradation, increasing the level of low-density lipoprotein (LDL) receptors on the surface of liver cells, reducing the level of LDL in plasma, thereby lowering blood lipids. Recaticimab can be used for the study of hypercholesterolemia .
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential .
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes .
Ponsegromab (PF 06946860) is a potent and selective humanized anti-GDF15 monoclonal antibody with anti-cachexia activity. Ponsegromab binds to GDF15 and prevents the binding of GDF15 to GFRAL, thereby blocking GDF15/GFRAL-mediated signaling. Ponsegromab can be used in the research of cancers .
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma .
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research .
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke .
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain .
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) .
Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM .
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells .
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research .
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19 .
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation .
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis .
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23 (IL-23). Mirikizumab binds to human and monkey IL-23 with high affinity, with Kd values of 21 pM and 55 pM, respectively. By inhibiting the binding of IL-23 to IL-23R, Mirikizumab modulates the immune response and holds potential for research in ulcerative colitis and Crohn's disease .
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody which inhibits a proliferation-inducing ligand (APRIL). Sibeprenlimab suppresses pathogenic immunoglobulins (IgA and IgM), while preserving antibody responses to mRNA-based vaccines against SARS-COV-2. Sibeprenlimab reduces urinary protein-to-creatinine ratio (UPCR) and glomerular filtration rate (GFR). Sibeprenlimab is promising for the research of IgA nephropathy (IgAN) .
Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation .
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N-terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research .
Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD) .
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis .
Nirsevimab (MEDI8897) is a recombinant monoclonal antibody against human respiratory syncytial virus (RSV). Nirsevimab has neutralizing activity against RSV A and RSV B viruses, with IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab can be used for research on respiratory infections .
Mirzotamab is an IgG1κ monoclonal antibody targeting to CD276/B7-H3 with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .
Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research .
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research .
Inetetamab is a monoclonal antibody binding to domain IV of HER2 receptor. Inetetamab alone or together with tyrosine kinase inhibitors has antitumor activities .
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer .
Magrolimab (Hu5F9-G4) is a humanized anti-CD47antibody. Magrolimab can block the "don't eat me" signal of CD47, thereby promoting macrophage mediated phagocytosis. Magrolimab has antitumor activity in malignant bone tumors and breast cancer .
Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases .
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .
Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2 .
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research .
Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases .
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis .
Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research .
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease .
Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies .
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia .
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) .
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research .
Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy .
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC) .
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies .
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research .
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH) .
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro .
Datopotamab (CDP7657) is a humanized anti trophoblast cell surface antigen 2 (TROP2) antibody. Datopotamab can generate antibody drug conjugates (ADC) (HY-141598) with DNA topoisomerase I inhibitor Deruxtecan (HY-13631E). Datopotamab can be used in the study of triple negative breast cancer and non-small cell lung cancer .
Nemolizumab (CIM331) is a humanized monoclonal antibody that targets the human interleukin-31 receptor a, preventing interleukin-31 (IL-31) from binding to its receptor and the subsequent signaling. Nemolizumab can help reduce itching and sleep disturbances, and it is being studied for atopic dermatitis (AD) .
Relatlimab (BMS-986016) is a human monoclonal antibodyanti-LAG-3antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer .
Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies .
Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models .
Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria .
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research .
Dectrekumab (QAX576) is a human monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research .
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) .
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex .
Odronextamab is a stable humanized IgG4 CD20 × CD3 bispecific antibody that binds to CD3 on T cells and CD20 on B cells, triggering anti-tumor activity. Odronextamab is expected to be used in oncology research .
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9 .
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models .
Trastuzumab (PBS) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (PBS) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities .
Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer .
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity .
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
Mecbotamab is a humanized IgG1-κ antibody targeting to AXL receptor tyrosine kinase (AXL). Mecbotamab can serves as a conditionally active biologic (CAB), which can be conjugated with MMAE (HY-15162) via a cleavable linker, to form ADC Mecbotamab vedotin (BA3011) .
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease .
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) .
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer .
Cadonilimab (AK104) is a humanized tetravalent IgG1 bispecific antibody targeting PD1/CTLA4. Cadonilimab blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC) .
Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma .
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research .
Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases .
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema .
Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis .
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research .
Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research .
Sirukumab (CNTO-136) is a humanized monoclonal anti-IL6 (Interleukin Related) IgG1κ antibody. Sirukumab binds to IL6, preventing IL6-mediated signal transduction and activation of transcriptional activators, thereby blocking the downstream biological effects of IL6. Sirukumab can be used in the study of active lupus nephritis and rheumatoid arthritis .
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis .
Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The IgG1 Fc fragment of Anbenitamab binds FcRγIIIa mediates potent antibody dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor cell proliferation. Anbenitamab has the potential for HER2-positive metastatic breast cancer (MBC) research .
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer .
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells .
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL) .
Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165) . Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research .
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways .
Zalutumumab is a high affinity, completely human IgG1 monoclonal antibody targeting EGFR. Zalutumumab binds to domain III of the EGF receptor and acts by blocking the binding of EGF and by sterically interfering with the active conformation of the receptor. Zalutumumab binds with IgG and its Fab fragment with EC50s of 7 and 19 nM, respectively. Zalutumumab can be used for the research of cancer .
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion .
Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) .
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .
Camoteskimab (AVTX-007) is an anti-IL-18 monoclonal antibody with fully humanized, high-affinity. Camoteskimab is promising for research of cardiovascular diseases and autoinflammatory diseases, including adult-onset Still’s disease (AOSD) and multiple myeloma .
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .
Muromonab is a monoclonal antibody targeting the CD3 receptor. Muromonab can block all cytotoxic T cell function. Muromonab also as an immunosuppressant agent given to reduce acute solid organ transplant rejection .
Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research .
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) .
Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death .
Anti-MERS-2E6 mAb (MERS-2E6; MERS Antibody-2E6), a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells.
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research .
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells .
Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
Trontinemab (RG6102) is a brain-penetrant, anti-amyloid, bispecific and humanizedized IgG1-κantibody, targeting to Aβ plaques and transferrin receptor 1 (TFR1). Trontinemab binds to fibrillar Aβ as well as Aβ plaques triggering plaque clearance by engaging immune cells on Alzheimer disease (AD) brain sections. Trontinemab also shows specific affinity to cynomolgus and human TFR1 .
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .
Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) .
Val-Cit-amide-Ph-Maytansine is an antibody and bispecific antigen-binding mol. that bind hepatocyte growth factor receptor c-Met (MET) or antibody-drug conjugates (ADCs) .
Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD) .
Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody against T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research of cancer .
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers.
.
Latozinemab (AL001) is a recombinant human anti-Sortilin monoclonal antibody. Latozinemab effectively binds Sortilin with a high affinity and blocks the interaction between progranulin protein (PGRN) and Sortilin receptor. Latozinemab has the potential for progranulin gene (GRN) mutations causative of Frontotemporal dementia (FTD) (FTD-GRN) research .
Val-Cit-amide-Cbz-N(Me)-Maytansine is an antibody and bispecific antigen-binding mol. that bind hepatocyte growth factor receptor c-Met (MET) or antibody-drug conjugates (ADCs) .
Toripalimab is the first domestic anti-tumor PD-1antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma .
CC-90002 is a humanized anti-CD47 monoclonal antibody (mAb). CC-90002 has a high affinity for binding to CD47 with a subnanomolar Kd value. CC-90002 can be used for the research of hematologic malignancies and solid tumors .
Cemavafusp is an anti-PD-L1 monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .
CTX-471 is a fully human monoclonal antibody of CD137. CTX-471 has bind affinity for recombinant human, cynomolgus macaque CD137 and mouse CD137 with Kd values of 50 nM, 61 nM and 748 nM, respectively. CTX-471 can be used for the research of immunomodulation and cancer .
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research .
Iladatuzumab vedotin (DCDS-0780A) is an antibody–drug conjugate (ADC) containing humanized IgG1 anti-human CD79B monoclonal antibody (MCDS0593A; HY-P99656) conjugated to MMAE via a protease labile linker. Iladatuzumab vedotin uses novel THIOMAB technology (TDC) to consistently conjugate two MMAE molecules per antibody using engineered cysteine residues. Iladatuzumab vedotin has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research .
Satralizumab, a humanized monoclonal antibody, is a potent Interleukine-6 (IL-6) inhibitor. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research .
Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment .
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research .
Obexelimab (XmAb5871) is a humanized anti-CD19antibody. Obexelimab works by inhibiting B cell receptor (BCR) mediated calcium influx and promoting the phosphorylation of Fc γ receptor IIb (FcγRIIb), which reduces B cell activation and function, leading to B cell apoptosis. Obexelimab can be used in research for rheumatoid arthritis and systemic lupus erythematosus .
Mepolizumab (anti-IL5) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell non-Hodgkin lymphoma (B-NHL) .
Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the activity of cytotoxic and memory T cells and induce anti-tumor immunity. Latikafusp has the potential for solid tumors research .Latikafusp may lead to the development of immunogenicity-mediated responses .
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models .
Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs) .
Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism .
Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
Natalizumab (Solution) is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
AC Antibody purification resin 2 is based on spherical, highly cross-linked agarose beads with a narrow size distribution and high mechanical stability. Used for the separation and purification of complex antibodies such as monoclonal antibody, double antibody, multi-antibody and Fc fusion protein .
Substrate: highly crosslinked agarose microspheres; Particle size: 65μm; Ligand: alkali-resistant recombinant Protein A; ADC purified resin.
Amivantamab (FUT8-KO) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab (FUT8-KO) inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis .
Sonelokimab (ALX 0761) is a trivalent bispecific nanobody composed of camel derived humanized IL-17Fantibodies, IL-17A/Fantibodies, and serum albumin VHHantibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid arthritis and psoriasis .
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research .
AC Antibody purification resin 1 is a nano agarose with a particle size of 69μm. AC Antibody purification resin 1 can be used in ADC purification. AC Antibody purification resin 1 contains a ligand: recombinant protein A.
Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of β-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sjögren’s syndrome and type I diabetes research .
Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia .
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers .
Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity .
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin (HY-109539). Gemtuzumab ozogamicin consists of a cytotoxic derivative of Calicheamicin (a cytotoxic antibiotic), and a monoclonal antibody. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia .
Sulfo-TAG NHS ester (disodium) is an N-hydroxysuccinimide ester that can be coupled to proteins via primary amine groups. Sulfo-TAG NHS ester (disodium) can be used for antibody labeling .
MAIPGG is a bifunctional chelating agent. MAIPGG can be for the radiolabeling of a variety of monoclonal antibodies with 99mTc or 186Re, which then can be used for radioimmunodetection and radioimmunotherapy of cancer .
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma .
Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493) .
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects .
Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO) .
Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis) .
Mipasetamab uzoptirine (ADCT-601) is an AXL-targeted antibody-drug conjugates (ADCs). Mipasetamab uzoptirine consists of a humanized anti-AXL antibody, a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine can be used for the research of cancers .
Mipasetamab is an IgG1κ antibody targeting to AXL, a tyrosine kinase receptor and an TAM Receptor. Mipasetamab involves in synthesis of ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC). ADCT-601 has anti-tumor activity .
KWAR23 is an anti-human SIRPαantibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research .
Empasiprubar (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. Empasiprubar binds to the Sushi-2 domain of C2, preventing the formation of C3 pre convertase and inhibiting the activation of classical and lectin pathways upstream of C3 activation. Empasiprubar can prevent complement mediated autoimmune hemolytic anemia and antibody mediated organ transplant rejection. Empasiprubar can prevent neuroglial lymphoconjunctival injury in GM1 antibody mediated mouse models .
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML) .
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research .
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma .
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research .
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL) .
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556). Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection .
Mezagitamab (TAK-079) is a IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement dependent cytotoxicity. Mezagitamab has potential application in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP) .
Sacituzumab is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab is used for the synthesis of antibody-drug conjugates (ADC) drugs. Antibody-drug conjugates with sacituzumab (sacituzumab govitecan) (HY-132254) targeting TROP-2 have been approved for the field of triple-negative breast cancer .
Izeltabart is a high-affinity humanized antibody targeting ADAM9. Izeltabart can be used as ADC Antibody for site-specific conjugation with Maytansinoid-based DM21-C (a Drug-Linker Conjugates for ADC), to synthesize IMGC936 (Antibody-Drug Conjugates (ADCs)) with strong anti-cancer activity. DM21-C is composed of Maytansinoid (microtubule inhibitor) and a stable tripeptide linker. IMGC936 exhibits cytotoxicity against ADAM9-positive human tumor cell lines and potent antitumor activity in xenograft tumor models .
Blontuvetmab (AT 004) is a caninized CD20 monoclonal antibody and is also a potent, selective, highly potent antagonist of A2aR receptor. Blontuvetmab behaves as Nociceptin (HY-P0183)/Orphanin (HY-P0183) FQ receptor (NOP) agonists displaying weak NOP affinity. Blontuvetmab inhibits 5'-N-Ethylcarboxamidoadenosine (NECA)-mediated A2aR activation and significantly reverses the ability of adenosine to suppress CD8 T cell activation, increasing levels of cytokines such as IFN-γ. Blontuvetmab Blontuvetmab can be used for the research of Canine B-cell lymphoma .
Seco-DUBA is a duocarmycin (DUBA) prodrug containing two hydroxyl groups, which can each be used for coupling to an antibody via a linker. Seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs) .
Modakafusp alfa (TAK-573) is a humanized, anti-CD38IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules, which delivers interferon-alpha to CD38-expressing cells. Modakafusp alfa has direct anti-proliferative activity on multiple myeloma (MM) cancer cells in vitro and induces robust and durable antitumor responses in MM xenograft tumor models. Modakafusp alfa in combination with anti-PD-1 antibodies induces immunomodulation and antitumor responses with good tolerance in mice .
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) is a human monoclonal IgG1. Anti-MERS-D12 mAb binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding .
Sintilimab (IBI308) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a KD value of 74 pM. Sintilimab blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer .
Angstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling .
Evinacumab (REGN1500) is a human anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody (IgG4 class antibody). Evinacumab reduces plasma lipids in dyslipidemic mice by blocking ANGPTL3. Evinacumab can be used in studies of homozygous familial hypercholesterolaemia (HoFH), refractory hypercholesterolaemia (both familial and non-familial) and severe hypertriglyceridaemia .
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research .
Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance .
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis .
Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity .
Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses .
2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .
PROTAC BRD4 Degrader-13 (compound 9d) is a von Hippel-Lindau system-based PROTAC BRD4 degrader with a linker that can be coupled to ADC antibodies to form PACs (PROTAC-antibody Conjugates). PROTAC BRD4 Degrader-13 can be coupled to STEAP1 and CLL1 antibodies to degrade BRD4 protein in PC3 prostate cancer cells with DC50 values of 0.025 nM and 6.0 nM, respectively .
HDP 30.1699, the derivative of α-Amanitin, shows considerable cross-links. The cysteine residues of the anti-HER2 THIOMAB antibody are used for conjugation of the cysteine reactive linker–Amanitin compound, HDP 30.1699, with a cleavable linker by maleimide chemistry .
Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPαantibody that blocks the binding of CD47 to SIRPα. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research .
Netakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis .
Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis .
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration .
Fenhexamid-butyric acid (Compound FHo) is a hapten designed based on fenhexamid, which can produce monoclonal antibodies with an IC50 value of 0.66-0.93 nM .
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection .
Tanfanercept (HL036337) is an anti-TNF-α monoclonal antibody. Tanfanercept is effective in ameliorating corneal erosions in a dry eye (DE) mouse model .
Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis .
Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic .
Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research .
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia .
Tomaralimab (OPN-305) is a humanised anti-TLR2 IgG4 monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS) .
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research .
9-(2-Carboxy-2-cyanovinyl)julolidine is a fluorescent molecular rotor. 9-(2-Carboxy-2-cyanovinyl)julolidine can be used to bind to IgG and Fab, and preparing antibodies .
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research .
Envafolimab (ASC 22; KN 035) is a recombinant protein of a humanized single-domain anti- PD-L1 antibody. Envafolimab is created by a fusion of the of anti-PD-L1 domain with Fc fragment of human IgG1 antibody. Envafolimab blocks interaction between PD-L1 and PD-1 with an IC50 value of 5.25?nM. Envafolimab has the potential for the research of solid tumors .
Lintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR? and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice .
Tarcocimab (OG1953) is a humanized anti-VEGFA monoclonal antibody (IgG1 type). Tarcocimab is available for research in retinal vein occlusion (RVO) and wet age-related macular degeneration (AMD).
Azintuxizumab vedotin (ABBV-838) is an antibody–drug conjugate (ADC) targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells .
Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA) .
Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis .
Firastotug is an IgG1κ antibody targeting CTLA4. CTLA4 is a cytotoxic T lymphocyte-associated protein and a key immune checkpoint in the fields of autoimmunity and cancer .
Gotistobart (ONC-392) is a humanized anti-CTLA-4antibody that confers immunotherapeutic effect by selective depletion of regulatory T cells (Treg) in the tumor microenvironment .
Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer .
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma .
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies .
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer .
Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation .
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection .
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions .
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively .
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research .
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research .
Becotatug (JMT-101) is an IgG1 antibody targeting EGFR that can also be conjugated to Afatinib (HY-10261) and Osimertinib (HY-15772) as a synthetic ADC .
Depatuxizumab is a brain-penetrant and humanized tumor-specific antiEGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer .
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa .
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research .
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects .
Brolucizumab (DLX1008) is a single-chain anti-VEGF-Aantibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer .
Coprelotamab (GB-221) is an IgG-κ monoclonal antibody targeting EGFR2. The commonly used expression system for Coprelotamab is CHO DG44 (Chinese Hamster Ovary) cells .
Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic .
Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .
Miptenalimab (BI-754111) is an anti-human LAG-3antibody (KD: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) .
Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity .
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain .
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis .
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections .
Benralizumab (anti-IL5RA ) (MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma study .
Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures , also has anti-cancer activity .
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells .
Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential .
Iscalimab (CFZ-533) is a non-depleting IGg1 monoclonal antibody targeting CD40 (KD: 0.3 nM). Iscalimab can be used for research of Graves' hyperthyroidism and autoimmune diseases .
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2 .
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research .
Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) and the cytotoxic agent Monomethyl auristatin E (MMAE). Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR .
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer .
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research .
Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) .
Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab can be used for age-related macular degeneration (AMD) research .
Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL .
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails .
Isecarosmab (M-6495) is an anti-ADAMTS monoclonal antibody (mAb) with a KD value of 3.65 pM. Isecarosmab has chondroprotective and anti-inflammatory activities. Isecarosmab can bind albumin to extend plasma half-life .
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (compound 21a), a camptothecin payload, can be conjugated to a monoclonal antibody (mAb) for the synthesis of camptothecin antibody-drug conjugate (ADC) .
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function .
Gumokimab (AK 111) is a monoclonal antibody targeting IL-17A, which can be used in the study of psoriasis, ankylosing spondylitis. Gumokimab competitively blocks the binding of human IL-17A to IL-17R.
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC) .
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab .
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease .
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity .
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model .
Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus .
Secukinumab (Anti-Human IL-17A) is a fully human anti-interleukin-17A monoclonal antibody. Anti-Human IL-17A can be used for research in psoriasis pathogenesis .
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies .
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies .
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion .
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis .
Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases .
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research .
Gancotamab (MM-302) is a HER2-targeted antibody-liposomal Doxorubicin conjugate with antitumor activity. Gancotamab encapsulates Doxorubicin to facilitate its delivery to HER2-overexpressing tumor cells .
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease .
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor .
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection .
Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc .
Rolinsatamab is a IgG1κ type chimeric antibody targeting to PRLR (prolactin receptor). Rolinsatamab can be conjugated with pyrrolobenzodiazepine (PDB) dimer SGD-1882 (HY-101127) via a cleavable maleimidocaproyl type linker, to form an antibody-drug conjugate, Rolinsatamab talirine. One Rolinsatamab talirine has an average of 2 site-specific drug attachment engineered cysteines (C242, C242'). The linker equips the valine-alanine dipeptide, as cathepsine B cleavage site. on an average of 2 site-specific drug attachment engineered cysteines (C242, C242') .
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation .
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer .
Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes .
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab binds to human N-terminal tau residues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD) .
Atrosab is a humanized IgG1 antagonistic anti-TNFR1antibody. Atrosab inhibits TNF-mediated apoptosis induction and IL-6 and IL-8 production. Atrosab can be used for research of inflammatory disease .
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator .
Aprutumab (BAY 1179470) is a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research .
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research .
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer .
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease .
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research .
Vulinacimab (HLX-06) is an anti-VEGFR-2 monoclonal antibody (mAb). Vulinacimab can be used in the research of cancers. VEGFR-2, overexpressed in certain tumors, is critical in angiogenesis and the proliferation, survival, migration and differentiation of endothelial cells .
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma .
Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40. Among them, OX40 is a member of the TNF receptor superfamily expressed on activated and memory T cell subsets and T regulatory cells .
Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity.
Danburstotug (IMC-001) is an IgG1-lambda anti-CD274 (PDL1, B7 homologue 1, B7H1) human monoclonal antibody. Danburstotug also is immunostimulant and antineoplastic .
Imbotolimod, immunoglobulin G1-kappa, is a humanized monoclonal antibody with anti-ERBB2 and antineoplastic activity. Imbotolimod is a derivative of telratolimod .
Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells .
MC-GGFG-AM-(10NH2-11F-Camptothecin) is an antibody drug conjugates (ADC). MC-GGFG-AM-(10NH2-11F-Camptothecin) binds to the anti-TROp-2 antibody sacituzumab via a hydrolysable pH-sensitive linker and has anti-tumor activity. MC-GGFG-AM-(10NH2-11F-Camptothecin) can be used for cancer research .
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20 + expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo .
MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH is a camptothecin derivative. MC-Gly-Gly-Phe-Gly-NH-CH2-O-cyclopropane-CH2COOH can be used for antibody drug conjugate (ADC) .
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research .
Abciximab (C7E3), a chimeric mouse/human monoclonal antibody fragment, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors .
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research .
Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimer's disease .
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM .
Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19 .
Tuparstobart (Incagn-02385) is an IgG1κ antibody targeting LAG-3. LAG-3 is an immune checkpoint receptor protein mainly expressed on activated T cells, NK cells, B cells and plasmacytoid dendritic cells .
Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM) .
Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases .
Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE). Disitamab vedotin enhances antitumor immunity .
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis .
Rilotumumab (AMG 102) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research .
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research .
Letolizumab (BMS-986004) is a monoclonal antibody targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time .
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer .
Omodenbamab is an anti-SpA (Staphylococcal protein A) human monoclonal antibody with a KD value of 0.0467 nM. Omodenbamab circumvents a key S. aureus evasion mechanism by targeting the cell wall moiety Protein A (SpA). Omodenbamab can be used in research of S. aureus bloodstream infection .
Tulisokibart (PRA023) is a humanized IgG1-κ monoclonal antibody targeting to TNFSF15/TL1A. Tulisokibart can be used to study a variety of inflammatory/fibrotic diseases, such as Crohn's Disease (CD) .
Elranatamab (PF-06863135) is an anti-CD3E/TNFRSF17 human IgG2κ monoclonal antibody . Recommend Isotype Controls: Human IgG2 kappa, Isotype Control (HY-P99002).
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers .
NCGC00229600 is an allosteric inverse agonist of thyrotropin receptor (TSHR). NCGC00229600 inhibits both TSH and stimulating antibody activation of TSHRs endogenously expressed in Graves' disease .
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
Emibetuzumab (LY2875358) is a humanized bivalent METantibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer .
Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction .
Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC) .
Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid beta A4 precursor protein) Aβ42 N3pGlu peptide monoclonal antibody. Remternetug recognizes a pyroglutamated form of Aβ that aggregates into amyloid plaques .
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research .
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research .
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash .
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) .
Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma .
Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy .
Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus .
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition .
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis .
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies .
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity .
Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease .
Blood group A pentasaccharide (A-Pentasaccharide), an oligosaccharide in urine, can inhibit the binding of anti-A antibody to blood group A substance .
γ-Globulins from human blood are a class of proteins in the blood. γ-Globulin is a protein fraction of blood serum containing many antibodies that protect against bacterial and viral infectious diseases. γ-Globulins from human blood is used for common variable immunodeficiency
Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD) .
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC) .
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research .
Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) .
Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against HBV surface antigen (HBsAg). Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .
Ragistomig is an anti-TNFRSF9/CD274 IgG1 monoclonal antibody composed of a κ light chain and a variable region with a λ light chain and an IgG1 heavy chain. The overall structure is a dimer composed of two identical IgG1 heavy chains .
Cy5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research .
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis .
Keliximab (SB-210396) is a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody with a Ki value of 1.0 nM for soluble CD4. Keliximab blocks T cell proliferation and inhibits IL-2 production. Keliximab can be used for cancer research .
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer .
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement .
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research .
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells .
Onfekafusp alfa (L19TNF) is a homotrimer that forms from engineered peptides for the L19 antibody in scFv format fused to human TNF. Onfekafusp alfa can be used for malignant glioma research .
Denecimig (Mim8) is a novel activated coagulation factor VIII-mimetic human bispecific antibody with anti-FIXa and anti-FX arms that potently stimulates FX activation resulting in efficacious haemostasis in vitro and in vivo .
Sulfo-Cy3 maleimide potassium is a fluorescent dye with a maleimide functionality at the end a short alkyl linker. Sulfo-Cy3 maleimide potassium can be used for the labeling of antibodies and other labile proteins .
Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research .
Eflapegrastim is a human IgG4 monoclonal antibody, is also a granulocyte colony-stimulating factor (G-CSF). Eflapegrastim targets to G-CSF receptor (c-Fms). Eflapegrastim stimulates proliferation and differentiation of neutrophil progenitor cells and maintains stable numbers of mature and functional neutrophils. Eflapegrastim also shortens the duration of neutropenia .
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD) .
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monomethyl vedotin. Zilovertamab vedotin binding to tumor cell ROR1 results in rapid internalization, trafficking to lysosomes, antibody–agent conjugate cleavage, and monomethyl vedotin release. Zilovertamab vedotin induces apoptosis. Zilovertamab vedotin can be used in research of cancer .
p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor .
Abetimus (LJP 394 free base) is an immunosuppressant consisting of four double-stranded DNA (dsDNA) oligonucleotides. Abetimus is capable of crosslinking anti-dsDNA antibodies on the surface of B cells, and decreases anti-dsDNA antibodies levels. Abetimus has the potential for research of systemic lupus erythematosus .
Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases .
Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies .
Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research .
Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease .
17-HDHA is a DHA-derived specialized proresolving mediator (SPM). 17-HDHA enhances the antibody-mediated immune response against influenza virus. 17-HDHA enhances the differentiation of B cells toward the CD27 + CD38 +antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells .
Obiltoxaximab (ETI 204) is the second and potent anti-protective antigen (PA) monoclonal antibody with immunogenicity. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication, promoting survival, and inhibiting bacterial spread to the periphery in animal models. Obiltoxaximab can be used in the research of inhalational anthrax, bacteremia and toxemia .
Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab .
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively .
Briobacept (BR 3FC) is a selective human monoclonal antibody targeting to BLyS (BAFF), induces B cells apoptosis. Briobacept is a recombinant glucoprotein, consists of 2 molecules from the BLyS receptor (BR3)and a Fc domain of human IgG1. Briobacept can be used in studies of rheumatoid arthritis (RA) .
Socazolimab (ZKAB001) is an anti-PD-L1 monoclonal antibody. Socazolimab has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma .
Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus .
Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors .
Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD) .
Sulfo-CY-5.5 NHS ester (Sulfo-Cyanine5.5 NHS ester) tripotassium is an amine-reactive ester of sulfonated far-red Cyanine5.5 fluorophore, which can be used to label antibodies, proteins, etc., as well as for in vivo NIR imaging .
Vobarilizumab (ALX-0061) is a humanized bispecific anti-IL-6R and anti-human serum albumin (ALB) monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis .
Spesolimab (BI 655130) is a mouse-derived humanized IgG1k antibody against IL-36R. IL-36 plays an important role in the immune system and Spesolimab is being investigated in palmoplantar pustulosis (PPP). Spesolimab was associated with a reduction in biomarkers associated with the innate, Th1/Th17 and neutrophil pathways .
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1 inhibitory axis. Acasunlimab can be used in research of cancer .
Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research .
Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFR C271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501. Losatuxizumab can be used for research of EGFR-expressing cancers .
Tilvestamab (BGB149) is a humanized anti-AXLantibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT phosphorylation. Tilvestamab can be used in cancer research, particularly in AXL overexpressing renal cell carcinomas .
Rosopatamab (HuJ591) is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 ( 177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency .
Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC) .
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia .
Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor .
Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. .
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 .
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
Stapokibart (CM310) is a humanised monoclonal antibody targeting IL-4Rα and efficiently blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit IL-4Rα. Stapokibart has the capacity to interact with IL-4Rα in humans, cynomolgus monkeys, and rats .
Sofituzumab vedotin (DMUC5754A) (solution) is an antibody-drug conjugate (ADC) that contains the humanized IgG1 anti-MUC16 monoclonal antibody and a potent anti-mitotic agent, monomethyl auristatin E (MMAE), linked through a protease-cleavable linker .
10NH2-11F-Camptothecin is a Camptothecin (HY-16560) analogue that serves as an ADC cytotoxin for the synthesis of antibody-drug conjugates (ADCs). 10NH2-11F-Camptothecin can inhibit tumor growth and is used in cancer research .
Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal, a glucocorticoid receptor agonist, is a drug-linker conjugate for ADC. Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal can be used to synthesize the anti-CD40 antibody agent conjugates (WO2019106608A1; example 9) .
Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively .
Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research .
Eldelumab (BMS-936557) is a human anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease .
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer .
Talquetamab (JNJ-64407564) is a humanized bispecific antibody that binds to GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and activation. Talquetamab (JNJ-64407564) has antitumor activity .
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies .
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .
Dafsolimab (SPV-T3a) is an IgG2a murine monoclonal antibody(anti-CD3). Dafsolimab can induce cell death through modulation and activation of the CD3/T cell receptor complex. Dafsolimab can be used for the research of graft-versus-host disease (GVHD) .
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
Trimethoprim fumaric acid (Compound CDI) is a universal hapten for ASGs (Antibacterial synergists) and can be used to design broadly specific monoclonal antibodies (mAbs) against ASGs. The mAb developed by Trimethoprim fumaric acid can be applied in ELISA to detect the residues of ASGs in foods of animal origin .
Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia .
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis .
TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity .
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5aantibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. Vilobelimab acts as a C5a inhibitor, inhibiting neutrophil activation, chemotaxis, and reducing inflammatory signalling, and may be used in studies related to sepsis, COVID-19, etc .
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Integrin α5β1 is a major fibronectin receptor involved in angiogenesis. Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs) .
Lecanemab (Mouse IGG2a) is a monoclonal antibody that targets soluble β-amyloid and has the potential to reduce cognitive decline. The variable region of Lecanemab (Mouse IGG2a) is consistent with that of Lecanemab, while the constant region is of Mouse IGG2a sequence. Lecanemab (Mouse IGG2a) holds promise for research in the field of Alzheimer's disease .
Flotetuzumab (MGD006; S80880) is an investigational CD123/CD3 bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to CD123 in target cells and CD3 in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML) .
Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research .
Ogalvibart (C-135-LS) is a human anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model .
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent .
Riliprubart (SAR445088) is an anti-C1s humanized monoclonal antibody that inhibits activated C1s in the proximal portion of the classical complement system. Riliprubart selectively inhibits activated C1s and prevents the enzymatic action of C1 on its substrates C4 and C2, thus inhibiting the formation of the classical pathway C3 convertase, C4b2a .
Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC)(Antibody-Drug Conjugates (ADCs)) based on a murine/human chimeric form of B-B4 (specific for CD138), linked to the maytansinoid agent DM4 by disulphide bonds. Indatuximab ravtansine shows anti-tumor activities .
Glucocorticoid receptor agonist-4 Ala-Ala-Mal (Compound Preparation 9) is an anti-human TNFαantibody-glucocorticoid receptor agonist (GC) conjugate. Glucocorticoid receptor agonist-4 Ala-Ala-Mal can be used in the study of autoimmune and inflammatory diseases .
Glucocorticoid receptor agonist-3 Ala-Ala-Mal (Compound Preparation 8) is an anti-human TNFαantibody-glucocorticoid receptor agonist (GC) conjugate. Glucocorticoid receptor agonist-3 Ala-Ala-Mal can be used in the study of autoimmune and inflammatory diseases .
Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research .
Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. Polatuzumab vedotin has the potential for the research of Large B-cell lymphomas (LBCL) .
Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease .
Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394) .
Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research .
Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1 + cell lines, including lymphoma cells .
2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan is a drug-linker conjugates for ADC, consiting of a cleavable linker and Exatecan (HY-13631). 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan can be linked to anti-Her3 antibody .
Platycoside E is a platycodigenin-type saponin isolated from the root of Platycodon grandiflorum with haemolytic activity and adjuvant potential. Platycoside E promotes the production of the sera OVA-specific IgG2a and IgG2bantibody in the ovalbumin (OVA)-immunized mice .
PROTAC BRD4 Degrader-10 (compound 8b) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-10 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 1.3 nM and 18 nM, respectively .
PROTAC BRD4 Degrader-11 (compound 9a) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-11 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.23 nM and 0.38 nM, respectively .
7Ethanol-10NH2-11F-Camptothecin is a Camptothecin (HY-16560) analogue that serves as an ADC cytotoxin for the synthesis of antibody-drug conjugates (ADCs). 7Ethanol-10NH2-11F-Camptothecin can inhibit tumor growth and is used in cancer research .
Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research .
Gevokizumab is a potent anti-IL-1βantibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II) .
Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research .
Ordesekimab (AMG 714; PRV-015) is a fully human IgG1κ anti-IL-15 (Interleukin Related) monoclonal antibody. The binding of Ordesekimab to IL-15 inhibits the interaction of IL-15 with the IL-2Rβ and common γ chain of the IL-15 receptor complex, but not with the IL-15Rα chain. Ordesekimab has the potential for study of nonresponsive celiac disease (NRCD) .
Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus, which causes COVID-19. Casirivimab is ineffective against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), which alters the lung response of K18-hACE2 mice to the SARS-CoV-2 δ variant, effectively reducing viral load and improving symptoms .
Suvizumab (KD-247) is an neutralizing antibodyanti-HIV-1. Suvizumab effectively neutralizes HIV-1MN, HIV-1SF2 and HIV-189.6 with IC50 values of 0.1 µg/mL, 1.0 µg/mL and 0.2 µg/mL, respectively. Suvizumab reduces the viral load of HIV. Suvizumab has good tolerance and can be used to prevent HIV infection .
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity .
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) .
ADC Control Human IgG1-vcMMAE is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAE and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is vcMMAE (HY-15575) .
Tilavonemab (ABBV-8E12) is a humanized anti-tauantibody that targets the extracellular form of pathological tau protein aggregates by binding to the N-terminal 25-30 amino acid residues of tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates, reduces the loss of brain volume, slows the progression of tau pathology, and improves cognitive abilities in transgenic mice expressing mutant human tau. Tilavonemab is used in Alzheimer's disease research .
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab also induces apoptosis and cycle arrest. Dalotuzumab in combination with other anticancer agents such as statins can enhance the antitumor activity of Dalotuzumab in vitro and in vivo .
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct comprised of a CD19-specific antibody domain fused to a trimerized extracellular domains of human 41BBL. Englumafusp alfa promotes CD19-specific 4-1BB cross-linking on the surface of T and NK cells .
Tarlatamab (AMG-757) is a bispecific T-cell engager (BiTE) antibody targeting delta-like ligand 3 (DLL3). DLL3 is a target that is selectively expressed in small-cell lung cancer (SCLC) tumors, but with minimal normal tissue expression. Tarlatamab has the KDs of 0.64 nM and 0.50 nM for human and nonhuman primate (NHP) DLL3, respectively. Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC research .
AgAuSe-COOH (1000 nm) is a fluorescent quantum dot that emits fluorescence in the near-infrared II region, with an emission peak reaching 1000 nm. AgAuSe-COOH (1000 nm) has the advantages of narrow band gap, large Stokes shift, and good photostability. AgAuSe-COOH (1000 nm) can bind proteins, antibodies, peptides, PEG, etc., and can be widely used in the field of biological imaging.
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .
Masavibart (ZRC3308-A7) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 (HY-145643) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
Nepuvibart (ZRC3308-B10) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Nepuvibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Nepuvibart can be used in combination with ZRC3308-A7 (HY-145642) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA)antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice .
ADC Control Human IgG1-Deruxtecan (DAR 4) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
ADC Control Human IgG1-vcMMAF is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAF and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is MC-Val-Cit-PAB-MMAF (vcMMAF; HY-112786) .
β Amyloid (1-14), human is a peptide fragment of β-amyloid protein (Aβ), which is obtained by hydrolysis of Aβ1-40 peptide by catalytic antibody light chain #7TR. β Amyloid (1-14), human can be used for Alzheimer's disease research .
PROTAC BRD4 Degrader-12 (compound 9c) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-12 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.39 nM and 0.24 nM, respectively .
CEX Cation-exchange resin 1 is an ion exchange chromatography resin based on monodisperse polystyrene/divinylbenzene (PS-DVB). The particle size of CEX Cation-exchange resin 1 is 50μm and the ligand is -CH2CH2CH2SO3-. CEX Cation-exchange resin 1 can be used for the separation and purification of antibodies, VLPs, viruses and proteins .
IgdE protease is a cysteine protease, which is initially isolated from Streptococcus agalactiae. IgdE protease digests monoclonal antibodies (mAbs) of the IgG1 type specifically at their upper hinge region, produces Fc/2, hinge peptide dimers, and Fab fragment. IgdE protease can be used in disulfide bonds and free thiol analysis, as it requires no reducing agents for cleavage .
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al .
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC50 of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC50 values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma .
Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively .
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research .
Pabinafusp alfa (JR-141) is a transferrin receptor-targeting antibody consisting of Iduronate 2-sulfatase (HY-P76399) and an anti-human transferrin receptor antibody. Pabinafusp alfa is blood-brain permeable and prevents heparan sulfate (HS) deposition in the central nervous system of mucopolysaccharidosis II (MPS II) mice. Pabinafusp alfa improves learning and prevents central nervous system neuronal damage in mice .
Hydroxy-PEG10-Boc is extacted from patent CN108707228 (example 0024) . Hydroxy-PEG10-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG10-Boc can be conjugated to Paclitaxel (HY-B0015) or docetaxel (HY-B0011) .
Tetramethylrhodamine-5-isothiocyanate is a potent fluorescent dye. Tetramethylrhodamine-5-isothiocyanate can be used for label PG-M3 antibody for rapid diagnosis of acute promyelocytic leukemia (APL). Tetramethylrhodamine-5-isothiocyanate can be used as probe to quantify in vivo the biodistribution of PLGA (poly(lactic-co-glycolic) acid) and PLGA/chitosan nanoparticles .
Zagotenemab (LY3303560) is a humanised anti-tauantibody that selectively binds and neutralises tau deposits in the brain. Zagotenemab can be used in Alzheimer's disease research .
Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC50: 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer .
AEX Anion-exchange resin 1 is a strong anion exchange chromatography resin, based on monodisperse polystyrene/divinylbenzene (PS-DVB), with a particle size of 50 μm and an ionic ligand of –CH2N + (CH3)3. AEX Anion-exchange resin 1 can be used for the separation and purification of biological macromolecules such as proteins, antibodies, and viral vaccines.
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC50s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity .
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .
Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17 μM at pH 6.0). Crovalimab can block cleavage of C5 by the C5 convertase and inhibite the activity of a C5 variant (p.Arg885His). Crovalimab inhibits C5b-9 formation significantly in all three complement pathways, the classical pathway (CP), lectin pathway (LP), and alternative pathway (AP). Crovalimab has the potential for paroxysmal nocturnal hemoglobinuria (PNH) and complement-mediated diseases research .
Mal-PEG2-VCP-Eribulin consists the ADCs linker (Mal-PEG2-VCP) and Eribulin (HY-13442). Eribulin is a mechanistically unique microtubule inhibitor and Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Mal-PEG2-VCP-Eribulin is an Eribulin-based agent for antibody conjugates .
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity .
Sofituzumab vedotin (DMUC5754A) is a MMAE-containing anti-MUC16antibody-drug conjugate (ADC) with a protease-cleavable linker. Sofituzumab vedotin can be used for the research of cancer .
Phospholipid-PEG-Biotin (MW 1000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 3400) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 10000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 20000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
PROTAC BRD4 Degrader-9 (compound 8a) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-9 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.86 nM and 7.6 nM, respectively .
Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation .
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) .
Tabituximab barzuxetan (exclude Y90) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101). Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research .
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal is a glucocorticoid receptor agonist. Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal can be used in anti-CD40 antibody agent conjugate (ADC). Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal can be used for the research of inflammation and immune regulation .
Valanafusp alfa (AGT-181) is a chimeric monoclonal antibody that fuses human α-L-iduronidase (IDUA) and targets the human insulin receptor (HIR). Valanafusp alfa has brain penetrating properties, making it useful for research on mucopolysaccharidosis type I (MPS I) .
Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1 .
Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to antigenic site III. Zamerovimab can be used in rabies studies .
SCH 40120 is a potent leukotriene inhibitor with antiinflammatory effects. SCH 40120 suppresses T cell proliferative responses, antigen-specific and poly-clonally-induced in vitro antibody responses. SCH 40120 suppresses an edematous response and inhibits the recruitment of circulating neutrophils into sites of inflammation. SCH 40120 is proming for rasearch of anti-psoriatic agents .
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs .
Ziltivekimab (COR-001) is a humanized monoclonal antibody against IL-6 that effectively reduces serum CRP levels. Ziltivekimab possesses anti-inflammatory activity and can be used in research related to chronic systemic inflammation associated with chronic kidney disease (CKD) and cardiovascular diseases such as atherosclerosis .
Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma .
Fmoc-DAP-N3 is a click chemistry reagent containing an azide group. Fmoc-DAP-N3 is a short, linear spacer molecule with Fmoc protected amino function. Fmoc-DAP-N3 can be used in click conjugation and amid bond formation either with small molecules or for bioconjugation with proteins and antibodies . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
Efzofitimod is a splice variant of the aminoacyl-tRNA synthetase HARS1, which is fused with the Fc segment of a human antibody. Efzofitimod targets the neuronal phospholipid NRP2 (neuropilin-2) and has anti-inflammatory and immunomodulatory activities. Efzofitimod can downregulate the innate and adaptive immune responses in inflammatory disease states, suppressing indirect lung disease (ILD) .
8-Mercaptoguanosine is an immunoadjuvant that affects the in vivo antibody response to the T-cell-independent antigen TNP-Ficoll. 8-Mercaptoguanosine enhances IgG1, IgG2, and IgG3 antibody responses, but has no effect on IgM antibody responses. 8-Mercaptoguanosine also enhances antibody responses to very weak antigens such as pneumococcal polysaccharide and restores antibody responses in immunodeficient xid mice that are non-reactive to TNP-Ficoll .
Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. Mertansine can be attached to a monoclonal antibody with a linker to create an antibody-drug conjugate (ADC) .
Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
Tomaymycin DM, a DNA alkylator, is a derivative of Tomaymycin, it is a PBD dimer, which is attached to tumor targeting antibodies to create antibody-drug conjugates (ADCs).
STING agonist-20-Ala-amide-PEG2-C2-NH2 is an active scaffold comprising a stimulator of interferon genes (STING). STING agonist-20-Ala-amide-PEG2-C2-NH2 can be used to synthesize immune-stimulating antibody conjugate (ISAC). STING agonist-20-Ala-amide-PEG2-C2-NH2 can be used for the research of cancer .
PF-303 is a potent, oral inhibitor of Bruton's tyrosine kinase (BTK) (IC50=0.64 nM). The melamine portion of PF-303 forms a covalent bond with BTK's Cys481, which is reversible and exhibits a high selectivity compared to irreversible covalent BTK inhibitors. PF-303 can be used to model and study the effects of BTK inhibition on the mature immune system, including effects on B-cell subsets, antibody responses, and T-cell-mediated activation .
Dap-NE hydrochloride is a dipeptide hydrochloride and a cleavable ADC Linker.Dap-NE hydrochloride can be used to connect Antibody and toxin molecules (Cytotoxin) to synthesize Antibody-Drug Conjugates (ADCs) .
STING agonist-20-Ala-amide-PEG2-C2-NH2 (Compound 30b) TFA is an active scaffold comprising a stimulator of interferon genes (STING). STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA can be used to synthesize immune-stimulating antibody conjugate (ISAC). STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA can be used for the research of cancer .
DM4-SMe is a metabolite of antibody-maytansin conjugates (AMCs) and a tubulin inhibitor, and also a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM4-SMe inhibits KB cells with an IC50 of 0.026 nM .
DGN549-L is a DNA alkylator and can be utilized for antibody conjugation at lysine residues. DGN549-L can be used in the synthesis of antibody-drug conjugates (ADCs) .
NMS-P945 is an ADC linker that can be used in the synthesis of antibody-drug conjugates (ADCs). NMS-P945 is suitable for conjugation to mAbs with reproducible Drug Antibody Ratio (DAR) >3.5 .
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .
Fmoc-N-(2-Boc-aminoethyl)-Gly-OH is a Fmoc-protected glycine derivative that can be used in antibody agent coupling (ADC) synthesis. ADC consists of antibodies that are linked to ADC cytotoxins via ADC junctions[1].
GPSVFPLAPSSK- 13C6 is the 13C labeled GPSVFPLAPSSK. GPSVFPLAPSSK is an IgG1 signature peptide of anti-SARS-CoV-2 antibodies. GPSVFPLAPSSK can be used for the quantification of the specific isolation of anti-SARS-CoV-2 antibodies .
Telisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used in cancer research .
Brentuximab vedotin solution is the solution form of Brentuximab vedotin (HY-P99107). Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE) .
DGKζ-IN-1 (compound 9) is an inhibitor of DGKζ. DGKζ-IN-1 can be used for research in cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody .
Benzyl 2-cyclopropyl-2-hydroxyacetate is an intermediate in the synthesis of ADC linker.The linker composed of Benzyl 2-cyclopropyl-2-hydroxyacetate can be coupled to Exatecan (HY-13631) and combined with antibodies (such as antibody hu2F7) .
CL2E-SN-38, a highly releasable and structurally stable antibody-SN-38-conjugate, is a part of the antibody drug conjugate (ADC). SN-38, the active metabolite of Irinotecan from camptothecins, is an Topoisomerase I inhibitor .
Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) consisting of a humanized immunoglobulin (IgG4) antibody directed against CD33 that is conjugated to the cytotoxic drug Calicheamicin (HY-19609). Calicheamicin is a cytotoxic antibiotic. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia (AML) .
CL2E-SN-38 TFA, a highly releasable and structurally stable antibody-SN-38-conjugate, is a part of the antibody drug conjugate (ADC). SN-38, the active metabolite of Irinotecan from camptothecins, is an Topoisomerase I inhibitor .
MC-Val-D-Cit-PAB-PNP is a cleavable peptide linker molecule used in the synthesis of antibody-drug conjugates (ADCs). MC-Val-D-Cit-PAB-PNP contains a maleimidocaproyl (Mc) group that can be conjugated to an antibody and a p-nitrophenol (PNP) group that allows the peptide to be linked to antitumor compounds.
Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer .
Maytansinoid B is a kind of ADC Cytotoxin. Maytansinoid B can be used to conjugates with antibodies to form antibody-drug conjugates (ADCs). Maytansinoids are known as antimitotic agents, binding to tubulin and inhibiting microtubule assembly. Maytansinoids induces G2/M arrest in the cell cycle to induce apoptosis .
Methylthiomcresol-succinaldehydic acid is a fenthion hapten that can be used for immunoreagent production (protein conjugates and polyclonal antibodies) .
PROTAC ERα Degrader-5 (compound LP2) consists an ADC linker and a PROTAC, whcih can be conjugated to an antibody to form PACs. PROTAC ERα Degrader-5 conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
DM3-SMe is a maytansine derivative and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM3-SMe shows highly cytotoxic activity in vitro with an IC50 of 0.0011 nM .
PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
PROTAC ER Degrader-2 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
CY5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy2 iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
CY7 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Malonylurea-cyclopentene-butanoic acid is a hapten. Malonylurea-cyclopentene-butanoic acid can be used as probe of antibody response and immunorecognition .
Glembatumumab vedotin (CDX-011) is an ADC(antibody-drug conjugates (ADCs)) comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects .
Fmoc-Gly-NH-CH2-O-Cyclopropane-CH2COOH is an intermediate in the synthesis of ADC linker.The linker composed of Benzyl 2-cyclopropyl-2-hydroxyacetate can be coupled to Exatecan (HY-13631) and combined with antibodies (such as antibody hu2F7) .
Polatuzumab vedotin solution is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. Polatuzumab vedotin solution has the potential for the research of Large B-cell lymphomas (LBCL) .
CY7-SE is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy2-SE iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
CY7-SE triethylamine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy5.5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy7.5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cyanine5.5 maleimide chloride is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Sulfo-Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy5.5 TEA is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy5.5 acetate is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy3 NHS ester bromide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Sulfo-Cy5-Mal is a fluorescent dye with the form of active ester that reacts with thiol groups in proteins to form stable conjugates. Sulfo-Cy5-Mal that can be used to label protein .
DGKζ-IN-4 is a DGK-zeta inhibitor. DGKζ-IN-4 can be used as an active component of pharmaceutical compositions. DGKζ-IN-4 is used to treat cancers associated with immune cell activation or cancers resistant to anti-PD-1 antibody/anti-PD-11 antibody treatment .
Mc-Val-Cit-PAB-Cl is a cleavable ADC linker. Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE with IC50s of 3.3 and 0.95 nM for BJAB and WSU cell lines in cytotoxicity assay).
6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
ATTO 590 Streptavidin is a streptavidin derivative of ATTO 590, it can label protein or antibody, the maximum excitation/emission wavelength: 594/622 nm.
ATTO 700 Streptavidin is a streptavidin derivative of ATTO 700, it can label protein or antibody, the maximum excitation/emission wavelength: 700/716 nm.
ATTO 594 Streptavidin is a streptavidin derivative of ATTO 594, it can label protein or antibody, the maximum excitation/emission wavelength: 603/626 nm.
ATTO 633 Streptavidin is a streptavidin derivative of ATTO 633, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
ATTO 565 Streptavidin is a streptavidin derivative of ATTO 565, it can label protein or antibody, the maximum excitation/emission wavelength: 564/590 nm.
ATTO 610 Streptavidin is a streptavidin derivative of ATTO 610, it can label protein or antibody, the maximum excitation/emission wavelength: 616/633 nm.
ATTO 725 Streptavidin is a streptavidin derivative of ATTO 725, it can label protein or antibody, the maximum excitation/emission wavelength: 728/751 nm.
ATTO 620 Streptavidin is a streptavidin derivative of ATTO 620, it can label protein or antibody, the maximum excitation/emission wavelength: 620/642 nm.
ATTO 647 Streptavidin is a streptavidin derivative of ATTO 647, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
ATTO 740 streptavidin is a streptavidin derivative of ATTO 740, it can label protein or antibody, the maximum excitation/emission wavelength: 743/763 nm.
ATTO 488 streptavidin is a streptavidin derivative of ATTO 488, it can label protein or antibody, the maximum excitation/emission wavelength: 500/520 nm.
ATTO 532 streptavidin is a streptavidin derivative of ATTO 532, it can label protein or antibody, the maximum excitation/emission wavelength: 532/552 nm.
ATTO 550 streptavidin is a streptavidin derivative of ATTO 550, it can label protein or antibody, the maximum excitation/emission wavelength: 554/576 nm.
ATTO 514 streptavidin is a streptavidin derivative of ATTO 514, it can label protein or antibody, the maximum excitation/emission wavelength: 511/531 nm.
ATTO 665 streptavidin is a streptavidin derivative of ATTO 665, it can label protein or antibody, the maximum excitation/emission wavelength: 663/680 nm.
ATTO 680 streptavidin is a streptavidin derivative of ATTO 680, it can label protein or antibody, the maximum excitation/emission wavelength: 681/698 nm.
Proteins separation resin is a hydrophobic interaction chromatography resin that can be used in the monoclonal antibody purification (Particle size: 65 μm) .
Mannosamine-lipoic acid adduct is a hapten. Mannosamine-lipoic acid adduct with hsIgG conjugation significantly reduces the antibody immune response against hsIgG .
Tyramide Amplification Buffer is a ready-to-use buffer primarily intended for immunostaining of cells and tissues by the technique of tyramide signal amplification (TSA). TSA Technology is based on a tyrosinase labeling system that reacts a tyrosine-labeled antibody with a fluorescently labeled tyramide using peroxidase to form a highly amplified fluorescent signal. For example, horseradish peroxidase (HRP) can catalyze the reaction of tyrosine and hydrogen peroxide under milder conditions to generate epoxy groups. Epoxy groups promote the binding of tyramide to adjacent amino acids to form fluorescently labeled products .
Mirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor α (FRα) antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A. Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage .
Cy5.5-SE (Cyanine5.5 NHS ester) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
EDTA-p-Bromoacetamido benzyl ((S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid) is a compound of EDTA and phenylbromoacetamide that can be coupled to antibodies .
Procymidone, a pesticide, is an immunogen hapten that can be combined with cOVA (carrier protein) to produce polyclonal antibodies. Procymidone has antifungal activity .
p-Nitrobenzyl mesylate (4-Nitrobenzyl mesylate; para-Nitrobenzyl mesylate) is a reagent used to alkylate phosphorothioates, forming phosphorothioate epitopes that can be recognized by specific antibodies.
COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) containing mRNA encoding COVID-19 Spike Protein , suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 Spike Protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 Spike Protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 Spike Protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
Tisotumab vedotin is an antibody drug conjugate (ADC) targeting tissue factor (TF), formed by covalently linking a fully human monoclonal antibody (TF-011) against TF with the microtubule disruptor Monomethyll Auristatin E (MMAE) (HY-15162). Tisotumab vedotin has immunomodulatory and anti-tumor activities, and can be used in the study of advanced or metastatic solid tumors such as cervical cancer .
ADC Control Human IgG1-Deruxtecan (DAR 8) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells .
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3E. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines .
Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM) .
Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted research of cancer .
ATTO 390 maleimide is a maleimide ester derivative of ATTO 390, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 390/476 nm.
ATTO 425 Maleimide is a maleimide ester derivative of ATTO 425, which can be used to label proteins or antibodies. The maximum excitation emission wavelength: 439/489 nm.
ATTO 465 Maleimid is a maleimide ester derivative of ATTO 465, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 453/506 nm.
ATTO 594 Maleimid is a maleimide ester derivative of ATTO 594, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 603/626 nm.
ATTO 633 Maleimid is a maleimide ester derivative of ATTO 633, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
ATTO 610 NHS-Ester is an activated ester derivative of ATTO 610, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 616/633 nm.
ATTO 610 Maleimid is a maleimide ester derivative of ATTO 610, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 616/633 nm.
ATTO 725 NHS-Ester is an activated ester derivative of ATTO 725, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
ATTO 725 Maleimid is a maleimide ester derivative of ATTO 725, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
ATTO 620 NHS-Ester is an activated ester derivative of ATTO 620, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 620/642 nm.
ATTO 620 Maleimid is a maleimide ester derivative of ATTO 620, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 620/642 nm.
ATTO 647 Maleimid is a maleimide ester derivative of ATTO 647, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
ATTO 665 maleimid is a maleimide ester derivative of ATTO 665, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 663/680 nm.
ATTO 514 maleimid is a maleimide ester derivative of ATTO 514, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 511/531 nm.
Cy5.5-SE (Cyanine5.5 NHS ester) DIPEA is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
Cy5.5-SE TEA (Cyanine5.5 NHS ester TEA) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
D-threo-PDMP hydrochloride is a glucosylceramide (GlcCer) synthase inhibitor that inhibits glucosylceramide (GlcCer) and lactosylceramide (LacCer) levels in B16 melanoma cells. D-threo-PDMP hydrochloride lacks reactivity to the other two surface antigens anti-melanoma monoclonal antibodies M562 and M622 and the major histocompatibility antigen anti-H-2KbDb monoclonal antibody, so it is specific for B16 melanoma sex .
Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase .
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis .
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer .
DM3 (Maytansinoid DM3) is a maytansine analog bearing disulfide or thiol groups and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs) .
MMAE-SMCC is a agent-linker conjugate for ADC. MMAE-SMCC is composed of a potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody agent conjugate.
GGFG-amide-glycol-amide-Exatecan (Intermediate 2) is an Exatecan (HY-13631) derivative and can be used in the synthesis of antibody-drug conjugates (ADCs) .
Dicamba 1-azidopropane (DCn) is an immunizing and heterologous hapten. Dicamba 1-azidopropane can be used to generate monoclonal antibodies specific of Dicamba .
Depatuxizumab mafodotin is an antibody-drug conjugate (ADC) that specifically targets the epidermal growth factor receptor (EGFR). Depatuxizumab mafodotin can be used for cancer research .
AXC-715 (T785) hydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1 . AXC-715, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants .
AXC-715 (T785) trihydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1 . AXC-715 trihydrochloride, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants .
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
SHR-A1201 is a HER2-targeting antibody-drug conjugate (ADC). SHR-A1201 is composed of a humanized anti-HER2 antibody (HY-P9907), a linker SMCC (HY-42360), and a microtubulin inhibitor payload Mertansine (HY-19792). SHR-A1201 can be used for research in HER2-positive breast cancer .
Boc-Gly-Gly-Phe-Gly-OH TFA, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
Eicosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Eicosanedioic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis
Hemiasterlin ((-)-Hemiasterlin) is an antimitotic marine natural product with potent anticancer effcts. Hemiasterlin can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs) .
Acitazanolast is an orally active antiallergic agent, can inhibit histamine release. Acitazanolast can be used in study of type I anaphylaxis (immediate) caused by IgE antibodies .
Glucocorticoid receptor agonist-4 (Compound Preparation 5) is a glucocorticoid receptor agonist that can be conjugated to TNF-α antibodies for the study of autoimmune and inflammatory diseases .
DL002 is a ADC linker that can be used to synthesize antibody-drug conjugates containing BCL-2 family protein degraders, and it's used in tumor research .
M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A .
M2e, human, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A, which is a valid and versatile vaccine candidate to protect against any strain of human influenza A .
Val-Cit-PAB-MMAF is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAF contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin polymerization inhibitor MMAF (HY-15579)
Val-Cit-PAB-MMAF sodium is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAF sodium contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin polymerization inhibitor MMAF (HY-15579)
7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) is a Camptothecin (HY-16560) analogue. 7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) is a ADC cytotoxin that can be used for synthesis of ADCs, and for cancer research .
Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
Maleimide-PEG8-Val-Ala-PAB is an ADC linker composed of the cleavable Val-Ala-PAB (HY-125933) linker and the probe molecule Maleimide (HY-W007324). Maleimide-PEG8-Val-Ala-PAB can be used to connect Cetuximab (HY-P9905) monoclonal antibody and CDK inhibitor SNS-032 (HY-10008) to synthesize antibody-drug conjugates (ADCs) .
Noraramtide (BHV-1100) is an antibody recruitment molecule. Noraramtide can specifically bind to CD38 molecules to recruit natural killer (NK) cells. Noraramtide enhances the ability of NK cells to kill tumor cells through antibody-dependent cellular cytotoxicity (ADCC). This mechanism allows NK cells to more effectively recognize and eliminate tumor cells while avoiding mutual killing between NK cells. Noraramtide can be used for the study of autologous cancer immunity .
Trastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC). Trastuzumab rezetecan is composed of a humanized anti-HER2 antibody (HY-P9907), a cleavable linker MC-Gly-Gly-Phe-Gly (HY-44246), and a topoisomerase I inhibitor payload Rezetecán (HY-147408). Trastuzumab rezetecan can be used for research in HER2-positive breast cancer .
Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis .
Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium .
Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC) .
Lebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4Rα/IL-13Rα1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases .
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20 + non-Hodgkin lymphomas (NHL) .
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .
Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities .
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants .
Anumigilimab (CSL-324) is an human IgG4 mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation .
Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) .
Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment .
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .
Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM) .
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo .
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .
Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis .
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research .
Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept binds to GAS6 and inhibits the interaction of GAS6 with AXL, thereby substantially reducing AXL signaled invasion and migration of highly metastatic cells in vitro and inhibiting metastatic disease in nonclinical models of aggressive human cancers. Batiraxcept is available for studies in advanced or metastatic clear cell renal cell carcinoma (ccRCC) and platinum sensitive recurrent ovarian cancer .
Goflikicept (RPH 104) is a hybrid protein that selectively binds and inactivates both circulating IL-1ß and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI) .
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL) .
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection .
Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection .
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
Ipafricept (OMP-54F28; FZD8-Fc) is a first class recombinant fusion protein with the extracellular part of the human frizzled-8 receptor fused to a human IgG1 Fc fragment that binds Wnt ligands, which blocks Wnt signaling. Ipafricept reduces tumor growth and results in a decrease in both liver and lung metastases combined with Gemcitabine (HY-17026) in pancreatic cancer mouse models. Ipafricept shows solid tumor inhibition activity with well tolerance, such as desmoid tumor, germ cell cancer, ovarian cancer .
Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions .
Ramatercept (ACE-031) is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy .
Recifercept (TA-46) is a soluble, recombinant fibroblast growth factor receptor 3 (FGFR3) molecule. Recifercept can be used as a decoy/ligand trap to decrease the amount of fibroblast growth factors that can bind to mutant FGFR3 receptors. Recifercept can be used for the research of achondroplasia .
Ontorpacept (TTI-621) is a soluble fusion protein that consists of the human SIRPα N-terminal (1-118) linked to the Fc region of human IgG1. The N-terminal (1-118)-fragment of ontorpacept is a binding domain for CD47 which is an inhibitor of phagocytosis by macrophages. Ontorpacept is a CD47-blocking checkpoint inhibitor with antitumor activity .
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment .
Denosumab (anti-TNFSF11) is a RANKL inhibitor that is effective against giant cell tumor of bone (GCTB).Denosumab eliminates RANK-positive tumor giant cells and reduces the relative content of proliferative, dense-cell tumor stromal cells .
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101; HY-12522), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research .
Dapirolizumab is a monoclonal antibodi against CD40 ligand. Dapirolizumab targets CD40L, blocks its interaction with CD40 receptors, and inhibits adaptive immune activation. Dapirolizumab attenuates systemic lupus erythematosus .
ABBV-383 (ABBV-383) is a BCMA × CD3 bispecific T-cell engager (BiTE) that can inhibit the activity of B-cell maturation antigen (BCMA) and activate the T-cell surface glycoprotein CD3 complex. ABBV-383 can be used for research in multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases .
DC41 is a DC1 derivative. DC1, a simplified analogue of CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer .
RS09 is a LPS peptide mimic serves as a candidate to be considered as a new class of TLR4 agonist adjuvant. RS09 increases antibody production in a vaccine setting .
LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
LEESGGGLVQPGGSMK acetate, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK acetate can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
Docosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Docosanedioic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Biotin-C2-maleimide is an antibody conjugate reagent, can bind to many biomolecules without significantly changing the biological activity of the target molecule .
Atrazine-3-mercaptopropanoic acid is a hapten. The IC50 value of polyclonal antibody (PcAb) 1 with coating Atrazine-3-mercaptopropanoic acid is 7.5 ng/mL .
N-Carbobenzoxy-D-homoserine (N-(Benzyloxycarbonyl)-D-homoserine) is D-homoserine with N-Carbobenzoxy protecting group, which can be used to synthesize Antibody-Drug Conjugates (ADCs).
AF488 amine is a bright, green-fluorescent dye used for labeling molecule such as antibodies. AF488 exhibits the λem and λex wavelength of 520 nm and 470 nm, respectively .
Nampt-IN-14 (example 3) is a potent NAMPT inhibitor with an IC50 of 0.2 nM. Nampt-IN-14 can be used in the synthesis of Antibody-drug Conjugate (ADC) .
VCP-Eribulin consists the ADCs linker (VCP) and Eribulin . Eribulin is a mechanistically unique microtubule inhibitor for cancer . VCP-Eribulin is an Eribulin-based agent for antibody conjugates .
Bis- PEG9- acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis- PEG9- acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity .
INX-SM-56 is a cytotoxin that can be used for the synthesis of anti-VISTA antibody agent conjugate. VISTA: V-region Immunoglobulin-containing Suppressor of T cell Activation .
trans-Stilbene-NHCO-(CH2)3-acid, a trans-stilbene hapten, can be used to elicit a panel of monoclonal antibodies that display a range of fluorescent spectral behavior .
N-Carbobenzoxy-L-homoserine (N-(Benzyloxycarbonyl)-L-homoserine) is L-homoserine with N-Carbobenzoxy protecting group, which can be used as a linker (ADC Linker) for the synthesis of Antibody-Drug Conjugates (ADCs).
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity .
6-TAMRA-d12 free acid is a deuterated-labeled 6-TAMRA, which is widely used in the preparation of fluorescent antibodies and as a fluorescent group for immunohistochemical avidin derivatives.
Lomifylline is a derivative of Xanthine (HY-W017389). Lomifylline can be used in research of sepsis and septic or endotoxic shock, when combined with an antibody to TNF or a TNF binding fragment .
AMCC-DM1 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker AMCC to make antibody drug conjugate. AMCC is a noncleavable linker .
Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine is an immune stimulator antibody conjugate (ISAC) comprising an anti-human epidermal growth factor receptor 2 (HER2)antibody, a STING agonist (ADU-S100) and a linker. Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine can be uesd for cancer research (WO2018200812A1; example 5) .
DC1, an analogue of the minor groove-binding DNA alkylator CC-1065, is a ADC Cytotoxin. DC1 can be used in synthesis of antibody-drug conjugates for the targeted treatment of cancer.
Duocarmycin GA is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin GA can be used against multi-agent resistant cell lines.
Duocarmycin MB is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin MB can be used against multi-agent resistant cell lines.
Duocarmycin MA is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin MA can be used against multi-agent resistant cell lines.
LEESGGGLVQPGGSMK TFA, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK TFA can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
AEEA-AEEA is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). AEEA-AEEA is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Phosphoric acid (sodium hydrate),≥99.0% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, as a laxative, and in combination with other sodium phosphates
SMP-93566 is a kind of antibody-drug conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer .
Potassium dihydrogen phosphate (Potassium phosphate monobasic), for molecular biology, ≥ 99% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates .
Mal-PEG4-VC-PAB-DMEA TFA is a degradable ADC linker containing a maleimide group and can be used to synthesize antibody conjugate active molecules (ADCs) .
Sulfo CY5.5 hydrazide is a sulfonated version of Cy5.5, which can be used to label antibodies, proteins, etc., and for in vivo NIR (far-infrared) imaging.
GD-9501-TFA is an auristatin S-based ADC linker with effective off-target toxicity characteristics, which can be used for the preparation of antibody-drug conjugates (ADCs) .
Seco-Duocarmycin TM is a DNA alkylator agent belonging to Duocarmycins family that inhibits DNA synthesis. Seco-Duocarmycin TM is a cytotoxic agent, used as the cytotoxic component in antibody-drug conjugates (ADC) [1].
N-Boc-diethanolamine is an Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-diethanolamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DGN462, a potent DNA-alkylating agent, shows anti-tumor activity, such as acute myeloid leukemia (AML). DGN462 can be used as a cytotoxic component of antibody-drug conjugates (ADCs) .
Fmoc-Lys-OH hydrochloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys-OH hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
SC209, an ADC cytotoxin extracted from patent WO2021247798, is used in synthesis of anti-EGFRantibody-drug conjugate ADC. SC209 is the payload of STRO-002 .
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan is a pharmaceutical composition containing antibody agent conjugate (ADC). (extracted from patent WO2021190581 Example 1-8) .
CypK (N-Cyclopropene-L-Lysine), a cyclopropene derivative of lysine, is efficiently incorporated into antibodies through genetic-code expansion. CypK is a minimal bioorthogonal handle for the creation of stable therapeutic protein conjugates .
Dazostinag (TAK-676 free base) is an agonist of stimulator of interferon genes (STING) protein with antineoplastic activity. Dazostinag can serve as a playload to synthesis antibody-drug conjugates (ADCs) .
(R)-NODAGA-tris(t-Bu ester) ((R)-NODAG) is a NODAGA derivative. (R)-NODAGA-tris(t-Bu ester) can be used to label peptides, antibodies, etc., and subsequently radiolabeled for PET imaging .
(S)-NODAGA-tris(t-Bu ester) ((S)-NODAG) is a NODAGA derivative. (S)-NODAGA-tris(t-Bu ester) can be used to label peptides, antibodies, etc., and subsequently radiolabeled for PET imaging .
Cy3B NHS ester is a fluorescent dye compound that is commonly used in biomarking and fluorescent labeling experiments, especially for labeling biomolecules containing amino functional groups (amine groups), such as proteins, antibodies or peptides.
Brigimadlin intermediate-1 is an intermediate of the E3 ubiquitin protein ligase MDM-2 inhibitor Brigimadlin (HY-152859) and can be used to synthesize Antibody-Drug Conjugates (ADCs) .
MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH is an ADC linker that can be combined with the cytotoxic Camptothecin (HY-16560) to form an ADC-related drug-linker conjugate (Drug- Linker Conjugates for ADC).MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH is conjugated to Camptothecin, which can further bind to the antibody Trastuzumab (HY-P9907) to form Antibody-Drug Conjugates (ADCs) .
MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH is an ADC linker that can be combined with the cytotoxic Camptothecin (HY-16560) to form ADC-related drug-linker conjugates (Drug-Linker Conjugates for ADC ).MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH is conjugated to Camptothecin, which can further bind to the antibody Trastuzumab (HY-P9907) to form Antibody-Drug Conjugates (ADCs) .
(+)-CBI-CDPI1 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI1 is an antibody agent conjugates (ADCs) toxin.
(+)-CBI-CDPI2 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI2 is an antibody agent conjugates (ADCs) toxin.
Duocarmycin DM, a DNA minor-groove alkylator, is an antibody agent conjugates (ADCs) toxin. Duocarmycin DM is based on its characteristic curved indole structure and a spirocyclopropylcyclohexadienone electrophile to act anticancer activity .
DM4-d6 is deuterium labeled DM4. DM4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody agent conjugate.
Mal-AMCHC-N-Propargylamide is a click chemistry reagent containing an azide group. Mal-AMCHC-N-Propargylamide can be a bio-conjugation reagent for antibody-agent-conjugate synthesis using Click-Chemistry .
MC-Gly-Gly-Phe-Boc is involved in the synthesis of antibody-drug conjugates (ADCs) to Trastuzumab (HY-P9907). MC-Gly-Gly-Phe-Boc can participate in cancer research .
Glycyllysine is a polypeptide that can be used in the synthesis of antibodies and amino acid type gemini surfactants. Glycyllysine has potential applications in modifying plasmid/gemini/lipid (P/G/L) nanoparticles transport carriers .
Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for Antibody-Drug Conjugates (ADCs) synthesis. Mal-Gly-PAB-Exatecan-D-glucuronic acid can be used for research of tumor research and diagnosis .
Exatecan-methylacetamide-OH (compound 6) is a Exatecan derivative with anticancer effects. Exatecan-methylacetamide-OH is an ADC cytotoxin that can be used to synthesize Antibody-Drug Conjugates (ADCs) (CN112125915A; compound 6) .
IMP 245 is a symmetric di-HSG bivalent hapten. IMP 245 has low toxicity, high affinity binding to available antibodies and absence of cross reactivity or non-specific binding with body components .
DEX-maleimide is a coupling agent that can be used to synthesize conjugates containing single-domain antibodies (VHH) conjugated with antigens and anti-inflammatory agents. DEX-maleimide can be used for research on autoimmune diseases .
MC-Gly-Gly-Phe-Gly-NH-CH2-O-amide-Eribulin (Compound 7) can be used as a linker-drug intermediate for the synthesis of antibody-drug conjugates (ADCs) .
Dimethyl-SGD-1882 (Dimethyl-PBD dimer) is a highly potent DNA alkylator, and is used as an antibody-drug conjugate (ADC) cytotoxin. PBD Dimer is a DNA alkylator which inhibits DNA replication .
Lorvotuzumab mertansine is an ADC consisting of a humanized N901 monoclonal antibody against CD56 bound to maytansinoid DM1 via a stable disulfide linker. Lorvotuzumab mertansine has antitumor activity .
SMCC-DM1 (DM1-SMCC) is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker SMCC to make antibody agent conjugate (ADC) .
Maleimide can be used for production of antibody-drug conjugate (ADC) which is used in cancer research. Maleimide also be leveraged for the preparation of fluorogenic probe, which is mainly used for the specific detection of thiol analytes .
Sulfo-PDBA-DM4 is a agent-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Sulfo-PDBA to make antibody agent conjugate (ADC). Sulfo-PDBA is a gluthatione cleavable linker.
JNJ4796 is an oral active fusion inhibitor of influenza virus, neutralizing influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion. JNJ4796 mimics the functionality of the broadly neutralizing antibodies (bnAbs) .
Tos-PEG12 is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). PEG12-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Tetraethylene glycol monotosylate is a cleavable and acylhydrazone-based ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetraethylene glycol monotosylate also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
N-(5-Hydroxypentyl)maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as Gemcitabine-O-Si(di-iso)-O-Mc (HY-130812) ) .
Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
Desmethyl Vc-seco-DUBA consists a cleavable ADC linker (Desmethyl Vc-seco) and a DNA alkylating agent (DUBA). Desmethyl Vc-seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs) .
2',3'-cGAMP-C2-SH is a cyclic di-nucleotide (CDN) that can be conjugated to antibodies or antigen-binding fragments targeting specific antigens in the microenvironment of diseased cells or tissue .
ΧΜΤ-1519 conjugate-1 (compound 31) is a linker for the HER-2 monoclonal antibody XMT-1519, which can be used to synthesize ADC and increase anti-tumor activity .
TAM558 is a payload molecule used for the synthesis of OMTX705. OMTX705 is a humanized anti-fibroblast-activating protein (FAP) antibody conjugated to the cytolysin TAM470 (HY-148128), with antitumor activity .
SMP-88480 is an Antibody-Drug Conjugates (ADCs). SMP-88480 is stable in mouse, monkey and human plasma and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer .
Fmoc-Val-Cit-PAB GMP is a GMP grade Fmoc-Val-Cit-PAB (HY-19318). Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
Preactivated PE-Cy5.5 Maleimide is a Preactivated PE-Cy5.5 Maleimide, which is a dye that can be used to label molecules such as dye that can be used to label molecules such as antibodies .
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs) . Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
MC-VC-PABC-C6-alpha-Amanitin is an antibody agent conjugate consisting of an anticancer toxin alpha-Amanitin (HY-19610) and a monoclonal antibody MC-VC-PABC-C6. Among them, alpha-Amanitin is a potent inhibitor of RNA polymerase IIα. MC-VC-PABC-C6-alpha-Amanitin accurately targets HER2 receptors, specifically recognizes HER2-positive tumor cells. It is widely used in breast cancer and gastric cancer research .
Anti-CD22-NMS249 is a CD22-targeting antibody-drug conjugate (ADC). Anti-CD22-NMS249 is composed of a humanized anti-CD22 antibody Pinatuzumab (HY-P99230), a cleavable linker (Mc-VC-PAB), and a DNA topoisomerase II inhibitor payload PNU-159682 (HY-16700). Anti-CD22-NMS249 can be used for research in non-Hodgkin lymphoma (NHL) .
MC-VA-PABC-MMAE is a agent-linker conjugate for ADC. MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE (HY-15162) .
2-[(4-Oxo-1,2,3-benzotriazin-3-yl)oxy]acetic acid (HBA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 2-[(4-Oxo-1,2,3-benzotriazin-3-yl)oxy]acetic acid can be combined with carrier proteins and used in antigen design .
6-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]hexanoic acid (MBH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]hexanoic acid can be combined with carrier proteins and used in antigen design .
6-(N-Phthalimidoylmethylthio)hexanoic acid (MFH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-(N-Phthalimidoylmethylthio)hexanoic acid can be combined with carrier proteins and used in antigen design .
2-(N-Phthalimidoylmethylthio)acetic acid (MFA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 2-(N-Phthalimidoylmethylthio)acetic acid can be combined with carrier proteins and used in antigen design .
3-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]propanoic acid (MBP) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 3-[(4-Oxo-1,2,3-benzotriazin-3-yl)methylthio]propanoic acid can be combined with carrier proteins and used in antigen design .
6-N-Phthalimidoy hexanoic acid (compound FH) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 6-N-Phthalimidoy hexanoic acid can be combined with carrier proteins and used in antigen design .
4-(N-Phthalimidoyl)butanoic acid (compound FB) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-(N-Phthalimidoyl)butanoic acid can be combined with carrier proteins and used in antigen design .
4-Ketobenztriazine-CH2COOH (compound BA) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 4-Ketobenztriazine-CH2COOH can be combined with carrier proteins and used in antigen design .
RL-6-Me-7-OH is a hapten that activates human and mouse MAIT cells (EC50=25µM). RL-6-Me-7-OH can be combined with carrier proteins and used in antigen design. RL-6-Me-7-OH can be used in inflammation and immunity research .
3-(((1,3-Dioxoisoindolin-2-yl)methyl)thio)propanoic acid (MFP) is a hapten with a carboxyl group at the end of its spacer arm, suitable for reacting with free amine groups of proteins. 3-(((1,3-Dioxoisoindolin-2-yl)methyl)thio)propanoic acid can be combined with carrier proteins and used in antigen design .
Macropa-NCS can be coupled with antibodies to form tumor-selective carrier molecules, which can be further combined with radionuclides as specific targeting cancer cell carriers, and is a linker-chelating agent in targeted alpha research (TAT) .
Bis-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG8-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Boc-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs .
H-Hyp-OMe hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). H-Hyp-OMe hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]<
Fmoc-Hyp(Bom)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Hyp(Bom)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs<
Boc-Hyp-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2]
H-cis-Hyp-OMe hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). H-cis-Hyp-OMe hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PR
H-Glu-OtBu is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). H-Glu-OtBu is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
Rezetecán (SHR9265) is a topoisomerase I inhibitor. In addition, Rezetecán can be used to synthesize Trastuzumab rezetecan, an antineoplastic agent. Rezetecán can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs) .
Procymidone (Standard) is the analytical standard of Procymidone. This product is intended for research and analytical applications. Procymidone, a pesticide, is an immunogen hapten that can be combined with cOVA (carrier protein) to produce polyclonal antibodies. Procymidone has antifungal activity .
MMAF (Monomethylauristatin F) hydrochloride is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
R(+)-Methylindazone (R(+)-IAA-94) is a potent indanyloxyacetic acid blocker of epithelial chloride channels. R(+)-Methylindazone inhibits Nef-sdAb19 (single-domain antibody) interaction and binds to negative factor (Nef) .
DGN549-C consists a cleavable ADC linker valine-alanine (va) and PBD dimer. DGN549 is a novel DNA-alkylating cytotoxic payload and can be used in the synthesis of antibody-agent conjugates (ADCs) .
Mal-PEG4-VC-PAB-DMEA is a cleavable ADC linker containing a Maleimide group. Mal-PEG4-VC-PAB-DMEA is used in the synthesis of antibody-drug conjugates (ADCs) .
Mal-PEG4-Val-Cit-PAB is a cleavable ADC linker containing a Maleimide group. Mal-PEG4-Val-Cit-PAB is used in the synthesis of antibody-drug conjugates (ADCs) .
Amino-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG9-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Mal-PEG1-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG1-NHS ester is PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Amino-Tri-(carboxyethoxymethyl)-methane is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-Tri-(carboxyethoxymethyl)-methan is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Bis-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Bromoacetyl-β-alanine is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs . N-Bromoacetyl-β-alanine is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Lys-Nε-SPDB-DM4 is a agent-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Lys-Nε-SPDB to make antibody agent conjugate (ADC) .
(R)-Azetidine-2-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). (R)-Azetidine-2-carboxylic acid is also a alkyl chain-based PROTAC linker that can be
Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(carboxyethoxymethyl)-methan hydrochloride is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
SN38-COOH is used for the synthesis of antibody-drug conjugates (ADCs). SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis .
DM-CO-(CH2)5-SMe is an anticancer agent derived from antibody-drug conjugates (ADC) metabolite with cytotoxicity to H1703, H1975, COLO704 and Colo720E cells .
Vari Fluor 750 Carboxylic acid (VF 750 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 555 Carboxylic acid (VF 555 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 647A Carboxylic acid (VF 647A Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 640 Carboxylic acid (VF 640 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 488 Carboxylic acid (VF 488 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 532 Carboxylic acid (VF 532 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 594 Carboxylic acid (VF 594 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 660 Carboxylic acid (VF 660 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 568 Carboxylic acid (VF 568 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 680 Carboxylic acid (VF 680 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Cyanazine-3-mercaptopropanoic acid (compound 6), a coating hapten, is a stable carrier-hapten complex. Polyclonal antibody obtained were with a high titer, with the IC50 of 10.2 ng/mL for Cyanazine-3-mercaptopropanoic acid .
Boc-Lys-PEG8-N-bis(D-glucose) (compound 89-5) is a drug linker that can be used in the synthesis of antibody-drug conjugates (ADCs) extracted from patent WO2023280227A2 .
(R)-TCB2 is the R-enantiomer of TCB2. TCB2 is a potent anti-human interleukin-2 antibody, facilitates heterodimeric IL-2 receptor signaling and improves anti-tumor immunity .
DM1-(PEG)4-DBCO is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DM1-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-Ahx-DM1 is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DBCO-PEG4-Ahx-DM1 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers .
Duocarmycin DM free base, a DNA minor-groove alkylator, is an antibody agent conjugates (ADCs) toxin. Duocarmycin DM free base is based on its characteristic curved indole structure and a spirocyclopropylcyclohexadienone electrophile to act anticancer activity .
m-PEG7-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG6-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG6-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG9-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG9-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG2-Tos is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG2-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
m-PEG2-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG2-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG3-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG3-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG4-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG5-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG5-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG8-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG8-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG4-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG7-MS is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-MS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG6-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
TCO-PEG4-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
TCO-PEG12-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG12-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Ponceau S (Acid Red 112) is a non-specific protein dye commonly used as a stain for Western blot. Ponceau S is used in an acidic aqueous solution that is compatible with antibody-antigen binding and dyes the proteins on the membrane red .
(4-NH2)-Exatecan, a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) (US20200306243A1, compound A) .
Boc-trans-D-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-trans-D-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
cis-4-Hydroxy-L-proline hydrochloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). cis-4-Hydroxy-L-proline hydrochloride is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Azetidin-3-ol hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azetidin-3-ol hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthes PROTAC.
TAM470 is a novel cytolysin, inhibiting tubulin polymerization and microtubule depolymerization. TAM470 can be used in the synthesis of OMTX705 as payload molecule, OMTX705 is a novel FAP-targeting antibody-drug conjugates (ADCs) with antitumor activity .
Tricine is widely used as a buffer in protein electrophoresis, nucleic acid analysis, and immunology, which can help adjust pH and stabilize chemical reactions. In addition, the compound can also be used in research in certain medical fields, such as in antibody detection and drug screening.
Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc (Example 2.28.6) is an ADC linker that can be used to synthesize antibody-conjugated active molecules (ADCs) .
E104 (compound 1) is a potent and selective TLR7 agonist. E104 can be delivered by antibody-drug conjugate (ADC) technology to elicit potent anticancer activity. E104 induces the activation of mouse macrophages and hPBMCs .
Fmoc-MMAF-OMe is an anticancer agent and tubulin polymerization inhibitor with an Fmoc protecting group. The active ingredient of Fmoc-MMAF-OMe, MMAF (HY-15579), is the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs) .
Dicamba-propionic acid (DCa3) is a heterologous hapten that can be used to develop high-affinity monoclonal antibodies (mAb) against Dicamba. The Dicamba-propionic acid- developed mAb can be used to determine the residual amount of Dicamba in environmental water samples .
NBDA (4-(α-N-L-alanine)-NBD) is a structural and functional analogue of the 2,4-dinitrophenyl group (DNP). NBDA can be used to detect and characterize antinitroaromatic antibodies, even in crude preparations, and possibly on cell surfaces .
MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
DNP-X acid (6-((2,4-Dinitrophenyl)amino)hexanoic acid), an amine-reactive building block for developing a probe, can be recognized by anti-DNP antibodies. DNP-X acid is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
Mal-Phe-C4-Val-Cit-PAB-DMEA is a cleavable ADC linker containing a Maleimide group. Mal-Phe-C4-Val-Cit-PAB-DMEA is used for making antibody-drug conjugate.
Biotin-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Biotin-PEG2-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
Mal-PEG1-acid is is a non-cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG1-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
m-PEG11-Amino is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG11-Amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
TFAX 568, SE is an orange fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 568, SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
Fmoc-Gly-Gly-D-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Gly-Gly-D-Phe-OH is the D-isomer of Fmoc-Gly-Gly-Phe-OH (HY-131833).
Fmoc-azetidine-3-carboxylic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Cyanine3 hydrazide dichloride is a carbonyl reactive dye. Cyanine3 hydrazide dichloride allows the labelling of various carbonyl-containing molecules such as antibodies and other glycoproteins after oxidation by periodate, proteins or reducing sugars after oxidative stress or deamination .
Fmoc-Gly-Gly-Phe-OH GMP is a GMP grade Fmoc-Gly-Gly-Phe-OH (HY-131833). Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885 (Comp Ie) is a neodegrader conjugate, can be used in the synthesis of antibody neoDegrader conjugate (AnDC) .
5-Lipoxygenase blocking peptide (Human/rat 5-LO 130-149) is a specific sequence fragment of 5-lipoxygenase (5-LOX), which can be utilized to prepare an antibody against 5-LOX .
Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains) . Abatacept is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive. Etanercept shows efficacy against rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis .
Corifollitropin alfa (Org 36286) is a long-acting recombinant follicle-stimulating hormone (FSH) analog. Corifollitropin alfa is a FSH Receptor agonist with an EC50 of 5.0 pM. Corifollitropin alfa stimulates ovulation and can be used in the research of infertility .
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
Tebentafusp (IMCgp100) is a bispecific fusion protein to target gp100 peptide-HLA-A*02:01 (a melanoma-associated antigen). Tebentafusp guides T cells to kill gp100-expressing tumor cells via a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain. Tebentafusp leads to inflammatory cytokines and cytolytic proteins production, resulting in the direct lysis of tumour cells .
Sozinibercept (OPT 302; VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats .
Abicipar pegol (AGN-150998, MP0112) is an anti-VEGF DARPin molecule, a novel class of small proteins containing ankyrin repeat domains engineered to bind with high specificity and affinity to target proteins. Abicipar pegol effectively inhibits angiogenesis and vascular permeability and is used in the study of diseases related to ocular inflammation by intravitreal injection, reducing mean retinal thickness and leakage area .
Eflepedocokin alfa is a recombinant fusion protein with potential cell protective activity. Eflepedocokin alfa consists of human IL-22 fused to human IgG2-Fc domain. Eflepedocokin alfa leads to the activation of IL-22/IL-22R-mediated signal transduction pathways as well as STAT3. Eflepedocokin alfa plays a role in immune response and bacterial infection, enhancing intestinal barrier function, intestinal immunity, and tissue repair .
Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes .
Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions .
Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia .
Efineptakin alfa (NT-17) is a long-acting recombinant human IL-7. Efineptakin alfa supports the proliferation and survival CD4 + and CD8 + cells in both human and mice. Efineptakin alfa can be used for glioblastoma research .
Ledelabricin alfa is a human proteoglycan 4 (PRG4) isoform A variant. PRG4 is a joint/boundary lubricant. Ledelabricin Alfa can be used for the research arthropathy .
Albinterferon alfa-2b is a type I interferon that activates novel genes and exerts potent antiviral and antiproliferative activity on target cells. Signaling by Albinterferon alfa-2b requires receptor-dependent activation of Stat1 and Stat2 to form a heterodimeric STAT that binds to the DNA-binding protein IRF-9 (p48) and forms ISGF-3 (IFN-stimulated gene factor 3). The driver genes are then further activated by ISGF-3 to achieve antiviral function .
Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases .
Insulin efsitora alfa (LY-3209590) is a selective agonist of insulin receptor (IR). Insulin efsitora alfa is a fusion protein composed of human IR agonists fused with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2) fragment, with a molecular weight of 64.1 kDa. Insulin efsitora alfa is well tolerated and has potential applications in diabetes .
Mipeginterferon alfa-2b is an interferon alpha-2b (IFNA2b) analogue, with an average number of 5 substituted among 11 amino groups (one N-terminal and 10 lysine N6). Mipeginterferon alfa-2b has the relative molecular mass of 40 kDa .
Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII). FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the research of Hemophilia A .
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research .
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors 4/5. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies .
Nemvaleukin alfa (ALKS 4230) is a IL-2 fusion protein that selectively binds to intermediate-affinity IL-2R. Nemvaleukin alfa is an activator of NK and effector T cells. Nemvaleukin alfa can be used for research of cancer .
Nab-Paclitaxel is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel (Paclitaxel: human albumin=1:9), in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel was associated with higher response rates and better tolerability, with favorable pharmacokinetic properties . (The product size below only indicate the effective content of Paclitaxel. The actual albumin quality depends on the batch. The ratio of each component in this product is Paclitaxel: albumin = 1:7-1:11.)
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
Sotiburafusp alfa is a bispecific fusion protein, which is a humanized VEGFR-1 extracellular domain fragment (129-228, 1-100 in the current sequence) fused via the peptide linker 101GGSGGSGGSGGSGGS 115 to the N-terminus of the heavy chain (116-564) of a humanized IgG1-kappa anti-human PD-L1 heavy chain variant L352>A, L353>A. Sotiburafusp alfa is also an angiogenesis inhibitor .
Monomethyl auristatin E (MMAE; SGD-1010) is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) to treat several different cancer types.
SPDP (SPDP Crosslinker) is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. It is a glutathione cleavable ADC linker used for the antibody-drug conjugates (ADCs) .
Fmoc-Gly-Gly-D-Phe-OtBu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Gly-Gly-D-Phe-OtBu is the R-isomer of Fmoc-Gly-Gly-Phe-OtBu (HY-44234) .
NH-bis-PEG2 is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH-bis-PEG2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Bis-PEG9-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG9-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG7-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG10-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG10-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG13-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG13-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG17-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG17-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG21-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG21-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG25-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG25-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Succinimidyl 3-(Bromoacetamido)propionate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . N-Succinimidyl 3-(Bromoacetamido)propionate is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Propargyl-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Fmoc-NH-PEG6-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG6-alcohol is extracted from patent WO2016030791, example comp 91 .
Methyl azetidine-3-carboxylate hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs<
Boc-C14-COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-C14-COOH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Boc-C16-COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-C16-COOH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys(Pal-Glu-OtBu)-OH is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
Glucocorticoid receptor agonist-1 phosphate(2,6-difluoro) Ala-Ala-Br is an Drug-linker conjugates for ADC that can be used as a reaction reagent for the synthesis of anti-CD40 antibody agent conjugates (ADCs) .
Vari Fluor 647 Carboxylic acid free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivative is an inactive labeled fluorescent dye, which can be used to label proteins, antibodies, polysaccharides. The use of Vari Fluor carboxylic acid derivatives requires carboxylic acid activation.
Cyclopropaneacetamide-Exatecan (Compound 2-A) is an ADC Cytotoxin and an Exatecan analogue. Cyclopropaneacetamide-Exatecan can be used in the synthesis of ADC such as anti-B7H3 antibody-Exatecan analogue conjugate (compound ADC-2) .
Corchoionoside C ((6S,9S)-Roseoside), an ionone glucoside, can be isolated from Capparis spinosa. Corchoionoside C inhibits the antigen-antibody reaction induced histamine release from rat peritoneal exudate cells .
JF646-Hoechst is a fluorescent red DNA probe that is an ideal substitute for large oligonucleotide-coupled antibodies used in PAINT experiments, especially for bacterial studies. JF646-Hoechst excitation/emission maximum =655/670 nm .
LiLo is a new bifunctional chelator that has the activity of forming kinetically stable chelates with metal ions (such as indium). After using LiLo to bind indium-111 to monoclonal antibodies, the in vitro stability and in vivo biodistribution of the conjugates are superior to those using other chelators.
Mal-Phe-C4-VC-PAB-MMAE is made by MMAE conjugated to Mal-Phe-C4-VC-PAB linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody agent conjugate.
Hydroxy-PEG4-acid is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
DBCO-Maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tr-PEG5-OH is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Tr-PEG5-OH is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
Tr-PEG8-OH is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Tr-PEG8-OH is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
DBCO-NHS ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fluorescein-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Bromoacetamido-PEG4-acid is also a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Tetrazine-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-Maleimide is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs) .
TFAX 594,SE is a red fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 594,SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
OH-Glu-Val-Cit-PAB-MMAE consists a cleavable ADC linker (OH-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies .
Polyphemusin II-Derived Peptide (T140), a CXCR4 inhibitor, shows high inhibitory activity against HIV-1 entry and the inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 .
Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz is a cleavable ADC linker containing 4 units of PEG, which can be used to synthesize active antibody conjugation molecules (ADC) .
MMAF intermediate 1 is an intermediate in the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A .
MMAF intermediate 2 is an intermediate for the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A .
CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .
CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker .
Cyclooctyne-O-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Cyclooctyne-O-PFP ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Amino-PEG8-Boc is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG8-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
N-Boc-PEG5-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG5-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-NHS ester (sodium) is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N-Boc-PEG1-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG1-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Boc-PEG7-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG7-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Boc-PEG2-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG2-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Boc-PEG4-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG4-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Boc-PEG9-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG9-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Boc-PEG6-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG6-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG10-acid is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG10-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
m-PEG11-acid is a non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG11-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Mal-Sulfo-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-Sulfo-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-SS-aldehyde is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-aldehyde is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-SS-NHS is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TFAX 488,TFP is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,TFP yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
DBCO-S-S-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-S-S-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
D-Proline, 4-hydroxy-, methyl ester hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). D-Proline, 4-hydroxy-, methyl ester hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
1-Cbz-3-Hydroxyazetidine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-3-Hydroxyazetidine is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
cis-4-Hydroxy-D-proline hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). cis-4-Hydroxy-D-proline hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
tans-4-Hydroxy-D-proline hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). tans-4-Hydroxy-D-proline hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PR
Ethyl azetidine-3-carboxylate hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Ethyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2]
mp-dLAE-PABC-MMAE is a agent-linker conjugate for ADC. mp-dLAE-PABC-MMAE contains a potent tubulin inhibitor Monomethyl auristatin E (HY-15162). mp-dLAE-PABC-MMAE can be used to synthesis antibody-drug conjugates (ADCs) .
HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers generated by hepatitis B vaccination. HEP-1 has the potential to be studied against viral infections .
Preactivated PE-Cy5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
Amino-PEG10-OH is non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG10-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Amino-PEG11-OH is non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG11-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Amino-PEG6-alcohol is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG6-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
m-PEG6-NHS ester is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.
m-PEG4-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG4-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Tetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
TCO-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-SS-amine is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Tetrazine-Ph-OPSS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-OPSS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-SS-Biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
22-(tert-Butoxy)-22-oxodocosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 22-(tert-Butoxy)-22-oxodocosanoic acid is also a alkyl chain-based PROTAC linker that can be used in t
BAY 1135626 is used to synthesize BAY 1129980, and use to anti-tumor research. BAY 1129980 is a Auristatin-based anti-C4.4A (LYPD3) antibody–agent conjugate (ADC), is used to non–small cell lung cancer (NSCLC) research .
Blood group A antigen tetraose type 5 (A-Tetrasaccharide) is a tetrasaccharide and a blood group specific oligosaccharide, inhibits the binding of anti-A antibody to blood group A substance. Blood group A antigen tetraose type 5 can be isolated from polar bear milk samples .
HCV-1 e2 Protein (484-499) is a peptide consisting of 16 amino acids. HCV-1 e2 Protein (484-499) is derived from the envelope 2 protein of hepatitis C virus in the sera from individuals with antibodies to HCV .
Preactivated APC-Cy5.5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
PVP-037.2 is a TLR7/8 agonist. PVP-037.2 can serve as an adjuvant to enhance vaccine-induced TH1 type immune responses, increasing the production of antigen-specific antibodies IgG1 and IgG2c .
Raludotatug Deruxtecan (DS-6000) is a novel antibody conjugate (ADC) targeting CDH6. Raludotatug Deruxtecan is conjugated with Raludotatug (HY-P990028) and Deruxtecan (HY-13631E). Raludotatug Deruxtecan can be used in the research of ovarian cancer and renal cancer.
Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation .
Auristatin F is a potent cytotoxin in antibo-conjugated agents and an analogue of MMAF. Auristatin F is a potent microtubule inhibitor and vascular damaging agent (VDA). Auristatin F inhibits cell division by preventing tubulin aggregation.Auristatin F can be used in antibody-drug conjugates (ADC) .
Propargyl-C1-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-C2-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
THP-PEG6-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . THP-PEG6-OH is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Amino-PEG4-alcohol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Amino-PEG4-alcohol is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Boc-N-bis(PEG4-OH) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-N-bis(PEG4-OH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DBCO-Sulfo-Link-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-Link-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Aminooxy-PEG4-alcohol is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG4-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Aminooxy-PEG2-alcohol is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Mal-PEG2-Val-Cit-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-Val-Cit-PAB-OH also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane is also a PEG/Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs .
BnO-PEG6-OH is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). BnO-PEG6-OH is also a PEG-based PROTAC linker can be used in the synthesis of PROTACs .
m-PEG10-amine is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG10-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
m-PEG12-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . m-PEG12-amine is also a non-cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
m-PEG12-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . m-PEG12-OH is also a non-cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Tr-PEG2-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Tr-PEG2-OH is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DBCO-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TFAX 488,SE dilithium is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,SE dilithium yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
DC10SMe is a DNA alkylator, can be used in the synthesis of antibody-drug conjugate (ADC). DC10SMe exhibits IC50s of 15 pM, 12 pM, and 12 pM for Ramos, Namalwa, and HL60/s cancer cells, respectively .
Gly3-VC-PAB-MMAE consists a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Gly3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
CL2-SN-38 is a cleavable linker-based agent-Linker conjugate, it can conjugate with the anti-Trop-2-humanized antibody hRS7. CL2-SN-38 can be used for the reasearch of cancer .
tans-4-Hydroxy-D-proline methyl ester hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). tans-4-Hydroxy-D-proline methyl ester hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 20-(tert-Butoxy)-20-oxoicosanoic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
1-N-Boc-3-hydroxyazetidine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-N-Boc-3-hydroxyazetidine is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
ATAC21, a linker-immune-stimulatory compound that can be formed by conjugating a noncleavable maleimide-PEG4 linker containing a succinimide group with an immune- stimulatory compound. ATAC21 can be combined with SBT-040 (anti-CD40 antibody) to form a conjugate .
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) is a topoisomerase I inhibitor, which can be delivered to cells through conjugated antibody targeting, and has good ADC activity in vivo and in vitro .
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a agent-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make antibody agent conjugate (ADC) .
NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) hydrochloride is a topoisomerase I inhibitor, which can be delivered to cells through conjugated antibody targeting, and has good ADC activity in vivo and in vitro .
Monomethyl auristatin E intermediate-1 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-3 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-4 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-5 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-2 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-6 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-7 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-8 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-9 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-10 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-11 is an intermediate reactant in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-12 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-13 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-14 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-15 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-16 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Monomethyl auristatin E intermediate-17 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
Fmoc-1,6-diaminohexane hydrochloride is the hydrochloride form of Fmoc-1,6-diaminohexane (HY-103664). Fmoc-1,6-diaminohexane hydrochloride conjugates with monoclonal antibody, and exhibits anticancer activity against p21-deficient cancer .
Maridebart cafraglutide (AMG 133) is an antibody-peptide conjugate acting as a GLP-1 receptor agonist and an antagonist of the GIP receptor. Maridebart cafraglutide reduces body weight and improve metabolic markers in male obese mice and cynomolgus monkeys. Maridebart cafraglutide is promising for research of obesity .
Amino-PEG5-C2-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG5-C2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bis-PEG2-PFP ester is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bis-PEG2-PFP ester is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
m-PEG5-succinimidyl carbonate is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-succinimidyl carbonate is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.
Tetrazine-Ph-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer .
Amidate-VC-PAB-MMAF consists a cleavable ADC linker (Amidate-VC-PAB) and a potent tubulin polymerization inhibitor (MMAF). Amidate-VC-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs). Amidate-VC-PAB-MMAF reduces off-target cytotoxicity of ADCs .
Ficain is an enzyme extract composed of several proteases that can be isolated from Ficus hispida L. and the latex of fig (Ficus carica). Ficain has different specificities in different proportions during fruit ripening. Ficain is widely used in protein hydrolysis, food, production of bioactive peptides and antibody fragments .
2,5-Dioxopyrrolidin-1-yl acrylate (N-Succinimidyl acrylate) is a protein crosslinker. 2,5-Dioxopyrrolidin-1-yl acrylate can react with a monoclonal anti-horseradish peroxidase IgG antibody (anti-HRP) to modify lysine residues .
AMOZ-CHPh-4-O-acid is a hapten, containing 2 carbon and 1 oxygen spacer. AMOZ-CHPh-4-O-acid can be used for antibody production. AMOZ-CHPh-4-O-acid is coupled to BSA for immunogens and coupled to OVA for coating antigens .
Potassium dihydrogen phosphate (Potassium phosphate monobasic), meets analytical specification of Ph. Eur., NF, E340 is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates, meets analytical specification of Ph. Eur., NF, E340 .
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer .
FITC (Fluorescein Isothiocyanate), is one of the green fluorescein derivatives widely used in biology. FITC has the characteristics of high absorptivity and excellent fluorescence quantum yield. The isothiocyanate group of FITC can be combined with amino, sulfhydryl, imidazole, tyrosyl, carbonyl and other groups on the protein, so as to achieve protein labeling including antibodies and lectins. In addition to its use as a protein marker, FITC can also be used as a fluorescent protein tracer to rapidly identify pathogens by labeling antibodies, or for microsequencing of proteins and peptides (HPLC). The maximum excitation wavelength of FITC is 494 nm. Once excited, it fluoresces yellow-green at a maximum emission wavelength of 520 nm. In addition, FITC is also a hapten that can induce contact hypersensitivity (CHS) and induce an atopic dermatitis model .
β-Glucuronide-dPBD-PEG5-NH2 TFA is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD.β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2 TFA, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 TFA can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 TFA has antitumor activity .
β-Glucuronide-dPBD-PEG5-NH2 is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD. β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 has antitumor activity .
MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
Boc-NH-PEG1-CH2CH2COOH is a cleavable (1 unit PEG) ADC linker and also a PEG- and Alkyl/ether-based PROTAC linker can be used in the synthesis of antibody-drug conjugates (ADCs) or PROTACs .
Amino-PEG3-C2-acid is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG3-C2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
N-Boc-N-bis(PEG2-OH) is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-N-bis(PEG2-OH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DBCO-Val-Cit-PABC-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-Val-Cit-PABC-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-NHCO-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-CONH-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-CONH-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N-Boc-cis-4-hydroxy-L-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-L-proline is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
1-Boc-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Boc-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2]
1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]
Exatecan Intermediate 5 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 5 can be used to synthesize Antibody-Drug Conjugates (ADCs).
Exatecan Intermediate 6 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 6 can be used to synthesize Antibody-Drug Conjugates (ADCs).
Exatecan Intermediate 7 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 7 can be used to synthesize Antibody-Drug Conjugates (ADCs).
Exatecan Intermediate 3 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 3 can be used to synthesize Antibody-Drug Conjugates (ADCs).
Mc-Val-Cit-PABC-PNP GMP is a GMP grade Mc-Val-Cit-PABC-PNP (HY-20336). Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research .
SB24011 is a STING-TRIM29 interaction inhibitor with a IC50 value of 3.85 μM. SB24011 enhances STING immunity by upregating STING protein levels, thereby enhancing the immunotherapy effect of STING agonists and anti-PD-1 antibodies through systemic anticancer immunity .
VISTA-IN-3 (Compound A4) is a potent VISTA small molecule inhibitor with a KD value of 0.49 μM. VISTA-IN-3 can induce the release of IFN-γ cytokines. VISTA-IN-3 synergistically enhances anti-cancer activity with PD-L1 antibody .
Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research .
MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC50 of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .
FZ-AD005 is a DLL3 target ADC compound containing a novel anti-DLL3 antibody, FZ-A038, and a valine–alanine (Val–Ala) dipeptide linker. FZ-AD005 can used in the research of small cell lung cancer .
SuO-Glu-Val-Cit-PAB-MMAE (NHS-Glutarate-Val-Cit-PAB-MMAE) consists a cleavable ADC linker (SuO-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
β-Amanitin is a cyclic peptide toxin in the poisonous Amanita phalloides mushroom. β-Amanitin inhibits inhibits eukaryotic RNA polymerase II and III. β-Amanitin inhibits protein synthesis. β-Amanitin can be used as a cytotoxic component of antibody-drug conjugates (ADCs) .
N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the Synthesis of ADCs or PROTACs.
Methyl 1-Boc-azetidine-3-carboxylate is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl 1-Boc-azetidine-3-carboxylate is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs [1
MP-PEG8-Val-Lys-Ala-7-MAD-MDCPT is a agent-linker conjugate for antibody-drug conjugate (ADC). MP-PEG8-Val-Lys-Ala-7-MAD-MDCPT has the potential for cancer and autoimmune disease research.
DBCO-PEG3-acid is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG3-acid contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
Highly purified Type I collagen, from porcine skin (Porcine Type I collagen, immunization grade) is an immune grade collagen derived from porcine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from canine skin (Canine Type I collagen, immunization grade) is an immune grade collagen derived from canine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from rat skin (Rat Type I collagen, immunization grade) is an immune grade collagen derived from rat skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified type I collagen, from mouse skin (Mouse Type I collagen, immunization grade) is an immune grade collagen derived from mouse skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from mouse intestine (Mouse Type II collagen, immunization grade) is an immune grade collagen derived from mouse intestine, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from chick skin (Chick type I collagen, immunization grade) is an immune grade collagen derived from chick skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type III collagen, from human placenta (Human Type III collagen, immunization grade) is an immune grade collagen derived from human placenta, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type III collagen, from porcine skin (Porcine Type III collagen, immunization grade) is an immune grade collagen derived from porcine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from rabbit skin (Canine Type I collagen, immunization grade) is an immune grade collagen derived from rabbit skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from human placenta (Human Type I collagen, immunization grade) is an immune grade collagen derived from human placenta, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type III collagen, from bovine skin (Bovine Type III collagen, immunization grade) is an immune grade collagen derived from bovine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Mecbotamab vedotin (BA301) is an IgG1 antibody inhibitor of anti-(human tyrosine kinase receptor AXL) (human-Mus musculus monoclonal BA301 γ1-chain). Mecbotamab vedotin can be used to make immunoconjugates for Methods of Axl-expressing cancers research .
TETS-Methyl benzoate(compound 2j) is a haptendirectly conjugated to the carrier protein via carboxylic acid function using the standard activated ester method .
DC41SMe, a DC1 derivative, shows cytotoxicity in Ramos, Namalwa, and HL60/s cells with IC50s ranging from 18-25 pM. DC1, a simplified analogue of CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer .
Propargyl-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
NH2-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-PEG8-acid also is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Amino-PEG2-C2-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG2-C2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG4-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG4-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG6-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG6-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG5-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG5-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG8-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG8-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG1-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG1-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
DBCO-PEG4-Maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
m-PEG5-CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Boc-NH-PEG4-CH2COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC). Boc-NH-PEG4-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
m-PEG10-alcohol (Decaethylene glycol monomethyl ether) is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . m-PEG10-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Mensacarcin, a highly complex polyketide, strongly inhibits cell growth universally in cancer cell lines and potently induces apoptosis in melanoma cells. Mensacarcin targets to mitochondria, affects energy metabolism in mitochondria, and activates caspase-dependent apoptotic pathways. Mensacarcin, an antibiotic, can be used as a cytotoxic component of antibody-drug conjugates (ADCs) .
BCOT-PEF3-OPFP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCOT-PEF3-OPFP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
1-Boc-azetidine-3-yl-methanol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Boc-azetidine-3-yl-methanol is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]
Methyl 1-Cbz-azetidine-3-carboxylate is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Methyl 1-Cbz-azetidine-3-carboxylate is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1
N-Boc-cis-4-hydroxy-L-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-L-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[2
Aminooxy-PEG2-BCN is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
UC-1V150 is a specific TLR7 (Toll-like receptor) agonist that stimulates cellular immune responses and has anti-tumor activity. UC-1V150 can be used to synthesize ISAC (Immune-Stimulating Antibody Conjugates) molecule .
Mal-PEG8-Val-Ala-PAB-Exatecan (Compound 9b) is an antibody-drug conjugate linker (ADC linker) that binds to Nectin-4 polypeptides conjugated to chemotherapeutic agents. Mal-PEG8-Val-Ala-PAB-Exatecan can be used for cancer research .
Nampt-IN-10 trihydrochloride (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 trihydrochloride shows cellular potency to A2780 and CORL23 cell lines with IC50 values of 5 and 19 nM, respectively. Nampt-IN-10 trihydrochloride can be used as a novel non-antimitotic payload for antibody-drug conjugate (ADC) .
Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) is a synthetic peptide analog which specifically binds to Hep G2 cells. Hepatitis B Virus Receptor Binding Fragment is a promising immunogen expected to elicit protective antibodies based on the concept of the attachment blockade pathway of virus neutralization .
VTSEGAGLQLQK- 13C6, 15N2 is the 13C and 15N labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA). VTSEGAGLQLQK can be used to bind anti-drug antibodies (ADA) in plasma and quantitatively analyze the therapeutic effect .
C12-TLRa is an adjuvant lipidoid. C12-TLRa acts as a structural component of LNP to enhance mRNA delivery. C12-TLRa substitution can increase antigen-specific antibody responses and B cell responses of clinically relevant mRNA-LNP vaccines .
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .
ATTO 488 carboxylic acid is a new fluorescent label based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 carboxylic acid is a carboxylic acid derivative of ATTO 488, which can be used to label proteins or antibodies.
ATTO 390 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 390 NHS ester is an NHS ester derivative of ATTO 390 that can be used to label proteins or antibodies.
ATTO 594 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 594 NHS ester is an NHS ester derivative of ATTO 594 that can be used to label proteins or antibodies.
ATTO 590 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 NHS ester is an NHS ester derivative of ATTO 590 that can be used to label proteins or antibodies.
ATTO 590 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 maleimide is a maleimide derivative of ATTO 590, which can be used to label proteins or antibodies.
ATTO 465 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 NHS ester is an NHS ester derivative of ATTO 465 that can be used to label proteins or antibodies.
ATTO 465 amine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 amine is an amine derivative of ATTO 465 and can be used to label proteins or antibodies.
ATTO 590 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 alkyne is an alkyne derivative of ATTO 590 and can be used to label proteins or antibodies.
ATTO 633 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 633 NHS ester is an NHS ester derivative of ATTO 633 that can be used to label proteins or antibodies.
ATTO 565 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 NHS ester is an NHS ester derivative of ATTO 565 that can be used to label proteins or antibodies.
ATTO 565 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 maleimide is a maleimide derivative of ATTO 565, which can be used to label proteins or antibodies.
ATTO 647 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 647 NHS ester is an NHS ester derivative of ATTO 647 that can be used to label proteins or antibodies.
ATTO 665 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 665 NHS ester is an NHS ester derivative of ATTO 665 that can be used to label proteins or antibodies.
ATTO 488 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 NHS ester is an NHS ester derivative of ATTO 488 that can be used to label proteins or antibodies.
ATTO 488 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 maleimide is a maleimide derivative of ATTO 488, which can be used to label proteins or antibodies.
ATTO 565 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 alkyne is an alkyne derivative of ATTO 565 and can be used to label proteins or antibodies.
ATTO 488 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 alkyne is an alkyne derivative of ATTO 488 and can be used to label proteins or antibodies.
ATTO 425 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 425 NHS ester is an NHS ester derivative of ATTO 425 that can be used to label proteins or antibodies.
ATTO 565 cadaverine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 cadaverine is a cadaverine derivative of ATTO 565, which can be used to label proteins or antibodies.
ATTO 550 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 NHS ester is an NHS ester derivative of ATTO 550 that can be used to label proteins or antibodies.
ATTO 550 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 maleimide is a maleimide derivative of ATTO 550, which can be used to label proteins or antibodies.
ATTO 514 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 NHS ester is an NHS ester derivative of ATTO 514 that can be used to label proteins or antibodies.
ATTO 514 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 alkyne is an alkyne derivative of ATTO 514 and can be used to label proteins or antibodies.
ATTO 550 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 alkyne is an alkyne derivative of ATTO 550 and can be used to label proteins or antibodies.
ATTO 532 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 NHS ester is an NHS ester derivative of ATTO 532 that can be used to label proteins or antibodies.
ATTO 532 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 maleimide is a maleimide derivative of ATTO 532, which can be used to label proteins or antibodies.
ATTO 532 iodacetamid is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 iodacetamid is an iodoacetamide derivative of ATTO 532, which can be used to label proteins or antibodies.
ATTO 700 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 NHS ester is an NHS ester derivative of ATTO 700 that can be used to label proteins or antibodies.
ATTO 700 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 maleimide is a maleimide derivative of ATTO 700, which can be used to label proteins or antibodies.
ATTO 740 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 NHS ester is an NHS ester derivative of ATTO 740 that can be used to label proteins or antibodies.
ATTO 740 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 maleimide is a maleimide derivative of ATTO 740, which can be used to label proteins or antibodies.
ATTO 680 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 NHS ester is an NHS ester derivative of ATTO 680 that can be used to label proteins or antibodies.
ATTO 680 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 maleimide is a maleimide derivative of ATTO 680, which can be used to label proteins or antibodies.
VTSEGAGLQLQK- 13C6, 15N2 (TFA) is the 13C- and 15N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .
Boc-Dap-NE (GMP) is Boc-Dap-NE (HY-78931) produced by using GMP guidelines. Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
(22R)-33,34,35-Trinorbacteriohopan-32-oic acid (compound 2c) is a hapten that can be covalently coupled to a carrier protein. (22R)-33,34,35-Trinorbacteriohopan-32-oic acid can be used in antibody generation and immunoassay .
M3554 is a novel anti-GD2 ADC designed based on humanized ch14.18 anti-GD2 antibody and has anti-tumor activity. The cytotoxicity of M3554 against the GD2-positive neuroblastoma cell line CHP134 was in the subnanomolar IC50 range.
Protein A (SPA) is an immunoglobulin (Ig) binding protein that exists on the surface of bacteria and can be freely secreted into the extracellular environment. Protein A blocks opsonization and phagocytosis and induces B-cell death in vitro by binding to the Fc region of antibodies and the Fab region of B-cell receptors. Protein A has the ability to inhibit opsonization and phagocytosis in vitro .
Highly purified Type II collagen, from porcine articular cartilage (Porcine Type II collagen, immunization grade) is an immune grade collagen derived from porcine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from porcine articular cartilage (Porcine Type XI collagen, immunization grade) is an immune grade collagen derived from porcine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from human placenta (Human Placenta Type V collagen, immunization grade) is an immune grade collagen derived from human placenta, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from chick sternal cartilage (Chick Type II collagen, immunization grade) is an immune grade collagen derived from chick sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type IX collagen, from bovine articular cartilage (Bovine Type IX collagen, immunization grade) is an immune grade collagen derived from bovine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified type II collagen, from rat sternal cartilage (Rat Type II collagen, immunization grade) is an immune grade collagen derived from rat sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from mouse sternal cartilage (Mouse Type II collagen, immunization grade) is an immune grade collagen derived from mouse sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type IX collagen, from chick articular cartilage (Chick Type IX collagen, immunization grade) is an immune grade collagen derived from chick articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from human sternal cartilage (Human Type XI collagen, immunization grade) is an immune grade collagen derived from human sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from human amnion (Human Amnion Type V collagen, immunization grade) is an immune grade collagen derived from human amnion, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type IX collagen, from porcine articular cartilage (Porcine Type IX collagen, immunization grade) is an immune grade collagen derived from porcine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from sheep articular cartilage (Sheep Type II collagen, immunization grade) is an immune grade collagen derived from sheep articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from goat articular cartilage (Goat Type II collagen, immunization grade) is an immune grade collagen derived from goat articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from human sternal cartilage (Human Type II collagen, immunization grade) is an immune grade collagen derived from human sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from bovine amnion (Bovine Amnion Type V collagen, immunization grade) is an immune grade collagen derived from bovine amnion, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from bovine articular cartilage (Bovine Type XI collagen, immunization grade) is an immune grade collagen derived from bovine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from chick articular cartilage (Chick Type XI collagen, immunization grade) is an immune grade collagen derived from chick articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
WS-917 is a potent and orally active ABCB1 modulator. WS-917 enhances ABCB1 ATPase activity. WS-917 significantly enhances the antitumor effect of paclitaxel combined with anti-PD-1 antibody. WS-917 promotes CD8 + T-cell activation .
MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA synthesis and causes frequent DNA single-strand breaks .
MC-GGFG-Exatecan (MC-GGFG-DX8951) is a agent-linker conjugate for ADC. MC-GGFG-Exatecan is a DX8951 (a DNA topoisomerase I inhibitor) derivative with protease cleavable MC-GGFG linker. MC-GGFG-Exatecan shows antitumor activity and can be used to prepare DX8951 antibody conjugate (ADC) .
DM4-SPDP is a agent-linker conjugate composed of a potent antitubulin agent DM4 and a linker SMCC to make antibody agent conjugate . SPDP is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls .
NH2-PEG5-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . NH2-PEG5-OH is also a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Mal-PEG2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-acid can be conjugated to Tubulysin (HY-128914) and its derivative cytotoxic molecule . Mal-PEG2-acid is also a PROTAC linker that can be used in the synthesis of PROTACs.
PTAD-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
APN-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
APN-PEG4-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
APN-PEG4-Amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-Amine (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
endo-BCN-PEG4-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . endo-BCN-PEG4-acid is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-HyNic is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-HyNic is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
HyNic-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . HyNic-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Bocaminooxyacetamide-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium is a fluorescent dye. 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium can be used to demonstrate retrograde axonal transport to label secondary antibodies and as a fluorescent whole cell stain .
TLR7/8 agonist 7 (compound 10) is a TLR7/8 agonist. TLR7/8 agonist 7 activates a variety of immune cells and it can be used to synthesize immune stimulating antibody conjugate (ISAC) molecules. TLR7/8 agonist 7 can be used for the research of immunity .
bisSP1 is an antibody agent conjugates linker . bisSP1 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
rel-Boc-Hyp-OMe is the isomer of Boc-Hyp-OMe (HY-65039), and can be used as an experimental control. Boc-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs .
(4R,5S)-Monomethyl auristatin E intermediate-6 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs) .
(S,S,R,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
(R,S,R,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
(R,S,S,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
DBCO-amine GMP is a GMP grade DBCO-amine (HY-W000423). DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, itcontains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
McMMAF GMP is a GMP grade McMMAF (HY-15578). McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
10NH2-11F-Camptothecin TFA is a Camptothecin (HY-16560) analogue that serves as an ADC cytotoxin for the synthesis of antibody-drug conjugates (ADCs). 10NH2-11F-Camptothecin TFA has anticancer effects (WO2022246576A1; compound 140) .
BODIPY TMR NHS ester is bright, orange fluorescent dye with Ex/Em of 544/570 nm. The NHS ester (or succinimidyl ester) of BODIPY TMR NHS ester is a popular tool for conjugating the dye to a protein or antibody. NHS esters can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules .
Puxitatug samrotecan drug-linker (AZD8205 drug-linker) is part of the anti-B7-H4antibody-conjugated active molecule ADC (drug-linker conjugate for ADC). Puxitatug samrotecan drug-linker contains a degradable ADC linker and a topoisomerase I inhibitor Exatecan (HY-13631) .
ORM-5029 is a first-in-class human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate (ADC) comprised of SMol006, a highly potent GSPT1 degrader, conjugated to Pertuzumab (HY-P9912). ORM-5029 can be used for study of cancer .
DBCO-NHS ester 2 is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 2 is a derivative of Dibenzylcyclooctyne (DBCO) used in copper-free click chemistry . DBCO-NHS ester 2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
3,4-Benzocoumarin is a kind of the expanded structure of coumarin derivatives.Coumarin is a chemical compound in the benzopyrone chemical class that can be found in many natural species. Coumarins possess variety of biological activities and unique photophysical properties . 3,4-Benzocoumarin, a AOH‐like compound , has the sensibility of the antibody with an IC50 of 919.2 ng/mL .
DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester), the DNP-X acid modified by succinimidyl ester, is an amine-reactive building block for developing a probe, which can be recognized by anti-DNP antibodies. DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester) is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
Amino-PEG4-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Amino-PEG4-CH2COOH is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm . N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa .
PC DBCO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC DBCO-PEG3-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Diazo Biotin-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Diazo Biotin-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG1-SS-alcohol is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-alcohol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
bis-PEG2-endo-BCN is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . bis-PEG2-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
PC Alkyne-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Alkyne-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
PC Biotin-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BCN-PEG3-VC-PFP ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-VC-PFP ester is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-PEG4-Biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG4-oxyamine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-oxyamine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
TCO-PEG3-Biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-Biotin is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Tetrazine-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-PEG4-oxyamine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-oxyamine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-PEG3-SS-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-SS-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG3-Biotin is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-Biotin is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG4-OH is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-oxyamine is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG4-hydrazide is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-hydrazide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-oxyamine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-alkyne is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BCN-PEG4-Ts is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-Ts is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Amino-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG4-amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-PEG4-aldehyde is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-aldehyde is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
TCO-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Amino-bis-PEG3-BCN is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG6-amine (hydrochloride) is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG6-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Mal-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG3 acetic-EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3 acetic-EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
γ-Amanitin an ADC cytotoxin and isolated from the mushroom. γ-Amanitin inhibits RNA polymerase II and disrupts synthesis of mRNA. γ-Amanitin shows similar effects to α-Amanitin and β-Amanitin. γ-Amanitin competitively binds to monoclonal antibody (mAb), with an IC50 of 163.1 ng/mL .
M50054 is a potent inhibitor of apoptosis. M50054 inhibits Etoposide-induced caspase-3 activation of U937 cells with an IC50 of 79 μg/mL. M50054 does not directly inhibit the enzymatic activity of caspase-3. M50054 can be used for the research anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia .
Anticancer agent 81 (Compound 37b3) is an anticancer agent and can induce tumor cell cycle arrest and apoptosis. Anticancer agent 81 can be used as a payload to conjugate with Trastuzumab (HY-P9907) to obtain the antibody–agent conjugate (ADC) T-PBA. T-PBA maintained its mode of target and internalization ability of Trastuzumab .
Tetrazine-PEG7-amine hydrochloride is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG7-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
CDN-A is a cyclic di-nucleotide, it can be used to synthesis antibody-drug conjugate (ADC). Cyclic di-nucleotides are potent stimulators of innate and adaptive immune responses. In humans, cyclic di-nucleotide, which are either produced endogenously in response to foreign DNA or by invading bacterial pathogens, trigger the innate immune system by activating the expression of interferon genes .
Vari Fluor 680 SE (VF 680 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=680 nm/700 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 488 SE (VF 488 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=488 nm/513 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 640 SE (VF 640 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=648 nm/664 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 425 SE (VF 425 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=430 nm/475 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 565 SE (VF 565 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=563 nm/594 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 660 SE (VF 660 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=660 nm/679 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 350 SE (VF 350 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=350 nm/448 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 568 SE (VF 568 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=573 nm/595 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 750 SE (VF 750 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=747 nm/770 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 555 SE (VF 555 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=550 nm/561 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 405 SE (VF 405 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=399 nm/421 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 532 SE (VF 532 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=532 nm/545 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 594 SE (VF 594 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=585 nm/609 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Tesirine intermediate-2 is the intermediate of Tesirine (HY-128952). Tesirine (SG3249), a pyrrole benzodiazepine (PBD) dimer, is a DNA small channel crosslinker with strong cytotoxicity. Tesirine can be used to synthesize Antibody-Drug Conjugates (ADCs), the warhead component of the payload is SG3199 (HY-101161), which has strong anticancer cell activity.
Tesirine intermediate-1 is the intermediate of Tesirine (HY-128952). Tesirine (SG3249), a pyrrole benzodiazepine (PBD) dimer, is a DNA small channel crosslinker with strong cytotoxicity. Tesirine can be used to synthesize Antibody-Drug Conjugates (ADCs), the warhead component of the payload is SG3199 (HY-101161), which has strong anticancer cell activity.
Desthiobiotin-PEG3-triazole-DBCO-sulfo-Maleimide is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Desthiobiotin-PEG3-triazole-DBCO-sulfo-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
ZINC05626394 is a cytochrome b5 reductase 3 inhibitor with activity by increasing nitric oxide bioavailability. ZINC05626394 may have potential applications in anti-cancer suppression, especially in combination with antibody drug conjugates (ADCs) and immune checkpoint inhibitors. The efficacy of ZINC05626394 may be limited by different mechanisms, including antigen-related resistance and failure of endocytosis .
Acyclovir (Aciclovir) is a potent, orally active antiviral agent. Acyclovir has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir induces cell cycle perturbation and apoptosis. Acyclovir prevents bacterial infections during induction therapy for acute leukaemia .
Acyclovir (Aciclovir) sodium is a potent, orally active antiviral agent. Acyclovir sodium has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir sodium induces cell cycle perturbation and apoptosis. Acyclovir sodium prevents bacterial infections during induction therapy for acute leukaemia .
Acyclovir (Standard) is the analytical standard of Acyclovir. This product is intended for research and analytical applications. Acyclovir (Aciclovir) is a potent, orally active antiviral agent. Acyclovir has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir induces cell cycle perturbation and apoptosis. Acyclovir prevents bacterial infections during induction therapy for acute leukaemia .
Acyclovir (Aciclovir) hydrochloride is a potent, orally active antiviral agent. Acyclovir hydrochloride has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir hydrochloride induces cell cycle perturbation and apoptosis. Acyclovir hydrochloride prevents bacterial infections during induction therapy for acute leukaemia .
Mycophenolate Mofetil-d4 is the deuterium labeled Mycophenolate Mofetil. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation[1].
DBCO-C6-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-C6-acid can be used in the synthesis of carmaphycin analogues . DBCO- C6- acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
m-PEG7-CH2CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG7-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
m-PEG7-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG7-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
m-PEG3-CH2CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
m-PEG6-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Gly-Gly-Gly-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Gly-Gly-Gly-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG4-SS-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
BCN-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG5-SS-amine is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG5-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-PEG4-SS-Py is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-Py is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Amino-bis-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
DBCO-PEG4-SS-TCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-SS-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Methyltetrazine-PEG4-SS-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-NHS ester is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Aminooxy-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Methyltetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-diazo-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-diazo-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-PEG3-propionic EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-propionic EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Cy7-YNE is a fluorescence labeling agent (Ex=700-770 nm，Em=790 nm). Cyanine dyes are used to label proteins, antibodies, and peptides. Cy7-YNE is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker compound extracted from patent WO2019195665A1, example 4-1. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a agent-linker conjugate for antibody-drug conjugate (ADC) .
BODIPY TMR-X SE is a potent fluorescent dye. BODIPY TMR-X SE can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, orange fluorescent light. (λex=544 nm, λem=570 nm) .
Endo-β-N-acetylglucosaminidase (Endo S) is a family 18 glycosyl hydrolase secreted by Streptococcus pyogenes. Endo-β-N-acetylglucosaminidase (Endo S) exclusively hydrolyzes the β-1,4-di-N-acetylchitobiose core of the asparagine-linked complex-type glycan on Asn-297 of the γ-chains of IgG antibody .
Cys-McMMAF is the released payload of AlMcMMAF, an anti-5T4 humanized A1 antibody conjugated to the microtubule disrupting MMAF (HY-15579) via a maleimidocaproyl linker. Cys-McMMAF has antitumor efficacy in two tumor mouse models (H1975 and MDA-MB-361-DYT2 models) .
(R,S,S,R,S)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
Endo-β-N-acetylglucosaminidase D (Endo D), isolated from Streptococcus pneumoniae. Endo-β-N-acetylglucosaminidase D hydrolyzes Fc N-glycan of intact IgG antibodies after sequential removal of the sialic acid, galactose, and internal GlcNAc residues in the N-glycan. Endo-β-N-acetylglucosaminidase D possesses transglycosylation activity with sugar oxazoline as the donor substrate .
TAM558 intermediate-1 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
TAM558 intermediate-24 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
TAM558 intermediate-34 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
TAM558 intermediate-4 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
TAM558 intermediate-54 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity .
(S,S,S,S,R)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
Auristatin F-d8 is deuterium labeled Auristatin F (HY-15583). Auristatin F is a potent cytotoxin in antibo-conjugated agents and an analogue of MMAF. Auristatin F is a potent microtubule inhibitor and vascular damaging agent (VDA). Auristatin F inhibits cell division by preventing tubulin aggregation.Auristatin F can be used in antibody-drug conjugates (ADC) .
Glucocorticoid receptor modulator 3 (Payload 6) is a thioester-containing glucocorticoid receptor modulator (IC50=0.6 nM). Glucocorticoid receptor modulator 3 is designed to inactivate unconjugated payloads rapidly through liver metabolism, thereby minimizing systemic exposure. Glucocorticoid receptor modulator 3 can be utilized in the development of antibody-drug conjugates (ADCs) targeting autoimmune diseases .
(4-NH2)-Exatecan-d5 is a deuterated labeled (4-NH2)-Exatecan . (4-NH2)-Exatecan (compound A), a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
Paclitaxel-2′-succinate NHS ester is a paclitaxel derivative with a succinic acid linker, in which the carboxyl group is activated by the NHS ester. The NHS ester group is highly reactive toward amino or hydroxyl groups and can be used to conjugate with other molecules such as peptides, proteins, antibodies, enzymes or polymers. Paclitaxel-2′-succinate NHS ester can be used in the development of nanomedicines and in the study of cancer therapy .
AM-9635 is a selective PI3Kδ inhibitor with oral bioavailability, good in vitro and in vivo activity and pharmacodynamic properties. AM-9635 inhibits PI3Kδ-dependent B cell receptor-mediated AKT phosphorylation and suppresses the production of specific IgG and IgM antibodies in rats immunized with Aplysia leocyanin (KLH).
Monomethyl auristatin E (MMAE) (Standard) is the analytical standard of Monomethyl auristatin E (HY-15162). This product is intended for research and analytical applications. Monomethyl auristatin E is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) against several different cancer types .
pan-KRAS-IN-16 is an anti-RAS small molecule derived from an intracellular antibody fragment with pan-RAS-effector protein-protein interaction inhibitor properties. pan-KRAS-IN-16 binds to a hydrophobic pocket near to the effector-binding switch regions of RAS. pan-KRAS-IN-16 prevents endogenous RAS-dependent signaling in tumor cell lines .
DRAQ5 is a novel cell permeant and far red-fluorescing DNA probe. DRAQ5 excites at a wavelength of 647 nm, close to the Ex, and produces a fluorescence spectrum extending from 665 nm out to beyond 780 nm wavelengths. DRAQ5 fluorescence reflects cellular DNA content. DRAQ5 can be used in combination with FITC and RPE-labelled antibodies, without the need for fluorescence compensation .
Auristatin E is a cytotoxic microtubule polymerization inhibitor with potent and selective antitumor activity. Auristatin E is a cytotoxin in antibody-drug conjugates (ADC). Auristatin E inhibits cell division by blocking the polymerisation of tubulin, promising for research in B-cell malignancies. Auristatin E, a synthetic analogue of the Dolastatin 10 (HY-15580), is linear peptides comprised of four amino acids .
DC44SMe, a phosphate proagent of cytotoxic DNA alkylator DC44, can be used in the synthesis of antibody-drug conjugate (ADC). DC44SMe exhibits IC50s of 2.0 nM, 2.8 nM, and 1.9 nM for Ramos, Namalwa, and HL60/s cancer cells, respectively. DC44SMe can be used for the targeted treatment of cancer .
DC4SMe, a phosphate proagent of cytotoxic DNA alkylator DC4, can be used in the synthesis of antibody-drug conjugate (ADC). DC4SMe exhibits IC50s of 1.9 nM, 2.9 nM, and 1.8 nM for Ramos, Namalwa, and HL60/s cancer cells, respectively. DC4SMe can be used for the targeted treatment of cancer .
S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is a glutathione cleavable ADC linker used for the antibody-drug conjugates (ADCs) and refers to the Alkyl-Chain composition. S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is the linker portions of the molecules employed for mAb attachment purposes .
Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG4-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG3-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG2-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG2-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-NH-PEG9-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG9-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Boc-NH-PEG6-CH2CH2COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC). Boc-NH-PEG6-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
7-O-(Amino-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Amino-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs) .
Ald-Ph-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Boc-aminooxy-amide-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-aminooxy-amide-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BCN-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
DBCO-PEG4-Propionic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Propionic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-acetic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Cyclooctyne-O-amido-PEG2-PFP ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-amido-PEG2-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Cyclooctyne-O-amido-PEG3-PFP ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-amido-PEG3-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Cyclooctyne-O-amido-PEG4-PFP ester is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Cyclooctyne-O-amido-PEG4-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
RS 09 TFA is a TLR4 agonist. RS 09 TFA promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro. RS 09 TFA acts as an adjuvant in vivo; RS 09 TFA enhances X-15 specific antibody serum concentrations, when administered with X-15-KLH in mice.
HE-S2 is an antibody-drug conjugate triggering a potent antitumor immune response. HE-S2 acts by blocking the PD-1/PD-L1 interaction and activating the Toll-like receptor 7/8 (TLR7/8) signaling pathway. HE-S2 has remarkable antitumor activity .
BODIPY TR-X (BODIPY TR-X NHS Ester) is a potent fluorescent dye. BODIPY TR-X can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, red fluorescent light. (λex=545 nm, λem=560 nm) .
(R)-IDO/TDO-IN-1 (compound 25) is an indoleamine-2,3-dioxygenase (IDO) inhibitor, with good pharmacokinetic properties. (R)-IDO/TDO-IN-1 exhibits anti-tumor activity in MC38 xenograft model. (R)-IDO/TDO-IN-1 shows synergistic effect with anti-PD-1 monoclonal antibody (SHR-1210) .
Mycophenolate Mofetil (Standard) is the analytical standard of Mycophenolate Mofetil. This product is intended for research and analytical applications. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation .
Highly purified Type I collagen, from bovine skin (Bovine Type I collagen, immunization grade) plays an important role in the structure and function of skin, bone, tendons, and many others. Type I collagen potently stimulates angiogenesis in vitro and in vivo. Highly purified Type I collagen, from bovine skin is an immunization grade that can be used for immunization to generate antibodies .
(R)-(4-NH2)-Exatecan is the R enantiomer of (4-NH2)-Exatecan (Compound A). (R)-(4-NH2)-Exatecan, a topoisomerase inhibitor, is a derivative of Exatecan. (R)-(4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
Glucocorticoid receptor modulator 4 (Compound DL5) is a conjugate of a linker and a glucocorticoid receptor modulator. Glucocorticoid receptor modulator 4 exhibits GRE Reporter activity in mTNF expressing K562 cell with an EC50 of 40 μM. Glucocorticoid receptor modulator 4 binds with an anti-tumor necrosis factor (TNF) antibody, and exhibits anti-inflammtory activity against arthritis in mouse models .
DSPE-PEG-IA, MW 3400 is an iodoacetyll PEG lipid. The polymer can form lipid bilayer or micelles spontaneoulsy in water. The lipophilic tails can be used to encapsulate hydrophobic therapeutic agents while the hydrophilic head can be used to encapuslate hydrophilic drugs/nutrient, such as antibody, mRNA/DNA. The iodoacetyl group is reactive with thiol to produce a thioether linkage. Reagent grade, for research use only.
Salubrinal is a cell-permeable and selective inhibitor of eIF2α dephosphorylation . Salubrinal acts as a dual-specificity phosphatase 2 (Dusp2) inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis . Salubrinal has antiviral activity against HSV-1 and inhibits dephosphorylation of eIF2α mediated by the HSV-1 protein ICP34.5 .
NAMPT inhibitor-linker 2 is a agent-linker conjugates for ADC, composed of an NAMPT inhibitor as a payload, and a linker. ADC-4 consists of an NAMPT inhibitor-linker 2 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526, with IC50s of <7 pM and 40 pM, respectively.
NH2-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . NH2-PEG2-C2-Boc is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DBCO-NHCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-amine is a cleavable ADC linker used to conjugate MMAE (HY-15162) and antibody (e.g., DBCO-VCpAB−MMAE and DBCO-TRX−MMAE with EC50s of 280 nM and 22 nM in SKBR3 cells, respectively) .
Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-NH-PEG2-CH2COOH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-8-amino-3,6-dioxaoctanoic acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Fmoc-N-methyl-PEG3-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-N-methyl-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Boc-NH-PEG4-CH2CH2COOH is a PEG-based PROTAC linker can be used in the synthesis of PROTAC . Boc-NH-PEG4-CH2CH2COOH is also a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC) .
Propargyl-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG6-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azidoethyl-SS-ethylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-PEG1-SS-PEG1-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azidoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azidoethyl-SS-ethylazide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylazide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . endo-BCN-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
TCO-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
NH2-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
(S)-GNE-987 (compound 4), the GNE-987 (a chimeric BET degrader) hydroxy-proline epimer, abrogates binding to von Hippel-Lindau and does not degrade BRD4 protein. (S)-GNE-987 binds to the BRD4 BD1(IC50=4 nM) and BD2 (3.9 nM) bromodomains and can be used to design PROTAC-Antibody Conjugate (PAC) .
PBD dimer-2 (compound 2c) is a C8-linked pyrrolobenzodiazepine dimer. PBD dimer-2 can span an extra base pair and cross-link the 5′-Pu-GA(T/A)TC-Py sequence. PBD dimer-2 can be used as a payload for antibody–agent conjugates (ADCs), and it can be used for the research of cancer .
Sulfo-Cy3-NHS disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate ions. Sulfo-Cy3-NHS disodium contains sulfonate ions and has improved water solubility. Sulfo-Cy3-NHS disodium can label biomolecules containing amine groups, such as proteins, antibodies or peptides.
Sulfo-Cy7.5 DBCO is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a DBCO group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Sulfo-Cy7.5 DBCO can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples .
2′-O-Methylguanosine 5′-monophosphate is the nucleotide complex group (pGm) of the ribosome and is primarily used for DNA conjugation. Today's antibodies recognize pGm, in descending order of importance, as the parent base, the methylated ribose moiety, and the phosphate group. 2′-O-Methylguanosine 5′-monophosphate can also be used to prepare RNA vaccines as a 5′-terminal nucleotide to block the RNA molecule .
AM-0687 is a selective inhibitor for PI3Kδ with an IC50 of 2.9 nM. AM-0687 decreases the levels of IgG and IgM specific antibodies, inhibits the anti-IgM/CD40L-induced proliferation of human B cell (IC50=0.8 nM) and the phosphorylation of AKT (IC50=0.7 nM), and exhibits anti-inflammatory efficacy .
Fibrostatin C (P-23924C) is an orally active prolyl hydroxylase inhibitor that also inhibits collagen biosynthesis. Fibrostatin C also increases the number of cytoplasmic granules immunoreactive with antibodies to collagen I or III. Fibrostatin C inhibits the secretion of type I collagen in Tenon's capsule fibroblasts. Fibrostatin C is promising for research of the wound fibrotic response in the wound of glaucoma filtering surgery .
DC1Sme, a DC1 derivative, exhibits IC50 values of 22 pM, 10 pM, 32 pM and 250 pM for Ramos, Namalwa, HL60/s and COLO 205 cancer cells, respectively. DC1, an analogue of the minor groove-binding DNA alkylator CC-1065, is a ADC Cytotoxin. DC1 can be used in synthesis of antibody-drug conjugates for the targeted treatment of cancer.
NAMPT inhibitor-linker 1 is a agent-linker conjugates for ADC, composed of an NAMPT inhibitor as a payload, and a linker. ADC-3 consists of an NAMPT inhibitor-linker 1 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526 cells, with IC50s of <3 pM and 9 pM, respectively.
6-O-2-Propyn-1-yl-D-galactose is a nonclaevable glycolinker for the functionalization of cytotoxic agents and applications in antibody-agent conjugation. 6-O-2-Propyn-1-yl-D-galactose is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-NHS ester 3 (Compound 12) is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 3 is a derivative of Dibenzylcyclooctyne (DBCO) obtained by activation of N-hydroxysuccinimide by the carboxylic acid moiety of both methyl-oxanorbornadiene (MeOND) and dibenzoazacyclooctyne (DIBAC) . DBCO-NHS ester 3 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Maleimido-tri(ethylene glycol)-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Maleimido-tri(ethylene glycol)-propionic acid is used for the preparation of neolymphostin-based ADC precursors for site-specific cysteine mutant trastuzumab-A114C conjugation . Maleimido-tri(ethylene glycol)-propionic acid also can be used as a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Propargyl-PEG1-SS-PEG1-propargyl is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG1-SS-PEG1-PFP ester is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azidoethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Methyltetrazine-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
7-O-(Cbz-N-amido-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Cbz-N-amido-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs) .
Alkyne-PEG4-SS-PEG4-alkyne is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Alkyne-PEG4-SS-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Amino-PEG4-bis-PEG3-propargyl is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Mal-PEG4-bis-PEG3-DBCO is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Mal-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Mal-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG3-CH2-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-CH2-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Acid-PEG1-bis-PEG3-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Acid-PEG1-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Aminooxy-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
6-Azido-hexylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 6-Azido-hexylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan is a Drug-Linker Conjugates for ADC, which comprises a topoisomerase inhibitor and a linker for ligand unit connecting. Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan can be used to synthesis antibody-drug conjugate (ADC) .
Edratide (TV 4710) is a synthetic peptide of 19 amino acid based on the complementarity-determining region 1 (CDR1) of a human anti-DNA antibody that expresses a major idiotype denoted 16/6 Id. Edratide reduces the rates of apoptosis (Apoptosis) and down-regulates of caspase-8 and caspase-3, up-regulates Bcl-xL. Edratide has the potential for the research of systemic lupus erythematosus (SLE) .
BCN-HS-PEG2-VA-PABC-SG3199 (Compound 4) is a pyrrolobenzodiazepine that can be used as a agent linker of antibody-drug conjugates (ADC) . BCN-HS-PEG2-VA-PABC-SG3199 is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
17(R)-HDHA (17(R)-HDoHE) is a pro-resolving mediator (SPM). 17(R)-HDHA enhances the differentiation of B cells toward the CD27(+)CD38(+) antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells. 17(R)-HDHA does not affect cell proliferation and is non-toxic to cells .
LMP7/LMP2-IN-1 (Compound 19) is the orally active inhibitor for immunoproteasome subunits LMP7 and LMP2 with IC50 of 257 and 10 nM. LMP7/LMP2-IN-1 reduces the generation of antibody, downregulates the cells in spleen germinal center B and in plasma in NP-OVA-immunized mice, and can be used in research about autoimmune diseases .
TLR7 agonist 20 hydrochloride is an imidazoquinoline analogue. TLR7 agonist 20 hydrochloride is a potent TLR7 specific agonist, with an EC50 value of 0.23 μM for hTLR7. TLR7 agonist 20 hydrochloride shows strong adjuvant activity on spike antibody levels which induces a strong T helper 1 (Th1) response with increase in IgG2b and IgG2c, in addition to IgG1 .
R-75317 is a specific platelet-activating factor (PAF) antagonist. R-75317 can prevent the decline in creatinine clearance (Ccr) in a rat model of glomerulonephritis induced by the injection of antibodies extracted from rabbits against rat glomerular basement membrane (GBM) antigens, delay the onset of proteinuria, and improve glomerular hypertrophy, mesangial matrix proliferation, and interstitial fibrosis. R-75317 may be useful in the study of glomerulonephritis .
N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-Ph-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DBCO-Amide-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-Amide-PEG5-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
NH2-PEG4-CH2CH2COOH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG4-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
DBCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG5-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG5-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG9-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG9-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG9-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG8-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-Br is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Br is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-thiol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-thiol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG2-NHBoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-NHBoc is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-NHBoc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Mal-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Propargyl-NH-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-NH-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Ald-Ph-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Amino-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Propargyl-C8-amido-PEG2-NHS ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-C8-amido-PEG2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
SM-360320 (CL-087) is a potent, orally active TLR7 agonist. SM-360320 is a immuno-modulator and exerts an antitumor effect. SM-360320 can act in synergy with DNA vaccines leading to an enhanced Th1 antibody response . SM-360320 can inhibit HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity .
Cy3 dimethyl iodide is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) with a dimethyl group in the iodide salt form. The iodide salt form increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. Cy3 dimethyl iodide binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
AN-12-H5 intermediate-1 ((2S,4S)-1-tert-butyl 2-methyl-4-hydroxypiperidine-1,2-dicarboxylate) is an intermediate of the viral inhibitor AN-12-H5 (HY-120900) and can be used to synthesize Antibody-Drug Conjugates (ADCs).
TLR7 agonist 20 (compound 23) is an imidazoquinoline analogue. TLR7 agonist 20 is a potent TLR7 specific agonist, with an EC50 value of 0.23 μM for hTLR7. TLR7 agonist 20 shows strong adjuvant activity on spike antibody levels which induces a strong T helper 1 (Th1) response with increase in IgG2b and IgG2c, in addition to IgG1 .
10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate is an acridinium ester that produces fluorescent 10-methyl-9-acridone upon oxidation with hydrogen peroxide, persulfate, and other oxidants under alkaline conditions. 10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate can be used in chemiluminescent assays, enzyme, antigen, antibody, and hormone immunoassays, and for the detection of oxidants in environmental, biological, and pharmaceutical samples .
Tinostamustine hydrochloride (EDO-S101 hydrochloride) is a compound with anti-multiple myeloma activity and the ability to promote CD38 expression. Tinostamustine hydrochloride enhances the sensitivity of tumor cells to the anti-CD38 monoclonal antibody daratumumab by increasing the acetylation level of histone H3. Tinostamustine hydrochloride can increase the expression of MICA and MICB, thereby activating NK cells. Tinostamustine hydrochloride can significantly delay tumor growth and improve the survival rate of mice .
Tesirine (SG3249) is an antibody-drug conjugate (ADC) pyrrolobenzodiazepine (PBD) dimer payload. Tesirine combines potent antitumor activity with desirable physicochemical properties such as favorable hydrophobicity and improved conjugation characteristics. SG3199 (HY-101161) is the released warhead component of the ADC payload Tesirine. SG3199 retains picomolar activity in a panel of cancer cell lines. PBD dimers are highly efficient DNA minor groove cross-linking agents with potent cytotoxicity .
Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA is a double claevable 3-unit and 4-unit PEG linker for antibody-agent-conjugation (ADC). Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA also is a PROTAC linker that can be used in the synthesis of PROTACs.
Propargyl-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG2-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
m-PEG4-Br is a cleavable ADC linker used in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab (HY-P9907). m-PEG4-Br is placed distally from the monomethyl auristatin E (MMAE) payload to yield an ADC with altered hydrophilicity, antigen binding, and in vitro potency . m-PEG4-Br also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196) . Hydroxy-PEG2-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.
Boc-NH-PEG4-CH2CH2NH2 a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-NH-PEG4-CH2CH2NH2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Hydroxy-PEG4-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191). Hydroxy-PEG4-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.
NH2-PEG6-CH2CH2COOH is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG6-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs .
Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196) . Hydroxy-PEG2-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.
DBCO-NHCO-PEG4-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG5-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG3-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG3-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG3-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG8-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG5-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG2-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
m-PEG6-azide is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG5-Tos is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG5-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SSPy is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Bocaminooxyacetamide-PEG2-Azido is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG2-Azido is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biotin-PEG1-azide is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG1-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-C6-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C6-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-C2-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Bis-sulfone-PEG3-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bis-sulfone-PEG3-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biotin-PEG4-SS-azide is a cleavable, biotin-labeled, ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Biotin-PEG4-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
2’,3’-cGAMP-C2-PPA is a cyclic dinucleotide interferon gene-stimulating protein (STING) agonist. 2’,3’-cGAMP-C2-PPA is a drug conjugated conjugate used to target antibody-drug conjugated conjugate (ADC) for the treatment of cancer. 2’,3’-cGAMP-C2-PPA can be used in the study of immune and tumor-related diseases .
APN-PEG36-tetrazine is an analogue of APN-PEG4-tetrazine. APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG36-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
N-butyryl-L-Homoserine lactone-d5 is the deuterium labeled N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm[1]. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa[2][3].
N3-D-Orn(Boc)-OH is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
N3-D-Orn(Boc)-OH (CHA) is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
CD19 CAR circRNA will express CD19 car protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
Oxazolone is a haptenizing agent that induces acute or chronic inflammation of the large intestine and is used to construct models of colitis. Oxazolone can cause Th1/Th2-dependent colitis with weight loss and diarrhea. Oxazolone-induced inflammation can be mitigated by neutralizing anti-IL-4 or anti-TNF-α antibodies or decoy IL-13R2-α-FC proteins .
Cyanine7.5 carboxylic is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid functional groups. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Cyanine7.5 carboxylic can be covalently bound to some biological molecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cyanine7.5 carboxylic acid chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid functional groups. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Cyanine7.5 carboxylic acid chloride can be covalently bound to some biological molecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
Sodium citrate buffer, 0.5M, pH 5.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer 0.5M pH 5.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer 0.5M pH 5.5 is the preferred solution for most antibodies. .
Sodium citrate buffer, 0.5M, pH 6.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 6.5 is the preferred solution for most antibodies .
NH2-PEG3-VC-PAB-MMAE is a drug-linker conjugate for ADC, consisting of a cleavable ADC linker (NH2-PEG3-VC-PAB) and a potent tubulin inhibitor Monomethyl auristatin E (MMAE) (HY-15162). NH2-PEG3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
Anisperimus (LF-150195) is an immunosuppressant with the activity of enhancing activation-induced T cell death. Anisperimus enhances the sensitivity of T cells to anti-CD95 antibodies and other inducers by promoting the activation of caspase-8 and caspase-10 at the level of the death-inducing signaling complex (DISC). Anisperimus also promotes the development of Foxp3-expressing regulatory CD4 T cells, thereby preventing central nervous system autoimmunity .
McMMAF (Maleimidocaproyl monomethylauristatin F) is a maleimido-caproyl linker, made by coupling the powerful microtubule inhibitor Monomethyl auristatin F (MMAF) with the protecting group maleimidocaproyl. McMMAF serves as an active molecule linker for ADC. McMMAF is non-cleavable and must be internalized and degraded within the cell to release cysteine-McMMAF as the active molecule. McMMAF can be conjugated with anti-BCMA antibodies to form J6M0-mcMMAF, promoting apoptosis and inhibiting tumor growth .
4-N3Pfp-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 4-N3Pfp-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C3-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C3-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C4-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C4-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C5-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-O-C1-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-O-C1-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-NHCO-PEG4-NH-Boc is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NH-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NH-Boc is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). The ADCs can be used in bacterial infections caused by Gram-negative bacteria . Propargyl-PEG8-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N-Butanoyl-DL-homoserine lactone ((Rac)-C4-HSL) is a racemic mixture of N-Butanoyl-D-homoserine lactone and N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa .
PC Biotin-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biotin-PEG3-SS-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG3-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-SS-NHS is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SS-NHS is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
PTAD-PEG4-N3 is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Hynic-PEG3-N3 is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Hynic-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Aminoxyacetamide-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminoxyacetamide-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Gly-Gly-Gly-PEG4-azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Gly-Gly-Gly-PEG4-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
3-Aminopropyltriethoxysilane (APTES) acts as a strong glue to immobilize biomolecules such as antibodies and enzymes to silicon and silicon derivatives such as silicon nitride (Si3N4 )) on. 3-Aminopropyltriethoxysilane also acts as a spacer, providing biomolecules with more spatial freedom during immobilization for higher specific activity. 3-Aminopropyltriethoxysilane can form a more stable, sensitive, and highly biocompatible bioanalytical platform by immobilizing biomolecules onto some solid materials, electrode materials, nanomaterials, and nanocomposites .
CD19 CAR mRNA (Mouse) will express mouse CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
16:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG5000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
7-Aminomethyl-10-methyl-11-fluoro camptothecin is a cytotoxin of MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (HY-132158). 7-Aminomethyl-10-methyl-11-fluoro camptothecin can be used for the synthesis of camptothecin antibody-drug conjugate (ADC) .
Sulfo-Cy7.5 dimethyl is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with a dimethyl group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Sulfo-Cy7.5 dimethyl binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group in the disodium salt form. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3 alkyne chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing a sulfonate ion and an alkyne functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy3 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3 azide plus is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with an azide functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The azide group of Cy3 azide plus can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3 maleimide chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing maleimide functional groups. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 maleimide chloride can undergo a "thiol-acrylamide" reaction with molecules containing sulfur-oxygen functional groups to form covalent bonds. Cy3 maleimide chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
di-DTPA-LTL is a bivalent hapten based on tyrosine-containing polypeptide design. di-DTPA-LTL has good hydrophilia and biological distribution. di-DTPA-LTL is labeled with 111In (indium) and 131I (iodine). di-DTPA-LTL achieves tumor radioimmunoimaging in primary colorectal cancer patients with CEA by injecting a fixed low dose (5 mg) of bispecific antibody (anti-CEA x, anti-DTPA) and di-DTPA antigen peptide (labeled 111In) into the patients .
7-Aminomethyl-10-methyl-11-fluoro camptothecin TFA is a cytotoxin of MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (HY-132158). 7-Aminomethyl-10-methyl-11-fluoro camptothecin TFA can be used for the synthesis of camptothecin antibody-drug conjugate (ADC) .
FL118-C3-O-C-amide-C-NH2-d5 formate is a deuterium labeled FL118-C3-O-C-amide-C-NH2 formate. FL118-C3-O-C-amide-C-NH2 formate is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
CD19 CAR mRNA (Human) will express Human CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
INI-4001 is a TLR7/8 agonist, with EC50 values of 1.89 μM and 4.86 μM for TLR7/8, respectively. INI-4001 induces signaling and SEAP production through TLR7 and TLR8. INI-4001 promotes the generation of high-affinity, specific antibodies against fentanyl, preventing fentanyl from crossing the blood-brain barrier, making it an effective adjuvant for fentanyl vaccines in the opioid use disorder (OUD) population .
5(6)-FITC (Fluorescein 5(6)-isothiocyanate) is an amine-reactive derivative of a fluorescent dye, characterized by high absorbance and excellent fluorescence quantum yield. The isothiocyanate group of FITC can react with various functional groups on proteins, including amines, thiols, imidazoles, tyrosines and carbonyls, enabling the labeling of proteins such as antibodies and lectins. 5(6)-FITC has a wide range of applications, including flow cytometry, immunofluorescence, protease assays and conjugation. The maximum excitation/emission wavelengths are 492/518 nm .
DBCO-(PEG2-VC-PAB-MMAE)2 is made by MMAE conjugated to the cleavable DBCO-(PEG2-VC-PAB)2 linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody agent conjugate . DBCO-(PEG2-VC-PAB-MMAE)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
CL2A-SN-38 is a agent-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects .
DBCO-(PEG2-Val-Cit-PAB)2 is a dual cleavable ADC linker for antibody-drug conjugates (ADCs). DBCO-(PEG2-Val-Cit-PAB)2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. DBCO-(PEG2-Val-Cit-PAB)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG8-NH2 (compound 3b) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NH2 is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NH2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azide-C2-SS-C2-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-SS-C2-biotin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-Val-Cit-PAB-OH is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-Ala-Ala-Asn-PAB is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Boc-gly-PEG3-endo-BCN is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Boc-gly-PEG3-endo-BCN is also a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-gly-PEG3-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N3-PEG5-aldehyde is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG5-aldehyde is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DBCO-PEG3-TCO is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-TCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. DBCO-PEG3-TCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Azido-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
(R)-8-Azido-2-(Fmoc-amino)octanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . (R)-8-Azido-2-(Fmoc-amino)octanoic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-O-C1-amido-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-O-C1-amido-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Cy7.5 tetrazine tetrafluoroborate is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a tetrazine group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Cy7.5 tetrazine tetrafluoroborate can perform efficient click reactions with molecules containing alkyne functional groups (such as alkyne) to form covalent bonds. It can be combined with biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH GMP is a GMP grade MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (HY-131990). MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Bactobolin C is an antibiotic produced by Pseudomonas sp. BMG13A7, which has strong antimicrobial and antitumor activities, can also inhibit antibody production and treat autoimmune encephalomyelitis. However, its undesirable toxicity limits its medicinal application. The unique chemical structure and promising biological activities of Bactobolin C have attracted people's interest in its total synthesis and new active analogs. So far, the structural modification of Bactobolin C has mainly focused on the hydroxyl groups on the amino acid side chains and backbone.
MC-VC-PABC-amide-PEG1-CH2-CC-885 (compound III) is a neoDegrader, a conjugate of the GSPT1 degrader/molecular glue CC-885 (HY-101488) and a linker. MC-VC-PABC-amide-PEG1-CH2-CC-885 can be conjugated to the antibody DAR3.7 that specifically targets CD56 to synthesize Antibody-Drug Conjugates (ADCs). MC-VC-PABC-amide-PEG1-CH2-CC-885 can also be conjugated to Belantamab (HY-P9980), Daratumumab (HY-P9915), huMy9-6 IgG1, Indatuximab (HY-P990607), Isatuximab (HY-P9976), lintuzumab IgG1, Pertuzumab (HY-P9912), OR000213, Rituximab (HY-P9913), Sacituzumab (HY-P99045), Trastuzumab (HY-P9907)and U3-1784 (HY-P990672) to form conjugates .
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azido-PEG9-acid is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Azido-PEG9-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
PC-Biotin-PEG4-PEG3-azide is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC-Biotin-PEG4-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-CH2-PEG5-azide is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-CH2-PEG5-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG4-amido-Lys(Fmoc)-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG4-amido-Lys(Fmoc)-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Methyltetrazine-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-PEG4-hydrazone-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
β-D-tetraacetylgalactopyranoside-PEG1-N3 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . β-D-tetraacetylgalactopyranoside-PEG1-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Sulfo-Cy3 amine is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cyanine7.5 azide chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with an azide functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Cyanine7.5 azide chloride can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cyanine7.5 azide chloride can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy5 amine is a dye derivative of Cyanine 5 (Cy5) (HY-D0821) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy5 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. The amine functionality of Sulfo-Cy5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy7.5 dicarboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 dicarboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
Sodium citrate buffer, 0.1M, pH 4.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.1M, pH 4.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.1M, pH 4.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.1M, pH 4.0 is used in the hydration of liposome film .
Lipopolysaccharides, from E. coli O26:B6 is a lipopolysaccharide endotoxin and TLR-4 activator that activates the disease-related molecular pattern (PAMP) of the immune system and induces cell secretion of migratory bodies. Lipopolysaccharides, from E. coli O26:B6 consists of an antigen-specific O-chain, some cells lack an O-antigen-side chain, and is recognized by the core-specific monoclonal antibody MAb J8-4C10 .
DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Val-Cit-PAB-MMAF is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N3-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG2-C2-PFP ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-C2-PFP ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG4-C2-Pfp ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-Pfp ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG9-amine is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG9-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG7-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG7-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG8-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-C2-SS-PEG2-C2-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C2-SS-PEG2-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Amino-PEG6-amido-bis-PEG5-N3 is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG6-amido-bis-PEG5-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-Ph-PEG4-bis-PEG3-N3 is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Amino-PEG4-bis-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG4-VC-PAB-Doxorubicin is a agent-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody agent conjugate (ADC) . Azide-PEG4-VC-PAB-Doxorubicin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DIBAC-GGFG-NH2CH2-Dxd (compound LP4), a Camptothecin (HY-16560) derivative, is a linker-payload of protein-agent conjugates . Dxd (HY-13631D) can be used as a payload for the antibody-coupling drug ADC (DS-8201a).DIBAC-GGFG-NH2CH2-Dxd is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
COVID-19 Spike Protein mRNA will express COVID-19 spike protein, and suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 spike protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 spike protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 spike protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
Sulfo-Cy3 hydrazide is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with hydrazine functionality. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The hydrazide group of Sulfo-Cy3 hydrazide can form hydrazinone coupling with molecules containing aldehydes or ketones to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy7.5 alkyne chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functional group of Cy7.5 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy7.5 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy7.5 carboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate ion (sulfonate) functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 carboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
(S,R,S)-MI-1061 is the isomer of MI-1061(HY-125858). (S,R,S)-MI-1061 can used to synthesize Antibody-Drug Conjugates (ADCs). MI-1061 is a potent, orally bioavailable, and chemically stable MDM2 (MDM2-p53 interaction) inhibitor (IC50=4.4 nM; Ki=0.16 nM). MI-1061 potently activates p53 and induces apoptosis in the SJSA-1 xenograft tumor tissue in mice. Anti-tumor activity .
Sodium citrate buffer, 0.5M, pH 5.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 5.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 5.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.5M, pH 5.0 is used as solution for captisol in animal tumor models .
DBCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG4-amine can be used in the synthesis of FPM-PEG4-DBCO (a homobifunctional azide-to-azide cross-linker) . DBCO-PEG4-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG8-NHS ester is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG8-NHS ester is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG5-alcohol is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG6-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-alcohol is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG3-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azide-PEG3-Tos is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG3-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-amine is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
TCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. TCO-PEG4-DBCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
CD19 car mRNA (Mouse)-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
Sulfo-Cy3-PEG2-TCO disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate and TCO groups. The TCO groups of Sulfo-Cy3-PEG2-TCO disodium react with tetrazine functional groups in highly specific click chemistry to form covalent bonds. Thus, Sulfo-Cy3-PEG2-TCO disodium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
sulfo-Cy7.5 amine is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The amine functionality of sulfo-Cy7.5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy7.5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
DOTAGA-anhydride is a DOTA-based metal chelator that can bind to radionuclides and is used to prepare radionuclide drug conjugates (RDCs). DOTAGA-anhydride can be used to label monoclonal antibodies (mAbs) such as trastuzumab (targeting HER2/neu receptor with an affinity of 5.5 nM) under mild conditions (PBS pH 7.4, 25 °C, 30 minutes) after chelation with indium-111. [111In-DOTAGA]-trastuzumab showed a tumor uptake of 65% ID/g in mice bearing breast cancer BT-474 xenografts 72 hours after injection, which is valuable for SPECT/CT imaging and biodistribution studies.
Raleukin (AMG-719) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects .
PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases .
Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 Fv and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL) .
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas .
SMYD3-IN-2 is a SMYD3 inhibitor against gastric cancer via inducing lethal autophagy. SMYD3-IN-2 has inhibitory for SMYD3 and BGC823 cells with IC50 values of 0.81 μM and 0.75 μM, respectively. SMYD3-IN-2 can be used for the research of cancer .
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung .
Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis .
Ziv-aflibercept is a soluble inhibitor of vascular endothelial growth factor (VEGF). Ziv-aflibercept is an adaptive variant of Aflibercept (HY-108801), Ziv-aflibercept has a low PH value and high osmotic pressure when compared to Aflibercept. Ziv-aflibercept has potential applications in metastatic colorectal carcinoma and retinal diseases .
Cinrebafusp alfa (PRS 343) is a high affinity CD137/HER2 bispecfic anticalin-based drug. Cinrebafusp alfa binds to recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa facilitates T-cell costimulation by tumor-localized, HER2-dependent 4-1BB clustering and activation, further enhancing T-cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential for HER2+ solid tumors research .
Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .
Abatacept (CTLA4lg; BMS-188667) powder is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). Abatacept powder is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
Naratuximab emtansine (IMGN529) is a CD37-targeted ADC consisting of a humanized IgG1 mAb coupled to the microtubule disruptor DM1. Naratuximab emtansine has high affinity and specificity for CD37, allowing ADC internalization, processing and intracellular release of DM1. Due to its ability to disrupt microtubule assembly, DM1 can subsequently induce cell cycle arrest and apoptosis .
GNE-987 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. GNE-987 exhibits picomolar cell BRD4 degradation activity (DC50=0.03 nM for EOL-1 AML cell line). GNE-987 binds equipotently to the BD1 and BD2 bromodomains of BRD4 with low nanomolar affinities (IC50=4.7 and 4.4 nM, respectively). GNE-987 incorporates a potent BET binder/inhibitor, a VHL-binding fragment, and a ten methylene spacer moiety. GNE-987 can be used in PROTAC-Antibody Conjugate (PAC) .
Azido-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs, such as the conjugate CPT-APO (CPT: Camptothecin (HY-16560)). Azido-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Aminooxy-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-C2-PEG3-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-PEG1-SS-PEG1-C2-Boc is a Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG1-SS-PEG1-C2-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-C2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Sulfo-Cy3-PEG3-biotin potassium is a biotin-modified derivative of Cy3 (Cyanine3) (HY-D0822) dye containing a TCO group. The TCO group of Sulfo-Cy3-PEG3-biotin potassium reacts with the tetrazine functional group in highly specific click chemistry to form a covalent bond. Thus, Sulfo-Cy3-PEG3-biotin potassium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples. And because it is labeled with biotin, it is often used in affinity chromatography experiments, such as immunoprecipitation.
Sulfo-Cy7.5 alkyne is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functionality of Sulfo-Cy7.5 alkyne can react with molecules containing the azide functionality to form covalent bonds. Sulfo-Cy7.5 alkyne can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
RC529-MDP is an immunoadjuvant, combination of Toll-like Receptor (TLR) (TLR4a) and NOD-like Receptor (NOD2a), which enhances innate immune responses. BRC529-MDP activity depends on the TLR4 and NOD2 signaling pathways. RC529-MDP induces high levels of cytokine Interleukin Related (IL-6) in a mouse model, has immune-stimulating activity. RC529-MDP increases OVA-specific antibody responses, T cell responses, and the proportion of memory T cells in an OVA (HY-P0286)-injected mouse model .
Propargyl-PEG4-CH2CO2-NHS (compound P-7) is a PEG derivative containing a propargyl group and an NHS group. Propargyl-PEG4-CH2CO2-NHS is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG4-CH2CO2-NHS is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
Azido-PEG4-C2-acid a PEG-based PROTAC linker can be used in the synthesis of vRucaparib-TP4. Azido-PEG4-C2-acid is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-Val-Cit-PAB-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-Val-Cit-PAB-PNP is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-PNP is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG3-Val-Cit-PAB-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-CH2-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Ald-CH2-PEG3-azide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Ald-CH2-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Bromo-PEG2-C2-azide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bromo-PEG2-C2-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Bromo-PEG2-C2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent containing an azide group. TCO-PEG2-Sulfo-NHS ester is a PEG linker containing a TCO moiety and a sulfo-NHS ester moiety. The sulfo group makes this molecule soluble in waqueous buffer. This reagent can be used to label antibodies, proteins and other primary amine-containing macromolecules with TCO moiety. Reagent grade, for research use only . TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
AMD 3329 octahydrobromide is a potent and selective anti-HIV-1 and HIV-2 compound with activity to inhibit viral replication. AMD 3329 blocks viral invasion by binding to the chemokine receptor CXCR4. AMD 3329 exhibits EC50 values as low as 0.8 and 1.6 nM when inhibiting HIV-1 and HIV-2 replication, showing better antiviral efficacy than AMD3100. AMD 3329 significantly inhibits the binding of specific CXCR4 monoclonal antibodies and the Ca(2+) flux induced by SDF-1alpha. AMD 3329 is also able to effectively interfere with virus-induced syncytium formation, with an EC50 value of 12 nM .
Azido-PEG4-CH2-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG5-CH2CO2H is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG5-CH2CO2H is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-CH2CO2H is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-CH2CH2COOH a PEG-based PROTAC linker can be used in the synthesis of BI-3663 (HY-111546), BI-4216 and BI-0319. Azido-PEG3-acid is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-CH2CH2COOH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-CH2CH2-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG3-CH2CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . N3-PEG3-CH2CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG2-C2-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
KRH-3955 is a CXCR4 antagonist with good bioavailability and potent anti-HIV-1 activity. KRH-3955 can effectively inhibit the replication of X4 HIV-1, including clinical isolates from different donors. KRH-3955 also shows activity against recombinant X4 HIV-1 containing reverse transcriptase, protease and tyrosinase resistance mutations. KRH-3955 can inhibit the binding of SDF-1alpha to CXCR4 and calcium ion signaling through this receptor. KRH-3955 inhibits the binding of an antibody against CXCR4 to CXCR4, showing a potent antagonistic effect on CXCR4. KRH-3955 shows an oral bioavailability of 25.6% in rats and can inhibit the replication of X4 HIV-1 in vivo .
Sulfo-Cy7.5 azide is a Cyanine 7.5 (Cy7.5) (HY-D0926) dye derivative with azide and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Sulfo-Cy7.5 azide can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Sulfo-Cy7.5 azide can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples. It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
PROTAC PD-L1 degrader-2 (compound C3) is an orally effective PROTAC targeting HPK1 (DC50=21.26 nM). HPK1 is a negative regulator of T cell receptors, which can lead to T cell dysfunction after abnormal activation. PROTAC PD-L1 degrader-2 can inhibit SLP76 and NF-κB signaling pathways and inhibit MAPK signal transduction, and has anticancer activity and immune activation. PROTAC PD-L1 degrader-2 has a certain oral bioavailability and can be combined with PD-L1 antibody therapy to achieve a tumor growth inhibition rate of 65.58%. PROTAC PD-L1 degrader-2 is composed of E3 ligase ligand Thalidomide (HY-14658; blue part), PROTAC linker tert-Butyl 3-oxoazetidine-1-carboxylate (HY-40146; black part), and target protein ligand HPK1-IN-51 (HY-162842; red part); the activity control of the target protein ligand can be HPK1 ligand 1 (HY-162841) [1] .
Antibody-Drug Conjugates (ADCs), a new class of treatment for cancer, are composed with a monoclonal antibody, a linker and a cytotoxic agent also referred to as a payload. To date, several ADCs have received market approval and more than 60 ADCs are currently in clinical trials. ADCs are one of the fastest growing classes of oncology drugs worldwide.
The payload or cytotoxic agent is the most important unit in the ADC. ADC has the capability to kill cancer cell depending on the potency of the payload. MCE provides 103 highly potent cytotoxins that contain auristatin derivatives, maytansinoids, calicheamicin, duocarmycin, pyrrolobenzodiazepines (PBDs), etc.
Antibody inhibitors are compounds with the same activity as the original therapeutic antibodies, which can be used as positive controls for drug efficacy evaluation and other studies. Antibody inhibitors can also assist in verifying the functional activity of the target protein. These antibody inhibitors are active in vivo and can achieve certain physiological functions by blocking or neutralizing target proteins, such as CD20, HER2, EGFR, VEGFR, TNF-α, etc. In drug screening, antibody inhibitor-based screening can be carried out to identify active compounds targeting target proteins and target diseases.
MCE can provide 896 antibody inhibitors that can be used for drug development in cancer, immunity, infection and other hot research areas.
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecular targets that are involved in the growth, progression, and spread of cancer.
There are several different types of targeted therapy. The most common types are small-molecule drugs and monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells, while monoclonal antibodies are usually used for targets that are located outside the cells. Because of high specificity, low side effect and potent anticancer activity, targeted therapy has become the mainstream of new anti-tumor drugs. Various targeted therapies have been approved by FDA and used in the treatment of diseases.
MCE carefully collects a unique of 107 targeted therapy drugs used in cancer treatment. MCE Targeted therapy drug library is a useful tool for the research of targeted therapy.
Immuno-Oncology is a type of immunotherapy that has the specific purpose of treating cancer. It works by stimulating our immune system to fight back. Normally, our immune system is able to destroy cancer cells in our body, however sometimes cancer cells can adapt and mutate, effectively hiding from our immune system. This is when tumors can develop and become a threat to our health. Immuno-oncology involves mobilizing lymphocytes to recognize and eliminate cancer cells using the body’s immune system. There are several immuno-oncology treatments available, including Immune cell therapy (CAR-T), monoclonal antibodies (mABs) and checkpoint inhibitors, cytokines and cancer vaccines.
MCE Small Molecule Immuno-Oncology Compound Library offers 535 bioactive tumor immunology compounds that target some important checkpoints such as PD1/PD-L1, CXCR, Sting, IDO, TLR, etc. This library is a useful tool for Immuno-oncology research.
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
Cy5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Sulfo-CY-5.5 NHS ester (Sulfo-Cyanine5.5 NHS ester) tripotassium is an amine-reactive ester of sulfonated far-red Cyanine5.5 fluorophore, which can be used to label antibodies, proteins, etc., as well as for in vivo NIR imaging .
CY5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Sulfo-Cy3 maleimide potassium is a fluorescent dye with a maleimide functionality at the end a short alkyl linker. Sulfo-Cy3 maleimide potassium can be used for the labeling of antibodies and other labile proteins .
AgAuSe-COOH (1000 nm) is a fluorescent quantum dot that emits fluorescence in the near-infrared II region, with an emission peak reaching 1000 nm. AgAuSe-COOH (1000 nm) has the advantages of narrow band gap, large Stokes shift, and good photostability. AgAuSe-COOH (1000 nm) can bind proteins, antibodies, peptides, PEG, etc., and can be widely used in the field of biological imaging.
Tetramethylrhodamine-5-isothiocyanate is a potent fluorescent dye. Tetramethylrhodamine-5-isothiocyanate can be used for label PG-M3 antibody for rapid diagnosis of acute promyelocytic leukemia (APL). Tetramethylrhodamine-5-isothiocyanate can be used as probe to quantify in vivo the biodistribution of PLGA (poly(lactic-co-glycolic) acid) and PLGA/chitosan nanoparticles .
Cy2 iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
CY7 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy3 NHS ester is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
CY7-SE is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy2-SE iodine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
CY7-SE triethylamine is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy5.5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy7.5 is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cyanine5.5 maleimide chloride is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Sulfo-Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy7.5 maleimide is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy5.5 TEA is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Cy5.5 acetate is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance .
Sulfo-Cy5-Mal is a fluorescent dye with the form of active ester that reacts with thiol groups in proteins to form stable conjugates. Sulfo-Cy5-Mal that can be used to label protein .
6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
ATTO 590 Streptavidin is a streptavidin derivative of ATTO 590, it can label protein or antibody, the maximum excitation/emission wavelength: 594/622 nm.
ATTO 700 Streptavidin is a streptavidin derivative of ATTO 700, it can label protein or antibody, the maximum excitation/emission wavelength: 700/716 nm.
ATTO 594 Streptavidin is a streptavidin derivative of ATTO 594, it can label protein or antibody, the maximum excitation/emission wavelength: 603/626 nm.
ATTO 633 Streptavidin is a streptavidin derivative of ATTO 633, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
ATTO 565 Streptavidin is a streptavidin derivative of ATTO 565, it can label protein or antibody, the maximum excitation/emission wavelength: 564/590 nm.
ATTO 610 Streptavidin is a streptavidin derivative of ATTO 610, it can label protein or antibody, the maximum excitation/emission wavelength: 616/633 nm.
ATTO 725 Streptavidin is a streptavidin derivative of ATTO 725, it can label protein or antibody, the maximum excitation/emission wavelength: 728/751 nm.
ATTO 620 Streptavidin is a streptavidin derivative of ATTO 620, it can label protein or antibody, the maximum excitation/emission wavelength: 620/642 nm.
ATTO 647 Streptavidin is a streptavidin derivative of ATTO 647, it can label protein or antibody, the maximum excitation/emission wavelength: 630/651 nm.
ATTO 740 streptavidin is a streptavidin derivative of ATTO 740, it can label protein or antibody, the maximum excitation/emission wavelength: 743/763 nm.
ATTO 488 streptavidin is a streptavidin derivative of ATTO 488, it can label protein or antibody, the maximum excitation/emission wavelength: 500/520 nm.
ATTO 532 streptavidin is a streptavidin derivative of ATTO 532, it can label protein or antibody, the maximum excitation/emission wavelength: 532/552 nm.
ATTO 550 streptavidin is a streptavidin derivative of ATTO 550, it can label protein or antibody, the maximum excitation/emission wavelength: 554/576 nm.
ATTO 514 streptavidin is a streptavidin derivative of ATTO 514, it can label protein or antibody, the maximum excitation/emission wavelength: 511/531 nm.
ATTO 665 streptavidin is a streptavidin derivative of ATTO 665, it can label protein or antibody, the maximum excitation/emission wavelength: 663/680 nm.
ATTO 680 streptavidin is a streptavidin derivative of ATTO 680, it can label protein or antibody, the maximum excitation/emission wavelength: 681/698 nm.
Tyramide Amplification Buffer is a ready-to-use buffer primarily intended for immunostaining of cells and tissues by the technique of tyramide signal amplification (TSA). TSA Technology is based on a tyrosinase labeling system that reacts a tyrosine-labeled antibody with a fluorescently labeled tyramide using peroxidase to form a highly amplified fluorescent signal. For example, horseradish peroxidase (HRP) can catalyze the reaction of tyrosine and hydrogen peroxide under milder conditions to generate epoxy groups. Epoxy groups promote the binding of tyramide to adjacent amino acids to form fluorescently labeled products .
Cy5.5-SE (Cyanine5.5 NHS ester) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
ATTO 390 maleimide is a maleimide ester derivative of ATTO 390, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 390/476 nm.
ATTO 425 Maleimide is a maleimide ester derivative of ATTO 425, which can be used to label proteins or antibodies. The maximum excitation emission wavelength: 439/489 nm.
ATTO 465 Maleimid is a maleimide ester derivative of ATTO 465, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 453/506 nm.
ATTO 594 Maleimid is a maleimide ester derivative of ATTO 594, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 603/626 nm.
ATTO 633 Maleimid is a maleimide ester derivative of ATTO 633, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
ATTO 610 NHS-Ester is an activated ester derivative of ATTO 610, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 616/633 nm.
ATTO 610 Maleimid is a maleimide ester derivative of ATTO 610, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 616/633 nm.
ATTO 725 NHS-Ester is an activated ester derivative of ATTO 725, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
ATTO 725 Maleimid is a maleimide ester derivative of ATTO 725, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 728/751 nm.
ATTO 620 NHS-Ester is an activated ester derivative of ATTO 620, which can directly label proteins or antibodies. The maximum excitation/emission wavelength: 620/642 nm.
ATTO 620 Maleimid is a maleimide ester derivative of ATTO 620, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 620/642 nm.
ATTO 647 Maleimid is a maleimide ester derivative of ATTO 647, which can be used to label proteins or antibodies, with maximum excitation/emission wavelengths: 630/651 nm.
ATTO 665 maleimid is a maleimide ester derivative of ATTO 665, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 663/680 nm.
ATTO 514 maleimid is a maleimide ester derivative of ATTO 514, which can be used to label proteins or antibodies. The maximum excitation/emission wavelength: 511/531 nm.
Cy5.5-SE TEA (Cyanine5.5 NHS ester TEA) is a CY dye. CY, short for Cyanine, is a compound consisting of two nitrogen atoms connected by an odd number of methyl units. Cyanine compounds have the characteristics of long wavelength, adjustable absorption and emission, high extinction coefficient, good water solubility and relatively simple synthesis . CY dyes are of en used for the labeling of proteins, antibodies and small molecular compounds. For the labeling of protein antibodies, the combination can be completed through a simple mixing reaction. Below, we introduce the labeling method of protein antibody labeling, which has certain reference significance . Storage: protect from light.
Biotin-C2-maleimide is an antibody conjugate reagent, can bind to many biomolecules without significantly changing the biological activity of the target molecule .
Dap-NE hydrochloride (GMP) is Dap-NE hydrochloride (HY-78932A) produced by using GMP guidelines. Dap-NE hydrochloride is an intermediate used in the synthesis of antibody-drug conjugates (ADCs) .
AF488 amine is a bright, green-fluorescent dye used for labeling molecule such as antibodies. AF488 exhibits the λem and λex wavelength of 520 nm and 470 nm, respectively .
ISATM51 (GMP) is a GMP grade ISATM51. ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .
Sulfo CY5.5 hydrazide is a sulfonated version of Cy5.5, which can be used to label antibodies, proteins, etc., and for in vivo NIR (far-infrared) imaging.
Cy3B NHS ester is a fluorescent dye compound that is commonly used in biomarking and fluorescent labeling experiments, especially for labeling biomolecules containing amino functional groups (amine groups), such as proteins, antibodies or peptides.
Fmoc-Val-Cit-PAB GMP is a GMP grade Fmoc-Val-Cit-PAB (HY-19318). Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
Preactivated PE-Cy5.5 Maleimide is a Preactivated PE-Cy5.5 Maleimide, which is a dye that can be used to label molecules such as dye that can be used to label molecules such as antibodies .
Vari Fluor 750 Carboxylic acid (VF 750 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 555 Carboxylic acid (VF 555 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 647A Carboxylic acid (VF 647A Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 640 Carboxylic acid (VF 640 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 488 Carboxylic acid (VF 488 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 532 Carboxylic acid (VF 532 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 594 Carboxylic acid (VF 594 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 660 Carboxylic acid (VF 660 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 568 Carboxylic acid (VF 568 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Vari Fluor 680 Carboxylic acid (VF 680 Carboxylic acid) free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivatives are unactivated labeled fluorescent dyes for protein, antibody, and polysaccharide labeling that require carboxylic acid activation for use .
Ponceau S (Acid Red 112) is a non-specific protein dye commonly used as a stain for Western blot. Ponceau S is used in an acidic aqueous solution that is compatible with antibody-antigen binding and dyes the proteins on the membrane red .
NBDA (4-(α-N-L-alanine)-NBD) is a structural and functional analogue of the 2,4-dinitrophenyl group (DNP). NBDA can be used to detect and characterize antinitroaromatic antibodies, even in crude preparations, and possibly on cell surfaces .
DNP-X acid (6-((2,4-Dinitrophenyl)amino)hexanoic acid), an amine-reactive building block for developing a probe, can be recognized by anti-DNP antibodies. DNP-X acid is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
TFAX 568, SE is an orange fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 568, SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
Cyanine3 hydrazide dichloride is a carbonyl reactive dye. Cyanine3 hydrazide dichloride allows the labelling of various carbonyl-containing molecules such as antibodies and other glycoproteins after oxidation by periodate, proteins or reducing sugars after oxidative stress or deamination .
Fmoc-Gly-Gly-Phe-OH GMP is a GMP grade Fmoc-Gly-Gly-Phe-OH (HY-131833). Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Vari Fluor 647 Carboxylic acid free acid is a carboxylic acid derivative of Vari Fluor. Vari Fluor carboxylic acid derivative is an inactive labeled fluorescent dye, which can be used to label proteins, antibodies, polysaccharides. The use of Vari Fluor carboxylic acid derivatives requires carboxylic acid activation.
JF646-Hoechst is a fluorescent red DNA probe that is an ideal substitute for large oligonucleotide-coupled antibodies used in PAINT experiments, especially for bacterial studies. JF646-Hoechst excitation/emission maximum =655/670 nm .
Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fluorescein-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TFAX 594,SE is a red fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 594,SE yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG) .
DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-NHS ester (sodium) is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TFAX 488,TFP is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,TFP yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
Preactivated PE-Cy5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
Preactivated APC-Cy5.5 Maleimide is a sulfhydryl reactive dye that reacts with free sulfhydryl groups on proteins. Preactivated APC-Cy5.5 Maleimide binds easily to proteins or antibodies, and does not change the spectral characteristics of APC-Cy/YF after activation.
TFAX 488,SE dilithium is a green fluorescent dye and exhibits pH-insensitivity over a very broad range (pH in the 4-10). TFAX 488,SE dilithium yields exceptionally bright, photostable conjugates with proteins or antibodies (such as goat anti-mouse IgG, streptavidin) .
FITC (Fluorescein Isothiocyanate), is one of the green fluorescein derivatives widely used in biology. FITC has the characteristics of high absorptivity and excellent fluorescence quantum yield. The isothiocyanate group of FITC can be combined with amino, sulfhydryl, imidazole, tyrosyl, carbonyl and other groups on the protein, so as to achieve protein labeling including antibodies and lectins. In addition to its use as a protein marker, FITC can also be used as a fluorescent protein tracer to rapidly identify pathogens by labeling antibodies, or for microsequencing of proteins and peptides (HPLC). The maximum excitation wavelength of FITC is 494 nm. Once excited, it fluoresces yellow-green at a maximum emission wavelength of 520 nm. In addition, FITC is also a hapten that can induce contact hypersensitivity (CHS) and induce an atopic dermatitis model .
Mc-Val-Cit-PABC-PNP GMP is a GMP grade Mc-Val-Cit-PABC-PNP (HY-20336). Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
ATTO 488 carboxylic acid is a new fluorescent label based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 carboxylic acid is a carboxylic acid derivative of ATTO 488, which can be used to label proteins or antibodies.
ATTO 390 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 390 NHS ester is an NHS ester derivative of ATTO 390 that can be used to label proteins or antibodies.
ATTO 594 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 594 NHS ester is an NHS ester derivative of ATTO 594 that can be used to label proteins or antibodies.
ATTO 590 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 NHS ester is an NHS ester derivative of ATTO 590 that can be used to label proteins or antibodies.
ATTO 590 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 maleimide is a maleimide derivative of ATTO 590, which can be used to label proteins or antibodies.
ATTO 465 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 NHS ester is an NHS ester derivative of ATTO 465 that can be used to label proteins or antibodies.
ATTO 465 amine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 465 amine is an amine derivative of ATTO 465 and can be used to label proteins or antibodies.
ATTO 590 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 590 alkyne is an alkyne derivative of ATTO 590 and can be used to label proteins or antibodies.
ATTO 633 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 633 NHS ester is an NHS ester derivative of ATTO 633 that can be used to label proteins or antibodies.
ATTO 565 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 NHS ester is an NHS ester derivative of ATTO 565 that can be used to label proteins or antibodies.
ATTO 565 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 maleimide is a maleimide derivative of ATTO 565, which can be used to label proteins or antibodies.
ATTO 647 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 647 NHS ester is an NHS ester derivative of ATTO 647 that can be used to label proteins or antibodies.
ATTO 665 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 665 NHS ester is an NHS ester derivative of ATTO 665 that can be used to label proteins or antibodies.
ATTO 488 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 NHS ester is an NHS ester derivative of ATTO 488 that can be used to label proteins or antibodies.
ATTO 488 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 maleimide is a maleimide derivative of ATTO 488, which can be used to label proteins or antibodies.
ATTO 565 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 alkyne is an alkyne derivative of ATTO 565 and can be used to label proteins or antibodies.
ATTO 488 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 488 alkyne is an alkyne derivative of ATTO 488 and can be used to label proteins or antibodies.
ATTO 425 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 425 NHS ester is an NHS ester derivative of ATTO 425 that can be used to label proteins or antibodies.
ATTO 565 cadaverine is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 565 cadaverine is a cadaverine derivative of ATTO 565, which can be used to label proteins or antibodies.
ATTO 550 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 NHS ester is an NHS ester derivative of ATTO 550 that can be used to label proteins or antibodies.
ATTO 550 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 maleimide is a maleimide derivative of ATTO 550, which can be used to label proteins or antibodies.
ATTO 514 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 NHS ester is an NHS ester derivative of ATTO 514 that can be used to label proteins or antibodies.
ATTO 514 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 514 alkyne is an alkyne derivative of ATTO 514 and can be used to label proteins or antibodies.
ATTO 550 alkyne is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 550 alkyne is an alkyne derivative of ATTO 550 and can be used to label proteins or antibodies.
ATTO 532 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 NHS ester is an NHS ester derivative of ATTO 532 that can be used to label proteins or antibodies.
ATTO 532 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 maleimide is a maleimide derivative of ATTO 532, which can be used to label proteins or antibodies.
ATTO 532 iodacetamid is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 532 iodacetamid is an iodoacetamide derivative of ATTO 532, which can be used to label proteins or antibodies.
ATTO 700 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 NHS ester is an NHS ester derivative of ATTO 700 that can be used to label proteins or antibodies.
ATTO 700 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 700 maleimide is a maleimide derivative of ATTO 700, which can be used to label proteins or antibodies.
ATTO 740 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 NHS ester is an NHS ester derivative of ATTO 740 that can be used to label proteins or antibodies.
ATTO 740 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 740 maleimide is a maleimide derivative of ATTO 740, which can be used to label proteins or antibodies.
ATTO 680 NHS ester is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 NHS ester is an NHS ester derivative of ATTO 680 that can be used to label proteins or antibodies.
ATTO 680 maleimide is a new fluorescent marker based on the Rhodamine structure. It has strong absorption, high fluorescence quantum yield, high thermal stability and photochemical stability, and is suitable for single molecule detection and high-resolution microscopy. ATTO 680 maleimide is a maleimide derivative of ATTO 680, which can be used to label proteins or antibodies.
Boc-Dap-NE (GMP) is Boc-Dap-NE (HY-78931) produced by using GMP guidelines. Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium is a fluorescent dye. 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid disodium can be used to demonstrate retrograde axonal transport to label secondary antibodies and as a fluorescent whole cell stain .
DBCO-amine GMP is a GMP grade DBCO-amine (HY-W000423). DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, itcontains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
McMMAF GMP is a GMP grade McMMAF (HY-15578). McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
BODIPY TMR NHS ester is bright, orange fluorescent dye with Ex/Em of 544/570 nm. The NHS ester (or succinimidyl ester) of BODIPY TMR NHS ester is a popular tool for conjugating the dye to a protein or antibody. NHS esters can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules .
DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester), the DNP-X acid modified by succinimidyl ester, is an amine-reactive building block for developing a probe, which can be recognized by anti-DNP antibodies. DNP-X, SE (6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester) is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
Vari Fluor 680 SE (VF 680 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=680 nm/700 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 488 SE (VF 488 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=488 nm/513 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 640 SE (VF 640 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=648 nm/664 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 425 SE (VF 425 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=430 nm/475 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 565 SE (VF 565 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=563 nm/594 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 660 SE (VF 660 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=660 nm/679 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 350 SE (VF 350 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=350 nm/448 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 568 SE (VF 568 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=573 nm/595 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 750 SE (VF 750 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=747 nm/770 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 555 SE (VF 555 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=550 nm/561 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 405 SE (VF 405 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=399 nm/421 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 532 SE (VF 532 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=532 nm/545 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Vari Fluor 594 SE (VF 594 SE) is a dye marker of the Vari Fluor SE series (Ex/Em=585 nm/609 nm). The Vari Fluor SE series of dyes are a class of fluorescent dyes containing NHS ester groups used to label free amines (-NHX) on antibodies, proteins, peptides, amine-modified oligonucleotides and other biomolecules.
Cy7-YNE is a fluorescence labeling agent (Ex=700-770 nm，Em=790 nm). Cyanine dyes are used to label proteins, antibodies, and peptides. Cy7-YNE is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BODIPY TMR-X SE is a potent fluorescent dye. BODIPY TMR-X SE can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, orange fluorescent light. (λex=544 nm, λem=570 nm) .
DRAQ5 is a novel cell permeant and far red-fluorescing DNA probe. DRAQ5 excites at a wavelength of 647 nm, close to the Ex, and produces a fluorescence spectrum extending from 665 nm out to beyond 780 nm wavelengths. DRAQ5 fluorescence reflects cellular DNA content. DRAQ5 can be used in combination with FITC and RPE-labelled antibodies, without the need for fluorescence compensation .
BODIPY TR-X (BODIPY TR-X NHS Ester) is a potent fluorescent dye. BODIPY TR-X can be used to label the primary amines (R-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. BODIPY TR-X binds to protein or antibody and has bright, red fluorescent light. (λex=545 nm, λem=560 nm) .
Sulfo-Cy3-NHS disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate ions. Sulfo-Cy3-NHS disodium contains sulfonate ions and has improved water solubility. Sulfo-Cy3-NHS disodium can label biomolecules containing amine groups, such as proteins, antibodies or peptides.
Sulfo-Cy7.5 DBCO is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a DBCO group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Sulfo-Cy7.5 DBCO can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples .
Cy3 dimethyl iodide is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) with a dimethyl group in the iodide salt form. The iodide salt form increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. Cy3 dimethyl iodide binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate is an acridinium ester that produces fluorescent 10-methyl-9-acridone upon oxidation with hydrogen peroxide, persulfate, and other oxidants under alkaline conditions. 10-Methyl-9-(phenoxycarbonyl) acridinium trifluoromethanesulfonate can be used in chemiluminescent assays, enzyme, antigen, antibody, and hormone immunoassays, and for the detection of oxidants in environmental, biological, and pharmaceutical samples .
Cyanine7.5 carboxylic is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid functional groups. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Cyanine7.5 carboxylic can be covalently bound to some biological molecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy7.5 dimethyl is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with a dimethyl group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Sulfo-Cy7.5 dimethyl binds to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3B amine chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group in the disodium salt form. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3 alkyne chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing a sulfonate ion and an alkyne functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy3 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3 azide plus is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with an azide functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The azide group of Cy3 azide plus can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy3 maleimide chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing maleimide functional groups. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 maleimide chloride can undergo a "thiol-acrylamide" reaction with molecules containing sulfur-oxygen functional groups to form covalent bonds. Cy3 maleimide chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
5(6)-FITC (Fluorescein 5(6)-isothiocyanate) is an amine-reactive derivative of a fluorescent dye, characterized by high absorbance and excellent fluorescence quantum yield. The isothiocyanate group of FITC can react with various functional groups on proteins, including amines, thiols, imidazoles, tyrosines and carbonyls, enabling the labeling of proteins such as antibodies and lectins. 5(6)-FITC has a wide range of applications, including flow cytometry, immunofluorescence, protease assays and conjugation. The maximum excitation/emission wavelengths are 492/518 nm .
Cy7.5 tetrazine tetrafluoroborate is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a tetrazine group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. Cy7.5 tetrazine tetrafluoroborate can perform efficient click reactions with molecules containing alkyne functional groups (such as alkyne) to form covalent bonds. It can be combined with biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH GMP is a GMP grade MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (HY-131990). MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Sulfo-Cy3 amine is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The amine functionality of Sulfo-Cy3 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy3 amine can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cyanine7.5 azide chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with an azide functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Cyanine7.5 azide chloride can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Cyanine7.5 azide chloride can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy5 amine is a dye derivative of Cyanine 5 (Cy5) (HY-D0821) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy5 is a near-infrared fluorescent dye commonly used in biolabeling and cell imaging. The amine functionality of Sulfo-Cy5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy7.5 dicarboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 dicarboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
Sulfo-Cy3 hydrazide is a Cyanine 3 (Cy3) (HY-D0822) dye derivative with hydrazine functionality. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The hydrazide group of Sulfo-Cy3 hydrazide can form hydrazinone coupling with molecules containing aldehydes or ketones to form covalent bonds. Therefore, Cy3 azide plus can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Cy7.5 alkyne chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functional group of Cy7.5 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy7.5 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy7.5 carboxylic acid is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) with carboxylic acid and sulfonate ion (sulfonate) functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used in biomedical research areas such as biomarkers and cell imaging. Sulfo-Cy7.5 carboxylic acid can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
Sulfo-Cy3-PEG2-TCO disodium is a derivative of Cy3 (Cyanine3) (HY-D0822) dye containing sulfonate and TCO groups. The TCO groups of Sulfo-Cy3-PEG2-TCO disodium react with tetrazine functional groups in highly specific click chemistry to form covalent bonds. Thus, Sulfo-Cy3-PEG2-TCO disodium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples.
sulfo-Cy7.5 amine is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing an amine group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The amine functionality of sulfo-Cy7.5 amine can react with carboxyl groups to form covalent bonds. Sulfo-Cy7.5 amine can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy3-PEG3-biotin potassium is a biotin-modified derivative of Cy3 (Cyanine3) (HY-D0822) dye containing a TCO group. The TCO group of Sulfo-Cy3-PEG3-biotin potassium reacts with the tetrazine functional group in highly specific click chemistry to form a covalent bond. Thus, Sulfo-Cy3-PEG3-biotin potassium can be covalently bound to some biomolecules (especially antibodies, proteins, etc.) to track their location and dynamic changes in biological samples. And because it is labeled with biotin, it is often used in affinity chromatography experiments, such as immunoprecipitation.
Sulfo-Cy7.5 alkyne is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functionality of Sulfo-Cy7.5 alkyne can react with molecules containing the azide functionality to form covalent bonds. Sulfo-Cy7.5 alkyne can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Sulfo-Cy7.5 azide is a Cyanine 7.5 (Cy7.5) (HY-D0926) dye derivative with azide and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Sulfo-Cy7.5 azide can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Sulfo-Cy7.5 azide can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples. It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) containing mRNA encoding COVID-19 Spike Protein , suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 Spike Protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 Spike Protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 Spike Protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
NODAGA-tris(t-Bu ester) (NODAG) is a NODAGA derivative. NODAGA-tris(t-Bu ester) can be used to label peptides, antibodies, etc., and subsequently radiolabeled for PET imaging .
Phospholipid-PEG-Biotin (MW 1000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 3400) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 10000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 20000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
EDTA-p-Bromoacetamido benzyl ((S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid) is a compound of EDTA and phenylbromoacetamide that can be coupled to antibodies .
Dap-NE hydrochloride (GMP) is Dap-NE hydrochloride (HY-78932A) produced by using GMP guidelines. Dap-NE hydrochloride is an intermediate used in the synthesis of antibody-drug conjugates (ADCs) .
ISATM51 (GMP) is a GMP grade ISATM51. ISATM51 is a vaccine adjuvant that enhances antigen-specific antibody titers and cytotoxic T lymphocyte (CTL) responses .
Phosphoric acid (sodium hydrate),≥99.0% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, as a laxative, and in combination with other sodium phosphates
Potassium dihydrogen phosphate (Potassium phosphate monobasic), for molecular biology, ≥ 99% is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates .
Fmoc-Val-Cit-PAB GMP is a GMP grade Fmoc-Val-Cit-PAB (HY-19318). Fmoc-Val-Cit-PAB is a cleavable antibody-conjugated active molecule (ADC) commonly used linker.
Tricine is widely used as a buffer in protein electrophoresis, nucleic acid analysis, and immunology, which can help adjust pH and stabilize chemical reactions. In addition, the compound can also be used in research in certain medical fields, such as in antibody detection and drug screening.
Fmoc-Gly-Gly-Phe-OH GMP is a GMP grade Fmoc-Gly-Gly-Phe-OH (HY-131833). Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Potassium dihydrogen phosphate (Potassium phosphate monobasic), meets analytical specification of Ph. Eur., NF, E340 is used as a buffer capacity reagent in molecular biology, biochemistry, and chromatography. For the preparation of biological buffers. It is also used to purify antibodies, and in combination with other sodium phosphates, meets analytical specification of Ph. Eur., NF, E340 .
Mc-Val-Cit-PABC-PNP GMP is a GMP grade Mc-Val-Cit-PABC-PNP (HY-20336). Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs) .
Highly purified Type I collagen, from porcine skin (Porcine Type I collagen, immunization grade) is an immune grade collagen derived from porcine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from canine skin (Canine Type I collagen, immunization grade) is an immune grade collagen derived from canine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from rat skin (Rat Type I collagen, immunization grade) is an immune grade collagen derived from rat skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified type I collagen, from mouse skin (Mouse Type I collagen, immunization grade) is an immune grade collagen derived from mouse skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from mouse intestine (Mouse Type II collagen, immunization grade) is an immune grade collagen derived from mouse intestine, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from chick skin (Chick type I collagen, immunization grade) is an immune grade collagen derived from chick skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type III collagen, from human placenta (Human Type III collagen, immunization grade) is an immune grade collagen derived from human placenta, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type III collagen, from porcine skin (Porcine Type III collagen, immunization grade) is an immune grade collagen derived from porcine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from rabbit skin (Canine Type I collagen, immunization grade) is an immune grade collagen derived from rabbit skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type I collagen, from human placenta (Human Type I collagen, immunization grade) is an immune grade collagen derived from human placenta, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type III collagen, from bovine skin (Bovine Type III collagen, immunization grade) is an immune grade collagen derived from bovine skin, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Boc-Dap-NE (GMP) is Boc-Dap-NE (HY-78931) produced by using GMP guidelines. Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
Protein A (SPA) is an immunoglobulin (Ig) binding protein that exists on the surface of bacteria and can be freely secreted into the extracellular environment. Protein A blocks opsonization and phagocytosis and induces B-cell death in vitro by binding to the Fc region of antibodies and the Fab region of B-cell receptors. Protein A has the ability to inhibit opsonization and phagocytosis in vitro .
Highly purified Type II collagen, from porcine articular cartilage (Porcine Type II collagen, immunization grade) is an immune grade collagen derived from porcine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from porcine articular cartilage (Porcine Type XI collagen, immunization grade) is an immune grade collagen derived from porcine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from human placenta (Human Placenta Type V collagen, immunization grade) is an immune grade collagen derived from human placenta, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from chick sternal cartilage (Chick Type II collagen, immunization grade) is an immune grade collagen derived from chick sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type IX collagen, from bovine articular cartilage (Bovine Type IX collagen, immunization grade) is an immune grade collagen derived from bovine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified type II collagen, from rat sternal cartilage (Rat Type II collagen, immunization grade) is an immune grade collagen derived from rat sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from mouse sternal cartilage (Mouse Type II collagen, immunization grade) is an immune grade collagen derived from mouse sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type IX collagen, from chick articular cartilage (Chick Type IX collagen, immunization grade) is an immune grade collagen derived from chick articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from human sternal cartilage (Human Type XI collagen, immunization grade) is an immune grade collagen derived from human sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from human amnion (Human Amnion Type V collagen, immunization grade) is an immune grade collagen derived from human amnion, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type IX collagen, from porcine articular cartilage (Porcine Type IX collagen, immunization grade) is an immune grade collagen derived from porcine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from sheep articular cartilage (Sheep Type II collagen, immunization grade) is an immune grade collagen derived from sheep articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from goat articular cartilage (Goat Type II collagen, immunization grade) is an immune grade collagen derived from goat articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type II collagen, from human sternal cartilage (Human Type II collagen, immunization grade) is an immune grade collagen derived from human sternal cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type V collagen, from bovine amnion (Bovine Amnion Type V collagen, immunization grade) is an immune grade collagen derived from bovine amnion, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from bovine articular cartilage (Bovine Type XI collagen, immunization grade) is an immune grade collagen derived from bovine articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
Highly purified Type XI collagen, from chick articular cartilage (Chick Type XI collagen, immunization grade) is an immune grade collagen derived from chick articular cartilage, which can stimulate the animal's immune system to produce specific antibodies against this collagen. Collagen is also a substrate for hydrolysis by MMPs .
DBCO-amine GMP is a GMP grade DBCO-amine (HY-W000423). DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, itcontains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
McMMAF GMP is a GMP grade McMMAF (HY-15578). McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent .
Desthiobiotin-PEG3-triazole-DBCO-sulfo-Maleimide is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Desthiobiotin-PEG3-triazole-DBCO-sulfo-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
Highly purified Type I collagen, from bovine skin (Bovine Type I collagen, immunization grade) plays an important role in the structure and function of skin, bone, tendons, and many others. Type I collagen potently stimulates angiogenesis in vitro and in vivo. Highly purified Type I collagen, from bovine skin is an immunization grade that can be used for immunization to generate antibodies .
DSPE-PEG-IA, MW 3400 is an iodoacetyll PEG lipid. The polymer can form lipid bilayer or micelles spontaneoulsy in water. The lipophilic tails can be used to encapsulate hydrophobic therapeutic agents while the hydrophilic head can be used to encapuslate hydrophilic drugs/nutrient, such as antibody, mRNA/DNA. The iodoacetyl group is reactive with thiol to produce a thioether linkage. Reagent grade, for research use only.
Sodium citrate buffer, 0.5M, pH 5.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer 0.5M pH 5.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer 0.5M pH 5.5 is the preferred solution for most antibodies. .
Sodium citrate buffer, 0.5M, pH 6.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 6.5 is the preferred solution for most antibodies .
3-Aminopropyltriethoxysilane (APTES) acts as a strong glue to immobilize biomolecules such as antibodies and enzymes to silicon and silicon derivatives such as silicon nitride (Si3N4 )) on. 3-Aminopropyltriethoxysilane also acts as a spacer, providing biomolecules with more spatial freedom during immobilization for higher specific activity. 3-Aminopropyltriethoxysilane can form a more stable, sensitive, and highly biocompatible bioanalytical platform by immobilizing biomolecules onto some solid materials, electrode materials, nanomaterials, and nanocomposites .
16:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG5000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
Concanavalin A (agarose) consists of Concanavalin A (HY-P2149) coupled to agarose. Concanavalin A is a tetrameric metalloprotein lectin isolated from Canavalia ensiformis (jack bean). Concanavalin A (agarose) is used for the purification of glycoproteins, polysaccharides and glycolipids as it binds molecules containing α-D-mannopyranosyl, α-D-glucopyranosyl and sterically related residues. Concanavalin A (agarose) has also be used in other application areas including purification of enzyme-antibody conjugates, purification of IgM and separation of membrane vesicles .
Bovine Serum Albumin, Acetylated (Ac-BSA) is a polypeptide of known structure with strong antigenicity. Bovine Serum Albumin, Acetylated produced a significant immune response, validating the accuracy and reliability of the experimental method. Bovine Serum Albumin, Acetylated can be used as a positive control substance in ELISA or WB experiments, and can be used in experiments with acetylated lysine monoclonal or polyclonal antibodies. Bovine Serum Albumin, Acetylated also improves encapsulation efficiency at low concentrations of PLGA, a polymer for biopharmaceutical delivery with biocompatibility, degradability, and controlled release properties .
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH GMP is a GMP grade MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (HY-131990). MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
Sodium citrate buffer, 0.1M, pH 4.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.1M, pH 4.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.1M, pH 4.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.1M, pH 4.0 is used in the hydration of liposome film .
Lipopolysaccharides, from E. coli O26:B6 is a lipopolysaccharide endotoxin and TLR-4 activator that activates the disease-related molecular pattern (PAMP) of the immune system and induces cell secretion of migratory bodies. Lipopolysaccharides, from E. coli O26:B6 consists of an antigen-specific O-chain, some cells lack an O-antigen-side chain, and is recognized by the core-specific monoclonal antibody MAb J8-4C10 .
1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
Sodium citrate buffer, 0.5M, pH 5.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 5.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 5.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.5M, pH 5.0 is used as solution for captisol in animal tumor models .
CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
CD19 car mRNA (Mouse)-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
NOTA-AE105 is an PET ligand of urokinase-type plasminogen activator receptor(uPAR), which can be radiolabeled by 64Cu and 68Ga. 68Ga-NOTA-AE105 and 64Cu-NOTA-AE105 shows high image contrast, resulting in clear tumor delineation .
Angstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling .
Influenza hemagglutinin (HA) epitope is a polypeptide. Influenza hemagglutinin (HA) epitope is conjugated to keyhole limpet hemocyanin to generate anti-HA polyclonal antibodies following immunization of rabbits .
CCP peptide TFA is a synthetic cyclic citrullinated peptide (CCP) and used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide TFA functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA) .
Cenupatide (UPARANT) is a Urokinase-type plasminogen activator receptor (uPAR) inhibitor. Cenupatide has anti-angiogenic and anti-inflammatory efficacy .
2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .
Humanized anti-tac (HAT) binding peptide is a peptide that can specifically bind to the Fc region of HAT. HAT is a humanized monoclonal antibody against the low affinity p55 subunit of the interleukin IL-2 receptor. Humanized anti-tac (HAT) binding peptide can be used to develop affinity chromatography media to purify specific monoclonal antibodies .
CCP peptide is a synthetic cyclic citrullinated peptide (CCP) and used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA) .
β Amyloid (1-14), human is a peptide fragment of β-amyloid protein (Aβ), which is obtained by hydrolysis of Aβ1-40 peptide by catalytic antibody light chain #7TR. β Amyloid (1-14), human can be used for Alzheimer's disease research .
Splenopentin diacetate is a synthetic immunomodulating pentapeptide corresponding to the residues 32-36 of the splenic hormone splenin. Splenopentin diacetate influences both early T and B cell differentiation, to increase the number of antibody-forming cells in mice after gamma irradiation .
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .
Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr is a undecapeptide, corresponding to the carboxy terminus of simian virus 40 large T antigen. Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr can be targeted by antibodies secreted from three mouse hybridomas, designated KT1, KT3, and KT4, produced antibodies that immunoprecipitated large T antigen .
Boc-Gly-Gly-Phe-Gly-OH TFA, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A .
Noraramtide (BHV-1100) is an antibody recruitment molecule. Noraramtide can specifically bind to CD38 molecules to recruit natural killer (NK) cells. Noraramtide enhances the ability of NK cells to kill tumor cells through antibody-dependent cellular cytotoxicity (ADCC). This mechanism allows NK cells to more effectively recognize and eliminate tumor cells while avoiding mutual killing between NK cells. Noraramtide can be used for the study of autologous cancer immunity .
RS09 is a LPS peptide mimic serves as a candidate to be considered as a new class of TLR4 agonist adjuvant. RS09 increases antibody production in a vaccine setting .
LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
LEESGGGLVQPGGSMK acetate, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK acetate can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
DSTYSLSSTLTLSK is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
LEESGGGLVQPGGSMK TFA, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK TFA can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .
Glycyllysine is a polypeptide that can be used in the synthesis of antibodies and amino acid type gemini surfactants. Glycyllysine has potential applications in modifying plasmid/gemini/lipid (P/G/L) nanoparticles transport carriers .
Rhodopsin Epitope Tag is a 9-amino acid peptide localized within the C-terminal region of bovine rhodopsin . Rhodopsin Epitope Tag is widely used as an epitope tag and can be recognized by a number of anti-rhodopsin antibodies.
BACE1 (485-501) is the carboxyl terminal of BACE1 (Beta-site APP cleaving enzyme 1). BACE1 (485-501) can be used as antigen to produce anti-BACE1-C antibody .
5-Lipoxygenase blocking peptide (Human/rat 5-LO 130-149) is a specific sequence fragment of 5-lipoxygenase (5-LOX), which can be utilized to prepare an antibody against 5-LOX .
DYKDDDDK peptide (FLAG) is a useful tool for investigating the function and localization of proteins whose antibodies (Abs) are not available. Often it is also used in a 3X FLAG format (3x DYKDDDDK Tag TFA) for purifying difficult proteins that accumulate in low abundance .
3x DYKDDDDK Tag is a useful tool for investigating the function and localization of proteins whose antibodies (Abs) are not available. Often it is also used in a 3X FLAG format (3x DYKDDDDK Tag) for purifying difficult proteins that accumulate in low abundance .
Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies .
Polyphemusin II-Derived Peptide (T140), a CXCR4 inhibitor, shows high inhibitory activity against HIV-1 entry and the inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 .
CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .
Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar is a decapeptide. Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar can be used to preparation of antibody-drug conjugate .
HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers generated by hepatitis B vaccination. HEP-1 has the potential to be studied against viral infections .
HCV-1 e2 Protein (484-499) is a peptide consisting of 16 amino acids. HCV-1 e2 Protein (484-499) is derived from the envelope 2 protein of hepatitis C virus in the sera from individuals with antibodies to HCV .
GluN1 (359-378) is an anti-N-methyl-D-aspartate
receptor (NMDAR) antibody. GluN1 (359-378) can cross the blood-brain barrier.
GluN1 (359-378) can be used to study anti-NMDAR encephalitis therapy targeting
the immune system .
Fmoc-D-homoArg(Et)2-OH (hydrochloride) is a Fmoc-protected derivative of D-Homoarginine (HArg) that renders peptides and proteins resistant to proteolysis by trypsin. Fmoc-D-homoArg(Et)2-OH (hydrochloride) can be used as a cleavable ADC linker to synthesize antibody-drug conjugates (ADCs) .
Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) is a synthetic peptide analog which specifically binds to Hep G2 cells. Hepatitis B Virus Receptor Binding Fragment is a promising immunogen expected to elicit protective antibodies based on the concept of the attachment blockade pathway of virus neutralization .
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .
VTSEGAGLQLQK- 13C6, 15N2 (TFA) is the 13C- and 15N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) (GN5) is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .
X-press Tag Peptide is a tag peptide used for protein purification. X-press Tag is also an N-terminal leader peptide; this N-terminal peptide contains a polyhistidine sequence, the Xpress epitope (part of bacteriophage T7 gene 10 protein) and an enterokinase cleavage site. Anti-Xpress antibodies recognize the Xpress epitope sequence found in this leader peptide.
S2-16 is a synthetic peptide from the S2 region of cardiac myosin. S2-16 is a cryptic epitope that induces myocarditis in Lewis rats. A cryptic epitope is an epitope that is not recognized by antibodies or T cells after the animal is immunized with the intact antigen. S2-16 can be used to study the mechanism of autoimmune myocarditis .
Edratide (TV 4710) is a synthetic peptide of 19 amino acid based on the complementarity-determining region 1 (CDR1) of a human anti-DNA antibody that expresses a major idiotype denoted 16/6 Id. Edratide reduces the rates of apoptosis (Apoptosis) and down-regulates of caspase-8 and caspase-3, up-regulates Bcl-xL. Edratide has the potential for the research of systemic lupus erythematosus (SLE) .
[Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)
G6PI 325-339 (human) hydrochloride is an efficient inducer of arthritis in B10.Q mice. G6PI 325-339 (human) hydrochloride primes Th1 and Th17 cells cross-reacted with the murine G6PI protein. G6PI 325-339 (human) hydrochloride induces arthritis model operating through a T and B cell-dependent pathway but without antibody effector mechanisms .
G6PI 325-339 (human) is an efficient inducer of arthritis in B10.Q mice. G6PI 325-339 (human) primes Th1 and Th17 cells cross-reacted with the murine G6PI protein. G6PI 325-339 (human) induces arthritis model operating through a T and B cell-dependent pathway but without antibody effector mechanisms .
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat has encephalitogenic activity and induces T?cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat produces a relapsing-remitting neurological disease with extensive plaque-like demyelination .
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) acetate is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate has encephalitogenic activity and induces T?cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate produces a relapsing-remitting neurological disease with extensive plaque-like demyelination .
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA produces a relapsing-remitting neurological disease with extensive plaque-like demyelination .
MCE Affinity Chromatography (AC) Columns are designed for purification of recombinant proteins with different tags, enzymes, antibodies, antigens and nucleic acids.
MCE Protein Transfection Reagent is a cationic lipid mixture for complexation with proteins, peptides, antibodies and other biologically active molecules to allow their direct intracellular delivery.
MCE Ultra High Sensitivity ECL Kit is an ultra-sensitive, luminol-based enhanced chemiluminescent substrate for detecting horseradish peroxidase (HRP) labeled antibodies on western blots.
MCE Protein A Plus Magnetic Agarose Beads can be used for the detection and purification of IgG from serum, ascites fluid, cell culture supernatant and other antibody samples.
MCE Protein A Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein A, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG, IgE, IgM.
MCE Protein G Plus Magnetic Agarose Beads can be used for the detection and purification of IgG from serum, ascites fluid, cell culture supernatant and other antibody samples.
MCE Protein L Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein L, effectively purifies mammalian monoclonal and polyclonal antibodies which have kappa light chain.
MCE PBS-T Powder (1 L of 1×) consists of NaCl, KCl, Phosphate and Tween 20, and is widely used in ELISA and Western Blot, and can also be used for antibody dilution and preparation of blocking solution.
MCE TBS Powder (1 L of 1×) consists of NaCl, KCl and Tris, and is widely used as washing buffer in immunocytochemistry, FISH or ELISA, and can also be used for antibody dilution and preparation of blocking solution.
MCE Rapid Blocking Buffer (TBS-T) Powder (100 mL of 1×) mainly consists of fish gelatin protein, and is widely used for the antibody blocking step in Western Blot or ELISA within 15 minutes.
MCE Protein G Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein G, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG3 and rat IgG2a.
MCE TBS-T Powder (1 L of 1×) consists of NaCl, KCl, Tris and Tween 20, and is widely used as washing buffer in immunocytochemistry, FISH or ELISA, and can also be used for antibody dilution and preparation of blocking solution.
MCE CHO Magnetic Beads (200 nm, 10 mg/mL) contain CHO functional groups, which react with primary amines on proteins or other molecules to form stable amide linkages，can covalently immobilize proteins for the affinity purification of antibodies, antigens and other biomolecules.
MCE SYBR Green qPCR Master Mix (Universal) is compatible with all qPCR instruments. 2× ready-to-use formulations which consist of antibody-mediated hot start polymerase, MgCl2, dNTPs and a proprietary reaction buffer, produce optimal results in qPCR experiments.
MCE NHS Magnetic Beads (200 nm, 10 mg/mL) contain N-hydroxysuccinimide (NHS) functional groups, which react with primary amines on proteins or
other molecules to form stable amide linkages，can covalently immobilize proteins for the affinity purification of antibodies, antigens and other
biomolecules.
MCE Streptavidin Agarose 6FF, a 6% highly cross-linked agarose reagent coupled with recombinant streptavidin, is an affinity chromatography medium for separation and purification of biotinylated peptides, antibodies, lectins, etc. The total binding capacity of Streptavidin Agarose 6FF is more than 200 nmol of D-Biotin/mL settled resin.
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer .
Quilizumab (Anti-Human IGHE Recombinant Antibody) is a humanized IgG1κ monoclonal antibody targeting immunoglobulin epsilon (also konwn as: IGHE, IgE). Quilizumab targets the M1-prime fragment of membrane-expressed IGHE/IgE, leading to IGHE/IgE switching and memory B cell depletion. Quilizumab has potential in asthma research .
Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gammaantibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease .
Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status .
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .
Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine .
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .
Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) is an anti-mouse/human/rat/monkey/hamster/canine/bovine IgG antibody inhibitor of TGF-β .
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis . Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease) .
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research .
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .
Inclacumab (Anti-Human selectin P Recombinant Antibody) is a human monoclonal IgG4 antibody selectively targets P-selectin with a Kd value of 9.9 nM. Inclacumab inhibits P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide bind with P-selectin with an IC50 value of 1.9 μg/mL and strongly inhibits cell adhesion .
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen and blocks CD80–CD28 binding. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma .
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .
Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research .
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer .
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a humanized recombinant anti-CD6 monoclonal antibody (MAb) targeting the extracellular SRCR distal domain 1 of CD6. Itolizumab reduces T-cell proliferation and inhibits the production of pro-inflammatory cytokines, such as INF-γ, TNFα and IL-6. Itolizumab can be used in the research of psoriasis, rheumatoid arthritis (RA), COVID-19 .
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer .
Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP)antibody, with potential anti-amyloid activity. Dezamizumab triggers immunotherapeutic clearance of amyloid. Dezamizumab can be used in research of Amyloid light-chain (AL) amyloidosis .
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .
Opucolimab is an anti-PD-L1 recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors .
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis .
Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma .
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN) .
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research .
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid .
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research .
Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin .
Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2 .
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell activation. Lirentelimab can be used for the research of eosinophilic gastritis and duodenitis .
Anti-pan-Glypican Antibody (HS20) is a kind of human IgG1, κ human antibody, targeting to human pan-Glypican. The recommend isotype control of Anti-pan-Glypican Antibody (HS20): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-E-Selectin Antibody (CL2) is a kind of mouse IgG2a, κ chimeric antibody, targeting to human E-Selectin. The recommend isotype control of Anti-E-Selectin Antibody (CL2): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD28 Antibody (9.3) is a kind of mouse IgG2a chimeric antibody, targeting to human CD28. The recommend isotype control of Anti-CD28 Antibody (9.3): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-MUC16 Antibody (VK8) is a kind of mouse IgG1, κ chimeric antibody, targeting to human MUC16. The recommend isotype control of Anti-MUC16 Antibody (VK8): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-GPC3 Antibody (YP7) is a kind of mouse IgG1, κ chimeric antibody, targeting to human GPC3. The recommend isotype control of Anti-GPC3 Antibody (YP7): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-BRCA1 Antibody (BR64) is a kind of mouse IgG1, κ chimeric antibody, targeting to human BRCA1. The recommend isotype control of Anti-BRCA1 Antibody (BR64): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-IFNγ Antibody (B133.5) is a kind of mouse IgG1 chimeric antibody, targeting to human IFNγ. The recommend isotype control of Anti-IFNγ Antibody (B133.5): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-GPC-2 Antibody (CT3) is a kind of mouse IgG1, κ chimeric antibody, targeting to human GPC-2. The recommend isotype control of Anti-GPC-2 Antibody (CT3): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin .
Anti-Fy3 Antibody (MIMA-29) is a kind of mouse IgG2a, κ chimeric antibody, targeting to human Fy3. The recommend isotype control of Anti-Fy3 Antibody (MIMA-29): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD44 Antibody (Hermes-1) is a kind of rat IgG2a, κ chimeric antibody, targeting to human CD44. The recommend isotype control of Anti-CD44 Antibody (Hermes-1): Rat IgG2a kappa, Isotype Control (HY-P990679).
Anti-CD71 Antibody (OKT-9) is a kind of mouse IgG1,?κ chimeric antibody, targeting to human CD71. The recommend isotype control of Anti-CD71 Antibody (OKT-9): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-CD3 Antibody (OKT-3) is a kind of mouse IgG2a,?κ chimeric antibody, targeting to human CD3. The recommend isotype control of Anti-CD3 Antibody (OKT-3): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD2 Antibody (CB.219) is a kind of mouse IgG2b, κ chimeric antibody, targeting to human CD2. The recommend isotype control of Anti-CD2 Antibody (CB.219): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Anti-c-myc Antibody (9E10) is a kind of mouse IgG1 chimeric antibody, targeting to human c-myc. The recommend isotype control of Anti-c-myc Antibody (9E10): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL) .
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma .
Anti-YB-1 Antibody (21A3) is a kind of mouse IgG1 chimeric antibody, targeting to human YB-1. The recommend isotype control of Anti-YB-1 Antibody (21A3): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-CD4 Antibody (OKT-4) is a kind of mouse IgG2b,?κ chimeric antibody, targeting to human CD4. The recommend isotype control of Anti-CD4 Antibody (OKT-4): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody that can be used for the research of cancer .
Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research .
Anti-CD19 Antibody (4G7) is a kind of mouse IgG1 chimeric antibody, targeting to human CD19. The recommend isotype control of Anti-CD19 Antibody (4G7): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-CD1a Antibody (OKT-6) is a kind of mouse IgG1 chimeric antibody, targeting to human CD1a. The recommend isotype control of Anti-CD1a Antibody (OKT-6): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-HIV gp120 Antibody (55-36) is a kind of mouse IgG1,?κ chimeric antibody, targeting to HIV gp120. The recommend isotype control of Anti-HIV gp120 Antibody (55-36): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin (Disitamab vedotin (HY-P9985)) .
Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC antibody) of antibody-drug conjugates to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia .
Brentuximab is a monoclonal antibody targeting CD30. Brentuximab is conjugated with monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107), which can induce apoptosis in primary effusion lymphoma cells. Brentuximab vedotin exhibits antitumor activity with an IC50 of 10 nM against human CD30+ cancer cells .
Anti-LCMV Nucleoprotein Antibody (VL-4) is a kind of rat IgG2a kappa in vivo mouse antibody, targeting to LCMV nucleoprotein. The recommend isotype control of Anti-LCMV Nucleoprotein Antibody (VL-4): Rat IgG2a kappa, Isotype Control (HY-P990679).
Anti-CD8α Antibody (OKT-8) is a kind of mouse IgG2a chimeric antibody, targeting to human CD8α. The recommend isotype control of Anti-CD8α Antibody (OKT-8): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD40 Antibody (G28.5) is a kind of mouse IgG1,?κ chimeric antibody, targeting to human CD40. The recommend isotype control of Anti-CD40 Antibody (G28.5): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases .
Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia .
Nipocalimab (M281) is a fully human, recombinant, aglycosylated IgG1 monoclonal antibody. Nipocalimab is a human deglycosylated IgG1 anti-FcRn monoclonal antibody that binds with picomolar affinity to Fc receptor (FcRn) at both endosomal pH 6.0 and extracellular pH 7.6 .
Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
Anti-Mouse CD28 Antibody (D665) is a kind of mouse IgG1 kappa in vivo mouse antibody, targeting to CD28. The recommend isotype control of Anti-Mouse CD28 Antibody (D665): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-Mouse CD28 Antibody (PV-1) is a kind of Armenian hamster IgG in vivo mouse antibody, targeting to CD28. The recommend isotype control of Anti-Mouse CD28 Antibody (PV-1): Armenian hamster IgG, Isotype Control (HY-P990305).
Anti-Rat CD28 Antibody (JJ316) is a kind of mouse IgG1 kappa in vivo mouse antibody, targeting to CD28. The recommend isotype control of Anti-Rat CD28 Antibody (JJ316): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-TROP-2 Antibody (Pr1E11) is a kind of mouse IgG1, κ chimeric antibody, targeting to human TROP-2. The recommend isotype control of Anti-TROP-2 Antibody (Pr1E11): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-IL-9 Antibody (MH9A4) is a kind of mouse IgG2b, κ chimeric antibody, targeting to human IL-9. The recommend isotype control of Anti-IL-9 Antibody (MH9A4): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Anti-Mouse PD-1 Antibody (J43) is a kind of Armenian hamster IgG in vivo mouse antibody, targeting to PD-1. The recommend isotype control of Anti-Mouse PD-1 Antibody (J43): Armenian hamster IgG, Isotype Control (HY-P990305).
Anti-MHC Class I Antibody (W6/32) is a kind of mouse IgG2a,?κ chimeric antibody, targeting to human MHC Class I. The recommend isotype control of Anti-MHC Class I Antibody (W6/32): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD32/FcγRIIA Antibody (IV.3) is a kind of mouse IgG2b chimeric antibody, targeting to human CD32/FcγRIIA. The recommend isotype control of Anti-CD32/FcγRIIA Antibody (IV.3): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Anti-Ganglioside GD2 Antibody (14G2a) is a kind of mouse IgG2a, κ chimeric antibody, targeting to human Ganglioside GD2. The recommend isotype control of Anti-Ganglioside GD2 Antibody (14G2a): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-c-Kit/CD117 Antibody (SR-1) is a kind of mouse IgG2a, κ chimeric antibody, targeting to human c-Kit/CD117. The recommend isotype control of Anti-c-Kit/CD117 Antibody (SR-1): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CEACAM7 Antibody (P3-7B) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CEACAM7. The recommend isotype control of Anti-CEACAM7 Antibody (P3-7B): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-CEACAM5 Antibody (4H11-8) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CEACAM5. The recommend isotype control of Anti-CEACAM5 Antibody (4H11-8): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Modotuximab (Anti-Human EGFR Recombinant Antibody) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab contains a portion of Futuximab that binds to two independent, non-overlapping epitopes on EGFR. Modotuximab promotes cross-linking of EGFR on the cell surface and promotes EGFR cellular internalization and degradation. Modotuximab has antitumor activity in vivo .
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection .
Anti-CD326/EpCAM Antibody (Ber-EP4) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CD326/EpCAM. The recommend isotype control of Anti-CD326/EpCAM Antibody (Ber-EP4): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b .
Linavonkibart (SRK 181) is a high-affinity, fully human antibody that selectively binds to latent TGFβ1 and inhibits its activation. Linavonkibart plays an important role in cancer .
Anti-Mouse myeloperoxidase/MPO Antibody (6D1) is a kind of mouse IgG2b kappa in vivo mouse antibody, targeting to MPO. The recommend isotype control of Anti-Mouse myeloperoxidase/MPO Antibody (6D1): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Anti-Glycophorin A (type M) Antibody (6A7M) is a kind of mouse IgG1, κ chimeric antibody, targeting to human Glycophorin A (type M). The recommend isotype control of Anti-Glycophorin A (type M) Antibody (6A7M): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-CTLA-4/CD152 Antibody (BN13) is a kind of mouse IgG2a, κ chimeric antibody, targeting to human CTLA-4/CD152. The recommend isotype control of Anti-CTLA-4/CD152 Antibody (BN13): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD47 Antibody (B6.H12) is a kind of mouse IgG1,?κ chimeric antibody, targeting to human CD47. The recommend isotype control of Anti-CD47 Antibody (B6.H12): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis .
Enfortumab is a humanized derived anti-Nectin-4antibody that can be conjugated with the highly efficient microtubule disruptor MMAE (HY-15162) to generate the antibody drug conjugate (ADC) Enfortumab vedotin (HY-P99016A). Enfortumab can be used for the study of locally advanced and metastatic urothelial carcinoma .
Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody that can be used for the research of atopic dermatitis (AD) in dogs .
Anti-IL-12 p70 Antibody (20C2) is a kind of rat IgG1, κ chimeric antibody, targeting to human IL-12 p70. The recommend isotype control of Anti-IL-12 p70 Antibody (20C2): Rat IgG1 kappa, Isotype Control (HY-P99979).
Ocrelizumab (Ocrevus) is a humanized anti-CD20 monoclonal antibody. Ocrelizumab can induce B cell depletion and inhibit multiple sclerosis lesions in mice through antibody dependent cytotoxicity (ADCC) .
Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer .
Anti-Mouse IFN gamma Antibody (XMG1.2) is a kind of rat IgG1 kappa in vivo mouse antibody, targeting to IFNγ. The recommend isotype control of Anti-Mouse IFN gamma Antibody (XMG1.2): Rat IgG1 kappa, Isotype Control (HY-P99979).
Anti-Human/Mouse GRP78 Antibody (C38) is a kind of mouse IgG2b kappa in vivo mouse antibody, targeting to GRP78. The recommend isotype control of Anti-Human/Mouse GRP78 Antibody (C38): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Renvistobart is an immunoglobulin G1-κ, anti-[Homo sapiens TIGIT (T cell immunoreceptor with Ig domain and ITIM, VSIG9, VSTM3)] Homo sapiens monoclonal antibody .
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel (HY-B0015) and Carboplatin (HY-17393), have enhanced inhibition on non-small-cell lung cancer .
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) .
Anti-CD220/Insulin Receptor Antibody (IR 83-22) is a kind of mouse IgG1 chimeric antibody, targeting to human CD220/Insulin Receptor. The recommend isotype control of Anti-CD220/Insulin Receptor Antibody (IR 83-22): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-Mouse CD20 Antibody (MB20-11) is a kind of mouse IgG2c kappa in vivo mouse antibody, targeting to CD20. The recommend isotype control of Anti-Mouse CD20 Antibody (MB20-11): Mouse IgG2c kappa, Isotype Control (HY-P99981).
Anti-Mouse TIM-3 Antibody (RMT3-23) is a kind of rat IgG2a kappa in vivo mouse antibody, targeting to TIM-3. The recommend isotype control of Anti-Mouse TIM-3 Antibody (RMT3-23): Rat IgG2a kappa, Isotype Control (HY-P990679).
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity .
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein .
Anti-IL-4 Antibody (MP4-25D2) is a kind of rat IgG1, κ chimeric antibody, targeting to human IL-4. The recommend isotype control of Anti-IL-4 Antibody (MP4-25D2): Rat IgG1 kappa, Isotype Control (HY-P99979).
Anti-CA19-9 Antibody (1116-NS-19-9) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CA19-9. The recommend isotype control of Anti-CA19-9 Antibody (1116-NS-19-9): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Elsilimomab (B-E8) is a IgG1 monoclonal antibody against interleukin-6 (IL-6), with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab can be used for the research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA) .
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets CD4. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma .
Anti-Mouse?CD8α Antibody (2.43) is a kind of rat?IgG2b?kappa in vivo mouse antibody, targeting to CD8α. The recommend isotype control of Anti-Mouse?CD8α Antibody (2.43): Rat IgG2b kappa, Isotype Control (HY-P990682).
Anti-Mouse?CD4 Antibody (GK1.5) is a kind of rat?IgG2b?kappa in vivo mouse antibody, targeting to CD4. The recommend isotype control of Anti-Mouse?CD4 Antibody (GK1.5): Rat IgG2b kappa, Isotype Control (HY-P990682).
Anti-Mouse TIM-4 Antibody (RMT4-53) is a kind of rat?IgG2b?kappa in vivo mouse antibody, targeting to TIM-4. The recommend isotype control of Anti-Mouse TIM-4 Antibody (RMT4-53): Rat IgG2b kappa, Isotype Control (HY-P990682).
Anti-Chikungunya virus E2 Antibody (CHK-265) is a kind of mouse IgG2c in vivo mouse antibody, targeting to B domain of the E2 glycoprotein of chikungunya virus. The recommend isotype control of Anti-Chikungunya virus E2 Antibody (CHK-265): Mouse IgG2c kappa, Isotype Control (HY-P99981).
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells .
Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells, thereby preventing CD40 signaling. Toralizumab, a immunosuppressive agent, has the potential for active systemic lupus erythematosus (SLE) research .
Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection .
Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study .
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment .
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) is a neutralizing antibody of IFNAR1. Anti-Mouse IFNAR1 Antibody (MAR1-5A3) reacts with IFNAR1 and inhibits IFNAR1 signaling in vitro and in vivo. Mouse IgG1 kappa, Isotype Control (HY-P99977) is the isotype control of Anti-Mouse IFNAR1 Antibody (MAR1-5A3) .
Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to rat Kappa Immunoglobulin Light Chain.
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells .
Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer .
Telisotuzumab (ABT-700) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity .
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions .
Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB .
Anti-MUC1/CD227 Antibody (C595 (NCRC48)) is a kind of mouse IgG3, κ chimeric antibody, targeting to human MUC1/CD227. The recommend isotype control of Anti-MUC1/CD227 Antibody (C595 (NCRC48)): Mouse IgG3 kappa, Isotype Control (HY-P99985).
Anti-Rat FcRn heavy chain heterodimers Antibody (1G3) is a kind of mouse IgG1 in vivo mouse antibody, targeting to FcRn heavy chain heterodimers. The recommend isotype control of Anti-Rat FcRn heavy chain heterodimers Antibody (1G3): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .
Anti-Human/Mouse denatured collagen type-I Antibody (XL313) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to human/mouse denatured collagen type-I.
Anti-NKG2D/CD314 Antibody (1D11) is a kind of mouse IgG1, κ chimeric antibody, targeting to human NKG2D/CD314. The recommend isotype control of Anti-NKG2D/CD314 Antibody (1D11): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-MAGEC2/CT10 Antibody (LX-CT10.5) is a kind of mouse IgG2a, κ chimeric antibody, targeting to human MAGEC2/CT10. The recommend isotype control of Anti-MAGEC2/CT10 Antibody (LX-CT10.5): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects .
Anti-Mouse IFN gamma Antibody (R4-6A2) is a kind of rat IgG1 kappa in vivo mouse antibody, targeting to IFNγ. The recommend isotype control of Anti-Mouse IFN gamma Antibody (R4-6A2): Rat IgG1 kappa, Isotype Control (HY-P99979).
Anti-Mouse Podoplanin/glycoprotein 38 Antibody (8.1.1) is a Syrian hamster-derived IgG type antibody inhibitor, targeting to mouse Podoplanin/glycoprotein 38.
Anti-Mouse/Rat/Human Osteopontin/SPP1 Antibody (MPIIIB10) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse/rat/human Osteopontin/SPP1.
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness .
Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAPantibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
Letaplimab (IBI-188) is a human IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis .
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity .
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA) .
Licaminlimab (OCS-02) is a single-chain anti-TNF alphaantibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation .
Anti-Mouse CD3ε Antibody (145-2C11) is a kind of Armenian hamster IgG1 in vivo mouse antibody, targeting to CD3ε. The recommend isotype control of Anti-Mouse CD3ε Antibody (145-2C11): Armenian hamster IgG, Isotype Control (HY-P990305).
Anti-West Nile/dengue virus E protein Antibody (E60) is a kind of mouse IgG2a kappa in vivo mouse antibody, targeting to West Nile/dengue virus E protein. The recommend isotype control of Anti-West Nile/dengue virus E protein Antibody (E60): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells.
Anti-MERS-3A1 mAb bocks the binding of MERS-CoV spike protein to DPP4 receptor .
Anti-Mouse PD-1 Antibody (29F.1A12) is a kind of rat IgG2a kappa in vivo mouse antibody, targeting to PD-1. The recommend isotype control of Anti-Mouse PD-1 Antibody (29F.1A12): Rat IgG2a kappa, Isotype Control (HY-P990679).
Anti-Mouse TNF-alpha/TNFSF2 Antibody (XT3.11) is a kind of rat IgG1 in vivo mouse antibody, targeting to TNF-alpha/TNFSF2. The recommend isotype control of Anti-Mouse TNF-alpha/TNFSF2 Antibody (XT3.11): Rat IgG1 kappa, Isotype Control (HY-P99979).
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively .
Anti-Mouse CD1d Antibody (20H2 (HB323)) is a kind of rat IgG1 kappa in vivo mouse antibody, targeting to CD1d. The recommend isotype control of Anti-Mouse CD1d Antibody (20H2 (HB323)): Rat IgG1 kappa, Isotype Control (HY-P99979).
Anti-Mouse IL-2 Antibody (S4B6-1) is a kind of rat IgG2a kappa in vivo mouse antibody, targeting to IL-2. The recommend isotype control of Anti-Mouse IL-2 Antibody (S4B6-1): Rat IgG2a kappa, Isotype Control (HY-P990679).
Anti-Mouse IL-4 Antibody (BVD6-24G2) is a kind of rat IgG1 kappa in vivo mouse antibody, targeting to IL-4. The recommend isotype control of Anti-Mouse IL-4 Antibody (BVD6-24G2): Rat IgG1 kappa, Isotype Control (HY-P99979).
Anti-CEACAM1/3/5/6/8 Antibody (6G5j) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CEACAM1/3/5/6/8. The recommend isotype control of Anti-CEACAM1/3/5/6/8 Antibody (6G5j): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Gantenerumab is a fully human anti-amyloid-β (Aβ) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-β binding. Gantenerumab can be used for Alzheimer's disease research .
Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma .
Anti-GC1q R/C1QBP Antibody (60.11) is a kind of mouse IgG1, κ chimeric antibody, targeting to human GC1q R/C1QBP. The recommend isotype control of Anti-GC1q R/C1QBP Antibody (60.11): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-CD54/ICAM-1 Antibody (R6-5-D6) is a kind of mouse IgG2a chimeric antibody, targeting to human CD54/ICAM-1. The recommend isotype control of Anti-CD54/ICAM-1 Antibody (R6-5-D6): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Anti-CD11a/LFA-1α Antibody (R7-1) is a kind of mouse IgG1 chimeric antibody, targeting to human CD11a/LFA-1α. The recommend isotype control of Anti-CD11a/LFA-1α Antibody (R7-1): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-Mouse TIM-1/CD365 Antibody (3D10) is a kind of rat IgG1 kappa in vivo mouse antibody, targeting to TIM-1/CD365. The recommend isotype control of Anti-Mouse TIM-1/CD365 Antibody (3D10): Rat IgG1 kappa, Isotype Control (HY-P99979).
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc) .
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity .
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine . Rovalpituzumab has activity against small cell lung cancer (SCLC) .
Efavaleukin alfa (AMG592) is a human monoclonal antibody. Efavaleukin alfa is composed of the IGHG1 Fc fragment fused to IL-2. The expression system of Efavaleukin alfa is usually CHO (Chinese Hamster Ovary) cells .
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes .
Lemalesomab (IMMU-MN3) is a mouse IgG1 Anti-NCA-90 monoclonal antibody and a Fab'fragment. Lemalesomab can be used for the research of inflammation, infectious lesions and infection imaging .
Anti-Mouse Pan-endothelial Cell Antigen/MECA-32 Antibody (MECA-32) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse Pan-endothelial Cell Antigen/MECA-32.
Puxitatug is an immunoglobulin G1-κ, anti-[Homo sapiens VTCN1 (Vset domain containing T cell activation inhibitor 1, B7 family member H4, B7H4, B7-H4)] Homo sapiens monoclonal antibody .
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors .
Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis .
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research .
Anti-CSF1R/CD115 Antibody (2-4A5-4) is a kind of rat IgG1, κ chimeric antibody, targeting to human CSF1R/CD115. The recommend isotype control of Anti-CSF1R/CD115 Antibody (2-4A5-4): Rat IgG1 kappa, Isotype Control (HY-P99979).
Anti-SARS-CoV-2 S protein Antibody (NTD, SARS2-29) is a kind of mouse IgG1 kappa in vivo mouse antibody, targeting to SARS-CoV-2 S protein. The recommend isotype control of Anti-SARS-CoV-2 S protein Antibody (NTD, SARS2-29): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM)antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is the anti-DLL3 arm of the bispecific T-cell engager (BiTE) antibody-Tarlatamab (AMG-757) (HY-P99575). Tarlatamab targets both DLL3 and CD3.
Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative) .
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults .
Ongericimab (JS002) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab has lipid-lowering efficacy. Ongericimab can be used in research of hypercholesteremia and hyperlipidemia .
Efungumab is a monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab can be used for research on invasive candidiasis (IC) .
Selicrelumab is an agonist CD40antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study .
Anti-Mouse NKG2D/CD314 Antibody (HMG2D) is a kind of Armenian hamster IgG in vivo mouse antibody, targeting to NKG2D/CD314. The recommend isotype control of Anti-Mouse NKG2D/CD314 Antibody (HMG2D): Armenian hamster IgG, Isotype Control (HY-P990305).
Anti-Mouse 4-1BB/CD137 Antibody (LOB12.3) is a kind of rat IgG1 kappa in vivo mouse antibody, targeting to 4-1BB/CD137. The recommend isotype control of Anti-Mouse 4-1BB/CD137 Antibody (LOB12.3): Rat IgG1 kappa, Isotype Control (HY-P99979).
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor .
Bexmarilimab (FP-1305) is a potent humanized anti-CLEVER-1IgG4-antibody with an IC50 value of 4.51 nM. Bexmarilimab is capable of inducing a phenotypic M2 to M1 immune switch of tumor-associated macrophages. Bexmarilimab can be used in research of cancer .
Ligelizumab (QGE 031) is a humanized high-affinity monoclonal anti-IgEantibody. Ligelizumab can be used for the research of chronic spontaneous urticarial .
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .
Anti-CD25/IL-2Rα Antibody (7G7B6) is a kind of mouse IgG2a chimeric antibody, targeting to human CD25/IL-2Rα. The recommend isotype control of Anti-CD25/IL-2Rα Antibody (7G7B6): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases .
Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may be helpful in inhibiting the cytokine response to SARS-CoV-2 in COVID-19. Clazakizumab can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection .
Livmoniplimab (ABBV-151) is a monoclonal antibody against GARP/TGF-β1 that can inhibit the release of active TGF-β1. Livmoniplimab has anti-tumor activity in colon cancer mice. Livmoniplimab can be used for the study of locally advanced or metastatic solid tumors .
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) .
Anti-Mouse 4-1BB/CD137 Antibody (3H3) is an IgG2a antibody agonist against mouse 4-1BB, derived from a rat host, capable of stimulating 4-1BB signaling in vivo.
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease .
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer .
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules .
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research .
Durvalumab (anti-PD-L1)(MEDI 4736) is a human anti-PD-L1 protein monoclonal antibody. Durvalumab (anti-PD-L1) completely blocks PD-L1 binding to PD-1 and CD80, IC 50 are 0.1 and 0.04 nM respectively, has anti-tumor activity .
Palivizumab (MEDI 493) is a humanized monoclonal antibody against respiratory syncytial virus (RSV). Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM. Palivizumab can prevent respiratory syncytial virus infection in cotton mice .
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .
Anti-Mouse?CD71/TfR1 Antibody (R17 217.1.3) is a kind of rat IgG2a kappa in vivo mouse antibody, targeting to CD71/TfR1. The recommend isotype control of Anti-Mouse?CD71/TfR1 Antibody (R17 217.1.3): Rat IgG2a kappa, Isotype Control (HY-P990679).
Recaticimab (SHR-1209) is a humanized monoclonal antibody that inhibits PCSK9. Recaticimab can bind to PCSK9 and mediate its degradation, increasing the level of low-density lipoprotein (LDL) receptors on the surface of liver cells, reducing the level of LDL in plasma, thereby lowering blood lipids. Recaticimab can be used for the study of hypercholesterolemia .
XmAb 5592 is a humanized, Fc-engineered anti-HM1.24antibody with enhanced binding to FcγRIIIa and FcγRIIa receptors, augments HM1.24-specific multiple myeloma (MM) cells lysis in vitro via antibody-dependent cellular cytotoxicity (ADCC) and antibody dependent cellular phagocytosis (ADCP) .
Anti-Mouse/Rat/Monkey/Human ICOS/CD278 Antibody (C398.4A) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse/rat/monkey/human ICOS/CD278.
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential .
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes .
Ponsegromab (PF 06946860) is a potent and selective humanized anti-GDF15 monoclonal antibody with anti-cachexia activity. Ponsegromab binds to GDF15 and prevents the binding of GDF15 to GFRAL, thereby blocking GDF15/GFRAL-mediated signaling. Ponsegromab can be used in the research of cancers .
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma .
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research .
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke .
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain .
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) .
Anti-Mouse CD122/IL-2Rβ Antibody (TM-Beta 1) is a kind of mouse IgG2b kappa in vivo mouse antibody, targeting to CD122/IL-2Rβ. The recommend isotype control of Anti-Mouse CD122/IL-2Rβ Antibody (TM-Beta 1): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM .
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells .
Anti-Mouse CD11a/LFA-1α Antibody (M17/4) is a kind of rat IgG2a kappa in vivo mouse antibody, targeting to CD11a/LFA-1α. The recommend isotype control of Anti-Mouse CD11a/LFA-1α Antibody (M17/4): Rat IgG2a kappa, Isotype Control (HY-P990679).
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research .
Anti-SARS-CoV-2 S protein Antibody (RBD epitope B, SARS2-34) is a kind of mouse IgG1 kappa in vivo mouse antibody, targeting to SARS-CoV-2 S protein. The recommend isotype control of Anti-SARS-CoV-2 S protein Antibody (RBD epitope B, SARS2-34): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Anti-SARS-CoV-2 S protein Antibody (RBD epitope A, SARS2-01) is a kind of mouse IgG1 kappa in vivo mouse antibody, targeting to SARS-CoV-2 S protein. The recommend isotype control of Anti-SARS-CoV-2 S protein Antibody (RBD epitope A, SARS2-01): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19 .
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation .
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research .
Anti-LFA-1α/CD11a Antibody (TS-1/22.1.1.13) is a kind of mouse IgG1 chimeric antibody, targeting to human LFA-1α/CD11a. The recommend isotype control of Anti-LFA-1α/CD11a Antibody (TS-1/22.1.1.13): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis .
Apitegromab (SRK-015) is an anti-promyostatin monoclonal antibody. Apitegromab can be used for the research of neuromuscular disease including spinal muscular atrophy .
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23 (IL-23). Mirikizumab binds to human and monkey IL-23 with high affinity, with Kd values of 21 pM and 55 pM, respectively. By inhibiting the binding of IL-23 to IL-23R, Mirikizumab modulates the immune response and holds potential for research in ulcerative colitis and Crohn's disease .
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody which inhibits a proliferation-inducing ligand (APRIL). Sibeprenlimab suppresses pathogenic immunoglobulins (IgA and IgM), while preserving antibody responses to mRNA-based vaccines against SARS-COV-2. Sibeprenlimab reduces urinary protein-to-creatinine ratio (UPCR) and glomerular filtration rate (GFR). Sibeprenlimab is promising for the research of IgA nephropathy (IgAN) .
Anti-Mouse Delta-like protein 1/DLL1 Antibody (HMD1-5) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse Delta-like protein 1/DLL1.
Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse Delta-like protein 4/DLL4.
Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation .
Tesnatilimab is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD) .
Anti-Mouse T15 VH and T15 VL regions of IgM Antibody (HB33) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse T15 VH and T15 VL regions of IgM.
Anti-Mouse/Human phosphorylated PD-1/CD279 Antibody (407.6G12) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse/human phosphorylated PD-1/CD279.
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N-terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research .
Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD) .
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis .
Clenoliximab (IDEC-151) is a macaque-human chimeric monoclonal antibody (immunoglobulin G4) specific for the CD4 molecule on the surface of T lymphocytes. Clenoliximab can be used for the research of rheumatoid arthritis .
Nirsevimab (MEDI8897) is a recombinant monoclonal antibody against human respiratory syncytial virus (RSV). Nirsevimab has neutralizing activity against RSV A and RSV B viruses, with IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab can be used for research on respiratory infections .
Mirzotamab is an IgG1κ monoclonal antibody targeting to CD276/B7-H3 with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .
Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research .
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research .
Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer .
Inetetamab is a monoclonal antibody binding to domain IV of HER2 receptor. Inetetamab alone or together with tyrosine kinase inhibitors has antitumor activities .
Anti-PD-L1/B7-H1 Antibody (29E.2A3) is a kind of mouse IgG2b, κ chimeric antibody, targeting to human PD-L1/B7-H1. The recommend isotype control of Anti-PD-L1/B7-H1 Antibody (29E.2A3): Mouse IgG2b kappa, Isotype Control (HY-P99982).
Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents .
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer .
Magrolimab (Hu5F9-G4) is a humanized anti-CD47antibody. Magrolimab can block the "don't eat me" signal of CD47, thereby promoting macrophage mediated phagocytosis. Magrolimab has antitumor activity in malignant bone tumors and breast cancer .
Anti-Influenza A virus NP Antibody (H16-L10-4R5 (HB-65)) is a kind of mouse IgG2a kappa in vivo mouse antibody, targeting to influenza virus nucleoprotein. The recommend isotype control of Anti-Influenza A virus NP Antibody (H16-L10-4R5 (HB-65)): Mouse IgG2a kappa, Isotype Control (HY-P99978).
Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases .
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .
Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .
Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand Angiopoietin-2 (Ang2) with high affinity, but shows no binding to Ang1 .
Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor .
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2 .
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research .
Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases .
Tinurilimab (Bay 1834942) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors .
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis .
Anti-Mouse CD40 Antibody (FGK4.5/FGK45) is a rat-derived IgG2a monoclonal antibody targeting mouse CD40. CD40 is a type I transmembrane glycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD40 can act as a co-stimulatory molecule to activate B cells, dendritic cells, monocytes, and other APCs, promoting anti-tumor T cell responses.
Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research .
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease .
Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies .
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia .
Landogrozumab (LY2495655) is an humanized anti-myostatin monoclonal antibody. Landogrozumab effectively improves muscle volume, hand grip strength and function. Landogrozumab can be used for the research of muscle wasting disease .
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) .
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research .
Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy .
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC) .
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies .
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research .
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH) .
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects .
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro .
Datopotamab (CDP7657) is a humanized anti trophoblast cell surface antigen 2 (TROP2) antibody. Datopotamab can generate antibody drug conjugates (ADC) (HY-141598) with DNA topoisomerase I inhibitor Deruxtecan (HY-13631E). Datopotamab can be used in the study of triple negative breast cancer and non-small cell lung cancer .
Nemolizumab (CIM331) is a humanized monoclonal antibody that targets the human interleukin-31 receptor a, preventing interleukin-31 (IL-31) from binding to its receptor and the subsequent signaling. Nemolizumab can help reduce itching and sleep disturbances, and it is being studied for atopic dermatitis (AD) .
Relatlimab (BMS-986016) is a human monoclonal antibodyanti-LAG-3antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer .
Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies .
Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models .
Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria .
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research .
Dectrekumab (QAX576) is a human monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research .
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) .
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex .
Odronextamab is a stable humanized IgG4 CD20 × CD3 bispecific antibody that binds to CD3 on T cells and CD20 on B cells, triggering anti-tumor activity. Odronextamab is expected to be used in oncology research .
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9 .
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer .
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models .
Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections .
Trastuzumab (PBS) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (PBS) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities .
Rocatinlimab (AMG 451) (KHK4083) is a fully human, non-fucosylated, immunoglobulin G1 (IgG1) anti-OX40 monoclonal antibody. Rocatinlimab can be used for the research of atopic dermatitis (AD) .
Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer .
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity .
Anti-Mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7) Antibody (10-3.6.2) is a mouse-derived IgG2c, κ type antibody inhibitor, targeting to mouse MHC Class II.
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
Mecbotamab is a humanized IgG1-κ antibody targeting to AXL receptor tyrosine kinase (AXL). Mecbotamab can serves as a conditionally active biologic (CAB), which can be conjugated with MMAE (HY-15162) via a cleavable linker, to form ADC Mecbotamab vedotin (BA3011) .
Fasinumab (Anti-Human NGF) is a human IgG4 monoclonal antibody to nerve growth factor (NGF). Fasinumab can be used in acute sciatica and knee osteoarthritis (OA) studies .
Mapatumumab (HGS-ETR1) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab can be used for the research of cancer .
Prezalumab (AMG 557) is a humanized IgG2 monoclonal antibody targets ICOSL and BAFF. Prezalumab demonstrates beneficial activities on the arthritis of systemic lupus erythematosus. Prezalumab can be used for the research of sjogren's syndrome cutaneous lupus erythematosus, psoriasis and systemic lupus erythematosus (SLE) .
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease .
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) .
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer .
Narnatumab (IMC-RON8) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab can be used for the research of cancer .
Anti-Mouse PD-L1/B7-H1 Antibody (10F.2H11) is a kind of rat?IgG2b?kappa in vivo mouse antibody, targeting to PD-L1/B7-H1. The recommend isotype control of Anti-Mouse PD-L1/B7-H1 Antibody (10F.2H11): Rat IgG2b kappa, Isotype Control (HY-P990682).
Cadonilimab (AK104) is a humanized tetravalent IgG1 bispecific antibody targeting PD1/CTLA4. Cadonilimab blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC) .
Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma .
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research .
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers .
Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases .
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema .
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research .
Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis .
Vatelizumab (GBR500) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). Vatelizumab can be used for the research of multiple sclerosis .
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia .
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research .
Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity (Kd: ?0.24?nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection .
Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research .
Sirukumab (CNTO-136) is a humanized monoclonal anti-IL6 (Interleukin Related) IgG1κ antibody. Sirukumab binds to IL6, preventing IL6-mediated signal transduction and activation of transcriptional activators, thereby blocking the downstream biological effects of IL6. Sirukumab can be used in the study of active lupus nephritis and rheumatoid arthritis .
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis .
Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The IgG1 Fc fragment of Anbenitamab binds FcRγIIIa mediates potent antibody dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor cell proliferation. Anbenitamab has the potential for HER2-positive metastatic breast cancer (MBC) research .
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer .
Anti-Mouse Nonclassical MHC Class I molecule Qa-1b Antibody (4C2.4A7.5H11) is a kind of mouse IgG1 in vivo mouse antibody, targeting to Nonclassical MHC Class I molecule Qa-1b. The recommend isotype control of Anti-Mouse Nonclassical MHC Class I molecule Qa-1b Antibody (4C2.4A7.5H11): Mouse IgG1 kappa, Isotype Control (HY-P99977).
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells .
Calpurbatug is an immunoglobulin G1 antibody. Calpurbatug has activity with anti-bacterial DNA-binding protein DNABII family and anti-human monoclonal TRL1068 γ1-chain .
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL) .
Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165) . Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research .
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways .
Zalutumumab is a high affinity, completely human IgG1 monoclonal antibody targeting EGFR. Zalutumumab binds to domain III of the EGF receptor and acts by blocking the binding of EGF and by sterically interfering with the active conformation of the receptor. Zalutumumab binds with IgG and its Fab fragment with EC50s of 7 and 19 nM, respectively. Zalutumumab can be used for the research of cancer .
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion .
Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) .
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .
Camoteskimab (AVTX-007) is an anti-IL-18 monoclonal antibody with fully humanized, high-affinity. Camoteskimab is promising for research of cardiovascular diseases and autoinflammatory diseases, including adult-onset Still’s disease (AOSD) and multiple myeloma .
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .
Muromonab is a monoclonal antibody targeting the CD3 receptor. Muromonab can block all cytotoxic T cell function. Muromonab also as an immunosuppressant agent given to reduce acute solid organ transplant rejection .
Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research .
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) .
Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death .
Anti-MERS-2E6 mAb (MERS-2E6; MERS Antibody-2E6), a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells.
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research .
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells .
Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
Trontinemab (RG6102) is a brain-penetrant, anti-amyloid, bispecific and humanizedized IgG1-κantibody, targeting to Aβ plaques and transferrin receptor 1 (TFR1). Trontinemab binds to fibrillar Aβ as well as Aβ plaques triggering plaque clearance by engaging immune cells on Alzheimer disease (AD) brain sections. Trontinemab also shows specific affinity to cynomolgus and human TFR1 .
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .
Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) .
Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD) .
Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody against T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research of cancer .
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers.
.
Latozinemab (AL001) is a recombinant human anti-Sortilin monoclonal antibody. Latozinemab effectively binds Sortilin with a high affinity and blocks the interaction between progranulin protein (PGRN) and Sortilin receptor. Latozinemab has the potential for progranulin gene (GRN) mutations causative of Frontotemporal dementia (FTD) (FTD-GRN) research .
Toripalimab is the first domestic anti-tumor PD-1antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma .
CC-90002 is a humanized anti-CD47 monoclonal antibody (mAb). CC-90002 has a high affinity for binding to CD47 with a subnanomolar Kd value. CC-90002 can be used for the research of hematologic malignancies and solid tumors .
Cemavafusp is an anti-PD-L1 monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .
KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 antibody targeting inducible costimulatory receptor (ICOS). KY-1044 depletes ICOS high cells via antibody-dependent cellular cytotoxicity (ADCC) through the engagement of FcgRIIIa. KY-1044 act as a costimulatory molecule on cells expressing lower ICOS levels, such as CD8 + TEff cells (through FcgR-dependent clustering). KY-1044 exploit the differential expression of ICOS on T-cell subtypes to improve the intratumoral immune contexture and restore an antitumor immune response .
Lunaxafusp is an anti-ERBB2 scFv-heavy-κ monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .
CTX-471 is a fully human monoclonal antibody of CD137. CTX-471 has bind affinity for recombinant human, cynomolgus macaque CD137 and mouse CD137 with Kd values of 50 nM, 61 nM and 748 nM, respectively. CTX-471 can be used for the research of immunomodulation and cancer .
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research .
Iladatuzumab vedotin (DCDS-0780A) is an antibody–drug conjugate (ADC) containing humanized IgG1 anti-human CD79B monoclonal antibody (MCDS0593A; HY-P99656) conjugated to MMAE via a protease labile linker. Iladatuzumab vedotin uses novel THIOMAB technology (TDC) to consistently conjugate two MMAE molecules per antibody using engineered cysteine residues. Iladatuzumab vedotin has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research .
Satralizumab, a humanized monoclonal antibody, is a potent Interleukine-6 (IL-6) inhibitor. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research .
Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment .
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research .
Refanezumab (GSK249320) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab can cross the blood-brain barrier (BBB) in animal stroke models. Refanezumab has the potential for the enhancement of recovery of function poststroke .
Obexelimab (XmAb5871) is a humanized anti-CD19antibody. Obexelimab works by inhibiting B cell receptor (BCR) mediated calcium influx and promoting the phosphorylation of Fc γ receptor IIb (FcγRIIb), which reduces B cell activation and function, leading to B cell apoptosis. Obexelimab can be used in research for rheumatoid arthritis and systemic lupus erythematosus .
Mepolizumab (anti-IL5) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell non-Hodgkin lymphoma (B-NHL) .
Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the activity of cytotoxic and memory T cells and induce anti-tumor immunity. Latikafusp has the potential for solid tumors research .Latikafusp may lead to the development of immunogenicity-mediated responses .
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models .
Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs) .
Batoclimab is a human anti-FcRn monoclonal antibody. Batoclimab can be used for the research of autoimmune diseases mediated by pathogenic IgG antibodies .
Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism .
Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
Natalizumab (Solution) is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
Amivantamab (FUT8-KO) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab (FUT8-KO) inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis .
Sonelokimab (ALX 0761) is a trivalent bispecific nanobody composed of camel derived humanized IL-17Fantibodies, IL-17A/Fantibodies, and serum albumin VHHantibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid arthritis and psoriasis .
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .
Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research .
Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity, and may enhance cytotoxic activity of Rituximab (HY-P9913). Urelumab can be used for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and other types of non-Hodgkin lymphoma (NHL) .
Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of β-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sjögren’s syndrome and type I diabetes research .
Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia .
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers .
Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity .
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin (HY-109539). Gemtuzumab ozogamicin consists of a cytotoxic derivative of Calicheamicin (a cytotoxic antibiotic), and a monoclonal antibody. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia .
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma .
Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493) .
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects .
Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO) .
Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis) .
Mipasetamab uzoptirine (ADCT-601) is an AXL-targeted antibody-drug conjugates (ADCs). Mipasetamab uzoptirine consists of a humanized anti-AXL antibody, a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine can be used for the research of cancers .
Mipasetamab is an IgG1κ antibody targeting to AXL, a tyrosine kinase receptor and an TAM Receptor. Mipasetamab involves in synthesis of ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC). ADCT-601 has anti-tumor activity .
Tegoprubart is a monoclonal antibody directed against CD40 ligand (CD40L), a key mediator of costimulation. Inhibition of CD40L reduces cellular and antibody-mediated immunity and creates a more tolerant immune environment. Tegoprubart was demonstrated to have in vivo efficacy in transplantation animal models.
KWAR23 is an anti-human SIRPαantibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research .
Empasiprubar (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. Empasiprubar binds to the Sushi-2 domain of C2, preventing the formation of C3 pre convertase and inhibiting the activation of classical and lectin pathways upstream of C3 activation. Empasiprubar can prevent complement mediated autoimmune hemolytic anemia and antibody mediated organ transplant rejection. Empasiprubar can prevent neuroglial lymphoconjunctival injury in GM1 antibody mediated mouse models .
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML) .
Encelimab is an anti-LAG3antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft) .
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research .
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma .
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research .
Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth .
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL) .
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556). Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection .
Ianalumab (VAY-736) is a human, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts antibody-dependent cytotoxic (ADCC), depending on effector cell activation mediated by immune receptor tyrosine activation motif (ITAM) .
Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer .
Mezagitamab (TAK-079) is a IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement dependent cytotoxicity. Mezagitamab has potential application in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP) .
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer .
Sacituzumab is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab is used for the synthesis of antibody-drug conjugates (ADC) drugs. Antibody-drug conjugates with sacituzumab (sacituzumab govitecan) (HY-132254) targeting TROP-2 have been approved for the field of triple-negative breast cancer .
Izeltabart is a high-affinity humanized antibody targeting ADAM9. Izeltabart can be used as ADC Antibody for site-specific conjugation with Maytansinoid-based DM21-C (a Drug-Linker Conjugates for ADC), to synthesize IMGC936 (Antibody-Drug Conjugates (ADCs)) with strong anti-cancer activity. DM21-C is composed of Maytansinoid (microtubule inhibitor) and a stable tripeptide linker. IMGC936 exhibits cytotoxicity against ADAM9-positive human tumor cell lines and potent antitumor activity in xenograft tumor models .
Blontuvetmab (AT 004) is a caninized CD20 monoclonal antibody and is also a potent, selective, highly potent antagonist of A2aR receptor. Blontuvetmab behaves as Nociceptin (HY-P0183)/Orphanin (HY-P0183) FQ receptor (NOP) agonists displaying weak NOP affinity. Blontuvetmab inhibits 5'-N-Ethylcarboxamidoadenosine (NECA)-mediated A2aR activation and significantly reverses the ability of adenosine to suppress CD8 T cell activation, increasing levels of cytokines such as IFN-γ. Blontuvetmab Blontuvetmab can be used for the research of Canine B-cell lymphoma .
Modakafusp alfa (TAK-573) is a humanized, anti-CD38IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules, which delivers interferon-alpha to CD38-expressing cells. Modakafusp alfa has direct anti-proliferative activity on multiple myeloma (MM) cancer cells in vitro and induces robust and durable antitumor responses in MM xenograft tumor models. Modakafusp alfa in combination with anti-PD-1 antibodies induces immunomodulation and antitumor responses with good tolerance in mice .
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) is a human monoclonal IgG1. Anti-MERS-D12 mAb binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding .
Sintilimab (IBI308) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a KD value of 74 pM. Sintilimab blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer .
Evinacumab (REGN1500) is a human anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody (IgG4 class antibody). Evinacumab reduces plasma lipids in dyslipidemic mice by blocking ANGPTL3. Evinacumab can be used in studies of homozygous familial hypercholesterolaemia (HoFH), refractory hypercholesterolaemia (both familial and non-familial) and severe hypertriglyceridaemia .
Inebilizumab (FUT8-KO) is Inebilizumab with the fucosyltransferase 8 gene (FUT8) knocked out. Inebilizumab (HY-P99113) is a monoclonal antibody (mAb) targeting CD19, exhibiting enhanced antibody-dependent cellular cytotoxicity (ADCC) against B cells. Inebilizumab can be used for research on multiple sclerosis and neuromyelitis optica .
Tenatumomab (ST2146) is a murine monoclonal antibody against tenascin-C. And tenascin-C, the large extracellular glycoprotein, is overexpressed in cancer. Tenatumomab has been used for Pretargeted Antibody Guided Radioimmunoresearch (PAGRIT), and delivering radionuclides to tumors via PAGRIT and direct 131Iodine labeling approach .
Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab retains species cross-reactivity with affinities of 0.93 nM to hICOS, 0.46 nM to cynomolgus ICOS, 3.7 nM to rat ICOS, and 0.64 nM to mICOS. Vopratelimab has antitumor immune response .
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research .
Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance .
Tavolixizumab (MEDI 0562; Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4) for use in cancer immunology research .
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis .
Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity .
Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses .
Dargistotug (M-6223) is a fully human IgG1 monoclonal antibody targeting TIGIT (T cell immune receptor with Ig domain and ITIM). TIGIT is an inhibitory immune checkpoint that promotes NK cell depletion and reduces the secretion of cytokines by binding to CD155 and other antibodies. It can also directly or indirectly inhibit effector T cells and upregulate Tregs cells, thereby exerting immunosuppression. Function .
Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPαantibody that blocks the binding of CD47 to SIRPα. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research .
Netakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis .
Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis .
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration .
Marstacimab (PF-06741086) is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody. Marstacimab can be used for the research of hemophilia .
Delpacibart is a humanized IgG1κ antibody targeting TFRC. TFRC is the most important membrane protein that regulates intracellular iron transport processes .
Ianalumab (FUT8-KO) is a human, decarboxylated antibody against BAFF-R. Ianalumab (FUT8-KO) can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab (FUT8-KO) exerts antibody-dependent cytotoxic (ADCC), depending on effector cell activation mediated by immune receptor tyrosine activation motif (ITAM) .
Human IgG1 (S239D/I332E) kappa, Isotype Control, a human-mouse chimeric monoclonal antibody, is an isotype control for Human IgG1 (S239D/I332E)κ antibody.
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection .
Tanfanercept (HL036337) is an anti-TNF-α monoclonal antibody. Tanfanercept is effective in ameliorating corneal erosions in a dry eye (DE) mouse model .
Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis .
Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic .
Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research .
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia .
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research .
Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis .
Tomaralimab (OPN-305) is a humanised anti-TLR2 IgG4 monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS) .
Ginisortamab (UCB6114) is a fully human IgG4P antiGremlin-1 monoclonal antibody. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors .
Golocdacimab (MEDI6570) is a fully human anti-LOX-1 monoclonal antibody. Golocdacimab (MEDI6570) has the potential for the research of type 2 diabetes .
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research .
Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research .
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research .
Envafolimab (ASC 22; KN 035) is a recombinant protein of a humanized single-domain anti- PD-L1 antibody. Envafolimab is created by a fusion of the of anti-PD-L1 domain with Fc fragment of human IgG1 antibody. Envafolimab blocks interaction between PD-L1 and PD-1 with an IC50 value of 5.25?nM. Envafolimab has the potential for the research of solid tumors .
Lintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR? and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice .
Tarcocimab (OG1953) is a humanized anti-VEGFA monoclonal antibody (IgG1 type). Tarcocimab is available for research in retinal vein occlusion (RVO) and wet age-related macular degeneration (AMD).
Azintuxizumab vedotin (ABBV-838) is an antibody–drug conjugate (ADC) targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells .
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities .
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia .
Telazorlimab (GBR-830) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab can be used for the research of autoimmune diseases .
Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA) .
Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis .
Firastotug is an IgG1κ antibody targeting CTLA4. CTLA4 is a cytotoxic T lymphocyte-associated protein and a key immune checkpoint in the fields of autoimmunity and cancer .
Oloctinebart is a humanized immunoglobulin G4-kappa, anti-LGALS3 monoclonal antibody. Oloctinebart is used for reduction of amyloid beta oligomers formation .
Gotistobart (ONC-392) is a humanized anti-CTLA-4antibody that confers immunotherapeutic effect by selective depletion of regulatory T cells (Treg) in the tumor microenvironment .
Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer .
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma .
Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies .
Blosozumab (LY2541546) is an anti-Human sclerostin (SOST)antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis .
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer .
Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation .
Lirilumab (IPH2102) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research .
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection .
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions .
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively .
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research .
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research .
Becotatug (JMT-101) is an IgG1 antibody targeting EGFR that can also be conjugated to Afatinib (HY-10261) and Osimertinib (HY-15772) as a synthetic ADC .
Depatuxizumab is a brain-penetrant and humanized tumor-specific antiEGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer .
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa .
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research .
Ulenistamab (PBP1510) is a first-in-class hunamised IgG1 monoclonal antibody targeting pancreatic adenocarcinoma upregulated factor (PAUF). Ulenistamab can be used for pancreatic cancer (PC) research .
Anivovetmab (KIND-030) is an anti-VP2 (parvovirus major capsid protein) monoclonal antibody (IgG2 type). Anivovetmab has the potential to study canine parvovirus infection.
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects .
Brolucizumab (DLX1008) is a single-chain anti-VEGF-Aantibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer .
Coprelotamab (GB-221) is an IgG-κ monoclonal antibody targeting EGFR2. The commonly used expression system for Coprelotamab is CHO DG44 (Chinese Hamster Ovary) cells .
Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic .
Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .
Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of spinal cord injury .
Miptenalimab (BI-754111) is an anti-human LAG-3antibody (KD: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .
Ontuxizumab (MORAb-004) is a humanized IgG1/κ anti-endosialin (TEM-1 or CD248) monoclonal antibody with antitumor effects. Ontuxizumab can be used for the research of cancer .
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody. Pelgifatamab can be covalently linked to a binding moiety of 225Ac and used for metastatic castration-resistant prostate cancer (mCRPC) research .
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) .
Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke .
Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity .
Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used in research of cancer .
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain .
Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is usually CHO (Chinese Hamster Ovary) cells .
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells .
Brodalumab (AMG 827) is a human anti-interleukin-17-receptor IgG2 monoclonal antibody that can be used for the research of moderate-to-severe plaque psoriasis and rheumatoid arthritis .
Ersodetug is an anti-INSR (insulin receptor) human IgG2 κ monoclonal antibody . Recommend Isotype Controls: Human IgG2 kappa, Isotype Control (HY-P99002).
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections .
Benralizumab (anti-IL5RA ) (MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma study .
Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures , also has anti-cancer activity .
Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research .
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells .
Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential .
Bentracimab (PB 2452) is a neutralizing monoclonal antibody that binds Ticagrelor (HY-1006) and its major active circulating metabolite with high affinity. Bentracimab can rapidly reverse the antiplatelet effect of Ticagrelor .
Iscalimab (CFZ-533) is a non-depleting IGg1 monoclonal antibody targeting CD40 (KD: 0.3 nM). Iscalimab can be used for research of Graves' hyperthyroidism and autoimmune diseases .
Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular dystrophy (DMD) .
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2 .
Ulviprubart (ABC-008) is a monoclonal antibody targeting the KLRG1 receptor that selectively depletes highly differentiated cytotoxic T cells. Ulviprubart can be used in the study of inclusion body myositis (IBM) .
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research .
Tezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma .
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer .
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research .
Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors .
Ontamalimab (SHP647) is a fully-human IgG2 monoclonal antibody targeting mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Ontamalimab can be used for the research of Crohn's disease .
Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) .
Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-High-temperature requirement A1 (HTRA1) antibody fragment. Galegenimab can be used for age-related macular degeneration (AMD) research .
Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL .
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails .
Tacatuzumab is an anti-AFP (alpha-fetoprotein protein) human IgG1 κ monoclonal antibody . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
Isecarosmab (M-6495) is an anti-ADAMTS monoclonal antibody (mAb) with a KD value of 3.65 pM. Isecarosmab has chondroprotective and anti-inflammatory activities. Isecarosmab can bind albumin to extend plasma half-life .
Minretumomab (CC-49) is a murine monoclonal antibody against TAG-72 (tumor-associated glycoprotein 72). Minretumomab is used in cancer and immunity research .
Mitumomab is an anti-idiotypic mouse IgG2b monoclonal antibody that mimics the ganglioside GD3. Mitumomab can be used for the research of small-cell lung carcinoma .
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function .
Gumokimab (AK 111) is a monoclonal antibody targeting IL-17A, which can be used in the study of psoriasis, ankylosing spondylitis. Gumokimab competitively blocks the binding of human IL-17A to IL-17R.
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC) .
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab .
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease .
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity .
Sontuzumab (AS1402) is a humanizedised IgG1κ MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer .
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model .
Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus .
Secukinumab (Anti-Human IL-17A) is a fully human anti-interleukin-17A monoclonal antibody. Anti-Human IL-17A can be used for research in psoriasis pathogenesis .
Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis .
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies .
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies .
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion .
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis .
Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases .
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research .
Gancotamab (MM-302) is a HER2-targeted antibody-liposomal Doxorubicin conjugate with antitumor activity. Gancotamab encapsulates Doxorubicin to facilitate its delivery to HER2-overexpressing tumor cells .
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease .
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor .
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection .
Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc .
Rolinsatamab is a IgG1κ type chimeric antibody targeting to PRLR (prolactin receptor). Rolinsatamab can be conjugated with pyrrolobenzodiazepine (PDB) dimer SGD-1882 (HY-101127) via a cleavable maleimidocaproyl type linker, to form an antibody-drug conjugate, Rolinsatamab talirine. One Rolinsatamab talirine has an average of 2 site-specific drug attachment engineered cysteines (C242, C242'). The linker equips the valine-alanine dipeptide, as cathepsine B cleavage site. on an average of 2 site-specific drug attachment engineered cysteines (C242, C242') .
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation .
Frunevetmab (NV-02) is a felinized anti-nerve growth factor (NGF) monoclonal antibody with a Kd of 20 pM. Frunevetmab can effectively decrease osteoarthritis (OA) pain in cats .
Human IgG1 lambda2, Isotype Control is a human monoclonal antibody that is the isotype control of human IgG1κ antibody. Isotype control antibodies can help remove non-specific signals from experimental results and assess the accuracy and reliability of the experiment .
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research .
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer .
Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes .
Amlitelimab () is an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb). Amlitelimab inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis .
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab binds to human N-terminal tau residues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD) .
Atrosab is a humanized IgG1 antagonistic anti-TNFR1antibody. Atrosab inhibits TNF-mediated apoptosis induction and IL-6 and IL-8 production. Atrosab can be used for research of inflammatory disease .
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator .
Aprutumab (BAY 1179470) is a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research .
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research .
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer .
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease .
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research .
Vulinacimab (HLX-06) is an anti-VEGFR-2 monoclonal antibody (mAb). Vulinacimab can be used in the research of cancers. VEGFR-2, overexpressed in certain tumors, is critical in angiogenesis and the proliferation, survival, migration and differentiation of endothelial cells .
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma .
Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40. Among them, OX40 is a member of the TNF receptor superfamily expressed on activated and memory T cell subsets and T regulatory cells .
Dapirolizumab pegol (CDP 7657) is a Fab'-IgG-κ class monoclonal antibody targeting CD40LG/TNFSF5 conjugated to a pegol moiety. Dapirolizumab pegol was originally cloned from the Norway rat (Rattus norvegicus).
Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity.
Danburstotug (IMC-001) is an IgG1-lambda anti-CD274 (PDL1, B7 homologue 1, B7H1) human monoclonal antibody. Danburstotug also is immunostimulant and antineoplastic .
Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells .
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20 + expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo .
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research .
Abciximab (C7E3), a chimeric mouse/human monoclonal antibody fragment, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors .
Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4 + and CD8 + T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity .
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research .
Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimer's disease .
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM .
Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as muscle growth inhibitor). Trevogrumab is used in studies of sarcopenia, including wasting atrophy, chronic diseases, and changes in food and nutritional intake .
Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19 .
Tuparstobart (Incagn-02385) is an IgG1κ antibody targeting LAG-3. LAG-3 is an immune checkpoint receptor protein mainly expressed on activated T cells, NK cells, B cells and plasmacytoid dendritic cells .
Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM) .
Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases .
Obertamig is an engineered, humanized, anti-CD3E/HLA-G monoclonal antibody with humanized CH2-CH3 modifications and consists of half immunoglobulin IgG1 λ2 and a single-chain variable fragment (scFv) .
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis .
Rilotumumab (AMG 102) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research .
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research .
Idactamab (INT-001) is an IgG1-κ antibody with in vivo activity across a spectrum of hematological malignancies. Idactamab can be used for prepare MEDI7247, a potent and specific ADC, targeting ASCT2 (SLC1A5) .
Letolizumab (BMS-986004) is a monoclonal antibody targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time .
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer .
Omodenbamab is an anti-SpA (Staphylococcal protein A) human monoclonal antibody with a KD value of 0.0467 nM. Omodenbamab circumvents a key S. aureus evasion mechanism by targeting the cell wall moiety Protein A (SpA). Omodenbamab can be used in research of S. aureus bloodstream infection .
Tulisokibart (PRA023) is a humanized IgG1-κ monoclonal antibody targeting to TNFSF15/TL1A. Tulisokibart can be used to study a variety of inflammatory/fibrotic diseases, such as Crohn's Disease (CD) .
Ecleralimab (CSJ-117; NVP-CSJ117) is a Fab-IgG1-λ2 antibody targeting the thymic stromal lymphopoietin TSLP. The expression system of Ecleralimab is usually CHO (Chinese Hamster Ovary) cells .
Elranatamab (PF-06863135) is an anti-CD3E/TNFRSF17 human IgG2κ monoclonal antibody . Recommend Isotype Controls: Human IgG2 kappa, Isotype Control (HY-P99002).
Ciduvectamig is an anti-CD3E/TMEFF2 human IgG4 κ monoclonal antibody . Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers .
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors .
Emibetuzumab (LY2875358) is a humanized bivalent METantibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer .
Tilogotamab (GEN-1029) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM) .
Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction .
Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4 + T cells. Priliximab can be used in research of rheumatoid arthritis (RA) .
Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC) .
Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid beta A4 precursor protein) Aβ42 N3pGlu peptide monoclonal antibody. Remternetug recognizes a pyroglutamated form of Aβ that aggregates into amyloid plaques .
Edrecolomab (Panorex) is a murine monoclonal antibody to the cell-surface glycoprotein 17-1A, expressed on epithelial tissues and on various carcinomas. Edrecolomab shows anti-tumor activity and can be used in colorectal carcinoma research .
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research .
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research .
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
Tregalizumab is a humanized anti-human CD4 monoclonal antibody (IgG1 type) that selectively activates the suppressive properties of regulatory T cells (Tregs) in vitro. Tregalizumab can be used in the research of autoimmune diseases (resulting from insufficient Treg activity) and allergies .
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash .
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) .
Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma .
Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy .
Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD) .
Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus .
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition .
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis .
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies .
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity .
Ociperlimab is a humanized IgG1 anti-TIGITantibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer .
Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease .
Briquilimab (JSP-191) is a non-toxic humanized monoclonal antibody targeting CD117 (c-Kit) to deplete hematopoietic stem cell (HSC). Briquilimab has safety to clear host marrow niche space to enable sufficient donor HSC engraftment and immune reconstitution as primary method of severe combined immunodeficiency (SCID) .
Grisnilimab (WT1), a IgG2a monoclonal antibodyanti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA .
Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD) .
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC) .
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research .
Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) .
Tuvirumab (OST 577; SDZ-OST 577) is a human IgG1 subclass monoclonal antibody directed against HBV surface antigen (HBsAg). Tuvirumab binds specifically and with high affinity (K=3.6 nM) to HBsAg. Tuvirumab has the potential for chronic hepatitis B research .
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .
Prafnosbart (DS-6016A) is an IgG1-kappa, anti-ACVR1 (activin A receptor type 1, ACVRLK2, ALK2, ACVR1A, SKR1) humanized monoclonal antibody. Prafnosbart can be used for bone metabolism disorders research .
Ragistomig is an anti-TNFRSF9/CD274 IgG1 monoclonal antibody composed of a κ light chain and a variable region with a λ light chain and an IgG1 heavy chain. The overall structure is a dimer composed of two identical IgG1 heavy chains .
Sulesomab (IMMU-MN3) is a murine monoclonal antibody fragment of the IgG1 class that binds to Normal Cross-Reactive Antigen-90 present on leukocytes. Sulesomab is cleared into infection nonspecifically through increased capillary membrane permeability .
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research .
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis .
Keliximab (SB-210396) is a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody with a Ki value of 1.0 nM for soluble CD4. Keliximab blocks T cell proliferation and inhibits IL-2 production. Keliximab can be used for cancer research .
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer .
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement .
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research .
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells .
Onfekafusp alfa (L19TNF) is a homotrimer that forms from engineered peptides for the L19 antibody in scFv format fused to human TNF. Onfekafusp alfa can be used for malignant glioma research .
Denecimig (Mim8) is a novel activated coagulation factor VIII-mimetic human bispecific antibody with anti-FIXa and anti-FX arms that potently stimulates FX activation resulting in efficacious haemostasis in vitro and in vivo .
Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research .
Eflapegrastim is a human IgG4 monoclonal antibody, is also a granulocyte colony-stimulating factor (G-CSF). Eflapegrastim targets to G-CSF receptor (c-Fms). Eflapegrastim stimulates proliferation and differentiation of neutrophil progenitor cells and maintains stable numbers of mature and functional neutrophils. Eflapegrastim also shortens the duration of neutropenia .
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody against IL-33. Itepekimab reduced airway inflammation and related tissue damage in preliminary clinical studies. Itepekimab has potential effects in asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD) .
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monomethyl vedotin. Zilovertamab vedotin binding to tumor cell ROR1 results in rapid internalization, trafficking to lysosomes, antibody–agent conjugate cleavage, and monomethyl vedotin release. Zilovertamab vedotin induces apoptosis. Zilovertamab vedotin can be used in research of cancer .
Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases .
Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies .
Orilanolimab (SYNT001) is a humanized, de-immunized and FcRn-blocking monoclonal antibody. Orilanolimab blocks the interaction between FcRn and the Fc portion of IgG molecules. Orilanolimab impedes IgG IC activation of the FcRn-mediated adaptive immune function. And Orilanolimab disrupts the associated pathways related to IgG homeostasis and innate and adaptive immunity .
Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research .
Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease .
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma .
Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D .
Obiltoxaximab (ETI 204) is the second and potent anti-protective antigen (PA) monoclonal antibody with immunogenicity. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication, promoting survival, and inhibiting bacterial spread to the periphery in animal models. Obiltoxaximab can be used in the research of inhalational anthrax, bacteremia and toxemia .
ATG-031 is a humanised anti-CD24 monoclonal antibody. ATG-031 effectively stimulates macrophage-mediated phagocytosis and induces cancer cell destruction by blocking the "don't eat me" signals that characterize the growth of many cancers. ATG-031 can be used in the study of haematological malignancies as well as solid tumours.
Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab .
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively .
Briobacept (BR 3FC) is a selective human monoclonal antibody targeting to BLyS (BAFF), induces B cells apoptosis. Briobacept is a recombinant glucoprotein, consists of 2 molecules from the BLyS receptor (BR3)and a Fc domain of human IgG1. Briobacept can be used in studies of rheumatoid arthritis (RA) .
Socazolimab (ZKAB001) is an anti-PD-L1 monoclonal antibody. Socazolimab has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma .
Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus .
Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors .
Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD) .
Vobarilizumab (ALX-0061) is a humanized bispecific anti-IL-6R and anti-human serum albumin (ALB) monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis .
Spesolimab (BI 655130) is a mouse-derived humanized IgG1k antibody against IL-36R. IL-36 plays an important role in the immune system and Spesolimab is being investigated in palmoplantar pustulosis (PPP). Spesolimab was associated with a reduction in biomarkers associated with the innate, Th1/Th17 and neutrophil pathways .
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1 inhibitory axis. Acasunlimab can be used in research of cancer .
Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research .
Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFR C271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501. Losatuxizumab can be used for research of EGFR-expressing cancers .
Tilvestamab (BGB149) is a humanized anti-AXLantibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT phosphorylation. Tilvestamab can be used in cancer research, particularly in AXL overexpressing renal cell carcinomas .
Rosopatamab (HuJ591) is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 ( 177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency .
Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC) .
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia .
Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor .
Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. .
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 .
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
Stapokibart (CM310) is a humanised monoclonal antibody targeting IL-4Rα and efficiently blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit IL-4Rα. Stapokibart has the capacity to interact with IL-4Rα in humans, cynomolgus monkeys, and rats .
Sofituzumab vedotin (DMUC5754A) (solution) is an antibody-drug conjugate (ADC) that contains the humanized IgG1 anti-MUC16 monoclonal antibody and a potent anti-mitotic agent, monomethyl auristatin E (MMAE), linked through a protease-cleavable linker .
Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively .
Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research .
Eldelumab (BMS-936557) is a human anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease .
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer .
Talquetamab (JNJ-64407564) is a humanized bispecific antibody that binds to GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and activation. Talquetamab (JNJ-64407564) has antitumor activity .
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies .
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .
Dafsolimab (SPV-T3a) is an IgG2a murine monoclonal antibody(anti-CD3). Dafsolimab can induce cell death through modulation and activation of the CD3/T cell receptor complex. Dafsolimab can be used for the research of graft-versus-host disease (GVHD) .
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia .
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis .
TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity .
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5aantibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. Vilobelimab acts as a C5a inhibitor, inhibiting neutrophil activation, chemotaxis, and reducing inflammatory signalling, and may be used in studies related to sepsis, COVID-19, etc .
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .
Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, binds to a unique epitope that is specific to the cytokine-binding site of the human βc receptor. Trabikibart has picomolar binding affinity for the human βc receptor. Trabikibart is a potent inhibitor of the combined effects of IL-3, GM-CSF and IL-5 on the survival of eosinophils. Trabikibart has the potential for chronic inflammatory diseases research .
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Integrin α5β1 is a major fibronectin receptor involved in angiogenesis. Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs) .
Lecanemab (Mouse IGG2a) is a monoclonal antibody that targets soluble β-amyloid and has the potential to reduce cognitive decline. The variable region of Lecanemab (Mouse IGG2a) is consistent with that of Lecanemab, while the constant region is of Mouse IGG2a sequence. Lecanemab (Mouse IGG2a) holds promise for research in the field of Alzheimer's disease .
Flotetuzumab (MGD006; S80880) is an investigational CD123/CD3 bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to CD123 in target cells and CD3 in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML) .
Cixutumumab (IMC-A12) is a human anti-IGF-1R monoclonal antibody with high affinity that inhibits ligand-dependent receptor activation and downstream signaling. Cixutumumab also mediates the internalization and degradation of IGF-IR. Cixutumumab shows broad-spectrum anti-tumour activity and can be used in studies of cancers such as lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer .
Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research .
Ogalvibart (C-135-LS) is a human anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model .
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent .
Riliprubart (SAR445088) is an anti-C1s humanized monoclonal antibody that inhibits activated C1s in the proximal portion of the classical complement system. Riliprubart selectively inhibits activated C1s and prevents the enzymatic action of C1 on its substrates C4 and C2, thus inhibiting the formation of the classical pathway C3 convertase, C4b2a .
Polzastobart (JTX-8064) is a humanized IgG4 monoclonal antagonist antibody that selectively binds LILRB2 and prevents it from binding its ligands, classical and non-classical MHC I molecules. Polzastobart enhances pro-inflammatory cytokine production in macrophages by blocking the ability of LILRB2 to bind HLA-A/B and/or HLA-G, a marker of immunotolerance on cancer cells. Polzastobart is a macrophage immune checkpoint inhibitor .
Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC)(Antibody-Drug Conjugates (ADCs)) based on a murine/human chimeric form of B-B4 (specific for CD138), linked to the maytansinoid agent DM4 by disulphide bonds. Indatuximab ravtansine shows anti-tumor activities .
Bifikafusp alfa (L19-IL2) is an immunoresearch fusion protein consisting of human L19 antibodies fused to the human cytokine interleukin 2 (IL2).Bifikafusp alfa is specific to the EDB domain of fibronectin. Bifikafusp alfa has anticancer activity .
Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research .
Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. Polatuzumab vedotin has the potential for the research of Large B-cell lymphomas (LBCL) .
Taldefgrobep alfa (BMS 986089; RG 6206; RO 7239361) is a potent inhibitory antibody targeting to human myostatin. Taldefgrobep alfa is a fusion protein composed of a human IgG1-Fc domain and Adnectin domain. Taldefgrobep alfa can be used for spinal muscular atrophy (SMA) research .
Atibuclimab, is a chimeric monoclonal antibody directed against CD14 and is composed of murine variable and human IgG4 Fc regions. Atibuclimab can be used for the research of amyotrophic lateral sclerosis . Atibuclimab attenuates LPS-induced symptoms and strongly inhibits LPS-induced proinflammatory cytokine release, while only delaying the release of the anti-inflammatory cytokines soluble TNF receptor type I and IL-1 receptor antagonist .
Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease .
Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394) .
Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research .
Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1 + cell lines, including lymphoma cells .
Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research .
Gevokizumab is a potent anti-IL-1βantibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II) .
Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research .
Ordesekimab (AMG 714; PRV-015) is a fully human IgG1κ anti-IL-15 (Interleukin Related) monoclonal antibody. The binding of Ordesekimab to IL-15 inhibits the interaction of IL-15 with the IL-2Rβ and common γ chain of the IL-15 receptor complex, but not with the IL-15Rα chain. Ordesekimab has the potential for study of nonresponsive celiac disease (NRCD) .
Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus, which causes COVID-19. Casirivimab is ineffective against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), which alters the lung response of K18-hACE2 mice to the SARS-CoV-2 δ variant, effectively reducing viral load and improving symptoms .
Suvizumab (KD-247) is an neutralizing antibodyanti-HIV-1. Suvizumab effectively neutralizes HIV-1MN, HIV-1SF2 and HIV-189.6 with IC50 values of 0.1 µg/mL, 1.0 µg/mL and 0.2 µg/mL, respectively. Suvizumab reduces the viral load of HIV. Suvizumab has good tolerance and can be used to prevent HIV infection .
Osemitamab is an IgG1 antibody targeting to human claudin-18.2. Osemitamab consists of human-Mus musculus monoclonal TST001 γ1-chain, disulfide with human-Mus musculus monoclonal TST001 κ-chain, dimer (ACI). Osemitamab in combination with Capecitabine (HY-B0016) and Oxaliplatin (HY-17371), can be used for G/GEJ cancer study .
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity .
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) .
ADC Control Human IgG1-vcMMAE is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAE and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is vcMMAE (HY-15575) .
Tilavonemab (ABBV-8E12) is a humanized anti-tauantibody that targets the extracellular form of pathological tau protein aggregates by binding to the N-terminal 25-30 amino acid residues of tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates, reduces the loss of brain volume, slows the progression of tau pathology, and improves cognitive abilities in transgenic mice expressing mutant human tau. Tilavonemab is used in Alzheimer's disease research .
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab also induces apoptosis and cycle arrest. Dalotuzumab in combination with other anticancer agents such as statins can enhance the antitumor activity of Dalotuzumab in vitro and in vivo .
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct comprised of a CD19-specific antibody domain fused to a trimerized extracellular domains of human 41BBL. Englumafusp alfa promotes CD19-specific 4-1BB cross-linking on the surface of T and NK cells .
Tarlatamab (AMG-757) is a bispecific T-cell engager (BiTE) antibody targeting delta-like ligand 3 (DLL3). DLL3 is a target that is selectively expressed in small-cell lung cancer (SCLC) tumors, but with minimal normal tissue expression. Tarlatamab has the KDs of 0.64 nM and 0.50 nM for human and nonhuman primate (NHP) DLL3, respectively. Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC research .
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .
Masavibart (ZRC3308-A7) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 (HY-145643) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
Nepuvibart (ZRC3308-B10) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Nepuvibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Nepuvibart can be used in combination with ZRC3308-A7 (HY-145642) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA)antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice .
ADC Control Human IgG1-Deruxtecan (DAR 4) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
ADC Control Human IgG1-vcMMAF is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAF and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is MC-Val-Cit-PAB-MMAF (vcMMAF; HY-112786) .
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al .
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC50 of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC50 values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma .
Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively .
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research .
Pabinafusp alfa (JR-141) is a transferrin receptor-targeting antibody consisting of Iduronate 2-sulfatase (HY-P76399) and an anti-human transferrin receptor antibody. Pabinafusp alfa is blood-brain permeable and prevents heparan sulfate (HS) deposition in the central nervous system of mucopolysaccharidosis II (MPS II) mice. Pabinafusp alfa improves learning and prevents central nervous system neuronal damage in mice .
Zagotenemab (LY3303560) is a humanised anti-tauantibody that selectively binds and neutralises tau deposits in the brain. Zagotenemab can be used in Alzheimer's disease research .
Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC50: 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer .
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC50s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity .
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .
Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17 μM at pH 6.0). Crovalimab can block cleavage of C5 by the C5 convertase and inhibite the activity of a C5 variant (p.Arg885His). Crovalimab inhibits C5b-9 formation significantly in all three complement pathways, the classical pathway (CP), lectin pathway (LP), and alternative pathway (AP). Crovalimab has the potential for paroxysmal nocturnal hemoglobinuria (PNH) and complement-mediated diseases research .
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity .
Sofituzumab vedotin (DMUC5754A) is a MMAE-containing anti-MUC16antibody-drug conjugate (ADC) with a protease-cleavable linker. Sofituzumab vedotin can be used for the research of cancer .
Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research .
Rat IgG2b kappa, Isotype Control is a rat IgG2b κ antibody isotype control that can be used to exclude or reduce false positive results caused by nonspecific binding .
Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation .
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) .
Tabituximab barzuxetan (exclude Y90) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101). Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research .
Lorukafusp alfa (14.18 mAb; hu14.18-IL2) is an immunocytokine consisting of the humanized 14.18 anti-GD2 mAb linked to IL210. Lorukafusp alfa has activity mediated by activation of antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity via the binding of hu14.18-IL2 to GD2 on the tumor cell surface, followed by binding to Fc receptors on effector cells along with activation of NK and T cells via IL2 receptor binding. Lorukafusp alfa has anti-tumor activity .
Valanafusp alfa (AGT-181) is a chimeric monoclonal antibody that fuses human α-L-iduronidase (IDUA) and targets the human insulin receptor (HIR). Valanafusp alfa has brain penetrating properties, making it useful for research on mucopolysaccharidosis type I (MPS I) .
Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1 .
Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to antigenic site III. Zamerovimab can be used in rabies studies .
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs .
Ziltivekimab (COR-001) is a humanized monoclonal antibody against IL-6 that effectively reduces serum CRP levels. Ziltivekimab possesses anti-inflammatory activity and can be used in research related to chronic systemic inflammation associated with chronic kidney disease (CKD) and cardiovascular diseases such as atherosclerosis .
Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma .
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
Efzofitimod is a splice variant of the aminoacyl-tRNA synthetase HARS1, which is fused with the Fc segment of a human antibody. Efzofitimod targets the neuronal phospholipid NRP2 (neuropilin-2) and has anti-inflammatory and immunomodulatory activities. Efzofitimod can downregulate the innate and adaptive immune responses in inflammatory disease states, suppressing indirect lung disease (ILD) .
Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
Rat IgG2a kappa, Isotype Control is a monoclonal antibody derived from rats, representing the immunoglobulin G2a (IgG2a) subclass with a kappa light chain. Rat IgG2a kappa, Isotype Control exhibits high efficiency in inducing K cell mediated cytotoxicity. Rat IgG2a kappa, Isotype Control is utilized in research investigating the roles of different immunoglobulin subclasses in tumor immunology .
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells .
Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML) .
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3E. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines .
Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM) .
Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase .
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis .
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer .
Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis .
Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium .
Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC) .
Lebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4Rα/IL-13Rα1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases .
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20 + non-Hodgkin lymphomas (NHL) .
Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab (HY-P9904), may be effective against multiple solid malignancies-most notably non-small cell lung cancer (NSCLC) .
Epoetin beta (rhEPO) is a recombinant form of erythropoietin. Epoetin beta is responsible for the maintenance of erythropoiesis and can be used for anaemia research .
Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP) .
Tanezumab (RN-624) is a humanized anti-NGF mAb with high affinity and specificity. Tanezumab blocks NGF binding to its receptors, p75 and TrkA, in the peripheral nervous system. Tanezumab can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia .
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .
IMAB027 (ASP1650) is a specific anti-CLDN6 mAb, while CLDN6 (Claudin 6) is a tight junction membrane protein, aberrantly expressed in various human cancer types, ovarian cancers particularly. IMAB 027 shows anti-tumor activity, and induces apoptosis in CLDN6 + ovarian and testicular cancer cell lines .
Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities .
Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease .
Torapsel (42-89-glycoprotein; WAY164339) is a fusion protein with immunoglobiln. Torapsel can be used to research the prevention of ischemia reperfusion injury.
Telitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease .
Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer .
Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. FcγRs bind and neutralize pathogenic IgG, thus forming a "decoy" or "scavenger" receptor that can reduce the severity of autoimmune diseases. Valziflocept can be used in studies of autoimmune diseases such as systemic lupus erythematosus (SLE) .
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants .
Aselizumab (HuDreg-55) is an humanized IgG4 mAb against L-selectin. However, L-selectin (CD62L) is a cell adhesion molecule expressed on circulating neutrophils. It regulates migrating cells to chemotaxis towards the site of injury. Aselizumab may be account for a high rate of infections and leucopenia after truma .
Anumigilimab (CSL-324) is an human IgG4 mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation .
Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) .
Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment .
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .
Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM) .
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo .
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .
Baminercept (BG 9924) is a lymphotoxin β receptor IgG fusion protein (LTβR-Ig). Baminercept can be used for the research of many autoimmune diseases including primary Sjögren's syndrome (SS) and rheumatoid arthritis (RA) .
Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis .
Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis .
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research .
Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept binds to GAS6 and inhibits the interaction of GAS6 with AXL, thereby substantially reducing AXL signaled invasion and migration of highly metastatic cells in vitro and inhibiting metastatic disease in nonclinical models of aggressive human cancers. Batiraxcept is available for studies in advanced or metastatic clear cell renal cell carcinoma (ccRCC) and platinum sensitive recurrent ovarian cancer .
Elarekibep (PRS-060) (AZD1402) is a high affinity, slowly dissociating, long-acting full antagonist of IL-4Ra. Elarekibep can be used for the research of T2 endotype asthma .
Goflikicept (RPH 104) is a hybrid protein that selectively binds and inactivates both circulating IL-1ß and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI) .
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL) .
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection .
Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection .
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
Ipafricept (OMP-54F28; FZD8-Fc) is a first class recombinant fusion protein with the extracellular part of the human frizzled-8 receptor fused to a human IgG1 Fc fragment that binds Wnt ligands, which blocks Wnt signaling. Ipafricept reduces tumor growth and results in a decrease in both liver and lung metastases combined with Gemcitabine (HY-17026) in pancreatic cancer mouse models. Ipafricept shows solid tumor inhibition activity with well tolerance, such as desmoid tumor, germ cell cancer, ovarian cancer .
Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions .
Ramatercept (ACE-031) is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy .
Recifercept (TA-46) is a soluble, recombinant fibroblast growth factor receptor 3 (FGFR3) molecule. Recifercept can be used as a decoy/ligand trap to decrease the amount of fibroblast growth factors that can bind to mutant FGFR3 receptors. Recifercept can be used for the research of achondroplasia .
Ontorpacept (TTI-621) is a soluble fusion protein that consists of the human SIRPα N-terminal (1-118) linked to the Fc region of human IgG1. The N-terminal (1-118)-fragment of ontorpacept is a binding domain for CD47 which is an inhibitor of phagocytosis by macrophages. Ontorpacept is a CD47-blocking checkpoint inhibitor with antitumor activity .
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment .
Denosumab (anti-TNFSF11) is a RANKL inhibitor that is effective against giant cell tumor of bone (GCTB).Denosumab eliminates RANK-positive tumor giant cells and reduces the relative content of proliferative, dense-cell tumor stromal cells .
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101; HY-12522), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research .
Dapirolizumab is a monoclonal antibodi against CD40 ligand. Dapirolizumab targets CD40L, blocks its interaction with CD40 receptors, and inhibits adaptive immune activation. Dapirolizumab attenuates systemic lupus erythematosus .
ABBV-383 (ABBV-383) is a BCMA × CD3 bispecific T-cell engager (BiTE) that can inhibit the activity of B-cell maturation antigen (BCMA) and activate the T-cell surface glycoprotein CD3 complex. ABBV-383 can be used for research in multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases .
Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains) . Abatacept is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive. Etanercept shows efficacy against rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis .
Asfotase alfa (ENB-0040) is a bone-targeted genetically engineered glycoprotein. Asfotase alfa increases the survival rate, bone mineralization and bone length and prevents mineralization defects of the feet, rib cage, lower limbs, jaw bones in Akp2 ?/? knockout mice. Asfotase alfa can be used for the research of perinatal, infantile, and juvenile-onset hypophosphatasia (HPP) .
Corifollitropin alfa (Org 36286) is a long-acting recombinant follicle-stimulating hormone (FSH) analog. Corifollitropin alfa is a FSH Receptor agonist with an EC50 of 5.0 pM. Corifollitropin alfa stimulates ovulation and can be used in the research of infertility .
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
Tebentafusp (IMCgp100) is a bispecific fusion protein to target gp100 peptide-HLA-A*02:01 (a melanoma-associated antigen). Tebentafusp guides T cells to kill gp100-expressing tumor cells via a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain. Tebentafusp leads to inflammatory cytokines and cytolytic proteins production, resulting in the direct lysis of tumour cells .
Sozinibercept (OPT 302; VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats .
Abicipar pegol (AGN-150998, MP0112) is an anti-VEGF DARPin molecule, a novel class of small proteins containing ankyrin repeat domains engineered to bind with high specificity and affinity to target proteins. Abicipar pegol effectively inhibits angiogenesis and vascular permeability and is used in the study of diseases related to ocular inflammation by intravitreal injection, reducing mean retinal thickness and leakage area .
Efbemalenograstim alfa (F 627) is a recombinant fusion protein. Efbemalenograstim alfa is a long acting dimeric granulocyte colony-stimulating factor (G-CSF) that contains two human G-CSF fused to a human immunoglobulin G2 (hIgG2)-Fc fragment with a peptide linker. Efbemalenograstim alfa induces the production of white blood cells .
Albinterferon alfa-2B (alb-IFN) is a recombinant protein consisting of interferon alfa-2b genetically fused to human albumin. Albinterferon alfa-2B can be used for the research of chronic hepatitis C .
Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naïve T-cell lymphoma (LSA). Tamtuvetmab has been approved by veterinary .
Eflepedocokin alfa is a recombinant fusion protein with potential cell protective activity. Eflepedocokin alfa consists of human IL-22 fused to human IgG2-Fc domain. Eflepedocokin alfa leads to the activation of IL-22/IL-22R-mediated signal transduction pathways as well as STAT3. Eflepedocokin alfa plays a role in immune response and bacterial infection, enhancing intestinal barrier function, intestinal immunity, and tissue repair .
Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes .
Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions .
Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia .
Efineptakin alfa (NT-17) is a long-acting recombinant human IL-7. Efineptakin alfa supports the proliferation and survival CD4 + and CD8 + cells in both human and mice. Efineptakin alfa can be used for glioblastoma research .
Ledelabricin alfa is a human proteoglycan 4 (PRG4) isoform A variant. PRG4 is a joint/boundary lubricant. Ledelabricin Alfa can be used for the research arthropathy .
Albinterferon alfa-2b is a type I interferon that activates novel genes and exerts potent antiviral and antiproliferative activity on target cells. Signaling by Albinterferon alfa-2b requires receptor-dependent activation of Stat1 and Stat2 to form a heterodimeric STAT that binds to the DNA-binding protein IRF-9 (p48) and forms ISGF-3 (IFN-stimulated gene factor 3). The driver genes are then further activated by ISGF-3 to achieve antiviral function .
Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases .
Insulin efsitora alfa (LY-3209590) is a selective agonist of insulin receptor (IR). Insulin efsitora alfa is a fusion protein composed of human IR agonists fused with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2) fragment, with a molecular weight of 64.1 kDa. Insulin efsitora alfa is well tolerated and has potential applications in diabetes .
Lepunafusp alfa (JR-171) is a BBB-penetrable fusion protein consisting of J-Brain Cargo and IDUA (a lysosomal enzyme, α-L-iduronidase). Lepunafusp alfa can reduce concentration of heparan sulfate (HS) and dermatan sulfate (DS). Lepunafusp alfa can be used for research of mucopolysaccharidosis type I .
Mipeginterferon alfa-2b is an interferon alpha-2b (IFNA2b) analogue, with an average number of 5 substituted among 11 amino groups (one N-terminal and 10 lysine N6). Mipeginterferon alfa-2b has the relative molecular mass of 40 kDa .
Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII). FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the research of Hemophilia A .
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research .
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors 4/5. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies .
Nemvaleukin alfa (ALKS 4230) is a IL-2 fusion protein that selectively binds to intermediate-affinity IL-2R. Nemvaleukin alfa is an activator of NK and effector T cells. Nemvaleukin alfa can be used for research of cancer .
Nab-Paclitaxel is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel (Paclitaxel: human albumin=1:9), in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel was associated with higher response rates and better tolerability, with favorable pharmacokinetic properties . (The product size below only indicate the effective content of Paclitaxel. The actual albumin quality depends on the batch. The ratio of each component in this product is Paclitaxel: albumin = 1:7-1:11.)
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
Sotiburafusp alfa is a bispecific fusion protein, which is a humanized VEGFR-1 extracellular domain fragment (129-228, 1-100 in the current sequence) fused via the peptide linker 101GGSGGSGGSGGSGGS 115 to the N-terminus of the heavy chain (116-564) of a humanized IgG1-kappa anti-human PD-L1 heavy chain variant L352>A, L353>A. Sotiburafusp alfa is also an angiogenesis inhibitor .
Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma .
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .
Raleukin (AMG-719) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects .
PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases .
Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 Fv and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL) .
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas .
Topsalysin is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice modle .
Bevifimod (PRTX-100) is a highly purified form of Staphylococcal protein A (SpA). Bevifimod can be used for idiopathic thrombocytopenic purpura (ITP) research .
SMYD3-IN-2 is a SMYD3 inhibitor against gastric cancer via inducing lethal autophagy. SMYD3-IN-2 has inhibitory for SMYD3 and BGC823 cells with IC50 values of 0.81 μM and 0.75 μM, respectively. SMYD3-IN-2 can be used for the research of cancer .
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung .
Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis .
Ziv-aflibercept is a soluble inhibitor of vascular endothelial growth factor (VEGF). Ziv-aflibercept is an adaptive variant of Aflibercept (HY-108801), Ziv-aflibercept has a low PH value and high osmotic pressure when compared to Aflibercept. Ziv-aflibercept has potential applications in metastatic colorectal carcinoma and retinal diseases .
Cinrebafusp alfa (PRS 343) is a high affinity CD137/HER2 bispecfic anticalin-based drug. Cinrebafusp alfa binds to recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa facilitates T-cell costimulation by tumor-localized, HER2-dependent 4-1BB clustering and activation, further enhancing T-cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential for HER2+ solid tumors research .
Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .
Abatacept (CTLA4lg; BMS-188667) powder is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). Abatacept powder is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases .
Sotatercept (mIgG2a) has direct cardioprotective actions, which reduces right ventricular (RV) remodeling and improves function in a pulmonary artery banding (PAB) mouse model .
Naratuximab emtansine (IMGN529) is a CD37-targeted ADC consisting of a humanized IgG1 mAb coupled to the microtubule disruptor DM1. Naratuximab emtansine has high affinity and specificity for CD37, allowing ADC internalization, processing and intracellular release of DM1. Due to its ability to disrupt microtubule assembly, DM1 can subsequently induce cell cycle arrest and apoptosis .
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor .
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer .
Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status .
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .
Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis . Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease) .
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research .
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .
Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer .
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .
Opucolimab is an anti-PD-L1 recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors .
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis .
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN) .
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research .
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin .
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody that can be used for the research of cancer .
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin (Disitamab vedotin (HY-P9985)) .
Brentuximab is a monoclonal antibody targeting CD30. Brentuximab is conjugated with monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107), which can induce apoptosis in primary effusion lymphoma cells. Brentuximab vedotin exhibits antitumor activity with an IC50 of 10 nM against human CD30+ cancer cells .
Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases .
Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
Modotuximab (Anti-Human EGFR Recombinant Antibody) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab contains a portion of Futuximab that binds to two independent, non-overlapping epitopes on EGFR. Modotuximab promotes cross-linking of EGFR on the cell surface and promotes EGFR cellular internalization and degradation. Modotuximab has antitumor activity in vivo .
Enfortumab is a humanized derived anti-Nectin-4antibody that can be conjugated with the highly efficient microtubule disruptor MMAE (HY-15162) to generate the antibody drug conjugate (ADC) Enfortumab vedotin (HY-P99016A). Enfortumab can be used for the study of locally advanced and metastatic urothelial carcinoma .
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel (HY-B0015) and Carboplatin (HY-17393), have enhanced inhibition on non-small-cell lung cancer .
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) .
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets CD4. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma .
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells .
Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer .
Telisotuzumab (ABT-700) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab has antitumor activity .
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions .
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .
Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects .
Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAPantibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity .
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively .
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc) .
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity .
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine . Rovalpituzumab has activity against small cell lung cancer (SCLC) .
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes .
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors .
Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM)antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .
Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative) .
Selicrelumab is an agonist CD40antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study .
Bexmarilimab (FP-1305) is a potent humanized anti-CLEVER-1IgG4-antibody with an IC50 value of 4.51 nM. Bexmarilimab is capable of inducing a phenotypic M2 to M1 immune switch of tumor-associated macrophages. Bexmarilimab can be used in research of cancer .
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .
Livmoniplimab (ABBV-151) is a monoclonal antibody against GARP/TGF-β1 that can inhibit the release of active TGF-β1. Livmoniplimab has anti-tumor activity in colon cancer mice. Livmoniplimab can be used for the study of locally advanced or metastatic solid tumors .
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer .
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules .
Palivizumab (MEDI 493) is a humanized monoclonal antibody against respiratory syncytial virus (RSV). Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM. Palivizumab can prevent respiratory syncytial virus infection in cotton mice .
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential .
Ponsegromab (PF 06946860) is a potent and selective humanized anti-GDF15 monoclonal antibody with anti-cachexia activity. Ponsegromab binds to GDF15 and prevents the binding of GDF15 to GFRAL, thereby blocking GDF15/GFRAL-mediated signaling. Ponsegromab can be used in the research of cancers .
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells .
Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .
Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation .
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research .
Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents .
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer .
Magrolimab (Hu5F9-G4) is a humanized anti-CD47antibody. Magrolimab can block the "don't eat me" signal of CD47, thereby promoting macrophage mediated phagocytosis. Magrolimab has antitumor activity in malignant bone tumors and breast cancer .
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .
Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand Angiopoietin-2 (Ang2) with high affinity, but shows no binding to Ang1 .
Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor .
Tinurilimab (Bay 1834942) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors .
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .
Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies .
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia .
Landogrozumab (LY2495655) is an humanized anti-myostatin monoclonal antibody. Landogrozumab effectively improves muscle volume, hand grip strength and function. Landogrozumab can be used for the research of muscle wasting disease .
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) .
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies .
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects .
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro .
Datopotamab (CDP7657) is a humanized anti trophoblast cell surface antigen 2 (TROP2) antibody. Datopotamab can generate antibody drug conjugates (ADC) (HY-141598) with DNA topoisomerase I inhibitor Deruxtecan (HY-13631E). Datopotamab can be used in the study of triple negative breast cancer and non-small cell lung cancer .
Relatlimab (BMS-986016) is a human monoclonal antibodyanti-LAG-3antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer .
Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models .
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research .
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) .
Odronextamab is a stable humanized IgG4 CD20 × CD3 bispecific antibody that binds to CD3 on T cells and CD20 on B cells, triggering anti-tumor activity. Odronextamab is expected to be used in oncology research .
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models .
Trastuzumab (PBS) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (PBS) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
Botensilimab (AGEN 1181), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer .
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .
Mapatumumab (HGS-ETR1) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab can be used for the research of cancer .
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) .
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer .
Cadonilimab (AK104) is a humanized tetravalent IgG1 bispecific antibody targeting PD1/CTLA4. Cadonilimab blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC) .
Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma .
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research .
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers .
Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases .
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research .
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The IgG1 Fc fragment of Anbenitamab binds FcRγIIIa mediates potent antibody dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor cell proliferation. Anbenitamab has the potential for HER2-positive metastatic breast cancer (MBC) research .
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer .
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL) .
Zalutumumab is a high affinity, completely human IgG1 monoclonal antibody targeting EGFR. Zalutumumab binds to domain III of the EGF receptor and acts by blocking the binding of EGF and by sterically interfering with the active conformation of the receptor. Zalutumumab binds with IgG and its Fab fragment with EC50s of 7 and 19 nM, respectively. Zalutumumab can be used for the research of cancer .
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .
Muromonab is a monoclonal antibody targeting the CD3 receptor. Muromonab can block all cytotoxic T cell function. Muromonab also as an immunosuppressant agent given to reduce acute solid organ transplant rejection .
Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research .
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) .
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research .
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells .
Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) .
Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody against T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research of cancer .
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers.
.
Toripalimab is the first domestic anti-tumor PD-1antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma .
KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 antibody targeting inducible costimulatory receptor (ICOS). KY-1044 depletes ICOS high cells via antibody-dependent cellular cytotoxicity (ADCC) through the engagement of FcgRIIIa. KY-1044 act as a costimulatory molecule on cells expressing lower ICOS levels, such as CD8 + TEff cells (through FcgR-dependent clustering). KY-1044 exploit the differential expression of ICOS on T-cell subtypes to improve the intratumoral immune contexture and restore an antitumor immune response .
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research .
Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell non-Hodgkin lymphoma (B-NHL) .
Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the activity of cytotoxic and memory T cells and induce anti-tumor immunity. Latikafusp has the potential for solid tumors research .Latikafusp may lead to the development of immunogenicity-mediated responses .
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models .
Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs) .
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .
Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity, and may enhance cytotoxic activity of Rituximab (HY-P9913). Urelumab can be used for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and other types of non-Hodgkin lymphoma (NHL) .
Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia .
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .
Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity .
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin (HY-109539). Gemtuzumab ozogamicin consists of a cytotoxic derivative of Calicheamicin (a cytotoxic antibiotic), and a monoclonal antibody. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia .
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma .
Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects .
Mipasetamab uzoptirine (ADCT-601) is an AXL-targeted antibody-drug conjugates (ADCs). Mipasetamab uzoptirine consists of a humanized anti-AXL antibody, a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine can be used for the research of cancers .
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML) .
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research .
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma .
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research .
Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth .
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL) .
Ianalumab (VAY-736) is a human, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts antibody-dependent cytotoxic (ADCC), depending on effector cell activation mediated by immune receptor tyrosine activation motif (ITAM) .
Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer .
Mezagitamab (TAK-079) is a IgG1λ anti-CD38 monoclonal antibody. Mezagitamab depletes tumor cells expressing CD38 through antibody and complement dependent cytotoxicity. Mezagitamab has potential application in relapsed/refractory multiple myeloma (RRMM) and idiopathic thrombocytopenic purpura (ITP) .
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer .
Sacituzumab is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab is used for the synthesis of antibody-drug conjugates (ADC) drugs. Antibody-drug conjugates with sacituzumab (sacituzumab govitecan) (HY-132254) targeting TROP-2 have been approved for the field of triple-negative breast cancer .
Izeltabart is a high-affinity humanized antibody targeting ADAM9. Izeltabart can be used as ADC Antibody for site-specific conjugation with Maytansinoid-based DM21-C (a Drug-Linker Conjugates for ADC), to synthesize IMGC936 (Antibody-Drug Conjugates (ADCs)) with strong anti-cancer activity. DM21-C is composed of Maytansinoid (microtubule inhibitor) and a stable tripeptide linker. IMGC936 exhibits cytotoxicity against ADAM9-positive human tumor cell lines and potent antitumor activity in xenograft tumor models .
Modakafusp alfa (TAK-573) is a humanized, anti-CD38IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules, which delivers interferon-alpha to CD38-expressing cells. Modakafusp alfa has direct anti-proliferative activity on multiple myeloma (MM) cancer cells in vitro and induces robust and durable antitumor responses in MM xenograft tumor models. Modakafusp alfa in combination with anti-PD-1 antibodies induces immunomodulation and antitumor responses with good tolerance in mice .
Sintilimab (IBI308) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a KD value of 74 pM. Sintilimab blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer .
Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab retains species cross-reactivity with affinities of 0.93 nM to hICOS, 0.46 nM to cynomolgus ICOS, 3.7 nM to rat ICOS, and 0.64 nM to mICOS. Vopratelimab has antitumor immune response .
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research .
Tavolixizumab (MEDI 0562; Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4) for use in cancer immunology research .
Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity .
Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses .
Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPαantibody that blocks the binding of CD47 to SIRPα. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research .
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .
Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis .
Ginisortamab (UCB6114) is a fully human IgG4P antiGremlin-1 monoclonal antibody. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors .
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research .
Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research .
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research .
Envafolimab (ASC 22; KN 035) is a recombinant protein of a humanized single-domain anti- PD-L1 antibody. Envafolimab is created by a fusion of the of anti-PD-L1 domain with Fc fragment of human IgG1 antibody. Envafolimab blocks interaction between PD-L1 and PD-1 with an IC50 value of 5.25?nM. Envafolimab has the potential for the research of solid tumors .
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia .
Gotistobart (ONC-392) is a humanized anti-CTLA-4antibody that confers immunotherapeutic effect by selective depletion of regulatory T cells (Treg) in the tumor microenvironment .
Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer .
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma .
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer .
Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation .
Lirilumab (IPH2102) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research .
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions .
Depatuxizumab is a brain-penetrant and humanized tumor-specific antiEGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer .
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
Ulenistamab (PBP1510) is a first-in-class hunamised IgG1 monoclonal antibody targeting pancreatic adenocarcinoma upregulated factor (PAUF). Ulenistamab can be used for pancreatic cancer (PC) research .
Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects .
Coprelotamab (GB-221) is an IgG-κ monoclonal antibody targeting EGFR2. The commonly used expression system for Coprelotamab is CHO DG44 (Chinese Hamster Ovary) cells .
Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .
Miptenalimab (BI-754111) is an anti-human LAG-3antibody (KD: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .
Ontuxizumab (MORAb-004) is a humanized IgG1/κ anti-endosialin (TEM-1 or CD248) monoclonal antibody with antitumor effects. Ontuxizumab can be used for the research of cancer .
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC) .
Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used in research of cancer .
Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is usually CHO (Chinese Hamster Ovary) cells .
Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures , also has anti-cancer activity .
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research .
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research .
Minretumomab (CC-49) is a murine monoclonal antibody against TAG-72 (tumor-associated glycoprotein 72). Minretumomab is used in cancer and immunity research .
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function .
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC) .
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab .
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies .
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion .
Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases .
Gancotamab (MM-302) is a HER2-targeted antibody-liposomal Doxorubicin conjugate with antitumor activity. Gancotamab encapsulates Doxorubicin to facilitate its delivery to HER2-overexpressing tumor cells .
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation .
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research .
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer .
Aprutumab (BAY 1179470) is a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research .
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research .
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer .
Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells .
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20 + expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo .
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research .
Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4 + and CD8 + T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity .
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM .
Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM) .
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis .
Rilotumumab (AMG 102) is an anti-HGF (anti-hepatocyte growth factor) monoclonal antibody, inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research .
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research .
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer .
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers .
CHES (N-Cyclohexyltaurine) is a zwitterionic buffer. CHES can bind to hemagglutinin (HA) emulating with sialic acid (SA) and receptor binding site (RBS)-targeting broadly neutralizing antibodies .
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors .
Emibetuzumab (LY2875358) is a humanized bivalent METantibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer .
Tilogotamab (GEN-1029) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM) .
Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC) .
Edrecolomab (Panorex) is a murine monoclonal antibody to the cell-surface glycoprotein 17-1A, expressed on epithelial tissues and on various carcinomas. Edrecolomab shows anti-tumor activity and can be used in colorectal carcinoma research .
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research .
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) .
Tabalumab (LY2127399) is a human anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralising activity against membrane bound and soluble BAFF. Tabalumab can be used in studies of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus .
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis .
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity .
Ociperlimab is a humanized IgG1 anti-TIGITantibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer .
Blood group A pentasaccharide (A-Pentasaccharide), an oligosaccharide in urine, can inhibit the binding of anti-A antibody to blood group A substance .
γ-Globulins from human blood are a class of proteins in the blood. γ-Globulin is a protein fraction of blood serum containing many antibodies that protect against bacterial and viral infectious diseases. γ-Globulins from human blood is used for common variable immunodeficiency
Briquilimab (JSP-191) is a non-toxic humanized monoclonal antibody targeting CD117 (c-Kit) to deplete hematopoietic stem cell (HSC). Briquilimab has safety to clear host marrow niche space to enable sufficient donor HSC engraftment and immune reconstitution as primary method of severe combined immunodeficiency (SCID) .
Grisnilimab (WT1), a IgG2a monoclonal antibodyanti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA .
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC) .
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research .
Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) .
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research .
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer .
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research .
Onfekafusp alfa (L19TNF) is a homotrimer that forms from engineered peptides for the L19 antibody in scFv format fused to human TNF. Onfekafusp alfa can be used for malignant glioma research .
Eflapegrastim is a human IgG4 monoclonal antibody, is also a granulocyte colony-stimulating factor (G-CSF). Eflapegrastim targets to G-CSF receptor (c-Fms). Eflapegrastim stimulates proliferation and differentiation of neutrophil progenitor cells and maintains stable numbers of mature and functional neutrophils. Eflapegrastim also shortens the duration of neutropenia .
Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research .
Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D .
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively .
Socazolimab (ZKAB001) is an anti-PD-L1 monoclonal antibody. Socazolimab has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma .
Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors .
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1 inhibitory axis. Acasunlimab can be used in research of cancer .
Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research .
Tilvestamab (BGB149) is a humanized anti-AXLantibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT phosphorylation. Tilvestamab can be used in cancer research, particularly in AXL overexpressing renal cell carcinomas .
Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC) .
Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. .
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .
Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer .
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research .
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer .
Talquetamab (JNJ-64407564) is a humanized bispecific antibody that binds to GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and activation. Talquetamab (JNJ-64407564) has antitumor activity .
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Integrin α5β1 is a major fibronectin receptor involved in angiogenesis. Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs) .
Flotetuzumab (MGD006; S80880) is an investigational CD123/CD3 bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to CD123 in target cells and CD3 in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML) .
Cixutumumab (IMC-A12) is a human anti-IGF-1R monoclonal antibody with high affinity that inhibits ligand-dependent receptor activation and downstream signaling. Cixutumumab also mediates the internalization and degradation of IGF-IR. Cixutumumab shows broad-spectrum anti-tumour activity and can be used in studies of cancers such as lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer .
Ogalvibart (C-135-LS) is a human anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model .
Polzastobart (JTX-8064) is a humanized IgG4 monoclonal antagonist antibody that selectively binds LILRB2 and prevents it from binding its ligands, classical and non-classical MHC I molecules. Polzastobart enhances pro-inflammatory cytokine production in macrophages by blocking the ability of LILRB2 to bind HLA-A/B and/or HLA-G, a marker of immunotolerance on cancer cells. Polzastobart is a macrophage immune checkpoint inhibitor .
Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research .
Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease .
Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1 + cell lines, including lymphoma cells .
Platycoside E is a platycodigenin-type saponin isolated from the root of Platycodon grandiflorum with haemolytic activity and adjuvant potential. Platycoside E promotes the production of the sera OVA-specific IgG2a and IgG2bantibody in the ovalbumin (OVA)-immunized mice .
Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses .
Gevokizumab is a potent anti-IL-1βantibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II) .
Osemitamab is an IgG1 antibody targeting to human claudin-18.2. Osemitamab consists of human-Mus musculus monoclonal TST001 γ1-chain, disulfide with human-Mus musculus monoclonal TST001 κ-chain, dimer (ACI). Osemitamab in combination with Capecitabine (HY-B0016) and Oxaliplatin (HY-17371), can be used for G/GEJ cancer study .
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab also induces apoptosis and cycle arrest. Dalotuzumab in combination with other anticancer agents such as statins can enhance the antitumor activity of Dalotuzumab in vitro and in vivo .
Tarlatamab (AMG-757) is a bispecific T-cell engager (BiTE) antibody targeting delta-like ligand 3 (DLL3). DLL3 is a target that is selectively expressed in small-cell lung cancer (SCLC) tumors, but with minimal normal tissue expression. Tarlatamab has the KDs of 0.64 nM and 0.50 nM for human and nonhuman primate (NHP) DLL3, respectively. Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC research .
Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .
Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al .
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC50 of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC50 values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma .
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC50s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity .
Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research .
Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation .
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) .
Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1 .
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells .
Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML) .
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3E. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines .
Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM) .
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer .
Eicosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Eicosanedioic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis
Hemiasterlin ((-)-Hemiasterlin) is an antimitotic marine natural product with potent anticancer effcts. Hemiasterlin can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs) .
Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis .
Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium .
Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC) .
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20 + non-Hodgkin lymphomas (NHL) .
Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab (HY-P9904), may be effective against multiple solid malignancies-most notably non-small cell lung cancer (NSCLC) .
Epoetin beta (rhEPO) is a recombinant form of erythropoietin. Epoetin beta is responsible for the maintenance of erythropoiesis and can be used for anaemia research .
Tanezumab (RN-624) is a humanized anti-NGF mAb with high affinity and specificity. Tanezumab blocks NGF binding to its receptors, p75 and TrkA, in the peripheral nervous system. Tanezumab can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia .
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .
IMAB027 (ASP1650) is a specific anti-CLDN6 mAb, while CLDN6 (Claudin 6) is a tight junction membrane protein, aberrantly expressed in various human cancer types, ovarian cancers particularly. IMAB 027 shows anti-tumor activity, and induces apoptosis in CLDN6 + ovarian and testicular cancer cell lines .
Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer .
Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) .
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .
Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM) .
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo .
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .
Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept binds to GAS6 and inhibits the interaction of GAS6 with AXL, thereby substantially reducing AXL signaled invasion and migration of highly metastatic cells in vitro and inhibiting metastatic disease in nonclinical models of aggressive human cancers. Batiraxcept is available for studies in advanced or metastatic clear cell renal cell carcinoma (ccRCC) and platinum sensitive recurrent ovarian cancer .
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
Ipafricept (OMP-54F28; FZD8-Fc) is a first class recombinant fusion protein with the extracellular part of the human frizzled-8 receptor fused to a human IgG1 Fc fragment that binds Wnt ligands, which blocks Wnt signaling. Ipafricept reduces tumor growth and results in a decrease in both liver and lung metastases combined with Gemcitabine (HY-17026) in pancreatic cancer mouse models. Ipafricept shows solid tumor inhibition activity with well tolerance, such as desmoid tumor, germ cell cancer, ovarian cancer .
Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions .
Ontorpacept (TTI-621) is a soluble fusion protein that consists of the human SIRPα N-terminal (1-118) linked to the Fc region of human IgG1. The N-terminal (1-118)-fragment of ontorpacept is a binding domain for CD47 which is an inhibitor of phagocytosis by macrophages. Ontorpacept is a CD47-blocking checkpoint inhibitor with antitumor activity .
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment .
Docosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Docosanedioic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Maleimide can be used for production of antibody-drug conjugate (ADC) which is used in cancer research. Maleimide also be leveraged for the preparation of fluorogenic probe, which is mainly used for the specific detection of thiol analytes .
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
Tebentafusp (IMCgp100) is a bispecific fusion protein to target gp100 peptide-HLA-A*02:01 (a melanoma-associated antigen). Tebentafusp guides T cells to kill gp100-expressing tumor cells via a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain. Tebentafusp leads to inflammatory cytokines and cytolytic proteins production, resulting in the direct lysis of tumour cells .
Efbemalenograstim alfa (F 627) is a recombinant fusion protein. Efbemalenograstim alfa is a long acting dimeric granulocyte colony-stimulating factor (G-CSF) that contains two human G-CSF fused to a human immunoglobulin G2 (hIgG2)-Fc fragment with a peptide linker. Efbemalenograstim alfa induces the production of white blood cells .
Efineptakin alfa (NT-17) is a long-acting recombinant human IL-7. Efineptakin alfa supports the proliferation and survival CD4 + and CD8 + cells in both human and mice. Efineptakin alfa can be used for glioblastoma research .
Albinterferon alfa-2b is a type I interferon that activates novel genes and exerts potent antiviral and antiproliferative activity on target cells. Signaling by Albinterferon alfa-2b requires receptor-dependent activation of Stat1 and Stat2 to form a heterodimeric STAT that binds to the DNA-binding protein IRF-9 (p48) and forms ISGF-3 (IFN-stimulated gene factor 3). The driver genes are then further activated by ISGF-3 to achieve antiviral function .
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research .
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors 4/5. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies .
Nemvaleukin alfa (ALKS 4230) is a IL-2 fusion protein that selectively binds to intermediate-affinity IL-2R. Nemvaleukin alfa is an activator of NK and effector T cells. Nemvaleukin alfa can be used for research of cancer .
Nab-Paclitaxel is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel (Paclitaxel: human albumin=1:9), in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel was associated with higher response rates and better tolerability, with favorable pharmacokinetic properties . (The product size below only indicate the effective content of Paclitaxel. The actual albumin quality depends on the batch. The ratio of each component in this product is Paclitaxel: albumin = 1:7-1:11.)
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease .
Corchoionoside C ((6S,9S)-Roseoside), an ionone glucoside, can be isolated from Capparis spinosa. Corchoionoside C inhibits the antigen-antibody reaction induced histamine release from rat peritoneal exudate cells .
Blood group A antigen tetraose type 5 (A-Tetrasaccharide) is a tetrasaccharide and a blood group specific oligosaccharide, inhibits the binding of anti-A antibody to blood group A substance. Blood group A antigen tetraose type 5 can be isolated from polar bear milk samples .
Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma .
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .
Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation .
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine can be used for the research of advanced breast cancer .
γ-Amanitin an ADC cytotoxin and isolated from the mushroom. γ-Amanitin inhibits RNA polymerase II and disrupts synthesis of mRNA. γ-Amanitin shows similar effects to α-Amanitin and β-Amanitin. γ-Amanitin competitively binds to monoclonal antibody (mAb), with an IC50 of 163.1 ng/mL .
(R)-IDO/TDO-IN-1 (compound 25) is an indoleamine-2,3-dioxygenase (IDO) inhibitor, with good pharmacokinetic properties. (R)-IDO/TDO-IN-1 exhibits anti-tumor activity in MC38 xenograft model. (R)-IDO/TDO-IN-1 shows synergistic effect with anti-PD-1 monoclonal antibody (SHR-1210) .
Mycophenolate Mofetil (Standard) is the analytical standard of Mycophenolate Mofetil. This product is intended for research and analytical applications. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation .
Fibrostatin C (P-23924C) is an orally active prolyl hydroxylase inhibitor that also inhibits collagen biosynthesis. Fibrostatin C also increases the number of cytoplasmic granules immunoreactive with antibodies to collagen I or III. Fibrostatin C inhibits the secretion of type I collagen in Tenon's capsule fibroblasts. Fibrostatin C is promising for research of the wound fibrotic response in the wound of glaucoma filtering surgery .
Incomplete Freund's adjuvant (IFA) (Montanide ISA-51) is an immunoadjuvant emulsified with antigen by its discoverer Jules T. Freund. Incomplete Freund's adjuvant (IFA) does not contain inactivated tuberculosis bacilli and consists of petroleum jelly containing lanolin. Incomplete Freund's adjuvant (IFA) induces high antibody titers and long-lasting effector T cell responses with no long-term effects on collagen disease, tumors, or death. Complete Freund's adjuvant (CFA) (HY-153808) is another type of Freund's Adjuvant that stimulates a stronger immune response .
Topsalysin is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice modle .
Cinrebafusp alfa (PRS 343) is a high affinity CD137/HER2 bispecfic anticalin-based drug. Cinrebafusp alfa binds to recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa facilitates T-cell costimulation by tumor-localized, HER2-dependent 4-1BB clustering and activation, further enhancing T-cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential for HER2+ solid tumors research .
Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .
The uPAR protein acts as a receptor for urokinase plasminogen activator, facilitating plasmin formation and signal transduction activation. It interacts with SRPX2 and forms a monomer. uPAR also interacts with MRC2 and SORL1, reducing PLAUR internalization. Additionally, the PLAUR-PLAU-SERPINE1 complex interacts with SORL1. uPAR Protein, Mouse (Biotinylated, HEK293, His-Avi) is the recombinant mouse-derived uPAR protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of uPAR Protein, Mouse (Biotinylated, HEK293, His-Avi) is 275 a.a., with molecular weight of 50-70 kDa.
uPAR Protein, a receptor for urokinase plasminogen activator, crucially localizes and facilitates plasmin formation. It mediates proteolysis-independent signal transduction by U-PA, regulated through negative feedback. uPAR, typically a monomer, interacts with SRPX2, MRC2, and forms a complex with FAP at invadopodia, contributing to proteolysis and signaling. It engages in a ternary complex with PLAU and SERPINE1, also interacting with SORL1, highlighting multifaceted cellular functions. uPAR Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived uPAR protein, expressed by HEK293, with C-His labeled tag. The total length of uPAR Protein, Cynomolgus (HEK293, His) is 283 a.a., with molecular weight of 60-70 kDa.
The uPAR protein is a receptor for urokinase plasminogen activator and actively localizes and promotes plasmin formation. It mediates proteolysis-independent signaling activated by U-PA and undergoes negative feedback regulation. uPAR Protein, Human (HEK293, His-Avi) is the recombinant human-derived uPAR protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of uPAR Protein, Human (HEK293, His-Avi) is 283 a.a., with molecular weight of 50-60 kDa.
The uPAR protein acts as a receptor for urokinase plasminogen activator, facilitating plasmin formation and signal transduction activation. It interacts with SRPX2 and forms a monomer. uPAR also interacts with MRC2 and SORL1, reducing PLAUR internalization. Additionally, the PLAUR-PLAU-SERPINE1 complex interacts with SORL1. uPAR Protein, Mouse (HEK293, His-Avi) is the recombinant mouse-derived uPAR protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of uPAR Protein, Mouse (HEK293, His-Avi) is 275 a.a., with molecular weight of 50-65 kDa.
The uPAR protein is a receptor for urokinase plasminogen activator and actively localizes and promotes plasmin formation. It mediates proteolysis-independent signaling activated by U-PA and undergoes negative feedback regulation. FITC-Labeled uPAR Protein, Human (HEK293, His) is the recombinant human-derived FITC-Labeled uPAR protein, expressed by HEK293 , with His labeled tag. The total length of FITC-Labeled uPAR Protein, Human (HEK293, His) is 281 a.a., with molecular weight of 45-60 kDa.
uPAR Protein, a receptor for urokinase plasminogen activator, actively localizes and facilitates plasmin formation. It mediates proteolysis-independent signal transduction activated by U-PA and undergoes negative-feedback regulation. As a monomer, it interacts with MRC2, SRPX2, and FAP at invadopodia. Engaging SORL1, it forms a ternary complex with PLAUR, PLAU, and SERPINE1, influencing PLAUR internalization. The interaction with SORL1 occurs via the N-terminal ectodomain, highlighting uPAR's multifaceted role in cellular functions. uPAR Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived uPAR protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of uPAR Protein, Human (Biotinylated, HEK293, His-Avi) is 283 a.a., with molecular weight of 50-65 kDa.
uPAR Protein, a receptor for urokinase plasminogen activator, actively localizes and facilitates plasmin formation. It mediates proteolysis-independent signal transduction activated by U-PA and undergoes negative-feedback regulation. As a monomer, it interacts with MRC2, SRPX2, and FAP at invadopodia. Engaging SORL1, it forms a ternary complex with PLAUR, PLAU, and SERPINE1, influencing PLAUR internalization. The interaction with SORL1 occurs via the N-terminal ectodomain, highlighting uPAR's multifaceted role in cellular functions. uPAR Protein, Human (Domain 1, HEK293, His) is the recombinant human-derived uPAR protein, expressed by HEK293, with C-His labeled tag. The total length of uPAR Protein, Human (Domain 1, HEK293, His) is 92 a.a., with molecular weight of 17-25 kDa.
uPAR Protein, a receptor for urokinase plasminogen activator, actively localizes and facilitates plasmin formation. It mediates proteolysis-independent signal transduction activated by U-PA and undergoes negative-feedback regulation. As a monomer, it interacts with MRC2, SRPX2, and FAP at invadopodia. Engaging SORL1, it forms a ternary complex with PLAUR, PLAU, and SERPINE1, influencing PLAUR internalization. The interaction with SORL1 occurs via the N-terminal ectodomain, highlighting uPAR's multifaceted role in cellular functions. uPAR Protein, Human (Domain 3, HEK293, His) is the recombinant human-derived uPAR protein, expressed by HEK293, with C-His labeled tag. The total length of uPAR Protein, Human (Domain 3, HEK293, His) is 92 a.a., with molecular weight of 25-35 kDa.
The uPAR protein is a receptor for urokinase plasminogen activator and actively localizes and promotes plasmin formation. It mediates proteolysis-independent signaling activated by U-PA and undergoes negative feedback regulation. uPAR Protein, Human (GST) is the recombinant human-derived uPAR protein, expressed by E. coli , with N-GST labeled tag.
uPAR Protein, a receptor for urokinase plasminogen activator, actively localizes and facilitates plasmin formation. It mediates proteolysis-independent signal transduction activated by U-PA and undergoes negative-feedback regulation. As a monomer, it interacts with MRC2, SRPX2, and FAP at invadopodia. Engaging SORL1, it forms a ternary complex with PLAUR, PLAU, and SERPINE1, influencing PLAUR internalization. The interaction with SORL1 occurs via the N-terminal ectodomain, highlighting uPAR's multifaceted role in cellular functions. uPAR Protein, Human (Domain 2&3, HEK293, His) is the recombinant human-derived uPAR protein, expressed by HEK293, with C-His labeled tag. The total length of uPAR Protein, Human (Domain 2&3, HEK293, His) is 191 a.a., with molecular weight of 33-45 kDa.
The uPAR protein is a receptor for urokinase plasminogen activator and actively localizes and promotes plasmin formation. It mediates proteolysis-independent signaling activated by U-PA and undergoes negative feedback regulation. uPAR Protein, Human (HEK293, His) is the recombinant human-derived uPAR protein, expressed by HEK293 , with C-6*His labeled tag.
The uPAR protein acts as a receptor for urokinase plasminogen activator, facilitating plasmin formation and signal transduction activation.It interacts with SRPX2 and forms a monomer.uPAR also interacts with MRC2 and SORL1, reducing PLAUR internalization.Additionally, the PLAUR-PLAU-SERPINE1 complex interacts with SORL1.uPAR Protein, Mouse (HEK293, His) is the recombinant mouse-derived uPAR protein, expressed by HEK293 , with C-His labeled tag.
uPAR (urokinase plasminogen activator receptor) possesses enzyme, protein, and receptor binding activities.It regulates apoptotic signaling, epidermal growth factor signaling, and cytochrome c release.uPAR is widely expressed in structures like decidua and spleen.Its human ortholog, PLAUR, is linked to rheumatoid arthritis.Investigating uPAR can reveal its role in cellular processes and shed light on diseases like rheumatoid arthritis.uPAR Protein, Mouse (HEK293, His-Fc) is the recombinant mouse-derived uPAR protein, expressed by HEK293 , with C-hFc, C-His labeled tag.
LYPD3/C4.4A protein facilitates cell migration and potentially influences urothelial cell-matrix interactions.It plays a role in tumor progression, binding to laminin-1 and laminin-5.Interactions with LGALS3, AGR2, and AGR3 emphasize its functional associations and impact in diverse biological processes.LYPD3/C4.4A Protein, Human (HEK293, His) is the recombinant human-derived LYPD3/C4.4A protein, expressed by HEK293 , with C-6*His labeled tag.
The LYPD3/C4.4A protein is a multifunctional cell surface molecule that is critical for cell migration and has been implicated in potential tumor progression. It binds laminin 1 and laminin 5, emphasizing its role in extracellular matrix interactions. LYPD3/C4.4A Protein, Mouse (HEK293, His) is the recombinant mouse-derived LYPD3/C4.4A protein, expressed by HEK293 , with C-His labeled tag.
MRC2 Protein potentially acts as an endocytotic lectin receptor with calcium-dependent lectin activity. It internalizes glycosylated ligands through clathrin-mediated endocytosis, releasing them in endosomes. MRC2 may control PLAUR/PLAU levels in the plasminogen activation system, regulating cell surface protease activity. It contributes to cellular uptake, remodeling, and degradation of extracellular collagen matrices, influencing collagen turnover in cancer and tissue destructive diseases. MRC2 collaborates with matrix metalloproteinases, interacting with type I collagen, forming a tri-molecular complex with PLAUR/UPAR and PLAU/pro-UPA, and directly engaging with collagen V, highlighting its versatile role in cellular processes related to extracellular matrix dynamics. MRC2 Protein, Human (HEK293, His) is the recombinant human-derived MRC2 protein, expressed by HEK293, with C-His labeled tag. The total length of MRC2 Protein, Human (HEK293, His) is 500 a.a., with molecular weight of 65-75 kDa.
Anti-MERS-D12 mAb is a human monoclonal IgG1. It binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding.
DM4-d6 is deuterium labeled DM4. DM4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody agent conjugate.
Mycophenolate Mofetil-d4 is the deuterium labeled Mycophenolate Mofetil. Mycophenolate mofetil (RS 61443) is the morpholinoethylester proagent of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation[1].
FL118-C3-O-C-amide-C-NH2-d5 formate is a deuterium labeled FL118-C3-O-C-amide-C-NH2 formate. FL118-C3-O-C-amide-C-NH2 formate is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
GPSVFPLAPSSK- 13C6 is the 13C labeled GPSVFPLAPSSK. GPSVFPLAPSSK is an IgG1 signature peptide of anti-SARS-CoV-2 antibodies. GPSVFPLAPSSK can be used for the quantification of the specific isolation of anti-SARS-CoV-2 antibodies .
6-TAMRA-d12 free acid is a deuterated-labeled 6-TAMRA, which is widely used in the preparation of fluorescent antibodies and as a fluorescent group for immunohistochemical avidin derivatives.
VTSEGAGLQLQK- 13C6, 15N2 is the 13C and 15N labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA). VTSEGAGLQLQK can be used to bind anti-drug antibodies (ADA) in plasma and quantitatively analyze the therapeutic effect .
VTSEGAGLQLQK- 13C6, 15N2 (TFA) is the 13C- and 15N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .
Auristatin F-d8 is deuterium labeled Auristatin F (HY-15583). Auristatin F is a potent cytotoxin in antibo-conjugated agents and an analogue of MMAF. Auristatin F is a potent microtubule inhibitor and vascular damaging agent (VDA). Auristatin F inhibits cell division by preventing tubulin aggregation.Auristatin F can be used in antibody-drug conjugates (ADC) .
(4-NH2)-Exatecan-d5 is a deuterated labeled (4-NH2)-Exatecan . (4-NH2)-Exatecan (compound A), a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
N-butyryl-L-Homoserine lactone-d5 is the deuterium labeled N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm[1]. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa[2][3].
Natriuretic Peptides A Antibody (YA1381) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1381), targeting Natriuretic Peptides A, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). Natriuretic Peptides A Antibody (YA1381) can be used for WB, IP experiment in human background.
Myoglobin Antibody (YA925) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA925), targeting Myoglobin, with a predicted molecular weight of 17 kDa. Myoglobin Antibody (YA925) can be used for WB,IHC-P,ICC/IF,IP experiment in human, mouse, rat background.
CD44 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to CD44. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
LYPD3; C4.4A; UNQ491/PRO1007; Ly6/PLAUR domain-containing protein 3; GPI-anchored metastasis-associated protein C4.4A homolog; Matrigel-induced gene C4 protein (MIG-C4)
IHC-P
Human
LYPD3 Antibody (YA1098) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1098), targeting LYPD3. LYPD3 Antibody (YA1098) can be used for IHC-P experiment in human background.
BrdU Antibody (YA578) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to BrdU. It can be used for IHC-P, ICC/IF, FC assays with tag free.
uPAR Antibody (YA1257) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1257), targeting uPAR. uPAR Antibody (YA1257) can be used for IHC-P experiment in human background.
CATE Antibody; CATE_HUMAN Antibody; Cathepsin E Antibody; Cathepsin E form II Antibody; CTSE Antibody; Erythrocyte membrane aspartic proteinase Antibody; Slow moving proteinase Antibody;
WB, IHC-P
Human, Mouse, Rat
CTSE Antibody is a rabbit-derived non-conjugated IgG antibody, targeting CTSE, with a predicted molecular weight of 43 kDa (observed band size: 48 kDa). CTSE Antibody can be used for WB, IHC-P experiments in human, mouse, rat backgrounds.
Calcitonin Antibody is an unconjugated, rabbit-derived, anti-Calcitonin monoclonal antibody. Calcitonin Antibody can be used for: IHC-P expriments in human background without labeling.
Parvalbumin Antibody (YA1249) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1249), targeting Parvalbumin. Parvalbumin Antibody (YA1249) can be used for WB, IHC-P, IP experiment in human background.
AKT 1 Antibody; AKT Antibody; AKT1 Antibody; AKT1_HUMAN Antibody; MGC99656 Antibody; PKB Antibody; PKB-ALPHA Antibody; PRKBA Antibody; Protein Kinase B Alpha Antibody; Protein kinase B Antibody; Proto-oncogene c-Akt Antibody; RAC Alpha Antibody; RAC Antibody; RAC-alpha serine/threonine-protein kinase Antibody; RAC-PK-alpha Antibody;
WB, ICC/IF, IHC-P
Human, Mouse
Phospho-Akt1(Ser473) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Phospho-Akt1(Ser473). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
NGFB Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-NGFB monoclonal antibody. NGFB Antibody can be used for: WB, IF-Cell, IF-Tissue, IHC-P, IHC-Fr expriments in human, rat, mouse ,Zebrafish background without labeling.
OPG Antibody is an unconjugated, approximately 46 kDa,mouse-derived, anti-OPG monoclonal antibody. OPG Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.
CD138 (syndecan 1) is a transmembrane proteoglycan that can bind a variety of cytokines and modulate their activity, as well as the activity of extracellular matrix components and influence many developmental processes. CD138 is expressed mainly in differentiating keratinocytes and is transiently upregulated in all layers of the epidermis upon tissue injury. It is also highly expressed on plasma cells and can be detected even on fibroblasts, vascular smooth muscle cells and endothelial cells. Up-regulation and down-regulation of CD138 on the cell surface often correlates with the gain of cancerous characteristics. Serum levels of the shedded soluble sCD138 are used as a prognostic factor of cancerogenesis.
SOD1 Antibody is an unconjugated, approximately 17 kDa, rabbit-derived, anti-SOD1 monoclonal antibody. SOD1 Antibody can be used for: WB, IF-Cell, IF-Tissue, IHC-P, FC expriments in human, mouse, rat background without labeling.
Cortactin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Cortactin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
SP7/Osterix Antibody is an unconjugated, approximately 45 kDa, rabbit-derived, anti-SP7/Osterix monoclonal antibody. SP7/Osterix Antibody can be used for: WB, IHC-P, IF-Tissue, IHC-Fr expriments in human, mouse, and rat background without labeling.
CAMEO Antibody;
heart odd homeobox 1 protein Antibody;
HOD Antibody;
Homeodomain-only protein Antibody;
HOP Antibody;
HOP homeobox Antibody;
HOP_HUMAN Antibody;
HOPX Antibody;
LAGY Antibody;
Lung cancer-associated Y protein Antibody;
NECC1 Antibody;
Not expressed in choriocarcinoma clone 1 Antibody;
Not expressed in choriocarcinoma protein 1 Antibody;
OB1 Antibody;
odd homeobox 1 protein Antibody;
Odd homeobox protein 1 Antibody;
OTTHUMP00000158970 Antibody;
SMAP31 Antibody;
TOTO Antibody
WB, IP
Human
HOPX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 8 kDa, targeting to HOPX. It can be used for WB, IP assays with tag free, in the background of Human.
Alpha-dystroglycan Antibody is an unconjugated, approximately 97 kDa, rabbit-derived, anti-Alpha-dystroglycan polyclonal antibody. Alpha-dystroglycan Antibody can be used for: WB, IHC-P, IF-Cell, FC expriments in human,mouse and rat background without labeling.
3 hydroxy 3 methylglutaryl CoA reductase Antibody;
3 hydroxy 3 methylglutaryl Coenzyme A reductase Antibody;
3 hydroxymethylglutaryl CoA reductase Antibody;
3-hydroxy-3-methylglutaryl CoA reductase (NADPH) Antibody;
3-hydroxy-3-methylglutaryl-coenzyme A reductase Antibody;
3H3M Antibody;
HMDH_HUMAN Antibody;
HMG CoA reductase Antibody;
HMG CoAR Antibody;
HMG-CoA reductase Antibody;
Hmgcr Antibody;
Hydroxymethylglutaryl CoA reductase Antibody;
LDLCQ3 Antibody;
MGC103269 Antibody;
Red Antibody
WB, IP
Human, Mouse
HMGCR Antibody is an unconjugated, approximately 97 kDa, rabbit-derived, anti-HMGCR monoclonal antibody. HMGCR Antibody can be used for: WB,IP expriments in human, mouse background without labeling.
Glucagon Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Glucagon, with a predicted molecular weight of 21 kDa. Glucagon Antibody can be used for WB, IHC-P experiments in human, mouse, rat backgrounds.
Cofilin 1 Antibody (YA1311) is a non-conjugated IgG antibody, targeting Cofilin 1, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Cofilin 1 Antibody (YA1311) can be used for WB, IF-Cell, FC experiment in Human, Mouse, Rat, Monkey background.
CDKN2A/p16INK4a Antibody is an unconjugated, approximately 16 kDa, rabbit-derived, anti-CDKN2A/p16INK4a monoclonal antibody. CDKN2A/p16INK4a Antibody can be used for: WB, IHC-P expriments in human background without labeling.
G-CSF Receptor Antibody (YA3373) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3373), targeting G-CSF Receptor, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). G-CSF Receptor Antibody (YA3373) can be used for WB, FC experiment in human background.
Caspase-12 Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-Caspase-12 monoclonal antibody. Caspase-12 Antibody can be used for: WB, IHC-P expriments in human, mouse, rat, background without labeling.
PSMB5/MB1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to PSMB5/MB1. It can be used for WB, IHC-P, IF-Cell, FC assays with tag free, in the background of Human,Mouse, Rat.
Quinolones Antibody (YA903) is an unconjugated, rabbit-derived, anti-Quinolones (YA903) monoclonal antibody. Quinolones Antibody (YA903) can be used for: ELISA expriments in species-independent background without labeling.
Clenbuterol Antibody (YA904) is an unconjugated, rabbit-derived, anti-Clenbuterol (YA904) monoclonal antibody. Clenbuterol Antibody (YA904) can be used for: ELISA expriments in background without labeling.
39.1 Antibody;
CK 17 Antibody;
CK17 Antibody;
CK-17 Antibody;
Cytokeratin-17 Antibody;
K17 Antibody;
K1C17_HUMAN Antibody;
Keratin 17 Antibody;
keratin 17 epitope S1 Antibody;
keratin 17 epitope S2 Antibody;
keratin 17 epitope S4 Antibody;
Keratin 17, type I Antibody;
Keratin Antibody;
Keratin type I cytoskeletal 17 Antibody;
keratin, type i cytoskeletal 17 [version 1] Antibody;
Keratin-17 Antibody;
KRT17 Antibody;
PC Antibody;
PC2 Antibody;
PCHC1 Antibody;
type I cytoskeletal 17 Antibody
WB, IHC-P, ICC/IF
Human, Mouse, Rat
Cytokeratin 17 Antibody (YA3438) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3438), targeting Cytokeratin 17, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). Cytokeratin 17 Antibody (YA3438) can be used for WB, IF-Cell, IF-Tissue, IHC-P experiment in human, Mouse, Rat background.
SN38 Antibody (YA923) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA923), targeting SN38. SN38 Antibody (YA923) can be used for WB, ELISA experiment in species independent background.
CD146 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to CD146. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.
ATF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to ATF2. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
CD107 antigen like family member A Antibody;
CD107 antigen-like family member A Antibody;
CD107a Antibody;
CD107a antigen Antibody;
LAMP 1 Antibody;
LAMP-1 Antibody;
LAMP1 Antibody;
LAMP1_HUMAN Antibody;
LAMPA Antibody;
LGP120 Antibody;
lgpA Antibody;
Lysosomal membrane glycoprotein 120KD Antibody;
Lysosomal Associated Membrane Protein 1 Antibody;
Lysosome associated membrane glycoprotein 1 Antibody;
Lysosome-associated membrane glycoprotein 1 Antibody;
Lysosome-associated membrane protein 1 Antibody;
OTTHUMP00000040663 Antibody
WB, IHC-P
Human
LAMP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
MARK2 Antibody (YA2104) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2104), targeting MARK2, with a predicted molecular weight of 88 kDa (observed band size: 78, 82 kDa). MARK2 Antibody (YA2104) can be used for WB, FC experiment in human, mouse, rat background.
CD107 antigen like family member A Antibody;
CD107 antigen-like family member A Antibody;
CD107a Antibody;
CD107a antigen Antibody;
LAMP 1 Antibody;
LAMP-1 Antibody;
LAMP1 Antibody;
LAMP1_HUMAN Antibody;
LAMPA Antibody;
LGP120 Antibody;
lgpA Antibody;
Lysosomal membrane glycoprotein 120KD Antibody;
Lysosomal Associated Membrane Protein 1 Antibody;
Lysosome associated membrane glycoprotein 1 Antibody;
Lysosome-associated membrane glycoprotein 1 Antibody;
Lysosome-associated membrane protein 1 Antibody;
OTTHUMP00000040663 Antibody;
WB, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
LAMP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP1. It can be used for WB, IHC-P, IF-Tissue, IHC-Fr assays with tag free, in the background of Human,Mouse,Rat.
NGFR Antibody (YA2774) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2774), targeting NGFR, with a predicted molecular weight of 45 kDa (observed band size: 75 kDa). NGFR Antibody (YA2774) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
PSMB1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to PSMB1. It can be used for WB, IF-Cell, IHC-P, FC assays with tag free, in the background of Human,Mouse, Rat.
18A2 Antibody;
42A Antibody;
calcium Placental protein Antibody;
Calvasculin Antibody;
CAPL Antibody;
Fibroblast specific protein 1 (FSP1) Antibody;
Fibroblast specific protein 1 Antibody;
Fibroblast specific protein Antibody;
FSP1 Antibody;
Leukemia multidrug resistance associated protein Antibody;
Malignant transformation suppression 1 (MTS1) Antibody;
Malignant transformation suppression 1 Antibody;
Metastasin Antibody;
MTS1 Antibody;
OTTHUMP00000015467 Antibody;
OTTHUMP00000015468 Antibody;
P9KA Antibody;
PEL98 Antibody;
Placental calcium-binding protein Antibody;
Protein Mts1 Antibody;
Protein S100 A4 Antibody;
Protein S100-A4 Antibody;
S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) Antibody;
S100 calcium binding protein A4 Antibody;
S100 calcium-binding protein A4 Antibody;
S100a4 Antibody;
S10A4_HUMAN Antibody
WB, ICC/IF, IHC-P, IP, FC
Human, Mouse
S100A4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to S100A4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
ABC30 Antibody;
abcC2 Antibody;
ATP binding cassette sub family C (CFTR/MRP) member 2 Antibody;
ATP binding cassette subfamily C member 2 Antibody;
ATP-binding cassette sub-family C member 2 Antibody;
Canalicular multidrug resistance protein Antibody;
Canalicular multispecific organic anion transporter 1 Antibody;
CMOAT Antibody;
CMOAT1 Antibody;
cMRP Antibody;
DJS Antibody;
KIAA1010 Antibody;
MRP 2 Antibody;
MRP2_HUMAN Antibody;
Multidrug resistance associated protein 2 Antibody;
Multidrug resistance-associated protein 2 Antibody;
WB, ICC/IF, FC
Human
MRP2/ABCC2 Antibody is an unconjugated, approximately 174 kDa, rabbit-derived, anti-MRP2/ABCC2 monoclonal antibody. MRP2/ABCC2 Antibody can be used for: WB, ICC/IF, FC expriments in human background without labeling.
The glutathione S-transferase (GST) family of enzymes comprises a long list of cytosolic, mitochondrial, and microsomal proteins that are capable of multiple reactions with a multitude of substrates, both endogenous and xenobiotic. Mammalian cytosolic GSTs are dimeric both subunits being from the same class of GSTs. The monomers are in the range of 22–29 kDa. Glutathione S-transferase is used to create the “GST gene fusion system” in genetic engineering. Here, GST is used to purify and detect proteins of interest.
Phospho-Hormone sensitive lipase (Ser853) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 117 kDa, targeting to Phospho-Hormone sensitive lipase (S853). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
CDKN2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to CDKN2A. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
C-TAK1 Antibody;
CDc25C associated protein kinase 1 Antibody;
CDc25C-associated protein kinase 1 Antibody;
cTAK1 Antibody;
ELKL motif kinase 2 Antibody;
EMK-2 Antibody;
Emk2 Antibody;
ETK 1 Antibody;
KIAA4230 Antibody;
KP78 Antibody;
MAP microtubule affinity regulating kinase 3 Antibody;
MAP/microtubule affinity-regulating kinase 3 Antibody;
Mark3 Antibody;
MARK3_HUMAN Antibody;
Par 1a Antibody;
PAR1A Antibody;
Protein kinase STK10 Antibody;
Ser/Thr protein kinase PAR-1 Antibody;
Serine threonine protein kinase p78 Antibody;
Serine/threonine-protein kinase p78 Antibody;
SerThr protein kinase PAR 1 Antibody
WB, ICC/IF, IP, FC
Mouse, Human
MARK3 Antibody (YA2150) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2150), targeting MARK3, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). MARK3 Antibody (YA2150) can be used for WB, ICC/IF, IP, FC experiment in mouse, human background.
Transcription factor AP2 alpha Antibody is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3441), targeting Transcription factor AP2 alpha, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). Transcription factor AP2 alpha Antibody (YA3441) can be used for WB, IF-Cell, IHC-P experiment in human, Mouse, Rat background.
cytoplasmic 1 Antibody;
MGC138448 Antibody;
NF ATc Antibody;
NF ATc1 Antibody;
NF-ATc Antibody;
NF-ATc1 Antibody;
NF-ATc1.2 Antibody;
NFAC1_HUMAN Antibody;
NFAT 2 Antibody;
NFAT transcription complex cytosolic component Antibody;
NFATC 1 Antibody;
NFATc Antibody;
NFATc1 Antibody;
Nuclear factor of activated T cells cytoplasmic 1 Antibody;
Nuclear factor of activated T cells cytoplasmic calcineurin dependent 1 Antibody;
Nuclear factor of activated T cells cytosolic component 1 Antibody;
nuclear factor of activated T-cells 'c' Antibody;
Nuclear factor of activated T-cells Antibody
WB, IHC-P, FC
Human
NFAT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 101 kDa, targeting to NFAT2. It can be used for WB, IHC-P, FC assays with tag free, in the background of Human.
Albumin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to Albumin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
ALIX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to ALIX. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Rat.
APC Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 312 kDa, targeting to APC. It can be used for WB,ICC,IP assays with tag free, in the background of Human, Mouse.
ATM Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 351 kDa, targeting to ATM. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
ATRX Antibody is a non-conjugated and Mouse origined monoclonal antibody about 280 kDa, targeting to ATRX. It can be used for ICC,IHC-P assays with tag free, in the background of Mouse.
Bad Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Bad. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
Bid Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Bid. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
Bim Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Bim. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Calbindin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Calbindin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Calpastatin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 120 kDa, targeting to Calpastatin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
Calreticulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Calreticulin. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
CNPase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to CNPase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
CREB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to CREB. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Desmin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Desmin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Doublecortin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to Doublecortin. It can be used for WB,FC assays with tag free, in the background of Human, Mouse, Rat.
Drosha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 159 kDa, targeting to Drosha. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human.
EGF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 130/10 kDa, targeting to EGF. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
EGFR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to EGFR. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
FAK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to FAK. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
FosB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to FosB. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
GABARAP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to GABARAP. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
GAPDH Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to GAPDH. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat, Chicken.
GFP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to GFP. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of .
Huntingtin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 348 kDa, targeting to Huntingtin. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Insulin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 12 kDa, targeting to Insulin. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human.
JunB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to JunB. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
MCU Antibody is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to MCU. It can be used for WB,FC assays with tag free, in the background of Human.
MGMT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to MGMT. It can be used for WB,IHC-P assays with tag free, in the background of Human.
MiTF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to MiTF. It can be used for WB,ICC,FC assays with tag free, in the background of Human, Mouse, Rat.
MLKL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MLKL. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Moesin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Moesin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Nanog Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Nanog. It can be used for WB,ICC/IF,FC,IHC-P assays with tag free, in the background of Human, Mouse.
NeuN Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to NeuN. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
nNOS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 161 kDa, targeting to nNOS. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Nucleolin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Nucleolin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
NUMB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to NUMB. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
OGT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 117 kDa, targeting to OGT. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Paxillin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to Paxillin. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
PCNA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to PCNA. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
PKR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to PKR. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
PTEN Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to PTEN. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
PUMA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to PUMA. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Ras Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Ras. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
Rb Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 106 kDa, targeting to Rb. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
RBPJK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to RBPJK. It can be used for WB assays with tag free, in the background of Human.
RelB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to RelB. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
Ret Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Ret. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
RHEB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to RHEB. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
RICTOR Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 192 kDa, targeting to RICTOR. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse.
RIP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to RIP. It can be used for WB,FC assays with tag free, in the background of Human.
SDHA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 73 kDa, targeting to SDHA. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Src Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Src. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
TrkA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to TrkA. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
TrkB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to TrkB. It can be used for WB,IHC-P assays with tag free, in the background of Mouse, Rat.
TXNIP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TXNIP. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
VASP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to VASP. It can be used for WB,IP assays with tag free, in the background of Human.
Vimentin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Vimentin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Vinculin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Vinculin. It can be used for WB,ICC/IF,IP,IHC assays with tag free, in the background of Human, Mouse, Rat.
Fibronectin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 272 kDa, targeting to Fibronectin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Hamartin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 130 kDa, targeting to Hamartin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
pVHL Antibody is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to pVHL. It can be used for IHC-P assays with tag free, in the background of Human.
Villin Antibody is an unconjugated, rabbit-derived, anti-Villin monoclonal antibody. Villin Antibody can be used for: WB, IHC-P, IP expriments in human background without labeling.
Islet 1 Antibody (YA1244) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1244), targeting Islet 1. Islet 1 Antibody (YA1244) can be used for WB, IF-Cell, IHC-P, FC, IHC-Fr experiment in human, mouse, rat background.
DKFZp686C01211 Antibody;
DNA binding factor KBF1 Antibody;
DNA binding factor KBF1 EBP1 Antibody;
DNA-binding factor KBF1 Antibody;
EBP 1 Antibody;
EBP-1 Antibody;
EBP1 Antibody;
KBF1 Antibody;
MGC54151 Antibody;
NF kappa B Antibody;
NF kappaB Antibody;
NF kappabeta Antibody;
NF kB1 Antibody;
NFkappaB Antibody;
NFKB 1 Antibody;
NFKB p105 Antibody;
NFKB p50 Antibody;
Nfkb1 Antibody;
NFKB1_HUMAN Antibody;
Nuclear factor kappa B DNA binding subunit Antibody;
Nuclear factor kappa-B, subunit 1 Antibody;
Nuclear factor NF kappa B p105 subunit Antibody;
Nuclear factor NF kappa B p50 subunit Antibody;
Nuclear factor NF-kappa-B p50 subunit Antibody;
Nuclear factor of kappa light chain gene enhancer in B cells 1 Antibody;
Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 Antibody;
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Antibody;
p105 Antibody;
p50 Antibody;
p84/NF-kappa-B1 p98 Antibody;
Transcription factor NFKB1 Antibody
WB, ICC/IF, IHC-P
Human, Mouse
NF-κB p105/p50 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to NF-κB p105/p50. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
HLA class I histocompatibility antigen E alpha chain Antibody;
EA1.2 Antibody;
EA2.1 Antibody;
HLA 6.2 Antibody;
HLA class I histocompatibility antigen alpha chain E Antibody;
HLA class I histocompatibility antigen E alpha chain precursor Antibody;
HLA class I histocompatibility antigen E alpha chain precursor Antibody;
HLA6.2 Antibody;
HLAE Antibody;
Lymphocyte antigen Antibody;
Major histocompatibility complex class I E Antibody;
MHC Antibody;
MHC class I antigen E Antibody;
MHC HLA E alpha 1 Antibody;
MHC HLA E alpha 2.1 Antibody;
QA1 Antibody
WB, IP, FC
Human
HLA E Antibody is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to HLA E . It can be used for WB, IP, FC assays with tag free, in the background of Human.
CD366 Antibody;
FLJ14428 Antibody;
HAVcr-2 Antibody;
Havcr2 Antibody;
HAVR2_HUMAN Antibody;
Hepatitis A virus cellular receptor 2 Antibody;
Kidney injury molecule 3 Antibody;
KIM 3 Antibody;
KIM3 Antibody;
T cell immunoglobulin and mucin domain containing 3 Antibody;
T cell immunoglobulin mucin 3 Antibody;
T-cell immunoglobulin and mucin domain-containing protein 3 Antibody;
T-cell immunoglobulin mucin family member 3 Antibody;
T-cell immunoglobulin mucin receptor 3 Antibody;
T-cell membrane protein 3 Antibody;
Tim 3 Antibody;
TIM-3 Antibody;
TIM3 Antibody;
TIMD-3 Antibody;
TIMD3 Antibody
WB, IHC-P, ICC/IF, FC
Human
TIM3 Antibody (YA1448) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA1448), targeting TIM3. TIM3 Antibody (YA1448) can be used for WB, IHC-P, IF-Cell, FC experiment in human background.
Caudal type homeo box 2 Antibody;
Caudal type homeo box transcription factor 2 Antibody;
Caudal type homeobox 2 Antibody;
Caudal type homeobox protein 2 Antibody;
Caudal type homeobox transcription factor 2 Antibody;
Caudal-type homeobox protein 2 Antibody;
CDX 2 Antibody;
CDX 3 Antibody;
CDX-3 Antibody;
CDx2 Antibody;
CDX2_HUMAN Antibody;
CDX3 Antibody;
Homeobox protein CDX 2 Antibody;
Homeobox protein CDX-2 Antibody
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
CDX2 Antibody is an unconjugated, approximately 34 kDa, rabbit-derived, anti-CDX2 monoclonal antibody. CDX2 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.
CYP11A1 Antibody is an unconjugated, approximately 53 kDa, rabbit-derived, anti-CYP11A1 polyclonal antibody. CYP11A1 Antibody can be used for: WB,IHC-F,IHC-P,ICC/IF expriments in human, mouse, rat background without labeling.
FLJ13874 Antibody; Heat shock 70 kDa protein 12A Antibody; heat shock 70kD protein 12A Antibody; heat shock 70kDa protein 12A Antibody; HS12A_HUMAN Antibody; Hspa12a Antibody; KIAA0417 Antibody
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
HspA12A Antibody (YA2947) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2947), targeting HspA12A, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). HspA12A Antibody (YA2947) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
COAA1_HUMAN Antibody;
Col10a 1 Antibody;
COL10A1 Antibody;
Collagen alpha 1(X) chain Antibody;
Collagen alpha-1(X) chain Antibody;
Collagen type X alpha 1 (Schmid metaphyseal chondrodysplasia) Antibody;
Collagen type X alpha 1 Antibody;
Collagen X alpha 1 polypeptide Antibody;
CollagenX Antibody;
fa66d11 Antibody;
fb10c08 Antibody;
OTTHUMP00000040411 Antibody;
Procollagen type X alpha 1 Antibody;
Schmid metaphyseal chondrodysplasia Antibody;
wu:fa66d11 Antibody;
wu:fb10c08 Antibody
WB
Human, Mouse, Rat
Collagen X Antibody is an unconjugated, approximately 66 kDa, rabbit-derived, anti-Collagen X monoclonal antibody. Collagen X Antibody can be used for: WB expriments in mouse, rat, human background without labeling.
Phospholipase C gamma 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 149 kDa, targeting to Phospholipase C gamma 1. It can be used for WB,ICC,IP assays with tag free, in the background of Human.
MDM2 Antibody (YA3442) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA3442), targeting MDM2, with a predicted molecular weight of 55 kDa (observed band size: 90 kDa). MDM2 Antibody (YA3442) can be used for WB, ICC/IF, IHC-P experiment in human, monkey background.
12S1644 Antibody; D12S1644 Antibody; IL 4 STAT Antibody; IL-4 Stat Antibody; IL4 STAT Antibody; Interleukin 4 Induced Antibody; Interleukin 4 Induced Transcription Factor IL4 STAT Antibody; Signal transducer and activator of transcription 6 Antibody; Signal Transducer And Activator Of Transcription 6 Interleukin 4 Induced Antibody; Signal Transducer And Activator Of Transcription 6 Nirs Variant 1 Antibody; Signal transducer and activator of transcription 6, interleukin 4 induced Antibody;
STAT 6 Antibody; STAT interleukin4 induced Antibody; STAT, interleukin4 induced Antibody; Stat6 Antibody; STAT6_HUMAN Antibody; STAT6B Antibody; STAT6C Antibody; Transcription factor IL 4 STAT Antibody;
WB, ICC/IF, IHC-P, IP
Human, Mouse
STAT6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 94 kDa, targeting to STAT6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
ABCG2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to ABCG2. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Alkaline Phosphatase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Alkaline Phosphatase. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
ALKBH1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to ALKBH1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Androgen receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 99 kDa, targeting to Androgen receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
APC6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to APC6. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.
A-RAF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to A-RAF. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Arginase-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Arginase-1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Atg12 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Atg12. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
ATG5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to ATG5. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat, Mouse, Monkey.
Bcl-2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl-2. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Bcl-XL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl-XL. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
BMAL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to BMAL1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Bmi1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to Bmi1. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
BNIP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to BNIP3. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
B-Raf Antibody is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to B-Raf. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
BRD2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to BRD2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
BRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 185 kDa, targeting to BRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Caspase-10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Caspase-10. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human.
Caspase-14 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 28 kDa, targeting to Caspase-14. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
Caspase-3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to Caspase-3. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
Caspase-6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Caspase-6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Caspase-8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Caspase-8. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
Caspase-9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Caspase-9. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Caveolin-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to Caveolin-1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
CD133 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to CD133. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
CD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to CD4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
CD40 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to CD40. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
CD41 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to CD41. It can be used for WB,IHC-P assays with tag free, in the background of Human.
CD43 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to CD43. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
CD46 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to CD46. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Rat.
CD47 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to CD47. It can be used for IHC-P assays with tag free, in the background of Human.
CD90 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to CD90. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
CD99 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD99. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
CDC23 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to CDC23. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
Cdc27 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to Cdc27. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Cdk4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk4. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Cdk5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Cdk5. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
Cdk6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Cdk6. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
CDT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to CDT1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Chk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to Chk2. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
c-Jun Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to c-Jun. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
COX IV Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to COX IV. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
COX2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 69 kDa, targeting to COX2. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Rat.
c-Rel Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to c-Rel. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Ctip1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to Ctip1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
Ctip2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100/110kDa, targeting to Ctip2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Cyclophilin A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Cyclophilin A. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Cytochrome C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Cytochrome C. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
DR5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to DR5. It can be used for WB,IP,IHC-P,FC assays with tag free, in the background of Human.
EEA1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 162 kDa, targeting to EEA1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
EGR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa., targeting to EGR1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Epac1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 104 kDa, targeting to Epac1. It can be used for WB,IHC-P,IP,ICC/IF assays with tag free, in the background of Human, Mouse.
ERK5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 115 kDa, targeting to ERK5. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.
ERp72 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 73 kDa, targeting to ERp72. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse, Rat.
FABP4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to FABP4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Fatty Acid Synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 273 kDa, targeting to Fatty Acid Synthase. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Filamin A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 281 kDa, targeting to Filamin A. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
FIP200 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to FIP200. It can be used for WB assays with tag free, in the background of Human, Mouse.
FOXO4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to FOXO4. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
FOXP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to FOXP3. It can be used for WB,ICC,FC assays with tag free, in the background of Human.
GCN2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to GCN2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
Gli1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Gli1. It can be used for WB,IHC-P assays with tag free, in the background of Mouse, Rat.
GPX1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 22 kDa, targeting to GPX1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
GRB2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Rat.
HDAC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to HDAC1. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse.
HDAC10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to HDAC10. It can be used for WB,ICC,IP assays with tag free, in the background of Human.
HDAC2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to HDAC2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
HDAC3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to HDAC3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
HDAC4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 120 kDa, targeting to HDAC4. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
HDAC6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to HDAC6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
Hes1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Hes1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
HMGB1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to HMGB1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
HSP60 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 61 kDa, targeting to HSP60. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
ISG15 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to ISG15. It can be used for WB assays with tag free, in the background of Human.
Jagged1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Jagged1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
JAK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 133 kDa, targeting to JAK1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
JNK2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46/54 kDa, targeting to JNK2. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
KLF4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to KLF4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Ku80 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Ku80. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
LRP6 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 180 kDa, targeting to LRP6. It can be used for WB,IHC-P assays with tag free, in the background of Human.
MAPK14 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 41 kDa, targeting to MAPK14. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
MCM2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to MCM2. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human.
MEK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to MEK1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
METTL3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to METTL3. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
MLH1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to MLH1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Mre11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to Mre11. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Mst2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Mst2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Myc-tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to Myc-tag. It can be used for WB,ELISA,IP assays with Myc-tag, in the background of .
N-Cadherin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 100 kDa, targeting to N-Cadherin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
NDRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to NDRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
NEDD8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 9 kDa, targeting to NEDD8. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat.
NFAT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to NFAT1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
NLRP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to NLRP3 . It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
NMDAR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 105 kDa, targeting to NMDAR1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
OPA1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 112 kDa, targeting to OPA1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Pan-Actin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 42kDa, targeting to Pan-Actin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Pan-Cadherin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to Pan-Cadherin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
PARP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to PARP2. It can be used for WB,FC assays with tag free, in the background of Human.
PCK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to PCK1. It can be used for ICC,IHC-P,WB assays with tag free, in the background of Human.
PDCD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to PDCD4. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
PDIA2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to PDIA2. It can be used for WB,FC assays with tag free, in the background of Human, Mouse, Rat.
PDIA6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to PDIA6. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
PDK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to PDK1. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
PDX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PDX1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
PFKFB3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to PFKFB3. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
PSD95 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 80 kDa, targeting to PSD95. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
Rab5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to Rab5. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
RAB7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to RAB7. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Rad51 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Rad51. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
RASA1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to RASA1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.
RbAP48 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to RbAP48. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
RbBP5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to RbBP5. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
RBM3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to RBM3. It can be used for ICC,IHC-P,FC assays with tag free, in the background of Mouse, Human, Rat.
RBP4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to RBP4. It can be used for WB,IHC-P assays with tag free, in the background of Human.
ROCK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 158 kDa, targeting to ROCK1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
RUNX2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to RUNX2. It can be used for ICC/IF,IHC-P,WB assays with tag free, in the background of Human, Mouse.
SIRT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to SIRT2. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.
SIRT5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to SIRT5. It can be used for WB assays with tag free, in the background of Human.
SIRT6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SIRT6. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Smad1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Smad1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Smad2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Smad2. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Smad3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to Smad3. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Smad4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Smad4. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Smad5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Smad5. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
SOCS2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to SOCS2. It can be used for WB,ICC,IF,IP,IHC-P assays with tag free, in the background of Human.
SOX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SOX1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
SOX10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to SOX10. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
SOX11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to SOX11. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
SOX18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to SOX18. It can be used for WB assays with tag free, in the background of Human.
SOX2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to SOX2. It can be used for IHC-P assays with tag free, in the background of Human.
SOX9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to SOX9. It can be used for WB,ICC/IF,IHC-P,IP,FC,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
SP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to SP1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
SPHK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to SPHK1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
SRC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 157 kDa, targeting to SRC1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
SUZ12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to SUZ12. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
TRAF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to TRAF2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Tyrosine Hydroxylase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Tyrosine Hydroxylase. It can be used for WB,ICC,IHC-P,FC,IF assays with tag free, in the background of Human, Mouse, Rat.
Ubiquitin D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Ubiquitin D. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
ULK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to ULK1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
VDAC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to VDAC1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
YAP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to YAP1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
Cathepsin B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Cathepsin B. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
Cathepsin D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45/28 kDa, targeting to Cathepsin D. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse.
CCR2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to CCR2. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
CD38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CD38. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human.
ERK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to ERK1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
ERK2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to ERK2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
FGFR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100,140 kDa, targeting to FGFR1. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
FGFR2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to FGFR2. It can be used for WB,IP assays with tag free, in the background of Human.
FGFR3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to FGFR3. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
FKBP12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to FKBP12. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
FKBP51 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to FKBP51. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Rat.
FKBP52 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to FKBP52. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
GLUT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to GLUT2. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
Glutathione Synthetase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Glutathione Synthetase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
IKK alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to IKK alpha. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
IKK gamma Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to IKK gamma. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
IRAK-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to IRAK-1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Lactate Dehydrogenase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Lactate Dehydrogenase. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
LXR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to LXR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
MMP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MMP3. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
PKC alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC alpha. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
PKC delta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC delta. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
PKC epsilon Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to PKC epsilon. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Beta Actin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to Beta Actin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
CD31 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to CD31. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human.
Cleaved PARP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 89 kDa, targeting to Cleaved PARP. It can be used for WB,ICC,IP,FC assays with tag free, in the background of Human.
GPX4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to GPX4. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
beta Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta Tubulin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
HER2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 138 kDa, targeting to HER2. It can be used for IHC-P,WB,ICC assays with tag free, in the background of Human.
Iba1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to Iba1. It can be used for WB,IHC-P,FC,IP,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
IRF3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to IRF3. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
MCL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to MCL1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
MMP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to MMP2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
PDGFR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 123 kDa, targeting to PDGFR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.
VGluT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa. It can be used for WB assays in the background of Human, Mouse, Rat.
SATB2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to SATB2. It can be used for WB,IF-Cell,IF-Tissue,IHC-P,FC assays in the background of Human, Mouse, Rat.
CDC37 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IHC-P,IP,FC assays in the background of Human, Mouse, Rat.
CD161 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to CD161. It can be used for WB, IHC-P, FC assays with tag free, in the background of Human.
HMGCS2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to HMGCS2. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse, Rat.
FOXA2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to FOXA2. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Gastric Mucin Antibody is an unconjugated, mouse-derived, anti-Gastric Mucin monoclonal antibody. Gastric Mucin Antibody can be used for: IHC-P expriments in human background without labeling.
IDH1 Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-IDH1 monoclonal antibody. IDH1 Antibody can be used for: WB, IHC-P, IP expriments in human, mouse, rat background without labeling.
CHRNA9 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CHRNA9 polyclonal antibody. CHRNA9 Antibody can be used for: WB, IHC-P expriments in human, rat background without labeling.
Goat Anti-Rabbit IgG Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting Goat Anti-Rabbit IgG, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). Goat Anti-Rabbit IgG Antibody can be used for WB, ELISA experiment in rabbit background.
Alpha 1 (VI) chain (61 AA) Antibody; CO6A1_HUMAN Antibody; COL6A1 Antibody; Collagen alpha-1(VI) chain Antibody; Collagen type VI alpha 1 Antibody; Collagen VI alpha 1 polypeptide Antibody; Collagen VI Antibody; Human mRNA for collagen VI alpha 2 C terminal globular domain Antibody; OPLL Antibody; PP3610 Antibody
WB, ICC/IF, IHC-P
Human, Mouse, Rat
Collagen VI Antibody (YA893) is an unconjugated, approximately 109 kDa, rabbit-derived, anti-Collagen VI (YA893) monoclonal antibody. Collagen VI Antibody (YA893) can be used for: WB, IF-Cell, IF-Tissue, IHC-P expriments in human, mouse, rat background without labeling.
S6K1 Antibody is an unconjugated, approximately 59 kDa, rabbit-derived, anti-S6K1 monoclonal antibody. S6K1 Antibody can be used for: WB, ICC/IF, IP expriments in human, rat, mouse background without labeling.
IRF6 Antibody (YA2662) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2662), targeting IRF6, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). IRF6 Antibody (YA2662) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
SRD5A2 Antibody is an unconjugated, approximately 28 kDa, rabbit-derived, anti-SRD5A2 monoclonal antibody. SRD5A2 Antibody can be used for: WB, IP expriments in human, rat background without labeling.
53BP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 214 kDa, targeting to TP53BP1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
AIF Antibody (YA636) is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to AIF. It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Annexin A2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Annexin A2. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
Bak Antibody (YA592) is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to Bak. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Bax Antibody (YA591) is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Bax. It can be used for WB,IF/ICC,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Calnexin Antibody (YA573) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Calnexin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Rat.
Catalase Antibody (YA552) is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Catalase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Catalase Antibody (YA811) is a non-conjugated and Mouse origined monoclonal antibody about 60kDa, targeting to Catalase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
CD40L Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to CD40L. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
CD42a Antibody is a non-conjugated and Mouse origined monoclonal antibody about 19 kDa, targeting to CD42a. It can be used for WB,IHC assays with tag free, in the background of Human, Mouse.
CD42b Antibody is a non-conjugated and Mouse origined monoclonal antibody about 72 kDa, targeting to CD42b. It can be used for IHC-P,FC assays with tag free, in the background of Human.
Cdc25B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to Cdc25B. It can be used for WB,IP assays with tag free, in the background of Human.
Clathrin heavy chain Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 191/187 kDa, targeting to Clathrin heavy chain. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Cyclin A2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to Cyclin A2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Cyclin D3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Cyclin D3. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
DNA-PKcs/PRKDC Antibody is a non-conjugated and Mouse origined monoclonal antibody about 469 kDa, targeting to DNA-PKcs/PRKDC. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
Dnmt3a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Dnmt3a. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
eIF4E Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to eIF4E. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse.
EpCAM Antibody (YA772) is a non-conjugated and Mouse origined monoclonal antibody about 35 kDa, targeting to EpCAM. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
Fas/CD95 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Fas(CD95). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
Fascin Antibody (YA445) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Fascin. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
FOXO1A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to FOXO1A. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
GFAP Antibody (YA755) is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to GFAP. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
GFAP Antibody (YA416) is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to GFAP. It can be used for WB,IHC-P,IP,IF assays with tag free, in the background of Human, Mouse, Rat.
Glucocorticoid Receptor alpha Antibody is a non-conjugated and Mouse origined monoclonal antibody about 86 kDa, targeting to Glucocorticoid Receptor alpha. It can be used for WB,IHC-P,FC,ICC assays with tag free, in the background of Human, Mouse.
Glu-Glu Tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to Glu-Glu Tag. It can be used for WB assays with Glu-Glu-tag, in the background of Species independent.
Histone H3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3. It can be used for WB,ICC/IF,IHC-P,IP,ChIP assays with tag free, in the background of Human, Mouse, Rat.
Histone H4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Hsp90 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Hsp90 alpha. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Monkey.
Hsp90 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Hsp90 beta. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Insulin degrading enzyme Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Insulin degrading enzyme. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Insulin Receptor Beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Insulin Receptor Beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.
Insulin Receptor R Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 144 kDa, targeting to Insulin Receptor R. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Lamin A/C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 74 kDa, targeting to Lamin A/C. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Lamin B1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to Lamin B1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
LAMP2a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP2a. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
LIN28A Antibody is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to LIN28A. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
Lin28B Antibody is a non-conjugated and Mouse origined monoclonal antibody about ~27 kDa, targeting to Lin28B. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
MEK1/2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to MEK1/2. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Met (C-Met) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Met (C-Met). It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
mTOR Antibody (YA281) is a non-conjugated and Rabbit origined monoclonal antibody about 289 kDa, targeting to mTOR. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Myosin heavy chain Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 224 kDa, targeting to Myosin heavy chain. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.
NMDAR2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 165 kDa, targeting to NMDAR2A. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.
PD-L1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to PD-L1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
RAB5C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to RAB5C. It can be used for WB,IHC-P assays with tag free, in the background of Human.
RAB8A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to RAB8A. It can be used for WB assays with tag free, in the background of Human.
Retinoic Acid Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoic Acid Receptor alpha. It can be used for WB,FC assays with tag free, in the background of Human.
RhoA Antibody (YA093) is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to RhoA. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
STAT1 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to STAT1 alpha. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.
STAT5a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to STAT5a. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
STAT5b Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 90 kDa, targeting to STAT5b. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
STING Antibody (YA048) is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to STING. It can be used for WB,FC assays with tag free, in the background of Human.
Survivin Antibody (YA045) is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to Survivin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Synaptophysin Antibody (YA043) is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Synaptophysin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
TrkA+B+C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to TrkA+B+C. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Ubiquitin Antibody (YA022) is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Ubiquitin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
V5-tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to V5-tag. It can be used for WB,ELISA assays with V5-tag, in the background of .
ATP citrate lyase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 121 kDa, targeting to ATP citrate lyase. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Carbonic Anhydrase I is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to Carbonic Anhydrase I . It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
ERK1/2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43/41 kDa, targeting to ERK1/2. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Integrin alpha V Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to Integrin alpha V. It can be used for WB,ICC,FC assays with tag free, in the background of Human.
PKA R2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa., targeting to PKA R2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Beta-Catenin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Beta-Catenin. It can be used for WB,IHC-P,IF,IP assays with tag free, in the background of Human, Mouse.
C/EBP Beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to C/EBP Beta. It can be used for WB,FC,IP assays with tag free, in the background of Human, Rat.
EIF2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to EIF2A. It can be used for WB,IHC-P assays with tag free, in the background of Human.
GRP78 BiP Antibody is a non-conjugated and Mouse origined monoclonal antibody about 72kDa, targeting to GRP78 BiP. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
xCT Antibody (YA652) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to xCT. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human, Mouse.
Trk B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to Trk B. It can be used for WB assays with tag free, in the background of Rat.
Anti-Aurora A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Aurora. It can be used for WB, IF, IHC-P, FC assays with tag free, in the background of Human, Mouse, Rat.
Mucin 5B Antibody is an unconjugated, mouse-derived, anti-Mucin 5B monoclonal antibody. Mucin 5B Antibody can be used for: IHC-P, FC, ELISA expriments in human background without labeling.
p38 MAPK Antibody is an unconjugated, approximately 41 kDa, anti-p38 MAPK monoclonal antibody. p38 MAPK Antibody can be used for: WB, IF-Cell, IF-Tissue expriments in human, mouse, rat background without labeling.
Cyclin B2 Antibody is an unconjugated, approximately 45 kDa, anti-Cyclin B2 monoclonal antibody. Cyclin B2 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.
NF-κB p65 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to NF-κB p65. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
AKT1 Antibody (YA834) is a non-conjugated and Mouse origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
ASK1 Antibody (YA609) is a non-conjugated and Rabbit origined monoclonal antibody about 155 kDa, targeting to ASK1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Caspase-6 p18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Caspase-6 p18. It can be used for WB,IP assays with tag free, in the background of Human.
CD45 Antibody (YA533) is a non-conjugated and Rabbit origined monoclonal antibody about 147 kDa., targeting to CD45. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
CD68 Antibody (YA798) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa., targeting to CD68. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
CD68 Antibody (YA529) is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to CD68. It can be used for WB assays with tag free, in the background of Human.
CD9 Antibody (YA524) is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD9. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
CDC42EP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 40 kDa, targeting to CDC42EP1. It can be used for WB assays with tag free, in the background of Human.
c-Fos Antibody (YA506) is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to c-Fos. It can be used for WB,IHC-P,FC assays with tag free, in the background of Mouse.
Chk1 Antibody (YA505) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
c-Kit Antibody (YA502) is a non-conjugated and Rabbit origined monoclonal antibody about 110 kDa, targeting to c-Kit. It can be used for WB,IHC-P assays with tag free, in the background of Human.
DNMT1 Antibody (YA781) is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to DNMT1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
Dnmt1 Antibody (YA476) is a non-conjugated and Rabbit origined monoclonal antibody about 183 kDa, targeting to Dnmt1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
E-Cadherin Antibody (YA778) is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to E-Cadherin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
E-Cadherin Antibody (YA470) is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to E-Cadherin. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
eIF4EBP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to eIF4EBP1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Glycogen synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Glycogen synthase. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
GST-Tag Antibody is a HRP-conjugated and Rabbit origined monoclonal antibody, targeting to GST-Tag. It can be used for WB assays with GST-tag, in the background of .
Histone H1.0 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Histone H1.0. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Histone H1.2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Histone H1.2. It can be used for WB,ICC/IF,IHC-P,ChIP assays with tag free, in the background of Human, Mouse, Rat.
Histone H2B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2B. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Histone H3.3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3.3. It can be used for WB,ICC/IF,IHC-P,ChIP assays with tag free, in the background of Human, Mouse.
Hsp70 Antibody (YA359) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Hsp70. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
JNK1+JNK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48/53 kDa, targeting to JNK1+JNK3. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat.
Ku70 Antibody (YA715) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
LAMP2 Antibody (YA713) is a non-conjugated and Mouse origined monoclonal antibody about 45 kDa, targeting to LAMP2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.
Methylmalonyl Coenzyme A mutase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Methylmalonyl Coenzyme A mutase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
MyD88 Antibody (YA280) is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to MyD88. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
Myosin light chain kinase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 211 kDa, targeting to Myosin light chain kinase. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
NQO1 Antibody (YA697) is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to NQO1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
NQO1 Antibody (YA261) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to NQO1. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.
p53 Antibody (YA250) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to p53. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
p53 DINP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to p53 DINP1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
PYK2 Antibody (YA115) is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to PYK2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Pyruvate Dehydrogenase E2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to Pyruvate Dehydrogenase E2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Retinoid X Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoid X Receptor alpha. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Rat.
SOD2 Antibody (YA071) is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to SOD2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
STAT1 Antibody (YA059) is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to STAT1. It can be used for WB,IP,FC assays with tag free, in the background of Human, Mouse.
STAT1 Antibody (YA667) is a non-conjugated and Mouse origined monoclonal antibody about 87kDa, targeting to STAT1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.
STAT2 Antibody (YA057) is a non-conjugated and Rabbit origined monoclonal antibody about 98 kDa, targeting to STAT2. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
STAT3 Antibody (YA056) is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to STAT3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
SUMO1 Antibody (YA046) is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to SUMO-1. It can be used for WB,ICC/IF,IHC-P,IP,FC,ChIP assays with tag free, in the background of Human, Mouse.
TAK1 Antibody (YA042) is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to TAK1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
WDR5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to WDR5. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
YB1 Antibody (YA004) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to YB1. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
ATF6 Antibody (YA831) is a non-conjugated and Mouse origined monoclonal antibody about 75 kDa, targeting to ATF6. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
CD73 Antibody (YA528) is a non-conjugated and Rabbit origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P assays with tag free, in the background of Human.
CD73 Antibody (YA797) is a non-conjugated and Mouse origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P,IF,FC assays with tag free, in the background of Human.
Dynamin 1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to Dynamin 1. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.
FGFR1 Oncogene Partner Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to FGFR1 Oncogene Partner. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
FGFR2/CD332 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 92 kDa, targeting to FGFR2/CD332. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
Galectin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Galectin 1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Glutamine Synthetase Antibody (YA751) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to Glutamine Synthetase. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
HSP70 Antibody (YA728) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to HSP70. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.
JAK2 Antibody (YA721) is a non-conjugated and Mouse origined monoclonal antibody about ~130kDa, targeting to JAK2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Notch 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 125 kDa, targeting to Notch 1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
PPAR gamma Antibody (YA122) is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to PPAR gamma. It can be used for WB assays with tag free, in the background of Human, Rat.
Calpain 1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to Calpain 1. It can be used for ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Calpain 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 80 kDa, targeting to Calpain 2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Rat.
Phospho-ATM (S1981) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 351 kDa, targeting to Phospho-ATM (S1981). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
Phospho-Creb (Ser133) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Phospho-Creb (S133). It can be used for WB,ICC,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Phospho-FAK (Tyr397) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to Phospho-FAK (Y397). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
Phospho-MLKL (Ser345) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-MLKL (S345). It can be used for WB,IHC-P assays with tag free, in the background of Mouse.
Phospho-PTEN (Ser380) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-PTEN(S380). It can be used for WB,ICC assays with tag free, in the background of Human.
Phospho-Rb (Ser807) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 106 kDa, targeting to Phospho-Rb(S807). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-Tau (Ser396) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau(S396). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Mouse, Rat, Human.
ATF4 Antibody (YA605) is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to ATF4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
BRCA1 Antibody (YA819) is a non-conjugated and Mouse origined monoclonal antibody about 208 kDa, targeting to BRCA1. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.
E2F1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to E2F1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Glucose Transporter GLUT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Glucose Transporter GLUT1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Ki67 Antibody (YA717) is a non-conjugated and Mouse origined monoclonal antibody about 359 kDa, targeting to Ki67. It can be used for IHC-P assays with tag free, in the background of Human, Mouse.
Ki67 Antibody (YA322) is a non-conjugated and Rabbit origined monoclonal antibody about 345-395 kDa, targeting to Ki67. It can be used for IHC,IF assays with tag free, in the background of Human, Mouse, Rat.
KMT6/EZH2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to KMT6/EZH2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
Phospho-Met Antibody (YA175) is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Phospho-Met (pY1349). It can be used for WB,IHC-P assays with tag free, in the background of Human.
Phospho-Src (Tyr419) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Phospho-Src(Y419). It can be used for WB,FC assays with tag free, in the background of Human.
TBK1 Antibody (YA662) is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to TBK1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
ZAP70 Antibody (YP4051) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to ZAP70. It can be used for WB,ICC,IHC-P,FC,IP assays with tag free, in the background of Human.
Lysozyme Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 17 kDa, targeting to Lysozyme. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Anoctamin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody, targeting to Anoctamin-1 (ANO1). It can be used for IHC-P, FC assays in the background of Human.
RPA32 Antibody (YA679) is a non-conjugated and Mouse origined monoclonal antibody about 32 kDa, targeting to RPA32. It can be used for WB, IHC-P, ICC/IF, IP assays with tag free, in the background of Human, Mouse, Rat.
Cytokeratin 20 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 20 monoclonal antibody. Cytokeratin 20 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.
Mucin 2 Antibody is an unconjugated, rabbit-derived, anti-Mucin 2 monoclonal antibody. Mucin 2 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.
Mucin 16 Antibody is an unconjugated, rabbit-derived, anti-Mucin 16 monoclonal antibody. Mucin 16 Antibody can be used for: WB, IHC-P expriments in human background without labeling.
Human, Mouse, Rat, Zebrafish, Monkey, Hamster, Plant
Beta Actin Antibody HRP Conjugated is a rabbit-derived HRP-conjugated antibody targeting beta-Actin with a molecular weight of approximately 42 KDa. Beta Actin Antibody HRP Conjugated can be used for WB experiments in human, mouse, rat, zebrafish, monkey, hamster, plant backgrounds.
Anti-Lactate Dehydrogenase A Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-Lactate Dehydrogenase A monoclonal antibody. Anti-Lactate Dehydrogenase A Antibody can be used for: WB, IHC-F, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.
AmCyan Tag Antibody (YA864) is an unconjugated, approximately 55 kDa, mouse-derived, anti-AmCyan Tag (YA864) monoclonal antibody. AmCyan Tag Antibody (YA864) can be used for: WB expriments in species-independent background without labeling.
COX IV Antibody (YA867) is an unconjugated, approximately 20 kDa, mouse-derived, anti-COX IV (YA867) monoclonal antibody. COX IV Antibody (YA867) can be used for: WB, IHC-F, IHC-P, ICC/IF, IP, FC expriments in human, mouse, rat, hamster, goat, monkey background without labeling.
DsbA Tag Antibody (YA868) is an unconjugated, approximately 23 kDa, mouse-derived, anti-DsbA Tag (YA868) monoclonal antibody. DsbA Tag Antibody (YA868) can be used for: WB expriments in Escherichia coli background without labeling.
ECFP Tag Antibody (YA871) is an unconjugated, mouse-derived, anti-ECFP Tag (YA871) monoclonal antibody. ECFP Tag Antibody (YA871) can be used for: WB expriments in species-independent background without labeling.
EYFP Tag Antibody (YA872) is an unconjugated, mouse-derived, anti-EYFP Tag (YA872) monoclonal antibody. EYFP Tag Antibody (YA872) can be used for: WB expriments in species-independent background without labeling.
GAPDH Antibody (HRP) (YA874) is a mouse-derived, anti-GAPDH (HRP) (YA874) monoclonal antibody. GAPDH Antibody (HRP) (YA874) can be used for: WB, ELISA expriments in human, mouse, rat background with HRP labeling.
HSV Tag Antibody (YA878) is an unconjugated, mouse-derived, anti-HSV Tag (YA878) monoclonal antibody. HSV Tag Antibody (YA878) can be used for: WB expriments in species-independent background without labeling.
mOrange Tag Antibody (YA880) is an unconjugated, mouse-derived, anti-mOrange Tag (YA880) monoclonal antibody. mOrange Tag Antibody (YA880) can be used for: WB expriments in species-independent background without labeling.
Plant Actin Antibody (YA881) is an unconjugated, approximately 42 kDa, mouse-derived, anti-Plant Actin (YA881) monoclonal antibody. Plant Actin Antibody (YA881) can be used for: WB expriments in Oryza sativa L, Brassica napus background without labeling.
RFP Tag Antibody (YA882) is an unconjugated, mouse-derived, anti-RFP Tag (YA882) monoclonal antibody. RFP Tag Antibody (YA882) can be used for: WB expriments in species-independent background without labeling.
S Tag Antibody (YA883) is an unconjugated, mouse-derived, anti-S Tag (YA883) monoclonal antibody. S Tag Antibody (YA883) can be used for: WB expriments in species-independent background without labeling.
SRT Tag Antibody (YA884) is an unconjugated, mouse-derived, anti-SRT Tag (YA884) monoclonal antibody. SRT Tag Antibody (YA884) can be used for: WB expriments in species-independent background without labeling.
TAP Tag Antibody (YA887) is an unconjugated, mouse-derived, anti-TAP Tag (YA887) monoclonal antibody. TAP Tag Antibody (YA887) can be used for: WB expriments in species-independent background without labeling.
Trx Tag Antibody (YA888) is an unconjugated, mouse-derived, anti-Trx Tag (YA888) monoclonal antibody. Trx Tag Antibody (YA888) can be used for: WB expriments in species-independent background without labeling.
Salbutamol Antibody (YA901) is an unconjugated, rabbit-derived, anti-Salbutamol (YA901) monoclonal antibody. Salbutamol Antibody (YA901) can be used for: ELISA expriments in background without labeling.
Neomycin Antibody (YA907) is an unconjugated, rabbit-derived, anti-Neomycin (YA907) monoclonal antibody. Neomycin Antibody (YA907) can be used for: ELISA expriments in background without labeling.
PEPD Antibody (YA1578) is a biotin-conjugated non-conjugated IgG antibody, targeting PEPD, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). PEPD Antibody (YA1578) can be used for WB experiment in human background.
Neurofascin Antibody (YA1710) is a biotin-conjugated non-conjugated IgG antibody, targeting Neurofascin, with a predicted molecular weight of 138 kDa (observed band size: 186,155,75 kDa). Neurofascin Antibody (YA1710) can be used for WB experiment in human, mouse, rat background.
SCIN Antibody (YA1911) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1911), targeting SCIN, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). SCIN Antibody (YA1911) can be used for WB, IHC-P experiment in human background.
SLBP Antibody (YA1981) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1981), targeting SLBP, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). SLBP Antibody (YA1981) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
CIRBP Antibody (YA2506) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2506), targeting CIRBP, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). CIRBP Antibody (YA2506) can be used for WB, IHC-P, IP experiment in human background.
FES Antibody (YA2820) is a biotin-conjugated non-conjugated IgG antibody, targeting FES, with a predicted molecular weight of 93 kDa (observed band size: 93 kDa). FES Antibody (YA2820) can be used for WB experiment in human background.
LCAT Antibody (YA2864) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2864), targeting LCAT, with a predicted molecular weight of 50 kDa (observed band size: 55 kDa). LCAT Antibody (YA2864) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
INMT Antibody (YA3101) is a biotin-conjugated non-conjugated IgG antibody, targeting INMT, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). INMT Antibody (YA3101) can be used for WB experiment in mouse background.
TPMT Antibody (YA3283) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3283), targeting TPMT, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). TPMT Antibody (YA3283) can be used for WB, IHC-P, IP experiment in human background.
Angiopoietin 1 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Angiopoietin 1. Angiopoietin 1 Antibody can be used for WB, IHC-P, ELISA experiments in human, rat backgrounds.
deltaTubulin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 51 kDa, targeting to delta Tubulin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Cyclin B1 Antibody (YA486) is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Cyclin B1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
Cyclin D1 Antibody (YA485) is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cyclin D1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Cyclin E1 Antibody (YA483) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Cyclin E1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Histone H2A.X Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H2A.X. It can be used for WB,IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Histone H2A.Z Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2A.Z. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
LC3B Antibody (YA308) is a non-conjugated and Rabbit origined monoclonal antibody about 14/16 kDa, targeting to LC3B. It can be used for WB,IP assays with tag free, in the background of Human.
MAPKAP Kinase 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to MAPKAP Kinase 2. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
Methionine Aminopeptidase 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Methionine Aminopeptidase 2. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
p53 (acetyl K382) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53 (acetyl K382). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
p53 (acetyl K370)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53(acetyl K370). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
Phospho-PDGFR beta (Y740) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Phospho-PDGFR beta (Y740). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.
Phospho-PKC alpha (T638) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Phospho-PKC alpha (T638). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Phospho-PKC zeta (T560) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-PKC zeta(T560). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-STAT3 (Ser727) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Phospho-STAT3 (S727). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat, Mouse.
Carbonic anhydrase 9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to Carbonic anhydrase 9. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Glutamate receptor 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Glutamate receptor 1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Mouse, Rat.
IKK alpha + IKK beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to IKK alpha + IKK beta. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
Proteasome 20S LMP7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 30 kDa, targeting to Proteasome 20S LMP7. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Phospho-Chk1 (Ser296) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-Chk1 (S296). It can be used for WB,IHC-P assays with tag free, in the background of Human.
Phospho-c-Jun(Ser63) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-c-Jun(S63). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.
Phospho-p53 (Ser392) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Phospho-p53 (S392). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Phospho-PLK1 (Thr210) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-PLK1(T210). It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human.
alpha Tubulin (acetyl K40) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to alpha Tubulin (acetyl K40). It can be used for WB assays with tag free, in the background of Human.
GSK3 beta Antibody (YA397) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to GSK3 beta. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Heme Oxygenase 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Heme Oxygenase 1(HO-1). It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human.
IL-1 beta Antibody (YA345) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to IL-1 beta. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
Phospho-c-Myc(Ser62) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-c-Myc(S62). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.
Phospho-SHP2 (Tyr542) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-SHP2(Y542). It can be used for WB,ICC,IP assays with tag free, in the background of Mouse.
CKMT2 Antibody (YA793) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to CKMT2 (3F4). It can be used for WB assays with tag free, in the background of Rat.
Hexokinase II Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to Hexokinase II. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat, Hamster.
STAT5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to STAT5. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Phospho-CDC37 (Ser13) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IP assays in the background of Human, Mouse, Rat.
Transferrin Receptor 1 Antibody is an unconjugated, approximately 85 kDa, rabbit-derived, anti-Transferrin Receptor 1 monoclonal antibody. Transferrin Receptor 1 Antibody can be used for: WB, IHC-P, IP, FC expriments in human, mouse, rat background without labeling.
Phospho-IRF3 (Ser386) Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-IRF3 (Ser386) polyclonal antibody. Phospho-IRF3 (Ser386) Antibody can be used for: WB, ICC/IF expriments in human background without labeling.
beta Tubulin Antibody (HRP) (YA865) is an approximately 50-55 kDa, mouse-derived, anti-beta Tubulin (HRP) (YA865) monoclonal antibody. beta Tubulin Antibody (HRP) (YA865) can be used for: WB expriments in human, mouse, monkey, hamster, rat background with HRP labeling.
E2 Tag Antibody (YA870) is an unconjugated, mouse-derived, anti-E2 Tag (YA870) monoclonal antibody. E2 Tag Antibody (YA870) can be used for: WB expriments in species-independent background without labeling.
Flag Tag Antibody (HRP) (YA873) is a Flag tag-conjugated, mouse-derived monoclonal antibody. Flag Tag Antibody (HRP) (YA873) can be used for: WB expriments in species-independent background.
HA Tag Antibody (HRP) (YA876) is a HA-conjugated, mouse-derived monoclonal antibody. HA Tag Antibody (HRP) (YA876) can be used for: WB, ELISA expriments in species-independent background.
His Tag Antibody (HRP) (YA877) is a HRP-conjugated, mouse-derived monoclonal antibody. His Tag Antibody (HRP) (YA877) can be used for: WB expriments in species-independent background.
T7 Tag Antibody (YA886) is an unconjugated, mouse-derived, anti-T7 Tag (YA886) monoclonal antibody. T7 Tag Antibody (YA886) can be used for: WB expriments in species-independent background without labeling.
VSV G tag Antibody (YA875) is an unconjugated, anti-VSV G tag (YA875) monoclonal antibody. VSV G tag Antibody (YA875) can be used for: expriments in background without labeling.
Malachite green Antibody (YA902) is an unconjugated, mouse-derived, anti-Malachite green (YA902) monoclonal antibody. Malachite green Antibody (YA902) can be used for: ELISA expriments in background without labeling.
Sudan I Antibody (YA905) is an unconjugated, rabbit-derived, anti-Sudan I (YA905) monoclonal antibody. Sudan I Antibody (YA905) can be used for: ELISA expriments in background without labeling.
GPNMB Antibody (YA1159) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1159), targeting GPNMB. GPNMB Antibody (YA1159) can be used for IHC-P experiment in human background.
Myoglobin Antibody (YA1175) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1175), targeting Myoglobin. Myoglobin Antibody (YA1175) can be used for IHC-P experiment in human background.
CRALBP Antibody (YA1306) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1306), targeting CRALBP, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). CRALBP Antibody (YA1306) can be used for WB, IHC-P experiment in mouse background.
FOXL2 Antibody (YA1324) is a biotin-conjugated non-conjugated IgG antibody, targeting FOXL2. FOXL2 Antibody (YA1324) can be used for IHC-P experiment in human, mouse background.
CENP-A Antibody (YA1325) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1325), targeting CENP-A, with a predicted molecular weight of 16 kDa (observed band size: 18 kDa). CENP-A Antibody (YA1325) can be used for WB, ICC/IF experiment in human background.
Nodal Antibody (YA1410) is a biotin-conjugated non-conjugated IgG antibody, targeting Nodal, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). Nodal Antibody (YA1410) can be used for WB experiment in human, mouse, rat background.
CLPP Antibody (YA1675) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1675), targeting CLPP, with a predicted molecular weight of 30 kDa (observed band size: 26 kDa). CLPP Antibody (YA1675) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
PRMT7 Antibody (YA1734) is a biotin-conjugated non-conjugated IgG antibody, targeting PRMT7, with a predicted molecular weight of 78 kDa (observed band size: 78 kDa). PRMT7 Antibody (YA1734) can be used for WB experiment in human, mouse, rat background.
Radixin Antibody (YA1810) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1810), targeting Radixin, with a predicted molecular weight of 69 kDa (observed band size: 80 kDa). Radixin Antibody (YA1810) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Artemin Antibody (YA2155) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2155), targeting Artemin, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Artemin Antibody (YA2155) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Thyroglobulin Antibody (YA2199) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2199), targeting Thyroglobulin, with a predicted molecular weight of 305 kDa (observed band size: 305 kDa). Thyroglobulin Antibody (YA2199) can be used for WB, IP experiment in human background.
AVEN Antibody (YA2219) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2219), targeting AVEN, with a predicted molecular weight of 39 kDa (observed band size: 50 kDa). AVEN Antibody (YA2219) can be used for WB, IHC-P experiment in human, mouse, rat background.
Transgelin Antibody (YA2346) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2346), targeting Transgelin, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Transgelin Antibody (YA2346) can be used for WB, IHC-P experiment in human background.
Cathepsin Z Antibody (YA2382) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2382), targeting Cathepsin Z, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). Cathepsin Z Antibody (YA2382) can be used for WB, IHC-P experiment in human background.
VEGFD Antibody (YA2385) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2385), targeting VEGFD, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). VEGFD Antibody (YA2385) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Involucrin Antibody (YA2488) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2488), targeting Involucrin, with a predicted molecular weight of 68 kDa (observed band size: 120 kDa). Involucrin Antibody (YA2488) can be used for WB, IHC-P, FC experiment in human, rat background.
PACSIN3 Antibody (YA2540) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2540), targeting PACSIN3, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). PACSIN3 Antibody (YA2540) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
ApoD Antibody (YA2584) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2584), targeting ApoD, with a predicted molecular weight of 21 kDa (observed band size: 28 kDa). ApoD Antibody (YA2584) can be used for WB, IHC-P experiment in human background.
TIRAP Antibody (YA2589) is a biotin-conjugated non-conjugated IgG antibody, targeting TIRAP, with a predicted molecular weight of 24 kDa (observed band size: 28 kDa). TIRAP Antibody (YA2589) can be used for WB experiment in human, mouse, rat background.
AMSH Antibody (YA2707) is a biotin-conjugated non-conjugated IgG antibody, targeting AMSH, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). AMSH Antibody (YA2707) can be used for WB experiment in human background.
BCKDK Antibody (YA2737) is a biotin-conjugated non-conjugated IgG antibody, targeting BCKDK, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). BCKDK Antibody (YA2737) can be used for WB experiment in human, mouse, rat background.
HLA F Antibody (YA2843) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2843), targeting HLA F, with a predicted molecular weight of 39 kDa (observed band size: 42 kDa). HLA F Antibody (YA2843) can be used for WB, IHC-P experiment in human background.
GEN1 Antibody (YA2908) is a biotin-conjugated non-conjugated IgG antibody, targeting GEN1, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). GEN1 Antibody (YA2908) can be used for WB experiment in human, mouse, rat background.
LTK Antibody (YA3047) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3047), targeting LTK, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). LTK Antibody (YA3047) can be used for WB, IHC-P experiment in human, rat background.
LRRC15 Antibody (YA3182) is a biotin-conjugated non-conjugated IgG antibody, targeting LRRC15, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). LRRC15 Antibody (YA3182) can be used for WB experiment in mouse, rat background.
RRAS Antibody (YA3212) is a biotin-conjugated non-conjugated IgG antibody, targeting RRAS, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). RRAS Antibody (YA3212) can be used for WB experiment in human background.
MTHFR Antibody (YA3258) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3258), targeting MTHFR, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). MTHFR Antibody (YA3258) can be used for WB, ICC/IF, IP experiment in human, mouse background.
NDRG2 Antibody (YA3295) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3295), targeting NDRG2, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). NDRG2 Antibody (YA3295) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in mouse, rat background.
Ovalbumin Antibody is an unconjugated, approximately 43 kDa, mouse-derived, Ovalbumin monoclonal antibody. Ovalbumin Antibody can be used for: WB expriments in chicken background without labeling.
ALKBH5 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-ALKBH5 monoclonal antibody. ALKBH5 Antibody can be used for: WB/IHC-P expriments in human,mouse,rat background without labeling.
Angiotensin Converting Enzyme 1 Antibody (YA2094) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2094), targeting Angiotensin Converting Enzyme 1, with a predicted molecular weight of 151 kDa (observed band size: 180 kDa). Angiotensin Converting Enzyme 1 Antibody (YA2094) can be used for WB, IHC-P experiment in mouse, rat background.
DYKDDDDK Tag (FLAG) Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to DYKDDDDK Tag(FLAG). It can be used for WB,IP,IF assays with DYKDDDDK-tag, in the background of .
AKT1/2/3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT1/2/3. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Histone H3 (acetyl K14) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K14). It can be used for WB,ICC/IF,IHC-P,IP,SNAP-ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse, Rat.
Histone H3 (acetyl K18) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K18). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
Histone H3 (acetyl K27) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K27). It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Histone H3 (acetyl K56) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K56). It can be used for WB,ICC/IF,IHC-P,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
Histone H4 (acetyl K16) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4 (acetyl K16). It can be used for WB,IHC-P,FC,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Histone H4 (acetyl K8) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4 (acetyl K8). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Histone H4 (acetyl K5) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4(acetyl K5). It can be used for WB,ICC/IF,IHC-P,IP,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse, Rat.
JNK1+JNK2+JNK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48/53 kDa, targeting to JNK1+JNK2+JNK3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Metabotropic glutamate receptor 5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 132 kDa, targeting to Metabotropic glutamate receptor 5. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
Myosin Light Chain 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 19 kDa, targeting to Myosin Light Chain 2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
p27 KIP 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to p27 KIP 1. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
PP2A alpha + beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to PP2A alpha + beta. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Pyruvate Dehydrogenase E1 beta subunit Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Pyruvate Dehydrogenase E1 beta subunit. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
RSK1 p90 Antibody (YA088) is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK1 p90. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Stathmin 1 Antibody (YA049) is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to Stathmin. It can be used for IHC-P assays with tag free, in the background of Human.
Stathmin 1 Antibody (YA050) is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Stathmin 1. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
Integrin alpha 5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 115 kDa, targeting to Integrin alpha 5. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Integrin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Integrin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Integrin beta 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Integrin beta 3. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
PKC beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
PKC beta 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to PKC beta 2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
Laminin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 198 kDa, targeting to Laminin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.
Argonaute 2 Antibody (YA612) is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to Argonaute 2. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
Cytochrome P450 17A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Cytochrome P450 17A1. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Phospho-AMPK alpha 2(Ser345) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Phospho-AMPK alpha 2(S345). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-EGFR Antibody (YA204) is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR(Y1068). It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human.
Phospho-eIF4G (Ser1108) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 175 kDa, targeting to Phospho-eIF4G (S1108). It can be used for WB,ICC assays with tag free, in the background of Human.
Phospho-FOXO3a(Ser253) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to Phospho-FOXO3a(S253). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Phospho-mTOR (Ser2448) Antibody (YA691) is a non-conjugated and Mouse origined monoclonal antibody about 289 kDa, targeting to Phospho-mTOR (S2448). It can be used for WB,IHC assays with tag free, in the background of Human, Mouse.
Glucose Transporter GLUT4 Antibody (YA753) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to Glucose Transporter GLUT4. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.
SQSTM1/p62 Antibody (YA669) is a non-conjugated and Mouse origined monoclonal antibody about 62 kDa, targeting to SQSTM1 / p62. It can be used for IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
TCF7L2/TCF4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to TCF7L2/TCF4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
TGF beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TGF beta 1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Beclin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Beclin 1. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
CARS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to CARS. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
eIF4G1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 175 kDa, targeting to eIF4G1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
FH Antibody (YA763) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to FH (2A3). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
GAD65 Antibody (YA758) is a non-conjugated and Mouse origined monoclonal antibody about 65 kDa, targeting to GAD65 (6D5). It can be used for WB assays with tag free, in the background of Human, Rat.
GSDME Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to GSDME. It can be used for WB,IP assays with tag free, in the background of Human.
Keap1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Keap1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-Vimentin (Ser56) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-Vimentin (Ser56). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
SIRT3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to SIRT3. It can be used for WB,IHC-P assays with tag free, in the background of Human.
SMYD4 Antibody (YA671) is a non-conjugated and Mouse origined monoclonal antibody about 89 kDa, targeting to SMYD4 (7C8). It can be used for WB assays with tag free, in the background of Human.
Cleaved-Caspase 9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to Cleaved-Caspase 9. It can be used for WB, IP assays with tag free, in the background of Human, Mouse.
Thymidylate Synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to thymidylate synthase. It can be used for WB, IHC-F, IHC-P, ICC/IF, IP assays with tag free, in the background of Human.
c-Myc Tag Antibody(HRP) (YA866) is a c-Myc tag-conjugated, mouse-derived monoclonal antibody. c-Myc Tag Antibody(HRP) (YA866) can be used for: WB, ELISA, IHC-P, IP expriments in species-independent background.
AGEs Antibody is an unconjugated, rabbit-derived, anti-AGEs polyclonal antibody. AGEs Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
Nucleophosmin Antibody (YA1008) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1008), targeting Nucleophosmin, with a predicted molecular weight of 33 kDa (observed band size: 38 kDa). Nucleophosmin Antibody (YA1008) can be used for WB, ChIP experiment in human, mouse background.
Nucleophosmin Antibody (YA1009) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1009), targeting Nucleophosmin, with a predicted molecular weight of 33 kDa (observed band size: 38 kDa). Nucleophosmin Antibody (YA1009) can be used for WB, IHC-P, IP experiment in human background.
ntpII Antibody (YA1077) is a biotin-conjugated non-conjugated IgG1 antibody, targeting ntpII, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). ntpII Antibody (YA1077) can be used for WB experiment in human, mouse, rat background.
Geminin Antibody (YA1139) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1139), targeting Geminin. Geminin Antibody (YA1139) can be used for IHC-P experiment in human background.
CDA Antibody (YA1148) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1148), targeting CDA. CDA Antibody (YA1148) can be used for IHC-P experiment in human background.
Smoothelin Antibody (YA1195) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1195), targeting Smoothelin. Smoothelin Antibody (YA1195) can be used for IHC-P experiment in human background.
CD169 Antibody (YA1293) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1293), targeting CD169. CD169 Antibody (YA1293) can be used for IHC-P, ICC/IF, FC experiment in human background.
CD33 Antibody (YA1308) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1308), targeting CD33. CD33 Antibody (YA1308) can be used for IHC-P experiment in human background.
ALOX15 Antibody (YA1309) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1309), targeting ALOX15. ALOX15 Antibody (YA1309) can be used for IHC-P, ICC/IF, FC experiment in human background.
Nova1 Antibody (YA1421) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1421), targeting Nova1, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Nova1 Antibody (YA1421) can be used for WB, IHC-P experiment in human, mouse, rat background.
NUDT9 Antibody (YA1453) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1453), targeting NUDT9, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). NUDT9 Antibody (YA1453) can be used for WB, ICC/IF experiment in human, rat background.
PAH Antibody (YA1696) is a biotin-conjugated non-conjugated IgG antibody, targeting PAH, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). PAH Antibody (YA1696) can be used for WB experiment in human, mouse, rat background.
PSS2 Antibody (YA1770) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1770), targeting PSS2, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). PSS2 Antibody (YA1770) can be used for WB, IP experiment in human background.
PUS1 Antibody (YA1783) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1783), targeting PUS1, with a predicted molecular weight of 47 kDa (observed band size: 44,47 kDa). PUS1 Antibody (YA1783) can be used for WB, ICC/IF, IP experiment in human, hamster, rat background.
Rab10 Antibody (YA1789) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1789), targeting Rab10, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Rab10 Antibody (YA1789) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
SGSM1 Antibody (YA1946) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1946), targeting SGSM1, with a predicted molecular weight of 130 kDa (observed band size: 130 kDa). SGSM1 Antibody (YA1946) can be used for WB, ICC/IF experiment in human background.
ACADS Antibody (YA1969) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1969), targeting ACADS, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). ACADS Antibody (YA1969) can be used for WB, IP experiment in human, mouse, rat background.
ALKBH2 Antibody (YA2047) is a biotin-conjugated non-conjugated IgG antibody, targeting ALKBH2, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). ALKBH2 Antibody (YA2047) can be used for WB experiment in human, mouse, rat background.
ALKBH4 Antibody (YA2050) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2050), targeting ALKBH4, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). ALKBH4 Antibody (YA2050) can be used for WB, IP experiment in human background.
GSC Antibody (YA2108) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2108), targeting GSC, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). GSC Antibody (YA2108) can be used for WB, IP experiment in human background.
SRP54 Antibody (YA2137) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2137), targeting SRP54, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). SRP54 Antibody (YA2137) can be used for WB, IHC-P, IP, FC experiment in mouse, rat, human background.
CBS Antibody (YA2148) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2148), targeting CBS, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). CBS Antibody (YA2148) can be used for WB, IHC-P, ICC/IF experiment in human background.
TIMM44 Antibody (YA2207) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2207), targeting TIMM44, with a predicted molecular weight of 51 kDa (observed band size: 45 kDa). TIMM44 Antibody (YA2207) can be used for WB, ICC/IF, IP experiment in human background.
CAD Antibody (YA2523) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2523), targeting CAD, with a predicted molecular weight of 243 kDa (observed band size: 260 kDa). CAD Antibody (YA2523) can be used for WB, ICC/IF, IP, FC experiment in human background.
CTRL Antibody (YA2667) is a biotin-conjugated non-conjugated IgG antibody, targeting CTRL, with a predicted molecular weight of 28 kDa (observed band size: 24,28 kDa). CTRL Antibody (YA2667) can be used for WB experiment in human, mouse, rat background.
DOHH Antibody (YA2717) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2717), targeting DOHH, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). DOHH Antibody (YA2717) can be used for WB, IP experiment in human background.
ENSA Antibody (YA2770) is a biotin-conjugated non-conjugated IgG antibody, targeting ENSA, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). ENSA Antibody (YA2770) can be used for WB experiment in human, mouse, rat background.
ETAA1 Antibody (YA2781) is a biotin-conjugated non-conjugated IgG antibody, targeting ETAA1, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). ETAA1 Antibody (YA2781) can be used for WB experiment in human background.
XPO4 Antibody (YA2785) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2785), targeting XPO4, with a predicted molecular weight of 130 kDa (observed band size: 130 kDa). XPO4 Antibody (YA2785) can be used for WB, IP experiment in human, rat background.
FADD Antibody (YA2793) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2793), targeting FADD, with a predicted molecular weight of 23 kDa (observed band size: 28 kDa). FADD Antibody (YA2793) can be used for WB, IHC-P experiment in human, mouse background.
FRAT1 Antibody (YA2863) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2863), targeting FRAT1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). FRAT1 Antibody (YA2863) can be used for WB, ICC/IF, IP experiment in human background.
EYA2 Antibody (YA2905) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2905), targeting EYA2, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). EYA2 Antibody (YA2905) can be used for WB, IP experiment in human background.
FKBP6 Antibody (YA2920) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2920), targeting FKBP6, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). FKBP6 Antibody (YA2920) can be used for WB, IHC-P experiment in human, mouse, rat background.
GRK6 Antibody (YA2952) is a biotin-conjugated non-conjugated IgG antibody, targeting GRK6, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). GRK6 Antibody (YA2952) can be used for WB experiment in human, mouse background.
HLF Antibody (YA2990) is a biotin-conjugated non-conjugated IgG antibody, targeting HLF, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). HLF Antibody (YA2990) can be used for WB experiment in human background.
Loricrin Antibody (YA3023) is a biotin-conjugated non-conjugated IgG antibody, targeting Loricrin, with a predicted molecular weight of 26 kDa. Loricrin Antibody (YA3023) can be used for WB, IHC-P experiment in human background.
hnRNP G T Antibody (YA3031) is a biotin-conjugated non-conjugated IgG antibody, targeting hnRNP G T, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). hnRNP G T Antibody (YA3031) can be used for WB experiment in human, mouse, rat background.
ME2 Antibody (YA3055) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3055), targeting ME2, with a predicted molecular weight of 65 kDa (observed band size: 65 kDa). ME2 Antibody (YA3055) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MLLT6 Antibody (YA3073) is a biotin-conjugated non-conjugated IgG antibody, targeting MLLT6, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). MLLT6 Antibody (YA3073) can be used for WB experiment in human background.
IGFBP6 Antibody (YA3076) is a biotin-conjugated non-conjugated IgG antibody, targeting IGFBP6, with a predicted molecular weight of 25 kDa (observed band size: 35 kDa). IGFBP6 Antibody (YA3076) can be used for WB experiment in human background.
ITPK1 Antibody (YA3125) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3125), targeting ITPK1, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). ITPK1 Antibody (YA3125) can be used for WB, IP experiment in human background.
KCTD21 Antibody (YA3134) is a biotin-conjugated non-conjugated IgG antibody, targeting KCTD21, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). KCTD21 Antibody (YA3134) can be used for WB experiment in human, mouse, rat background.
PPCS Antibody (YA3177) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3177), targeting PPCS, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). PPCS Antibody (YA3177) can be used for WB, IP experiment in human background.
RPS8 Antibody (YA3220) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3220), targeting RPS8, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). RPS8 Antibody (YA3220) can be used for WB, ICC/IF, IP experiment in human, mouse, rat, hamster background.
MSRB3 Antibody (YA3252) is a biotin-conjugated non-conjugated IgG antibody, targeting MSRB3, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). MSRB3 Antibody (YA3252) can be used for WB experiment in mouse, rat background.
MTX3 Antibody (YA3261) is a biotin-conjugated non-conjugated IgG antibody, targeting MTX3, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). MTX3 Antibody (YA3261) can be used for WB experiment in mouse, rat background.
NCAPH2 Antibody (YA3289) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3289), targeting NCAPH2, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). NCAPH2 Antibody (YA3289) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Klotho Antibody (YA3355) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3355), targeting Klotho, with a predicted molecular weight of 116 kDa (observed band size: 62 kDa). Klotho Antibody (YA3355) can be used for WB, IHC-P experiment in human, mouse background.
Ravtansine (DM4) is a maytansinoid, a chemical derivative of maytansine being investigated as the cytotoxic payload of a number of antibody-drug conjugates (ADCs). Microtubules are dynamic cytoskeletal polymers that switch stochastically between states of growing and shortening, called “dynamic instability”. They function in the precise segregation of chromosomes during cell division, transport of cellular cargos, and positioning and movement of intracellular organelles. Inhibition of microtubule function leads to cell cycle arrest and cell death. Microtubule-targeted drugs including the Vinca alkaloids, taxanes, and epothilones suppress the dynamic instability of microtubules, induce mitotic arrest, inhibit cell proliferation and induce apoptosis. The anticancer properties of maytansinoids have been attributed to their ability to disrupt microtubule function. The maytansinoid emtansine (DM1), for example, binds at the ends of microtubules and thereby suppress their dynamic instability. It is synthesized in order to link maytansinoids to antibodies via disulfide bonds. Maytansinoids inhibit tubulin polymerization and microtubule assembly and enhance microtubule destabilization, so there is potent suppression of microtubule dynamics resulting in a mitotic block and subsequent apoptotic cell death. DM4 can be used in the preparation of antibody drug conjugate. Although S-methyl DM1 and S-methyl DM4 inhibited microtubule assembly more weakly than maytansine, they suppressed dynamic instability more strongly than maytansine. Like vinblastine, the maytansinoids potently suppress microtubule dynamic instability by binding to a small number of high affinity sites, most likely at microtubule ends. Thus, the maytansine derivatives that result from cellular metabolism of the antibody conjugates are themselves potent microtubule poisons, interacting with microtubules as effectively as or more effectively than the parent molecule.
Phospho-Tau (Ser202/Thr205) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau(S396). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Mouse, Rat, Human.
CDC42 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to CDC42. It can be used for WB、IHC-P、FC assays with tag free, in the background of Human, Mouse,Rat.
Histone H2A(acetyl K9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2A(acetyl K9). It can be used for WB,ICC/IF,IHC-P,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
Histone H2A (hydroxyl Y39) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2A(hydroxyl Y39). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Histone H2B (acetyl K20) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2B(acetyl K20). It can be used for WB,ICC/IF,IHC-P,FC,IP,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.
Histone H3 (di methyl K9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (di methyl K9). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Histone H3 (mono methyl K18) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl K18). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Histone H3 (mono methyl K36)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl K36). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
Histone H3 (mono methyl R2)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl R2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
Histone H4 (tri methyl K20) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 11 kDa, targeting to Histone H4 (tri methyl K20). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-STAT3 (Tyr705) Antibody (YA146) is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Phospho-STAT3(Tyr705). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Glutathione Peroxidase 1 Antibody (YA404) is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to Glutathione Peroxidase 1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
PKA 2 beta (regulatory subunit)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 46 kDa, targeting to PKA 2 beta (regulatory subunit). It can be used for WB,IP,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Phospho-GSK3 beta(Ser 9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-GSK3 beta(Ser 9). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
Phospho-Hsp27 (Ser82) Antibody (YA187) is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to Phospho-Hsp27(S82). It can be used for WB,IP assays with tag free, in the background of Human.
Phospho-IKB alpha (Ser32) Antibody (YA183) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha(S32). It can be used for WB,ICC,IP assays with tag free, in the background of Human, Mouse.
Phospho-JAK2 (Tyr1007+Tyr1008) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to Phospho-JAK2(Y1007+Y1008). It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Phospho-NF-κB p65 (Ser529) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Phospho-NF-κB p65(S529). It can be used for WB,IP,FC,IHC-P assays with tag free, in the background of Human.
Phospho-p95/NBS1 (Ser343) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Phospho-p95/NBS1 (S343). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
Phospho-Smad3 (Ser423/Ser425) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-Smad3(S423/S425). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-STAT1 (Ser727) Antibody (YA148) is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Phospho-STAT1(S727). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-YAP1 (Ser127) Antibody (YA137) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-YAP1 (S127). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
AMPK gamma 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to AMPK gamma 1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
CD63 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD63. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Cyclin D2 Antibody (YA789) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to Cyclin D2 (6E11). It can be used for WB assays with tag free, in the background of Human.
Glucocorticoid Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Glucocorticoid Receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Noggin Antibody (YA698) is a non-conjugated and Mouse origined monoclonal antibody about 26 kDa, targeting to Noggin (1D2). It can be used for WB,ICC/IF assays with tag free, in the background of Transfected.
Phospho-CDC37 (Ser13) Antibody (YA219) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IP assays in the background of Human, Mouse, Rat.
Dynactin Subunit 1 Antibody (YA869) is an unconjugated, approximately 142 kDa, mouse-derived, anti-Dynactin Subunit 1 (YA869) monoclonal antibody. Dynactin Subunit 1 Antibody (YA869) can be used for: WB, IP expriments in human background without labeling.
HBcAg Antibody (YA910) is an unconjugated, mouse-derived, anti-HBcAg (YA910) monoclonal antibody. HBcAg Antibody (YA910) can be used for: IHC-P expriments in human background without labeling.
Anthrax Protective gen Antibody (YA1060) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1060), targeting Anthrax Protective gen. Anthrax Protective gen Antibody (YA1060) can be used for ELISA experiment in bacillusanthracis background.
ATIC Antibody (YA1072) is a biotin-conjugated non-conjugated IgG1 antibody, targeting ATIC, with a predicted molecular weight of 65 kDa (observed band size: 65 kDa). ATIC Antibody (YA1072) can be used for WB experiment in human, mouse, rat background.
Phostensin Antibody (YA1074) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Phostensin, with a predicted molecular weight of 68 kDa (observed band size: 110/26 kDa). Phostensin Antibody (YA1074) can be used for WB experiment in human background.
CAST Antibody (YA1216) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1216), targeting CAST. CAST Antibody (YA1216) can be used for IHC-P experiment in human background.
Inhibin alpha Antibody (YA1232) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1232), targeting Inhibin alpha. Inhibin alpha Antibody (YA1232) can be used for IHC-P experiment in human background.
J-chain Antibody (YA1290) is a biotin-conjugated non-conjugated IgG antibody, targeting J-chain. J-chain Antibody (YA1290) can be used for IHC-P experiment in human, mouse, rat background.
CBP Antibody (YA1314) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1314), targeting CBP, with a predicted molecular weight of 300 kDa (observed band size: 300 kDa). CBP Antibody (YA1314) can be used for WB, ICC/IF experiment in human background.
SMARCD1 Antibody (YA1321) is a biotin-conjugated non-conjugated IgG antibody, targeting SMARCD1, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). SMARCD1 Antibody (YA1321) can be used for WB experiment in human, mouse background.
CD168 Antibody (YA1322) is a biotin-conjugated non-conjugated IgG antibody, targeting CD168, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). CD168 Antibody (YA1322) can be used for WB experiment in human, mouse, rat, monkey background.
NDUFB2 Antibody (YA1335) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1335), targeting NDUFB2, with a predicted molecular weight of 12 kDa (observed band size: 12 kDa). NDUFB2 Antibody (YA1335) can be used for WB, IHC-P experiment in human, mouse, rat background.
MVP Antibody (YA1417) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1417), targeting MVP, with a predicted molecular weight of 99 kDa (observed band size: 99 kDa). MVP Antibody (YA1417) can be used for WB, IHC-P experiment in human, mouse, rat background.
MICA Antibody (YA1464) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1464), targeting MICA. MICA Antibody (YA1464) can be used for FC, ELISA experiment in human background.
Phospho-MLKL (Ser358) Antibody (YA1623) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-MLKL (Ser358), with a predicted molecular weight of 54 kDa. Phospho-MLKL (Ser358) Antibody (YA1623) can be used for WB, IHC-P experiment in human background.
PIN1 Antibody (YA1635) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1635), targeting PIN1, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). PIN1 Antibody (YA1635) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MGST1 Antibody (YA1636) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1636), targeting MGST1, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). MGST1 Antibody (YA1636) can be used for WB, IHC-P experiment in human, rat background.
SNX5 Antibody (YA1712) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1712), targeting SNX5, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). SNX5 Antibody (YA1712) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
PGD Antibody (YA1727) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1727), targeting PGD, with a predicted molecular weight of 53 kDa (observed band size: 49 kDa). PGD Antibody (YA1727) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
PRSS8 Antibody (YA1761) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1761), targeting PRSS8, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). PRSS8 Antibody (YA1761) can be used for WB, IP experiment in human background.
PWP1 Antibody (YA1784) is a biotin-conjugated non-conjugated IgG antibody, targeting PWP1, with a predicted molecular weight of 56 kDa (observed band size: 75 kDa). PWP1 Antibody (YA1784) can be used for WB experiment in human background.
Rab7B Antibody (YA1798) is a biotin-conjugated non-conjugated IgG antibody, targeting Rab7B, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Rab7B Antibody (YA1798) can be used for WB experiment in human background.
Glypican 1 Antibody (YA1809) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1809), targeting Glypican 1, with a predicted molecular weight of 62 kDa (observed band size: 55 kDa). Glypican 1 Antibody (YA1809) can be used for WB, ICC/IF experiment in human background.
RASSF2 Antibody (YA1834) is a biotin-conjugated non-conjugated IgG antibody, targeting RASSF2, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). RASSF2 Antibody (YA1834) can be used for WB experiment in human background.
RAVER2 Antibody (YA1837) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1837), targeting RAVER2, with a predicted molecular weight of 74 kDa (observed band size: 74 kDa). RAVER2 Antibody (YA1837) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
SNAP29 Antibody (YA2008) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2008), targeting SNAP29, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). SNAP29 Antibody (YA2008) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
COMT Antibody (YA2014) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2014), targeting COMT, with a predicted molecular weight of 30 kDa (observed band size: 24,28 kDa). COMT Antibody (YA2014) can be used for WB, IHC-P experiment in human, mouse, rat background.
Tec Antibody (YA2181) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2181), targeting Tec, with a predicted molecular weight of 74 kDa (observed band size: 58-75 kDa). Tec Antibody (YA2181) can be used for WB, ICC/IF experiment in human background.
TIAM2 Antibody (YA2200) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2200), targeting TIAM2, with a predicted molecular weight of 190 kDa (observed band size: 190 kDa). TIAM2 Antibody (YA2200) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
ApoF Antibody (YA2203) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2203), targeting ApoF, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). ApoF Antibody (YA2203) can be used for WB, ICC/IF experiment in human background.
Translin Associated Protein X Antibody (YA2257) is a biotin-conjugated non-conjugated IgG antibody, targeting Translin Associated Protein X, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Translin Associated Protein X Antibody (YA2257) can be used for WB experiment in human, mouse, rat background.
Bora Antibody (YA2292) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2292), targeting Bora, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). Bora Antibody (YA2292) can be used for WB, IP experiment in human, mouse, rat background.
TXNDC9 Antibody (YA2309) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2309), targeting TXNDC9, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). TXNDC9 Antibody (YA2309) can be used for WB, IHC-P experiment in human background.
TR AP Antibody (YA2321) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2321), targeting TR AP, with a predicted molecular weight of 37 kDa (observed band size: 35,42 kDa). TR AP Antibody (YA2321) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
UFC1 Antibody (YA2347) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2347), targeting UFC1, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). UFC1 Antibody (YA2347) can be used for WB, IHC-P experiment in human, mouse, rat background.
UFD1 Antibody (YA2352) is a biotin-conjugated non-conjugated IgG antibody, targeting UFD1, with a predicted molecular weight of 35 kDa (observed band size: 40 kDa). UFD1 Antibody (YA2352) can be used for WB experiment in human background.
Elongation Factor Ts Antibody (YA2524) is a biotin-conjugated non-conjugated IgG antibody, targeting Elongation Factor Ts, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). Elongation Factor Ts Antibody (YA2524) can be used for WB experiment in human background.
LGR6 Antibody (YA2531) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2531), targeting LGR6, with a predicted molecular weight of 104 kDa (observed band size: 104 kDa). LGR6 Antibody (YA2531) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
TRIM29 Antibody (YA2552) is a biotin-conjugated non-conjugated IgG antibody, targeting TRIM29, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). TRIM29 Antibody (YA2552) can be used for WB experiment in human, mouse, rat background.
Adenosine Deaminase Antibody (YA2607) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2607), targeting Adenosine Deaminase, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Adenosine Deaminase Antibody (YA2607) can be used for WB, ICC/IF, IP experiment in human, rat background.
HLA B Antibody (YA2612) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2612), targeting HLA B, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). HLA B Antibody (YA2612) can be used for WB, IHC-P experiment in human background.
Phospho-PTS (Ser19) Antibody (YA2636) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2636), targeting Phospho-PTS (Ser19), with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). Phospho-PTS (Ser19) Antibody (YA2636) can be used for WB, IHC-P, IP experiment in human background.
Bcl2 L14 Antibody (YA2740) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2740), targeting Bcl2 L14, with a predicted molecular weight of 37 kDa (observed band size: 43 kDa). Bcl2 L14 Antibody (YA2740) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Emerin Antibody (YA2765) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2765), targeting Emerin, with a predicted molecular weight of 29 kDa (observed band size: 35 kDa). Emerin Antibody (YA2765) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse background.
Oncostatin M Antibody (YA2813) is a biotin-conjugated non-conjugated IgG antibody, targeting Oncostatin M, with a predicted molecular weight of 28 kDa (observed band size: 22 kDa). Oncostatin M Antibody (YA2813) can be used for WB experiment in human, mouse, rat background.
FDPS Antibody (YA2817) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2817), targeting FDPS, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). FDPS Antibody (YA2817) can be used for WB, IHC-P experiment in human, hamster background.
DLX3 Antibody (YA2867) is a biotin-conjugated non-conjugated IgG antibody, targeting DLX3, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). DLX3 Antibody (YA2867) can be used for WB experiment in human background.
GNB3 Antibody (YA2945) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2945), targeting GNB3, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). GNB3 Antibody (YA2945) can be used for WB, IHC-P experiment in human, mouse, rat background.
ATRIP Antibody (YA2965) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2965), targeting ATRIP, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). ATRIP Antibody (YA2965) can be used for WB, ICC/IF experiment in human, mouse, rat background.
HDLBP Antibody (YA2969) is a biotin-conjugated non-conjugated IgG antibody, targeting HDLBP, with a predicted molecular weight of 141 kDa (observed band size: 141 kDa). HDLBP Antibody (YA2969) can be used for WB experiment in human background.
Ihh Antibody (YA3011) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3011), targeting Ihh, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Ihh Antibody (YA3011) can be used for WB, IHC-P experiment in human, mouse background.
MVK Antibody (YA3093) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3093), targeting MVK, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). MVK Antibody (YA3093) can be used for WB, IP experiment in human background.
MYH10 Antibody (YA3114) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3114), targeting MYH10, with a predicted molecular weight of 229 kDa (observed band size: 229 kDa). MYH10 Antibody (YA3114) can be used for WB, IP experiment in human, mouse background.
ORAI3 Antibody (YA3128) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3128), targeting ORAI3, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). ORAI3 Antibody (YA3128) can be used for WB, IHC-P experiment in human background.
KIFC1 Antibody (YA3142) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3142), targeting KIFC1, with a predicted molecular weight of 74 kDa (observed band size: 74 kDa). KIFC1 Antibody (YA3142) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
KRIT1 Antibody (YA3147) is a biotin-conjugated non-conjugated IgG antibody, targeting KRIT1, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). KRIT1 Antibody (YA3147) can be used for WB experiment in human, mouse, rat background.
PPCEL Antibody (YA3175) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3175), targeting PPCEL, with a predicted molecular weight of 84 kDa (observed band size: 72 kDa). PPCEL Antibody (YA3175) can be used for WB, IHC-P, IP experiment in human, mouse, rat, hamster background.
SBDS Antibody (YA3227) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3227), targeting SBDS, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). SBDS Antibody (YA3227) can be used for WB, ICC/IF, IP experiment in human background.
SEC24D Antibody (YA3229) is a biotin-conjugated non-conjugated IgG antibody, targeting SEC24D, with a predicted molecular weight of 113 kDa (observed band size: 113 kDa). SEC24D Antibody (YA3229) can be used for WB experiment in human, mouse, rat background.
MST4 Antibody (YA3253) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3253), targeting MST4, with a predicted molecular weight of 47 kDa (observed band size: 52 kDa). MST4 Antibody (YA3253) can be used for WB, ICC/IF, IP experiment in human, rat background.
YTHDC2 Antibody (YA3317) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3317), targeting YTHDC2, with a predicted molecular weight of 161 kDa (observed band size: 161 kDa). YTHDC2 Antibody (YA3317) can be used for WB, IP experiment in human background.
CD81; TAPA1; TSPAN28; CD81 antigen; 26 kDa cell surface protein TAPA-1; Target of the antiproliferative Antibody 1; Tetraspanin-28; Tspan-28; CD81
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse
CD81 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD81. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
Histone H2B (mono methyl R79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 14 kDa, targeting to Histone H2B(mono methyl R79). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-Glycogen synthase 1 (S641) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-Glycogen synthase 1(S641). It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Ubiquitin-like modifier-activating enzyme 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Ubiquitin-like modifier-activating enzyme 1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
AMPK alpha 1 Antibody (YA624) is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to AMPK alpha 1. It can be used for WB,ICC/IF,FC,IP assays with tag free, in the background of Human, Rat.
AMPK alpha 2 Antibody (YA833) is a non-conjugated and Mouse origined monoclonal antibody about 62 kDa, targeting to AMPK alpha 2. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Acetyl CoA Carboxylase 1 (ACC1) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 266 kDa, targeting to Acetyl CoA Carboxylase 1(ACC1). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
Bcl2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl2. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse.
CARM1 Antibody (YA812) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to CARM1 (2B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
CDK16 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to CDK16. It can be used for WB assays with tag free, in the background of Human.
Cyclin A1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Cyclin A1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
eIF4B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to eIF4B. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Fatty Acid Synthase Antibody (YA766) is a non-conjugated and Mouse origined monoclonal antibody about 273 kDa, targeting to Fatty Acid Synthase (2F9). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Flotillin 1 Antibody (YA760) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to Flotillin 1 (6H9). It can be used for WB assays with tag free, in the background of Mouse, Rat.
Glutathione Reductase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Glutathione Reductase. It can be used for WB assays with tag free, in the background of Human, Mouse.
Lactate Dehydrogenase C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Lactate Dehydrogenase C. It can be used for WB assays with tag free, in the background of Human.
LC3B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 15 kDa, targeting to LC3B. It can be used for WB,ICC/IF,IHC-F,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Liver Arginase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Liver Arginase. It can be used for WB,IHC-P assays with tag free, in the background of Mouse, Rat.
SSB Antibody (YA668) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to SSB (4B10). It can be used for WB assays with tag free, in the background of Human.
Wnt5b Antibody (YA653) is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to Wnt5b (3D1). It can be used for WB assays with tag free, in the background of Transfected.
AMACR Antibody (YA1086) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1086), targeting AMACR, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). AMACR Antibody (YA1086) can be used for WB, ICC/IF experiment in rat, human background.
Rad9 Antibody (YA1087) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1087), targeting Rad9, with a predicted molecular weight of 43 kDa (observed band size: 60 kDa). Rad9 Antibody (YA1087) can be used for WB, IP experiment in human, mouse, rat, monkey background.
QSOX1 Antibody (YA1121) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1121), targeting QSOX1. QSOX1 Antibody (YA1121) can be used for IHC-P experiment in human background.
TPSB2 Antibody (YA1131) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1131), targeting TPSB2. TPSB2 Antibody (YA1131) can be used for IHC-P experiment in human background.
Annexin VII Antibody (YA1138) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1138), targeting Annexin VII. Annexin VII Antibody (YA1138) can be used for IHC-P experiment in human background.
DEK Antibody (YA1210) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1210), targeting DEK. DEK Antibody (YA1210) can be used for IHC-P experiment in human background.
Caldesmon/CDM Antibody (YA1301) is a biotin-conjugated non-conjugated IgG antibody, targeting Caldesmon/CDM, with a predicted molecular weight of 93 kDa (observed band size: 75 kDa). Caldesmon/CDM Antibody (YA1301) can be used for IHC-P experiment in human, mouse, rat background.
CD58 Antibody (YA1305) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1305), targeting CD58, with a predicted molecular weight of 28 kDa (observed band size: 65-70 kDa). CD58 Antibody (YA1305) can be used for WB, ICC/IF, FC experiment in human background.
PDCD2 Antibody (YA1312) is a biotin-conjugated non-conjugated IgG antibody, targeting PDCD2, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). PDCD2 Antibody (YA1312) can be used for WB experiment in human, mouse, rat background.
Nicastrin Antibody (YA1397) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1397), targeting Nicastrin, with a predicted molecular weight of 78 kDa (observed band size: 110-120 kDa). Nicastrin Antibody (YA1397) can be used for WB, IP experiment in human, mouse, rat background.
GPRC5D Antibody (YA1446) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1446), targeting GPRC5D. GPRC5D Antibody (YA1446) can be used for FC, ELISA experiment in human background.
N WASP Antibody (YA1465) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1465), targeting N WASP, with a predicted molecular weight of 55 kDa (observed band size: 65 kDa). N WASP Antibody (YA1465) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse background.
MICB Antibody (YA1466) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1466), targeting MICB. MICB Antibody (YA1466) can be used for FC, ELISA experiment in human background.
Olfactory Marker Protein Antibody (YA1474) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1474), targeting Olfactory Marker Protein, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Olfactory Marker Protein Antibody (YA1474) can be used for WB, IP experiment in mouse, rat background.
PSCA Antibody (YA1479) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1479), targeting PSCA. PSCA Antibody (YA1479) can be used for FC, ELISA experiment in human background.
ROR1 Antibody (YA1486) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1486), targeting ROR1. ROR1 Antibody (YA1486) can be used for FC, ELISA experiment in human background.
TIGIT Antibody (YA1497) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1497), targeting TIGIT. TIGIT Antibody (YA1497) can be used for FC, ELISA experiment in human background.
ApoE Antibody (YA1516) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1516), targeting ApoE, with a predicted molecular weight of 36 kDa. ApoE Antibody (YA1516) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse background.
Intestinal Alkaline Phosphatase Antibody (YA1559) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1559), targeting Intestinal Alkaline Phosphatase, with a predicted molecular weight of 57 kDa (observed band size: 68 kDa). Intestinal Alkaline Phosphatase Antibody (YA1559) can be used for WB, IHC-P experiment in human background.
Gelsolin Antibody (YA1570) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1570), targeting Gelsolin, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). Gelsolin Antibody (YA1570) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
Prolactin Antibody (YA1586) is a biotin-conjugated non-conjugated IgG antibody, targeting Prolactin, with a predicted molecular weight of 26 kDa (observed band size: 23 kDa). Prolactin Antibody (YA1586) can be used for WB experiment in human background.
Phospholamban Antibody (YA1622) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1622), targeting Phospholamban, with a predicted molecular weight of 6 kDa (observed band size: 12,24 kDa). Phospholamban Antibody (YA1622) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
NUP153 Antibody (YA1671) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1671), targeting NUP153, with a predicted molecular weight of 154 kDa (observed band size: 154 kDa). NUP153 Antibody (YA1671) can be used for WB, ICC/IF, FC experiment in human background.
Menin Antibody (YA1673) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1673), targeting Menin, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). Menin Antibody (YA1673) can be used for WB, IP experiment in human, rat background.
Prealbumin Antibody (YA1719) is a biotin-conjugated non-conjugated IgG antibody, targeting Prealbumin, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). Prealbumin Antibody (YA1719) can be used for WB experiment in rat background.
PRMT3 Antibody (YA1731) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1731), targeting PRMT3, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). PRMT3 Antibody (YA1731) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
KAT1 Antibody (YA1737) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1737), targeting KAT1, with a predicted molecular weight of 50 kDa (observed band size: 45 kDa). KAT1 Antibody (YA1737) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Prothrombin Antibody (YA1753) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1753), targeting Prothrombin, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). Prothrombin Antibody (YA1753) can be used for WB, IHC-P experiment in mouse, rat background.
RALB Antibody (YA1816) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1816), targeting RALB, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). RALB Antibody (YA1816) can be used for WB, IP experiment in human, mouse background.
USP11 Antibody (YA1846) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1846), targeting USP11, with a predicted molecular weight of 110 kDa (observed band size: 110 kDa). USP11 Antibody (YA1846) can be used for WB, IP experiment in human, rat background.
RanGAP1 Antibody (YA1900) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1900), targeting RanGAP1, with a predicted molecular weight of 64 kDa (observed band size: 64,90 kDa). RanGAP1 Antibody (YA1900) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Hex Antibody (YA1902) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1902), targeting Hex, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). Hex Antibody (YA1902) can be used for WB, IP experiment in human background.
SENP1 Antibody (YA1915) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1915), targeting SENP1, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). SENP1 Antibody (YA1915) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
HuR Antibody (YA1933) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1933), targeting HuR, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). HuR Antibody (YA1933) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
OS9 Antibody (YA1939) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1939), targeting OS9, with a predicted molecular weight of 76 kDa (observed band size: 83,97 kDa). OS9 Antibody (YA1939) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
AAMP Antibody (YA1963) is a biotin-conjugated non-conjugated IgG antibody, targeting AAMP, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). AAMP Antibody (YA1963) can be used for WB experiment in human, mouse, rat background.
XRCC3 Antibody (YA1984) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1984), targeting XRCC3, with a predicted molecular weight of 38 kDa (observed band size: 42 kDa). XRCC3 Antibody (YA1984) can be used for WB, FC experiment in human, mouse, rat background.
SUN2 Antibody (YA2025) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2025), targeting SUN2, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). SUN2 Antibody (YA2025) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Spermine Synthase Antibody (YA2043) is a biotin-conjugated non-conjugated IgG antibody, targeting Spermine Synthase, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Spermine Synthase Antibody (YA2043) can be used for WB experiment in human background.
SSX2IP Antibody (YA2065) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2065), targeting SSX2IP, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). SSX2IP Antibody (YA2065) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
Staufen Antibody (YA2077) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2077), targeting Staufen, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). Staufen Antibody (YA2077) can be used for WB, IHC-P experiment in human, mouse, rat background.
Baf57 Antibody (YA2110) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2110), targeting Baf57, with a predicted molecular weight of 47 kDa (observed band size: 57 kDa). Baf57 Antibody (YA2110) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
PGAM1 Antibody (YA2156) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2156), targeting PGAM1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). PGAM1 Antibody (YA2156) can be used for WB, FC experiment in human, mouse, rat background.
AS160 Antibody (YA2170) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2170), targeting AS160, with a predicted molecular weight of 147 kDa (observed band size: 160 kDa). AS160 Antibody (YA2170) can be used for WB, IP experiment in human background.
Lactoferrin Antibody (YA2274) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2274), targeting Lactoferrin, with a predicted molecular weight of 78 kDa (observed band size: 85 kDa). Lactoferrin Antibody (YA2274) can be used for WB, ICC/IF, IP experiment in human background.
Bok Antibody (YA2289) is a biotin-conjugated non-conjugated IgG antibody, targeting Bok, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Bok Antibody (YA2289) can be used for WB experiment in human, rat background.
Calretinin Antibody (YA2336) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2336), targeting Calretinin, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Calretinin Antibody (YA2336) can be used for WB, ICC/IF experiment in rat background.
RGS18 Antibody (YA2354) is a biotin-conjugated non-conjugated IgG antibody, targeting RGS18, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). RGS18 Antibody (YA2354) can be used for WB experiment in human background.
USO1 Antibody (YA2389) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2389), targeting USO1, with a predicted molecular weight of 108 kDa (observed band size: 108 kDa). USO1 Antibody (YA2389) can be used for WB, IP experiment in mouse background.
BMF Antibody (YA2436) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2436), targeting BMF, with a predicted molecular weight of 21 kDa (observed band size: 24 kDa). BMF Antibody (YA2436) can be used for WB, FC experiment in human, mouse, rat background.
IFRD1 Antibody (YA2507) is a biotin-conjugated non-conjugated IgG antibody, targeting IFRD1, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). IFRD1 Antibody (YA2507) can be used for WB experiment in human background.
RBM43 Antibody (YA2520) is a biotin-conjugated non-conjugated IgG antibody, targeting RBM43, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). RBM43 Antibody (YA2520) can be used for WB experiment in human background.
MUC13 Antibody (YA2738) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2738), targeting MUC13. MUC13 Antibody (YA2738) can be used for IHC-P experiment in human background.
MADCAM1 Antibody (YA2744) is a biotin-conjugated non-conjugated IgG antibody, targeting MADCAM1, with a predicted molecular weight of 40 kDa (observed band size: 60 kDa). MADCAM1 Antibody (YA2744) can be used for WB experiment in human background.
PR3 Antibody (YA2756) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2756), targeting PR3, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). PR3 Antibody (YA2756) can be used for WB, IHC-P experiment in human background.
CAB39 Antibody (YA2761) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2761), targeting CAB39, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). CAB39 Antibody (YA2761) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
EPS15R Antibody (YA2776) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2776), targeting EPS15R, with a predicted molecular weight of 94 kDa (observed band size: 130 kDa). EPS15R Antibody (YA2776) can be used for WB, IP experiment in human background.
Factor D Antibody (YA2791) is a biotin-conjugated non-conjugated IgG antibody, targeting Factor D, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). Factor D Antibody (YA2791) can be used for WB experiment in human background.
HMGN2 Antibody (YA2839) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2839), targeting HMGN2, with a predicted molecular weight of 9 kDa (observed band size: 18 kDa). HMGN2 Antibody (YA2839) can be used for WB, IHC-P experiment in human background.
DAB2 Antibody (YA2852) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2852), targeting DAB2, with a predicted molecular weight of 82 kDa (observed band size: 96 kDa). DAB2 Antibody (YA2852) can be used for WB, IHC-P, IP experiment in human background.
DGKA Antibody (YA2861) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2861), targeting DGKA, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). DGKA Antibody (YA2861) can be used for WB, IHC-P, IP experiment in human background.
DNAJC12 Antibody (YA2870) is a biotin-conjugated non-conjugated IgG antibody, targeting DNAJC12, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). DNAJC12 Antibody (YA2870) can be used for WB experiment in human background.
GAA Antibody (YA2872) is a biotin-conjugated non-conjugated IgG antibody, targeting GAA, with a predicted molecular weight of 105 kDa (observed band size: 120,100,75 kDa). GAA Antibody (YA2872) can be used for WB experiment in human, mouse, rat background.
SNAP alpha Antibody (YA2875) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2875), targeting SNAP alpha, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). SNAP alpha Antibody (YA2875) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
GPD2 Antibody (YA2958) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2958), targeting GPD2, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). GPD2 Antibody (YA2958) can be used for WB, IP experiment in human, mouse, rat background.
PITX3 Antibody (YA2974) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2974), targeting PITX3, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). PITX3 Antibody (YA2974) can be used for WB, IP, FC experiment in human, mouse, rat background.
HJURP Antibody (YA2987) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2987), targeting HJURP, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). HJURP Antibody (YA2987) can be used for WB, IHC-P experiment in human background.
IL-26 Antibody (YA3015) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3015), targeting IL-26, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). IL-26 Antibody (YA3015) can be used for WB, IHC-P, IP experiment in human background.
Phospho-Paxillin (Tyr118) Antibody (YA3083) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Paxillin (Tyr118), with a predicted molecular weight of 65 kDa (observed band size: 68 kDa). Phospho-Paxillin (Tyr118) Antibody (YA3083) can be used for WB experiment in human, mouse, rat background.
Cytokeratin 6A Antibody (YA3098) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3098), targeting Cytokeratin 6A, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). Cytokeratin 6A Antibody (YA3098) can be used for WB, IHC-P, ICC/IF experiment in human background.
NgR3 Antibody (YA3105) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3105), targeting NgR3, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). NgR3 Antibody (YA3105) can be used for WB, ICC/IF experiment in human, mouse, rat background.
NUP155 Antibody (YA3123) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3123), targeting NUP155, with a predicted molecular weight of 155 kDa (observed band size: 155 kDa). NUP155 Antibody (YA3123) can be used for WB, ICC/IF experiment in human background.
Serine Racemase Antibody (YA3236) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3236), targeting Serine Racemase, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). Serine Racemase Antibody (YA3236) can be used for WB, IP experiment in human background.
NCK1 Antibody (YA3294) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3294), targeting NCK1, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). NCK1 Antibody (YA3294) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
DHFR Antibody (YA3335) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3335), targeting DHFR, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). DHFR Antibody (YA3335) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Histone H3 (mono+di+tri methyl K79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono+di+tri methyl K79). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
PI 3 Kinase p85 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to PI 3 Kinase p85 alpha. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
alpha Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to alpha Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
CD105 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to CD105. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Fibrillarin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Fibrillarin. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
GFAP Antibody (YA756) is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to GFAP (9A2). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
Ki67 Antibody (YA001) is a non-conjugated and Rat origined monoclonal antibody, targeting to Ki67. It can be used for IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
PGK1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 45 kDa, targeting to PGK1. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
Lamin B2 Antibody (YA989) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA989), targeting Lamin B2, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). Lamin B2 Antibody (YA989) can be used for WB, IP experiment in human, mouse background.
Lamin B2 Antibody (YA990) is a biotin-conjugated non-conjugated IgG antibody, targeting Lamin B2, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). Lamin B2 Antibody (YA990) can be used for WB experiment in human, mouse, rat background.
Human IgM Antibody (YA1062) is a mouse-derived non-conjugated IgG2a antibody (Clone NO.: YA1062), targeting Human IgM. Human IgM Antibody (YA1062) can be used for ELISA, IHC-P experiment in human background.
GADD45A Antibody (YA1076) is a biotin-conjugated non-conjugated IgG1 antibody, targeting GADD45A, with a predicted molecular weight of 18 kDa (observed band size: 22 kDa). GADD45A Antibody (YA1076) can be used for WB experiment in human, mouse, rat background.
Aldose Reductase Antibody (YA1083) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Aldose Reductase, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Aldose Reductase Antibody (YA1083) can be used for WB experiment in human, mouse, rat background.
CD69 Antibody (YA1118) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1118), targeting CD69. CD69 Antibody (YA1118) can be used for IHC-P experiment in human background.
SCGN Antibody (YA1167) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1167), targeting SCGN. SCGN Antibody (YA1167) can be used for IHC-P experiment in human background.
LOX1 Antibody (YA1300) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1300), targeting LOX1, with a predicted molecular weight of 31 kDa (observed band size: 55 kDa). LOX1 Antibody (YA1300) can be used for WB, ICC/IF, FC experiment in human background.
DPEP1 Antibody (YA1302) is a biotin-conjugated non-conjugated IgG antibody, targeting DPEP1. DPEP1 Antibody (YA1302) can be used for IHC-P experiment in human, rat background.
CD21 Antibody (YA1307) is a biotin-conjugated non-conjugated IgG antibody, targeting CD21, with a predicted molecular weight of 113 kDa (observed band size: 155 kDa). CD21 Antibody (YA1307) can be used for IHC-P experiment in human, mouse, rat background.
GITR Antibody (YA1333) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1333), targeting GITR. GITR Antibody (YA1333) can be used for FC, ELISA experiment in human background.
NDUFB4 Antibody (YA1338) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1338), targeting NDUFB4, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). NDUFB4 Antibody (YA1338) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
TACI Antibody (YA1385) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1385), targeting TACI. TACI Antibody (YA1385) can be used for FC, ELISA experiment in human background.
NIT1 Antibody (YA1401) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1401), targeting NIT1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). NIT1 Antibody (YA1401) can be used for WB, IP experiment in human, mouse, rat background.
NTPCR Antibody (YA1444) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1444), targeting NTPCR, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). NTPCR Antibody (YA1444) can be used for WB, IP experiment in human background.
Claudin 18.2 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Claudin 18.2, with a predicted molecular weight of 28 kDa. Claudin 18.2 Antibody can be used for WB, IHC-P, ICC/IF, FC experiments in human, mouse, rat backgrounds.
PRKRA Antibody (YA1522) is a biotin-conjugated non-conjugated IgG antibody, targeting PRKRA, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). PRKRA Antibody (YA1522) can be used for WB experiment in human, mouse, rat background.
SEC23A Antibody (YA1544) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1544), targeting SEC23A, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). SEC23A Antibody (YA1544) can be used for WB, FC experiment in human background.
PIWIL1 Antibody (YA1551) is a biotin-conjugated non-conjugated IgG antibody, targeting PIWIL1, with a predicted molecular weight of 99 kDa (observed band size: 99 kDa). PIWIL1 Antibody (YA1551) can be used for WB experiment in human, mouse, rat background.
Lipoprotein Lipase Antibody (YA1576) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1576), targeting Lipoprotein Lipase, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). Lipoprotein Lipase Antibody (YA1576) can be used for WB, IHC-P experiment in human background.
ARFRP1 Antibody (YA1639) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1639), targeting ARFRP1, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). ARFRP1 Antibody (YA1639) can be used for WB, IP experiment in rat background.
PIN4 Antibody (YA1641) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1641), targeting PIN4, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). PIN4 Antibody (YA1641) can be used for WB, IP experiment in human, rat, hamster background.
DAP12 Antibody (YA1651) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1651), targeting DAP12, with a predicted molecular weight of 12 kDa (observed band size: 12 kDa). DAP12 Antibody (YA1651) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Inhibin beta B Antibody (YA1677) is a biotin-conjugated non-conjugated IgG antibody, targeting Inhibin beta B, with a predicted molecular weight of 45 kDa (observed band size: 52 kDa). Inhibin beta B Antibody (YA1677) can be used for WB experiment in human, mouse, rat background.
Rab45 Antibody (YA1792) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1792), targeting Rab45, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). Rab45 Antibody (YA1792) can be used for WB, ICC/IF experiment in human, mouse background.
Relaxin 2 Antibody (YA1855) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1855), targeting Relaxin 2, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Relaxin 2 Antibody (YA1855) can be used for WB, IHC-P experiment in human, mouse, rat background.
RRM2 Antibody (YA1885) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1885), targeting RRM2, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). RRM2 Antibody (YA1885) can be used for WB, ICC/IF, IP experiment in human background.
Tetranectin Antibody (YA1895) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1895), targeting Tetranectin, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Tetranectin Antibody (YA1895) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Fibrinogen gamma Chain Antibody (YA1896) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1896), targeting Fibrinogen gamma Chain, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Fibrinogen gamma Chain Antibody (YA1896) can be used for WB, FC experiment in human background.
SCAI Antibody (YA1906) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1906), targeting SCAI, with a predicted molecular weight of 70 kDa (observed band size: 60 kDa). SCAI Antibody (YA1906) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
NDUFB8 Antibody (YA1947) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1947), targeting NDUFB8, with a predicted molecular weight of 22 kDa (observed band size: 19 kDa). NDUFB8 Antibody (YA1947) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
ACAT1 Antibody (YA1971) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1971), targeting ACAT1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). ACAT1 Antibody (YA1971) can be used for WB, IP experiment in human background.
NUDEL Antibody (YA1972) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1972), targeting NUDEL, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). NUDEL Antibody (YA1972) can be used for WB, IHC-P experiment in human, mouse, rat background.
SMAC Antibody (YA1993) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1993), targeting SMAC, with a predicted molecular weight of 27 kDa (observed band size: 21 kDa). SMAC Antibody (YA1993) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Protein Jumonji Antibody (YA2010) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2010), targeting Protein Jumonji, with a predicted molecular weight of 139 kDa (observed band size: 139 kDa). Protein Jumonji Antibody (YA2010) can be used for WB, ICC/IF experiment in human background.
SUN1 Antibody (YA2022) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2022), targeting SUN1, with a predicted molecular weight of 87 kDa (observed band size: 98 kDa). SUN1 Antibody (YA2022) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
SNRPD3 Antibody (YA2026) is a biotin-conjugated non-conjugated IgG antibody, targeting SNRPD3, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). SNRPD3 Antibody (YA2026) can be used for WB experiment in human, rat background.
SNX1 Antibody (YA2044) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2044), targeting SNX1, with a predicted molecular weight of 59 kDa (observed band size: 74 kDa). SNX1 Antibody (YA2044) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SPINK5 Antibody (YA2046) is a biotin-conjugated non-conjugated IgG antibody, targeting SPINK5, with a predicted molecular weight of 121 kDa (observed band size: 121 kDa). SPINK5 Antibody (YA2046) can be used for WB experiment in human background.
SRP72 Antibody (YA2063) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2063), targeting SRP72, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). SRP72 Antibody (YA2063) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Syndecan 3 Antibody (YA2114) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2114), targeting Syndecan 3, with a predicted molecular weight of 45 kDa (observed band size: 60 kDa). Syndecan 3 Antibody (YA2114) can be used for WB, IP experiment in human, mouse, rat background.
Transmembrane Protein 30B Antibody (YA2220) is a biotin-conjugated non-conjugated IgG antibody, targeting Transmembrane Protein 30B, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). Transmembrane Protein 30B Antibody (YA2220) can be used for WB experiment in human background.
AZI2 Antibody (YA2226) is a biotin-conjugated non-conjugated IgG antibody, targeting AZI2, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). AZI2 Antibody (YA2226) can be used for WB experiment in human, rat background.
HAUS7 Antibody (YA2343) is a biotin-conjugated non-conjugated IgG antibody, targeting HAUS7, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). HAUS7 Antibody (YA2343) can be used for WB experiment in human background.
Wnt16 Antibody (YA2421) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2421), targeting Wnt16, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Wnt16 Antibody (YA2421) can be used for WB, IP experiment in human, mouse, rat background.
Renalase Antibody (YA2473) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2473), targeting Renalase, with a predicted molecular weight of 38 kDa (observed band size: 42 kDa). Renalase Antibody (YA2473) can be used for WB, IHC-P experiment in human, mouse, rat background.
ACAP2 Antibody (YA2485) is a biotin-conjugated non-conjugated IgG antibody, targeting ACAP2, with a predicted molecular weight of 88 kDa (observed band size: 88 kDa). ACAP2 Antibody (YA2485) can be used for WB experiment in human, hamster, rat background.
NDUFB1 Antibody (YA2504) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2504), targeting NDUFB1, with a predicted molecular weight of 7 kDa (observed band size: 7 kDa). NDUFB1 Antibody (YA2504) can be used for WB, IHC-P experiment in human background.
NEDD4 Antibody (YA2510) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2510), targeting NEDD4, with a predicted molecular weight of 149 kDa (observed band size: 115 kDa). NEDD4 Antibody (YA2510) can be used for WB, IP experiment in human, mouse, rat background.
OR1A1 Antibody (YA2513) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2513), targeting OR1A1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). OR1A1 Antibody (YA2513) can be used for WB, IP experiment in human, mouse, rat background.
CSHL1 Antibody (YA2565) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2565), targeting CSHL1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). CSHL1 Antibody (YA2565) can be used for WB, IHC-P experiment in human background.
MAGOH Antibody (YA2569) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2569), targeting MAGOH, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). MAGOH Antibody (YA2569) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
SMCHD1 Antibody (YA2571) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2571), targeting SMCHD1, with a predicted molecular weight of 226 kDa (observed band size: 226 kDa). SMCHD1 Antibody (YA2571) can be used for WB, IHC-P experiment in human background.
CTP Synthase Antibody (YA2574) is a biotin-conjugated non-conjugated IgG antibody, targeting CTP Synthase, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). CTP Synthase Antibody (YA2574) can be used for WB experiment in human background.
Phospho-Nucleophosmin (Thr199) Antibody (YA2622) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2622), targeting Phospho-Nucleophosmin (Thr199), with a predicted molecular weight of 33 kDa (observed band size: 38 kDa). Phospho-Nucleophosmin (Thr199) Antibody (YA2622) can be used for WB, IHC-P, IP experiment in human, rat background.
ADAM15 Antibody (YA2650) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2650), targeting ADAM15, with a predicted molecular weight of 93 kDa (observed band size: 90/100 kDa). ADAM15 Antibody (YA2650) can be used for WB, IHC-P experiment in human background.
PSAP Antibody (YA2683) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2683), targeting PSAP, with a predicted molecular weight of 58 kDa (observed band size: 78 kDa). PSAP Antibody (YA2683) can be used for WB, IHC-P experiment in human background.
Rad52 Antibody (YA2716) is a biotin-conjugated non-conjugated IgG antibody, targeting Rad52, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). Rad52 Antibody (YA2716) can be used for WB experiment in human background.
Hippocalcin Antibody (YA2752) is a biotin-conjugated non-conjugated IgG antibody, targeting Hippocalcin, with a predicted molecular weight of 22 kDa (observed band size: 26 kDa). Hippocalcin Antibody (YA2752) can be used for WB experiment in human, mouse, rat background.
PLTP Antibody (YA2754) is a biotin-conjugated non-conjugated IgG antibody, targeting PLTP, with a predicted molecular weight of 55 kDa (observed band size: 80 kDa). PLTP Antibody (YA2754) can be used for WB experiment in human, rat background.
FAM98B Antibody (YA2801) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2801), targeting FAM98B, with a predicted molecular weight of 46 kDa (observed band size: 37 kDa). FAM98B Antibody (YA2801) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Fibulin 1 Antibody (YA2831) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2831), targeting Fibulin 1, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). Fibulin 1 Antibody (YA2831) can be used for WB, IP experiment in human, mouse background.
FNTA Antibody (YA2841) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2841), targeting FNTA, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). FNTA Antibody (YA2841) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
DENN Antibody (YA2858) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2858), targeting DENN, with a predicted molecular weight of 183 kDa (observed band size: 220 kDa). DENN Antibody (YA2858) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
DTYMK Antibody (YA2874) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2874), targeting DTYMK, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). DTYMK Antibody (YA2874) can be used for WB, IHC-P, IP experiment in human background.
VPS28 Antibody (YA2897) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2897), targeting VPS28, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). VPS28 Antibody (YA2897) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
ERCC8 Antibody (YA2901) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2901), targeting ERCC8, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). ERCC8 Antibody (YA2901) can be used for WB, IP experiment in human background.
NLK Antibody (YA2939) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2939), targeting NLK, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). NLK Antibody (YA2939) can be used for WB, FC experiment in human background.
GMEB1 Antibody (YA2942) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2942), targeting GMEB1, with a predicted molecular weight of 63 kDa (observed band size: 80 kDa). GMEB1 Antibody (YA2942) can be used for WB, IP experiment in human background.
GPRC5B Antibody (YA2964) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2964), targeting GPRC5B, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). GPRC5B Antibody (YA2964) can be used for WB, IP experiment in human, mouse, rat background.
GSTA3 Antibody (YA2978) is a biotin-conjugated non-conjugated IgG antibody, targeting GSTA3, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). GSTA3 Antibody (YA2978) can be used for WB experiment in human, mouse, rat background.
NUP50 Antibody (YA3126) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3126), targeting NUP50, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). NUP50 Antibody (YA3126) can be used for WB, ICC/IF, IP experiment in human background.
Dystrophin Antibody (YA3224) is a biotin-conjugated non-conjugated IgG antibody, targeting Dystrophin, with a predicted molecular weight of 427 kDa (observed band size: 427 kDa). Dystrophin Antibody (YA3224) can be used for WB experiment in human, mouse, rat background.
NDUFA1 Antibody (YA3297) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3297), targeting NDUFA1, with a predicted molecular weight of 8 kDa (observed band size: 8 kDa). NDUFA1 Antibody (YA3297) can be used for WB, IHC-P, IP experiment in human background.
DNA Polymerase beta Antibody (YA3378) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3378), targeting DNA Polymerase beta, with a predicted molecular weight of 38 kDa. DNA Polymerase beta Antibody (YA3378) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
LRRK2 Antibody (YA2821) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2821), targeting LRRK2, with a predicted molecular weight of 286 kDa (observed band size: 286 kDa). LRRK2 Antibody (YA2821) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
Phospho-LRRK2(Ser935) Antibody is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3424), targeting LRRK2, with a predicted molecular weight of 286 kDa (observed band size: 286 kDa). Phospho-LRRK2(Ser935) Antibody can be used for WB,ICC/IF experiment in human, mouse background.
SpI1 Antibody (YA117) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PU.1/Spi1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.
Phospho-Histone H2A.X (Ser139) Antibody (YA190) is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Phospho-Histone H2A.X(S139). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Acetyl Coenzyme A Carboxylase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 277 kDa, targeting to Acetyl Coenzyme A Carboxylase. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
Asparagine Synthetase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to Asparagine Synthetase. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
Bcl2 Antibody (YA824) is a non-conjugated and Mouse origined monoclonal antibody about 26 kDa, targeting to Bcl2 (1D8). It can be used for WB assays with tag free, in the background of Human, Rat, Mouse.
Wnt5a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to Wnt5a. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
GLO1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Lactoylglutathione lyase (GLO1). It can be used for WB,FC assays in the background of Human, Mouse, Rat.
CEACAM1 Antibody is an unconjugated, approximately 120-150 kDa, rabbit-derived, anti-CEACAM1 monoclonal antibody. CEACAM1 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human background without labeling.
FXR1 Antibody is an unconjugated, approximately 70 kDa, rabbit-derived, anti-FXR1 monoclonal antibody. FXR1 Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse, rat background without labeling.
Strep-Tag II Antibody (YA885) is an unconjugated, rabbit-derived, anti-Strep-Tag II (YA885) monoclonal antibody. Strep-Tag II Antibody (YA885) can be used for: WB、IF、IP expriments in species-independent background without labeling.
Thrombomodulin Antibody (YA891) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA891) monoclonal antibody. Thrombomodulin Antibody (YA891) can be used for: WB, ICC/IF, IP expriments in human background without labeling.
Thrombomodulin Antibody (YA892) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA892) monoclonal antibody. Thrombomodulin Antibody (YA892) can be used for: WB expriments in mouse, rat background without labeling.
Sulfadimidine Antibody (YA906) is an unconjugated, rabbit-derived, anti-Sulfadimidine (YA906) monoclonal antibody. Sulfadimidine Antibody (YA906) can be used for: ELISA expriments in background without labeling.
NO tyrosine; nTyr; Nitrotyrosine; nitro-Tyrosine; nitro Tyrosine.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Rat
3-Nitrotyrosine Antibody is an unconjugated, rabbit-derived, anti-3-Nitrotyrosine polyclonal antibody. 3-Nitrotyrosine Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse background without labeling.
HARS Antibody (YA977) is a biotin-conjugated non-conjugated IgG1 antibody, targeting HARS, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). HARS Antibody (YA977) can be used for WB experiment in human, mouse, monkey background.
HARS Antibody (YA978) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA978), targeting HARS, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). HARS Antibody (YA978) can be used for WB, IP experiment in human background.
4E BP2 Antibody (YA1079) is a biotin-conjugated non-conjugated IgG1 antibody, targeting 4E BP2, with a predicted molecular weight of 13 kDa (observed band size: 15-20 kDa). 4E BP2 Antibody (YA1079) can be used for WB experiment in human, mouse, rat background.
Mannose Phosphate Isomerase Antibody (YA1085) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1085), targeting Mannose Phosphate Isomerase, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). Mannose Phosphate Isomerase Antibody (YA1085) can be used for WB, ICC/IF experiment in human, rat background.
Luteinizing Hormone beta Antibody (YA1095) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1095), targeting Luteinizing Hormone beta. Luteinizing Hormone beta Antibody (YA1095) can be used for IHC-P experiment in human background.
FOXJ1 Antibody (YA1107) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1107), targeting FOXJ1. FOXJ1 Antibody (YA1107) can be used for IHC-P experiment in human background.
Mesothelin Antibody (YA1157) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1157), targeting Mesothelin. Mesothelin Antibody (YA1157) can be used for IHC-P experiment in human background.
SLC39A6 Antibody (YA1187) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1187), targeting SLC39A6. SLC39A6 Antibody (YA1187) can be used for IHC-P experiment in human background.
SOX17 Antibody (YA1199) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1199), targeting SOX17. SOX17 Antibody (YA1199) can be used for IHC-P experiment in human background.
DDX4 Antibody (YA1208) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1208), targeting DDX4. DDX4 Antibody (YA1208) can be used for IHC-P experiment in human background.
DGKZ Antibody (YA1222) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1222), targeting DGKZ. DGKZ Antibody (YA1222) can be used for IHC-P experiment in human background.
Ornithine Carbamoyltransferase/OTC Antibody (YA1230) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1230), targeting Ornithine Carbamoyltransferase/OTC. Ornithine Carbamoyltransferase/OTC Antibody (YA1230) can be used for IHC-P experiment in human background.
Pancreatic Lipase Antibody (YA1248) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1248), targeting Pancreatic Lipase. Pancreatic Lipase Antibody (YA1248) can be used for IHC-P experiment in human background.
CD20 Antibody (YA1303) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1303), targeting CD20, with a predicted molecular weight of 35 kDa (observed band size: 33 kDa). CD20 Antibody (YA1303) can be used for WB, IHC-P, FC experiment in human background.
p44/42 MAPK Antibody (YA1304) is a biotin-conjugated non-conjugated IgG antibody, targeting p44/42 MAPK, with a predicted molecular weight of 44/42 kDa (observed band size: 44/42 kDa). p44/42 MAPK Antibody (YA1304) can be used for WB experiment in human, mouse, rat background.
CD50 Antibody (YA1316) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1316), targeting CD50. CD50 Antibody (YA1316) can be used for IHC-P, ICC/IF, FC experiment in human background.
CDK8 Antibody (YA1323) is a biotin-conjugated non-conjugated IgG antibody, targeting CDK8, with a predicted molecular weight of 53 kDa (observed band size: 55 kDa). CDK8 Antibody (YA1323) can be used for IHC-P experiment in human, mouse background.
Granzyme B Antibody (YA1326) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1326), targeting Granzyme B with observed band size of 32 kDa. Granzyme B Antibody (YA1326) can be used for WB, IP, ICC/IF, IHC-P experiment in human, mouse, rat background.
NEK4 Antibody (YA1358) is a biotin-conjugated non-conjugated IgG antibody, targeting NEK4, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). NEK4 Antibody (YA1358) can be used for WB experiment in human background.
BAG2 Antibody (YA1398) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1398), targeting BAG2, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). BAG2 Antibody (YA1398) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Niemann Pick C2 Antibody (YA1399) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1399), targeting Niemann Pick C2, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Niemann Pick C2 Antibody (YA1399) can be used for WB, IHC-P experiment in human, mouse, rat background.
SLC12A1 Antibody (YA1403) is a biotin-conjugated non-conjugated IgG antibody, targeting SLC12A1, with a predicted molecular weight of 121 kDa (observed band size: 150 kDa). SLC12A1 Antibody (YA1403) can be used for WB experiment in human background.
ADAM9 Antibody (YA1428) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1428), targeting ADAM9. ADAM9 Antibody (YA1428) can be used for FC, ELISA experiment in human background.
YTHDF1 Antibody (YA1429) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1429), targeting YTHDF1, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). YTHDF1 Antibody (YA1429) can be used for WB, IP experiment in human, hamster background.
Phospho-Nucleolin (Thr84) Antibody (YA1440) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Nucleolin (Thr84), with a predicted molecular weight of 77 kDa (observed band size: 100 kDa). Phospho-Nucleolin (Thr84) Antibody (YA1440) can be used for WB experiment in human background.
Furin Antibody (YA1441) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1441), targeting Furin, with a predicted molecular weight of 87 kDa (observed band size: 87 kDa). Furin Antibody (YA1441) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
HES5 Antibody (YA1449) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1449), targeting HES5, with a predicted molecular weight of 18 kDa . HES5 Antibody (YA1449) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
PSGL1 Antibody (YA1456) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1456), targeting PSGL1, with a predicted molecular weight of 43 kDa (observed band size: 120 kDa). PSGL1 Antibody (YA1456) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
Thyroid Peroxidase Antibody (YA1480) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1480), targeting Thyroid Peroxidase, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). Thyroid Peroxidase Antibody (YA1480) can be used for WB, IHC-P, IP experiment in human background.
LIGHT Antibody (YA1512) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1512), targeting LIGHT. LIGHT Antibody (YA1512) can be used for FC, ELISA experiment in human background.
VAMP8 Antibody (YA1552) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1552), targeting VAMP8, with a predicted molecular weight of 11 kDa (observed band size: 15 kDa). VAMP8 Antibody (YA1552) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
PDLIM7 Antibody (YA1566) is a biotin-conjugated non-conjugated IgG antibody, targeting PDLIM7, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). PDLIM7 Antibody (YA1566) can be used for WB experiment in human background.
6-phosphofructokinase type B; PFK-B; Phosphohexokinase
WB, ICC/IF
Mouse, Rat
PFKL Antibody (YA1597) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1597), targeting PFKL, with a predicted molecular weight of 85 kDa (observed band size: 85 kDa). PFKL Antibody (YA1597) can be used for WB, ICC/IF experiment in mouse, rat background.
Angiopoietin 2 Antibody (YA1598) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1598), targeting Angiopoietin 2, with a predicted molecular weight of 57 kDa. Angiopoietin 2 Antibody (YA1598) can be used for WB, IHC-P experiment in human, mouse, rat background.
Cathepsin S Antibody (YA1614) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1614), targeting Cathepsin S, with a predicted molecular weight of 37 kDa (observed band size: 25 kDa). Cathepsin S Antibody (YA1614) can be used for WB, IHC-P, ICC/IF experiment in human background.
ATG13 Antibody (YA1650) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1650), targeting ATG13, with a predicted molecular weight of 57 kDa (observed band size: 72 kDa). ATG13 Antibody (YA1650) can be used for WB, IP experiment in human, mouse, rat background.
MOV10 Antibody (YA1669) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1669), targeting MOV10, with a predicted molecular weight of 114 kDa (observed band size: 114 kDa). MOV10 Antibody (YA1669) can be used for WB, IHC-P experiment in human, mouse, rat background.
PMCA1 Antibody (YA1676) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1676), targeting PMCA1, with a predicted molecular weight of 135 kDa (observed band size: 130-250 kDa). PMCA1 Antibody (YA1676) can be used for WB, IHC-P experiment in human, mouse, rat background.
POLDIP2 Antibody (YA1680) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1680), targeting POLDIP2, with a predicted molecular weight of 42 kDa (observed band size: 38 kDa). POLDIP2 Antibody (YA1680) can be used for WB, IP experiment in human background.
PRAME Antibody (YA1711) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1711), targeting PRAME, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). PRAME Antibody (YA1711) can be used for WB, IHC-P, IP experiment in human, mouse background.
CRTC3 Antibody (YA1748) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1748), targeting CRTC3, with a predicted molecular weight of 67 kDa (observed band size: 78 kDa). CRTC3 Antibody (YA1748) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PSF1 Antibody (YA1763) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1763), targeting PSF1, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). PSF1 Antibody (YA1763) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
HBEGF Antibody (YA1801) is a biotin-conjugated non-conjugated IgG antibody, targeting HBEGF, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). HBEGF Antibody (YA1801) can be used for WB experiment in human, rat background.
RBBP4 Antibody (YA1843) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1843), targeting RBBP4, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). RBBP4 Antibody (YA1843) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat, hamster background.
Rel B Antibody (YA1852) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1852), targeting Rel B, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). Rel B Antibody (YA1852) can be used for WB, IP experiment in human, mouse, rat background.
SEP15 Antibody (YA1924) is a biotin-conjugated non-conjugated IgG antibody, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). SEP15 Antibody (YA1924) can be used for WB experiment in human background.
SESN2 Antibody (YA1934) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1934), targeting SESN2, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). SESN2 Antibody (YA1934) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
SFPQ Antibody (YA1940) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1940), targeting SFPQ, with a predicted molecular weight of 76 kDa (observed band size: 100 kDa). SFPQ Antibody (YA1940) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
SFRP4 Antibody (YA1943) is a biotin-conjugated non-conjugated IgG antibody, targeting SFRP4, with a predicted molecular weight of 40 kDa (observed band size: 53-55 kDa). SFRP4 Antibody (YA1943) can be used for WB experiment in human, mouse, rat background.
ABAT Antibody (YA1964) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1964), targeting ABAT, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). ABAT Antibody (YA1964) can be used for WB, IP experiment in rat background.
Adrenodoxin Antibody (YA2005) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2005), targeting Adrenodoxin, with a predicted molecular weight of 19 kDa (observed band size: 14 kDa). Adrenodoxin Antibody (YA2005) can be used for WB, IHC-P, IP experiment in human, mouse background.
ADRM1 Antibody (YA2007) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2007), targeting ADRM1, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). ADRM1 Antibody (YA2007) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
MFF Antibody (YA2012) is a biotin-conjugated non-conjugated IgG antibody, targeting MFF, with a predicted molecular weight of 38 kDa (observed band size: 34 kDa). MFF Antibody (YA2012) can be used for WB experiment in human, mouse, rat background.
AER61 Antibody (YA2015) is a biotin-conjugated non-conjugated IgG antibody, targeting AER61, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). AER61 Antibody (YA2015) can be used for WB experiment in human, rat background.
OGA Antibody (YA2041) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2041), targeting OGA, with a predicted molecular weight of 103 kDa (observed band size: 130 kDa). OGA Antibody (YA2041) can be used for WB, IHC-P, IP experiment in human, mouse background.
FE65 Antibody (YA2058) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2058), targeting FE65, with a predicted molecular weight of 77 kDa (observed band size: 100 kDa). FE65 Antibody (YA2058) can be used for WB, IHC-P, ICC/IF experiment in human background.
PCB Antibody (YA2060) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2060), targeting PCB, with a predicted molecular weight of 130 kDa (observed band size: 130 kDa). PCB Antibody (YA2060) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Aquaporin 2 Antibody (YA2142) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2142), targeting Aquaporin 2, with a predicted molecular weight of 29 kDa (observed band size: 37 kDa). Aquaporin 2 Antibody (YA2142) can be used for WB, IHC-P, IP experiment in human background.
TDP 43 Antibody (YA2172) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2172), targeting TDP 43, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). TDP 43 Antibody (YA2172) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
NDUFAF1 Antibody (YA2179) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2179), targeting NDUFAF1, with a predicted molecular weight of 38 kDa (observed band size: 33 kDa). NDUFAF1 Antibody (YA2179) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
Transmembrane Protein 161B Antibody (YA2209) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2209), targeting Transmembrane Protein 161B, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). Transmembrane Protein 161B Antibody (YA2209) can be used for WB, IP experiment in human background.
Transmembrane Protein 9B Antibody (YA2228) is a biotin-conjugated non-conjugated IgG antibody, targeting Transmembrane Protein 9B, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Transmembrane Protein 9B Antibody (YA2228) can be used for WB experiment in human, mouse, rat background.
TRIM23 Antibody (YA2269) is a biotin-conjugated non-conjugated IgG antibody, targeting TRIM23, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). TRIM23 Antibody (YA2269) can be used for WB experiment in human, mouse, rat background.
TFG Antibody (YA2281) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2281), targeting TFG, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). TFG Antibody (YA2281) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
TrpV5 Antibody (YA2284) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2284), targeting TrpV5, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). TrpV5 Antibody (YA2284) can be used for WB, IP experiment in human, mouse, rat background.
TRUB2 Antibody (YA2286) is a biotin-conjugated non-conjugated IgG antibody, targeting TRUB2, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). TRUB2 Antibody (YA2286) can be used for WB experiment in human background.
C9orf167 Antibody (YA2325) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2325), targeting C9orf167, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). C9orf167 Antibody (YA2325) can be used for WB, IP experiment in human background.
MTH1 Antibody (YA2330) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2330), targeting MTH1, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). MTH1 Antibody (YA2330) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
GRASP65 Antibody (YA2335) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2335), targeting GRASP65, with a predicted molecular weight of 46 kDa (observed band size: 65 kDa). GRASP65 Antibody (YA2335) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
NPHS2 Antibody (YA2370) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2370), targeting NPHS2, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). NPHS2 Antibody (YA2370) can be used for WB, IHC-P experiment in human, mouse, rat background.
NUDC Antibody (YA2371) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2371), targeting NUDC, with a predicted molecular weight of 38 kDa (observed band size: 42 kDa). NUDC Antibody (YA2371) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Cullin 1 Antibody (YA2378) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2378), targeting Cullin 1, with a predicted molecular weight of 90 kDa (observed band size: 90 kDa). Cullin 1 Antibody (YA2378) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
WAPL Antibody (YA2397) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2397), targeting WAPL, with a predicted molecular weight of 133 kDa (observed band size: 160 kDa). WAPL Antibody (YA2397) can be used for WB, ICC/IF, IP experiment in human background.
VPS18 Antibody (YA2445) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2445), targeting VPS18, with a predicted molecular weight of 110 kDa (observed band size: 100 kDa). VPS18 Antibody (YA2445) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
ZYX Antibody (YA2459) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2459), targeting ZYX, with a predicted molecular weight of 61 kDa (observed band size: 78 kDa). ZYX Antibody (YA2459) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
Surfeit Locus Protein 4 Antibody (YA2465) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2465), targeting Surfeit Locus Protein 4, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). Surfeit Locus Protein 4 Antibody (YA2465) can be used for WB, ICC/IF experiment in human, mouse, rat background.
CRABP1 Antibody (YA2467) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2467), targeting CRABP1, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). CRABP1 Antibody (YA2467) can be used for WB, IP experiment in human, mouse background.
DDX17 Antibody (YA2489) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2489), targeting DDX17, with a predicted molecular weight of 80 kDa (observed band size: 70,80 kDa). DDX17 Antibody (YA2489) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
PAF1 Antibody (YA2505) is a biotin-conjugated non-conjugated IgG antibody, targeting PAF1, with a predicted molecular weight of 60 kDa (observed band size: 80 kDa). PAF1 Antibody (YA2505) can be used for WB experiment in human, mouse, rat background.
COG6 Antibody (YA2530) is a biotin-conjugated non-conjugated IgG antibody, targeting COG6, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). COG6 Antibody (YA2530) can be used for WB experiment in human, mouse background.
Coilin Antibody (YA2532) is a biotin-conjugated non-conjugated IgG antibody, targeting Coilin, with a predicted molecular weight of 63 kDa (observed band size: 80 kDa). Coilin Antibody (YA2532) can be used for WB experiment in human background.
Kaiso Antibody (YA2543) is a biotin-conjugated non-conjugated IgG antibody, targeting Kaiso, with a predicted molecular weight of 74 kDa (observed band size: 85 kDa). Kaiso Antibody (YA2543) can be used for WB experiment in human, mouse, rat background.
ApoB Antibody (YA2566) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2566), targeting ApoB, with a predicted molecular weight of 516 kDa (observed band size: 516 kDa). ApoB Antibody (YA2566) can be used for WB, IP, FC experiment in human background.
CrkL Antibody (YA2577) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2577), targeting CrkL, with a predicted molecular weight of 34 kDa (observed band size: 39 kDa). CrkL Antibody (YA2577) can be used for WB, IHC-P, ICC/IF experiment in human background.
Cyclin T1 Antibody (YA2600) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2600), targeting Cyclin T1, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). Cyclin T1 Antibody (YA2600) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
ADK Antibody (YA2689) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2689), targeting ADK, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). ADK Antibody (YA2689) can be used for WB, IHC-P experiment in human, mouse, rat background.
DNAJA4 Antibody (YA2702) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2702), targeting DNAJA4, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). DNAJA4 Antibody (YA2702) can be used for WB, IP experiment in human, rat background.
DOCK2 Antibody (YA2710) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2710), targeting DOCK2, with a predicted molecular weight of 212 kDa (observed band size: 212 kDa). DOCK2 Antibody (YA2710) can be used for WB, IHC-P experiment in human background.
DOCK8 Antibody (YA2713) is a biotin-conjugated non-conjugated IgG antibody, targeting DOCK8, with a predicted molecular weight of 239 kDa (observed band size: 239 kDa). DOCK8 Antibody (YA2713) can be used for WB experiment in human background.
ZNF217 Antibody (YA2723) is a biotin-conjugated non-conjugated IgG antibody, targeting ZNF217, with a predicted molecular weight of 115 kDa (observed band size: 125 kDa). ZNF217 Antibody (YA2723) can be used for WB experiment in human background.
Renin Antibody (YA2727) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2727), targeting Renin, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Renin Antibody (YA2727) can be used for WB, FC experiment in human background.
ApoA Antibody (YA2732) is a biotin-conjugated non-conjugated IgG antibody, targeting ApoA, with a predicted molecular weight of 227 kDa (observed band size: 501 kDa). ApoA Antibody (YA2732) can be used for WB experiment in human background.
BAP1 Antibody (YA2733) is a biotin-conjugated non-conjugated IgG antibody, targeting BAP1, with a predicted molecular weight of 80 kDa (observed band size: 95 kDa). BAP1 Antibody (YA2733) can be used for WB experiment in human background.
ELK1 Antibody (YA2758) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2758), targeting ELK1, with a predicted molecular weight of 45 kDa (observed band size: 62 kDa). ELK1 Antibody (YA2758) can be used for WB, IHC-P, IP, ChIP experiment in human background.
Epsin 1 Antibody (YA2778) is a biotin-conjugated non-conjugated IgG antibody, targeting Epsin 1, with a predicted molecular weight of 60 kDa (observed band size: 90 kDa). Epsin 1 Antibody (YA2778) can be used for WB experiment in human, mouse, rat background.
Citrate Synthetase Antibody (YA2802) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2802), targeting Citrate Synthetase, with a predicted molecular weight of 52 kDa (observed band size: 45 kDa). Citrate Synthetase Antibody (YA2802) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
CSDE1 Antibody (YA2828) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2828), targeting CSDE1, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). CSDE1 Antibody (YA2828) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
ERG Antibody (YA2842) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2842), targeting ERG, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). ERG Antibody (YA2842) can be used for WB, IHC-P, ICC/IF, ChIP experiment in human, mouse, rat background.
GOT2 Antibody (YA2862) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2862), targeting GOT2, with a predicted molecular weight of 48 kDa (observed band size: 43 kDa). GOT2 Antibody (YA2862) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
GNE Antibody (YA2917) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2917), targeting GNE, with a predicted molecular weight of 79 kDa (observed band size: 75 kDa). GNE Antibody (YA2917) can be used for WB, IP experiment in human background.
GBP1 Antibody (YA2930) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2930), targeting GBP1, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). GBP1 Antibody (YA2930) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
GNAQ Antibody (YA2938) is a biotin-conjugated non-conjugated IgG antibody, targeting GNAQ, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). GNAQ Antibody (YA2938) can be used for WB experiment in mouse, rat background.
HCE Antibody (YA2959) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2959), targeting HCE, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). HCE Antibody (YA2959) can be used for WB, ICC/IF, IP experiment in human, rat background.
ICAM2 Antibody (YA3007) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3007), targeting ICAM2, with a predicted molecular weight of 31 kDa (observed band size: 50-60 kDa). ICAM2 Antibody (YA3007) can be used for WB, IHC-P, IP experiment in human, mouse background.
ICAM3 Antibody (YA3009) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3009), targeting ICAM3, with a predicted molecular weight of 60 kDa (observed band size: 110-160 kDa). ICAM3 Antibody (YA3009) can be used for WB, IHC-P, IP experiment in human, rat background.
HMGCL Antibody (YA3024) is a biotin-conjugated non-conjugated IgG antibody, targeting HMGCL, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). HMGCL Antibody (YA3024) can be used for WB experiment in human background.
NDEL1 Antibody (YA3094) is a biotin-conjugated non-conjugated IgG antibody, targeting NDEL1, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). NDEL1 Antibody (YA3094) can be used for WB experiment in human, mouse background.
KCTD3 Antibody (YA3137) is a biotin-conjugated non-conjugated IgG antibody, targeting KCTD3, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). KCTD3 Antibody (YA3137) can be used for WB experiment in human background.
RAP80 Antibody (YA3208) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3208), targeting RAP80, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). RAP80 Antibody (YA3208) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Septin 8 Antibody (YA3234) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3234), targeting Septin 8, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). Septin 8 Antibody (YA3234) can be used for WB, IP experiment in hamster, rat background.
MMP26 Antibody (YA3240) is a biotin-conjugated non-conjugated IgG antibody, targeting MMP26, with a predicted molecular weight of 30 kDa (observed band size: 19 kDa). MMP26 Antibody (YA3240) can be used for WB experiment in human, hamster, rat background.
N4BP1 Antibody (YA3286) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3286), targeting N4BP1, with a predicted molecular weight of 99 kDa (observed band size: 99 kDa). N4BP1 Antibody (YA3286) can be used for WB, IP experiment in human background.
NAT1 Antibody (YA3288) is a biotin-conjugated non-conjugated IgG antibody, targeting NAT1, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). NAT1 Antibody (YA3288) can be used for WB experiment in human, mouse, rat background.
Hemopexin Antibody (YA3381) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3381), targeting Hemopexin, with a predicted molecular weight of 52 kDa (observed band size: 70-75 kDa). Hemopexin Antibody (YA3381) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
PRKCG; PKCG; Protein kinase C gamma type; PKC-gamma
WB, ICC/IF
Human, Mouse, Rat
PKC gamma Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC gamma. It can be used for WB,IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-AMPK alpha 1 (Ser496) Antibody (YA226) is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (S496). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
CD147 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to CD147. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
CD68 Antibody (YA799) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD68 (9H5). It can be used for IHC-P,ICC/IF assays with tag free, in the background of Human.
CKMT1 Antibody (YA794) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to CKMT1 (1A6). It can be used for WB assays with tag free, in the background of Human, Mouse.
DDX3 Antibody (YA784) is a non-conjugated and Mouse origined monoclonal antibody about 73 kDa, targeting to DDX3 (6G8). It can be used for WB,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Rat, Mouse, Monkey.
MYD88; Myeloid differentiation primary response protein MyD88
ICC/IF, WB, IHC-F, IHC-P, ELISA
Human, Mouse, Rat
MyD88 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 33 kDa, targeting to MyD88. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
SYP; Synaptophysin; Major synaptic vesicle protein p38
WB, IHC-P
Human, Mouse, Rat
Synaptophysin Antibody (YA664) is a non-conjugated and Mouse origined monoclonal antibody about 34 kDa, targeting to Synaptophysin (10C8). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Human, Monkey, Rat, Mouse, Saccharomyces cerevisiae, Pichia pastoris, Hamster
GAPDH Antibody (YA848) is a non-conjugated and Mouse origined monoclonal antibody about 36 kDa. It can be used for WB assays with tag free, in the background of Human, Monkey, Rat, Mouse, Hamster, Saccharomyces cerevisiae, Pichia pastoris.
Human, Mouse, Monkey, Goat, Hamster, Rat, Chlamydomonas Reinhardtii
beta Tubulin Antibody (YA839) is a non-conjugated and Mouse origined monoclonal antibody about 50-55 kDa, targeting to Tubulin beta chain (TUBB). It can be used for WB,ICC/IF assays in the background of Human, Mouse, Monkey, Goat, Hamster, Rat, Chlamydomonas Reinhardtii.
FDFT1 Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-FDFT1 monoclonal antibody. FDFT1 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.
MMAF Antibody (YA900) is an unconjugated, mouse-derived, anti-MMAF (YA900) monoclonal antibody. MMAF Antibody (YA900) can be used for: ELISA in background without labeling.
C Reactive Protein Antibody (YA939) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA939), targeting C Reactive Protein. C Reactive Protein Antibody (YA939) can be used for ELISA experiment in human background.
C Reactive Protein Antibody (YA940) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA940), targeting C Reactive Protein. C Reactive Protein Antibody (YA940) can be used for ELISA experiment in human background.
C Reactive Protein Antibody (YA941) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA941), targeting C Reactive Protein, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). C Reactive Protein Antibody (YA941) can be used for WB, IHC-P, IP experiment in human background.
Wnt3 Antibody (YA1081) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Wnt3, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). Wnt3 Antibody (YA1081) can be used for WB experiment in human, mouse, rat background.
SCD1 Antibody (YA1163) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1163), targeting SCD1. SCD1 Antibody (YA1163) can be used for IHC-P experiment in human background.
MRP4 Antibody (YA1166) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1166), targeting MRP4. MRP4 Antibody (YA1166) can be used for IHC-P experiment in human background.
HOXB13 Antibody (YA1198) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1198), targeting HOXB13. HOXB13 Antibody (YA1198) can be used for IHC-P experiment in human background.
FBP1 Antibody (YA1264) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1264), targeting FBP1. FBP1 Antibody (YA1264) can be used for IHC-P experiment in human background.
S100A2 Antibody (YA1317) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1317), targeting S100A2. S100A2 Antibody (YA1317) can be used for IHC-P experiment in human background.
AMHR2 Antibody (YA1337) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1337), targeting AMHR2. AMHR2 Antibody (YA1337) can be used for FC, ELISA experiment in human background.
HVEM Antibody (YA1342) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1342), targeting HVEM. HVEM Antibody (YA1342) can be used for FC, ELISA experiment in human background.
NDUFS8 Antibody (YA1352) is a biotin-conjugated non-conjugated IgG antibody, targeting NDUFS8, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). NDUFS8 Antibody (YA1352) can be used for WB experiment in mouse, rat background.
NEK9 Antibody (YA1362) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1362), targeting NEK9, with a predicted molecular weight of 107 kDa (observed band size: 107 kDa). NEK9 Antibody (YA1362) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
Peroxiredoxin 4 Antibody (YA1443) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1443), targeting Peroxiredoxin 4, with a predicted molecular weight of 31 kDa (observed band size: 27 kDa). Peroxiredoxin 4 Antibody (YA1443) can be used for WB, IHC-P experiment in human, mouse, rat background.
Firefly Luciferase Antibody (YA1495) is a biotin-conjugated non-conjugated IgG antibody, targeting Firefly Luciferase, with a predicted molecular weight of 61 kDa. Firefly Luciferase Antibody (YA1495) can be used for WB, ICC/IF experiment in fire fly background.
Raptor Antibody (YA1519) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1519), targeting Raptor, with a predicted molecular weight of 149 kDa. Raptor Antibody (YA1519) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Endo G Antibody (YA1529) is a biotin-conjugated non-conjugated IgG antibody, targeting Endo G, with a predicted molecular weight of 33 kDa (observed band size: 30 kDa). Endo G Antibody (YA1529) can be used for WB experiment in human, mouse, rat background.
Phospho-Parvin alpha (Ser8) Antibody (YA1539) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1539), targeting Phospho-Parvin alpha (Ser8), with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). Phospho-Parvin alpha (Ser8) Antibody (YA1539) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PCBP2 Antibody (YA1543) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1543), targeting PCBP2, with a predicted molecular weight of 39 kDa (observed band size: 35-45 kDa). PCBP2 Antibody (YA1543) can be used for WB, IP experiment in mouse, rat background.
ADAM17 Antibody (YA1562) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1562), targeting ADAM17, with a predicted molecular weight of 93 kDa. ADAM17 Antibody (YA1562) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
PEX11B Antibody (YA1594) is a biotin-conjugated non-conjugated IgG antibody, targeting PEX11B, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). PEX11B Antibody (YA1594) can be used for WB experiment in human, mouse background.
Phospho-Phospholamban (Ser16) Antibody (YA1618) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Phospholamban (Ser16), with a predicted molecular weight of 6 kDa (observed band size: 12,24 kDa). Phospho-Phospholamban (Ser16) Antibody (YA1618) can be used for WB experiment in human, mouse background.
Thioredoxin Interacting Protein Antibody (YA1627) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1627), targeting Thioredoxin Interacting Protein, with a predicted molecular weight of 44 kDa. Thioredoxin Interacting Protein Antibody (YA1627) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
PICK1 Antibody (YA1632) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1632), targeting PICK1, with a predicted molecular weight of 47 kDa (observed band size: 50 kDa). PICK1 Antibody (YA1632) can be used for WB, IP experiment in human background.
NOXA2 Antibody (YA1649) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1649), targeting NOXA2, with a predicted molecular weight of 60 kDa (observed band size: 67 kDa). NOXA2 Antibody (YA1649) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Centromere autoantigen A; Centromere protein A; CENP-A
WB
Human
CENPA Antibody (YA1653) is a biotin-conjugated non-conjugated IgG antibody, targeting CENPA, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). CENPA Antibody (YA1653) can be used for WB experiment in human background.
PERP Antibody (YA1674) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1674), targeting PERP, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). PERP Antibody (YA1674) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PRC1 Antibody (YA1716) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1716), targeting PRC1, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). PRC1 Antibody (YA1716) can be used for WB, IHC-P, IP experiment in human, rat background.
Caveolin 1 Antibody (YA1782) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1782), targeting Caveolin 1, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Caveolin 1 Antibody (YA1782) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
QK1 Antibody (YA1788) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1788), targeting QK1, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). QK1 Antibody (YA1788) can be used for WB, IP experiment in human, mouse, rat background.
Rab22A Antibody (YA1791) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1791), targeting Rab22A, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). Rab22A Antibody (YA1791) can be used for WB, IP experiment in human, mouse, rat background.
REEP2 Antibody (YA1850) is a biotin-conjugated non-conjugated IgG antibody, targeting REEP2, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). REEP2 Antibody (YA1850) can be used for WB experiment in human background.
Cellubrevin Antibody (YA1872) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1872), targeting Cellubrevin, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). Cellubrevin Antibody (YA1872) can be used for WB, ICC/IF, IP, FC experiment in human background.
FHL2 Antibody (YA1875) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1875), targeting FHL2, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). FHL2 Antibody (YA1875) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
SAMD9 Antibody (YA1901) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1901), targeting SAMD9, with a predicted molecular weight of 184 kDa (observed band size: 184 kDa). SAMD9 Antibody (YA1901) can be used for WB, ICC/IF experiment in human background.
HIPK2 Antibody (YA1913) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1913), targeting HIPK2, with a predicted molecular weight of 131 kDa (observed band size: 130,100 kDa). HIPK2 Antibody (YA1913) can be used for WB, ICC/IF, IP, FC experiment in human, mouse background.
Alcohol Dehydrogenase Antibody (YA1948) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1948), targeting Alcohol Dehydrogenase, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). Alcohol Dehydrogenase Antibody (YA1948) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
PAG1 Antibody (YA1968) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1968), targeting PAG1, with a predicted molecular weight of 47 kDa (observed band size: 80 kDa). PAG1 Antibody (YA1968) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
SLC25A12 Antibody (YA1985) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1985), targeting SLC25A12, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). SLC25A12 Antibody (YA1985) can be used for WB, IP experiment in mouse, rat background.
AdSS 2 Antibody (YA2011) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2011), targeting AdSS 2, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). AdSS 2 Antibody (YA2011) can be used for WB, ICC/IF experiment in human, mouse, rat background.
SPON2 Antibody (YA2049) is a biotin-conjugated non-conjugated IgG antibody, targeting SPON2, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). SPON2 Antibody (YA2049) can be used for WB experiment in human, mouse, rat background.
AGPS Antibody (YA2053) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2053), targeting AGPS, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). AGPS Antibody (YA2053) can be used for WB, IHC-P, IP experiment in human background.
Triosephosphate Isomerase Antibody (YA2066) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2066), targeting Triosephosphate Isomerase, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). Triosephosphate Isomerase Antibody (YA2066) can be used for WB, FC experiment in human, mouse, rat background.
PEN2 Antibody (YA2118) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2118), targeting PEN2, with a predicted molecular weight of 12 kDa (observed band size: 12 kDa). PEN2 Antibody (YA2118) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Synaptophysin Like Protein 1 Antibody (YA2124) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2124), targeting Synaptophysin Like Protein 1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). Synaptophysin Like Protein 1 Antibody (YA2124) can be used for WB, IHC-P experiment in human background.
TAGAP Antibody (YA2141) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2141), targeting TAGAP, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). TAGAP Antibody (YA2141) can be used for WB, IP experiment in human, rat background.
BUB3 Antibody (YA2180) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2180), targeting BUB3, with a predicted molecular weight of 37 kDa (observed band size: 40 kDa). BUB3 Antibody (YA2180) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
ATPB Antibody (YA2214) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2214), targeting ATPB, with a predicted molecular weight of 57 kDa (observed band size: 52 kDa). ATPB Antibody (YA2214) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat, monkey background.
Transmembrane Protein 85 Antibody (YA2225) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2225), targeting Transmembrane Protein 85, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Transmembrane Protein 85 Antibody (YA2225) can be used for WB, IP experiment in human, mouse, rat, hamster background.
CHD1L Antibody (YA2236) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2236), targeting CHD1L, with a predicted molecular weight of 101 kDa (observed band size: 101 kDa). CHD1L Antibody (YA2236) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse background.
Gephyrin Antibody (YA2246) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2246), targeting Gephyrin, with a predicted molecular weight of 80 kDa (observed band size: 93 kDa). Gephyrin Antibody (YA2246) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
BAT3 Antibody (YA2251) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2251), targeting BAT3, with a predicted molecular weight of 119 kDa (observed band size: 150 kDa). BAT3 Antibody (YA2251) can be used for WB, ICC/IF experiment in human, mouse, rat background.
DDX6 Antibody (YA2252) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2252), targeting DDX6, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). DDX6 Antibody (YA2252) can be used for WB, IHC-P experiment in human, mouse, rat background.
GPA33 Antibody (YA2266) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2266), targeting GPA33, with a predicted molecular weight of 36 kDa (observed band size: 50 kDa). GPA33 Antibody (YA2266) can be used for WB, IHC-P, IP experiment in human background.
MBD2 Antibody (YA2279) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2279), targeting MBD2, with a predicted molecular weight of 43 kDa (observed band size: 43/32/29 kDa). MBD2 Antibody (YA2279) can be used for WB, IHC-P, ICC/IF experiment in human background.
NQO2 Antibody (YA2287) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2287), targeting NQO2, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). NQO2 Antibody (YA2287) can be used for WB, FC experiment in human, mouse, rat background.
TLE1 Antibody (YA2291) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2291), targeting TLE1, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). TLE1 Antibody (YA2291) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
alpha 1-adaptin Antibody (YA2295) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2295), targeting alpha 1-adaptin, with a predicted molecular weight of 108 kDa (observed band size: 108 kDa). alpha 1-adaptin Antibody (YA2295) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SMURF2 Antibody (YA2372) is a biotin-conjugated non-conjugated IgG antibody, targeting SMURF2, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). SMURF2 Antibody (YA2372) can be used for WB experiment in human, mouse, rat background.
TIMM50 Antibody (YA2390) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2390), targeting TIMM50, with a predicted molecular weight of 40 kDa (observed band size: 36 kDa). TIMM50 Antibody (YA2390) can be used for WB, IHC-P experiment in human, mouse background.
VPS41 Antibody (YA2409) is a biotin-conjugated non-conjugated IgG antibody, targeting VPS41, with a predicted molecular weight of 99 kDa (observed band size: 99 kDa). VPS41 Antibody (YA2409) can be used for WB experiment in human, mouse, rat background.
WAVE 1 Antibody (YA2416) is a biotin-conjugated non-conjugated IgG antibody, targeting WAVE 1, with a predicted molecular weight of 62 kDa (observed band size: 90 kDa). WAVE 1 Antibody (YA2416) can be used for WB experiment in human, mouse, rat background.
WDR1 Antibody (YA2417) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2417), targeting WDR1, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). WDR1 Antibody (YA2417) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Neuronatin Antibody (YA2435) is a biotin-conjugated non-conjugated IgG antibody, targeting Neuronatin, with a predicted molecular weight of 9 kDa (observed band size: 9 kDa). Neuronatin Antibody (YA2435) can be used for WB experiment in human, mouse background.
MAG Antibody (YA2458) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2458), targeting MAG, with a predicted molecular weight of 69 kDa (observed band size: 100 kDa). MAG Antibody (YA2458) can be used for WB, IP, FC experiment in human, mouse, rat background.
CRMP5 Antibody (YA2497) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2497), targeting CRMP5, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). CRMP5 Antibody (YA2497) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
CIP4 Antibody (YA2503) is a biotin-conjugated non-conjugated IgG antibody, targeting CIP4, with a predicted molecular weight of 68 kDa (observed band size: 80 kDa). CIP4 Antibody (YA2503) can be used for WB experiment in human, mouse, rat background.
WAS Antibody (YA2539) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2539), targeting WAS, with a predicted molecular weight of 53 kDa (observed band size: 60 kDa). WAS Antibody (YA2539) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
NOXA Antibody (YA2553) is a biotin-conjugated non-conjugated IgG antibody, targeting NOXA, with a predicted molecular weight of 6 kDa (observed band size: 10 kDa). NOXA Antibody (YA2553) can be used for WB experiment in human background.
VPS24 Antibody (YA2562) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2562), targeting VPS24, with a predicted molecular weight of 25 kDa (observed band size: 29 kDa). VPS24 Antibody (YA2562) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
CYB5R3 Antibody (YA2587) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2587), targeting CYB5R3, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). CYB5R3 Antibody (YA2587) can be used for WB, IHC-P experiment in human, rat background.
Cytochrome P450 Reductase Antibody (YA2619) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2619), targeting Cytochrome P450 Reductase, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). Cytochrome P450 Reductase Antibody (YA2619) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Hsp75 Antibody (YA2625) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2625), targeting Hsp75, with a predicted molecular weight of 80 kDa (observed band size: 75 kDa). Hsp75 Antibody (YA2625) can be used for WB, IHC-P, ICC/IF experiment in human background.
DDAH1 Antibody (YA2661) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2661), targeting DDAH1, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). DDAH1 Antibody (YA2661) can be used for WB, IP experiment in human background.
CPT2 Antibody (YA2715) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2715), targeting CPT2, with a predicted molecular weight of 74 kDa (observed band size: 74 kDa). CPT2 Antibody (YA2715) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
SAP97 Antibody (YA2731) is a biotin-conjugated non-conjugated IgG antibody, targeting SAP97, with a predicted molecular weight of 100 kDa (observed band size: 140 kDa). SAP97 Antibody (YA2731) can be used for WB experiment in human, mouse, rat background.
Cadherin 10 Antibody (YA2764) is a biotin-conjugated non-conjugated IgG antibody, targeting Cadherin 10, with a predicted molecular weight of 88 kDa (observed band size: 110 kDa). Cadherin 10 Antibody (YA2764) can be used for WB experiment in human, mouse, rat background.
ENO3 Antibody (YA2768) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2768), targeting ENO3, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). ENO3 Antibody (YA2768) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PAX2 Antibody (YA2818) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2818), targeting PAX2, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). PAX2 Antibody (YA2818) can be used for WB, IHC-P, FC experiment in human, mouse background.
CTBP2 Antibody (YA2835) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2835), targeting CTBP2, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). CTBP2 Antibody (YA2835) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Cytokeratin 9 Antibody (YA2851) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2851), targeting Cytokeratin 9, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). Cytokeratin 9 Antibody (YA2851) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
MYH7B Antibody (YA2857) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2857), targeting MYH7B, with a predicted molecular weight of 226 kDa (observed band size: 221 kDa). MYH7B Antibody (YA2857) can be used for WB, IHC-P experiment in human, mouse, rat background.
TNFRSF19 Antibody (YA2865) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2865), targeting TNFRSF19, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). TNFRSF19 Antibody (YA2865) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
Epoxide Hydrolase 1 Antibody (YA2895) is a biotin-conjugated non-conjugated IgG antibody, targeting Epoxide Hydrolase 1, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). Epoxide Hydrolase 1 Antibody (YA2895) can be used for WB experiment in human, mouse background.
GFPT2 Antibody (YA2914) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2914), targeting GFPT2, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). GFPT2 Antibody (YA2914) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
GRSF1 Antibody (YA2955) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2955), targeting GRSF1, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). GRSF1 Antibody (YA2955) can be used for WB, ICC/IF experiment in human background.
ATP4B Antibody (YA2972) is a biotin-conjugated non-conjugated IgG antibody, targeting ATP4B, with a predicted molecular weight of 33 kDa (observed band size: 55 kDa). ATP4B Antibody (YA2972) can be used for WB experiment in human background.
HADHA Antibody (YA2980) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2980), targeting HADHA, with a predicted molecular weight of 83 kDa (observed band size: 78 kDa). HADHA Antibody (YA2980) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
HKDC1 Antibody (YA2988) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2988), targeting HKDC1, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). HKDC1 Antibody (YA2988) can be used for WB, IP experiment in human background.
gamma Adaptin Antibody (YA2993) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2993), targeting gamma Adaptin, with a predicted molecular weight of 91 kDa (observed band size: 100 kDa). gamma Adaptin Antibody (YA2993) can be used for WB, IHC-P experiment in human, mouse, rat background.
HPRT Antibody (YA3000) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3000), targeting HPRT, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). HPRT Antibody (YA3000) can be used for WB, IP experiment in human, rat background.
Histone H2A Antibody (YA3008) is a biotin-conjugated non-conjugated IgG antibody, targeting Histone H2A, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). Histone H2A Antibody (YA3008) can be used for WB experiment in human, rat background.
IQGAP2 Antibody (YA3022) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3022), targeting IQGAP2, with a predicted molecular weight of 181 kDa (observed band size: 181 kDa). IQGAP2 Antibody (YA3022) can be used for WB, IHC-P experiment in human background.
HMBS Antibody (YA3061) is a biotin-conjugated non-conjugated IgG antibody, targeting HMBS, with a predicted molecular weight of 39 kDa (observed band size: 42 kDa). HMBS Antibody (YA3061) can be used for WB experiment in human, mouse, rat background.
NOP10 Antibody (YA3116) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3116), targeting NOP10, with a predicted molecular weight of 8 kDa (observed band size: 8 kDa). NOP10 Antibody (YA3116) can be used for WB, IHC-P experiment in human background.
OTX1 Antibody (YA3129) is a biotin-conjugated non-conjugated IgG antibody, targeting OTX1, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). OTX1 Antibody (YA3129) can be used for WB experiment in human, mouse, rat background.
KCTD9 Antibody (YA3138) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3138), targeting KCTD9, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). KCTD9 Antibody (YA3138) can be used for WB, ICC/IF experiment in human background.
PAX9 Antibody (YA3145) is a biotin-conjugated non-conjugated IgG antibody, targeting PAX9, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). PAX9 Antibody (YA3145) can be used for WB experiment in human, mouse, rat background.
Pleckstrin Antibody (YA3163) is a biotin-conjugated non-conjugated IgG antibody, targeting Pleckstrin, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). Pleckstrin Antibody (YA3163) can be used for WB experiment in human background.
Prohibitin Antibody (YA3183) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3183), targeting Prohibitin, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). Prohibitin Antibody (YA3183) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
SARA Antibody (YA3226) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3226), targeting SARA, with a predicted molecular weight of 156 kDa (observed band size: 156 kDa). SARA Antibody (YA3226) can be used for WB, IHC-P, IP experiment in human background.
MS2 Antibody (YA3247) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3247), targeting MS2, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). MS2 Antibody (YA3247) can be used for WB, IP experiment in human, mouse background.
Tissue Factor Pathway Inhibitor Antibody (YA3272) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3272), targeting Tissue Factor Pathway Inhibitor, with a predicted molecular weight of 35 kDa (observed band size: 40-55 kDa). Tissue Factor Pathway Inhibitor Antibody (YA3272) can be used for WB, IP experiment in human background.
MOG Antibody (YA3277) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3277), targeting MOG, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). MOG Antibody (YA3277) can be used for WB, ICC/IF experiment in rat background.
MYO1B Antibody (YA3284) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3284), targeting MYO1B, with a predicted molecular weight of 132 kDa (observed band size: 132 kDa). MYO1B Antibody (YA3284) can be used for WB, IHC-P experiment in human, mouse, rat background.
Reelin Antibody (YA3340) is a biotin-conjugated non-conjugated IgG antibody, targeting Reelin, with a predicted molecular weight of 388 kDa (observed band size: 388 kDa). Reelin Antibody (YA3340) can be used for WB experiment in human, rat background.
CHMP6 Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-CHMP6 polyclonal antibody. CHMP6 Antibody can be used for: WB,IHC-P expriments in Human, Mouse background without labeling.
PARP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to PARP. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
VEGF Receptor 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 152 kDa, targeting to VEGF Receptor 2. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Rat.
MMP9 Antibody (YA285) is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to MMP9. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Rat,Mouse.
Caspase recruitment domain-containing protein 9; hCARD9
WB
Human
CARD9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to CARD9. It can be used for WB assays with tag free, in the background of Human.
CD3G Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to CD3G. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
ERCC1 Antibody (YA770) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to ERCC1 (7F6). It can be used for WB assays with tag free, in the background of Human.
Ezrin Antibody (YA767) is a non-conjugated and Mouse origined monoclonal antibody about 69 kDa, targeting to Ezrin (2C12). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Fibronectin Antibody (YA762) is a non-conjugated and Mouse origined monoclonal antibody about 272 kDa, targeting to Fibronectin (1E2). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Glycogen Synthase 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Glycogen Synthase 1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
Phospho-ERK1/2 (Thr202/Thr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44,42 kDa, targeting to Phospho-ERK1/2 (Thr202/Thr185). It can be used for WB,IP assays with tag free, in the background of Human, Hamster, Rat.
Phospho-ERK1/2 (Tyr204/Tyr187) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42,44 kDa, targeting to Phospho-ERK1/2 (Tyr204/Tyr187). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
PRMT6 Antibody (YA685) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to PRMT6 (2C3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
SMYD1 Antibody (YA672) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to SMYD1 (2E11). It can be used for WB assays with tag free, in the background of Rat.
Annexin VI Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to Annexin A6 (ANXA6). It can be used for WB,IHC-P,IP assays in the background of Human, Mouse, Rat.
FACL4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to FACL4. It can be used for WB, IF-Cell, IHC-P, FC assays with tag free, in the background of Human, Mouse, Rat.
UHRF1 Antibody (YA1056) is a biotin-conjugated non-conjugated IgG2b antibody, targeting UHRF1, with a predicted molecular weight of 90 kDa (observed band size: 90 kDa). UHRF1 Antibody (YA1056) can be used for WB experiment in human, mouse background.
PRKCT; PRKCQ; nPKC-theta; Protein kinase C theta type
IHC-P
Human
PRKCQ Antibody (YA1106) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1106), targeting PRKCQ. PRKCQ Antibody (YA1106) can be used for IHC-P experiment in human background.
CRX Antibody (YA1184) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1184), targeting CRX. CRX Antibody (YA1184) can be used for IHC-P experiment in human background.
NFE2 Antibody (YA1209) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1209), targeting NFE2. NFE2 Antibody (YA1209) can be used for IHC-P experiment in human background.
TRP2 Antibody (YA1250) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1250), targeting TRP2. TRP2 Antibody (YA1250) can be used for IHC-P experiment in human background.
Alpha B Crystallin Antibody (YA1292) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1292), targeting Alpha B Crystallin, with a predicted molecular weight of 20 kDa (observed band size: 22 kDa). Alpha B Crystallin Antibody (YA1292) can be used for WB, IHC-P experiment in mouse, rat background.
ASGPR Antibody (YA1298) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1298), targeting ASGPR, with a predicted molecular weight of 33 kDa (observed band size: 40-50 kDa). ASGPR Antibody (YA1298) can be used for WB, IHC-P, ICC/IF, FC, IP experiment in human background.
BAFFR Antibody (YA1356) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1356), targeting BAFFR. BAFFR Antibody (YA1356) can be used for FC, ELISA experiment in human background.
NELFE Antibody (YA1365) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1365), targeting NELFE, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). NELFE Antibody (YA1365) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
TRIM56 Antibody (YA1384) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1384), targeting TRIM56, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). TRIM56 Antibody (YA1384) can be used for WB, ICC/IF experiment in human background.
NONO Antibody (YA1406) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1406), targeting NONO, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). NONO Antibody (YA1406) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
NTH1 Antibody (YA1435) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1435), targeting NTH1, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). NTH1 Antibody (YA1435) can be used for WB, ICC/IF experiment in human background.
GITR-L Antibody (YA1515) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1515), targeting GITR-L. GITR-L Antibody (YA1515) can be used for FC, ELISA experiment in human background.
PABPN1 Antibody (YA1521) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1521), targeting PABPN1, with a predicted molecular weight of 33 kDa (observed band size: 50 kDa). PABPN1 Antibody (YA1521) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
Sprouty 2 Antibody (YA1604) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1604), targeting Sprouty 2, with a predicted molecular weight of 35 kDa (observed band size: 42 kDa). Sprouty 2 Antibody (YA1604) can be used for WB, IHC-P, ICC/IF, IP experiment in human, rat background.
PHD3 Antibody (YA1612) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1612), targeting PHD3, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). PHD3 Antibody (YA1612) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
TAF3 Antibody (YA1621) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1621), targeting TAF3, with a predicted molecular weight of 104 kDa (observed band size: 140 kDa). TAF3 Antibody (YA1621) can be used for WB, IHC-P experiment in human background.
PIST Antibody (YA1647) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1647), targeting PIST, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). PIST Antibody (YA1647) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse background.
Cellular retinoic acid-binding protein II; CRABP-II
WB, ICC/IF
Human
CRABP2 Antibody (YA1652) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1652), targeting CRABP2, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). CRABP2 Antibody (YA1652) can be used for WB, ICC/IF experiment in human background.
TRMT2A Antibody (YA1663) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1663), targeting TRMT2A, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). TRMT2A Antibody (YA1663) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
POLD1 Antibody (YA1718) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1718), targeting POLD1, with a predicted molecular weight of 124 kDa (observed band size: 124 kDa). POLD1 Antibody (YA1718) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
BANF1 Antibody (YA1740) is a biotin-conjugated non-conjugated IgG antibody, targeting BANF1, with a predicted molecular weight of 10 kDa (observed band size: 10 kDa). BANF1 Antibody (YA1740) can be used for WB experiment in human background.
PSMB10 Antibody (YA1767) is a biotin-conjugated non-conjugated IgG antibody, targeting PSMB10, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). PSMB10 Antibody (YA1767) can be used for WB experiment in human, rat background.
CoREST Antibody (YA1813) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1813), targeting CoREST, with a predicted molecular weight of 53 kDa (observed band size: 66 kDa). CoREST Antibody (YA1813) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Annexin V Antibody (YA1829) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1829), targeting Annexin V, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Annexin V Antibody (YA1829) can be used for WB, ICC/IF experiment in human, mouse, rat background.
RNA Helicase A Antibody (YA1870) is a biotin-conjugated non-conjugated IgG antibody, targeting RNA Helicase A, with a predicted molecular weight of 141 kDa (observed band size: 141 kDa). RNA Helicase A Antibody (YA1870) can be used for WB experiment in rat background.
RRM1 Antibody (YA1883) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1883), targeting RRM1, with a predicted molecular weight of 90 kDa (observed band size: 90 kDa). RRM1 Antibody (YA1883) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Lipin 1 Antibody (YA1909) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1909), targeting Lipin 1, with a predicted molecular weight of 99 kDa (observed band size: 130 kDa). Lipin 1 Antibody (YA1909) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
ILF2 Antibody (YA1944) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1944), targeting ILF2, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). ILF2 Antibody (YA1944) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
CDX1 Antibody (YA1962) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1962), targeting CDX1, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). CDX1 Antibody (YA1962) can be used for WB, ICC/IF experiment in human background.
ACADM; Medium-chain specific acyl-CoA dehydrogenase; mitochondrial; MCAD
WB, ICC/IF
Human, Mouse, Rat
ACADM Antibody (YA1967) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1967), targeting ACADM, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). ACADM Antibody (YA1967) can be used for WB, ICC/IF experiment in human, mouse, rat background.
ACOX1 Antibody (YA1979) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1979), targeting ACOX1, with a predicted molecular weight of 75 kDa (observed band size: 74,48 kDa). ACOX1 Antibody (YA1979) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
ALDH1L1 Antibody (YA2031) is a biotin-conjugated non-conjugated IgG antibody, targeting ALDH1L1, with a predicted molecular weight of 99 kDa (observed band size: 99 kDa). ALDH1L1 Antibody (YA2031) can be used for WB experiment in mouse, rat background.
Monoamine Oxidase B Antibody (YA2039) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2039), targeting Monoamine Oxidase B, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Monoamine Oxidase B Antibody (YA2039) can be used for WB, IHC-P experiment in human background.
VAMP1 Antibody (YA2056) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2056), targeting VAMP1, with a predicted molecular weight of 13 kDa (observed band size: 16 kDa). VAMP1 Antibody (YA2056) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Alpha gal A; GALA; Galactosidase; alpha; GLA; Melibiase
WB, IHC-P, ICC/IF, IP, FC
Human
Galactosidase alpha Antibody (YA2078) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2078), targeting Galactosidase alpha, with a predicted molecular weight of 49 kDa (observed band size: 46 kDa). Galactosidase alpha Antibody (YA2078) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
MDH1 Antibody (YA2082) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2082), targeting MDH1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). MDH1 Antibody (YA2082) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
Syntaxin 16 Antibody (YA2119) is a biotin-conjugated non-conjugated IgG antibody, targeting Syntaxin 16, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). Syntaxin 16 Antibody (YA2119) can be used for WB experiment in human, mouse, rat background.
ODC1 Antibody (YA2123) is a biotin-conjugated non-conjugated IgG antibody, targeting ODC1, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). ODC1 Antibody (YA2123) can be used for WB experiment in human, mouse, rat background.
SAM68 Antibody (YA2136) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2136), targeting SAM68, with a predicted molecular weight of 48 kDa (observed band size: 68 kDa). SAM68 Antibody (YA2136) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Aprataxin Antibody (YA2138) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2138), targeting Aprataxin, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Aprataxin Antibody (YA2138) can be used for WB, ICC/IF experiment in human background.
c-Myb Antibody (YA2168) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2168), targeting c-Myb, with a predicted molecular weight of 72 kDa (observed band size: 78 kDa). c-Myb Antibody (YA2168) can be used for WB, IHC-P experiment in human background.
Rab27A Antibody (YA2206) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2206), targeting Rab27A, with a predicted molecular weight of 25 kDa (observed band size: 28 kDa). Rab27A Antibody (YA2206) can be used for WB, ICC/IF, IP, FC experiment in human background.
Transmembrane Protein 192 Antibody (YA2215) is a biotin-conjugated non-conjugated IgG antibody, targeting Transmembrane Protein 192, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). Transmembrane Protein 192 Antibody (YA2215) can be used for WB experiment in human background.
Emi1 Antibody (YA2233) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2233), targeting Emi1, with a predicted molecular weight of 50 kDa (observed band size: 56 kDa). Emi1 Antibody (YA2233) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Tensin 4 Antibody (YA2234) is a biotin-conjugated non-conjugated IgG antibody, targeting Tensin 4, with a predicted molecular weight of 77 kDa (observed band size: 90 kDa). Tensin 4 Antibody (YA2234) can be used for WB experiment in human, mouse, rat background.
TRIF Antibody (YA2263) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2263), targeting TRIF, with a predicted molecular weight of 76 kDa (observed band size: 98 kDa). TRIF Antibody (YA2263) can be used for WB, IP experiment in human, mouse, rat background.
beta IV Tubulin Antibody (YA2267) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2267), targeting beta IV Tubulin, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). beta IV Tubulin Antibody (YA2267) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
AA930854; TNFR1 associated DEATH domain protein; tradd
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
TRADD Antibody (YA2276) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2276), targeting TRADD, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). TRADD Antibody (YA2276) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Transcription Termination Factor 2 Antibody (YA2303) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2303), targeting Transcription Termination Factor 2, with a predicted molecular weight of 130 kDa (observed band size: 130 kDa). Transcription Termination Factor 2 Antibody (YA2303) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
C3orf38 Antibody (YA2319) is a biotin-conjugated non-conjugated IgG antibody, targeting C3orf38, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). C3orf38 Antibody (YA2319) can be used for WB experiment in human background.
Caldesmon Antibody (YA2332) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2332), targeting Caldesmon, with a predicted molecular weight of 93 kDa (observed band size: 70-80 kDa). Caldesmon Antibody (YA2332) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Oxytocin Receptor Antibody (YA2360) is a biotin-conjugated non-conjugated IgG antibody, targeting Oxytocin Receptor, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). Oxytocin Receptor Antibody (YA2360) can be used for WB experiment in human, mouse, rat background.
USP10 Antibody (YA2362) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2362), targeting USP10, with a predicted molecular weight of 87 kDa (observed band size: 110 kDa). USP10 Antibody (YA2362) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
MST1 Antibody (YA2368) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2368), targeting MST1, with a predicted molecular weight of 80 kDa (observed band size: 85 kDa). MST1 Antibody (YA2368) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
TRPM7 Antibody (YA2391) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2391), targeting TRPM7, with a predicted molecular weight of 213 kDa (observed band size: 213 kDa). TRPM7 Antibody (YA2391) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
CBX2 Antibody (YA2423) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2423), targeting CBX2, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). CBX2 Antibody (YA2423) can be used for WB, FC experiment in human, mouse, rat background.
Wnt2b Antibody (YA2424) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2424), targeting Wnt2b, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). Wnt2b Antibody (YA2424) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Dynamin 2 Antibody (YA2464) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2464), targeting Dynamin 2, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). Dynamin 2 Antibody (YA2464) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CBX4 Antibody (YA2490) is a biotin-conjugated non-conjugated IgG antibody, targeting CBX4, with a predicted molecular weight of 61 kDa (observed band size: 50 kDa). CBX4 Antibody (YA2490) can be used for WB experiment in human, mouse, rat background.
NAP1L1 Antibody (YA2492) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2492), targeting NAP1L1, with a predicted molecular weight of 45 kDa (observed band size: 52,60 kDa). NAP1L1 Antibody (YA2492) can be used for WB, FC experiment in human, mouse, rat background.
PIM1 Antibody (YA2502) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2502), targeting PIM1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). PIM1 Antibody (YA2502) can be used for WB, IHC-P experiment in human background.
RASGRP1 Antibody (YA2546) is a biotin-conjugated non-conjugated IgG antibody, targeting RASGRP1, with a predicted molecular weight of 90 kDa (observed band size: 90 kDa). RASGRP1 Antibody (YA2546) can be used for WB experiment in human background.
Cathepsin L/V/K/H Antibody (YA2547) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2547), targeting Cathepsin L/V/K/H, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). Cathepsin L/V/K/H Antibody (YA2547) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
BHMT Antibody (YA2549) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2549), targeting BHMT, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). BHMT Antibody (YA2549) can be used for WB, IHC-P, IP experiment in human background.
Cullin 5 Antibody (YA2585) is a biotin-conjugated non-conjugated IgG antibody, targeting Cullin 5, with a predicted molecular weight of 91 kDa (observed band size: 91 kDa). Cullin 5 Antibody (YA2585) can be used for WB experiment in human, mouse, rat background.
PUM2 Antibody (YA2586) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2586), targeting PUM2, with a predicted molecular weight of 114 kDa (observed band size: 114 kDa). PUM2 Antibody (YA2586) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
DAP1 Antibody (YA2641) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2641), targeting DAP1, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). DAP1 Antibody (YA2641) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
DAZAP1 Antibody (YA2646) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2646), targeting DAZAP1, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). DAZAP1 Antibody (YA2646) can be used for WB, IP experiment in human, mouse, rat background.
DDX21 Antibody (YA2663) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2663), targeting DDX21, with a predicted molecular weight of 87 kDa (observed band size: 87 kDa). DDX21 Antibody (YA2663) can be used for WB, ICC/IF experiment in human background.
WIF1 Antibody (YA2664) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2664), targeting WIF1, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). WIF1 Antibody (YA2664) can be used for WB, IP experiment in human, mouse, rat background.
FGF19 Antibody (YA2672) is a biotin-conjugated non-conjugated IgG antibody, targeting FGF19, with a predicted molecular weight of 24 kDa (observed band size: 36 kDa). FGF19 Antibody (YA2672) can be used for WB experiment in human background.
ACTR1B Antibody (YA2686) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2686), targeting ACTR1B, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). ACTR1B Antibody (YA2686) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Stanniocalcin 1 Antibody (YA2690) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2690), targeting Stanniocalcin 1, with a predicted molecular weight of 28 kDa (observed band size: 31-37 kDa). Stanniocalcin 1 Antibody (YA2690) can be used for WB, IP experiment in human background.
BarX1 Antibody (YA2735) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2735), targeting BarX1, with a predicted molecular weight of 27 kDa (observed band size: 32 kDa). BarX1 Antibody (YA2735) can be used for WB, IP experiment in human, rat, hamster background.
BGAT Antibody (YA2741) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2741), targeting BGAT, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). BGAT Antibody (YA2741) can be used for WB, IP experiment in human, mouse, rat background.
CD229 Antibody (YA2779) is a biotin-conjugated non-conjugated IgG antibody, targeting CD229, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). CD229 Antibody (YA2779) can be used for WB experiment in human background.
CLIP170 Antibody (YA2810) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2810), targeting CLIP170, with a predicted molecular weight of 162 kDa (observed band size: 170 kDa). CLIP170 Antibody (YA2810) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
ARF5 Antibody (YA2836) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2836), targeting ARF5, with a predicted molecular weight of 21 kDa (observed band size: 18 kDa). ARF5 Antibody (YA2836) can be used for WB, FC experiment in human, mouse, rat background.
Activin binding protein; Follistatin; FS; fst; Human follistatin gene
WB
Rat
Follistatin Antibody (YA2847) is a biotin-conjugated non-conjugated IgG antibody, targeting Follistatin, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). Follistatin Antibody (YA2847) can be used for WB experiment in rat background.
beta Glucuronidase Antibody (YA2853) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2853), targeting beta Glucuronidase, with a predicted molecular weight of 75 kDa (observed band size: 78 kDa). beta Glucuronidase Antibody (YA2853) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Tat SF1 Antibody (YA2886) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2886), targeting Tat SF1, with a predicted molecular weight of 86 kDa (observed band size: 140 kDa). Tat SF1 Antibody (YA2886) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse background.
C10orf63 Antibody (YA2894) is a biotin-conjugated non-conjugated IgG antibody, targeting C10orf63, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). C10orf63 Antibody (YA2894) can be used for WB experiment in human, mouse background.
GALT Antibody (YA2925) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2925), targeting GALT, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). GALT Antibody (YA2925) can be used for WB, IP experiment in human, mouse, rat background.
GlyT2 Antibody (YA2936) is a biotin-conjugated non-conjugated IgG antibody, targeting GlyT2, with a predicted molecular weight of 87 kDa (observed band size: 87 kDa). GlyT2 Antibody (YA2936) can be used for WB experiment in human, rat background.
GSK3 alpha Antibody (YA2971) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2971), targeting GSK3 alpha, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). GSK3 alpha Antibody (YA2971) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Dysferlin Antibody (YA3036) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3036), targeting Dysferlin, with a predicted molecular weight of 237 kDa (observed band size: 280 kDa). Dysferlin Antibody (YA3036) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
HPDL Antibody (YA3042) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3042), targeting HPDL, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). HPDL Antibody (YA3042) can be used for WB, IP experiment in human background.
RALBP1 Antibody (YA3053) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3053), targeting RALBP1, with a predicted molecular weight of 76 kDa (observed band size: 95 kDa). RALBP1 Antibody (YA3053) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
GARS Antibody (YA3054) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3054), targeting GARS, with a predicted molecular weight of 83 kDa (observed band size: 75 kDa). GARS Antibody (YA3054) can be used for WB, IHC-P experiment in human, mouse, rat background.
Meckelin Antibody (YA3057) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3057), targeting Meckelin, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). Meckelin Antibody (YA3057) can be used for WB, ICC/IF experiment in human background.
HuC/HuD Antibody (YA3060) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3060), targeting HuC/HuD, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). HuC/HuD Antibody (YA3060) can be used for WB, IP experiment in rat background.
MRAS Antibody (YA3080) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3080), targeting MRAS, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). MRAS Antibody (YA3080) can be used for WB, IP experiment in human, mouse, rat background.
Integrin beta 5 Antibody (YA3108) is a biotin-conjugated non-conjugated IgG antibody, targeting Integrin beta 5, with a predicted molecular weight of 88 kDa (observed band size: 88 kDa). Integrin beta 5 Antibody (YA3108) can be used for WB experiment in human, hamster, rat background.
PMF 1 Antibody (YA3165) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3165), targeting PMF 1, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). PMF 1 Antibody (YA3165) can be used for WB, IP experiment in human, mouse, rat background.
LIS1 Antibody (YA3173) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3173), targeting LIS1, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). LIS1 Antibody (YA3173) can be used for WB, IP experiment in hamster, rat background.
FTCD Antibody (YA3213) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3213), targeting FTCD, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). FTCD Antibody (YA3213) can be used for WB, IHC-P, FC experiment in human background.
RPS20 Antibody (YA3219) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3219), targeting RPS20, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). RPS20 Antibody (YA3219) can be used for WB, IHC-P experiment in human, mouse, rat, hamster background.
MKLP1 Antibody (YA3233) is a biotin-conjugated non-conjugated IgG antibody, targeting MKLP1, with a predicted molecular weight of 110 kDa (observed band size: 110 kDa). MKLP1 Antibody (YA3233) can be used for WB experiment in human background.
TERF1 Antibody (YA3239) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3239), targeting TERF1, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). TERF1 Antibody (YA3239) can be used for WB, ICC/IF experiment in human, mouse background.
MRPS31 Antibody (YA3246) is a biotin-conjugated non-conjugated IgG antibody, targeting MRPS31, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). MRPS31 Antibody (YA3246) can be used for WB experiment in rat background.
MS4A14 Antibody (YA3249) is a biotin-conjugated non-conjugated IgG antibody, targeting MS4A14, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). MS4A14 Antibody (YA3249) can be used for WB experiment in human, rat background.
SV40 T Antigen Antibody (YA3256) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3256), targeting SV40 T Antigen, with a predicted molecular weight of 82 kDa (observed band size: 90 kDa). SV40 T Antigen Antibody (YA3256) can be used for WB, ICC/IF, IP experiment in species independent background.
GBA Antibody (YA3257) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3257), targeting GBA, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). GBA Antibody (YA3257) can be used for WB, IHC-P experiment in human, rat background.
MYO19 Antibody (YA3282) is a biotin-conjugated non-conjugated IgG antibody, targeting MYO19, with a predicted molecular weight of 109 kDa (observed band size: 109 kDa). MYO19 Antibody (YA3282) can be used for WB experiment in human, mouse background.
VPS35 Antibody (YA3314) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3314), targeting VPS35, with a predicted molecular weight of 92 kDa (observed band size: 81 kDa). VPS35 Antibody (YA3314) can be used for WB, IHC-P experiment in human, mouse, rat background.
Adenosine A1 Receptor Antibody (YA3341) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3341), targeting Adenosine A1 Receptor, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). Adenosine A1 Receptor Antibody (YA3341) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
BRCC36 Antibody (YA2298) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2298), targeting BRCC36, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). BRCC36 Antibody (YA2298) can be used for WB, IP experiment in human, mouse, rat background.
FLJ14301; OODD; Protein Wnt-10a ; SSPS; STHAG4; Wingless type MMTV integration site family member 10A Antibody; WN10A_HUMAN; wnt10a;
WB, ICC/IF, IHC-P
Human, Mouse
Wnt10a Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Wnt10a, with a predicted molecular weight of 46 kDa. Wnt10a Antibody can be used for WB, ICC/IF, IHC-P experiments in human, mouse backgrounds.
Acetyl-p53 (Lys370) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Acetyl-p53 (Lys370). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
ATF6 Antibody (YA604) is a non-conjugated and Rabbit origined monoclonal antibody about 75 kDa, targeting to ATF6. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
ATG3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to ATG3. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
CAP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to CAP2. It can be used for WB,IP assays with tag free, in the background of Human.
Caspase 11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Caspase 11. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
CDK9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to CDK9. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Cyclin B1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Cyclin B1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Cyclin E1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 47 kDa, targeting to Cyclin E1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Cyclin H Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Cyclin H. It can be used for WB assays with tag free, in the background of Human.
Dual specificity protein phosphatase VHR; VHR; Vaccinia H1-related phosphatase
WB, IHC-F, IHC-P, ICC/IF, FC, IP
Human, Mouse, Rat
DUSP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 20 kDa, targeting to DUSP3. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
HDAC2 Antibody (YA742) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to HDAC2 (2D9). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Monkey.
RUNX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to RUNX. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
STAT4; Signal transducer and activator of transcription 4
WB, IHC-P, IP
Human
STAT4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 86 kDa, targeting to STAT4. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
TRIM21 Antibody (YA658) is a non-conjugated and Mouse origined monoclonal antibody about 54 kDa, targeting to TRIM21 (5B9). It can be used for WB assays with tag free, in the background of Human.
TCTP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to TCTP. It can be used for WB,ICC/IF,IP assays in the background of Human, Mouse, Rat.
FCGR1A Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-FCGR1A monoclonal antibody. FCGR1A Antibody can be used for: WB, IHC-P, FC expriments in human background without labeling.
DM1 Antibody (YA898) is an unconjugated, mouse-derived, anti-DM1 (YA898) monoclonal antibody. DM1 Antibody (YA898) can be used for: ELISA expriments without labeling.
IL-19 Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting IL-19, with a predicted molecular weight of 20 kDa. IL-19 Antibody can be used for WB, IHC-P experiment in human background.
Phospho-Rb2 p130 (Ser952) Antibody (YA1034) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1034), targeting Phospho-Rb2 p130 (Ser952), with a predicted molecular weight of 128 kDa (observed band size: 128 kDa). Phospho-Rb2 p130 (Ser952) Antibody (YA1034) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Phospho-Rb2 p130 (Thr986) Antibody (YA1035) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1035), targeting Phospho-Rb2 p130 (Thr986), with a predicted molecular weight of 128 kDa (observed band size: 128 kDa). Phospho-Rb2 p130 (Thr986) Antibody (YA1035) can be used for WB, IP experiment in human background.
GTF2H1 Antibody (YA1067) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1067), targeting GTF2H1, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). GTF2H1 Antibody (YA1067) can be used for WB, ICC/IF, IP experiment in human background.
4E BP3 Antibody (YA1080) is a biotin-conjugated non-conjugated IgG1 antibody, targeting 4E BP3, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). 4E BP3 Antibody (YA1080) can be used for WB experiment in human, mouse, rat background.
CD79B Antibody (YA1128) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1128), targeting CD79B. CD79B Antibody (YA1128) can be used for IHC-P experiment in human background.
Glycophorin C Antibody (YA1156) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1156), targeting Glycophorin C. Glycophorin C Antibody (YA1156) can be used for IHC-P experiment in human background.
BANK1; B-cell scaffold protein with ankyrin repeats
IHC-P
Human
BANK1 Antibody (YA1179) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1179), targeting BANK1. BANK1 Antibody (YA1179) can be used for IHC-P experiment in human background.
Desmoglein 3 Antibody (YA1215) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1215), targeting Desmoglein 3. Desmoglein 3 Antibody (YA1215) can be used for IHC-P experiment in human background.
FOXP1 Antibody (YA1283) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1283), targeting FOXP1. FOXP1 Antibody (YA1283) can be used for IHC-P experiment in human background.
NEK7 Antibody (YA1360) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1360), targeting NEK7, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). NEK7 Antibody (YA1360) can be used for WB, IP experiment in mouse, rat background.
neurogranin (protein kinase C substrate; RC3); RC3; hng
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Neurogranin Antibody (YA1383) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1383), targeting Neurogranin, with a predicted molecular weight of 8 kDa (observed band size: 14-16 kDa). Neurogranin Antibody (YA1383) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
PGC1 beta Antibody (YA1411) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1411), targeting PGC1 beta, with a predicted molecular weight of 113 kDa (observed band size: 113 kDa). PGC1 beta Antibody (YA1411) can be used for WB, IP experiment in human, mouse, rat background.
TARBP2 Antibody (YA1433) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1433), targeting TARBP2, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). TARBP2 Antibody (YA1433) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
ORP1 Antibody (YA1477) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1477), targeting ORP1, with a predicted molecular weight of 108 kDa (observed band size: 109,50 kDa). ORP1 Antibody (YA1477) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
ORP150 Antibody (YA1478) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1478), targeting ORP150, with a predicted molecular weight of 111 kDa (observed band size: 150 kDa). ORP150 Antibody (YA1478) can be used for WB, IHC-P experiment in human, mouse, rat background.
CD138 Antibody (YA1490) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA1490), targeting CD138. CD138 Antibody (YA1490) can be used for WB,IHC-P,ICC/IF,FC,ELISA experiment in human background.
CS1 Antibody (YA1492) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1492), targeting CS1. CS1 Antibody (YA1492) can be used for FC, ELISA experiment in human background.
PAIP1 Antibody (YA1528) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1528), targeting PAIP1, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). PAIP1 Antibody (YA1528) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
PCPTP1 Antibody (YA1549) is a biotin-conjugated non-conjugated IgG antibody, targeting PCPTP1, with a predicted molecular weight of 74 kDa (observed band size: 74 kDa). PCPTP1 Antibody (YA1549) can be used for WB experiment in rat background.
PDZK1 Antibody (YA1571) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1571), targeting PDZK1, with a predicted molecular weight of 57 kDa (observed band size: 70 kDa). PDZK1 Antibody (YA1571) can be used for WB, IP experiment in human background.
MC4R Antibody (YA1645) is a biotin-conjugated non-conjugated IgG antibody, targeting MC4R, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). MC4R Antibody (YA1645) can be used for WB experiment in human, mouse, rat background.
Rad50 Antibody (YA1681) is a biotin-conjugated non-conjugated IgG antibody, targeting Rad50, with a predicted molecular weight of 154 kDa (observed band size: 154 kDa). Rad50 Antibody (YA1681) can be used for WB experiment in human background.
PPP2R5E Antibody (YA1708) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1708), targeting PPP2R5E, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). PPP2R5E Antibody (YA1708) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
SLP2 Antibody (YA1720) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1720), targeting SLP2, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). SLP2 Antibody (YA1720) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
PSME1 Antibody (YA1766) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1766), targeting PSME1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). PSME1 Antibody (YA1766) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
ATAD2 Antibody (YA1794) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1794), targeting ATAD2, with a predicted molecular weight of 159 kDa (observed band size: 180 kDa). ATAD2 Antibody (YA1794) can be used for WB, ICC/IF, FC experiment in human background.
Transferrin Receptor 2 Antibody (YA1845) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1845), targeting Transferrin Receptor 2, with a predicted molecular weight of 89 kDa (observed band size: 100 kDa). Transferrin Receptor 2 Antibody (YA1845) can be used for WB, IHC-P experiment in human background.
Intra Acrosomal Protein Antibody (YA1856) is a biotin-conjugated non-conjugated IgG antibody, targeting Intra Acrosomal Protein, with a predicted molecular weight of 28 kDa (observed band size: 14-36 kDa). Intra Acrosomal Protein Antibody (YA1856) can be used for WB experiment in human background.
Retinoic Acid Receptor gamma Antibody (YA1860) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1860), targeting Retinoic Acid Receptor gamma, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Retinoic Acid Receptor gamma Antibody (YA1860) can be used for WB, ICC/IF experiment in human, rat background.
C4 Binding Protein Antibody (YA1873) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1873), targeting C4 Binding Protein, with a predicted molecular weight of 28 kDa (observed band size: 45 kDa). C4 Binding Protein Antibody (YA1873) can be used for WB, IHC-P, ICC/IF, IP experiment in human, rat background.
KA1 Antibody (YA1879) is a biotin-conjugated non-conjugated IgG antibody, targeting KA1, with a predicted molecular weight of 107 kDa (observed band size: 107 kDa). KA1 Antibody (YA1879) can be used for WB experiment in human, mouse, rat background.
NEK2 Antibody (YA1910) is a biotin-conjugated non-conjugated IgG antibody, targeting NEK2, with a predicted molecular weight of 52 kDa (observed band size: 48/44 kDa). NEK2 Antibody (YA1910) can be used for WB experiment in human background.
Nucleostemin Antibody (YA1918) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1918), targeting Nucleostemin, with a predicted molecular weight of 62 kDa (observed band size: 65 kDa). Nucleostemin Antibody (YA1918) can be used for WB, ICC/IF, FC experiment in human background.
IRF9 Antibody (YA1923) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1923), targeting IRF9, with a predicted molecular weight of 44 kDa (observed band size: 48 kDa). IRF9 Antibody (YA1923) can be used for WB, ICC/IF, FC experiment in human background.
DPD Antibody (YA2000) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2000), targeting DPD, with a predicted molecular weight of 111 kDa (observed band size: 111 kDa). DPD Antibody (YA2000) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
NDUFS4 Antibody (YA2072) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2072), targeting NDUFS4, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). NDUFS4 Antibody (YA2072) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
ALS2CR8 Antibody (YA2075) is a biotin-conjugated non-conjugated IgG antibody, targeting ALS2CR8, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). ALS2CR8 Antibody (YA2075) can be used for WB experiment in human background.
STK33 Antibody (YA2085) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2085), targeting STK33, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). STK33 Antibody (YA2085) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Striatin 4 Antibody (YA2088) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2088), targeting Striatin 4, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). Striatin 4 Antibody (YA2088) can be used for WB, ICC/IF, IP experiment in human background.
TAF1C Antibody (YA2139) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2139), targeting TAF1C, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). TAF1C Antibody (YA2139) can be used for WB, IP experiment in human background.
PLEKHA1 Antibody (YA2145) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2145), targeting PLEKHA1, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). PLEKHA1 Antibody (YA2145) can be used for WB, IP experiment in human background.
ARFGEF2 Antibody (YA2146) is a biotin-conjugated non-conjugated IgG antibody, targeting ARFGEF2, with a predicted molecular weight of 202 kDa (observed band size: 202 kDa). ARFGEF2 Antibody (YA2146) can be used for WB experiment in human, mouse, rat background.
ARHGAP25 Antibody (YA2149) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2149), targeting ARHGAP25, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). ARHGAP25 Antibody (YA2149) can be used for WB, IHC-P experiment in human, rat background.
Aconitase 2 Antibody (YA2151) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2151), targeting Aconitase 2, with a predicted molecular weight of 85 kDa (observed band size: 85 kDa). Aconitase 2 Antibody (YA2151) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
ARPC2 Antibody (YA2152) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2152), targeting ARPC2, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). ARPC2 Antibody (YA2152) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
TCEA1 Antibody (YA2158) is a biotin-conjugated non-conjugated IgG antibody, targeting TCEA1, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). TCEA1 Antibody (YA2158) can be used for WB experiment in human, mouse, rat, monkey background.
CENPC Antibody (YA2227) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2227), targeting CENPC, with a predicted molecular weight of 107 kDa (observed band size: 107 kDa). CENPC Antibody (YA2227) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Max Dimerization Protein 3 Antibody (YA2229) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2229), targeting Max Dimerization Protein 3, with a predicted molecular weight of 23 kDa (observed band size: 28 kDa). Max Dimerization Protein 3 Antibody (YA2229) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
TPP1 Antibody (YA2244) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2244), targeting TPP1, with a predicted molecular weight of 61 kDa (observed band size: 61/48 kDa). TPP1 Antibody (YA2244) can be used for WB, IHC-P experiment in human background.
Epac2 Antibody (YA2323) is a biotin-conjugated non-conjugated IgG antibody, targeting Epac2, with a predicted molecular weight of 116 kDa (observed band size: 116 kDa). Epac2 Antibody (YA2323) can be used for WB experiment in human, mouse, rat background.
Activin Receptor Type IIB Antibody (YA2345) is a biotin-conjugated non-conjugated IgG antibody, targeting Activin Receptor Type IIB, with a predicted molecular weight of 58 kDa (observed band size: 65 kDa). Activin Receptor Type IIB Antibody (YA2345) can be used for WB experiment in human, mouse, rat background.
Transmembrane Protease Serine 2 Antibody (YA2356) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2356), targeting Transmembrane Protease Serine 2, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Transmembrane Protease Serine 2 Antibody (YA2356) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Vitronectin Antibody (YA2402) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2402), targeting Vitronectin, with a predicted molecular weight of 54 kDa (observed band size: 70 kDa). Vitronectin Antibody (YA2402) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
RORB Antibody (YA2407) is a biotin-conjugated non-conjugated IgG antibody, targeting RORB, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). RORB Antibody (YA2407) can be used for WB experiment in human, mouse background.
Cystathionase Antibody (YA2452) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2452), targeting Cystathionase, with a predicted molecular weight of 45 kDa (observed band size: 42 kDa). Cystathionase Antibody (YA2452) can be used for WB, IP experiment in human background.
Tight Junction Protein ZO 3 Antibody (YA2456) is a biotin-conjugated non-conjugated IgG antibody, targeting Tight Junction Protein ZO 3, with a predicted molecular weight of 101 kDa (observed band size: 140 kDa). Tight Junction Protein ZO 3 Antibody (YA2456) can be used for WB experiment in human, rat background.
CDT2 Antibody (YA2474) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2474), targeting CDT2, with a predicted molecular weight of 79 kDa (observed band size: 79 kDa). CDT2 Antibody (YA2474) can be used for WB, IHC-P experiment in human background.
hnRNP A1 Antibody (YA2484) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2484), targeting hnRNP A1, with a predicted molecular weight of 39 kDa (observed band size: 33 kDa). hnRNP A1 Antibody (YA2484) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CLPTM1 Antibody (YA2521) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2521), targeting CLPTM1, with a predicted molecular weight of 76 kDa (observed band size: 90 kDa). CLPTM1 Antibody (YA2521) can be used for WB, IP experiment in human background.
CPSF6 Antibody (YA2554) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2554), targeting CPSF6, with a predicted molecular weight of 59 kDa (observed band size: 70 kDa). CPSF6 Antibody (YA2554) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Phospho-Hormone Sensitive Lipase (Ser855) Antibody (YA2599) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Hormone Sensitive Lipase (Ser855), with a predicted molecular weight of 117 kDa (observed band size: 83 kDa). Phospho-Hormone Sensitive Lipase (Ser855) Antibody (YA2599) can be used for WB experiment in human background.
CYFIP1 Antibody (YA2605) is a biotin-conjugated non-conjugated IgG antibody, targeting CYFIP1, with a predicted molecular weight of 145 kDa (observed band size: 145 kDa). CYFIP1 Antibody (YA2605) can be used for WB experiment in human, mouse, rat background.
Cytochrome C Oxidase subunit Vic Antibody (YA2611) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2611), targeting Cytochrome C Oxidase subunit Vic, with a predicted molecular weight of 9 kDa (observed band size: 12 kDa). Cytochrome C Oxidase subunit Vic Antibody (YA2611) can be used for WB, IHC-P experiment in human, mouse, rat background.
FLAP Antibody (YA2703) is a biotin-conjugated non-conjugated IgG antibody, targeting FLAP, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). FLAP Antibody (YA2703) can be used for WB experiment in human background.
Tropomodulin 2 Antibody (YA2771) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2771), targeting Tropomodulin 2, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). Tropomodulin 2 Antibody (YA2771) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
HIRA Antibody (YA2782) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2782), targeting HIRA, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). HIRA Antibody (YA2782) can be used for WB, ICC/IF, IP, FC experiment in human background.
ESE1 Antibody (YA2784) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2784), targeting ESE1, with a predicted molecular weight of 41 kDa (observed band size: 47 kDa). ESE1 Antibody (YA2784) can be used for WB, FC experiment in human, mouse, rat background.
eIF3E Antibody (YA2826) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2826), targeting eIF3E, with a predicted molecular weight of 52 kDa (observed band size: 45 kDa). eIF3E Antibody (YA2826) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Phospholipase A2 Activator Protein Antibody (YA2834) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2834), targeting Phospholipase A2 Activator Protein, with a predicted molecular weight of 87 kDa (observed band size: 75 kDa). Phospholipase A2 Activator Protein Antibody (YA2834) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
HDAC11 Antibody (YA2884) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2884), targeting HDAC11, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). HDAC11 Antibody (YA2884) can be used for WB, IP experiment in human background.
Arginase 2 Antibody (YA2893) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2893), targeting Arginase 2, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). Arginase 2 Antibody (YA2893) can be used for WB, ICC/IF, FC experiment in human background.
Glycerol Kinase Antibody (YA2899) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2899), targeting Glycerol Kinase, with a predicted molecular weight of 61 kDa (observed band size: 50 kDa). Glycerol Kinase Antibody (YA2899) can be used for WB, IP, FC experiment in human, mouse, rat background.
ETV6 Antibody (YA2916) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2916), targeting ETV6, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). ETV6 Antibody (YA2916) can be used for WB, ICC/IF, FC experiment in human background.
Torsin 1A Antibody (YA2935) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2935), targeting Torsin 1A, with a predicted molecular weight of 38 kDa (observed band size: 35 kDa). Torsin 1A Antibody (YA2935) can be used for WB, FC experiment in human background.
GOLGA1 Antibody (YA2948) is a biotin-conjugated non-conjugated IgG antibody, targeting GOLGA1, with a predicted molecular weight of 88 kDa (observed band size: 88 kDa). GOLGA1 Antibody (YA2948) can be used for WB experiment in human background.
LMO4 Antibody (YA2953) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2953), targeting LMO4, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). LMO4 Antibody (YA2953) can be used for WB, IP experiment in human, mouse background.
Nucleoporin p62 Antibody (YA2997) is a biotin-conjugated non-conjugated IgG antibody, targeting Nucleoporin p62, with a predicted molecular weight of 53 kDa (observed band size: 70 kDa). Nucleoporin p62 Antibody (YA2997) can be used for WB experiment in human background.
Renilla Luciferase Antibody (YA3013) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3013), targeting Renilla Luciferase, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Renilla Luciferase Antibody (YA3013) can be used for WB, ICC/IF experiment in renilla reniformis background.
KAT7 Antibody (YA3027) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3027), targeting KAT7, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). KAT7 Antibody (YA3027) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
MTAP Antibody (YA3085) is a biotin-conjugated non-conjugated IgG antibody, targeting MTAP, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). MTAP Antibody (YA3085) can be used for WB experiment in human, mouse background.
NSDHL Antibody (YA3120) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3120), targeting NSDHL, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). NSDHL Antibody (YA3120) can be used for WB, IP experiment in human background.
KIF5B Antibody (YA3141) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3141), targeting KIF5B, with a predicted molecular weight of 110 kDa (observed band size: 110 kDa). KIF5B Antibody (YA3141) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
killin; p53-regulated DNA replication inhibitor; CWS4; KILLIN
WB
Human, Mouse, Rat
Killin Antibody (YA3144) is a biotin-conjugated non-conjugated IgG antibody, targeting Killin, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Killin Antibody (YA3144) can be used for WB experiment in human, mouse, rat background.
lox; LYOX; Lysyl oxidase; Protein lysine 6 oxidase
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
LOX Antibody (YA3153) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3153), targeting LOX, with a predicted molecular weight of 47 kDa. LOX Antibody (YA3153) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
PRKCQ; PRKCT; Protein kinase C theta type; nPKC-theta
WB
Human, Rat
PKC theta Antibody (YA3162) is a biotin-conjugated non-conjugated IgG antibody, targeting PKC theta, with a predicted molecular weight of 82 kDa (observed band size: 79 kDa). PKC theta Antibody (YA3162) can be used for WB experiment in human, rat background.
PNKP Antibody (YA3167) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3167), targeting PNKP, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). PNKP Antibody (YA3167) can be used for WB, IHC-P, IP experiment in human background.
MAS1L Antibody (YA3198) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3198), targeting MAS1L, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). MAS1L Antibody (YA3198) can be used for WB, IP experiment in human, mouse, rat background.
MDH2 Antibody (YA3207) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3207), targeting MDH2, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). MDH2 Antibody (YA3207) can be used for WB, IHC-P experiment in human, rat background.
MEF2A Antibody (YA3209) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3209), targeting MEF2A, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). MEF2A Antibody (YA3209) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Mint3 Antibody (YA3242) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3242), targeting Mint3, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). Mint3 Antibody (YA3242) can be used for WB, ICC/IF experiment in human, mouse background.
Myelin membrane encephalitogenic protein; Myelin A1 protein
WB
Human, Rat
Myelin Basic Protein Antibody (YA3271) is a biotin-conjugated non-conjugated IgG antibody, targeting Myelin Basic Protein, with a predicted molecular weight of 33 kDa (observed band size: 18 kDa). Myelin Basic Protein Antibody (YA3271) can be used for WB experiment in human, rat background.
CREB Regulated Transcription Coactivator 2 Antibody (YA3279) is a biotin-conjugated non-conjugated IgG antibody, targeting CREB Regulated Transcription Coactivator 2, with a predicted molecular weight of 73 kDa (observed band size: 80 kDa). CREB Regulated Transcription Coactivator 2 Antibody (YA3279) can be used for WB experiment in human background.
ADAM10 Antibody (YA3292) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3292), targeting ADAM10, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). ADAM10 Antibody (YA3292) can be used for WB, IP experiment in human, mouse, rat background.
VAV2 Antibody (YA3312) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3312), targeting VAV2, with a predicted molecular weight of 101 kDa (observed band size: 101 kDa). VAV2 Antibody (YA3312) can be used for WB, ICC/IF, IP experiment in human background.
CDc2 related protein kinase; CDC28; CDC2A; CDk 2; CDK1; CDK2; CDK2_HUMAN ; CDKN2; MPF; p33(CDK2) Antibody
WB, ICC/IF, IHC-P, IP, FC
Human, Mouse, Rat
Cdk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse,Rat.
Antigen identified by monoclonal Antibody Ki 67; Antigen KI67; KIA; Ki67; MKI67; Proliferation related Ki 67 antigen; Antigen KI-67; KI67_MOUSE.
IHC-P, IHC-F, ICC/IF
Human
Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: IHC-P, IHC-F, ICC, IF expriments in human background without labeling.
Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187) Antibody (YA455) is a non-conjugated and Rabbit origined monoclonal antibody about 41/43 kDa, targeting to Erk1 (pT202/pY204) + Erk2 (pT185/pY187). It can be used for WB,IP,IHC-P assays with tag free, in the background of Human.
AKT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
ATG7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to ATG7. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
BDNF Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 28 kDa, targeting to BDNF. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
DDB1 Antibody (YA785) is a non-conjugated and Mouse origined monoclonal antibody about 127 kDa, targeting to DDB1 (2D6). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
gamma Catenin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to gamma Catenin. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
Glutamine Synthetase Antibody (YA405) is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to Glutamine Synthetase. It can be used for WB assays with tag free, in the background of Mouse, Rat.
MMP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,IP assays with tag free, in the background of Human.
SOD2 Antibody (YA670) is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to SOD2 (4C4). It can be used for WB assays with tag free, in the background of Human.
VEGFA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to VEGFA. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Apotransferrin; beta 1 metal binding globulin; serotransferrin; TF
WB, IHC-P, ICC/IF
Human
Transferrin Antibody (YA840) is a non-conjugated and Mouse origined monoclonal antibody about 77 kDa. It can be used for WB,IHC-P,ICC/IF assays in the background of Human.
S1PR4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to S1PR4. It can be used for WB, IHC-P assays with tag free, in the background of Rat.
DLAT Antibody (YA912) is an unconjugated, approximately 69 kDa, mouse-derived, anti-DLAT (YA912) monoclonal antibody. DLAT Antibody (YA912) can be used for: WB, ICC/IF, IP expriments in human, mouse background without labeling.
ATG10 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to ATG10. It can be used for WB,IHC assays with tag free, in the background of Human and mouse.
FYB Antibody (YA973) is a biotin-conjugated non-conjugated IgG1 antibody, targeting FYB, with a predicted molecular weight of 85 kDa (observed band size: 120 kDa). FYB Antibody (YA973) can be used for WB experiment in human background.
FYB Antibody (YA974) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA974), targeting FYB, with a predicted molecular weight of 85 kDa (observed band size: 120 kDa). FYB Antibody (YA974) can be used for WB, IHC-P, ICC/IF experiment in mouse, human background.
Natriuretic Peptides B Antibody (YA999) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA999), targeting Natriuretic Peptides B. Natriuretic Peptides B Antibody (YA999) can be used for ELISA experiment in human background.
Natriuretic Peptides B Antibody (YA1000) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1000), targeting Natriuretic Peptides B. Natriuretic Peptides B Antibody (YA1000) can be used for ELISA experiment in human background.
Natriuretic Peptides B Antibody (YA1001) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1001), targeting Natriuretic Peptides B. Natriuretic Peptides B Antibody (YA1001) can be used for ELISA experiment in human background.
MAGEA3 Antibody (YA1109) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1109), targeting MAGEA3. MAGEA3 Antibody (YA1109) can be used for IHC-P experiment in human background.
Galectin 9 Antibody (YA1127) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1127), targeting Galectin 9. Galectin 9 Antibody (YA1127) can be used for IHC-P experiment in human background.
GCET2 Antibody (YA1132) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1132), targeting GCET2. GCET2 Antibody (YA1132) can be used for IHC-P experiment in human background.
MCM5 Antibody (YA1140) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1140), targeting MCM5. MCM5 Antibody (YA1140) can be used for IHC-P experiment in human background.
Claudin 8 Antibody (YA1169) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1169), targeting Claudin 8. Claudin 8 Antibody (YA1169) can be used for IHC-P experiment in human background.
SPINK1 Antibody (YA1204) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1204), targeting SPINK1. SPINK1 Antibody (YA1204) can be used for IHC-P experiment in human background.
DPEP3 Antibody (YA1235) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1235), targeting DPEP3. DPEP3 Antibody (YA1235) can be used for IHC-P experiment in human background.
TRBC1 Antibody (YA1238) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1238), targeting TRBC1. TRBC1 Antibody (YA1238) can be used for IHC-P experiment in human background.
Uroplakin II/UPII Antibody (YA1259) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1259), targeting Uroplakin II/UPII. Uroplakin II/UPII Antibody (YA1259) can be used for IHC-P experiment in human background.
GABA A Receptor alpha 1 Antibody (YA1315) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1315), targeting GABA A Receptor alpha 1, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). GABA A Receptor alpha 1 Antibody (YA1315) can be used for WB, IHC-P experiment in mouse, rat background.
RNF8 Antibody (YA1344) is a biotin-conjugated non-conjugated IgG antibody, targeting RNF8, with a predicted molecular weight of 56 kDa (observed band size: 60 kDa). RNF8 Antibody (YA1344) can be used for WB experiment in human, rat background.
NDUFS6 Antibody (YA1347) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1347), targeting NDUFS6, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). NDUFS6 Antibody (YA1347) can be used for WB, IP experiment in human, mouse, rat, hamster background.
NOLC1 Antibody (YA1416) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1416), targeting NOLC1, with a predicted molecular weight of 74 kDa (observed band size: 110 kDa). NOLC1 Antibody (YA1416) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
MEF2C Antibody (YA1438) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1438), targeting MEF2C, with a predicted molecular weight of 51 kDa (observed band size: 50-60 kDa). MEF2C Antibody (YA1438) can be used for WB, IHC-P experiment in human, rat background.
NUP107 Antibody (YA1460) is a biotin-conjugated non-conjugated IgG antibody, targeting NUP107, with a predicted molecular weight of 106 kDa (observed band size: 106 kDa). NUP107 Antibody (YA1460) can be used for WB experiment in human, rat background.
HLA DRB1 Antibody (YA1487) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1487), targeting HLA DRB1, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). HLA DRB1 Antibody (YA1487) can be used for WB, IHC-P, ICC/IF experiment in human background.
p60 Katanin Antibody (YA1511) is a biotin-conjugated non-conjugated IgG antibody, targeting p60 Katanin, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). p60 Katanin Antibody (YA1511) can be used for WB experiment in human background.
Versican Core Protein Antibody (YA1534) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1534), targeting Versican Core Protein, with a predicted molecular weight of 373 kDa (observed band size: 373 kDa). Versican Core Protein Antibody (YA1534) can be used for WB, IHC-P experiment in human, mouse, rat background.
BUB1 Antibody (YA1567) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1567), targeting BUB1, with a predicted molecular weight of 122 kDa (observed band size: 122 kDa). BUB1 Antibody (YA1567) can be used for WB, IHC-P experiment in human, mouse, rat background.
UFM1 Antibody (YA1577) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1577), targeting UFM1, with a predicted molecular weight of 9 kDa (observed band size: 9 kDa). UFM1 Antibody (YA1577) can be used for WB, IHC-P, IP experiment in human, mouse background.
CD52 Antibody (YA1581) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1581), targeting CD52, with a predicted molecular weight of 8 kDa (observed band size: 8 kDa). CD52 Antibody (YA1581) can be used for WB, IP experiment in mouse background.
Midkine Antibody (YA1582) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1582), targeting Midkine, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). Midkine Antibody (YA1582) can be used for WB, IP experiment in human background.
Angiopoietin 1 Antibody (YA1592) is a biotin-conjugated non-conjugated IgG antibody, targeting Angiopoietin 1, with a predicted molecular weight of 58 kDa (observed band size: 75 kDa). Angiopoietin 1 Antibody (YA1592) can be used for WB experiment in human, rat background.
ALP; hALP; N acetyltransferase like protein; NAT10; NET43
WB, ICC/IF, IP
Human, Rat
NAT10 Antibody (YA1595) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1595), targeting NAT10, with a predicted molecular weight of 116 kDa (observed band size: 116 kDa). NAT10 Antibody (YA1595) can be used for WB, ICC/IF, IP experiment in human, rat background.
PMP70 Antibody (YA1628) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1628), targeting PMP70, with a predicted molecular weight of 75 kDa (observed band size: 70 kDa). PMP70 Antibody (YA1628) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
ATOH1 Antibody (YA1637) is a biotin-conjugated non-conjugated IgG antibody, targeting ATOH1, with a predicted molecular weight of 38 kDa. ATOH1 Antibody (YA1637) can be used for WB experiment in human, mouse, rat background.
PIP5K1C Antibody (YA1644) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1644), targeting PIP5K1C, with a predicted molecular weight of 72 kDa (observed band size: 90,87 kDa). PIP5K1C Antibody (YA1644) can be used for WB, IP experiment in human, mouse background.
DARC Antibody (YA1654) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1654), targeting DARC, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). DARC Antibody (YA1654) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse background.
PLSCR3 Antibody (YA1672) is a biotin-conjugated non-conjugated IgG antibody, targeting PLSCR3, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). PLSCR3 Antibody (YA1672) can be used for WB experiment in human, mouse, rat background.
SynGAP Antibody (YA1689) is a biotin-conjugated non-conjugated IgG antibody, targeting SynGAP, with a predicted molecular weight of 148 kDa (observed band size: 148 kDa). SynGAP Antibody (YA1689) can be used for WB experiment in rat background.
Prostatic Acid Phosphatase Antibody (YA1706) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1706), targeting Prostatic Acid Phosphatase, with a predicted molecular weight of 45 kDa (observed band size: 50 kDa). Prostatic Acid Phosphatase Antibody (YA1706) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
Phospho-PRC1 (Thr481) Antibody (YA1713) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1713), targeting Phospho-PRC1 (Thr481), with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). Phospho-PRC1 (Thr481) Antibody (YA1713) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Prostaglandin D Synthase Antibody (YA1739) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1739), targeting Prostaglandin D Synthase, with a predicted molecular weight of 21 kDa (observed band size: 26 kDa). Prostaglandin D Synthase Antibody (YA1739) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
LRG1 Antibody (YA1787) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1787), targeting LRG1, with a predicted molecular weight of 38 kDa (observed band size: 45 kDa). LRG1 Antibody (YA1787) can be used for WB, IHC-P, IP experiment in human background.
Profilin 1 Antibody (YA1796) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1796), targeting Profilin 1, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). Profilin 1 Antibody (YA1796) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
RYBP Antibody (YA1797) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1797), targeting RYBP, with a predicted molecular weight of 25 kDa (observed band size: 32 kDa). RYBP Antibody (YA1797) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Dnmt3b Antibody (YA1806) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1806), targeting Dnmt3b, with a predicted molecular weight of 96 kDa (observed band size: 97 kDa). Dnmt3b Antibody (YA1806) can be used for WB, ICC/IF experiment in human, mouse, rat background.
TrpC1 Antibody (YA1814) is a biotin-conjugated non-conjugated IgG antibody, targeting TrpC1, with a predicted molecular weight of 91 kDa (observed band size: 120 kDa). TrpC1 Antibody (YA1814) can be used for WB experiment in human, mouse, rat background.
GTPase NRAS Antibody (YA1830) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1830), targeting GTPase NRAS, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). GTPase NRAS Antibody (YA1830) can be used for WB, IP experiment in human, mouse, rat background.
GTPase HRAS Antibody (YA1833) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1833), targeting GTPase HRAS, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). GTPase HRAS Antibody (YA1833) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
GSK3 alpha/beta Antibody (YA1862) is a biotin-conjugated non-conjugated IgG antibody, targeting GSK3 alpha/beta, with a predicted molecular weight of 51 kDa (observed band size: 51,47 kDa). GSK3 alpha/beta Antibody (YA1862) can be used for WB experiment in human, rat, hamster background.
HIF1AN Antibody (YA1907) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1907), targeting HIF1AN, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). HIF1AN Antibody (YA1907) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
5 Lipoxygenase Antibody (YA1937) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1937), targeting 5 Lipoxygenase, with a predicted molecular weight of 78 kDa (observed band size: 78 kDa). 5 Lipoxygenase Antibody (YA1937) can be used for WB, IHC-F, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
GDF3 Antibody (YA1965) is a biotin-conjugated non-conjugated IgG antibody, targeting GDF3, with a predicted molecular weight of 41 kDa (observed band size: 16,41 kDa). GDF3 Antibody (YA1965) can be used for WB experiment in human, mouse, rat background.
SMG1 Antibody (YA1987) is a biotin-conjugated non-conjugated IgG antibody, targeting SMG1, with a predicted molecular weight of 411 kDa (observed band size: 411 kDa). SMG1 Antibody (YA1987) can be used for WB experiment in human, mouse, rat background.
SMARCA5 Antibody (YA2013) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2013), targeting SMARCA5, with a predicted molecular weight of 122 kDa (observed band size: 122 kDa). SMARCA5 Antibody (YA2013) can be used for WB, ICC/IF experiment in human, mouse, rat background.
AGXT Antibody (YA2020) is a biotin-conjugated non-conjugated IgG antibody, targeting AGXT, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). AGXT Antibody (YA2020) can be used for WB experiment in mouse, rat background.
MAGE1 Antibody (YA2051) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2051), targeting MAGE1, with a predicted molecular weight of 34 kDa (observed band size: 46 kDa). MAGE1 Antibody (YA2051) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Frizzled 8 Antibody (YA2052) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2052), targeting Frizzled 8, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). Frizzled 8 Antibody (YA2052) can be used for WB, IHC-P experiment in human, mouse, rat background.
Fibrinogen alpha Chain Antibody (YA2069) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2069), targeting Fibrinogen alpha Chain, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). Fibrinogen alpha Chain Antibody (YA2069) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
KARS Antibody (YA2076) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2076), targeting KARS, with a predicted molecular weight of 68 kDa (observed band size: 73 kDa). KARS Antibody (YA2076) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
IMPDH2 Antibody (YA2091) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2091), targeting IMPDH2, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). IMPDH2 Antibody (YA2091) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Syntaxin 3 Antibody (YA2102) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2102), targeting Syntaxin 3, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Syntaxin 3 Antibody (YA2102) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Pulmonary Surfactant Associated Protein D Antibody (YA2107) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2107), targeting Pulmonary Surfactant Associated Protein D, with a predicted molecular weight of 38 kDa (observed band size: 43 kDa). Pulmonary Surfactant Associated Protein D Antibody (YA2107) can be used for WB, IHC-P experiment in rat background.
T Box Transcription Factor T Antibody (YA2144) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2144), targeting T Box Transcription Factor T, with a predicted molecular weight of 47 kDa (observed band size: 47,41 kDa). T Box Transcription Factor T Antibody (YA2144) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in mouse, rat, human background.
SERCA1 ATPase Antibody (YA2157) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2157), targeting SERCA1 ATPase, with a predicted molecular weight of 110 kDa (observed band size: 100 kDa). SERCA1 ATPase Antibody (YA2157) can be used for WB, IHC-P, IP experiment in human background.
ATE1 Antibody (YA2178) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2178), targeting ATE1, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). ATE1 Antibody (YA2178) can be used for WB, IHC-P experiment in human, rat background.
GSTK1 Antibody (YA2188) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2188), targeting GSTK1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). GSTK1 Antibody (YA2188) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
Thioredoxin 2 Antibody (YA2192) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2192), targeting Thioredoxin 2, with a predicted molecular weight of 18 kDa (observed band size: 13 kDa). Thioredoxin 2 Antibody (YA2192) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Transmembrane Protein 43 Antibody (YA2223) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2223), targeting Transmembrane Protein 43, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Transmembrane Protein 43 Antibody (YA2223) can be used for WB, IHC-P experiment in human, rat background.
CT A Antibody (YA2232) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2232), targeting CT A, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). CT A Antibody (YA2232) can be used for WB, ICC/IF, IP, FC experiment in human background.
Topoisomerase I Antibody (YA2237) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2237), targeting Topoisomerase I, with a predicted molecular weight of 91 kDa (observed band size: 91 kDa). Topoisomerase I Antibody (YA2237) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
APRIL Antibody (YA2258) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2258), targeting APRIL, with a predicted molecular weight of 27 kDa (observed band size: 35 kDa). APRIL Antibody (YA2258) can be used for WB, ICC/IF experiment in human, mouse, rat background.
BTF3 Antibody (YA2305) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2305), targeting BTF3, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). BTF3 Antibody (YA2305) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
RNase L Antibody (YA2314) is a biotin-conjugated non-conjugated IgG antibody, targeting RNase L, with a predicted molecular weight of 84 kDa (observed band size: 80 kDa). RNase L Antibody (YA2314) can be used for WB experiment in human background.
Thioredoxin Reductase 1 Antibody (YA2315) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2315), targeting Thioredoxin Reductase 1, with a predicted molecular weight of 71 kDa (observed band size: 55 kDa). Thioredoxin Reductase 1 Antibody (YA2315) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
NCX1 Antibody (YA2331) is a biotin-conjugated non-conjugated IgG antibody, targeting NCX1, with a predicted molecular weight of 109 kDa (observed band size: 109 kDa). NCX1 Antibody (YA2331) can be used for WB experiment in human, mouse, rat background.
UCHL5 Antibody (YA2339) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2339), targeting UCHL5, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). UCHL5 Antibody (YA2339) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
RING1 Antibody (YA2351) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2351), targeting RING1, with a predicted molecular weight of 42 kDa (observed band size: 50 kDa). RING1 Antibody (YA2351) can be used for WB, IHC-P, ICC/IF experiment in human background.
KLC1 Antibody (YA2363) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2363), targeting KLC1, with a predicted molecular weight of 65 kDa (observed band size: 65 kDa). KLC1 Antibody (YA2363) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
MRC2 Antibody (YA2364) is a biotin-conjugated non-conjugated IgG antibody, targeting MRC2, with a predicted molecular weight of 167 kDa (observed band size: 190 kDa). MRC2 Antibody (YA2364) can be used for WB experiment in human background.
Desmoplakin Antibody (YA2379) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2379), targeting Desmoplakin, with a predicted molecular weight of 332 kDa (observed band size: 270 kDa). Desmoplakin Antibody (YA2379) can be used for WB, ICC/IF, FC experiment in human, rat background.
BPR Antibody (YA2393) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2393), targeting BPR, with a predicted molecular weight of 37 kDa (observed band size: 32 kDa). BPR Antibody (YA2393) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
Leukotriene A4 Hydrolase Antibody (YA2400) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2400), targeting Leukotriene A4 Hydrolase, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). Leukotriene A4 Hydrolase Antibody (YA2400) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SLC22A1 Antibody (YA2426) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2426), targeting SLC22A1, with a predicted molecular weight of 61 kDa (observed band size: 72 kDa). SLC22A1 Antibody (YA2426) can be used for WB, FC experiment in human background.
CD55 Antibody (YA2440) is a biotin-conjugated non-conjugated IgG antibody, targeting CD55, with a predicted molecular weight of 41 kDa (observed band size: 78 kDa). CD55 Antibody (YA2440) can be used for WB experiment in human background.
PAR2 Antibody (YA2455) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2455), targeting PAR2, with a predicted molecular weight of 44 kDa (observed band size: 55 kDa). PAR2 Antibody (YA2455) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Legumain Antibody (YA2469) is a biotin-conjugated non-conjugated IgG antibody, targeting Legumain, with a predicted molecular weight of 49 kDa (observed band size: 36,57 kDa). Legumain Antibody (YA2469) can be used for WB experiment in human, mouse, rat background.
Carboxypeptidase A1/A2/B Antibody (YA2486) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2486), targeting Carboxypeptidase A1/A2/B, with a predicted molecular weight of 47 kDa (observed band size: 44 kDa). Carboxypeptidase A1/A2/B Antibody (YA2486) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
GDNF Antibody (YA2491) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2491), targeting GDNF, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). GDNF Antibody (YA2491) can be used for WB, FC experiment in human, mouse, rat background.
ETS1 Antibody (YA2494) is a biotin-conjugated non-conjugated IgG antibody, targeting ETS1, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). ETS1 Antibody (YA2494) can be used for WB experiment in human, mouse background.
alpha A Crystallin Antibody (YA2495) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2495), targeting alpha A Crystallin, with a predicted molecular weight of 20 kDa (observed band size: 17 kDa). alpha A Crystallin Antibody (YA2495) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Collagen VI alpha 1 Antibody (YA2533) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2533), targeting Collagen VI alpha 1, with a predicted molecular weight of 109 kDa (observed band size: 147 kDa). Collagen VI alpha 1 Antibody (YA2533) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
NUP62CL Antibody (YA2544) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2544), targeting NUP62CL, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). NUP62CL Antibody (YA2544) can be used for WB, IP experiment in human background.
Phospho-CDK1/2 (Thr14) Antibody (YA2572) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2572), targeting Phospho-CDK1/2 (Thr14), with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). Phospho-CDK1/2 (Thr14) Antibody (YA2572) can be used for WB, IHC-P, IP experiment in human background.
Cullin 3 Antibody (YA2578) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2578), targeting Cullin 3, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). Cullin 3 Antibody (YA2578) can be used for WB, IP experiment in human, mouse, rat background.
Cyclin E2 Antibody (YA2594) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2594), targeting Cyclin E2, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). Cyclin E2 Antibody (YA2594) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
MBNL1 Antibody (YA2601) is a biotin-conjugated non-conjugated IgG antibody, targeting MBNL1, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). MBNL1 Antibody (YA2601) can be used for WB experiment in human, mouse background.
Muscarinic Acetylcholine Receptor M2 Antibody (YA2610) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2610), targeting Muscarinic Acetylcholine Receptor M2, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Muscarinic Acetylcholine Receptor M2 Antibody (YA2610) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
CARD11 Antibody (YA2615) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2615), targeting CARD11, with a predicted molecular weight of 133 kDa (observed band size: 133 kDa). CARD11 Antibody (YA2615) can be used for WB, ICC/IF experiment in human, mouse background.
NR2E1 Antibody (YA2648) is a biotin-conjugated non-conjugated IgG antibody, targeting NR2E1, with a predicted molecular weight of 43 kDa (observed band size: 48 kDa). NR2E1 Antibody (YA2648) can be used for WB experiment in human, mouse, rat background.
FHIT Antibody (YA2677) is a biotin-conjugated non-conjugated IgG antibody, targeting FHIT, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). FHIT Antibody (YA2677) can be used for WB experiment in human, rat background.
FOXF1 Antibody (YA2681) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2681), targeting FOXF1, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). FOXF1 Antibody (YA2681) can be used for WB, ICC/IF, FC experiment in human background.
Kallikrein 2 Antibody (YA2729) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2729), targeting Kallikrein 2, with a predicted molecular weight of 29 kDa (observed band size: 33 kDa). Kallikrein 2 Antibody (YA2729) can be used for WB, ICC/IF experiment in human, mouse, rat background.
SESN1 Antibody (YA2739) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2739), targeting SESN1, with a predicted molecular weight of 57 kDa (observed band size: 70 kDa). SESN1 Antibody (YA2739) can be used for WB, FC experiment in human, mouse, rat background.
Cystatin A Antibody (YA2760) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2760), targeting Cystatin A, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). Cystatin A Antibody (YA2760) can be used for WB, FC experiment in human, mouse, rat background.
CCL21 Antibody (YA2775) is a biotin-conjugated non-conjugated IgG antibody, targeting CCL21, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). CCL21 Antibody (YA2775) can be used for WB experiment in human background.
NAIP Antibody (YA2792) is a biotin-conjugated non-conjugated IgG antibody, targeting NAIP, with a predicted molecular weight of 160 kDa (observed band size: 160 kDa). NAIP Antibody (YA2792) can be used for WB experiment in human background.
Somatostatin Receptor 5 Antibody (YA2800) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2800), targeting Somatostatin Receptor 5, with a predicted molecular weight of 39 kDa (observed band size: 42 kDa). Somatostatin Receptor 5 Antibody (YA2800) can be used for WB, FC experiment in human, mouse, rat background.
CLPX Antibody (YA2814) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2814), targeting CLPX, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). CLPX Antibody (YA2814) can be used for WB, ICC/IF experiment in human, mouse, rat, hamster background.
RACGAP1 Antibody (YA2881) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2881), targeting RACGAP1, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). RACGAP1 Antibody (YA2881) can be used for WB, IHC-P, ICC/IF experiment in human background.
HOXA5 Antibody (YA2907) is a biotin-conjugated non-conjugated IgG antibody, targeting HOXA5, with a predicted molecular weight of 29 kDa (observed band size: 43 kDa). HOXA5 Antibody (YA2907) can be used for WB experiment in human, mouse, rat background.
HOXA9 Antibody (YA2909) is a biotin-conjugated non-conjugated IgG antibody, targeting HOXA9, with a predicted molecular weight of 30 kDa (observed band size: 35 kDa). HOXA9 Antibody (YA2909) can be used for WB experiment in human background.
WDR4 Antibody (YA2924) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2924), targeting WDR4, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). WDR4 Antibody (YA2924) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
PRSS2 Antibody (YA2931) is a biotin-conjugated non-conjugated IgG antibody, targeting PRSS2, with a predicted molecular weight of 26 kDa (observed band size: 30 kDa). PRSS2 Antibody (YA2931) can be used for WB experiment in human, mouse, rat background.
BPIFF; HDLCQ10; CETP; Lipid transfer protein I; Cholesteryl ester transfer protein
WB, IP
Human
CETP Antibody (YA2981) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2981), targeting CETP, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). CETP Antibody (YA2981) can be used for WB, IP experiment in human background.
EG VEGF Antibody (YA2991) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2991), targeting EG VEGF, with a predicted molecular weight of 12 kDa (observed band size: 12 kDa). EG VEGF Antibody (YA2991) can be used for WB, FC experiment in human, mouse background.
HMG4 Antibody (YA2992) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2992), targeting HMG4, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). HMG4 Antibody (YA2992) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
MPP1 Antibody (YA3077) is a biotin-conjugated non-conjugated IgG antibody, targeting MPP1, with a predicted molecular weight of 52 kDa (observed band size: 55 kDa). MPP1 Antibody (YA3077) can be used for WB experiment in human background.
IRF1 Antibody (YA3118) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3118), targeting IRF1, with a predicted molecular weight of 37 kDa (observed band size: 48 kDa). IRF1 Antibody (YA3118) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
IRF2 Antibody (YA3130) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3130), targeting IRF2, with a predicted molecular weight of 39 kDa (observed band size: 50 kDa). IRF2 Antibody (YA3130) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
NCF4 Antibody (YA3139) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3139), targeting NCF4, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). NCF4 Antibody (YA3139) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
LYVE1 Antibody (YA3148) is a biotin-conjugated non-conjugated IgG antibody, targeting LYVE1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). LYVE1 Antibody (YA3148) can be used for WB experiment in human, mouse, rat background.
POLG Antibody (YA3170) is a biotin-conjugated non-conjugated IgG antibody, targeting POLG, with a predicted molecular weight of 140 kDa (observed band size: 140 kDa). POLG Antibody (YA3170) can be used for WB experiment in human background.
MAD2L2 Antibody (YA3190) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3190), targeting MAD2L2, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). MAD2L2 Antibody (YA3190) can be used for WB, ICC/IF, IP experiment in human background.
MetRS Antibody (YA3196) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3196), targeting MetRS, with a predicted molecular weight of 101 kDa (observed band size: 101 kDa). MetRS Antibody (YA3196) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
MAT1A Antibody (YA3199) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3199), targeting MAT1A, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). MAT1A Antibody (YA3199) can be used for WB, IP experiment in human, mouse, rat background.
NG2 Antibody (YA3221) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3221), targeting NG2, with a predicted molecular weight of 251 kDa (observed band size: 251 kDa). NG2 Antibody (YA3221) can be used for WB, IHC-P, FC experiment in human background.
uPA Antibody (YA3248) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3248), targeting uPA, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). uPA Antibody (YA3248) can be used for WB, IHC-P experiment in human, mouse, rat background.
Thrombospondin 1 Antibody (YA3275) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3275), targeting Thrombospondin 1, with a predicted molecular weight of 129 kDa (observed band size: 170 kDa). Thrombospondin 1 Antibody (YA3275) can be used for WB, IHC-P, IP experiment in human, mouse background.
USF1 Antibody (YA3309) is a biotin-conjugated non-conjugated IgG antibody, targeting USF1, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). USF1 Antibody (YA3309) can be used for WB experiment in human, mouse background.
PHD1 Antibody (YA3325) is a biotin-conjugated non-conjugated IgG antibody, targeting PHD1, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). PHD1 Antibody (YA3325) can be used for WB experiment in human, rat background.
CLGN; MEG 1 antigen; Calnexin-T; Calmegin precursor; Calmegin
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Calmegin Antibody (YA2296) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2296), targeting Calmegin, with a predicted molecular weight of 70 kDa (observed band size: 100 kDa). Calmegin Antibody (YA2296) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
BSA Antibodyis a non-conjugated and mouse origined monoclonal antibody about 66 kDa, targeting to BSA. It can be used for WB,ELISA assays with tag free, in the background of Cow.
NME4 Antibody(YA3454) is a mouse-derived non-conjugated IgG antibody, targeting NME4, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). NME3 Antibody (YA3454) can be used for WB, IHC-P experiment in human background.
IL-6 Antibody (YA724) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB, IF-Cell assays with tag free, in the background of Rat, Mouse.
Cyclin H Antibody (YA788) is a non-conjugated and Mouse origined monoclonal antibody about 38 kDa, targeting to Cyclin H (1A7). It can be used for WB assays with tag free, in the background of Human, Mouse.
ENO1 Antibody (YA773) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to ENO1 (3F7). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
FOXP3; IPEX; JM2; Forkhead box protein P3; Scurfin
WB, ICC/IF
Human, Mouse, Rat
FOXP3 Antibody (YA759) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to FOXP3. It can be used for WB,ICC/IF assays with tag free, in the background of Transfected.
Glucose 6 Phosphate Dehydrogenase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Glucose 6 Phosphate Dehydrogenase. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.
PPP4C Antibody (YA687) is a non-conjugated and Mouse origined monoclonal antibody about 35 kDa, targeting to PPP4C (2F11). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
TGF alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to TGF alpha. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Ubiquitin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to Ubiquitin. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
FOXP3; IPEX; JM2; Forkhead box protein P3; Scurfin
WB, IHC-P
Human
Anti-FOXP3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to FOXP3. It can be used for WB, IHC-P assays with tag free, in the background of Human.
MMAE Antibody (YA899) is an unconjugated, rabbit-derived, anti-MMAE (YA899) monoclonal antibody. MMAE Antibody (YA899) can be used for: ELISA expriments without labeling.
EPX Antibody is an unconjugated, approximately 79 kDa, rabbit-derived, anti-EPX polyclonal antibody. EPX Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
LPP; Lipoma-preferred partner; LIM domain-containing preferred translocation partner in lipoma
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat, Monkey, Hamster
LPP Antibody (YA993) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA993), targeting LPP, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). LPP Antibody (YA993) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat, monkey, hamster background.
LPP; Lipoma-preferred partner; LIM domain-containing preferred translocation partner in lipoma
WB, IHC-P, ICC/IF
Human, Mouse, Rat
LPP Antibody (YA994) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA994), targeting LPP, with a predicted molecular weight of 66 kDa (observed band size: 70 kDa). LPP Antibody (YA994) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
CKM; CKMM; Creatine kinase M-type; Creatine kinase M chain; M-CK
ELISA
Human
CKM Antibody (YA1061) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1061), targeting CKM. CKM Antibody (YA1061) can be used for ELISA experiment in human background.
RUNX3 Antibody (YA1141) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1141), targeting RUNX3. RUNX3 Antibody (YA1141) can be used for IHC-P experiment in human background.
CENPF; Centromere protein F; CENP-F; AH antigen; Kinetochore protein CENPF; Mitosin
IHC-P
Human
CENPF Antibody (YA1161) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1161), targeting CENPF. CENPF Antibody (YA1161) can be used for IHC-P experiment in human background.
HMGA1 Antibody (YA1185) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1185), targeting HMGA1. HMGA1 Antibody (YA1185) can be used for IHC-P experiment in human background.
IGJ; Immunoglobulin J Chain; IGJ; Joining chain of multimeric IgA and IgM
IHC-P
Human
IGJ Antibody (YA1218) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1218), targeting IGJ. IGJ Antibody (YA1218) can be used for IHC-P experiment in human background.
P cadherin Antibody (YA1234) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1234), targeting P cadherin. P cadherin Antibody (YA1234) can be used for IHC-P experiment in human background.
Ataxin 3 Antibody (YA1294) is a biotin-conjugated non-conjugated IgG antibody, targeting Ataxin 3. Ataxin 3 Antibody (YA1294) can be used for IHC-P experiment in human, mouse, rat background.
CD23 Antibody (YA1296) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1296), targeting CD23. CD23 Antibody (YA1296) can be used for IHC-P, ICC/IF, FC experiment in human background.
Keratin 15 Antibody (YA1310) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1310), targeting Keratin 15, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Keratin 15 Antibody (YA1310) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
KMT5A Antibody (YA1376) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1376), targeting KMT5A, with a predicted molecular weight of 43 kDa (observed band size: 50 kDa). KMT5A Antibody (YA1376) can be used for WB, FC experiment in human, mouse, rat background.
CD30 Antibody (YA1390) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1390), targeting CD30, with a predicted molecular weight of 64 kDa (observed band size: 120 kDa). CD30 Antibody (YA1390) can be used for WB, IHC-P experiment in human background.
NRG3 Antibody (YA1432) is a biotin-conjugated non-conjugated IgG antibody, targeting NRG3, with a predicted molecular weight of 78 kDa (observed band size: 55 kDa). NRG3 Antibody (YA1432) can be used for WB experiment in human, rat background.
Cadherin 16 Antibody (YA1476) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1476), targeting Cadherin 16, with a predicted molecular weight of 90 kDa (observed band size: 120 kDa). Cadherin 16 Antibody (YA1476) can be used for WB, IHC-P, IP experiment in human, mouse background.
4-1BB Antibody (YA1506) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1506), targeting 4-1BB. 4-1BB Antibody (YA1506) can be used for FC, ELISA experiment in human background.
P-Cadherin Antibody (YA1535) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1535), targeting P-Cadherin, with a predicted molecular weight of 97 kDa (observed band size: 130-150 kDa). P-Cadherin Antibody (YA1535) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
DNA Nucleotidylexotransferase Antibody (YA1555) is a biotin-conjugated non-conjugated IgG antibody, targeting DNA Nucleotidylexotransferase, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). DNA Nucleotidylexotransferase Antibody (YA1555) can be used for WB experiment in human background.
KDM5A Antibody (YA1564) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1564), targeting KDM5A, with a predicted molecular weight of 192 kDa (observed band size: 192 kDa). KDM5A Antibody (YA1564) can be used for WB, ICC/IF, IP, FC experiment in human, mouse background.
Matrin 3 Antibody (YA1573) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1573), targeting Matrin 3, with a predicted molecular weight of 95 kDa (observed band size: 125 kDa). Matrin 3 Antibody (YA1573) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
PGM1 Antibody (YA1603) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1603), targeting PGM1, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). PGM1 Antibody (YA1603) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Netrin 1 Antibody (YA1642) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1642), targeting Netrin 1, with a predicted molecular weight of 68 kDa (observed band size: 75 kDa). Netrin 1 Antibody (YA1642) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PON2 Antibody (YA1688) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1688), targeting PON2, with a predicted molecular weight of 39 kDa (observed band size: 40-42 kDa). PON2 Antibody (YA1688) can be used for WB, IHC-P, IP experiment in human background.
PPP2R5D Antibody (YA1705) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1705), targeting PPP2R5D, with a predicted molecular weight of 70 kDa (observed band size: 70,66 kDa). PPP2R5D Antibody (YA1705) can be used for WB, IP experiment in human, mouse, rat background.
PREB Antibody (YA1729) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1729), targeting PREB, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). PREB Antibody (YA1729) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
RPS19 Antibody (YA1752) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1752), targeting RPS19, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). RPS19 Antibody (YA1752) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
EB3 Antibody (YA1775) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1775), targeting EB3, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). EB3 Antibody (YA1775) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Rab9 Antibody (YA1800) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1800), targeting Rab9, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Rab9 Antibody (YA1800) can be used for WB, IHC-P experiment in human, mouse background.
RAP1 Antibody (YA1824) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1824), targeting RAP1, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). RAP1 Antibody (YA1824) can be used for WB, IP experiment in human, mouse, rat background.
Rab25 Antibody (YA1881) is a biotin-conjugated non-conjugated IgG antibody, targeting Rab25, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Rab25 Antibody (YA1881) can be used for WB experiment in human background.
RRP4 Antibody (YA1886) is a biotin-conjugated non-conjugated IgG antibody, targeting RRP4, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). RRP4 Antibody (YA1886) can be used for WB experiment in human, mouse, rat background.
Zinc finger protein 797; Zinc finger protein SALL4
WB, IHC-P
Human
Sall4 Antibody (YA1899) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1899), targeting Sall4, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). Sall4 Antibody (YA1899) can be used for WB, IHC-P experiment in human background.
GRIM19 Antibody (YA1952) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1952), targeting GRIM19, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). GRIM19 Antibody (YA1952) can be used for WB, IHC-P, ICC/IF experiment in human background.
Xanthine Oxidase Antibody (YA1957) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1957), targeting Xanthine Oxidase, with a predicted molecular weight of 146 kDa (observed band size: 146 kDa). Xanthine Oxidase Antibody (YA1957) can be used for WB, IHC-P experiment in human, mouse, rat background.
Exonuclease WRN; RecQ3; RECQL2; RECQL3; Werner syndrome helicase; WRN
WB
Human
WRN Antibody (YA2021) is a biotin-conjugated non-conjugated IgG antibody, targeting WRN, with a predicted molecular weight of 162 kDa (observed band size: 200 kDa). WRN Antibody (YA2021) can be used for WB experiment in human background.
ALAS2 Antibody (YA2028) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2028), targeting ALAS2, with a predicted molecular weight of 65 kDa (observed band size: 65 kDa). ALAS2 Antibody (YA2028) can be used for WB, IP experiment in human, mouse, rat background.
BACH1 Antibody (YA2061) is a biotin-conjugated non-conjugated IgG antibody, targeting BACH1, with a predicted molecular weight of 141 kDa (observed band size: 105 kDa). BACH1 Antibody (YA2061) can be used for WB experiment in human background.
Cardiac Troponin C Antibody (YA2125) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2125), targeting Cardiac Troponin C, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). Cardiac Troponin C Antibody (YA2125) can be used for WB, IHC-P experiment in human, mouse, rat background.
Aspartate aminotransferase; cytoplasmic; Glutamate oxaloacetate transaminase 1; Transaminase A
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
Aspartate Aminotransferase Antibody (YA2175) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2175), targeting Aspartate Aminotransferase, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). Aspartate Aminotransferase Antibody (YA2175) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Ataxin 1 Antibody (YA2177) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2177), targeting Ataxin 1, with a predicted molecular weight of 87 kDa (observed band size: 105 kDa). Ataxin 1 Antibody (YA2177) can be used for WB, IP experiment in mouse background.
OTX2; Homeobox protein OTX2; Orthodenticle homolog 2
WB
Human
OTX2 Antibody (YA2210) is a biotin-conjugated non-conjugated IgG antibody, targeting OTX2, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). OTX2 Antibody (YA2210) can be used for WB experiment in human background.
BAT5 Antibody (YA2253) is a biotin-conjugated non-conjugated IgG antibody, targeting BAT5, with a predicted molecular weight of 63 kDa (observed band size: 55 kDa). BAT5 Antibody (YA2253) can be used for WB experiment in human, rat background.
Niemann Pick C1 Antibody (YA2290) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2290), targeting Niemann Pick C1, with a predicted molecular weight of 142 kDa (observed band size: 180 kDa). Niemann Pick C1 Antibody (YA2290) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Telomeric Repeat Binding Factor 2 Antibody (YA2304) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2304), targeting Telomeric Repeat Binding Factor 2, with a predicted molecular weight of 60 kDa (observed band size: 66 kDa). Telomeric Repeat Binding Factor 2 Antibody (YA2304) can be used for WB, IHC-P, ICC/IF experiment in human background.
Biglycan Antibody (YA2307) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2307), targeting Biglycan, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). Biglycan Antibody (YA2307) can be used for WB, IP, FC experiment in human, mouse, rat background.
EHMT2 Antibody (YA2373) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2373), targeting EHMT2, with a predicted molecular weight of 132 kDa (observed band size: 170 kDa). EHMT2 Antibody (YA2373) can be used for WB, IHC-P experiment in human background.
NEK6 Antibody (YA2396) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2396), targeting NEK6, with a predicted molecular weight of 36 kDa (observed band size: 28 kDa). NEK6 Antibody (YA2396) can be used for WB, IP experiment in human, mouse, rat background.
Phospho-c Myb (Ser11) Antibody (YA2404) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2404), targeting Phospho-c Myb (Ser11), with a predicted molecular weight of 72 kDa (observed band size: 80 kDa). Phospho-c Myb (Ser11) Antibody (YA2404) can be used for WB, IHC-P, IP, ChIP experiment in human background.
ATP1A3 Antibody (YA2462) is a biotin-conjugated non-conjugated IgG antibody, targeting ATP1A3, with a predicted molecular weight of 112 kDa (observed band size: 100-150 kDa). ATP1A3 Antibody (YA2462) can be used for WB experiment in human, mouse, rat background.
haloacid dehalogenase like hydrolase domain containing 5; CECR5
WB, IP
Human
CECR5 Antibody (YA2477) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2477), targeting CECR5, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). CECR5 Antibody (YA2477) can be used for WB, IP experiment in human background.
VAV3 Antibody (YA2515) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2515), targeting VAV3, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). VAV3 Antibody (YA2515) can be used for WB, ICC/IF, IP, FC experiment in human, mouse background.
Syndecan 1 Antibody (YA2526) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2526), targeting Syndecan 1, with a predicted molecular weight of 32 kDa (observed band size: 35 kDa). Syndecan 1 Antibody (YA2526) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
RCC1 Antibody (YA2642) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2642), targeting RCC1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). RCC1 Antibody (YA2642) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Gemin 3 Antibody (YA2678) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2678), targeting Gemin 3, with a predicted molecular weight of 92 kDa (observed band size: 100 kDa). Gemin 3 Antibody (YA2678) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
Phospho-Dishevelled 2 (Ser143) Antibody (YA2688) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Dishevelled 2 (Ser143), with a predicted molecular weight of 79 kDa (observed band size: 90-95 kDa). Phospho-Dishevelled 2 (Ser143) Antibody (YA2688) can be used for WB experiment in human, mouse background.
AK2 Antibody (YA2691) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2691), targeting AK2, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). AK2 Antibody (YA2691) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CSK Antibody (YA2742) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2742), targeting CSK, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). CSK Antibody (YA2742) can be used for WB, IHC-P experiment in human, mouse, rat background.
PIM2 Antibody (YA2750) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2750), targeting PIM2, with a predicted molecular weight of 34 kDa (observed band size: 37 kDa). PIM2 Antibody (YA2750) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
EMAP II Antibody (YA2763) is a biotin-conjugated non-conjugated IgG antibody, targeting EMAP II, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). EMAP II Antibody (YA2763) can be used for WB experiment in human, rat background.
CRMP4 Antibody (YA2777) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2777), targeting CRMP4, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). CRMP4 Antibody (YA2777) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Activin Receptor Type IIA Antibody (YA2795) is a biotin-conjugated non-conjugated IgG antibody, targeting Activin Receptor Type IIA, with a predicted molecular weight of 58 kDa (observed band size: 85 kDa). Activin Receptor Type IIA Antibody (YA2795) can be used for WB experiment in human, mouse, rat background.
PYGO2 Antibody (YA2848) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2848), targeting PYGO2, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). PYGO2 Antibody (YA2848) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
Cubilin Antibody (YA2866) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2866), targeting Cubilin, with a predicted molecular weight of 399 kDa (observed band size: 399 kDa). Cubilin Antibody (YA2866) can be used for WB, IHC-P experiment in human background.
KAT2A Antibody (YA2900) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2900), targeting KAT2A, with a predicted molecular weight of 94 kDa (observed band size: 94 kDa). KAT2A Antibody (YA2900) can be used for WB, IP experiment in human background.
FADS1 Antibody (YA2910) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2910), targeting FADS1, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). FADS1 Antibody (YA2910) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Jagged 2 Antibody (YA2941) is a non-conjugated IgG antibody, targeting Jagged 2, with a predicted molecular weight of 133 kDa (observed band size: 145 kDa). Jagged 2 Antibody (YA2941) can be used for WB experiment in human, mouse background.
Monoacylglycerol Lipase Antibody (YA2946) is a biotin-conjugated non-conjugated IgG antibody, targeting Monoacylglycerol Lipase, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Monoacylglycerol Lipase Antibody (YA2946) can be used for WB experiment in human background.
Connexin 32 Antibody (YA2960) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2960), targeting Connexin 32, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Connexin 32 Antibody (YA2960) can be used for WB, IHC-P, FC experiment in human background.
Caspr2 Antibody (YA2970) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2970), targeting Caspr2, with a predicted molecular weight of 148 kDa (observed band size: 160 kDa). Caspr2 Antibody (YA2970) can be used for WB, IHC-P experiment in human, mouse, rat background.
alpha/beta Synuclein Antibody (YA2999) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2999), targeting alpha/beta Synuclein, with a predicted molecular weight of 14 kDa (observed band size: 18 kDa). alpha/beta Synuclein Antibody (YA2999) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Histone H1.3 Antibody (YA3006) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3006), targeting Histone H1.3, with a predicted molecular weight of 22 kDa (observed band size: 30 kDa). Histone H1.3 Antibody (YA3006) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
IFITM1 Antibody (YA3066) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3066), targeting IFITM1, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). IFITM1 Antibody (YA3066) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
rBPI; BPIFD1; CAP 57; BPI; Bactericidal permeability-increasing protein
WB, ICC/IF, FC
Human
BPI Antibody (YA3068) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3068), targeting BPI, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). BPI Antibody (YA3068) can be used for WB, ICC/IF, FC experiment in human background.
Integrin beta 6 Antibody (YA3122) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3122), targeting Integrin beta 6, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). Integrin beta 6 Antibody (YA3122) can be used for WB, IP experiment in human, mouse, rat background.
MMP13 Antibody (YA3143) is a biotin-conjugated non-conjugated IgG antibody, targeting MMP13, with a predicted molecular weight of 54 kDa. MMP13 Antibody (YA3143) can be used for WB experiment in human, mouse background.
Lamin B Receptor Antibody (YA3151) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3151), targeting Lamin B Receptor, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). Lamin B Receptor Antibody (YA3151) can be used for WB, IHC-P, IP experiment in human background.
PAX7 Antibody (YA3152) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3152), targeting PAX7, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). PAX7 Antibody (YA3152) can be used for WB, FC experiment in human, mouse, rat background.
MAPK6 Antibody (YA3194) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3194), targeting MAPK6, with a predicted molecular weight of 83 kDa (observed band size: 105 kDa). MAPK6 Antibody (YA3194) can be used for WB, IHC-P, IP experiment in human, mouse background.
Tissue Type Plasminogen Activator Antibody (YA3206) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3206), targeting Tissue Type Plasminogen Activator, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). Tissue Type Plasminogen Activator Antibody (YA3206) can be used for WB, IHC-P experiment in human, mouse, rat background.
MLD Antibody (YA3235) is a biotin-conjugated non-conjugated IgG antibody, targeting MLD, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). MLD Antibody (YA3235) can be used for WB experiment in human background.
ASS1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to ASS1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Rat.
ATG10 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to ATG10. It can be used for WB,IP assays with tag free, in the background of Human.
Fas Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Fas. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
FTO; KIAA1752; Alpha-ketoglutarate-dependent dioxygenase FTO; Fat mass and obesity-associated protein
WB, IHC-P
Human
FTO Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to FTO. It can be used for WB,IHC-P assays with tag free, in the background of Human.
GATA6 Antibody (YA757) is a non-conjugated and Mouse origined monoclonal antibody about 60 kDa, targeting to GATA6 (3H3). It can be used for WB assays with tag free, in the background of Human.
HK1; Hexokinase-1; Brain form hexokinase; Hexokinase type I; HK I
WB
Human, Mouse, Rat
Hexokinase I Antibody (YA739) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to Hexokinase I (6B8). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
IL-18 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to IL-18. It can be used for WB,IHC-P assays with tag free, in the background of Human.
NF-KB p65 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to NF-KB p65. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
Parkin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Parkin. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Phospho-CDK1/2/3 (Thr14) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Phospho-CDK1/2/3 (Thr14). It can be used for WB,IP assays with tag free, in the background of Human, Hamster.
Phospho-Cyclin B1 (Ser126) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-Cyclin B1 (Ser126). It can be used for WB,IP assays with tag free, in the background of Human.
Phospho-Cyclin E1 (Thr395) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 47 kDa, targeting to Phospho-Cyclin E1 (Thr395). It can be used for WB assays with tag free, in the background of Human.
Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44,42 kDa, targeting to Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
nPKC eta; PKC h; PKC L; PKCh; PKCL; Prkch; PRKCL; Protein kinase C eta
WB, IP
Human, Mouse, Rat
PKC eta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC eta. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
Vitamin D Binding Protein Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Vitamin D Binding Protein. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-ULK1 (Ser556) Antibody is an unconjugated, approximately 113 kDa (Calculated)/130 kDa (Observed), rabbit-derived, anti-ULK1 (Ser556) monoclonal antibody. Phospho-ULK1 (Ser556) Antibody can be used for: WB expriments in human, mouse background without labeling.
Beta casein Antibody is an unconjugated, approximately 25 kDa, rabbit-derived, anti-Beta casein monoclonal antibody. Beta casein Antibody can be used for: WB,IP expriments in human background without labeling.
SMARCC1 Antibody (YA1046) is a biotin-conjugated non-conjugated IgG1 antibody, targeting SMARCC1, with a predicted molecular weight of 123 kDa (observed band size: 155 kDa). SMARCC1 Antibody (YA1046) can be used for WB experiment in human background.
SMARCC1 Antibody (YA1047) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1047), targeting SMARCC1, with a predicted molecular weight of 123 kDa (observed band size: 155 kDa). SMARCC1 Antibody (YA1047) can be used for WB, ICC/IF, IP, FC experiment in human, rat background.
CRTC1 Antibody (YA1070) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1070), targeting CRTC1, with a predicted molecular weight of 67 kDa (observed band size: 78 kDa). CRTC1 Antibody (YA1070) can be used for WB, ICC/IF, IP, FC experiment in human background.
Switch Associated Protein 70 Antibody (YA1073) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1073), targeting Switch Associated Protein 70, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). Switch Associated Protein 70 Antibody (YA1073) can be used for WB, IP experiment in human, mouse, rat, monkey background.
15 PGDH Antibody (YA1096) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1096), targeting 15 PGDH. 15 PGDH Antibody (YA1096) can be used for IHC-P experiment in human background.
SPI1; Transcription factor PU.1; 31 kDa-transforming protein
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat, Hamster
PU.1/SPI1 Antibody (YA1116) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1116), targeting PU.1/SPI1. PU.1/SPI1 Antibody (YA1116) can be used for WB,IHC-P,ICC/IF,IP experiment in Human,Mouse,Hamster,Rat background.
Annexin A10 Antibody (YA1134) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1134), targeting Annexin A10. Annexin A10 Antibody (YA1134) can be used for IHC-P experiment in human background.
MCM3 Antibody (YA1137) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1137), targeting MCM3. MCM3 Antibody (YA1137) can be used for IHC-P experiment in human background.
Aquaporin 3 Antibody (YA1145) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1145), targeting Aquaporin 3. Aquaporin 3 Antibody (YA1145) can be used for IHC-P experiment in human background.
DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1)
IHC-P
Human
SATB1 Antibody (YA1154) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1154), targeting SATB1. SATB1 Antibody (YA1154) can be used for IHC-P experiment in human background.
Granulin Antibody (YA1162) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1162), targeting Granulin. Granulin Antibody (YA1162) can be used for WB,IHC-P,ICC/IF,FC,IP experiment in human background.
S100A8 Antibody (YA1170) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1170), targeting S100A8. S100A8 Antibody (YA1170) can be used for IHC-P experiment in human background.
Cyclin D3/CCND3 Antibody (YA1201) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1201), targeting Cyclin D3/CCND3. Cyclin D3/CCND3 Antibody (YA1201) can be used for IHC-P experiment in human background.
ICOS Antibody (YA1212) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1212), targeting ICOS. ICOS Antibody (YA1212) can be used for IHC-P experiment in human background.
LPCAT1 Antibody (YA1275) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1275), targeting LPCAT1. LPCAT1 Antibody (YA1275) can be used for IHC-P experiment in human background.
PEG10 Antibody (YA1277) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1277), targeting PEG10. PEG10 Antibody (YA1277) can be used for IHC-P experiment in human background.
CCR6 Antibody (YA1291) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1291), targeting CCR6, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). CCR6 Antibody (YA1291) can be used for WB, IHC-P experiment in human background.
USP22 Antibody (YA1334) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1334), targeting USP22, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). USP22 Antibody (YA1334) can be used for WB, ICC/IF, IP, FC experiment in human background.
CB1 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting CB1, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). CB1 Antibody can be used for WB, IHC-P, IHC-F, ICC/IF, ELISA experiments in human, rat backgrounds.
KSR1 Antibody (YA1391) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1391), targeting KSR1, with a predicted molecular weight of 102 kDa (observed band size: 120 kDa). KSR1 Antibody (YA1391) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
IL-2 Antibody (YA1454) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1454), targeting IL-2. IL-2 Antibody (YA1454) can be used for FC, ELISA experiment in human background.
NKp30 Antibody (YA1471) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1471), targeting NKp30. NKp30 Antibody (YA1471) can be used for FC, ELISA experiment in human background.
PCK2 Antibody (YA1547) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1547), targeting PCK2, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). PCK2 Antibody (YA1547) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
PDE1B Antibody (YA1553) is a biotin-conjugated non-conjugated IgG antibody, targeting PDE1B, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). PDE1B Antibody (YA1553) can be used for WB experiment in human, mouse, rat background.
Calsequestrin 1 Antibody (YA1561) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1561), targeting Calsequestrin 1, with a predicted molecular weight of 45 kDa (observed band size: 63 kDa). Calsequestrin 1 Antibody (YA1561) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
GATA4 Antibody (YA1568) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1568), targeting GATA4, with a predicted molecular weight of 45 kDa (observed band size: 54 kDa). GATA4 Antibody (YA1568) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
TNFAIP8 Antibody (YA1600) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1600), targeting TNFAIP8, with a predicted molecular weight of 23 kDa (observed band size: 21-23 kDa). TNFAIP8 Antibody (YA1600) can be used for WB, IP experiment in human background.
Presenilin 2 Antibody (YA1605) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1605), targeting Presenilin 2, with a predicted molecular weight of 50 kDa (observed band size: 23 kDa). Presenilin 2 Antibody (YA1605) can be used for WB, IP experiment in human, mouse, rat background.
Tryptophan tRNA Ligase Antibody (YA1608) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1608), targeting Tryptophan tRNA Ligase, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). Tryptophan tRNA Ligase Antibody (YA1608) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
PHAPI2 Antibody (YA1610) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1610), targeting PHAPI2, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). PHAPI2 Antibody (YA1610) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
ADAR1 Antibody (YA1658) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1658), targeting ADAR1, with a predicted molecular weight of 136 kDa (observed band size: 150 kDa). ADAR1 Antibody (YA1658) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Integrin alpha 9 Antibody (YA1660) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1660), targeting Integrin alpha 9, with a predicted molecular weight of 114 kDa (observed band size: 140 kDa). Integrin alpha 9 Antibody (YA1660) can be used for WB, IHC-P experiment in human, mouse, rat background.
CPS1 Antibody (YA1661) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1661), targeting CPS1, with a predicted molecular weight of 165 kDa (observed band size: 150 kDa). CPS1 Antibody (YA1661) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
PKN1 Antibody (YA1664) is a biotin-conjugated non-conjugated IgG antibody, targeting PKN1, with a predicted molecular weight of 104 kDa (observed band size: 120 kDa). PKN1 Antibody (YA1664) can be used for WB experiment in rat background.
Desmocollin 3 Antibody (YA1702) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1702), targeting Desmocollin 3, with a predicted molecular weight of 100 kDa (observed band size: 100 kDa). Desmocollin 3 Antibody (YA1702) can be used for WB, ICC/IF experiment in human background.
Fructose 6 Phosphate Kinase Antibody (YA1715) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1715), targeting Fructose 6 Phosphate Kinase, with a predicted molecular weight of 85 kDa (observed band size: 85 kDa). Fructose 6 Phosphate Kinase Antibody (YA1715) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PRKACG; cAMP-dependent protein kinase catalytic subunit gamma; PKA C-gamma
WB, IP
Human, Mouse, Rat
PKA C gamma Antibody (YA1726) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1726), targeting PKA C gamma, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). PKA C gamma Antibody (YA1726) can be used for WB, IP experiment in human, mouse, rat background.
TREX1 Antibody (YA1732) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1732), targeting TREX1, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). TREX1 Antibody (YA1732) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
GIT1 Antibody (YA1745) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1745), targeting GIT1, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). GIT1 Antibody (YA1745) can be used for WB, FC experiment in human, mouse, rat background.
U1A Antibody (YA1760) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1760), targeting U1A, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). U1A Antibody (YA1760) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
DNA mismatch repair protein Msh2; MutS protein homolog 2
WB
Human, Rat
MSH2 Antibody (YA1774) is a biotin-conjugated non-conjugated IgG antibody, targeting MSH2, with a predicted molecular weight of 105 kDa (observed band size: 105 kDa). MSH2 Antibody (YA1774) can be used for WB experiment in human, rat background.
Rad51D Antibody (YA1808) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1808), targeting Rad51D, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). Rad51D Antibody (YA1808) can be used for WB, IP experiment in human, mouse, rat background.
CRADD; MGC9163; RAIDD; Death adaptor molecule RAIDD; Death domain containing protein CRADD
WB, IP
Human
RAIDD Antibody (YA1815) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1815), targeting RAIDD, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). RAIDD Antibody (YA1815) can be used for WB, IP experiment in human background.
TNNI2; Troponin I; fast skeletal muscle; Troponin I; fast-twitch isoform
WB, IP
Human, Mouse, Rat
Troponin I Antibody (YA1832) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1832), targeting Troponin I, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Troponin I Antibody (YA1832) can be used for WB, IP experiment in human, mouse, rat background.
LGR5 Antibody (YA1842) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1842), targeting LGR5, with a predicted molecular weight of 100 kDa (observed band size: 100 kDa). LGR5 Antibody (YA1842) can be used for WB, IP, FC experiment in human, mouse, rat background.
GluA4 Antibody (YA1889) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1889), targeting GluA4, with a predicted molecular weight of 101 kDa (observed band size: 101 kDa). GluA4 Antibody (YA1889) can be used for WB, FC experiment in human, mouse, rat background.
Frizzled 9 Antibody (YA1930) is a biotin-conjugated non-conjugated IgG antibody, targeting Frizzled 9, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). Frizzled 9 Antibody (YA1930) can be used for WB experiment in human, mouse, rat background.
SF2 Antibody (YA1936) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1936), targeting SF2, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). SF2 Antibody (YA1936) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
SNX9 Antibody (YA1953) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1953), targeting SNX9, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). SNX9 Antibody (YA1953) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
FCAR; CD89; Immunoglobulin alpha Fc receptor; IgA Fc receptor; CD89
WB, IHC-P, ICC/IF, IP, FC
Human
CD89 Antibody (YA1960) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1960), targeting CD89, with a predicted molecular weight of 32 kDa (observed band size: 70 kDa). CD89 Antibody (YA1960) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
ACSS2; ACSA; ACAS2; AceCS; MYH7B; Acetyl CoA synthetase
WB
Human
ACSS2 Antibody (YA1983) is a biotin-conjugated non-conjugated IgG antibody, targeting ACSS2, with a predicted molecular weight of 79 kDa (observed band size: 79 kDa). ACSS2 Antibody (YA1983) can be used for WB experiment in human background.
ADH5 Antibody (YA1998) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1998), targeting ADH5, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). ADH5 Antibody (YA1998) can be used for WB, IHC-P, IP experiment in human background.
FRA1 Antibody (YA2027) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2027), targeting FRA1, with a predicted molecular weight of 29 kDa (observed band size: 39 kDa). FRA1 Antibody (YA2027) can be used for WB, ICC/IF experiment in human background.
ATP7B Antibody (YA2029) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2029), targeting ATP7B, with a predicted molecular weight of 157 kDa (observed band size: 157 kDa). ATP7B Antibody (YA2029) can be used for WB, ICC/IF, FC experiment in human background.
CTBP1 Antibody (YA2030) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2030), targeting CTBP1, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). CTBP1 Antibody (YA2030) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
GCK; Glucokinase; Hexokinase type IV; HK IV; Hexokinase-4; HK4; Hexokinase-D
WB
Human
Glucokinase Antibody (YA2040) is a biotin-conjugated non-conjugated IgG antibody, targeting Glucokinase, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Glucokinase Antibody (YA2040) can be used for WB experiment in human background.
CD66b Antibody (YA2071) is a biotin-conjugated non-conjugated IgG antibody, targeting CD66b, with a predicted molecular weight of 38 kDa (observed band size: 75 kDa). CD66b Antibody (YA2071) can be used for WB experiment in human background.
STUB1 Antibody (YA2096) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2096), targeting STUB1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). STUB1 Antibody (YA2096) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Exportin 5 Antibody (YA2100) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2100), targeting Exportin 5, with a predicted molecular weight of 136 kDa (observed band size: 136 kDa). Exportin 5 Antibody (YA2100) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
AP2 alpha Antibody (YA2109) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2109), targeting AP2 alpha, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). AP2 alpha Antibody (YA2109) can be used for WB, IP experiment in rat background.
GTPBP4 Antibody (YA2189) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2189), targeting GTPBP4, with a predicted molecular weight of 74 kDa (observed band size: 80 kDa). GTPBP4 Antibody (YA2189) can be used for WB, IHC-P, IP, FC experiment in human background.
TIMELESS Antibody (YA2204) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2204), targeting TIMELESS, with a predicted molecular weight of 139 kDa (observed band size: 150 kDa). TIMELESS Antibody (YA2204) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
ENTPD5 Antibody (YA2218) is a biotin-conjugated non-conjugated IgG antibody, targeting ENTPD5, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). ENTPD5 Antibody (YA2218) can be used for WB experiment in human, mouse, rat background.
IRS2 Antibody (YA2271) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2271), targeting IRS2, with a predicted molecular weight of 137 kDa (observed band size: 185 kDa). IRS2 Antibody (YA2271) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
KLF10 Antibody (YA2349) is a biotin-conjugated non-conjugated IgG antibody, targeting KLF10, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). KLF10 Antibody (YA2349) can be used for WB experiment in human, mouse, rat background.
CPEB1 Antibody (YA2357) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2357), targeting CPEB1, with a predicted molecular weight of 63 kDa (observed band size: 70 kDa). CPEB1 Antibody (YA2357) can be used for WB, IP experiment in human background.
Cathelicidin Antibody (YA2380) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2380), targeting Cathelicidin, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Cathelicidin Antibody (YA2380) can be used for WB, IHC-P, IP experiment in human background.
VWF; von Willebrand factor; von Willebrand antigen II; F8VWF
WB, IHC-P
Rat
von Willebrand Factor Antibody (YA2406) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2406), targeting von Willebrand Factor, with a predicted molecular weight of 309 kDa (observed band size: 309 kDa). von Willebrand Factor Antibody (YA2406) can be used for WB, IHC-P experiment in rat background.
VPS11 Antibody (YA2437) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2437), targeting VPS11, with a predicted molecular weight of 108 kDa (observed band size: 108 kDa). VPS11 Antibody (YA2437) can be used for WB, IHC-P, FC experiment in human, mouse background.
MBD1 Antibody (YA2441) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2441), targeting MBD1, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). MBD1 Antibody (YA2441) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
ENT2 Antibody (YA2442) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2442), targeting ENT2, with a predicted molecular weight of 50 kDa (observed band size: 55-65 kDa). ENT2 Antibody (YA2442) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
RYK Antibody (YA2481) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2481), targeting RYK, with a predicted molecular weight of 68 kDa (observed band size: 72 kDa). RYK Antibody (YA2481) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Perilipin 1 Antibody (YA2538) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2538), targeting Perilipin 1, with a predicted molecular weight of 56 kDa (observed band size: 62 kDa). Perilipin 1 Antibody (YA2538) can be used for WB, ICC/IF experiment in human, mouse background.
CTCF Antibody (YA2570) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2570), targeting CTCF, with a predicted molecular weight of 83 kDa (observed band size: 140 kDa). CTCF Antibody (YA2570) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
VEGFB Antibody (YA2627) is a biotin-conjugated non-conjugated IgG antibody, targeting VEGFB, with a predicted molecular weight of 22 kDa (observed band size: 16-62 kDa). VEGFB Antibody (YA2627) can be used for WB experiment in human, mouse background.
GRIK2 Antibody (YA2705) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2705), targeting GRIK2, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). GRIK2 Antibody (YA2705) can be used for WB, IHC-P experiment in human, mouse, rat background.
FRA2 Antibody (YA2718) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2718), targeting FRA2, with a predicted molecular weight of 35 kDa (observed band size: 45 kDa). FRA2 Antibody (YA2718) can be used for WB, IP, FC experiment in human, mouse, rat background.
Actin Related Protein 2 Antibody (YA2725) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2725), targeting Actin Related Protein 2, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Actin Related Protein 2 Antibody (YA2725) can be used for WB, ICC/IF experiment in human, mouse, rat background.
eIF3B Antibody (YA2745) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2745), targeting eIF3B, with a predicted molecular weight of 92 kDa (observed band size: 117 kDa). eIF3B Antibody (YA2745) can be used for WB, IHC-P experiment in human background.
Bcr Antibody (YA2746) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2746), targeting Bcr, with a predicted molecular weight of 143 kDa (observed band size: 160 kDa). Bcr Antibody (YA2746) can be used for WB, IHC-P, IP experiment in human, rat background.
RPS3 Antibody (YA2755) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2755), targeting RPS3, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). RPS3 Antibody (YA2755) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
DNA Polymerase gamma Antibody (YA2783) is a biotin-conjugated non-conjugated IgG antibody, targeting DNA Polymerase gamma, with a predicted molecular weight of 140 kDa (observed band size: 140 kDa). DNA Polymerase gamma Antibody (YA2783) can be used for WB experiment in human, mouse, rat background.
Fanconi anemia complementation group B; FA2; FAB; FACB; FAAP90; FAAP95
WB
Human, Mouse
FANCB Antibody (YA2804) is a biotin-conjugated non-conjugated IgG antibody, targeting FANCB, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). FANCB Antibody (YA2804) can be used for WB experiment in human, mouse background.
Neurocan Antibody (YA2846) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2846), targeting Neurocan, with a predicted molecular weight of 143 kDa (observed band size: 130/270 kDa). Neurocan Antibody (YA2846) can be used for WB, IHC-P, IP experiment in human background.
Caveolin 3 Antibody (YA2869) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2869), targeting Caveolin 3, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Caveolin 3 Antibody (YA2869) can be used for WB, IP experiment in human, mouse, rat background.
PCBP1 Antibody (YA2927) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2927), targeting PCBP1, with a predicted molecular weight of 37 kDa (observed band size: 40 kDa). PCBP1 Antibody (YA2927) can be used for WB, IP experiment in human, mouse, rat background.
ATP1A2 Antibody (YA2934) is a biotin-conjugated non-conjugated IgG antibody, targeting ATP1A2, with a predicted molecular weight of 112 kDa (observed band size: 102 kDa). ATP1A2 Antibody (YA2934) can be used for WB experiment in human, mouse, rat background.
GRK2 Antibody (YA2949) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2949), targeting GRK2, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). GRK2 Antibody (YA2949) can be used for WB, IP experiment in human background.
ADP ribosylation factor 6; ARF6; Small GTP binding protein
WB, ICC/IF
Human, Mouse, Rat
ARF6 Antibody (YA3016) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3016), targeting ARF6, with a predicted molecular weight of 20 kDa. ARF6 Antibody (YA3016) can be used for WB, ICC/IF experiment in human, mouse, rat background.
CEAR; HNRPM; HTGR1; NAGR1; HNRPM4; HNRNPM4; hnRNP M
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
hnRNP M Antibody (YA3034) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3034), targeting hnRNP M, with a predicted molecular weight of 78 kDa (observed band size: 78 kDa). hnRNP M Antibody (YA3034) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
LLGL1 Antibody (YA3043) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3043), targeting LLGL1, with a predicted molecular weight of 115 kDa (observed band size: 115 kDa). LLGL1 Antibody (YA3043) can be used for WB, IP experiment in human background.
IDH2 Antibody (YA3065) is a biotin-conjugated non-conjugated IgG antibody, targeting IDH2, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). IDH2 Antibody (YA3065) can be used for WB experiment in human, rat background.
Optineurin Antibody (YA3127) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3127), targeting Optineurin, with a predicted molecular weight of 66 kDa (observed band size: 75 kDa). Optineurin Antibody (YA3127) can be used for WB, IHC-P experiment in human background.
CDC45 Antibody (YA3158) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3158), targeting CDC45, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). CDC45 Antibody (YA3158) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
MGST3 Antibody (YA3223) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3223), targeting MGST3, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). MGST3 Antibody (YA3223) can be used for WB, IHC-P, IP experiment in human background.
TGOLN2 Antibody (YA3228) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3228), targeting TGOLN2, with a predicted molecular weight of 46 kDa (observed band size: 90 kDa). TGOLN2 Antibody (YA3228) can be used for WB, IHC-P, IP experiment in human background.
Metalloproteinase Inhibitor 2 Antibody (YA3262) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3262), targeting Metalloproteinase Inhibitor 2, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). Metalloproteinase Inhibitor 2 Antibody (YA3262) can be used for WB, FC experiment in human background.
Dynein Light Chain Tctex Type 1 Antibody (YA3263) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3263), targeting Dynein Light Chain Tctex Type 1, with a predicted molecular weight of 12 kDa (observed band size: 12 kDa). Dynein Light Chain Tctex Type 1 Antibody (YA3263) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
NEDD8 Activating Enzyme E1C Antibody (YA3296) is a biotin-conjugated non-conjugated IgG antibody, targeting NEDD8 Activating Enzyme E1C, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). NEDD8 Activating Enzyme E1C Antibody (YA3296) can be used for WB experiment in human, mouse background.
Human IgG4 Antibody (YA3327) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3327), targeting Human IgG4, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Human IgG4 Antibody (YA3327) can be used for WB, IHC-P experiment in human background.
RING2 Antibody (YA3330) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3330), targeting RING2, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). RING2 Antibody (YA3330) can be used for WB, IHC-P experiment in human background.
KAT9 Antibody (YA3382) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3382), targeting KAT9, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). KAT9 Antibody (YA3382) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
MMP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,FC,ICC/IF,IHC-P assays with tag free, in the background of Human.
CANX; Calnexin; IP90; Major histocompatibility complex class I antigen-binding protein p88; p90
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
Calnexin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 68 kDa, targeting to Calnexin. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Caspase 7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Caspase 7. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Mouse, Rat.
Prominin-1; Antigen AC133; Prominin-like protein 1; CD133.
WB
Human
CD133 Antibody (YA809) is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to CD133 (8F2). It can be used for WB assays with tag free, in the background of Human.
Cystatin C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to Cystatin C. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Glutaminase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 73 kDa, targeting to Glutaminase. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
HDAC6 Antibody (YA740) is a non-conjugated and Mouse origined monoclonal antibody about 131 kDa, targeting to HDAC6 (3B2). It can be used for WB assays with tag free, in the background of Human, Rat.
IL-1 beta Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 17 kDa, targeting to IL-1 beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
M-CSF Antibody is a non-conjugated and Rabbit origined monoclonal antibody, targeting to M-CSF. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
NLRP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 118 kDa, targeting to NLRP3. It can be used forWB,IHC-P,ICC/IF assays with tag free, in the background of Mouse, Rat.
RPA70 Antibody (YA678) is a non-conjugated and Mouse origined monoclonal antibody about 68 kDa, targeting to RPA70 (8C3). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Monkey, Mouse, Rat.
TSG101 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TSG101. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
STING Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 42 kDa, targeting to STING. It can be used for WB assays with N-6*His-tag, in the background of Human, Mouse.
Microtubule associated protein 2; MAP2A; MAP2B; MAP2C
WB, ICC/IF, IHC-P
Human, Mouse, Rat
MAP2 Antibody is an unconjugated, approximately 60 kDa, rabbit-derived, anti-MAP2 polyclonal antibody. MAP2 Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.
IRS1 Antibody is an unconjugated, approximately 137 kDa, rabbit-derived, anti-IRS1 polyclonal antibody. IRS1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat and predicted: chicken background without labeling.
OCLN_HUMAN; Occludin; Ocl; BLCPMG; PPP1R115; PTORCH1; Tight junction protein occludin
WB, IHC-P, ICC/IF
Human, Mouse, Rat
OCLN Antibody is an unconjugated, approximately 59 kDa, rabbit-derived, anti-OCLN polyclonal antibody. OCLN Antibody can be used for: WB,IHC-P,ICC/IF expriments in human, mouse, rat background without labeling.
alpha Skeletal Muscle Actin Antibody (YA930) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA930), targeting alpha Skeletal Muscle Actin, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). alpha Skeletal Muscle Actin Antibody (YA930) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
alpha Skeletal Muscle Actin Antibody (YA931) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA931), targeting alpha Skeletal Muscle Actin. alpha Skeletal Muscle Actin Antibody (YA931) can be used for IHC-P experiment in human background.
KDM5C Antibody (YA1063) is a mouse-derived non-conjugated IgG2a antibody (Clone NO.: YA1063), targeting KDM5C, with a predicted molecular weight of 176 kDa (observed band size: 220 kDa). KDM5C Antibody (YA1063) can be used for WB, ICC/IF experiment in human background.
CD28 Antibody (YA1092) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1092), targeting CD28. CD28 Antibody (YA1092) can be used for IHC-P experiment in human background.
GDA Antibody (YA1136) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1136), targeting GDA. GDA Antibody (YA1136) can be used for IHC-P experiment in human background.
Glycophorin A Antibody (YA1151) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1151), targeting Glycophorin A. Glycophorin A Antibody (YA1151) can be used for IHC-P experiment in human background.
Placental lactogen Antibody (YA1191) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1191), targeting Placental lactogen. Placental lactogen Antibody (YA1191) can be used for IHC-P experiment in human background.
PP14434; CTEN; TNS4; Tensin-4; C-terminal tensin-like protein
IHC-P
Human
TNS4/CTEN Antibody (YA1233) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1233), targeting TNS4/CTEN. TNS4/CTEN Antibody (YA1233) can be used for IHC-P experiment in human background.
TSH Receptor/TSH-R Antibody (YA1252) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1252), targeting TSH Receptor/TSH-R. TSH Receptor/TSH-R Antibody (YA1252) can be used for IHC-P experiment in human background.
Cell death protein RIP,Receptor-interacting protein 1
WB, IHC-F, IHC-P, FC, ICC/IF, IP
Human, Mouse, Rat
p-RIPK1(S166) Antibody (YA1284) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1284), targeting p-RIPK1(S166), with a predicted molecular weight of 75 kDa, (observed band size: 75 kDa). p-RIPK1(S166) Antibody (YA1284) can be used for WB, IHC-F, IHC-P, FC, ICC/IF, IP experiment in human, mouse, rat background.
CSF-1R Antibody (YA1299) is a biotin-conjugated non-conjugated IgG antibody, targeting CSF-1R, with a predicted molecular weight of 109 kDa (observed band size: 109 kDa). CSF-1R Antibody (YA1299) can be used for IHC-P experiment in human background.
NDUFB11 Antibody (YA1331) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1331), targeting NDUFB11, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). NDUFB11 Antibody (YA1331) can be used for WB, IHC-P experiment in human, mouse, rat background.
NDUFC2 Antibody (YA1343) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1343), targeting NDUFC2, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). NDUFC2 Antibody (YA1343) can be used for WB, IHC-P experiment in human background.
CD70 Antibody (YA1409) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1409), targeting CD70. CD70 Antibody (YA1409) can be used for FC, ELISA experiment in human background.
vesicle-associated membrane protein 2 (synaptobrevin 2); SYB2; VAMP-2
WB, IP
Human, Mouse, Rat
VAMP2 Antibody (YA1418) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1418), targeting VAMP2, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). VAMP2 Antibody (YA1418) can be used for WB, IP experiment in human, mouse, rat background.
DDAH2 Antibody (YA1447) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1447), targeting DDAH2, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). DDAH2 Antibody (YA1447) can be used for WB, IP experiment in human, mouse, rat background.
NUDT19 Antibody (YA1450) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1450), targeting NUDT19, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). NUDT19 Antibody (YA1450) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
NXF1 Antibody (YA1468) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1468), targeting NXF1, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). NXF1 Antibody (YA1468) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
NTB-A Antibody (YA1472) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1472), targeting NTB-A. NTB-A Antibody (YA1472) can be used for FC, ELISA experiment in human background.
Uteroglobin Antibody (YA1532) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1532), targeting Uteroglobin, with a predicted molecular weight of 10 kDa (observed band size: 16 kDa). Uteroglobin Antibody (YA1532) can be used for WB, FC experiment in human, mouse, rat background.
Interferon beta Antibody (YA1560) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1560), targeting Interferon beta, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). Interferon beta Antibody (YA1560) can be used for WB, IP experiment in human background.
PEF1 Antibody (YA1572) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1572), targeting PEF1, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). PEF1 Antibody (YA1572) can be used for WB, IP experiment in human, mouse, rat background.
C1qb; Complement component 1 q subcomponent B chain
WB, IHC-P, ICC/IF
Human
C1QB Antibody (YA1634) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1634), targeting C1QB, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). C1QB Antibody (YA1634) can be used for WB, IHC-P, ICC/IF experiment in human background.
COPS8 Antibody (YA1679) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1679), targeting COPS8, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). COPS8 Antibody (YA1679) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
WIPI1 Antibody (YA1721) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1721), targeting WIPI1, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). WIPI1 Antibody (YA1721) can be used for WB, IHC-P experiment in human, mouse, rat background.
ASH2L Antibody (YA1723) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1723), targeting ASH2L, with a predicted molecular weight of 69 kDa (observed band size: 80 kDa). ASH2L Antibody (YA1723) can be used for WB, ICC/IF, IP experiment in human, rat background.
AFP regulator 1; Zinc finger and homeodomain protein 2
WB, ICC/IF
Human, Rat
ZHX2 Antibody (YA1746) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1746), targeting ZHX2, with a predicted molecular weight of 92 kDa (observed band size: 110 kDa). ZHX2 Antibody (YA1746) can be used for WB, ICC/IF experiment in human, rat background.
PSMA4 Antibody (YA1765) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1765), targeting PSMA4, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). PSMA4 Antibody (YA1765) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Sprouty 4 Antibody (YA1780) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1780), targeting Sprouty 4, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Sprouty 4 Antibody (YA1780) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
PBR Antibody (YA1785) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1785), targeting PBR, with a predicted molecular weight of 11 kDa (observed band size: 19 kDa). PBR Antibody (YA1785) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
Pyrophosphatase 1 Antibody (YA1786) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1786), targeting Pyrophosphatase 1, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Pyrophosphatase 1 Antibody (YA1786) can be used for WB, IP experiment in human, mouse background.
GABA Transporter 1 Antibody (YA1795) is a biotin-conjugated non-conjugated IgG antibody, targeting GABA Transporter 1, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). GABA Transporter 1 Antibody (YA1795) can be used for WB experiment in human, mouse, rat background.
RACK1 Antibody (YA1804) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1804), targeting RACK1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). RACK1 Antibody (YA1804) can be used for WB, IHC-P experiment in human, mouse, rat background.
Phospho-Synapsin I (Ser9) Antibody (YA1864) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1864), targeting Phospho-Synapsin I (Ser9), with a predicted molecular weight of 74 kDa (observed band size: 77 kDa). Phospho-Synapsin I (Ser9) Antibody (YA1864) can be used for WB, IHC-P experiment in human, rat background.
GEF H1 Antibody (YA1877) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1877), targeting GEF H1, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). GEF H1 Antibody (YA1877) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Exocyst Complex Component 3 Antibody (YA1887) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1887), targeting Exocyst Complex Component 3, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). Exocyst Complex Component 3 Antibody (YA1887) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
GATOR complex protein SEH1; Nup107-160 subcomplex subunit SEH1
WB, IP
Human, Mouse, Rat
SEH1L Antibody (YA1919) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1919), targeting SEH1L, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). SEH1L Antibody (YA1919) can be used for WB, IP experiment in human, mouse, rat background.
GATAD2A Antibody (YA1966) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1966), targeting GATAD2A, with a predicted molecular weight of 68 kDa (observed band size: 65,68 kDa). GATAD2A Antibody (YA1966) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
SLAMF6 Antibody (YA1977) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1977), targeting SLAMF6, with a predicted molecular weight of 37 kDa (observed band size: 60 kDa). SLAMF6 Antibody (YA1977) can be used for WB, ICC/IF, IP experiment in human background.
HCAK1; Ig kappa chain C region; IGKC; IMMUNOGLOBULIN InV; Km
WB, IHC-P, ICC/IF
Human
Human kappa Light Chain Antibody (YA1996) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1996), targeting Human kappa Light Chain, with a predicted molecular weight of 12 kDa (observed band size: 26 kDa). Human kappa Light Chain Antibody (YA1996) can be used for WB, IHC-P, ICC/IF experiment in human background.
MAOA; Amine oxidase [flavin-containing] A; Monoamine oxidase type A; MAO-A
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
Monoamine Oxidase A Antibody (YA2036) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2036), targeting Monoamine Oxidase A, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). Monoamine Oxidase A Antibody (YA2036) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SPOP Antibody (YA2054) is a biotin-conjugated non-conjugated IgG antibody, targeting SPOP, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). SPOP Antibody (YA2054) can be used for WB experiment in human background.
EN1 Antibody (YA2055) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2055), targeting EN1, with a predicted molecular weight of 40 kDa (observed band size: 55 kDa). EN1 Antibody (YA2055) can be used for WB, IP, FC experiment in human, mouse, rat background.
FAAH1 Antibody (YA2064) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2064), targeting FAAH1, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). FAAH1 Antibody (YA2064) can be used for WB, IHC-P experiment in human, mouse background.
Zinc Alpha 2 Glycoprotein Antibody (YA2103) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2103), targeting Zinc Alpha 2 Glycoprotein, with a predicted molecular weight of 34 kDa (observed band size: 43 kDa). Zinc Alpha 2 Glycoprotein Antibody (YA2103) can be used for WB, IHC-P, IP experiment in human background.
alpha COP I Antibody (YA2105) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2105), targeting alpha COP I, with a predicted molecular weight of 138 kDa (observed band size: 138 kDa). alpha COP I Antibody (YA2105) can be used for WB, IHC-P experiment in human, mouse, rat background.
FANCA Antibody (YA2112) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2112), targeting FANCA, with a predicted molecular weight of 163 kDa (observed band size: 163 kDa). FANCA Antibody (YA2112) can be used for WB, IP experiment in human background.
DDB2 Antibody (YA2127) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2127), targeting DDB2, with a predicted molecular weight of 48 kDa (observed band size: 45 kDa). DDB2 Antibody (YA2127) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
ARHQ; RASL7A; Rho related GTP binding protein RhoQ; Rhoq; TC10A
WB, ICC/IF
Human, Rat
RHOQ Antibody (YA2182) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2182), targeting RHOQ, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). RHOQ Antibody (YA2182) can be used for WB, ICC/IF experiment in human, rat background.
Thioredoxin Like Protein 1 Antibody (YA2312) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2312), targeting Thioredoxin Like Protein 1, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Thioredoxin Like Protein 1 Antibody (YA2312) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
DHICA Oxidase Antibody (YA2327) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2327), targeting DHICA Oxidase, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). DHICA Oxidase Antibody (YA2327) can be used for WB, IHC-P, IP experiment in human background.
Claudin 11 Antibody (YA2334) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2334), targeting Claudin 11, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). Claudin 11 Antibody (YA2334) can be used for WB, FC experiment in human, mouse, rat background.
RANTES Antibody (YA2383) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2383), targeting RANTES, with a predicted molecular weight of 10 kDa (observed band size: 10 kDa). RANTES Antibody (YA2383) can be used for WB, ICC/IF experiment in human background.
IQGAP1; KIAA0051; Ras GTPase-activating-like protein IQGAP1; p195
WB, IHC-P, ICC/IF, FC
Human, Mouse
IQGAP1 Antibody (YA2388) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2388), targeting IQGAP1, with a predicted molecular weight of 189 kDa (observed band size: 180 kDa). IQGAP1 Antibody (YA2388) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
CBR3 Antibody (YA2395) is a biotin-conjugated non-conjugated IgG antibody, targeting CBR3, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). CBR3 Antibody (YA2395) can be used for WB experiment in human background.
Tissue Factor Antibody (YA2471) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2471), targeting Tissue Factor, with a predicted molecular weight of 33 kDa (observed band size: 45 kDa). Tissue Factor Antibody (YA2471) can be used for WB, IHC-P experiment in human, mouse, rat background.
BCAR1 Antibody (YA2560) is a biotin-conjugated non-conjugated IgG antibody, targeting BCAR1, with a predicted molecular weight of 93 kDa (observed band size: 130 kDa). BCAR1 Antibody (YA2560) can be used for WB experiment in human, mouse, rat background.
PAX5; Paired box protein Pax-5; B-cell-specific transcription factor; BSAP
WB, IHC-P, ICC/IF, FC
Human, Mouse
PAX5 Antibody (YA2597) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2597), targeting PAX5, with a predicted molecular weight of 42 kDa (observed band size: 45 kDa). PAX5 Antibody (YA2597) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
SUMO4 Antibody (YA2621) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2621), targeting SUMO4, with a predicted molecular weight of 11 kDa (observed band size: 15 kDa). SUMO4 Antibody (YA2621) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
DD5; EDD; EDD1; hHYD; HYD; Rat100; Ubiquitin protein ligase; UBR5
WB
Human, Mouse
EDD Antibody (YA2630) is a biotin-conjugated non-conjugated IgG antibody, targeting EDD, with a predicted molecular weight of 309 kDa (observed band size: 309 kDa). EDD Antibody (YA2630) can be used for WB experiment in human, mouse background.
SLAMF1 Antibody (YA2639) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2639), targeting SLAMF1, with a predicted molecular weight of 37 kDa (observed band size: 85 kDa). SLAMF1 Antibody (YA2639) can be used for WB, IP, FC experiment in human background.
Pannexin 1 Antibody (YA2649) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2649), targeting Pannexin 1, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). Pannexin 1 Antibody (YA2649) can be used for WB, IP experiment in human background.
PRKCZ; PKC2; Protein kinase C zeta type; nPKC-zeta
WB, IHC-P
Human, Mouse, Rat
Phospho-PKC zeta (Thr560) Antibody (YA2679) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2679), targeting Phospho-PKC zeta (Thr560), with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). Phospho-PKC zeta (Thr560) Antibody (YA2679) can be used for WB, IHC-P experiment in human, mouse, rat background.
Ubiquitin Conjugating Enzyme E2 C Antibody (YA2734) is a biotin-conjugated non-conjugated IgG antibody, targeting Ubiquitin Conjugating Enzyme E2 C, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Ubiquitin Conjugating Enzyme E2 C Antibody (YA2734) can be used for WB experiment in human background.
M6PR Antibody (YA2736) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2736), targeting M6PR, with a predicted molecular weight of 31 kDa (observed band size: 42 kDa). M6PR Antibody (YA2736) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
FKBP38 Antibody (YA2803) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2803), targeting FKBP38, with a predicted molecular weight of 45 kDa (observed band size: 52 kDa). FKBP38 Antibody (YA2803) can be used for WB, ICC/IF, FC experiment in human background.
KDM2A Antibody (YA2812) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2812), targeting KDM2A, with a predicted molecular weight of 133 kDa (observed band size: 133 kDa). KDM2A Antibody (YA2812) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Cofilin Antibody (YA2822) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2822), targeting Cofilin, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Cofilin Antibody (YA2822) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
guanine nucleotide binding protein (G protein); alpha 13; G13
WB, IHC-P
Human
GNA13 Antibody (YA2878) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2878), targeting GNA13, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). GNA13 Antibody (YA2878) can be used for WB, IHC-P experiment in human background.
GABARAPL2 Antibody (YA2882) is a biotin-conjugated non-conjugated IgG antibody, targeting GABARAPL2, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). GABARAPL2 Antibody (YA2882) can be used for WB experiment in human, rat background.
LGI1 Antibody (YA2885) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2885), targeting LGI1, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). LGI1 Antibody (YA2885) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
SPT5 Antibody (YA2904) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2904), targeting SPT5, with a predicted molecular weight of 121 kDa (observed band size: 155 kDa). SPT5 Antibody (YA2904) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
CCL23 Antibody (YA2929) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2929), targeting CCL23, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). CCL23 Antibody (YA2929) can be used for WB, ICC/IF experiment in human background.
MERTK Antibody (YA2966) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2966), targeting MERTK, with a predicted molecular weight of 110 kDa (observed band size: 188 kDa). MERTK Antibody (YA2966) can be used for WB, IHC-P, IP experiment in human background.
HDAC8 Antibody (YA2994) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2994), targeting HDAC8, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). HDAC8 Antibody (YA2994) can be used for WB, IP experiment in human background.
HMGB2 Antibody (YA2995) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2995), targeting HMGB2, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). HMGB2 Antibody (YA2995) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat, hamster background.
HLA C Antibody (YA3019) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3019), targeting HLA C, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). HLA C Antibody (YA3019) can be used for WB, IP experiment in human, mouse background.
NADH dehydrogenase (ubiquinone) Fe-S protein 2; 49kDa; CI-49
WB, IHC-P, IP
Human
NDUFS2 Antibody (YA3097) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3097), targeting NDUFS2, with a predicted molecular weight of 53 kDa (observed band size: 49 kDa). NDUFS2 Antibody (YA3097) can be used for WB, IHC-P, IP experiment in human background.
IRF8 Antibody (YA3121) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3121), targeting IRF8, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). IRF8 Antibody (YA3121) can be used for WB, IHC-P, IP experiment in human background.
kappa Opioid Receptor Antibody (YA3132) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3132), targeting kappa Opioid Receptor, with a predicted molecular weight of 43 kDa (observed band size: 60 kDa). kappa Opioid Receptor Antibody (YA3132) can be used for WB, IP experiment in rat background.
Charcot-Leyden crystal protein 2; CLC2; Galectin-14; Gal-14
WB, ICC/IF
Rat
LGALS14 Antibody (YA3169) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3169), targeting LGALS14, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). LGALS14 Antibody (YA3169) can be used for WB, ICC/IF experiment in rat background.
Caspase 14 Antibody (YA3180) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3180), targeting Caspase 14, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). Caspase 14 Antibody (YA3180) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Phospho-ATM (Ser1981) Antibody (YA3181) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-ATM (Ser1981), with a predicted molecular weight of 351 kDa. Phospho-ATM (Ser1981) Antibody (YA3181) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
regulator of G protein signaling 6; GAP; S914; HA117
WB
Human
RGS6 Antibody (YA3211) is a biotin-conjugated non-conjugated IgG antibody, targeting RGS6, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). RGS6 Antibody (YA3211) can be used for WB experiment in human background.
HLA G antigen; MHC class I antigen G; HLA-G; HLA60; HLAG
WB
Human
HLA G Antibody (YA3225) is a biotin-conjugated non-conjugated IgG antibody, targeting HLA G, with a predicted molecular weight of 38 kDa (observed band size: 42 kDa). HLA G Antibody (YA3225) can be used for WB experiment in human background.
Endothelin B receptor; ET-B; ET-BR; Endothelin receptor non-selective type
WB, IP
Human
Endothelin Receptor B Antibody (YA3255) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3255), targeting Endothelin Receptor B, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Endothelin Receptor B Antibody (YA3255) can be used for WB, IP experiment in human background.
FGF21 Antibody (YA3276) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3276), targeting FGF21, with a predicted molecular weight of 22 kDa. FGF21 Antibody (YA3276) can be used for WB, IHC-P experiment in human, mouse, rat background.
ADFP; Adipophilin; Adipose differentiation related protein; ADRP; Perilipin-2; PLIN2
WB, ICC/IF, FC
Human, Mouse, Rat
Perilipin 2 Antibody (YA3298) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3298), targeting Perilipin 2, with a predicted molecular weight of 48 kDa. Perilipin 2 Antibody (YA3298) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Ubiquitin 60S Ribosomal Protein L40 Antibody (YA3299) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3299), targeting Ubiquitin 60S Ribosomal Protein L40, with a predicted molecular weight of 15 kDa (observed band size: 10 kDa). Ubiquitin 60S Ribosomal Protein L40 Antibody (YA3299) can be used for WB, ICC/IF, IP experiment in human background.
GCET1 Antibody (YA3320) is a biotin-conjugated non-conjugated IgG antibody, targeting GCET1, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). GCET1 Antibody (YA3320) can be used for WB experiment in human, mouse, rat background.
ATP Citrate Lyase Antibody (YA829) is a non-conjugated and Mouse origined monoclonal antibody about 121 kDa, targeting to ATP Citrate Lyase (3D9). It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Monkey.
Creatine Kinase B type Antibody (YA492) is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Creatine Kinase B type. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
eIF5A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to eIF5A. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)
WB, IHC-P, IP
Human, Mouse, Rat, Hamster
Hsc70 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to Hsc70. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
Hsp70 1B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Hsp70 1B. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
JAK2 Antibody (YA330) is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to JAK2. It can be used for WB assays with tag free, in the background of Human, Mouse.
N Cadherin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100 kDa, targeting to N Cadherin. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
Mucin 5AC Antibody is an unconjugated, approximately 220-600 kDa, rabbit-derived, anti-Mucin 5AC monoclonal antibody. Mucin 5AC Antibody can be used for: WB, IHC-P, ICC/IF expriments in human background without labeling.
Growth hormone receptor Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Growth hormone receptor polyclonal antibody. Growth hormone receptor Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.
beta Catenin Antibody (YA936) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA936), targeting beta Catenin, with a predicted molecular weight of 85 kDa (observed band size: 92 kDa). beta Catenin Antibody (YA936) can be used for WB, IHC-P experiment in human, mouse, rat background.
beta Catenin Antibody (YA937) is a biotin-conjugated non-conjugated IgG1 antibody, targeting beta Catenin, with a predicted molecular weight of 85 kDa (observed band size: 92 kDa). beta Catenin Antibody (YA937) can be used for WB experiment in human, mouse, rat background.
beta Catenin Antibody (YA938) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA938), targeting beta Catenin, with a predicted molecular weight of 85 kDa (observed band size: 85 kDa). beta Catenin Antibody (YA938) can be used for WB, IHC-P, IP experiment in human, mouse, rat, hamster background.
Elongation factor 2 Antibody (YA962) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA962), targeting Elongation factor 2, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). Elongation factor 2 Antibody (YA962) can be used for WB, ICC/IF, ChIP experiment in human background.
Elongation factor 2 Antibody (YA963) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA963), targeting Elongation factor 2, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). Elongation factor 2 Antibody (YA963) can be used for WB, ICC/IF experiment in human, mouse, monkey, rat background.
Elongation factor 2 Antibody (YA964) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA964), targeting Elongation factor 2, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). Elongation factor 2 Antibody (YA964) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Phospho-Rb (Thr356) Antibody (YA1029) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1029), targeting Phospho-Rb (Thr356), with a predicted molecular weight of 106 kDa (observed band size: 110 kDa). Phospho-Rb (Thr356) Antibody (YA1029) can be used for WB, IHC-P, IP experiment in human, rat background.
Phospho-Rb (Ser780) Antibody (YA1030) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1030), targeting Phospho-Rb (Ser780), with a predicted molecular weight of 106 kDa (observed band size: 110 kDa). Phospho-Rb (Ser780) Antibody (YA1030) can be used for WB, IP experiment in human, rat background.
Phospho-Rb (Ser811) Antibody (YA1031) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Rb (Ser811), with a predicted molecular weight of 106 kDa (observed band size: 110 kDa). Phospho-Rb (Ser811) Antibody (YA1031) can be used for WB experiment in human, hamster background.
Phospho-Rb (Ser608) Antibody (YA1032) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1032), targeting Phospho-Rb (Ser608), with a predicted molecular weight of 106 kDa (observed band size: 110 kDa). Phospho-Rb (Ser608) Antibody (YA1032) can be used for WB, IHC-P experiment in human, rat background.
Phospho-Rb (Thr252) Antibody (YA1033) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1033), targeting Phospho-Rb (Thr252), with a predicted molecular weight of 106 kDa (observed band size: 110 kDa). Phospho-Rb (Thr252) Antibody (YA1033) can be used for WB, IHC-P experiment in human, rat background.
UHRF1 Antibody (YA1057) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1057), targeting UHRF1. UHRF1 Antibody (YA1057) can be used for IHC-P experiment in human background.
aldehyde dehydrogenase 3 family; member A1; ALDH3; ALDHIII
IHC-P
Human
ALDH3A1 Antibody (YA1120) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1120), targeting ALDH3A1. ALDH3A1 Antibody (YA1120) can be used for IHC-P experiment in human background.
MCM6 Antibody (YA1146) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1146), targeting MCM6. MCM6 Antibody (YA1146) can be used for IHC-P experiment in human background.
CLDN5; AWAL; TMVCF; Claudin-5; Transmembrane protein deleted in VCFS; TMDVCF
IHC-P
Human
Claudin 5 Antibody (YA1164) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1164), targeting Claudin 5. Claudin 5 Antibody (YA1164) can be used for IHC-P experiment in human background.
SLAMF7/CS1 Antibody (YA1177) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1177), targeting SLAMF7/CS1. SLAMF7/CS1 Antibody (YA1177) can be used for IHC-P experiment in human background.
c-Maf Antibody (YA1178) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1178), targeting c-Maf. c-Maf Antibody (YA1178) can be used for IHC-P experiment in human background.
hnRNP K Antibody (YA1194) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1194), targeting hnRNP K. hnRNP K Antibody (YA1194) can be used for IHC-P experiment in human background.
Keratin 6 Antibody (YA1319) is a biotin-conjugated non-conjugated IgG antibody, targeting Keratin 6, with a predicted molecular weight of 60 kDa (observed band size: 56 kDa). Keratin 6 Antibody (YA1319) can be used for WB experiment in human, mouse, rat background.
CD200 Antibody (YA1375) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1375), targeting CD200. CD200 Antibody (YA1375) can be used for FC, ELISA experiment in human background.
CD37 Antibody (YA1393) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1393), targeting CD37. CD37 Antibody (YA1393) can be used for FC, ELISA experiment in human background.
PRKCA; PKCA; PRKACA; Protein kinase C alpha type; PKC-A; PKC-alpha
WB, IHC-P
Human, Rat
Phospho-PKC (Ser660) Antibody (YA1394) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1394), targeting Phospho-PKC (Ser660), with a predicted molecular weight of 77 kDa (observed band size: 78-85 kDa). Phospho-PKC (Ser660) Antibody (YA1394) can be used for WB, IHC-P experiment in human, rat background.
Protein lin-28 homolog A; LIN28A; CSDD1; LIN28; ZCCHC1
WB, IHC-P, ICC/IF, IP, FC
Human
LIN28 Antibody (YA1473) is a biotin-conjugated non-conjugated IgG antibody, targeting LIN28, with a predicted molecular weight of 23 kDa. LIN28 Antibody (YA1473) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
PVR; PVS; Poliovirus receptor; Nectin-like protein 5; NECL-5; CD155
FC, ELISA
Human
CD155 Antibody (YA1485) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1485), targeting CD155. CD155 Antibody (YA1485) can be used for FC, ELISA experiment in human background.
NPR3 Antibody (YA1541) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1541), targeting NPR3, with a predicted molecular weight of 60 kDa (observed band size: 70 kDa). NPR3 Antibody (YA1541) can be used for WB, FC experiment in human, mouse, rat background.
RING finger protein 134; Mel18 and Bmi1-like RING finger
WB, ICC/IF, IP
Mouse, Rat
PCGF6 Antibody (YA1545) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1545), targeting PCGF6, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). PCGF6 Antibody (YA1545) can be used for WB, ICC/IF, IP experiment in mouse, rat background.
Caspase 6 Antibody (YA1557) is a biotin-conjugated non-conjugated IgG antibody, targeting Caspase 6, with a predicted molecular weight of 33 kDa (observed band size: 11,33 kDa). Caspase 6 Antibody (YA1557) can be used for WB experiment in human, rat background.
PDPK1; PDK1; 3-phosphoinositide-dependent protein kinase 1; hPDK1
WB
Human, Mouse, Rat
PDPK1 Antibody (YA1569) is a biotin-conjugated non-conjugated IgG antibody, targeting PDPK1, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). PDPK1 Antibody (YA1569) can be used for WB experiment in human, mouse, rat background.
MRP1 Antibody (YA1583) is a biotin-conjugated non-conjugated IgG antibody, targeting MRP1, with a predicted molecular weight of 172 kDa. MRP1 Antibody (YA1583) can be used for WB, FC experiment in human background.
Plexin A1 Antibody (YA1593) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1593), targeting Plexin A1, with a predicted molecular weight of 211 kDa (observed band size: 211 kDa). Plexin A1 Antibody (YA1593) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
GNB2 Antibody (YA1613) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1613), targeting GNB2, with a predicted molecular weight of 37 kDa (observed band size: 32 kDa). GNB2 Antibody (YA1613) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Phospholipase C beta 1 Antibody (YA1626) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospholipase C beta 1, with a predicted molecular weight of 138 kDa (observed band size: 138 kDa). Phospholipase C beta 1 Antibody (YA1626) can be used for WB experiment in rat background.
ENDOGL1 Antibody (YA1685) is a biotin-conjugated non-conjugated IgG antibody, targeting ENDOGL1, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). ENDOGL1 Antibody (YA1685) can be used for WB experiment in human background.
LIM Kinase 1 Antibody (YA1686) is a biotin-conjugated non-conjugated IgG antibody, targeting LIM Kinase 1, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). LIM Kinase 1 Antibody (YA1686) can be used for WB experiment in human, mouse background.
Lipoamide Dehydrogenase Antibody (YA1694) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1694), targeting Lipoamide Dehydrogenase, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Lipoamide Dehydrogenase Antibody (YA1694) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
ABCE1 Antibody (YA1699) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1699), targeting ABCE1, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). ABCE1 Antibody (YA1699) can be used for WB, IP experiment in human, mouse, rat background.
PRPF4 Antibody (YA1757) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1757), targeting PRPF4, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). PRPF4 Antibody (YA1757) can be used for WB, IP experiment in human, mouse background.
PRPF8 Antibody (YA1759) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1759), targeting PRPF8, with a predicted molecular weight of 274 kDa (observed band size: 274 kDa). PRPF8 Antibody (YA1759) can be used for WB, IHC-P experiment in human background.
PSMA Antibody (YA1764) is a biotin-conjugated non-conjugated IgG antibody, targeting PSMA, with a predicted molecular weight of 84 kDa (observed band size: 100 kDa). PSMA Antibody (YA1764) can be used for WB experiment in human background.
Phospho-MDM2 (Ser166) Antibody (YA1888) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1888), targeting Phospho-MDM2 (Ser166), with a predicted molecular weight of 55 kDa (observed band size: 90 kDa). Phospho-MDM2 (Ser166) Antibody (YA1888) can be used for WB, IHC-P experiment in human, rat background.
Yes1 Antibody (YA1897) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1897), targeting Yes1, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). Yes1 Antibody (YA1897) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CRMP1 Antibody (YA1941) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1941), targeting CRMP1, with a predicted molecular weight of 62 kDa (observed band size: 64-80 kDa). CRMP1 Antibody (YA1941) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Syntaxin 1A Antibody (YA2001) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2001), targeting Syntaxin 1A, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Syntaxin 1A Antibody (YA2001) can be used for WB, IP, FC experiment in human, mouse, rat background.
SMYD3 Antibody (YA2003) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2003), targeting SMYD3, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). SMYD3 Antibody (YA2003) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Somatostatin Receptor 3 Antibody (YA2032) is a biotin-conjugated non-conjugated IgG antibody, targeting Somatostatin Receptor 3, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). Somatostatin Receptor 3 Antibody (YA2032) can be used for WB experiment in human background.
ALDOA Antibody (YA2037) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2037), targeting ALDOA, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). ALDOA Antibody (YA2037) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Myf5; Class C basic helix loop helix protein 2; bHLHc2
WB, IP
Human, Mouse, Rat
MYF5 Antibody (YA2045) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2045), targeting MYF5, with a predicted molecular weight of 28 kDa (observed band size: 37 kDa). MYF5 Antibody (YA2045) can be used for WB, IP experiment in human, mouse, rat background.
Mitochondrial Fission 1 Protein Antibody (YA2098) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2098), targeting Mitochondrial Fission 1 Protein, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Mitochondrial Fission 1 Protein Antibody (YA2098) can be used for WB, IHC-P, ICC/IF experiment in human, cow background.
TINF2 Antibody (YA2126) is a biotin-conjugated non-conjugated IgG antibody, targeting TINF2, with a predicted molecular weight of 50 kDa (observed band size: 40 kDa). TINF2 Antibody (YA2126) can be used for WB experiment in human, mouse, rat background.
Kininogen 1 Antibody (YA2140) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2140), targeting Kininogen 1, with a predicted molecular weight of 72 kDa (observed band size: 56/130 kDa). Kininogen 1 Antibody (YA2140) can be used for WB, IHC-P, IP experiment in human background.
RNF40 Antibody (YA2165) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2165), targeting RNF40, with a predicted molecular weight of 114 kDa (observed band size: 130 kDa). RNF40 Antibody (YA2165) can be used for WB, IHC-P, IP experiment in mouse, rat, human background.
Cullin 2 Antibody (YA2202) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2202), targeting Cullin 2, with a predicted molecular weight of 87 kDa (observed band size: 87 kDa). Cullin 2 Antibody (YA2202) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
U2AF2 Antibody (YA2221) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2221), targeting U2AF2, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). U2AF2 Antibody (YA2221) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Cripto 1 Antibody (YA2245) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2245), targeting Cripto 1, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Cripto 1 Antibody (YA2245) can be used for WB, ICC/IF, IP, FC experiment in human background.
UAP1 Antibody (YA2265) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2265), targeting UAP1, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). UAP1 Antibody (YA2265) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Wilms Tumor Protein Antibody (YA2277) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2277), targeting Wilms Tumor Protein, with a predicted molecular weight of 49 kDa (observed band size: 55 kDa). Wilms Tumor Protein Antibody (YA2277) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
PSMA1 Antibody (YA2301) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2301), targeting PSMA1, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). PSMA1 Antibody (YA2301) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
U1 small nuclear ribonucleoprotein C; U1 snRNP C; U1-C
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Rat
U1C Antibody (YA2326) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2326), targeting U1C, with a predicted molecular weight of 17 kDa (observed band size: 21 kDa). U1C Antibody (YA2326) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
USP13 Antibody (YA2367) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2367), targeting USP13, with a predicted molecular weight of 97 kDa (observed band size: 97 kDa). USP13 Antibody (YA2367) can be used for WB, ICC/IF, IP experiment in human background.
Pyruvate Dehydrogenase E1 beta Antibody (YA2374) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2374), targeting Pyruvate Dehydrogenase E1 beta, with a predicted molecular weight of 39 kDa (observed band size: 35 kDa). Pyruvate Dehydrogenase E1 beta Antibody (YA2374) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
PSMA2 Antibody (YA2384) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2384), targeting PSMA2, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). PSMA2 Antibody (YA2384) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Chromogranin B Antibody (YA2422) is a biotin-conjugated non-conjugated IgG antibody, targeting Chromogranin B, with a predicted molecular weight of 78 kDa (observed band size: 125 kDa). Chromogranin B Antibody (YA2422) can be used for WB experiment in human, mouse, rat background.
DOPA Decarboxylase Antibody (YA2428) is a biotin-conjugated non-conjugated IgG antibody, targeting DOPA Decarboxylase, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). DOPA Decarboxylase Antibody (YA2428) can be used for WB experiment in human, mouse, rat background.
XIAP Antibody (YA2429) is a biotin-conjugated non-conjugated IgG antibody, targeting XIAP, with a predicted molecular weight of 56 kDa (observed band size: 53 kDa). XIAP Antibody (YA2429) can be used for WB experiment in human, mouse, rat background.
Actin Regulatory Protein CAPG Antibody (YA2476) is a biotin-conjugated non-conjugated IgG antibody, targeting Actin Regulatory Protein CAPG, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). Actin Regulatory Protein CAPG Antibody (YA2476) can be used for WB experiment in human, mouse, rat background.
CELF2 Antibody (YA2480) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2480), targeting CELF2, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). CELF2 Antibody (YA2480) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
E1B AP5 Antibody (YA2548) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2548), targeting E1B AP5, with a predicted molecular weight of 96 kDa (observed band size: 118 kDa). E1B AP5 Antibody (YA2548) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
PVR; PVS; Poliovirus receptor; Nectin-like protein 5; NECL-5; CD155
WB, IP
Human
Poliovirus Receptor Antibody (YA2556) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2556), targeting Poliovirus Receptor, with a predicted molecular weight of 45 kDa (observed band size: 70 kDa). Poliovirus Receptor Antibody (YA2556) can be used for WB, IP experiment in human background.
Cullin 4A/4B Antibody (YA2583) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2583), targeting Cullin 4A/4B, with a predicted molecular weight of 104 kDa (observed band size: 88,104 kDa). Cullin 4A/4B Antibody (YA2583) can be used for WB, IHC-P experiment in human, hamster, rat background.
Protein kinase C delta type; Tyrosine-protein kinase PRKCD; nPKC-delta
WB, IHC-P, IP
Human
Phospho-PKC delta (Ser299) Antibody (YA2628) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2628), targeting Phospho-PKC delta (Ser299), with a predicted molecular weight of 78 kDa (observed band size: 78 kDa). Phospho-PKC delta (Ser299) Antibody (YA2628) can be used for WB, IHC-P, IP experiment in human background.
Ephrin A1 Antibody (YA2657) is a biotin-conjugated non-conjugated IgG antibody, targeting Ephrin A1, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). Ephrin A1 Antibody (YA2657) can be used for WB experiment in human background.
AKR1C1/AKR1C2 Antibody (YA2675) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2675), targeting AKR1C1/AKR1C2, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). AKR1C1/AKR1C2 Antibody (YA2675) can be used for WB, FC experiment in human, mouse, rat background.
GOLPH2 Antibody (YA2747) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2747), targeting GOLPH2, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). GOLPH2 Antibody (YA2747) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
KAP3; KIF3AP; Kifap3; Kinesin associated protein 3; SMAP
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
KIFAP3 Antibody (YA2769) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2769), targeting KIFAP3, with a predicted molecular weight of 91 kDa (observed band size: 91-100 kDa). KIFAP3 Antibody (YA2769) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CHX10 Antibody (YA2790) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2790), targeting CHX10, with a predicted molecular weight of 39 kDa (observed band size: 50 kDa). CHX10 Antibody (YA2790) can be used for WB, FC experiment in human, mouse, rat background.
RNA-binding protein Musashi homolog 1; Musashi-1; MSI1
WB, IHC-P, ICC/IF, IP, FC
Human
Musashi 1 Antibody (YA2815) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2815), targeting Musashi 1, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). Musashi 1 Antibody (YA2815) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
PMEL; ME20-M; Premelanosome protein; Silver locus protein homolog; PMEL17; SILV
WB, IHC-P
Human
Melanocyte Protein PMEL Antibody (YA2829) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2829), targeting Melanocyte Protein PMEL, with a predicted molecular weight of 70 kDa (observed band size: 100 kDa). Melanocyte Protein PMEL Antibody (YA2829) can be used for WB, IHC-P experiment in human background.
Cystatin B Antibody (YA2849) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2849), targeting Cystatin B, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). Cystatin B Antibody (YA2849) can be used for WB, IHC-P experiment in human, rat background.
CHMP2B Antibody (YA2855) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2855), targeting CHMP2B, with a predicted molecular weight of 24 kDa (observed band size: 28 kDa). CHMP2B Antibody (YA2855) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
EFEMP1 Antibody (YA2883) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2883), targeting EFEMP1, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). EFEMP1 Antibody (YA2883) can be used for WB, IHC-P, IP experiment in human background.
ANPR B Antibody (YA2913) is a biotin-conjugated non-conjugated IgG antibody, targeting ANPR B, with a predicted molecular weight of 117 kDa (observed band size: 117 kDa). ANPR B Antibody (YA2913) can be used for WB experiment in human, mouse, rat background.
ACVR1 Antibody (YA2943) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2943), targeting ACVR1, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). ACVR1 Antibody (YA2943) can be used for WB, IP experiment in human, mouse, rat background.
Trefoil Factor 2 Antibody (YA2950) is a biotin-conjugated non-conjugated IgG antibody, targeting Trefoil Factor 2, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). Trefoil Factor 2 Antibody (YA2950) can be used for WB experiment in human background.
GPR182 Antibody (YA2961) is a biotin-conjugated non-conjugated IgG antibody, targeting GPR182, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). GPR182 Antibody (YA2961) can be used for WB experiment in human, mouse, rat background.
MCJ Antibody (YA2982) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2982), targeting MCJ, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). MCJ Antibody (YA2982) can be used for WB, IHC-P experiment in human, mouse, rat background.
C3/C5 convertase; Complement factor B; PBF2; Properdin factor B
WB
Human
Complement factor B Antibody (YA2984) is a biotin-conjugated non-conjugated IgG antibody, targeting Complement factor B, with a predicted molecular weight of 86 kDa (observed band size: 100 kDa). Complement factor B Antibody (YA2984) can be used for WB experiment in human background.
CD1C Antibody (YA2986) is a biotin-conjugated non-conjugated IgG antibody, targeting CD1C, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). CD1C Antibody (YA2986) can be used for WB experiment in human background.
Homer1 Antibody (YA3035) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3035), targeting Homer1, with a predicted molecular weight of 40 kDa (observed band size: 46 kDa). Homer1 Antibody (YA3035) can be used for WB, IP experiment in mouse, rat background.
MSI2; RNA-binding protein Musashi homolog 2; Musashi-2
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
Musashi 2 Antibody (YA3045) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3045), targeting Musashi 2, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). Musashi 2 Antibody (YA3045) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Phospho-Histone H1.4 (Thr17) Antibody (YA3049) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3049), targeting Phospho-Histone H1.4 (Thr17), with a predicted molecular weight of 22 kDa (observed band size: 30 kDa). Phospho-Histone H1.4 (Thr17) Antibody (YA3049) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
MAP3K4 Antibody (YA3050) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3050), targeting MAP3K4, with a predicted molecular weight of 182 kDa (observed band size: 200 kDa). MAP3K4 Antibody (YA3050) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
MYH9 Antibody (YA3113) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3113), targeting MYH9, with a predicted molecular weight of 227 kDa (observed band size: 227 kDa). MYH9 Antibody (YA3113) can be used for WB, IHC-P, IP experiment in human, rat background.
CCR9 Antibody (YA3119) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3119), targeting CCR9, with a predicted molecular weight of 42 kDa. CCR9 Antibody (YA3119) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Monocarboxylic Acid Transporter 1 Antibody (YA3244) is a biotin-conjugated non-conjugated IgG antibody, targeting Monocarboxylic Acid Transporter 1, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Monocarboxylic Acid Transporter 1 Antibody (YA3244) can be used for WB experiment in human background.
Mucin 4 Antibody (YA3264) is a biotin-conjugated non-conjugated IgG antibody, targeting Mucin 4, with a predicted molecular weight of 542 kDa (observed band size: 120 kDa). Mucin 4 Antibody (YA3264) can be used for WB experiment in human background.
NDUFAF5 Antibody (YA3304) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3304), targeting NDUFAF5, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). NDUFAF5 Antibody (YA3304) can be used for WB, IHC-P, IP experiment in human, mouse background.
Mitochondrial Ferritin Antibody (YA3353) is a biotin-conjugated non-conjugated IgG antibody, targeting Mitochondrial Ferritin, with a predicted molecular weight of 28 kDa (observed band size: 22 kDa). Mitochondrial Ferritin Antibody (YA3353) can be used for WB experiment in human background.
Desmoglein 2 Antibody (YA2299) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2299), targeting Desmoglein 2, with a predicted molecular weight of 122 kDa (observed band size: 160 kDa). Desmoglein 2 Antibody (YA2299) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
WTAP Antibody is a rabbit-derived non-conjugated IgG antibody, targeting WTAP, with a predicted molecular weight of 44 kDa (observed band size: 55 kDa). WTAP Antibody (YA1657) can be used for WB, IHC-P, IF experiment in human,Mouse,Rat. background.
Adipose Triglyceride Lipase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Adipose Triglyceride Lipase. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
CSNK1A1; Casein kinase I isoform alpha; CKI-alpha; CK1
WB, IP
Human, Rat
Casein Kinase 1 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Casein Kinase 1 alpha. It can be used for WB,IP assays with tag free, in the background of Human, Rat.
CD31 Antibody (YA806) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to CD31 (2D3). It can be used for WB, IF-Cell, IF-Tissue, IHC-P, mIHC assays with tag free, in the background of Human.
Collagen alpha-2(I) chain (Alpha-2 type I collagen)
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
Collagen I alpha 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 129 kDa, targeting to Collagen I alpha 2. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
eIF1A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to eIF1A. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
NOS3; Nitric oxide synthase; endothelial; Constitutive NOS; cNOS; EC-NOS; Endothelial NOS; eNOS; NOS type III; NOSIII
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
eNOS Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 133 kDa, targeting to eNOS. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Phospho-NF-KB p65 (Ser536) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 60 kDa, targeting to Phospho-NF-KB p65 (Ser536). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-NF-KB p65 (Thr254) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 60 kDa, targeting to Phospho-NF-KB p65 (Thr254). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Raf1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 73 kDa, targeting to Raf1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
RhoA Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to RhoA. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
RPS6; OK/SW-cl.2; 40S ribosomal protein S6; Phosphoprotein NP33
WB, ICC/IF, IP
Human, Mouse, Rat, Monkey
RPS6 Antibody (YA677) is a non-conjugated and Mouse origined monoclonal antibody about 29 kDa, targeting to RPS6 (7B10). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Tau Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Tau. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
TLR4; Toll-like receptor 4; hToll; CD antigen CD284
WB, FC
Human
Toll-Like Receptor 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 96 kDa, targeting to Toll-Like Receptor 4. It can be used for WB,FC assays with tag free, in the background of Human.
CCBR1; Cysteine/glutamate transporter; SLC7A11; solute carrier family 7; xCT
WB, IP
Human, Mouse
xCT Antibody (YA006) is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to xCT. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
S100 calcium binding protein A11; MLN70; S100C; HEL-S-43
WB, IHC-P
Human, Mouse, Rat
S100A11 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 12 kDa, targeting to Protein S100-A11 (S100A11). It can be used for WB,IHC-P assays in the background of Human, Mouse, Rat.
MPO Antibody is an unconjugated, approximately 84 kDa, rabbit-derived, anti-MPO polyclonal antibody. MPO Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, dog, horse, rabbit, guinea pig background without labeling.
ALDH2; ALDM; Aldehyde dehydrogenase; mitochondrial; ALDH class 2; ALDH-E2; ALDHI
WB
Human, Mouse, Rat, Monkey, Hamster
ALDH2 Antibody (YA928) is a biotin-conjugated non-conjugated IgG1 antibody, targeting ALDH2, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). ALDH2 Antibody (YA928) can be used for WB experiment in human, mouse, rat, monkey, hamster background.
ALDH2; ALDM; Aldehyde dehydrogenase; mitochondrial; ALDH class 2; ALDH-E2; ALDHI
WB, IHC-P, IP
Human, Mouse
ALDH2 Antibody (YA929) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA929), targeting ALDH2, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). ALDH2 Antibody (YA929) can be used for WB, IHC-P, IP experiment in human, mouse background.
PRKCA; PKCA; PRKACA; Protein kinase C alpha type; PKC-A; PKC-alpha
WB, IHC-P
Human, Mouse, Rat
Phospho-PKC alpha (Ser657) Antibody (YA1023) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1023), targeting Phospho-PKC alpha (Ser657), with a predicted molecular weight of 77 kDa (observed band size: 80 kDa). Phospho-PKC alpha (Ser657) Antibody (YA1023) can be used for WB, IHC-P experiment in human, mouse, rat background.
PRKCA; PKCA; PRKACA; Protein kinase C alpha type; PKC-A; PKC-alpha
WB, IHC-P, IP
Human, Mouse, Rat
Phospho-PKC alpha (Thr638) Antibody (YA1024) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1024), targeting Phospho-PKC alpha (Thr638), with a predicted molecular weight of 77 kDa (observed band size: 80 kDa). Phospho-PKC alpha (Thr638) Antibody (YA1024) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
TRIM33 Antibody (YA1066) is a biotin-conjugated non-conjugated IgG2a antibody, targeting TRIM33, with a predicted molecular weight of 123 kDa (observed band size: 140 kDa). TRIM33 Antibody (YA1066) can be used for WB experiment in human background.
GRAP2 Antibody (YA1078) is a biotin-conjugated non-conjugated IgG2b antibody, targeting GRAP2, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). GRAP2 Antibody (YA1078) can be used for WB experiment in human background.
FAP; Seprase; 170 kDa melanoma membrane-bound gelatinase; Fibroblast activation protein alpha; Integral membrane serine protease
WB, IHC-P
Human
FAP Antibody (YA1090) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1090), targeting FAP, with a predicted molecular weight of Calculated band size: 88 kDa (observed band size: 95 kDa). FAP Antibody (YA1090) can be used for WB, IHC-P experiment in human background.
ABHD5 Antibody (YA1108) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1108), targeting ABHD5. ABHD5 Antibody (YA1108) can be used for IHC-P experiment in human background.
Hemoglobin subunit alpha Antibody (YA1173) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1173), targeting Hemoglobin subunit alpha. Hemoglobin subunit alpha Antibody (YA1173) can be used for IHC-P experiment in human background.
Baf180 Antibody (YA1176) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1176), targeting Baf180. Baf180 Antibody (YA1176) can be used for IHC-P experiment in human background.
URI1 Antibody (YA1207) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1207), targeting URI1. URI1 Antibody (YA1207) can be used for IHC-P experiment in human background.
DPEP1/MDP Antibody (YA1231) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1231), targeting DPEP1/MDP. DPEP1/MDP Antibody (YA1231) can be used for IHC-P experiment in human background.
TRP1 Antibody (YA1247) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1247), targeting TRP1. TRP1 Antibody (YA1247) can be used for IHC-P experiment in human background.
LY75 Antibody (YA1262) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1262), targeting LY75. LY75 Antibody (YA1262) can be used for IHC-P experiment in human background.
BTLA; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; CD antigen CD272
FC, ELISA
Human
BTLA Antibody (YA1364) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1364), targeting BTLA. BTLA Antibody (YA1364) can be used for FC, ELISA experiment in human background.
Nogo B Receptor Antibody (YA1414) is a biotin-conjugated non-conjugated IgG antibody, targeting Nogo B Receptor, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Nogo B Receptor Antibody (YA1414) can be used for WB experiment in human, mouse, rat background.
CLEC12A Antibody (YA1419) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1419), targeting CLEC12A. CLEC12A Antibody (YA1419) can be used for FC, ELISA experiment in human background.
FAP; Seprase; 170 kDa melanoma membrane-bound gelatinase; Fibroblast activation protein alpha; Integral membrane serine protease
IHC-P, FC, ELISA
Human
FAP Antibody (YA1442) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1442), targeting FAP. FAP Antibody (YA1442) can be used for IHC-P, FC, ELISA experiment in human background.
CDH13; CDHH; H-cadherin; Heart cadherin; P105; T cad; T Cadherin; Truncated cadherin
WB, IHC-P
Human, Mouse, Rat
H Cadherin Antibody (YA1470) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1470), targeting H Cadherin, with a predicted molecular weight of 78 kDa (observed band size: 105,130 kDa). H Cadherin Antibody (YA1470) can be used for WB, IHC-P experiment in human, mouse, rat background.
Nuclear Mitotic Apparatus Protein 1 Antibody (YA1526) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1526), targeting Nuclear Mitotic Apparatus Protein 1, with a predicted molecular weight of 238 kDa (observed band size: 238 kDa). Nuclear Mitotic Apparatus Protein 1 Antibody (YA1526) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
PAR6 Antibody (YA1536) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1536), targeting PAR6, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). PAR6 Antibody (YA1536) can be used for WB, IP experiment in human, mouse, rat background.
ATP synthase lipid-binding protein; ATP synthase membrane subunit c locus 1
WB, ICC/IF
Human
ATP Synthase C Antibody (YA1633) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1633), targeting ATP Synthase C, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). ATP Synthase C Antibody (YA1633) can be used for WB, ICC/IF experiment in human background.
MSP Antibody (YA1648) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1648), targeting MSP, with a predicted molecular weight of 56 kDa (observed band size: 60 kDa). MSP Antibody (YA1648) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Uroplakin 3A Antibody (YA1697) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1697), targeting Uroplakin 3A. Uroplakin 3A Antibody (YA1697) can be used for IHC-P, FC experiment in human background.
PKD2 Antibody (YA1730) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1730), targeting PKD2, with a predicted molecular weight of 97 kDa (observed band size: 105 kDa). PKD2 Antibody (YA1730) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
PSMC5 Antibody (YA1768) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1768), targeting PSMC5, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). PSMC5 Antibody (YA1768) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
DFFRX; FAF; Fafl; Fam; hFAM; MRX99; Usp9x; X chromosome; X-linked
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
USP9X Antibody (YA1811) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1811), targeting USP9X, with a predicted molecular weight of 290 kDa (observed band size: 290 kDa). USP9X Antibody (YA1811) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Calmodulin Antibody (YA1827) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1827), targeting Calmodulin, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Calmodulin Antibody (YA1827) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
DKK3; REIC; Dickkopf-related protein 3; Dickkopf-3; Dkk-3; hDkk-3
WB, ICC/IF, IP
Human, Mouse, Rat
DKK3 Antibody (YA1851) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1851), targeting DKK3, with a predicted molecular weight of 38 kDa (observed band size: 60 kDa). DKK3 Antibody (YA1851) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Destrin Antibody (YA1859) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1859), targeting Destrin, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Destrin Antibody (YA1859) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Semaphorin 4D Antibody (YA1922) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1922), targeting Semaphorin 4D, with a predicted molecular weight of 96 kDa (observed band size: 120 kDa). Semaphorin 4D Antibody (YA1922) can be used for WB, ICC/IF experiment in human background.
EBF1 Antibody (YA1938) is a biotin-conjugated non-conjugated IgG antibody, targeting EBF1, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). EBF1 Antibody (YA1938) can be used for WB experiment in human, mouse background.
Galectin 7 Antibody (YA1945) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1945), targeting Galectin 7, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). Galectin 7 Antibody (YA1945) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
TAB1 Antibody (YA1951) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1951), targeting TAB1, with a predicted molecular weight of 55 kDa (observed band size: 60 kDa). TAB1 Antibody (YA1951) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
EHD1; H PAST; hPAST1; PAST; PAST homolog 1; PAST1; Tilin
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
EHD1 Antibody (YA1970) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1970), targeting EHD1, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). EHD1 Antibody (YA1970) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Axonin1; AXT; Cntn2; Contactin2; TAG 1; TAG564; TAX1
WB, ICC/IF, FC
Human, Mouse
CNTN2 Antibody (YA1975) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1975), targeting CNTN2, with a predicted molecular weight of 113 kDa (observed band size: 135 kDa). CNTN2 Antibody (YA1975) can be used for WB, ICC/IF, FC experiment in human, mouse background.
Dynactin Subunit 5 Antibody (YA1990) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1990), targeting Dynactin Subunit 5, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Dynactin Subunit 5 Antibody (YA1990) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
aldehyde dehydrogenase 7 family member A1; EPD; PDE; ATQ1
WB, ICC/IF, IP
Human, Mouse
ALDH7A1 Antibody (YA2034) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2034), targeting ALDH7A1, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). ALDH7A1 Antibody (YA2034) can be used for WB, ICC/IF, IP experiment in human, mouse background.
ATP1B1 Antibody (YA2084) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2084), targeting ATP1B1, with a predicted molecular weight of 35 kDa (observed band size: 40-50 kDa). ATP1B1 Antibody (YA2084) can be used for WB, IHC-P experiment in human, mouse, rat background.
Cyclophilin 40 Antibody (YA2099) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2099), targeting Cyclophilin 40, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Cyclophilin 40 Antibody (YA2099) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Transcription Factor 21 Antibody (YA2101) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2101), targeting Transcription Factor 21, with a predicted molecular weight of 20 kDa (observed band size: 26 kDa). Transcription Factor 21 Antibody (YA2101) can be used for WB, IP, FC experiment in human background.
AP-A Antibody (YA2164) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2164), targeting AP-A, with a predicted molecular weight of 109 kDa (observed band size: 160 kDa). AP-A Antibody (YA2164) can be used for WB, IHC-P experiment in human background.
ATP synthase lipid-binding protein; ATP synthase membrane subunit c locus 1
WB, IHC-P, IP
Human, Rat
ATP5G Antibody (YA2205) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2205), targeting ATP5G, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). ATP5G Antibody (YA2205) can be used for WB, IHC-P, IP experiment in human, rat background.
Axil; Axin like protein; Axin2; Axis inhibition protein 2; Conductin
WB
Human, Mouse, Rat
Axin 2 Antibody (YA2222) is a biotin-conjugated non-conjugated IgG antibody, targeting Axin 2, with a predicted molecular weight of 94 kDa (observed band size: 94 kDa). Axin 2 Antibody (YA2222) can be used for WB experiment in human, mouse, rat background.
WSTF Antibody (YA2224) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2224), targeting WSTF, with a predicted molecular weight of 171 kDa (observed band size: 185 kDa). WSTF Antibody (YA2224) can be used for WB, FC experiment in human, mouse, rat background.
GOLPH4 Antibody (YA2239) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2239), targeting GOLPH4, with a predicted molecular weight of 82 kDa (observed band size: 130 kDa). GOLPH4 Antibody (YA2239) can be used for WB, IHC-P experiment in human background.
Thrombopoietin Receptor Antibody (YA2241) is a biotin-conjugated non-conjugated IgG antibody, targeting Thrombopoietin Receptor, with a predicted molecular weight of 71 kDa (observed band size: 85 kDa). Thrombopoietin Receptor Antibody (YA2241) can be used for WB experiment in human, mouse, rat background.
bHLHa1; NDR2; NDRF; neuroD related factor; NeuroD2; neurogenic differentiation 2
WB
Human, Mouse, Rat
NeuroD2 Antibody (YA2369) is a biotin-conjugated non-conjugated IgG antibody, targeting NeuroD2, with a predicted molecular weight of 41 kDa (observed band size: 48 kDa). NeuroD2 Antibody (YA2369) can be used for WB experiment in human, mouse, rat background.
PROC; Vitamin K-dependent protein C; Anticoagulant protein C; Autoprothrombin IIA; Blood coagulation factor XIV
WB
Human
Protein C Antibody (YA2461) is a biotin-conjugated non-conjugated IgG antibody, targeting Protein C, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Protein C Antibody (YA2461) can be used for WB experiment in human background.
Leptin Receptor Antibody (YA2493) is a biotin-conjugated non-conjugated IgG antibody, targeting Leptin Receptor, with a predicted molecular weight of 132 kDa (observed band size: 150 kDa). Leptin Receptor Antibody (YA2493) can be used for WB experiment in human, mouse, rat background.
Chromogranin A Antibody (YA2496) is a biotin-conjugated non-conjugated IgG antibody, targeting Chromogranin A, with a predicted molecular weight of 51 kDa (observed band size: 92 kDa). Chromogranin A Antibody (YA2496) can be used for WB experiment in rat background.
ZBTB7A Antibody (YA2501) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2501), targeting ZBTB7A, with a predicted molecular weight of 61 kDa (observed band size: 70 kDa). ZBTB7A Antibody (YA2501) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
Claudin 3 Antibody (YA2512) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2512), targeting Claudin 3, with a predicted molecular weight of 23 kDa (observed band size: 20 kDa). Claudin 3 Antibody (YA2512) can be used for WB, ICC/IF, IP experiment in human background.
Tyrosinase Antibody (YA2522) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2522), targeting Tyrosinase, with a predicted molecular weight of 60 kDa (observed band size: 70-80 kDa). Tyrosinase Antibody (YA2522) can be used for WB, IHC-P, ICC/IF experiment in human background.
Haptoglobin Antibody (YA2545) is a biotin-conjugated non-conjugated IgG antibody, targeting Haptoglobin, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Haptoglobin Antibody (YA2545) can be used for WB experiment in human, mouse, rat background.
NCF1 Antibody (YA2575) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2575), targeting NCF1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). NCF1 Antibody (YA2575) can be used for WB, IP experiment in human background.
KIF4A Antibody (YA2653) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2653), targeting KIF4A, with a predicted molecular weight of 140 kDa (observed band size: 150 kDa). KIF4A Antibody (YA2653) can be used for WB, FC experiment in human, mouse background.
DGCR8 Antibody (YA2680) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2680), targeting DGCR8, with a predicted molecular weight of 86 kDa (observed band size: 120 kDa). DGCR8 Antibody (YA2680) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
MMP11 Antibody (YA2682) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2682), targeting MMP11, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). MMP11 Antibody (YA2682) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
DKK1; Dickkopf-related protein 1; Dickkopf-1; Dkk-1; hDkk-1; SK
WB, IHC-P, ICC/IF, FC
Human, Rat
DKK1 Antibody (YA2706) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2706), targeting DKK1, with a predicted molecular weight of 29 kDa (observed band size: 38 kDa). DKK1 Antibody (YA2706) can be used for WB, IHC-P, ICC/IF, FC experiment in human, rat background.
Olig1 Antibody (YA2726) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2726), targeting Olig1, with a predicted molecular weight of 28 kDa (observed band size: 35 kDa). Olig1 Antibody (YA2726) can be used for WB, FC experiment in human, mouse, rat background.
PIAS2 Antibody (YA2730) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2730), targeting PIAS2, with a predicted molecular weight of 68 kDa (observed band size: 55 kDa). PIAS2 Antibody (YA2730) can be used for WB, ICC/IF experiment in human, mouse, rat background.
beta Dystroglycan Antibody (YA2751) is a biotin-conjugated non-conjugated IgG antibody, targeting beta Dystroglycan, with a predicted molecular weight of 97 kDa (observed band size: 42-44 kDa). beta Dystroglycan Antibody (YA2751) can be used for WB experiment in human background.
Inhibin beta A Antibody (YA2780) is a biotin-conjugated non-conjugated IgG antibody, targeting Inhibin beta A, with a predicted molecular weight of 47 kDa (observed band size: 43 kDa). Inhibin beta A Antibody (YA2780) can be used for WB experiment in human, mouse, rat background.
FNTB Antibody (YA2844) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2844), targeting FNTB, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). FNTB Antibody (YA2844) can be used for WB, IP experiment in human background.
TACC3; ERIC1; Transforming acidic coiled-coil-containing protein 3; ERIC-1
WB, IHC-P, ICC/IF
Human, Mouse, Rat
TACC3 Antibody (YA2921) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2921), targeting TACC3, with a predicted molecular weight of 90 kDa (observed band size: 140 kDa). TACC3 Antibody (YA2921) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
RDC1 Antibody (YA2957) is a biotin-conjugated non-conjugated IgG antibody, targeting RDC1, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). RDC1 Antibody (YA2957) can be used for WB experiment in human, mouse, rat background.
Metabotropic Glutamate Receptor 3 Antibody (YA2977) is a biotin-conjugated non-conjugated IgG antibody, targeting Metabotropic Glutamate Receptor 3, with a predicted molecular weight of 99 kDa (observed band size: 330 kDa). Metabotropic Glutamate Receptor 3 Antibody (YA2977) can be used for WB experiment in human, mouse, rat background.
MMP8 Antibody (YA3030) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3030), targeting MMP8, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). MMP8 Antibody (YA3030) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Phospho-GCN2 (Thr899) Antibody (YA3033) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-GCN2 (Thr899), with a predicted molecular weight of 187 kDa (observed band size: 220 kDa). Phospho-GCN2 (Thr899) Antibody (YA3033) can be used for WB experiment in human background.
JAG1; JAGL1; Protein jagged-1; Jagged1; hJ1; CD339
WB, IHC-P
Human
Jagged 1 Antibody (YA3091) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3091), targeting Jagged 1, with a predicted molecular weight of 134 kDa (observed band size: 180 kDa). Jagged 1 Antibody (YA3091) can be used for WB, IHC-P experiment in human background.
C11orf43; IGF 2; IGF II; IGF2; INSIGF; Somatomedin A
WB, ICC/IF
Human
IGF2 Antibody (YA3192) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3192), targeting IGF2, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). IGF2 Antibody (YA3192) can be used for WB, ICC/IF experiment in human background.
mGluR1 Antibody (YA3195) is a biotin-conjugated non-conjugated IgG antibody, targeting mGluR1, with a predicted molecular weight of 132 kDa (observed band size: 101 kDa). mGluR1 Antibody (YA3195) can be used for WB experiment in human, mouse, rat background.
EBP50 Antibody (YA3202) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3202), targeting EBP50, with a predicted molecular weight of 39 kDa (observed band size: 50 kDa). EBP50 Antibody (YA3202) can be used for WB, IHC-P experiment in human, rat background.
AQP4; Aquaporin-4; AQP-4; Mercurial-insensitive water channel; MIWC; WCH4
IHC-P
Human, Rat
Aquaporin 4 Antibody (YA3204) is a biotin-conjugated non-conjugated IgG antibody, targeting Aquaporin 4. Aquaporin 4 Antibody (YA3204) can be used for IHC-P experiment in human, rat background.
Mitofilin Antibody (YA3231) is a biotin-conjugated non-conjugated IgG antibody, targeting Mitofilin, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). Mitofilin Antibody (YA3231) can be used for WB experiment in human background.
MT-CO2; COX2; CO2; Cytochrome c oxidase II; MTCO2; COII; COXII
WB, IHC-F, IHC-P, ICC/IF, IP
Human
MTCO2 Antibody (YA3254) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3254), targeting MTCO2, with a predicted molecular weight of 26 kDa (observed band size: 21 kDa). MTCO2 Antibody (YA3254) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
NDUFAF4 Antibody (YA3302) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3302), targeting NDUFAF4, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). NDUFAF4 Antibody (YA3302) can be used for WB, ICC/IF, IP experiment in human background.
Ubiquitin Conjugating Enzyme E2 L3 Antibody (YA3303) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3303), targeting Ubiquitin Conjugating Enzyme E2 L3, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). Ubiquitin Conjugating Enzyme E2 L3 Antibody (YA3303) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Ubiquitin Conjugation Factor E4 B Antibody (YA3308) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3308), targeting Ubiquitin Conjugation Factor E4 B, with a predicted molecular weight of 146 kDa (observed band size: 146 kDa). Ubiquitin Conjugation Factor E4 B Antibody (YA3308) can be used for WB, ICC/IF experiment in human, rat background.
SOS1 Antibody (YA3313) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3313), targeting SOS1, with a predicted molecular weight of 152 kDa (observed band size: 152 kDa). SOS1 Antibody (YA3313) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-PAK4/5/6 (Ser474/Ser560/Ser602), with a predicted molecular weight of 64,80,75 kDa (observed band size: 64,80,75 kDa). Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333) can be used for WB experiment in human, mouse, rat background.
PRPF31 Antibody (YA3338) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3338), targeting PRPF31, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). PRPF31 Antibody (YA3338) can be used for WB, ICC/IF experiment in human, mouse, rat background.
CRCP Antibody (YA3350) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3350), targeting CRCP, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). CRCP Antibody (YA3350) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CD73 is a 70 kD glycophosphatidylinositol (GPI)-linked 5'-nucleotidase, which is also known as ecto-5'-nucleotidase. It converts adenosine monophosphate (AMP) to adenosine. CD73 is expressed on subsets of T and B cells, mesenchymal stem cells, follicular dendritic cells, endothelial cells, and epithelial cells. It has been reported that CD73 costimulates T cell activation, and mediates adhesion of lymphocytes to follicular dendritic cells and endothelial cells.
STAT5A; STAT5; Signal transducer and activator of transcription 5A
WB, IHC-P, ICC/IF
Human, Rat, Mouse
Phospho-Stat5 (Tyr694) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to Phospho-Stat5(Y694). It can be used for WB,IHC-P,IF-Cell assays with tag free, in the background of Human, Rat, Mouse.
BRCA1; RNF53; Breast cancer type 1 susceptibility protein; RING finger protein 53
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Rat
BRCA1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 208 kDa, targeting to BRCA1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Rat.
FYN Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 61 kDa, targeting to FYN. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Lactate Dehydrogenase A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Lactate Dehydrogenase A. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Rat.
MLH1; COCA2; DNA mismatch repair protein Mlh1; MutL protein homolog 1
WB, ICC/IF
Human, Monkey
MLH1 Antibody (YA703) is a non-conjugated and Mouse origined monoclonal antibody about 85 kDa, targeting to MLH1 (4C1). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.
EP300; P300; Histone acetyltransferase p300; p300 HAT; E1A-associated protein p300
ICC/IF, WB, IHC-F, IHC-P, ELISA
Human, Mouse, Rat
p300 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 264 kDa, targeting to p300. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Phospho-JAK2 (Tyr1007/1008) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 131 kDa, targeting to Phospho-JAK2 (Tyr1007/1008). It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Phospho-YAP1 (Ser127) Antibody (YA136) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-YAP1 (Ser127). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
STAT3; APRF; Signal transducer and activator of transcription 3; Acute-phase response factor
WB, IHC-P
Human, Rat, Mouse
STAT3 Antibody (YA666) is a non-conjugated and Mouse origined monoclonal antibody about 88 kDa, targeting to STAT3 (6H10). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat, Mouse.
DNA topoisomerase II; DNA topoisomerase II-alpha; TOP2; TP2A; alpha isozyme, Topoisomerase II alpha
WB, IHC-P, IP
Human, Mouse, Rat
TOP2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 174 kDa, targeting to TOP2A. It can be used for WB, IHC-P, IP assays with tag free, in the background of Human, Mouse, Rat.
Nestin Antibody is an unconjugated, approximately 268 kDa, rabbit-derived, anti-Nestin monoclonal antibody. Nestin Antibody can be used for: WB, IF-Cell, IF-Tissue, IHC-P expriments in human background without labeling.
OXYR_HUMAN; Oxytocin receptor; OXTR; OTR1; OT-R; OTR; OT R; OTR 1; OXT R
WB, ELISA, IHC-P
Human, Mouse, Rat
Oxytocin R Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-Oxytocin R polyclonal antibody. Oxytocin R Antibody can be used for: WB, ELISA, IHC-P expriments in human, mouse, rat, and predicted: dog, pig, cow, horse background without labeling.
DBC 1 Antibody (YA955) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA955), targeting DBC 1, with a predicted molecular weight of 103 kDa (observed band size: 130 kDa). DBC 1 Antibody (YA955) can be used for WB, ICC/IF, IP experiment in human, mouse, rat, monkey background.
DBC 1 Antibody (YA956) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA956), targeting DBC 1, with a predicted molecular weight of 103 kDa (observed band size: 130 kDa). DBC 1 Antibody (YA956) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
E Cadherin Antibody is a rabbit-derived non-conjugated IgG antibody , targeting E Cadherin, with a predicted molecular weight of 97 kDa (observed band size: 135 kDa). E Cadherin Antibody can be used for WB, IHC-P, IHC-F, ICC/IF, ELISA experiment in human, mouse, rat background.
GST3 Antibody (YA975) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA975), targeting GST3, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). GST3 Antibody (YA975) can be used for WB, IHC-F, IHC-P, ICC/IF, FC experiment in human background.
GST3 Antibody (YA976) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA976), targeting GST3. GST3 Antibody (YA976) can be used for IHC-P experiment in human background.
XRCC1; DNA repair protein XRCC1; X-ray repair cross-complementing protein 1
WB
Human
XRCC1 Antibody (YA1058) is a biotin-conjugated non-conjugated IgG1 antibody, targeting XRCC1, with a predicted molecular weight of 69 kDa (observed band size: 82 kDa). XRCC1 Antibody (YA1058) can be used for WB experiment in human background.
XRCC1; DNA repair protein XRCC1; X-ray repair cross-complementing protein 1
WB, IHC-P, ICC/IF
Human, Mouse, Rat
XRCC1 Antibody (YA1059) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1059), targeting XRCC1, with a predicted molecular weight of 69 kDa. XRCC1 Antibody (YA1059) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
MAGEC2 Antibody (YA1114) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1114), targeting MAGEC2. MAGEC2 Antibody (YA1114) can be used for IHC-P experiment in human background.
Transcription Factor AP 2 gamma Antibody (YA1142) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1142), targeting Transcription Factor AP 2 gamma. Transcription Factor AP 2 gamma Antibody (YA1142) can be used for IHC-P experiment in human background.
SAGE1 Antibody (YA1150) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1150), targeting SAGE1. SAGE1 Antibody (YA1150) can be used for IHC-P experiment in human background.
GRB7 Antibody (YA1165) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1165), targeting GRB7. GRB7 Antibody (YA1165) can be used for IHC-P experiment in human background.
NCR1 Antibody (YA1192) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1192), targeting NCR1. NCR1 Antibody (YA1192) can be used for IHC-P experiment in human background.
TN-X Antibody (YA1237) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1237), targeting TN-X. TN-X Antibody (YA1237) can be used for IHC-P experiment in human background.
C3BR,Complement receptor type 1,C3b/C4b receptor,CD35
IHC-P
Human
CD35 Antibody (YA1328) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1328), targeting CD35. CD35 Antibody (YA1328) can be used for IHC-P experiment in human background.
USP28 Antibody (YA1336) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1336), targeting USP28, with a predicted molecular weight of 122 kDa (observed band size: 135 kDa). USP28 Antibody (YA1336) can be used for WB, ICC/IF, FC experiment in human background.
Activated factor Xa heavy chain; Coagulation factor X; F10; factor Xa; FXA; Prothrombinase; Stuart factor
WB, IHC-P
Human
Factor X Antibody (YA1349) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1349), targeting Factor X, with a predicted molecular weight of 55 kDa (observed band size: 74 kDa). Factor X Antibody (YA1349) can be used for WB, IHC-P experiment in human background.
B7H6 Antibody (YA1354) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1354), targeting B7H6. B7H6 Antibody (YA1354) can be used for FC, ELISA experiment in human background.
BTN3A1 Antibody (YA1366) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1366), targeting BTN3A1. BTN3A1 Antibody (YA1366) can be used for FC, ELISA experiment in human background.
NEFL; NF68; NFL; Neurofilament light polypeptide; NF-L; 68 kDa neurofilament protein; Neurofilament triplet L protein
WB, IHC-P, FC, ELISA
Human
NEFL Antibody (YA1425) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1425), targeting NEFL, with a predicted molecular weight of 62 kDa (observed band size: 72 kDa). NEFL Antibody (YA1425) can be used for WB, IHC-P, FC, ELISA experiment in human background.
Nuf2 Antibody (YA1455) is a biotin-conjugated non-conjugated IgG antibody, targeting Nuf2, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Nuf2 Antibody (YA1455) can be used for WB experiment in human background.
LAG3 Antibody (YA1461) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1461), targeting LAG3. LAG3 Antibody (YA1461) can be used for FC, ELISA experiment in human background.
GRM5 Antibody (YA1509) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1509), targeting GRM5, with a predicted molecular weight of 132 kDa. GRM5 Antibody (YA1509) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
STAT5A; STAT5; Signal transducer and activator of transcription 5A
WB, IHC-P
Human, Mouse
Phospho-STAT5(Tyr694) Antibody (YA1513) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1513), targeting Phospho-STAT5(Tyr694), with a predicted molecular weight of 91 kDa . Phospho-STAT5(Tyr694) Antibody (YA1513) can be used for WB, IHC-P experiment in human, mouse background.
SGK1 Antibody (YA1525) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1525), targeting SGK1, with a predicted molecular weight of 49 kDa. SGK1 Antibody (YA1525) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
VPS26 Antibody (YA1546) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1546), targeting VPS26, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). VPS26 Antibody (YA1546) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
XPO1; CRM1; Exportin-1; Exp1; Chromosome region maintenance 1 protein homolog
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
CRM1 Antibody (YA1554) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1554), targeting CRM1, with a predicted molecular weight of 123 kDa (observed band size: 110 kDa). CRM1 Antibody (YA1554) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
FGFR4 Antibody (YA1588) is a biotin-conjugated non-conjugated IgG antibody, targeting FGFR4, with a predicted molecular weight of 88 kDa. FGFR4 Antibody (YA1588) can be used for WB experiment in human, mouse, rat background.
TRPM8 Antibody (YA1609) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1609), targeting TRPM8, with a predicted molecular weight of 128 kDa (observed band size: 128 kDa). TRPM8 Antibody (YA1609) can be used for WB, ICC/IF experiment in human, mouse background.
Importin 9 Antibody (YA1625) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1625), targeting Importin 9, with a predicted molecular weight of 116 kDa (observed band size: 116 kDa). Importin 9 Antibody (YA1625) can be used for WB, ICC/IF, IP experiment in human background.
Niemann Pick C1 Like 1 Antibody (YA1656) is a biotin-conjugated non-conjugated IgG antibody, targeting Niemann Pick C1 Like 1, with a predicted molecular weight of 149 kDa. Niemann Pick C1 Like 1 Antibody (YA1656) can be used for WB experiment in human background.
WTAP Antibody (YA1657) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1657), targeting WTAP, with a predicted molecular weight of 44 kDa (observed band size: 55 kDa). WTAP Antibody (YA1657) can be used for WB, IHC-P, IP experiment in human background.
MYO7A Antibody (YA1665) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1665), targeting MYO7A, with a predicted molecular weight of 254 kDa (observed band size: 254 kDa). MYO7A Antibody (YA1665) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
RNA Polymerases I/II/III Subunit ABC1 Antibody (YA1684) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1684), targeting RNA Polymerases I/II/III Subunit ABC1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). RNA Polymerases I/II/III Subunit ABC1 Antibody (YA1684) can be used for WB, IHC-P experiment in human, mouse, rat background.
MBD3; Methyl-CpG-binding domain protein 3; Methyl-CpG-binding protein MBD3
WB, ICC/IF, IP, FC
Human, Mouse, Rat
MBD3 Antibody (YA1695) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1695), targeting MBD3, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). MBD3 Antibody (YA1695) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
PTF1A Antibody (YA1707) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1707), targeting PTF1A, with a predicted molecular weight of 35 kDa (observed band size: 48 kDa). PTF1A Antibody (YA1707) can be used for WB, IP experiment in human, rat background.
PFDN5 Antibody (YA1717) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1717), targeting PFDN5, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). PFDN5 Antibody (YA1717) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Dopamine Receptor D3 Antibody (YA1742) is a biotin-conjugated non-conjugated IgG antibody, targeting Dopamine Receptor D3, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). Dopamine Receptor D3 Antibody (YA1742) can be used for WB experiment in human, mouse, rat background.
E2F6 Antibody (YA1771) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1771), targeting E2F6, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). E2F6 Antibody (YA1771) can be used for WB, ICC/IF, FC experiment in human background.
ERp28; ERP29_HUMAN; ERp31; HEL S 107; PDI-DB; PDIA9
WB, IHC-P, ICC/IF
Human, Mouse, Rat
ERp29 Antibody (YA1793) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1793), targeting ERp29, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). ERp29 Antibody (YA1793) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
PARK7; Protein DJ-1; Oncogene DJ1; Parkinson disease protein 7
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
PARK7/DJ1 Antibody (YA1799) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1799), targeting PARK7/DJ1, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). PARK7/DJ1 Antibody (YA1799) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Cytochrome P450 1B1 Antibody (YA1836) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1836), targeting Cytochrome P450 1B1, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). Cytochrome P450 1B1 Antibody (YA1836) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
cadherin 4; type 1; R-cadherin (retinal); CAD4; RCAD; R-CAD
WB, IP
Human, Mouse, Rat
R Cadherin Antibody (YA1844) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1844), targeting R Cadherin, with a predicted molecular weight of 100 kDa (observed band size: 130 kDa). R Cadherin Antibody (YA1844) can be used for WB, IP experiment in human, mouse, rat background.
p16 Arc; ARPC5; ARC16; Arp2/3 protein complex subunit p16
WB, IHC-P, IP
Human, Mouse, Rat
p16 ARC Antibody (YA1854) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1854), targeting p16 ARC, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). p16 ARC Antibody (YA1854) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Complex III Subunit 5 Antibody (YA1865) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1865), targeting Complex III Subunit 5, with a predicted molecular weight of 30 kDa (observed band size: 24 kDa). Complex III Subunit 5 Antibody (YA1865) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Interleukin 1 receptor associated kinase 2; IRAK 2; Irak2
WB, IP, FC
Human
IRAK2 Antibody (YA1867) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1867), targeting IRAK2, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). IRAK2 Antibody (YA1867) can be used for WB, IP, FC experiment in human background.
Phospho-Presenilin 2 (Ser330) Antibody (YA1878) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Presenilin 2 (Ser330), with a predicted molecular weight of 50 kDa (observed band size: 23 kDa). Phospho-Presenilin 2 (Ser330) Antibody (YA1878) can be used for WB experiment in human, mouse, rat background.
ApoL1 Antibody (YA1893) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1893), targeting ApoL1, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). ApoL1 Antibody (YA1893) can be used for WB, ICC/IF, IP, FC experiment in human background.
S100 alpha9; Calgranulin-B; Leukocyte L1 complex heavy chain
WB, IHC-F, IHC-P, ICC/IF
Mouse
S100 alpha9 Antibody (YA1894) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1894), targeting S100 alpha9, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). S100 alpha9 Antibody (YA1894) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in mouse background.
Activin Receptor Type IA Antibody (YA1994) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1994), targeting Activin Receptor Type IA, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). Activin Receptor Type IA Antibody (YA1994) can be used for WB, IP experiment in human, mouse background.
ApoH Antibody (YA2042) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2042), targeting ApoH, with a predicted molecular weight of 38 kDa (observed band size: 55 kDa). ApoH Antibody (YA2042) can be used for WB, ICC/IF, IP experiment in human, rat background.
CTNNA1 Antibody (YA2057) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2057), targeting CTNNA1, with a predicted molecular weight of 100 kDa (observed band size: 100 kDa). CTNNA1 Antibody (YA2057) can be used for WB, IP experiment in human, mouse, rat background.
STIP1 Antibody (YA2080) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2080), targeting STIP1, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). STIP1 Antibody (YA2080) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Angiopoietin Like 4 Antibody (YA2090) is a biotin-conjugated non-conjugated IgG antibody, targeting Angiopoietin Like 4, with a predicted molecular weight of 45 kDa (observed band size: 55 kDa). Angiopoietin Like 4 Antibody (YA2090) can be used for WB experiment in human background.
Stromal Interaction Molecule 1 Antibody (YA2092) is a biotin-conjugated non-conjugated IgG antibody, targeting Stromal Interaction Molecule 1, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). Stromal Interaction Molecule 1 Antibody (YA2092) can be used for WB experiment in human, mouse, rat background.
GSTO1 Antibody (YA2095) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2095), targeting GSTO1, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). GSTO1 Antibody (YA2095) can be used for WB, IHC-P, ICC/IF experiment in human, rat background.
Angiotensinogen Antibody (YA2097) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2097), targeting Angiotensinogen, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Angiotensinogen Antibody (YA2097) can be used for WB, IHC-P, IP experiment in mouse background.
PSMD4 Antibody (YA2115) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2115), targeting PSMD4, with a predicted molecular weight of 41 kDa (observed band size: 50 kDa). PSMD4 Antibody (YA2115) can be used for WB, IP, FC experiment in human, mouse, rat background.
DIAPH1 Antibody (YA2160) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2160), targeting DIAPH1, with a predicted molecular weight of 141 kDa (observed band size: 155 kDa). DIAPH1 Antibody (YA2160) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
p24; p25; p25alpha; TPPP; TPPP/p25; TPPP1; Tubulin polymerization promoting protein
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
TPPP Antibody (YA2185) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2185), targeting TPPP, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). TPPP Antibody (YA2185) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Thymidine Kinase Antibody (YA2195) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2195), targeting Thymidine Kinase, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). Thymidine Kinase Antibody (YA2195) can be used for WB, IP experiment in human background.
ATP6V0D1 Antibody (YA2208) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2208), targeting ATP6V0D1, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). ATP6V0D1 Antibody (YA2208) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
SAA4 Antibody (YA2216) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2216), targeting SAA4, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). SAA4 Antibody (YA2216) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
ELMO1; KIAA0281; Engulfment and cell motility protein 1; Protein ced-12 homolog
WB, ICC/IF, IP, FC
Human, Mouse, Rat
ELMO1 Antibody (YA2243) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2243), targeting ELMO1, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). ELMO1 Antibody (YA2243) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
PHF8 Antibody (YA2324) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2324), targeting PHF8, with a predicted molecular weight of 118 kDa (observed band size: 140 kDa). PHF8 Antibody (YA2324) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
AKR1C3 Antibody (YA2338) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2338), targeting AKR1C3, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). AKR1C3 Antibody (YA2338) can be used for WB, ICC/IF, IP, FC experiment in human background.
NR0B1 Antibody (YA2341) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2341), targeting NR0B1, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). NR0B1 Antibody (YA2341) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Prolactin Receptor Antibody (YA2411) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2411), targeting Prolactin Receptor, with a predicted molecular weight of 70 kDa (observed band size: 95 kDa). Prolactin Receptor Antibody (YA2411) can be used for WB experiment in human, mouse, rat background.
DISC1 Antibody (YA2430) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2430), targeting DISC1, with a predicted molecular weight of 94 kDa (observed band size: 100 kDa). DISC1 Antibody (YA2430) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Bravo; hBravo; Neuronal cell adhesion molecule; Ng CAM related; NgCAM related cell adhesion molecule; Nr CAM; Nrcam
WB, IP
Human
NrCAM Antibody (YA2444) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2444), targeting NrCAM, with a predicted molecular weight of 144 kDa (observed band size: 144 kDa). NrCAM Antibody (YA2444) can be used for WB, IP experiment in human background.
Zinc finger protein 160; Zinc finger protein HZF5; Zinc finger protein Kr18
WB, IP
Human, Mouse, Rat
ZNF160 Antibody (YA2453) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2453), targeting ZNF160, with a predicted molecular weight of 94 kDa (observed band size: 74 kDa). ZNF160 Antibody (YA2453) can be used for WB, IP experiment in human, mouse, rat background.
IRF7 Antibody (YA2463) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2463), targeting IRF7, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). IRF7 Antibody (YA2463) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
PIAS1; PIAS2; PIAS3; Protein inhibitor of activated STAT protein 1
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
PIAS1/2 Antibody (YA2475) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2475), targeting PIAS1/2, with a predicted molecular weight of 72 kDa (observed band size: 76 kDa). PIAS1/2 Antibody (YA2475) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
FIG4 Antibody (YA2516) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2516), targeting FIG4, with a predicted molecular weight of 104 kDa (observed band size: 104 kDa). FIG4 Antibody (YA2516) can be used for WB, IP experiment in human background.
CLIC4; Chloride intracellular channel protein 4; Intracellular chloride ion channel protein p64H1
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
CLIC4 Antibody (YA2517) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2517), targeting CLIC4, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). CLIC4 Antibody (YA2517) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
GRP94 Antibody (YA2519) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2519), targeting GRP94, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). GRP94 Antibody (YA2519) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
Neurogenin 2 Antibody (YA2527) is a biotin-conjugated non-conjugated IgG antibody, targeting Neurogenin 2, with a predicted molecular weight of 29 kDa (observed band size: 25 kDa). Neurogenin 2 Antibody (YA2527) can be used for WB experiment in human, mouse, rat background.
COX5B; Cytochrome c oxidase subunit 5B; mitochondrial; Cytochrome c oxidase polypeptide Vb
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
COX5B Antibody (YA2550) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2550), targeting COX5B, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). COX5B Antibody (YA2550) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
SMC protein 3; Bamacan; SMC3; BAM; BMH; CSPG6; SMC3L1
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
SMC3 Antibody (YA2551) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2551), targeting SMC3, with a predicted molecular weight of 142 kDa (observed band size: 142 kDa). SMC3 Antibody (YA2551) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Salivary alpha Amylase Antibody (YA2558) is a biotin-conjugated non-conjugated IgG antibody, targeting Salivary alpha Amylase, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). Salivary alpha Amylase Antibody (YA2558) can be used for WB experiment in human background.
APOM; G3A; NG20; HSPC336; Apolipoprotein M; Apo-M; ApoM; Protein G3a
WB, IHC-P, FC
Human
ApoM Antibody (YA2580) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2580), targeting ApoM, with a predicted molecular weight of 21 kDa (observed band size: 25 kDa). ApoM Antibody (YA2580) can be used for WB, IHC-P, FC experiment in human background.
Apo AIV; APOA 4; ApoA IV; APOA4; Apolipoprotein A IV; Apolipoprotein A4
WB, IP
Human
ApoA4 Antibody (YA2592) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2592), targeting ApoA4, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). ApoA4 Antibody (YA2592) can be used for WB, IP experiment in human background.
Uracil DNA Glycosylase Antibody (YA2598) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2598), targeting Uracil DNA Glycosylase, with a predicted molecular weight of 35 kDa (observed band size: 32 kDa). Uracil DNA Glycosylase Antibody (YA2598) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Cyclophilin F Antibody (YA2602) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2602), targeting Cyclophilin F, with a predicted molecular weight of 22 kDa (observed band size: 18 kDa). Cyclophilin F Antibody (YA2602) can be used for WB, IHC-P experiment in human, mouse, rat background.
PRKCG; PKCG; Protein kinase C gamma type; PKC-gamma
WB, IHC-P
Human, Mouse
Phospho-PKC zeta/lambda (Thr410/Thr412) Antibody (YA2631) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2631), targeting Phospho-PKC zeta/lambda (Thr410/Thr412), with a predicted molecular weight of 78 kDa (observed band size: 78 kDa). Phospho-PKC zeta/lambda (Thr410/Thr412) Antibody (YA2631) can be used for WB, IHC-P experiment in human, mouse background.
DCAMKL1 Antibody (YA2655) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2655), targeting DCAMKL1, with a predicted molecular weight of 82 kDa (observed band size: 82 kDa). DCAMKL1 Antibody (YA2655) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
AK3L1 Antibody (YA2693) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2693), targeting AK3L1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). AK3L1 Antibody (YA2693) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
LHX3 Antibody (YA2698) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2698), targeting LHX3, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). LHX3 Antibody (YA2698) can be used for WB, IP, FC experiment in human, mouse, rat background.
MYL2 Antibody (YA2709) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2709), targeting MYL2, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). MYL2 Antibody (YA2709) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
DYNLL1 Antibody (YA2724) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2724), targeting DYNLL1, with a predicted molecular weight of 10 kDa (observed band size: 10 kDa). DYNLL1 Antibody (YA2724) can be used for WB, IHC-P, IP experiment in human, mouse background.
E2F4 Antibody (YA2728) is a biotin-conjugated non-conjugated IgG antibody, targeting E2F4, with a predicted molecular weight of 44 kDa (observed band size: 65 kDa). E2F4 Antibody (YA2728) can be used for WB experiment in human background.
ECM1; Extracellular matrix protein 1; Secretory component p85
WB, IHC-F, IHC-P, ICC/IF, IP
Human
Extracellular Matrix Protein 1 Antibody (YA2787) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2787), targeting Extracellular Matrix Protein 1, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). Extracellular Matrix Protein 1 Antibody (YA2787) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
UCHL3 Antibody (YA2811) is a biotin-conjugated non-conjugated IgG antibody, targeting UCHL3, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). UCHL3 Antibody (YA2811) can be used for WB experiment in human, mouse, rat background.
GLB1 Antibody (YA2816) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2816), targeting GLB1, with a predicted molecular weight of 76 kDa (observed band size: 95 kDa). GLB1 Antibody (YA2816) can be used for WB, FC experiment in human, mouse, rat background.
HIF Prolyl Hydroxylases Antibody (YA2975) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2975), targeting HIF Prolyl Hydroxylases, with a predicted molecular weight of 57 kDa (observed band size: 43 kDa). HIF Prolyl Hydroxylases Antibody (YA2975) can be used for WB, IHC-P, IP experiment in human background.
DNM3; Dyn3; DynaIII; dynamin 2; Dynamin; Dynamin3; T dynamin
WB
Human, Mouse
Dynamin 3 Antibody (YA2979) is a biotin-conjugated non-conjugated IgG antibody, targeting Dynamin 3, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). Dynamin 3 Antibody (YA2979) can be used for WB experiment in human, mouse background.
Cytokeratin 12 Antibody (YA3004) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3004), targeting Cytokeratin 12, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Cytokeratin 12 Antibody (YA3004) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Homeobox protein Hox-B9; Hox-2E; Hox-2.5; HOXB9; HOX2E
WB, ICC/IF, IP
Human
HOXB9 Antibody (YA3017) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3017), targeting HOXB9, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). HOXB9 Antibody (YA3017) can be used for WB, ICC/IF, IP experiment in human background.
PHOX2B Antibody (YA3028) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3028), targeting PHOX2B, with a predicted molecular weight of 32 kDa (observed band size: 35 kDa). PHOX2B Antibody (YA3028) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
LIG1; DNA ligase 1; DNA ligase I; Polydeoxyribonucleotide synthase [ATP] 1
WB, IHC-F, IHC-P, ICC/IF
Human, Rat
LIG1 Antibody (YA3038) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3038), targeting LIG1, with a predicted molecular weight of 102 kDa (observed band size: 102 kDa). LIG1 Antibody (YA3038) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
LINE 1 ORF1p Antibody (YA3039) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3039), targeting LINE 1 ORF1p, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). LINE 1 ORF1p Antibody (YA3039) can be used for WB, IP experiment in human background.
ITPA Antibody (YA3104) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3104), targeting ITPA, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). ITPA Antibody (YA3104) can be used for WB, IHC-P experiment in human background.
PTBP1 Antibody (YA3189) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3189), targeting PTBP1, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). PTBP1 Antibody (YA3189) can be used for WB, IHC-P experiment in human, mouse, hamster background.
Semaphorin 7A Antibody (YA3232) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3232), targeting Semaphorin 7A, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). Semaphorin 7A Antibody (YA3232) can be used for WB, IHC-P, IP experiment in human background.
TRAPPC2 Antibody (YA3287) is a biotin-conjugated non-conjugated IgG antibody, targeting TRAPPC2, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). TRAPPC2 Antibody (YA3287) can be used for WB experiment in human background.
delta Sarcoglycan Antibody (YA3326) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3326), targeting delta Sarcoglycan, with a predicted molecular weight of 32 kDa (observed band size: 35 kDa). delta Sarcoglycan Antibody (YA3326) can be used for WB, IHC-P, IP experiment in human background.
CD66c; CEACAM6; CEAL; NCA; Non specific cross reacting antigen; Normal cross reacting antigen
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
CEACAM6 Antibody (YA3351) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3351), targeting CEACAM6, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). CEACAM6 Antibody (YA3351) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
LILRB4/CD85k Antibody is a non-conjugated and Mouse origined monoclonal antibody , targeting to LILRB4/CD85k. It can be used for IHC-P,ICC/IF,FC,ELISA assays with tag free, in the background of Human.
beta III Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta III Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
C3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to C3. It can be used for WB,IHC-P assays with tag free, in the background of Human.
CaMK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to CaMK1. It can be used for WB assays with tag free, in the background of Mouse, Rat.
CRK Antibody (YA790) is a non-conjugated and Mouse origined monoclonal antibody about 34 kDa, targeting to CRK (3H7). It can be used for WB assays with tag free, in the background of Human.
Cyclin D1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 34 kDa, targeting to Cyclin D1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
KGF Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to KGF. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Mitofusin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Mitofusin 1. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat, Hamster.
MMP12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MMP12. It can be used for WB,IP assays with tag free, in the background of Human, Rat, Hamster.
Phospho-GSK3 (Tyr216/Tyr279) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Phospho-GSK3 (Tyr216/Tyr279). It can be used for WB,IP assays with tag free, in the background of Mouse, Rat.
STAT3; APRF; Signal transducer and activator of transcription 3; Acute-phase response factor
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Phospho-STAT3 (Tyr705) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 88 kDa, targeting to Phospho-STAT3 (Tyr705). It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Dxd, OQM5SD32BQ, UNII-OQM5SD32BQ, Exatecan derivative, Exatecan derivative for ADC
ELISA
Species independent
DXd Antibody (YA897) is an unconjugated, mouse-derived, anti-DXd (YA897) monoclonal antibody. DXd Antibody (YA897) can be used for: ELISA expriments in species-independent background without labeling.
L glycoprotein; L-HBsAg; LHB; Large S protein; Large surface protein; Major surface antigen; S; HBSAG_HBVC5.
ELISA
HBsAg Antibody (YA913) is an unconjugated, approximately 44 kDa, mouse-derived, anti-HBsAg (YA913) monoclonal antibody. HBsAg Antibody (YA913) can be used for: ELISA, expriments without labeling.
Aquaporin 5 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-Aquaporin 5 polyclonal antibody. Aquaporin 5 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, sheep background without labeling.
CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR
WB
Human
CAMKIV Antibody (YA942) is a biotin-conjugated non-conjugated IgG2a antibody, targeting CAMKIV, with a predicted molecular weight of 52 kDa (observed band size: 55 kDa). CAMKIV Antibody (YA942) can be used for WB experiment in human background.
CAMK4; CAMK; CAMK-GR; CAMKIV; Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR
WB, IHC-P, ICC/IF, IP, FC
Human
CAMKIV Antibody (YA943) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA943), targeting CAMKIV, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). CAMKIV Antibody (YA943) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
15 Lipoxygenase 1 Antibody (YA1091) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1091), targeting 15 Lipoxygenase 1. 15 Lipoxygenase 1 Antibody (YA1091) can be used for IHC-P experiment in human background.
DNA helicase V; FBP; FUBP; Fubp1; Fubp4; FUSE-binding protein 1; HDH V
IHC-P
Human
FUBP1 Antibody (YA1119) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1119), targeting FUBP1. FUBP1 Antibody (YA1119) can be used for IHC-P experiment in human background.
Brk/PTK6 Antibody (YA1203) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1203), targeting Brk/PTK6. Brk/PTK6 Antibody (YA1203) can be used for IHC-P experiment in human background.
NR0B1/DAX1 Antibody (YA1205) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1205), targeting NR0B1/DAX1. NR0B1/DAX1 Antibody (YA1205) can be used for IHC-P experiment in human background.
TP73; P73; Tumor protein p73; p53-like transcription factor; p53-related protein
IHC-P
Human
p73 Antibody (YA1240) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1240), targeting p73. p73 Antibody (YA1240) can be used for IHC-P experiment in human background.
CD163L1 Antibody (YA1258) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1258), targeting CD163L1. CD163L1 Antibody (YA1258) can be used for IHC-P experiment in human background.
Periostin Antibody (YA1280) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1280), targeting Periostin. Periostin Antibody (YA1280) can be used for IHC-P experiment in human background.
LMAN1 Antibody (YA1427) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1427), targeting LMAN1, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). LMAN1 Antibody (YA1427) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
CD114 Antibody (YA1431) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1431), targeting CD114. CD114 Antibody (YA1431) can be used for FC, ELISA experiment in human background.
APO A2; Apo AII; APOA 2; ApoA II; APOA2; APOAII; Apolipoprotein A II
WB, ICC/IF, FC
Human, Rat
ApoA2 Antibody (YA1459) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1459), targeting ApoA2, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). ApoA2 Antibody (YA1459) can be used for WB, ICC/IF, FC experiment in human, rat background.
CD220; HHF5; human insulin receptor; Insr; Insulin receptor subunit beta; IR 1; IR
WB, ICC/IF
Human, Rat
Insulin Receptor Antibody (YA1540) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1540), targeting Insulin Receptor, with a predicted molecular weight of 156 kDa (observed band size: 95 kDa). Insulin Receptor Antibody (YA1540) can be used for WB, ICC/IF experiment in human, rat background.
SAMHD1 Antibody (YA1542) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1542), targeting SAMHD1, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). SAMHD1 Antibody (YA1542) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
E3 ubiquitin-protein ligase RNF115; Rabring 7; Zinc finger protein 364
WB
Human, Rat
ZNF364 Antibody (YA1579) is a biotin-conjugated non-conjugated IgG antibody, targeting ZNF364, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). ZNF364 Antibody (YA1579) can be used for WB experiment in human, rat background.
SDHB; SDH; SDH1; Succinate dehydrogenase [ubiquinone] iron-sulfur subunit; mitochondrial; Iron-sulfur subunit of complex II; Ip
WB, IHC-P, IP, FC
Human, Mouse, Rat
SDHB Antibody (YA1580) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1580), targeting SDHB, with a predicted molecular weight of 32 kDa. SDHB Antibody (YA1580) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
P2Y6 Antibody (YA1691) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1691), targeting P2Y6, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). P2Y6 Antibody (YA1691) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
LI Cadherin Antibody (YA1709) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1709), targeting LI Cadherin, with a predicted molecular weight of 92 kDa (observed band size: 120 kDa). LI Cadherin Antibody (YA1709) can be used for WB, IHC-P, IP experiment in human background.
PSEN1; AD3; PS1; PSNL1; Presenilin-1; PS-1; Protein S182
WB, ICC/IF, IP
Human, Mouse, Rat
Presenilin 1 Antibody (YA1722) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1722), targeting Presenilin 1, with a predicted molecular weight of 53 kDa (observed band size: 20 kDa). Presenilin 1 Antibody (YA1722) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
KAT13A Antibody (YA1735) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1735), targeting KAT13A, with a predicted molecular weight of 157 kDa (observed band size: 157 kDa). KAT13A Antibody (YA1735) can be used for WB, IHC-P, IP experiment in human background.
Proteasome alpha 6 Antibody (YA1749) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1749), targeting Proteasome alpha 6, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). Proteasome alpha 6 Antibody (YA1749) can be used for WB, ICC/IF experiment in human, mouse, rat background.
betaR; CXC11; CXCL11; H174; I TAC; IP9; ITAC; SCYB11; SCYB9B
WB, ICC/IF
Human
CXCL11 Antibody (YA1769) is a biotin-conjugated non-conjugated IgG antibody, targeting CXCL11, with a predicted molecular weight of 10 kDa. CXCL11 Antibody (YA1769) can be used for WB, ICC/IF experiment in human background.
PUM1 Antibody (YA1781) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1781), targeting PUM1, with a predicted molecular weight of 126 kDa (observed band size: 140 kDa). PUM1 Antibody (YA1781) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
LIG1; DNA ligase 1; DNA ligase I; Polydeoxyribonucleotide synthase [ATP] 1
WB, IHC-P, ICC/IF
Human, Rat
DNA Ligase I Antibody (YA1790) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1790), targeting DNA Ligase I, with a predicted molecular weight of 102 kDa (observed band size: 140 kDa). DNA Ligase I Antibody (YA1790) can be used for WB, IHC-P, ICC/IF experiment in human, rat background.
CRLR activity-modifying protein 1; Calcitonin-receptor-like receptor activity-modifying protein 1
WB
Human, Mouse, Rat
RAMP1 Antibody (YA1818) is a biotin-conjugated non-conjugated IgG antibody, targeting RAMP1, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). RAMP1 Antibody (YA1818) can be used for WB experiment in human, mouse, rat background.
hnRNP C1/C2 Antibody (YA1874) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1874), targeting hnRNP C1/C2, with a predicted molecular weight of 34 kDa (observed band size: 40 kDa). hnRNP C1/C2 Antibody (YA1874) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Septin 7 Antibody (YA1927) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1927), targeting Septin 7, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Septin 7 Antibody (YA1927) can be used for WB, ICC/IF experiment in human, mouse, rat background.
CDK5RAP3 Antibody (YA1928) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1928), targeting CDK5RAP3, with a predicted molecular weight of 57 kDa (observed band size: 70 kDa). CDK5RAP3 Antibody (YA1928) can be used for WB, IHC-P, IP experiment in human, mouse background.
CP64; L plastin; LC64P; LCP1; LPL; Lplastin; Plastin 2; PLS2
WB, IHC-P, ICC/IF
Human, Mouse, Rat
Plastin L Antibody (YA1942) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1942), targeting Plastin L, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). Plastin L Antibody (YA1942) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Neurofilament light polypeptide Antibody (YA1961) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1961), targeting Neurofilament light polypeptide, with a predicted molecular weight of 62 kDa (observed band size: 68 kDa). Neurofilament light polypeptide Antibody (YA1961) can be used for WB, IHC-P, IP experiment in mouse background.
Collagen XI alpha 1 Antibody (YA1976) is a biotin-conjugated non-conjugated IgG antibody, targeting Collagen XI alpha 1, with a predicted molecular weight of 181 kDa (observed band size: 150 kDa). Collagen XI alpha 1 Antibody (YA1976) can be used for WB experiment in human background.
MLLT10; AF10; Protein AF-10; ALL1-fused gene from chromosome 10 protein
WB, IHC-P
Human
AF10 Antibody (YA2017) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2017), targeting AF10, with a predicted molecular weight of 113 kDa (observed band size: 140 kDa). AF10 Antibody (YA2017) can be used for WB, IHC-P experiment in human background.
Tomoregulin 2 Antibody (YA2035) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2035), targeting Tomoregulin 2, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Tomoregulin 2 Antibody (YA2035) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
CEND1; BM88; Cell cycle exit and neuronal differentiation protein 1; BM88 antigen
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
CEND1 Antibody (YA2129) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2129), targeting CEND1, with a predicted molecular weight of 15 kDa (observed band size: 22 kDa). CEND1 Antibody (YA2129) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
AP2S1 Antibody (YA2132) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2132), targeting AP2S1, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). AP2S1 Antibody (YA2132) can be used for WB, IP, FC experiment in human, mouse, rat background.
Ah receptor; AhR; Class E basic helix-loop-helix protein 76; bHLHe76; AHR
WB
Human
Aryl Hydrocarbon Receptor Antibody (YA2162) is a biotin-conjugated non-conjugated IgG antibody, targeting Aryl Hydrocarbon Receptor, with a predicted molecular weight of 96 kDa (observed band size: 100 kDa). Aryl Hydrocarbon Receptor Antibody (YA2162) can be used for WB experiment in human background.
APT1; hAPT1; LPL1; LYPLA1; Lysophospholipase 1; LYSOPLA; LysoPLA I
WB, ICC/IF, FC
Human, Mouse, Rat
Lysophospholipase 1 Antibody (YA2197) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2197), targeting Lysophospholipase 1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). Lysophospholipase 1 Antibody (YA2197) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Cellular Apoptosis Susceptibility Antibody (YA2264) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2264), targeting Cellular Apoptosis Susceptibility, with a predicted molecular weight of 110 kDa (observed band size: 98 kDa). Cellular Apoptosis Susceptibility Antibody (YA2264) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
EWSR1; EWS; RNA-binding protein EWS; EWS oncogene; Ewing sarcoma breakpoint region 1 protein
WB, IHC-P, ICC/IF
Human, Mouse, Rat
EWSR1 Antibody (YA2270) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2270), targeting EWSR1, with a predicted molecular weight of 68 kDa (observed band size: 85 kDa). EWSR1 Antibody (YA2270) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Rab4; RAB4A; HRES 1; RAB4; Ras related protein Rab 4A
WB, ICC/IF, FC
Human, Mouse, Rat
Rab4 Antibody (YA2272) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2272), targeting Rab4, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). Rab4 Antibody (YA2272) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
TRIM24 Antibody (YA2273) is a biotin-conjugated non-conjugated IgG antibody, targeting TRIM24, with a predicted molecular weight of 117 kDa (observed band size: 117 kDa). TRIM24 Antibody (YA2273) can be used for WB experiment in human background.
DUSP6 Antibody (YA2280) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2280), targeting DUSP6, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). DUSP6 Antibody (YA2280) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Cernunno; Nhej1; Non homologous end joining factor 1; Protein cernunnos; XLF; XRCC4 like factor
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
XLF Antibody (YA2300) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2300), targeting XLF, with a predicted molecular weight of 33 kDa (observed band size: 39 kDa). XLF Antibody (YA2300) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
APO C1; Apo CI; APOC 1; ApoC I; APOC1; APOC1B; ApolipoproteinCI
WB, IHC-P, ICC/IF, IP, FC
Human
ApoC1 Antibody (YA2348) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2348), targeting ApoC1, with a predicted molecular weight of 9 kDa (observed band size: 9 kDa). ApoC1 Antibody (YA2348) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
FASPS; FASPS1; hPER 2; hPER2; KIAA0347; PER2; Period 2
WB, ICC/IF, FC
Human
PER2 Antibody (YA2353) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2353), targeting PER2, with a predicted molecular weight of 137 kDa (observed band size: 137 kDa). PER2 Antibody (YA2353) can be used for WB, ICC/IF, FC experiment in human background.
Estrogen Inducible Protein pS2 Antibody (YA2377) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2377), targeting Estrogen Inducible Protein pS2, with a predicted molecular weight of 9 kDa (observed band size: 9 kDa). Estrogen Inducible Protein pS2 Antibody (YA2377) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
Nogo Receptor Antibody (YA2405) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2405), targeting Nogo Receptor, with a predicted molecular weight of 51 kDa (observed band size: 66 kDa). Nogo Receptor Antibody (YA2405) can be used for WB, IP experiment in human, mouse background.
XPD Antibody (YA2434) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2434), targeting XPD, with a predicted molecular weight of 87 kDa (observed band size: 80 kDa). XPD Antibody (YA2434) can be used for WB, ICC/IF experiment in human background.
RNA Polymerase II Subunit B3 Antibody (YA2447) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2447), targeting RNA Polymerase II Subunit B3, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). RNA Polymerase II Subunit B3 Antibody (YA2447) can be used for WB, IHC-P experiment in human, mouse, rat background.
GATA3 Antibody (YA2499) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2499), targeting GATA3, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). GATA3 Antibody (YA2499) can be used for WB, IHC-P, ICC/IF, ChIP, FC experiment in human background.
Clusterin alpha Chain Antibody (YA2525) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2525), targeting Clusterin alpha Chain, with a predicted molecular weight of 52 kDa (observed band size: 42 kDa). Clusterin alpha Chain Antibody (YA2525) can be used for WB, IP experiment in rat background.
Keratin; type I cytoskeletal 17; Cytokeratin-17; CK-17; Keratin-17; K17
WB, IHC-P, IP
Human
Cytokeratin 17 Antibody (YA2534) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2534), targeting Cytokeratin 17, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). Cytokeratin 17 Antibody (YA2534) can be used for WB, IHC-P, IP experiment in human background.
CDC25C Antibody (YA2624) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2624), targeting CDC25C, with a predicted molecular weight of 53 kDa (observed band size: 60 kDa). CDC25C Antibody (YA2624) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
Nicotinic Acetylcholine Receptor alpha 5 Antibody (YA2659) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2659), targeting Nicotinic Acetylcholine Receptor alpha 5, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). Nicotinic Acetylcholine Receptor alpha 5 Antibody (YA2659) can be used for WB, IP, FC experiment in human, mouse, rat background.
Phospho-TAOK1/2/3 (Ser181/Ser181/Ser177) Antibody (YA2660) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2660), targeting Phospho-TAOK1/2/3 (Ser181/Ser181/Ser177), with a predicted molecular weight of 116 kDa (observed band size: 105,116,138 kDa). Phospho-TAOK1/2/3 (Ser181/Ser181/Ser177) Antibody (YA2660) can be used for WB, IHC-P experiment in human, mouse, rat background.
LIG4; DNA ligase 4; DNA ligase IV; Polydeoxyribonucleotide synthase [ATP] 4
WB
Human
DNA Ligase IV Antibody (YA2699) is a biotin-conjugated non-conjugated IgG antibody, targeting DNA Ligase IV, with a predicted molecular weight of 104 kDa (observed band size: 104 kDa). DNA Ligase IV Antibody (YA2699) can be used for WB experiment in human background.
MCM4; CDC21; DNA replication licensing factor MCM4; CDC21 homolog; P1-CDC21
WB, IP, FC
Human, Mouse
MCM4 Antibody (YA2708) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2708), targeting MCM4, with a predicted molecular weight of 97 kDa (observed band size: 97 kDa). MCM4 Antibody (YA2708) can be used for WB, IP, FC experiment in human, mouse background.
RhoGAP Antibody (YA2819) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2819), targeting RhoGAP, with a predicted molecular weight of 172 kDa (observed band size: 190 kDa). RhoGAP Antibody (YA2819) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
FLI1 Antibody (YA2837) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2837), targeting FLI1, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). FLI1 Antibody (YA2837) can be used for WB, IHC-P experiment in human, rat background.
PEX19 Antibody (YA2888) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2888), targeting PEX19, with a predicted molecular weight of 33 kDa (observed band size: 35,40 kDa). PEX19 Antibody (YA2888) can be used for WB, ICC/IF, IP, FC experiment in human, rat background.
GCLC Antibody (YA2898) is a biotin-conjugated non-conjugated IgG antibody, targeting GCLC, with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). GCLC Antibody (YA2898) can be used for WB experiment in human, mouse, rat background.
Talin 2 Antibody (YA2933) is a biotin-conjugated non-conjugated IgG antibody, targeting Talin 2, with a predicted molecular weight of 272 kDa (observed band size: 272 kDa). Talin 2 Antibody (YA2933) can be used for WB experiment in human, mouse, rat background.
KMT6 Antibody (YA3032) is a biotin-conjugated non-conjugated IgG antibody, targeting KMT6, with a predicted molecular weight of 85 kDa (observed band size: 98 kDa). KMT6 Antibody (YA3032) can be used for WB experiment in human background.
Tuberin Antibody (YA3037) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3037), targeting Tuberin, with a predicted molecular weight of 201 kDa (observed band size: 201 kDa). Tuberin Antibody (YA3037) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
MLRW; HLA-DRA1; MHC class II antigen DRA; HLA class II histocompatibility antigen; DR alpha chain
WB, IHC-P, ICC/IF, FC
Human
HLA DR Antibody (YA3084) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3084), targeting HLA DR, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). HLA DR Antibody (YA3084) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Hsp20 Antibody (YA3174) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3174), targeting Hsp20, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Hsp20 Antibody (YA3174) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
NCAM1 Antibody (YA3222) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3222), targeting NCAM1, with a predicted molecular weight of 95 kDa (observed band size: 180 kDa). NCAM1 Antibody (YA3222) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
TAOK1 Antibody (YA3259) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3259), targeting TAOK1, with a predicted molecular weight of 116 kDa (observed band size: 116 kDa). TAOK1 Antibody (YA3259) can be used for WB, IP experiment in human, mouse, rat background.
Drebrin Antibody (YA3318) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3318), targeting Drebrin, with a predicted molecular weight of 71 kDa (observed band size: 120 kDa). Drebrin Antibody (YA3318) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Ephrin B2 Antibody (YA3385) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3385), targeting Ephrin B2, with a predicted molecular weight of 37 kDa (observed band size: 50 kDa). Ephrin B2 Antibody (YA3385) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MPO Antibody is an unconjugated, approximately 84 kDa, mouse-derived, anti-MPO monoclonal antibody. MPO Antibody can be used for: WB, IHC-P, IF-Cell, IF-Tissue expriments in human, mouse, rat background without labeling.
IL-3RB Antibody is a non-conjugated and mouse origined monoclonal antibody about 97 kDa, targeting to IL-3RB. It can be used for WB,IHC-P,FC,ELISA assays with tag free, in the background of Huma,Mouse,Rat.
LDLR Antibody is an unconjugated, approximately 92 kDa, rabbit-derived, anti-LDLR monoclonal antibody. LDLR Antibody can be used for: WB, IHC-P expriments in human, mouse background without labeling.
SPI1 Antibody (YA118) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PU.1. It can be used for WB,IHC-P assays with tag free, in the background of Human.
ICAM1; Intercellular adhesion molecule 1; ICAM-1; Major group rhinovirus receptor; CD antigen CD54
WB, IHC-P, ICC/IF, FC
Human
ICAM1 Antibody (YA725) is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human.
AIFM1; AIF; PDCD8; Apoptosis-inducing factor 1; mitochondrial; Programmed cell death protein 8
WB, ICC/IF
Human
AIF Antibody (YA835) is a non-conjugated and Mouse origined monoclonal antibody about 67 kDa, targeting to AIF (8H1). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
ICAM1; Intercellular adhesion molecule 1; ICAM-1; Major group rhinovirus receptor; CD antigen CD54
WB, IHC-P, IP
Human
ICAM1 Antibody (YA352) is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 266 kDa, targeting to Phospho-Acetyl Coenzyme A Carboxylase (Ser79). It can be used for WB assays with tag free, in the background of Human.
PRKAR2A; PKR2; PRKAR2; cAMP-dependent protein kinase type II-alpha regulatory subunit
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat, Pig
Phospho-PKA RII alpha (Ser99) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 46 kDa, targeting to Phospho-PKA RII alpha (Ser99). It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Pig.
Phospho-Tau (Ser198) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser198). It can be used for WB,IP assays with tag free, in the background of Human.
Phospho-Tau (Ser404) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Ser404). It can be used for WB assays with tag free, in the background of Human, Rat.
Phospho-Tau (Thr181) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Thr181). It can be used for WB,IP assays with tag free, in the background of Human.
p53 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to p53 tumor protein. It can be used for WB,IHC,IF, ELISA assays in the background of Human, Mouse, Rat, Monkey.
Myb-like; SWIRM and MPN domains 1; 2ADUB; 2A-DUB; RP4-592A1.1
WB, IHC-P
Human, Mouse
MYSM1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 95 kDa, targeting to MYSM1. It can be used for WB,IHC-P assays in the background of Human, Mouse.
CREB1; Cyclic AMP-responsive element-binding protein 1; CREB-1; cAMP-responsive element-binding protein 1
WB, ICC/IF, IHC-P
Human, Mouse, Rat
FMRP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to FMRP. It can be used for WB, IF-Cell, IF-Tissue, IHC-P assays with tag free, in the background of Human, Mouse, Rat.
FOXO1; FKHR; FOXO1A; Forkhead box protein O1; Forkhead box protein O1A; Forkhead in rhabdomyosarcoma
WB, IHC-F, IHC-P, ICC/IF, ELISA, ChIP
Human, Mouse, Rat, Pig
FOXO1 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting FOXO1, with a predicted molecular weight of 78 kDa . FOXO1 Antibody can be used for WB, IHC-F, IHC-P, ICC/IF, ELISA, ChIP experiments in human, mouse, rat, pig backgrounds.
PODXL Antibody (YA1100) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1100), targeting PODXL. PODXL Antibody (YA1100) can be used for IHC-P experiment in human background.
Nampt Antibody (YA1183) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1183), targeting Nampt. Nampt Antibody (YA1183) can be used for IHC-P experiment in human background.
HMGA2; HMGIC; High mobility group protein HMGI-C; High mobility group AT-hook protein 2
IHC-P
Human
HMGA2 Antibody (YA1186) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1186), targeting HMGA2. HMGA2 Antibody (YA1186) can be used for IHC-P experiment in human background.
NKX6-1; NKX6A; Homeobox protein Nkx-6.1; Homeobox protein NK-6 homolog A
IHC-P
Human
NKX6.1 Antibody (YA1219) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1219), targeting NKX6.1. NKX6.1 Antibody (YA1219) can be used for IHC-P experiment in human background.
Calpain Small Subunit 1 Antibody (YA1221) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1221), targeting Calpain Small Subunit 1. Calpain Small Subunit 1 Antibody (YA1221) can be used for IHC-P experiment in human background.
Sialoadhesin/CD169 Antibody (YA1260) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1260), targeting Sialoadhesin/CD169. Sialoadhesin/CD169 Antibody (YA1260) can be used for IHC-P experiment in human background.
CD207; CD207 antigen; langerin; CD207 molecule; CLEC4K; Langerhans cell specific c type lectin; Langerin
IHC-P
Human
Langerin Antibody (YA1266) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1266), targeting Langerin. Langerin Antibody (YA1266) can be used for IHC-P experiment in human background.
CD27 Antibody (YA1278) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1278), targeting CD27. CD27 Antibody (YA1278) can be used for IHC-P experiment in human background.
EPHA2 Antibody (YA1339) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1339), targeting EPHA2. EPHA2 Antibody (YA1339) can be used for FC, ELISA experiment in human background.
MALT1 Antibody (YA1341) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1341), targeting MALT1, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). MALT1 Antibody (YA1341) can be used for WB, ICC/IF, FC experiment in human background.
Nesprin3 Antibody (YA1371) is a biotin-conjugated non-conjugated IgG antibody, targeting Nesprin3, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). Nesprin3 Antibody (YA1371) can be used for WB experiment in human background.
NEFH; KIAA0845; NFH; Neurofilament heavy polypeptide; NF-H; 200 kDa neurofilament protein; Neurofilament triplet H protein
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
Neurofilament Heavy Polypeptide Antibody (YA1378) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1378), targeting Neurofilament Heavy Polypeptide, with a predicted molecular weight of 112 kDa (observed band size: 180-220 kDa). Neurofilament Heavy Polypeptide Antibody (YA1378) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
KLRG1 Antibody (YA1422) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1422), targeting KLRG1. KLRG1 Antibody (YA1422) can be used for FC, ELISA experiment in human background.
BCMA Antibody (YA1501) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1501), targeting BCMA. BCMA Antibody (YA1501) can be used for FC, ELISA experiment in human background.
HIP 1; hip1; HIP1/PDGFRB fusion gene; HIPI; Huntingtin interacting protein 1
WB, ICC/IF, IP
Human, Mouse, Rat
HIP1 Antibody (YA1523) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1523), targeting HIP1, with a predicted molecular weight of 116 kDa (observed band size: 116 kDa). HIP1 Antibody (YA1523) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Prostate Specific Antigen Antibody (YA1537) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1537), targeting Prostate Specific Antigen, with a predicted molecular weight of 29 kDa (observed band size: 34 kDa). Prostate Specific Antigen Antibody (YA1537) can be used for WB, IHC-P experiment in human background.
Pellino 1 Antibody (YA1575) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1575), targeting Pellino 1, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). Pellino 1 Antibody (YA1575) can be used for WB, IP experiment in human, rat background.
Phospho-PRKD2 (Ser876) Antibody (YA1662) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1662), targeting Phospho-PRKD2 (Ser876), with a predicted molecular weight of 97 kDa (observed band size: 105 kDa). Phospho-PRKD2 (Ser876) Antibody (YA1662) can be used for WB, IP experiment in human background.
A esterase 1; Arylesterase 1; ESA; MVCD5; Paraoxonase 1; PON1
WB, IHC-P, IP
Human
PON1 Antibody (YA1666) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1666), targeting PON1, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). PON1 Antibody (YA1666) can be used for WB, IHC-P, IP experiment in human background.
POT1; Protection of telomeres protein 1; hPot1; POT1-like telomere end-binding protein
WB
Human, Mouse, Rat
POT1 Antibody (YA1690) is a biotin-conjugated non-conjugated IgG antibody, targeting POT1, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). POT1 Antibody (YA1690) can be used for WB experiment in human, mouse, rat background.
Protein phosphatase 1G; PP2C-gamma; Protein phosphatase magnesium-dependent 1 gamma
WB
Human, Mouse, Rat
PPM1G Antibody (YA1698) is a biotin-conjugated non-conjugated IgG antibody, targeting PPM1G, with a predicted molecular weight of 59 kDa (observed band size: 75 kDa). PPM1G Antibody (YA1698) can be used for WB experiment in human, mouse, rat background.
PDE4D Antibody (YA1714) is a biotin-conjugated non-conjugated IgG antibody, targeting PDE4D, with a predicted molecular weight of 91 kDa (observed band size: 91 kDa). PDE4D Antibody (YA1714) can be used for WB experiment in human background.
Proteasome alpha 2 Antibody (YA1744) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1744), targeting Proteasome alpha 2, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). Proteasome alpha 2 Antibody (YA1744) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Cytokeratin 4 Antibody (YA1762) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1762), targeting Cytokeratin 4, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). Cytokeratin 4 Antibody (YA1762) can be used for WB, IP experiment in human, rat background.
Meis homeobox 2; Meis1 related gene 1; MEIS2; MGC2820; MRG1
WB, FC
Human, Mouse, Rat
MEIS2 Antibody (YA1778) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1778), targeting MEIS2, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). MEIS2 Antibody (YA1778) can be used for WB, FC experiment in human, mouse, rat background.
GAD67 Antibody (YA1807) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1807), targeting GAD67, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). GAD67 Antibody (YA1807) can be used for WB, IP experiment in human background.
Sulfotransferase 2A1 Antibody (YA1861) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1861), targeting Sulfotransferase 2A1, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). Sulfotransferase 2A1 Antibody (YA1861) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
RhoGDI Antibody (YA1863) is a biotin-conjugated non-conjugated IgG antibody, targeting RhoGDI, with a predicted molecular weight of 23 kDa (observed band size: 26 kDa). RhoGDI Antibody (YA1863) can be used for WB experiment in human, mouse, rat background.
SCARB1 Antibody (YA1908) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1908), targeting SCARB1, with a predicted molecular weight of 61 kDa (observed band size: 80 kDa). SCARB1 Antibody (YA1908) can be used for WB, IP experiment in human, mouse background.
SET Antibody (YA1935) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1935), targeting SET, with a predicted molecular weight of 33 kDa (observed band size: 39 kDa). SET Antibody (YA1935) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Ubiquitin Conjugating Enzyme E2 N Antibody (YA1978) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1978), targeting Ubiquitin Conjugating Enzyme E2 N, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Ubiquitin Conjugating Enzyme E2 N Antibody (YA1978) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
SLCO5A1 Antibody (YA1991) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1991), targeting SLCO5A1, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). SLCO5A1 Antibody (YA1991) can be used for WB, IHC-P experiment in human, mouse background.
IKZF3; ZNFN1A3; Zinc finger protein Aiolos; Ikaros family zinc finger protein 3
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
IKZF3 Antibody (YA2116) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2116), targeting IKZF3, with a predicted molecular weight of 58 kDa (observed band size: 70 kDa). IKZF3 Antibody (YA2116) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SMN1; SMN; SMNT; SMN2; SMNC; Survival motor neuron protein; Component of gems 1; Gemin-1
WB, IHC-P, IP
Human, Mouse, Rat
SMN Antibody (YA2194) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2194), targeting SMN, with a predicted molecular weight of 32 kDa (observed band size: 36 kDa). SMN Antibody (YA2194) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
IGHG2; immunoglobulin Gm2; immunoglobulin heavy constant gamma 2 (G2m marker)
WB, IHC-P, ICC/IF
Human
Human IgG2 Antibody (YA2196) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2196), targeting Human IgG2, with a predicted molecular weight of 36 kDa (observed band size: 53 kDa). Human IgG2 Antibody (YA2196) can be used for WB, IHC-P, ICC/IF experiment in human background.
GABA A Receptor alpha 5 Antibody (YA2249) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2249), targeting GABA A Receptor alpha 5, with a predicted molecular weight of 52 kDa (observed band size: 70 kDa). GABA A Receptor alpha 5 Antibody (YA2249) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PSMD14 Antibody (YA2250) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2250), targeting PSMD14, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). PSMD14 Antibody (YA2250) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Septin 2 Antibody (YA2254) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2254), targeting Septin 2, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Septin 2 Antibody (YA2254) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
SMC4 Antibody (YA2340) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2340), targeting SMC4, with a predicted molecular weight of 147 kDa (observed band size: 160 kDa). SMC4 Antibody (YA2340) can be used for WB, ICC/IF, FC experiment in human, mouse background.
Distal less homeo box 5; Dlx 5; Homeo box protein DLX 5
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
DLX5 Antibody (YA2342) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2342), targeting DLX5, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). DLX5 Antibody (YA2342) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Phospho-Cannabinoid Receptor I (Ser316) Antibody (YA2350) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Cannabinoid Receptor I (Ser316), with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). Phospho-Cannabinoid Receptor I (Ser316) Antibody (YA2350) can be used for WB experiment in human background.
Complex III Subunit 7 Antibody (YA2358) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2358), targeting Complex III Subunit 7, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). Complex III Subunit 7 Antibody (YA2358) can be used for WB, IHC-P, IP experiment in human, rat background.
CDC25 Antibody (YA2450) is a biotin-conjugated non-conjugated IgG antibody, targeting CDC25, with a predicted molecular weight of 145 kDa (observed band size: 145 kDa). CDC25 Antibody (YA2450) can be used for WB experiment in rat background.
Il1rak; IRAK; Irak1; IRAK1-S; mPLK; Pelle; Pelle homolog; Pelle-like protein kinase; Plpk
WB, ICC/IF, IP
Human
IRAK1 Antibody (YA2454) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2454), targeting IRAK1, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). IRAK1 Antibody (YA2454) can be used for WB, ICC/IF, IP experiment in human background.
SF20 Antibody (YA2528) is a biotin-conjugated non-conjugated IgG antibody, targeting SF20, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). SF20 Antibody (YA2528) can be used for WB experiment in human background.
NDUFS1 Antibody (YA2535) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2535), targeting NDUFS1, with a predicted molecular weight of 79 kDa (observed band size: 75 kDa). NDUFS1 Antibody (YA2535) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
NOTCH4; INT3; Neurogenic locus notch homolog protein 4; Notch 4; hNotch4
WB
Human
Notch4 Antibody (YA2557) is a biotin-conjugated non-conjugated IgG antibody, targeting Notch4, with a predicted molecular weight of 210 kDa (observed band size: 36 kDa). Notch4 Antibody (YA2557) can be used for WB experiment in human background.
RAD23A; UV excision repair protein RAD23 homolog A; HR23A; hHR23A
WB, FC
Human, Mouse, Rat
hHR23A Antibody (YA2591) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2591), targeting hHR23A, with a predicted molecular weight of 40 kDa (observed band size: 55 kDa). hHR23A Antibody (YA2591) can be used for WB, FC experiment in human, mouse, rat background.
PAR4 Antibody (YA2603) is a biotin-conjugated non-conjugated IgG antibody, targeting PAR4, with a predicted molecular weight of 37 kDa (observed band size: 40 kDa). PAR4 Antibody (YA2603) can be used for WB experiment in human, mouse, rat background.
SFN; HME1; 14-3-3 protein sigma; Epithelial cell marker protein 1; Stratifin
WB, IHC-P
Human, Rat
14-3-3 sigma Antibody (YA2654) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2654), targeting 14-3-3 sigma, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). 14-3-3 sigma Antibody (YA2654) can be used for WB, IHC-P experiment in human, rat background.
YWHAG; 14-3-3 protein gamma; Protein kinase C inhibitor protein 1; KCIP-1
WB
Human, Mouse, Rat
14-3-3 gamma Antibody (YA2668) is a biotin-conjugated non-conjugated IgG antibody, targeting 14-3-3 gamma, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). 14-3-3 gamma Antibody (YA2668) can be used for WB experiment in human, mouse, rat background.
DNAJB6 Antibody (YA2704) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2704), targeting DNAJB6, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). DNAJB6 Antibody (YA2704) can be used for WB, IHC-P experiment in human, mouse, rat background.
TNNT2; Cardiac muscle troponin T; Troponin T; cardiac muscle; troponin T type 2 (cardiac)
WB, IHC-P
Human, Mouse, Rat
Cardiac Troponin T Antibody (YA2719) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2719), targeting Cardiac Troponin T, with a predicted molecular weight of 36 kDa (observed band size: 40 kDa). Cardiac Troponin T Antibody (YA2719) can be used for WB, IHC-P experiment in human, mouse, rat background.
Fetuin A Antibody (YA2824) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2824), targeting Fetuin A, with a predicted molecular weight of 39 kDa (observed band size: 45-50 kDa). Fetuin A Antibody (YA2824) can be used for WB, IP experiment in human, mouse background.
CSNK2A1; CK2A1; Casein kinase II subunit alpha; CK II alpha
WB
Human, Mouse, Rat
CSNK2A1 Antibody (YA2833) is a biotin-conjugated non-conjugated IgG antibody, targeting CSNK2A1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). CSNK2A1 Antibody (YA2833) can be used for WB experiment in human, mouse, rat background.
Entactin Antibody (YA2887) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2887), targeting Entactin, with a predicted molecular weight of 136 kDa (observed band size: 136 kDa). Entactin Antibody (YA2887) can be used for WB, IHC-P experiment in human background.
PDE2A Antibody (YA2989) is a biotin-conjugated non-conjugated IgG antibody, targeting PDE2A, with a predicted molecular weight of 106 kDa (observed band size: 106 kDa). PDE2A Antibody (YA2989) can be used for WB experiment in human, mouse, rat background.
DNA methyltransferase 1 associated protein 1; DNMAP1; DNMTAP1; EAF2; SWC4
WB, ICC/IF
Human, Mouse, Rat
DMAP1 Antibody (YA2998) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2998), targeting DMAP1, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). DMAP1 Antibody (YA2998) can be used for WB, ICC/IF experiment in human, mouse, rat background.
CTNNA3 Antibody (YA3001) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3001), targeting CTNNA3, with a predicted molecular weight of 100 kDa (observed band size: 100 kDa). CTNNA3 Antibody (YA3001) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
ITGA6; CD49 antigen-like family member F; VLA-6; CD49f
WB, IHC-P
Human, Mouse, Rat
Integrin alpha 6 Antibody (YA3020) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3020), targeting Integrin alpha 6, with a predicted molecular weight of 127 kDa (observed band size: 127 kDa). Integrin alpha 6 Antibody (YA3020) can be used for WB, IHC-P experiment in human, mouse, rat background.
MYLK Antibody (YA3133) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3133), targeting MYLK, with a predicted molecular weight of 211 kDa. MYLK Antibody (YA3133) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CDC5 Antibody (YA3160) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3160), targeting CDC5, with a predicted molecular weight of 92 kDa (observed band size: 100 kDa). CDC5 Antibody (YA3160) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
LGALS3BP Antibody (YA3171) is a biotin-conjugated non-conjugated IgG antibody, targeting LGALS3BP, with a predicted molecular weight of 65 kDa (observed band size: 100 kDa). LGALS3BP Antibody (YA3171) can be used for WB experiment in human background.
FUS; FUS-CHOP; TLS; 75 kDa DNA-pairing protein; Oncogene FUS; Oncogene TLS; POMP75; Translocated in liposarcoma protein
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
FUS Antibody (YA3197) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3197), targeting FUS, with a predicted molecular weight of 53 kDa (observed band size: 70 kDa). FUS Antibody (YA3197) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
G-CSF Antibody (YA3307) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3307), targeting G-CSF, with a predicted molecular weight of 22 kDa (observed band size: 25 kDa). G-CSF Antibody (YA3307) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
APOC3; APO C3; Apo CIII; ApoC III; APOC3; ApoCIII; Apolipoprotein C III; Apolipoprotein C3
WB, IHC-P
Human
ApoC3 Antibody (YA3349) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3349), targeting ApoC3, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). ApoC3 Antibody (YA3349) can be used for WB, IHC-P experiment in human background.
Dynein Intermediate Chain 1 Antibody (YA3374) is a biotin-conjugated non-conjugated IgG antibody, targeting Dynein Intermediate Chain 1, with a predicted molecular weight of 79 kDa (observed band size: 79 kDa). Dynein Intermediate Chain 1 Antibody (YA3374) can be used for WB experiment in human, mouse, rat background.
GAL4 Antibody (YA3377) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3377), targeting GAL4, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). GAL4 Antibody (YA3377) can be used for WB, IHC-P experiment in human, rat background.
NRSF; RE1 silencing transcription factor; Repressor binding to the X2 box; rest; X2 box repressor; XBR
WB
Human
RES Antibody (YA3380) is a biotin-conjugated non-conjugated IgG antibody, targeting RES, with a predicted molecular weight of 122 kDa (observed band size: 160 kDa). RES Antibody (YA3380) can be used for WB experiment in human background.
Chk1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Cytochrome P450 17A1 Antibody (YA786) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to Cytochrome P450 17A1 (6E1). It can be used for WB assays with tag free, in the background of Human.
GSK3 beta Antibody (YA744) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to GSK3 beta. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.
Hsp70 1A Antibody (YA727) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Hsp70 1A (1D9). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
MMP9; CLG4B; Matrix metalloproteinase-9; MMP-9; 92 kDa gelatinase; 92 kDa type IV collagenase; Gelatinase B; GELB
WB, IHC-P, ICC/IF
Human, Mouse, Rat
MMP9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 78 kDa, targeting to MMP9. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
RhoA/B/C Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to RhoA/B/C. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
TNF alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to TNF alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
ZAP70 Antibody (YA651) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to ZAP70 (4B2). It can be used for WB,IP assays with tag free, in the background of Human.
DRD2 Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-DRD2 polyclonal antibody. DRD2 Antibody can be used for: WB expriments in rat, mouse and predicted: human background without labeling.
Bone morphogenetic protein 2; BMP 2; BMP 2A; BMP2A; BMP-2; BMP2_HUMAN.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
BMP2 Antibody is an unconjugated, approximately 13/44 kDa, rabbit-derived, anti-BMP2 polyclonal antibody. BMP2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, cow, horse, rabbit, sheep background without labeling.
Beta Actin (Fruit Fly) Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting Beta Actin (Fruit Fly), with a predicted molecular weight of 42 kDa. Beta Actin (Fruit Fly) Antibody can be used for WB experiment in fruit fly background.
MonoMethyl-Histone H3 Antibody (YA998) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA998), targeting MonoMethyl-Histone H3, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). MonoMethyl-Histone H3 Antibody (YA998) can be used for WB, ICC/IF experiment in human, mouse background.
Placental Alkaline Phosphatase Antibody (YA1038) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Placental Alkaline Phosphatase, with a predicted molecular weight of 58 kDa (observed band size: 70 kDa). Placental Alkaline Phosphatase Antibody (YA1038) can be used for WB experiment in human background.
Placental Alkaline Phosphatase Antibody (YA1039) is a biotin-conjugated non-conjugated IgG antibody, targeting Placental Alkaline Phosphatase, with a predicted molecular weight of 58 kDa (observed band size: 70 kDa). Placental Alkaline Phosphatase Antibody (YA1039) can be used for WB experiment in human background.
X ray repair cross complementing protein 4; DNA repair protein XRCC4; DNA double strand break repair
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
XRCC4 Antibody (YA1082) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1082), targeting XRCC4, with a predicted molecular weight of 38 kDa (observed band size: 38-45 kDa). XRCC4 Antibody (YA1082) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
alpha 1 Spectrin Antibody (YA1125) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1125), targeting alpha 1 Spectrin. alpha 1 Spectrin Antibody (YA1125) can be used for IHC-P experiment in human background.
ROR2 Antibody (YA1135) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1135), targeting ROR2. ROR2 Antibody (YA1135) can be used for IHC-P experiment in human background.
SPARC; ON; SPARC; Basement-membrane protein 40; BM-40; Osteonectin; ON; Secreted protein acidic and rich in cysteine
IHC-P
Human
SPARC Antibody (YA1202) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1202), targeting SPARC. SPARC Antibody (YA1202) can be used for IHC-P experiment in human background.
SLC29A1; solute carrier family 29 (equilibrative nucleoside transporter); member 1; ENT1
IHC-P
Human
ENT1 Antibody (YA1251) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1251), targeting ENT1. ENT1 Antibody (YA1251) can be used for IHC-P experiment in human background.
C4.4A/LYPD3 Antibody (YA1295) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1295), targeting C4.4A/LYPD3, with a predicted molecular weight of 36 kDa (observed band size: 70 kDa). C4.4A/LYPD3 Antibody (YA1295) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
BCSG1; Breast cancer specific gene 1 protein; Gamma synuclein; Persyn; PRSN; SNCG; SR; Synoretin; Synuclein gamma
WB, IHC-P, ICC/IF, IP, FC
Human, Rat
gamma Sarcoglycan Antibody (YA1357) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1357), targeting gamma Sarcoglycan, with a predicted molecular weight of 13 kDa (observed band size: 16 kDa). gamma Sarcoglycan Antibody (YA1357) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, rat background.
IL-6R Antibody is a mouse-derived non-conjugated IgG1 antibody, targeting IL-6R, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). IL-6R Antibody can be used for WB,IHC-P,ICC/IF,FC,ELISA experiments in human, mouse backgrounds.
DOT 1; DOT1L; KMT4; Histone methyltransferase DOT1L; H3 lysine-79 specific
WB, IHC-P
Human, Mouse
KMT4 Antibody (YA1402) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1402), targeting KMT4, with a predicted molecular weight of 165 kDa (observed band size: 185 kDa). KMT4 Antibody (YA1402) can be used for WB, IHC-P experiment in human, mouse background.
DNAM1 Antibody (YA1436) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1436), targeting DNAM1. DNAM1 Antibody (YA1436) can be used for FC, ELISA experiment in human background.
Heparanase 1 Antibody (YA1601) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1601), targeting Heparanase 1, with a predicted molecular weight of 61 kDa (observed band size: 65 kDa). Heparanase 1 Antibody (YA1601) can be used for WB, IP experiment in human, mouse, rat background.
RANK Antibody (YA1607) is a biotin-conjugated non-conjugated IgG antibody, targeting RANK, with a predicted molecular weight of 66 kDa (observed band size: 80 kDa). RANK Antibody (YA1607) can be used for WB experiment in human background.
PQ-rich protein; PQR protein; Proline- and histidine-rich protein; T-cell death-associated gene 51 protein
WB, IHC-F, IHC-P, ICC/IF
Human
PHLDA1 Antibody (YA1616) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1616), targeting PHLDA1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). PHLDA1 Antibody (YA1616) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
NAPSIN A Antibody (YA1630) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1630), targeting NAPSIN A, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). NAPSIN A Antibody (YA1630) can be used for WB, IHC-P, IP experiment in human background.
Homeobox prospero like protein; Prospero homeobox protein 1; prospero-related homeobox gene 1; PROX1
WB
Rat
PROX1 Antibody (YA1754) is a biotin-conjugated non-conjugated IgG antibody, targeting PROX1, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). PROX1 Antibody (YA1754) can be used for WB experiment in rat background.
DNA mismatch repair gene; DNA mismatch repair protein PMS2; HNPCC4; PMS1 protein homolog 2
WB, IHC-P, ICC/IF
Human
PMS2 Antibody (YA1772) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1772), targeting PMS2, with a predicted molecular weight of 96 kDa (observed band size: 150 kDa). PMS2 Antibody (YA1772) can be used for WB, IHC-P, ICC/IF experiment in human background.
ras-related C3 botulinum toxin substrate 3 (rho family; small GTP binding protein Rac3)
WB, IHC-P
Human, Mouse, Rat
Rac3 Antibody (YA1802) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1802), targeting Rac3, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Rac3 Antibody (YA1802) can be used for WB, IHC-P experiment in human, mouse, rat background.
PRMT5 Antibody (YA1853) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1853), targeting PRMT5, with a predicted molecular weight of 73 kDa (observed band size: 72 kDa). PRMT5 Antibody (YA1853) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
KRT14; Keratin; type I cytoskeletal 14; Cytokeratin-14; CK-14; Keratin-14; K14
WB, IHC-P, ICC/IF
Human, Mouse, Rat
Cytokeratin 14 Antibody (YA1876) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1876), targeting Cytokeratin 14, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Cytokeratin 14 Antibody (YA1876) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
MIF Antibody (YA1912) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1912), targeting MIF, with a predicted molecular weight of 12 kDa (observed band size: 13 kDa). MIF Antibody (YA1912) can be used for WB, IP, FC experiment in human, mouse, rat background.
Secretory Phospholipase A2 Antibody (YA1916) is a biotin-conjugated non-conjugated IgG antibody, targeting Secretory Phospholipase A2, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). Secretory Phospholipase A2 Antibody (YA1916) can be used for WB experiment in human, mouse, rat background.
LHX2; LH2; LIM/homeobox protein Lhx2; Homeobox protein LH-2; LIM homeobox protein 2
WB
Human, Mouse, Rat
LHX2 Antibody (YA1973) is a biotin-conjugated non-conjugated IgG antibody, targeting LHX2, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). LHX2 Antibody (YA1973) can be used for WB experiment in human, mouse, rat background.
ANG5; Angiopoietin 5; Angiopoietin like 3; ANGPT5; ANGPTL3; ANL3; FHBL2
WB, ICC/IF
Human, Mouse, Rat
ANGPTL3 Antibody (YA2016) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2016), targeting ANGPTL3, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). ANGPTL3 Antibody (YA2016) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MC1R Antibody (YA2019) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2019), targeting MC1R, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). MC1R Antibody (YA2019) can be used for WB, IHC-P experiment in human background.
alpha Actinin 4 Antibody (YA2062) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2062), targeting alpha Actinin 4, with a predicted molecular weight of 105 kDa (observed band size: 105 kDa). alpha Actinin 4 Antibody (YA2062) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Lactate Dehydrogenase B Antibody (YA2070) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2070), targeting Lactate Dehydrogenase B, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). Lactate Dehydrogenase B Antibody (YA2070) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
GCDFP 15 Antibody (YA2242) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2242), targeting GCDFP 15, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). GCDFP 15 Antibody (YA2242) can be used for WB, ICC/IF, IP experiment in human background.
GABA A Receptor beta 1 Antibody (YA2261) is a biotin-conjugated non-conjugated IgG antibody, targeting GABA A Receptor beta 1, with a predicted molecular weight of 54 kDa (observed band size: 48 kDa). GABA A Receptor beta 1 Antibody (YA2261) can be used for WB experiment in human, mouse, rat background.
4 1BBL Antibody (YA2316) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2316), targeting 4 1BBL, with a predicted molecular weight of 27 kDa (observed band size: 25-32 kDa). 4 1BBL Antibody (YA2316) can be used for WB, IP experiment in human background.
RNA Polymerase beta Antibody (YA2403) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2403), targeting RNA Polymerase beta, with a predicted molecular weight of 151 kDa (observed band size: 151 kDa). RNA Polymerase beta Antibody (YA2403) can be used for WB, IP experiment in e.coli background.
CD226 Antibody (YA2412) is a biotin-conjugated non-conjugated IgG antibody, targeting CD226, with a predicted molecular weight of 39 kDa (observed band size: 60-80 kDa). CD226 Antibody (YA2412) can be used for WB experiment in human background.
JAK3 Antibody (YA2466) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2466), targeting JAK3, with a predicted molecular weight of 125 kDa (observed band size: 125 kDa). JAK3 Antibody (YA2466) can be used for WB, ICC/IF experiment in human background.
Bmp7; Bone morphogenetic protein 7; Eptotermin alfa; OP 1; Osteogenic protein 1
WB, IP
Human, Mouse, Rat
BMP7 Antibody (YA2555) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2555), targeting BMP7, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). BMP7 Antibody (YA2555) can be used for WB, IP experiment in human, mouse, rat background.
Phospho-Elongation Factor 2 (Thr56/Thr58) Antibody (YA2581) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Elongation Factor 2 (Thr56/Thr58), with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). Phospho-Elongation Factor 2 (Thr56/Thr58) Antibody (YA2581) can be used for WB experiment in human background.
DOK1; Docking protein 1; Downstream of tyrosine kinase 1; p62(dok); pp62
WB, ICC/IF
Human, Mouse, Rat
DOK1 Antibody (YA2868) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2868), targeting DOK1, with a predicted molecular weight of 52 kDa (observed band size: 65 kDa). DOK1 Antibody (YA2868) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Kallikrein 5 Antibody (YA2889) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2889), targeting Kallikrein 5, with a predicted molecular weight of 32 kDa (observed band size: 37 kDa). Kallikrein 5 Antibody (YA2889) can be used for WB, ICC/IF, FC experiment in human, mouse background.
brPTB; MIBP; nPTB; Polypyrimidine tract binding protein 2; PTB like protein; PTBP 2Ptbp2; Splicing regulator
WB, IHC-P, ICC/IF
Human, Mouse, Rat
PTBP2 Antibody (YA2902) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2902), targeting PTBP2, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). PTBP2 Antibody (YA2902) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
class II beta tubulin isotype; Beta2; Tubulin beta 2 chain; TUBB; TUBB2
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
beta II Tubulin Antibody (YA3010) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3010), targeting beta II Tubulin, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). beta II Tubulin Antibody (YA3010) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
IKB epsilon Antibody (YA3012) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3012), targeting IKB epsilon, with a predicted molecular weight of 53 kDa (observed band size: 48 kDa). IKB epsilon Antibody (YA3012) can be used for WB, IP experiment in human background.
IL-1 Receptor Accessory Protein Antibody (YA3014) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3014), targeting IL-1 Receptor Accessory Protein, with a predicted molecular weight of 65 kDa (observed band size: 78 kDa). IL-1 Receptor Accessory Protein Antibody (YA3014) can be used for WB, IP experiment in human background.
RBMX; HNRPG; RBMXP1; RNA-binding motif protein; X chromosome; Glycoprotein p43; Heterogeneous nuclear ribonucleoprotein G; hnRNP G
WB, IHC-F, IHC-P, ICC/IF
Human
hnRNP G Antibody (YA3029) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3029), targeting hnRNP G, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). hnRNP G Antibody (YA3029) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
IRAKM Antibody (YA3052) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3052), targeting IRAKM, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). IRAKM Antibody (YA3052) can be used for WB, IP experiment in human background.
Phospho-beta Catenin (Ser33/Ser37) Antibody (YA3096) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-beta Catenin (Ser33/Ser37), with a predicted molecular weight of 85 kDa (observed band size: 92 kDa). Phospho-beta Catenin (Ser33/Ser37) Antibody (YA3096) can be used for WB experiment in human, rat background.
NME3 Antibody (YA3110) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3110), targeting NME3, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). NME3 Antibody (YA3110) can be used for WB, IHC-P, IP experiment in human background.
HDAC7 Antibody (YA3146) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3146), targeting HDAC7, with a predicted molecular weight of 103 kDa (observed band size: 124 kDa). HDAC7 Antibody (YA3146) can be used for WB, FC experiment in human, mouse, rat background.
M-CSF Receptor Antibody (YA3205) is a biotin-conjugated non-conjugated IgG antibody, targeting M-CSF Receptor, with a predicted molecular weight of 109 kDa (observed band size: 109 kDa). M-CSF Receptor Antibody (YA3205) can be used for WB experiment in human background.
TFEB; BHLHE35; Transcription factor EB; Class E basic helix-loop-helix protein 35; bHLHe35
WB, IHC-F, IHC-P, ICC/IF, IP
Human
Transcription Factor EB Antibody (YA3266) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3266), targeting Transcription Factor EB, with a predicted molecular weight of 53 kDa (observed band size: 65-70 kDa). Transcription Factor EB Antibody (YA3266) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Growth Hormone 1 Antibody (YA3267) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3267), targeting Growth Hormone 1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). Growth Hormone 1 Antibody (YA3267) can be used for WB, IHC-P, IP experiment in human background.
HLA class II histocompatibility antigen; DP beta 1 chain; HLADPB1; HLADP1B; HLADM
WB, IHC-P, ICC/IF, IP
Human
HLA DPB1 Antibody (YA3273) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3273), targeting HLA DPB1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). HLA DPB1 Antibody (YA3273) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
8 hydroxyguanine DNA glycosylase; AP lyase; HMMH; HOGG1; MMH; MUTM; N glycosylase; Ogg1; OGH 1
WB
Human
OGG1 Antibody (YA3356) is a biotin-conjugated non-conjugated IgG antibody, targeting OGG1, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). OGG1 Antibody (YA3356) can be used for WB experiment in human background.
Histone deacetylase complex subunit Sin 3a; Paired amphipathic helix protein Sin 3a; SIN3 homolog A
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
mSin3A Antibody (YA3368) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3368), targeting mSin3A, with a predicted molecular weight of 145 kDa (observed band size: 150 kDa). mSin3A Antibody (YA3368) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
DHCR7 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting DHCR7, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). DHCR7 Antibody can be used for WB,
ELISA experiments in mouse backgrounds.
ABCB5 P-gp; ATP binding cassette sub family B (MDR/TAP) member 5; P glycoprotein ABCB5
WB, ICC/IF
Human
ABCB5 Antibody (YA836) is a non-conjugated and Mouse origined monoclonal antibody about 139 kDa, targeting to ABCB5 (8D2). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
Aromatase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to Aromatase. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
Cyclic AMP-dependent transcription factor ATF-4; CREB-2; cAMP-responsive element-binding protein 2; DNA-binding protein TAXREB67
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
ATF4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 39 kDa, targeting to ATF4. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
BTK Antibody (YA816) is a non-conjugated and Mouse origined monoclonal antibody about 76 kDa, targeting to BTK (5B12). It can be used for WB,IP assays with tag free, in the background of Human.
PTPRC; CD45; Receptor-type tyrosine-protein phosphatase C; Leukocyte common antigen; L-CA; T200; CD antigen CD45
WB, IHC-P
Human, Mouse
CD45 Antibody (YA800) is a non-conjugated and Mouse origined monoclonal antibody about 147 kDa, targeting to CD45. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
c-Fos Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to c-Fos. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Cyclophilin B Antibody (YA787) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to Cyclophilin B (5F10). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat, Mouse.
EGFR Antibody (YA775) is a non-conjugated and Mouse origined monoclonal antibody about 134 kDa, targeting to EGFR (6H11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Monkey.
FOXO1; FKHR; FOXO1A; Forkhead box protein O1; Forkhead box protein O1A; Forkhead in rhabdomyosarcoma
WB, IHC-F, IHC-P, ICC/IF
Human
FOXO1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to FOXO1. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
gamma Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to gamma Tubulin. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
JAK1 Antibody (YA722) is a non-conjugated and Mouse origined monoclonal antibody about 133 kDa, targeting to JAK1 (8B8). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
LRP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 505 kDa, targeting to LRP1. It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Phospho-GSK3 beta (Ser9) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-GSK3 beta (Ser9). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
SQSTM1/p62 Antibody (YA062) is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to SQSTM1/p62. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
Thioredoxin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Thioredoxin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
TREM2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to TREM2. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
WDR77 Antibody (YA655) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to WDR77 (8A10). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
CD34 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CD34 polyclonal antibody. CD34 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit background without labeling.
BAG1; HAP; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-associated athanogene 1
WB
Human, Mouse, Rat
BAG1 Antibody (YA932) is a biotin-conjugated non-conjugated IgG1 antibody, targeting BAG1, with a predicted molecular weight of 39 kDa (observed band size: 52,46,33 kDa). BAG1 Antibody (YA932) can be used for WB experiment in human, mouse, rat background.
BAG1; HAP; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-associated athanogene 1
WB, IHC-P, IP
Human
BAG1 Antibody (YA933) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA933), targeting BAG1, with a predicted molecular weight of 39 kDa (observed band size: 52/46/33 kDa). BAG1 Antibody (YA933) can be used for WB, IHC-P, IP experiment in human background.
DNA PKcs Antibody (YA957) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA957), targeting DNA PKcs, with a predicted molecular weight of 469 kDa (observed band size: 450 kDa). DNA PKcs Antibody (YA957) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
DNA PKcs Antibody (YA958) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA958), targeting DNA PKcs, with a predicted molecular weight of 469 kDa (observed band size: 450 kDa). DNA PKcs Antibody (YA958) can be used for WB, ICC/IF, IP experiment in human background.
DNA PKcs Antibody (YA959) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA959), targeting DNA PKcs, with a predicted molecular weight of 469 kDa (observed band size: 469 kDa). DNA PKcs Antibody (YA959) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
NSE Antibody (YA1004) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1004), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1004) can be used for WB, ELISA experiment in human, mouse, rat background.
NSE Antibody (YA1005) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1005), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1005) can be used for WB, ELISA experiment in human, mouse, rat background.
NSE Antibody (YA1006) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1006), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1006) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
NSE Antibody (YA1007) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1007), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1007) can be used for WB, ELISA experiment in human, mouse, rat background.
Scavenging Receptor SR-BI Antibody (YA1160) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1160), targeting Scavenging Receptor SR-BI. Scavenging Receptor SR-BI Antibody (YA1160) can be used for IHC-P experiment in human background.
Nucleolysin TIA 1 isoform p40; p40 TIA 1; TIA1 protein; TIAL1; TIAR
IHC-P
Human
TIA1 Antibody (YA1229) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1229), targeting TIA1. TIA1 Antibody (YA1229) can be used for IHC-P experiment in human background.
EDG1 Antibody (YA1239) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1239), targeting EDG1. EDG1 Antibody (YA1239) can be used for IHC-P experiment in human background.
INSL3 Antibody (YA1241) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1241), targeting INSL3. INSL3 Antibody (YA1241) can be used for IHC-P experiment in human background.
4-1BB Ligand Antibody (YA1329) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1329), targeting 4-1BB Ligand. 4-1BB Ligand Antibody (YA1329) can be used for FC, ELISA experiment in human background.
NF2 Antibody (YA1386) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1386), targeting NF2, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). NF2 Antibody (YA1386) can be used for WB, IP experiment in human, mouse, rat background.
PDK2 Antibody (YA1395) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1395), targeting PDK2, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). PDK2 Antibody (YA1395) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
CD5 Antibody (YA1404) is a biotin-conjugated non-conjugated IgG antibody, targeting CD5, with a predicted molecular weight of 55 kDa. CD5 Antibody (YA1404) can be used for WB,IHC-P,ICC/IF,IP experiment in human background.
SLC31A1; COPT1; CTR1; solute carrier family 31 member 1
WB
Human, Mouse, Rat, Hamster
SLC31A1 Antibody (YA1408) is a biotin-conjugated non-conjugated IgG antibody, targeting SLC31A1, with a predicted molecular weight of 21 kDa (observed band size: 26-34 kDa). SLC31A1 Antibody (YA1408) can be used for WB experiment in human, mouse, rat, hamster background.
Coagulation factor XIIIa; F13A; F13a1; Fibrin stabilizing factor; A subunit; Fibrinoligase; TGase; Transglutaminase A chain
WB, IHC-P
Human
Factor XIIIa Antibody (YA1631) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1631), targeting Factor XIIIa, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). Factor XIIIa Antibody (YA1631) can be used for WB, IHC-P experiment in human background.
SCGB2A2; MGB1; UGB2; Mammaglobin-A; Mammaglobin-1; Secretoglobin family 2A member 2
WB, IHC-P
Human, Rat
Mammaglobin A Antibody (YA1682) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1682), targeting Mammaglobin A, with a predicted molecular weight of 10 kDa (observed band size: 18 kDa). Mammaglobin A Antibody (YA1682) can be used for WB, IHC-P experiment in human, rat background.
CRISPR Cas9 SA Antibody (YA1683) is a biotin-conjugated non-conjugated IgG antibody, targeting CRISPR Cas9 SA, with a predicted molecular weight of 124 kDa. CRISPR Cas9 SA Antibody (YA1683) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in staphylococcus aureus background.
PP1C beta Antibody (YA1703) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1703), targeting PP1C beta, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). PP1C beta Antibody (YA1703) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Prion Protein Antibody (YA1725) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1725), targeting Prion Protein, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). Prion Protein Antibody (YA1725) can be used for WB, IHC-P experiment in human, mouse, rat background.
ACTR3; ARP3; Actin-related protein 3; Actin-like protein 3
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
Actin Related Protein 3 Antibody (YA1755) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1755), targeting Actin Related Protein 3, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). Actin Related Protein 3 Antibody (YA1755) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
eIF2B5 Antibody (YA1803) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1803), targeting eIF2B5, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). eIF2B5 Antibody (YA1803) can be used for WB, IHC-P, ICC/IF experiment in human background.
Golgin subfamily A member 2; 130 kDa cis-Golgi matrix protein; GM130; GM130 autoantigen; Golgin-95
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat, Monkey, Cow, Dog
GM130 Antibody (YA1820) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1820), targeting GM130, with a predicted molecular weight of 113 kDa (observed band size: 130 kDa). GM130 Antibody (YA1820) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat, monkey, cow, dog background.
REA Antibody (YA1848) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1848), targeting REA, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). REA Antibody (YA1848) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
KRT10; KPP; Keratin; type I cytoskeletal 10; Cytokeratin-10; CK-10; Keratin-10; K10
WB, IHC-P
Human, Hamster, Mouse, Rat
Cytokeratin 10 Antibody (YA1857) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1857), targeting Cytokeratin 10, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Cytokeratin 10 Antibody (YA1857) can be used for WB, IHC-P experiment in human, hamster, mouse, rat background.
PGR; NR3C3; Progesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3
WB, IHC-P, ICC/IF, IP
Human
Progesterone Receptor Antibody (YA1866) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1866), targeting Progesterone Receptor, with a predicted molecular weight of 99 kDa (observed band size: 118 kDa). Progesterone Receptor Antibody (YA1866) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
SYN 2; SYN II; SYN IIa; SYN IIb; SYN2; Synapsin2; SynapsinII; SYNII; SYNIIa; SYNIIb
WB, IHC-P
Human, Mouse, Rat
Synapsin 2 Antibody (YA1898) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1898), targeting Synapsin 2, with a predicted molecular weight of 63 kDa (observed band size: 75 kDa). Synapsin 2 Antibody (YA1898) can be used for WB, IHC-P experiment in human, mouse, rat background.
Sarcomeric alpha Actinin Antibody (YA1903) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1903), targeting Sarcomeric alpha Actinin, with a predicted molecular weight of 104 kDa (observed band size: 104 kDa). Sarcomeric alpha Actinin Antibody (YA1903) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Core protein II; QCR2; mitochondrial; Ubiquinol cytochrome c reductase core protein II; UQCR2; Uqcrc2
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
Complex III Subunit 2 Antibody (YA1929) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1929), targeting Complex III Subunit 2, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). Complex III Subunit 2 Antibody (YA1929) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
ACTN3; Alpha-actinin-3; Alpha-actinin skeletal muscle isoform 3; F-actin cross-linking protein
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
ACTN3 Antibody (YA1997) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1997), targeting ACTN3, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). ACTN3 Antibody (YA1997) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
12 Lipoxygenase Antibody (YA2038) is a biotin-conjugated non-conjugated IgG antibody, targeting 12 Lipoxygenase, with a predicted molecular weight of 76 kDa (observed band size: 70 kDa). 12 Lipoxygenase Antibody (YA2038) can be used for WB experiment in human, rat background.
BMP6; VGR; Bone morphogenetic protein 6; BMP-6; VG-1-related protein; VG-1-R; VGR-1
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
BMP6 Antibody (YA2048) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2048), targeting BMP6, with a predicted molecular weight of 57 kDa (observed band size: 42 kDa). BMP6 Antibody (YA2048) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
alpha Sarcoglycan Antibody (YA2068) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2068), targeting alpha Sarcoglycan, with a predicted molecular weight of 43 kDa (observed band size: 50 kDa). alpha Sarcoglycan Antibody (YA2068) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
MCM7 Antibody (YA2171) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2171), targeting MCM7, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). MCM7 Antibody (YA2171) can be used for WB, ICC/IF, FC experiment in human background.
Glycodelin Antibody (YA2193) is a biotin-conjugated non-conjugated IgG antibody, targeting Glycodelin, with a predicted molecular weight of 21 kDa (observed band size: 24 kDa). Glycodelin Antibody (YA2193) can be used for WB experiment in human background.
CD83; CD83 antigen; hCD83; B-cell activation protein; Cell surface protein HB15; CD antigen CD83
WB
Human, Mouse, Rat
CD83 Antibody (YA2260) is a biotin-conjugated non-conjugated IgG antibody, targeting CD83, with a predicted molecular weight of 23 kDa (observed band size: 45 kDa). CD83 Antibody (YA2260) can be used for WB experiment in human, mouse, rat background.
Olfactomedin 4 Antibody (YA2288) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2288), targeting Olfactomedin 4, with a predicted molecular weight of 57 kDa (observed band size: 54 kDa). Olfactomedin 4 Antibody (YA2288) can be used for WB, IP experiment in human, mouse, rat background.
BRCA1-associated ATM activator 1; BRCA1-associated protein required for ATM activation protein 1
WB, ICC/IF, IP
Human
BRAT1 Antibody (YA2294) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2294), targeting BRAT1, with a predicted molecular weight of 88 kDa (observed band size: 88 kDa). BRAT1 Antibody (YA2294) can be used for WB, ICC/IF, IP experiment in human background.
CCT2; 99D8.1; CCTB; T-complex protein 1 subunit beta; TCP-1-beta; CCT-beta
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
CCT2 Antibody (YA2320) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2320), targeting CCT2, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). CCT2 Antibody (YA2320) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
MAD1L1 Antibody (YA2449) is a biotin-conjugated non-conjugated IgG antibody, targeting MAD1L1, with a predicted molecular weight of 83 kDa (observed band size: 80 kDa). MAD1L1 Antibody (YA2449) can be used for WB experiment in human, mouse, rat background.
SF3A3 Antibody (YA2478) is a biotin-conjugated non-conjugated IgG antibody, targeting SF3A3, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). SF3A3 Antibody (YA2478) can be used for WB experiment in human, mouse, rat, hamster background.
TP53BP2 Antibody (YA2576) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2576), targeting TP53BP2, with a predicted molecular weight of 126 kDa (observed band size: 150 kDa). TP53BP2 Antibody (YA2576) can be used for WB, IHC-P, ICC/IF experiment in human background.
CollagenX; COL10A1; COAA1; Collagen type X alpha 1
WB
Human, Mouse, Rat
Collagen X alpha 1 Antibody (YA2582) is a biotin-conjugated non-conjugated IgG antibody, targeting Collagen X alpha 1, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). Collagen X alpha 1 Antibody (YA2582) can be used for WB experiment in human, mouse, rat background.
Phospho-GATA3 (Ser308) Antibody (YA2593) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2593), targeting Phospho-GATA3 (Ser308), with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). Phospho-GATA3 (Ser308) Antibody (YA2593) can be used for WB, IHC-P, IP experiment in human background.
Hsp47 Antibody (YA2608) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2608), targeting Hsp47, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). Hsp47 Antibody (YA2608) can be used for WB, IHC-P experiment in human, mouse, rat background.
Phospho-Moesin (Thr558) Antibody (YA2614) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2614), targeting Phospho-Moesin (Thr558), with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). Phospho-Moesin (Thr558) Antibody (YA2614) can be used for WB, IHC-P experiment in human, rat background.
Nicotinic Acetylcholine Receptor alpha 4 Antibody (YA2616) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2616), targeting Nicotinic Acetylcholine Receptor alpha 4, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). Nicotinic Acetylcholine Receptor alpha 4 Antibody (YA2616) can be used for WB, IP experiment in human, mouse, rat background.
HOXB4; HOX2F; Homeobox protein Hox-B4; Homeobox protein Hox-2.6; Homeobox protein Hox-2F
WB, ICC/IF, IP
Human, Mouse, Rat
HOXB4 Antibody (YA2687) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2687), targeting HOXB4, with a predicted molecular weight of 28 kDa (observed band size: 34 kDa). HOXB4 Antibody (YA2687) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
CDC123 Antibody (YA2773) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2773), targeting CDC123, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). CDC123 Antibody (YA2773) can be used for WB, IP, FC experiment in human, mouse, rat background.
PLA X polypeptide; RP23-414L19.4; RPL7A; SURF3; surfeit 3; TRUP
WB, IHC-P
Human, Mouse, Rat
RPL7A Antibody (YA2859) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2859), targeting RPL7A, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). RPL7A Antibody (YA2859) can be used for WB, IHC-P experiment in human, mouse, rat background.
GAP43; Neuromodulin; Axonal membrane protein GAP-43; Growth-associated protein 43; Neural phosphoprotein B-50; pp46
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
GAP43 Antibody (YA2891) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2891), targeting GAP43, with a predicted molecular weight of 25 kDa (observed band size: 46 kDa). GAP43 Antibody (YA2891) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
GFPT1 Antibody (YA2912) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2912), targeting GFPT1, with a predicted molecular weight of 79 kDa (observed band size: 79 kDa). GFPT1 Antibody (YA2912) can be used for WB, IHC-P, IP experiment in human background.
PLA2G2A Antibody (YA2918) is a biotin-conjugated non-conjugated IgG antibody, targeting PLA2G2A, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). PLA2G2A Antibody (YA2918) can be used for WB experiment in human, mouse, rat background.
ALAS1 Antibody (YA3021) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3021), targeting ALAS1, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). ALAS1 Antibody (YA3021) can be used for WB, ICC/IF experiment in human background.
Glutamate Dehydrogenase 1 Antibody (YA3026) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3026), targeting Glutamate Dehydrogenase 1, with a predicted molecular weight of 61 kDa. Glutamate Dehydrogenase 1 Antibody (YA3026) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Recessive polycystic kidney disease protein Tg737 homolog; Tetratricopeptide repeat protein 10; TPR repeat protein 10
WB
Human, Mouse, Rat
IFT88 Antibody (YA3069) is a biotin-conjugated non-conjugated IgG antibody, targeting IFT88, with a predicted molecular weight of 93 kDa (observed band size: 93 kDa). IFT88 Antibody (YA3069) can be used for WB experiment in human, mouse, rat background.
PRAS40 Antibody (YA3179) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3179), targeting PRAS40, with a predicted molecular weight of 27 kDa (observed band size: 40 kDa). PRAS40 Antibody (YA3179) can be used for WB, IP experiment in human, rat background.
MRPL11; CGI-113; 39S ribosomal protein L11; mitochondrial; L11mt; MRP-L11
WB, IHC-F, IHC-P, ICC/IF
Human
Mitochondrial Ribosomal Protein L11 Antibody (YA3230) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3230), targeting Mitochondrial Ribosomal Protein L11, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Mitochondrial Ribosomal Protein L11 Antibody (YA3230) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
SFT Antibody (YA3238) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3238), targeting SFT, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). SFT Antibody (YA3238) can be used for WB, IHC-P, IP experiment in human, mouse background.
MEF2A/MEF2C Antibody (YA3324) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3324), targeting MEF2A/MEF2C, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). MEF2A/MEF2C Antibody (YA3324) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Cyclin A1/A2 Antibody (YA3336) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3336), targeting Cyclin A1/A2, with a predicted molecular weight of 52,49 kDa (observed band size: 52/49 kDa). Cyclin A1/A2 Antibody (YA3336) can be used for WB, IP experiment in human background.
CD5 Antibody (YA3453) is a non-conjugated IgG1 antibody, targeting CD5, with a predicted molecular weight of 55 kDa. CD5 Antibody (YA3453) can be used for WB,IHC-P,FC,ELISA experiment in human，mouse background.
Argonaute 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 97 kDa, targeting to Argonaute 2. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
F4/80 Antibody is a non-conjugated and Rat origined monoclonal antibody, targeting to F4/80. It can be used for IHC-P,ICC/IF,FC assays with tag free, in the background of Mouse.
Glutathione Peroxidase 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to Glutathione Peroxidase 4. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
SPP1; BNSP; OPN; PSEC0156; Osteopontin; Bone sialoprotein 1; Nephropontin; Secreted phosphoprotein 1; SPP-1; Urinary stone protein; Uropontin
WB, IHC-P, ELISA
Human, Mouse, Rat
Osteopontin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 35 kDa, targeting to Osteopontin. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Phospho-EGFR (Tyr1068) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1068). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
Phospho-EGFR (Tyr1092) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1092). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Phospho-EGFR (Tyr1173) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1173). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
Phospho-p53 (Ser37) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Phospho-p53 (Ser37). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-p53 (Ser6) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Phospho-p53 (Ser6). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
STAT1; Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84
ICC/IF, WB, IHC-F, IHC-P, IP, ELISA
Human, Mouse, Rat, Monkey
Phospho-STAT1 (Tyr701) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 87 kDa, targeting to Phospho-STAT1 (Tyr701). It can be used for ICC/IF,WB,IHC-F,IHC-P,IP,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Survivin Antibody (YA665) is a non-conjugated and Mouse origined monoclonal antibody about 16 kDa, targeting to Survivin (8B9). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.
AACT Antibody (YA1103) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1103), targeting AACT. AACT Antibody (YA1103) can be used for IHC-P experiment in human background.
alpha 1-Antitrypsin Antibody (YA1122) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1122), targeting alpha 1-Antitrypsin. alpha 1-Antitrypsin Antibody (YA1122) can be used for IHC-P experiment in human background.
CDC7 Antibody (YA1152) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1152), targeting CDC7. CDC7 Antibody (YA1152) can be used for IHC-P experiment in human background.
PDCD6; ALG2; Programmed cell death protein 6; Apoptosis-linked gene 2 protein homolog
IHC-P
Human
PDCD6/ALG-2 Antibody (YA1265) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1265), targeting PDCD6/ALG-2. PDCD6/ALG-2 Antibody (YA1265) can be used for IHC-P experiment in human background.
SFTPA1 + SFTPA2 Antibody (YA1318) is a biotin-conjugated non-conjugated IgG antibody, targeting SFTPA1 + SFTPA2, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). SFTPA1 + SFTPA2 Antibody (YA1318) can be used for WB experiment in human, mouse, rat background.
PDL2 Antibody (YA1348) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1348), targeting PDL2. PDL2 Antibody (YA1348) can be used for FC, ELISA experiment in human background.
Factor IX Antibody (YA1353) is a biotin-conjugated non-conjugated IgG antibody, targeting Factor IX, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Factor IX Antibody (YA1353) can be used for WB experiment in human background.
CCR8 Antibody (YA1373) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1373), targeting CCR8. CCR8 Antibody (YA1373) can be used for FC, ELISA experiment in human background.
NFYA; Nuclear transcription factor Y subunit alpha; CAAT box DNA-binding protein subunit A; Nuclear transcription factor Y subunit A; NF-YA
WB, IP
Human, Mouse, Rat
NFYA Antibody (YA1396) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1396), targeting NFYA, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). NFYA Antibody (YA1396) can be used for WB, IP experiment in human, mouse, rat background.
PGF Antibody (YA1434) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1434), targeting PGF. PGF Antibody (YA1434) can be used for FC, ELISA experiment in human background.
HIF2 alpha Antibody (YA1445) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1445), targeting HIF2 alpha, with a predicted molecular weight of 96 kDa. HIF2 alpha Antibody (YA1445) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
IL-23 alpha Antibody (YA1463) is a biotin-conjugated non-conjugated IgG antibody, targeting IL-23 alpha, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). IL-23 alpha Antibody (YA1463) can be used for WB experiment in human background.
p40 Antibody (YA1500) is a biotin-conjugated non-conjugated IgG antibody, targeting p40, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). p40 Antibody (YA1500) can be used for WB experiment in human background.
T bet; T box 21; T PET; TBET; TBLYM; Tbx21; TPET; Transcription factor TBLYM
IHC-P, FC
Human
T Box Protein 21 Antibody (YA1502) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1502), targeting T Box Protein 21. T Box Protein 21 Antibody (YA1502) can be used for IHC-P, FC experiment in human background.
PD L2 Antibody (YA1584) is a biotin-conjugated non-conjugated IgG antibody, targeting PD L2, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). PD L2 Antibody (YA1584) can be used for WB experiment in human, rat background.
PFKP Antibody (YA1599) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1599), targeting PFKP, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). PFKP Antibody (YA1599) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Mast Cell Chymase Antibody (YA1629) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1629), targeting Mast Cell Chymase, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). Mast Cell Chymase Antibody (YA1629) can be used for WB, IHC-P experiment in human background.
Serotonin Transporter Antibody (YA1638) is a biotin-conjugated non-conjugated IgG antibody, targeting Serotonin Transporter, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). Serotonin Transporter Antibody (YA1638) can be used for WB experiment in human, mouse, rat background.
FHL1 Antibody (YA1668) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1668), targeting FHL1, with a predicted molecular weight of 36 kDa (observed band size: 30 kDa). FHL1 Antibody (YA1668) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Proteasome beta 9 Antibody (YA1747) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1747), targeting Proteasome beta 9, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). Proteasome beta 9 Antibody (YA1747) can be used for WB, ICC/IF experiment in human, mouse, rat background.
PLGF Antibody (YA1812) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1812), targeting PLGF, with a predicted molecular weight of 25 kDa (observed band size: 23 kDa). PLGF Antibody (YA1812) can be used for WB, ICC/IF, IHC-P experiment in human, mouse, rat background.
Integrin alpha IIb Antibody (YA1839) is a biotin-conjugated non-conjugated IgG antibody, targeting Integrin alpha IIb, with a predicted molecular weight of 113 kDa (observed band size: 137 kDa). Integrin alpha IIb Antibody (YA1839) can be used for WB experiment in human, rat background.
Syntaxin 4 Antibody (YA1849) is a biotin-conjugated non-conjugated IgG antibody, targeting Syntaxin 4, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). Syntaxin 4 Antibody (YA1849) can be used for WB experiment in human, mouse, rat background.
PSEN1; AD3; PS1; PSNL1; Presenilin-1; PS-1; Protein S182
WB
Human
Phospho-Presenilin 1 (Ser310) Antibody (YA1868) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Presenilin 1 (Ser310), with a predicted molecular weight of 53 kDa (observed band size: 22 kDa). Phospho-Presenilin 1 (Ser310) Antibody (YA1868) can be used for WB experiment in human background.
IRF5 Antibody (YA1884) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1884), targeting IRF5, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). IRF5 Antibody (YA1884) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
SH2D1A Antibody (YA1950) is a biotin-conjugated non-conjugated IgG antibody, targeting SH2D1A, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). SH2D1A Antibody (YA1950) can be used for WB experiment in human, mouse, rat background.
Elongation factor 1 gamma Antibody (YA2004) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2004), targeting Elongation factor 1 gamma, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Elongation factor 1 gamma Antibody (YA2004) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Axam2; Senp2; Sentrin specific protease 2; SMT3 specific isopeptidase 2; Smt3ip2
WB, IHC-P, ICC/IF
Human
SENP2 Antibody (YA2024) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2024), targeting SENP2, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). SENP2 Antibody (YA2024) can be used for WB, IHC-P, ICC/IF experiment in human background.
alpha Internexin Antibody (YA2067) is a biotin-conjugated non-conjugated IgG antibody, targeting alpha Internexin, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). alpha Internexin Antibody (YA2067) can be used for WB experiment in human, mouse, rat background.
LRP8; APOER2; Low-density lipoprotein receptor-related protein 8; LRP-8; Apolipoprotein E receptor 2
WB, IP
Human, Rat, Hamster
ApoER2 Antibody (YA2128) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2128), targeting ApoER2, with a predicted molecular weight of 106 kDa (observed band size: 130,106 kDa). ApoER2 Antibody (YA2128) can be used for WB, IP experiment in human, rat, hamster background.
APPBP1 Antibody (YA2131) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2131), targeting APPBP1, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). APPBP1 Antibody (YA2131) can be used for WB, IP experiment in human background.
KAT8 Antibody (YA2230) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2230), targeting KAT8, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). KAT8 Antibody (YA2230) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
TCP1; CCT1; CCTA; T-complex protein 1 subunit alpha; TCP-1-alpha; CCT-alpha
WB, IHC-P, ICC/IF, IP
Human
TCP 1 alpha Antibody (YA2238) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2238), targeting TCP 1 alpha, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). TCP 1 alpha Antibody (YA2238) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
NKX3-1; NKX3.1; NKX3A; Homeobox protein Nkx-3.1; Homeobox protein NK-3 homolog A
WB, IHC-P
Human
NKX3.1 Antibody (YA2317) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2317), targeting NKX3.1, with a predicted molecular weight of 26 kDa (observed band size: 32 kDa). NKX3.1 Antibody (YA2317) can be used for WB, IHC-P experiment in human background.
BMP15; GDF9B; Bone morphogenetic protein 15; BMP-15; Growth/differentiation factor 9B; GDF-9B
WB, FC
Human, Mouse, Rat
BMP15 Antibody (YA2381) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2381), targeting BMP15, with a predicted molecular weight of 45 kDa (observed band size: 50 kDa). BMP15 Antibody (YA2381) can be used for WB, FC experiment in human, mouse, rat background.
VPS4A Antibody (YA2413) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2413), targeting VPS4A, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). VPS4A Antibody (YA2413) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
KIF2C; KNSL6; Kinesin-like protein KIF2C; Kinesin-like protein 6; Mitotic centromere-associated kinesin; MCAK
WB, ICC/IF, FC
Human
MCAK Antibody (YA2414) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2414), targeting MCAK, with a predicted molecular weight of 81 kDa (observed band size: 81 kDa). MCAK Antibody (YA2414) can be used for WB, ICC/IF, FC experiment in human background.
YY1; Delta transcription factor; INO80 complex subunit S; NF-E1; Yin and yang 1; YY-1
WB, IP
Human, Mouse, Rat
YY1 Antibody (YA2446) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2446), targeting YY1, with a predicted molecular weight of 45 kDa (observed band size: 65 kDa). YY1 Antibody (YA2446) can be used for WB, IP experiment in human, mouse, rat background.
Butyrylcholinesterase Antibody (YA2460) is a biotin-conjugated non-conjugated IgG antibody, targeting Butyrylcholinesterase, with a predicted molecular weight of 68 kDa (observed band size: 90 kDa). Butyrylcholinesterase Antibody (YA2460) can be used for WB experiment in human background.
CGBP Antibody (YA2487) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2487), targeting CGBP, with a predicted molecular weight of 76 kDa (observed band size: 76 kDa). CGBP Antibody (YA2487) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
NEFM; NEF3; NFM; Neurofilament medium polypeptide; NF-M; 160 kDa neurofilament protein; Neurofilament 3; Neurofilament triplet M protein
WB, IHC-P, ICC/IF, IP
Human
Neurofilament Medium Antibody (YA2529) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2529), targeting Neurofilament Medium, with a predicted molecular weight of 102 kDa (observed band size: 160 kDa). Neurofilament Medium Antibody (YA2529) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
CDC42; CDC42Hs; G25K; TKS; MIG5; Ras like protein TC25
WB
Human
Phospho-Rac1/CDC42 (Ser71) Antibody (YA2604) is a non-conjugated IgG antibody, targeting Phospho-Rac1/CDC42 (Ser71), with a predicted molecular weight of 21 kDa (observed band size: 24 kDa). Phospho-Rac1/CDC42 (Ser71) Antibody (YA2604) can be used for WB experiment in human background.
CDCA5; Cell division cycle associated protein 5; Cell division cycle-associated protein 5; p35; Sororin
WB, IHC-P, ICC/IF, FC
Human
CDCA5 Antibody (YA2609) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2609), targeting CDCA5, with a predicted molecular weight of 28 kDa (observed band size: 35 kDa). CDCA5 Antibody (YA2609) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Thromboxane A Synthase Antibody (YA2670) is a biotin-conjugated non-conjugated IgG antibody, targeting Thromboxane A Synthase, with a predicted molecular weight of 61 kDa (observed band size: 54 kDa). Thromboxane A Synthase Antibody (YA2670) can be used for WB experiment in human, mouse background.
HRH3 Antibody (YA2701) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2701), targeting HRH3, with a predicted molecular weight of 49 kDa (observed band size: 45 kDa). HRH3 Antibody (YA2701) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
APLP2; APPL2; Amyloid-like protein 2; APLP-2; APPH; Amyloid protein homolog; CDEI box-binding protein; CDEBP
WB
Human, Rat
APLP2 Antibody (YA2722) is a biotin-conjugated non-conjugated IgG antibody, targeting APLP2, with a predicted molecular weight of 87 kDa (observed band size: 115 kDa). APLP2 Antibody (YA2722) can be used for WB experiment in human, rat background.
Tryptophan 5 Hydroxylase 1 Antibody (YA2749) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2749), targeting Tryptophan 5 Hydroxylase 1, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Tryptophan 5 Hydroxylase 1 Antibody (YA2749) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
family with sequence similarity 50 member A; 9F; XAP5; HXC26; HXC-26; DXS9928E
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat, Hamster
FAM50A Antibody (YA2799) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2799), targeting FAM50A, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). FAM50A Antibody (YA2799) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat, hamster background.
LRP2 Antibody (YA2876) is a biotin-conjugated non-conjugated IgG antibody, targeting LRP2, with a predicted molecular weight of 522 kDa (observed band size: 280 kDa). LRP2 Antibody (YA2876) can be used for WB experiment in human, mouse, rat background.
Elongation Factor 1A2 Antibody (YA2879) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2879), targeting Elongation Factor 1A2, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Elongation Factor 1A2 Antibody (YA2879) can be used for WB, IP experiment in human, mouse, rat background.
BRE1-A; hBRE1; RING finger protein 20; E3 ubiquitin-protein ligase BRE1A; RNF20
WB, ICC/IF, IP, FC
Human, Mouse
RNF20 Antibody (YA2880) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2880), targeting RNF20, with a predicted molecular weight of 114 kDa (observed band size: 114 kDa). RNF20 Antibody (YA2880) can be used for WB, ICC/IF, IP, FC experiment in human, mouse background.
PDE4B Antibody (YA2932) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2932), targeting PDE4B, with a predicted molecular weight of 83 kDa (observed band size: 95 kDa). PDE4B Antibody (YA2932) can be used for WB, FC experiment in human, mouse background.
PELP1 Antibody (YA2962) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2962), targeting PELP1, with a predicted molecular weight of 120 kDa (observed band size: 160 kDa). PELP1 Antibody (YA2962) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
HSD17B1 Antibody (YA3048) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3048), targeting HSD17B1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). HSD17B1 Antibody (YA3048) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Integrin alpha E Antibody (YA3051) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3051), targeting Integrin alpha E. Integrin alpha E Antibody (YA3051) can be used for IHC-P experiment in human background.
LEF1 Antibody (YA3164) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3164), targeting LEF1, with a predicted molecular weight of 44 kDa (observed band size: 25-58 kDa). LEF1 Antibody (YA3164) can be used for WB, ICC/IF experiment in human background.
DLG2; Disks large homolog 2; Channel-associated protein of synapse-110; Chapsyn-110; Postsynaptic density protein PSD-93
WB, IP
Human, Rat
PSD93 Antibody (YA3187) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3187), targeting PSD93, with a predicted molecular weight of 98 kDa (observed band size: 110 kDa). PSD93 Antibody (YA3187) can be used for WB, IP experiment in human, rat background.
E3 ubiquitin-protein ligase ZNRF2; ZNRF2; Zinc/RING finger protein 2; RNF202; Protein Ells2
WB, IHC-P
Human, Mouse, Rat
ZNRF2 Antibody (YA3191) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3191), targeting ZNRF2, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). ZNRF2 Antibody (YA3191) can be used for WB, IHC-P experiment in human, mouse, rat background.
S100P; S100E; Protein S100-P; Protein S100-E; S100 calcium-binding protein P
WB, IHC-P, ICC/IF, IP
Human
S100P Antibody (YA3210) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3210), targeting S100P, with a predicted molecular weight of 10 kDa (observed band size: 10 kDa). S100P Antibody (YA3210) can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
Dopamine Receptor D1 Antibody (YA3270) is a biotin-conjugated non-conjugated IgG antibody, targeting Dopamine Receptor D1, with a predicted molecular weight of 49 kDa (observed band size: 75 kDa). Dopamine Receptor D1 Antibody (YA3270) can be used for WB experiment in human, mouse, rat background.
HEC; HsHec1; hsNDC80; Kinetochore protein Hec1; Kinetochore-associated protein 2; KNTC2; ndc80; TID3
WB, IP
Human, Mouse, Rat
HEC1 Antibody (YA3339) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3339), targeting HEC1, with a predicted molecular weight of 74 kDa (observed band size: 74 kDa). HEC1 Antibody (YA3339) can be used for WB, IP experiment in human, mouse, rat background.
Bone marrow stromal antigen 2; BST2; CD317; HM1.24 antigen; NPC A 7; Tetherin
WB, IHC-P, FC
Human
BST2 Antibody (YA3357) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3357), targeting BST2, with a predicted molecular weight of 20 kDa (observed band size: 28-40 kDa). BST2 Antibody (YA3357) can be used for WB, IHC-P, FC experiment in human background.
Plasma Kallikrein Antibody (YA3363) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3363), targeting Plasma Kallikrein, with a predicted molecular weight of 71 kDa (observed band size: 80 kDa). Plasma Kallikrein Antibody (YA3363) can be used for WB, IHC-P, IP experiment in human, rat background.
AMBP Antibody (YA3369) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3369), targeting AMBP, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). AMBP Antibody (YA3369) can be used for WB, IHC-P experiment in human background.
HSD11B1 Antibody (YA3376) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3376), targeting HSD11B1, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). HSD11B1 Antibody (YA3376) can be used for WB, IHC-P experiment in human, mouse, rat background.
KDM1B Antibody (YA3383) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3383), targeting KDM1B, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). KDM1B Antibody (YA3383) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
NOTCH1; TAN1; Neurogenic locus notch homolog protein 1; Notch 1; hN1; Translocation-associated notch protein TAN-1
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
Notch1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 273 kDa, targeting to Notch1. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
CDK2; CDKN2; Cyclin-dependent kinase 2; Cell division protein kinase 2; p33 protein kinase
WB, IP
Human, Hamster, Rat
Phospho-CDK2 (Tyr15) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Phospho-CDK2 (Tyr15). It can be used for WB,IP assays with tag free, in the background of Human, Hamster, Rat.
WFDC2; Epididymis-specific he4; Epididymal protein 4; DJ461P17.6; EDDM4; HE4; WAP5
WB, ICC/IF, IHC-P, IP, FC
Human, Mouse
HE4 Antibody (YA889) is an unconjugated, approximately 13-19 kDa, rabbit-derived, anti-HE4 (YA889) monoclonal antibody. HE4 Antibody (YA889) can be used for: WB, IF-Cell, IF-Tissue, IHC-P, IP, FC expriments in human, mouse background without labeling.
MUC16 Antibody (YA890) is an unconjugated, approximately 1519 kDa, anti-MUC16 (YA890) monoclonal antibody. MUC16 Antibody (YA890) can be used for: WB, IF-Cell, IF-Tissue, IHC-P, FC expriments in human background without labeling.
Leptin Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Leptin, with a predicted molecular weight of 16 kDa . Leptin Antibody can be used for IHC-P, IHC-F, ICC/IF, ELISA experiments in human, mouse, rat, pig, sheep backgrounds.
KRT16; KRT16A; Keratin; type I cytoskeletal 16; Cytokeratin-16; CK-16; Keratin-16; K16
WB, IHC-P
Human, Mouse, Rat
Cytokeratin 16 Antibody (YA948) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA948), targeting Cytokeratin 16, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Cytokeratin 16 Antibody (YA948) can be used for WB, IHC-P experiment in human, mouse, rat background.
KRT16; KRT16A; Keratin; type I cytoskeletal 16; Cytokeratin-16; CK-16; Keratin-16; K16
WB, IHC-P
Human
Cytokeratin 16 Antibody (YA949) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA949), targeting Cytokeratin 16, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Cytokeratin 16 Antibody (YA949) can be used for WB, IHC-P experiment in human background.
Lipocalin 2 Antibody (YA991) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Lipocalin 2. Lipocalin 2 Antibody (YA991) can be used for ELISA experiment in human, rat background.
Lipocalin 2 Antibody (YA992) is a biotin-conjugated non-conjugated IgG antibody, targeting Lipocalin 2, with a predicted molecular weight of 23 kDa. Lipocalin 2 Antibody (YA992) can be used for WB, IHC-P, ICC/IF experiment in human background.
Lymphocyte-specific protein 1; Protein pp52; 52 kDa phosphoprotein; Lymphocyte-specific antigen WP34; 47 kDa actin-binding protein
IHC-P
Human
LSP1 Antibody (YA1089) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1089), targeting LSP1. LSP1 Antibody (YA1089) can be used for IHC-P experiment in human background.
CD53 Antibody (YA1115) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1115), targeting CD53. CD53 Antibody (YA1115) can be used for IHC-P experiment in human background.
MAGP2 Antibody (YA1117) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1117), targeting MAGP2. MAGP2 Antibody (YA1117) can be used for IHC-P experiment in human background.
MEF2B Antibody (YA1155) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1155), targeting MEF2B. MEF2B Antibody (YA1155) can be used for IHC-P experiment in human background.
MYBBP1A Antibody (YA1387) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1387), targeting MYBBP1A, with a predicted molecular weight of 149 kDa (observed band size: 149 kDa). MYBBP1A Antibody (YA1387) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Synaptosomal-associated protein 25; SNAP-25; Super protein; SUP; Synaptosomal-associated 25 kDa protein; SNAP25; SNAP
WB, ICC/IF, IP
Human, Mouse, Rat
SNAP25 Antibody (YA1412) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1412), targeting SNAP25, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). SNAP25 Antibody (YA1412) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
TFE3; BHLHE33; Transcription factor E3; Class E basic helix-loop-helix protein 33; bHLHe33
IHC-P, ICC/IF, FC
Human
Transcription Factor E3 Antibody (YA1508) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1508), targeting Transcription Factor E3. Transcription Factor E3 Antibody (YA1508) can be used for IHC-P, ICC/IF, FC experiment in human background.
NBN; NBS; NBS1; P95; Nibrin; Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1
WB, ICC/IF, IP
Human
p95/NBS1 Antibody (YA1520) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1520), targeting p95/NBS1, with a predicted molecular weight of 85 kDa (observed band size: 95 kDa). p95/NBS1 Antibody (YA1520) can be used for WB, ICC/IF, IP experiment in human background.
PAI1 Antibody (YA1524) is a biotin-conjugated non-conjugated IgG antibody, targeting PAI1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). PAI1 Antibody (YA1524) can be used for WB experiment in human, mouse background.
PCSK9 Antibody (YA1550) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1550), targeting PCSK9, with a predicted molecular weight of 74 kDa (observed band size: 65/80 kDa). PCSK9 Antibody (YA1550) can be used for WB, IP experiment in human background.
MMP14 Antibody (YA1590) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1590), targeting MMP14, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). MMP14 Antibody (YA1590) can be used for WB, IHC-P, IP experiment in human, hamster background.
Fc fragment of IgG; low affinity IIb; receptor (CD32); CD32; FCG2; CD32B; FCGR2; IGFR2
WB, IHC-P
Human, Rat
CD32B Antibody (YA1615) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1615), targeting CD32B, with a predicted molecular weight of 34 kDa (observed band size: 44 kDa). CD32B Antibody (YA1615) can be used for WB, IHC-P experiment in human, rat background.
PEDF Antibody (YA1687) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1687), targeting PEDF, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). PEDF Antibody (YA1687) can be used for WB, FC experiment in human background.
Syntrophin alpha 1 Antibody (YA1828) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1828), targeting Syntrophin alpha 1, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Syntrophin alpha 1 Antibody (YA1828) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
YWHAQ; 14-3-3 protein theta; 14-3-3 protein T-cell; 14-3-3 protein tau; Protein HS1
WB
Human, Mouse, Rat
14-3-3 theta Antibody (YA1955) is a biotin-conjugated non-conjugated IgG antibody, targeting 14-3-3 theta, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). 14-3-3 theta Antibody (YA1955) can be used for WB experiment in human, mouse, rat background.
Carbonic Anhydrase 1 Antibody (YA1982) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1982), targeting Carbonic Anhydrase 1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). Carbonic Anhydrase 1 Antibody (YA1982) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat, zebra fish background.
Estrogen Related Receptor gamma Antibody (YA2009) is a biotin-conjugated non-conjugated IgG antibody, targeting Estrogen Related Receptor gamma, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Estrogen Related Receptor gamma Antibody (YA2009) can be used for WB experiment in human, mouse, rat background.
SNCA; NACP; PARK1; Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
WB, IHC-P, IP
Human, Rat
alpha Synuclein Antibody (YA2073) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2073), targeting alpha Synuclein, with a predicted molecular weight of 14 kDa (observed band size: 18 kDa). alpha Synuclein Antibody (YA2073) can be used for WB, IHC-P, IP experiment in human, rat background.
STK3 Antibody (YA2083) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2083), targeting STK3, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). STK3 Antibody (YA2083) can be used for WB, IHC-P, IP experiment in human, mouse, rat, hamster background.
Glutathione Peroxidase 2 Antibody (YA2153) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2153), targeting Glutathione Peroxidase 2, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). Glutathione Peroxidase 2 Antibody (YA2153) can be used for WB, IHC-P experiment in human background.
T box 3; T-box protein 3; Tbx3; TBX3 ISO; UMS; XHL
WB, IP
Mouse
T Box Protein 3 Antibody (YA2154) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2154), targeting T Box Protein 3, with a predicted molecular weight of 79 kDa (observed band size: 79 kDa). T Box Protein 3 Antibody (YA2154) can be used for WB, IP experiment in mouse background.
Tropomyosin alpha 1 Chain Antibody (YA2183) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2183), targeting Tropomyosin alpha 1 Chain, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Tropomyosin alpha 1 Chain Antibody (YA2183) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Galectin 8 Antibody (YA2186) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2186), targeting Galectin 8, with a predicted molecular weight of 36 kDa (observed band size: 40 kDa). Galectin 8 Antibody (YA2186) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
ATG16L1; APG16L; Autophagy-related protein 16-1; APG16-like 1
WB
Human, Mouse, Rat
ATG16L1 Antibody (YA2187) is a biotin-conjugated non-conjugated IgG antibody, targeting ATG16L1, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). ATG16L1 Antibody (YA2187) can be used for WB experiment in human, mouse, rat background.
Cytochrome P450 26A1 Antibody (YA2259) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2259), targeting Cytochrome P450 26A1, with a predicted molecular weight of 56 kDa (observed band size: 50 kDa). Cytochrome P450 26A1 Antibody (YA2259) can be used for WB, IHC-P experiment in human, rat background.
Superoxide Dismutase 3 Antibody (YA2420) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2420), targeting Superoxide Dismutase 3, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). Superoxide Dismutase 3 Antibody (YA2420) can be used for WB, IHC-P experiment in human background.
PHD2 Antibody (YA2431) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2431), targeting PHD2, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). PHD2 Antibody (YA2431) can be used for WB, IP experiment in human background.
Cyclooxygenase 2 Antibody (YA2541) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2541), targeting Cyclooxygenase 2, with a predicted molecular weight of 69 kDa (observed band size: 74 kDa). Cyclooxygenase 2 Antibody (YA2541) can be used for WB, ICC/IF, IP experiment in mouse background.
14-3-3 epsilon; 14-3-3E; 143E; KCIP-1; MDCR; Protein kinase C inhibitor protein-1; YWHAE
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
14-3-3 epsilon Antibody (YA2629) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2629), targeting 14-3-3 epsilon, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). 14-3-3 epsilon Antibody (YA2629) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
D4 GDI Antibody (YA2638) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2638), targeting D4 GDI, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). D4 GDI Antibody (YA2638) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Phospho-Src (Tyr530) Antibody (YA2656) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2656), targeting Phospho-Src (Tyr530), with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). Phospho-Src (Tyr530) Antibody (YA2656) can be used for WB, IP experiment in rat background.
Adiponectin receptor protein 1; Progestin and adipoQ receptor family member I; CGI-45; PAQR1; ADIPOR1
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
Adiponectin Receptor 1 Antibody (YA2700) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2700), targeting Adiponectin Receptor 1, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). Adiponectin Receptor 1 Antibody (YA2700) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
DCML; GATA binding protein 2; GATA binding protein 3; HDR; HDRS; IMD21; MONOMAC; NFE1B
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
GATA2/3 Antibody (YA2767) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2767), targeting GATA2/3, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). GATA2/3 Antibody (YA2767) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
HTR7 Antibody (YA2796) is a biotin-conjugated non-conjugated IgG antibody, targeting HTR7, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). HTR7 Antibody (YA2796) can be used for WB experiment in human, mouse, rat background.
Chloride intracellular channel protein 1; Chloride channel ABP; Nuclear chloride ion channel 27; NCC27; Regulatory nuclear chloride ion channel protein; hRNCC
WB, ICC/IF, IP
Human, Mouse, Rat, Hamster
CLIC1 Antibody (YA2807) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2807), targeting CLIC1, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). CLIC1 Antibody (YA2807) can be used for WB, ICC/IF, IP experiment in human, mouse, rat, hamster background.
KIAA0057; TRAM like protein; Tram2; Translocating chain associating membrane protein 2; Translocation associated membrane protein 2
WB
Human, Mouse, Rat
TRAM2 Antibody (YA2825) is a biotin-conjugated non-conjugated IgG antibody, targeting TRAM2, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). TRAM2 Antibody (YA2825) can be used for WB experiment in human, mouse, rat background.
Kir2.1 Antibody (YA2871) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2871), targeting Kir2.1, with a predicted molecular weight of 48 kDa (observed band size: 53 kDa). Kir2.1 Antibody (YA2871) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Protein S Antibody (YA2919) is a biotin-conjugated non-conjugated IgG antibody, targeting Protein S, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). Protein S Antibody (YA2919) can be used for WB experiment in human background.
Tenascin Antibody (YA2996) is a biotin-conjugated non-conjugated IgG antibody, targeting Tenascin, with a predicted molecular weight of 241 kDa. Tenascin Antibody (YA2996) can be used for WB experiment in human background.
CC2D1A Antibody (YA3002) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3002), targeting CC2D1A, with a predicted molecular weight of 104 kDa (observed band size: 130 kDa). CC2D1A Antibody (YA3002) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Phospho-alpha Tubulin (Tyr272) Antibody (YA3041) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3041), targeting Phospho-alpha Tubulin (Tyr272), with a predicted molecular weight of 50 kDa (observed band size: 54 kDa). Phospho-alpha Tubulin (Tyr272) Antibody (YA3041) can be used for WB, ICC/IF experiment in human background.
MRPS18B Antibody (YA3082) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3082), targeting MRPS18B, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). MRPS18B Antibody (YA3082) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
WB, IHC-P, IP
Human
LAT Antibody (YA3161) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3161), targeting LAT, with a predicted molecular weight of 28 kDa (observed band size: 36 kDa). LAT Antibody (YA3161) can be used for WB, IHC-P, IP experiment in human background.
Ubiquitin Protein Ligase E3A Antibody (YA3306) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3306), targeting Ubiquitin Protein Ligase E3A, with a predicted molecular weight of 101 kDa (observed band size: 101 kDa). Ubiquitin Protein Ligase E3A Antibody (YA3306) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
WWOX Antibody (YA3315) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3315), targeting WWOX, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). WWOX Antibody (YA3315) can be used for WB, IHC-P, IP experiment in human, mouse background.
mtTFA Antibody (YA3360) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3360), targeting mtTFA, with a predicted molecular weight of 29 kDa (observed band size: 24 kDa). mtTFA Antibody (YA3360) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Carbonic Anhydrase 2 Antibody (YA3362) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3362), targeting Carbonic Anhydrase 2, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). Carbonic Anhydrase 2 Antibody (YA3362) can be used for WB, IHC-P experiment in human, mouse, rat background.
Caspr1 Antibody (YA3371) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3371), targeting Caspr1, with a predicted molecular weight of 156 kDa (observed band size: 165 kDa). Caspr1 Antibody (YA3371) can be used for WB, IHC-P experiment in human, mouse, rat background.
ZIC; Zic protein member 1; Zinc finger protein 201; Zinc finger protein ZIC1; ZNF201
WB, ICC/IF, FC
Human, Mouse, Rat
ZIC 1 Antibody (YA3372) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3372), targeting ZIC 1, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). ZIC 1 Antibody (YA3372) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
EDG2 Antibody (YA3375) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3375), targeting EDG2, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). EDG2 Antibody (YA3375) can be used for WB, IHC-P, IP experiment in human background.
Apoptosis regulator BAX; BAX; Bcl-2-like protein 4; BCL2-associated X protein; Bcl2-L-4; BCL2L4
WB, IHC-P
Human, Mouse, Rat
BAX Antibody (YA825) is a non-conjugated and Mouse origined monoclonal antibody about 21 kDa, targeting to BAX. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Apoptosis regulator BAX; BAX; Bcl-2-like protein 4; BCL2-associated X protein; Bcl2-L-4; BCL2L4
WB
Human, Monkey
Bax Antibody (YA826) is a non-conjugated and Mouse origined monoclonal antibody about 21 kDa, targeting to Bax (2B12). It can be used for WB assays with tag free, in the background of Human, Monkey.
BRAF Antibody is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to BRAF (4E1). It can be used for WB assays with tag free, in the background of Human, Mouse.
FGF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to FGF2. It can be used for WB assays with tag free, in the background of Human.
FOXO3; FKHRL1; FOXO3A; Forkhead box protein O3; AF6q21 protein; Forkhead in rhabdomyosarcoma-like 1
WB
Human
FOXO3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to FOXO3. It can be used for WB assays with tag free, in the background of Human.
IGF1R; Insulin-like growth factor 1 receptor; Insulin-like growth factor I receptor; IGF-I receptor; CD antigen CD221
WB, IHC-P
Human
IGF1 Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 155 kDa, targeting to IGF1 Receptor. It can be used for WB,IHC-P assays with tag free, in the background of Human.
NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3
WB, IHC-P, IP
Human, Mouse, Rat
IKB alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to IKB alpha. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
IL-4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to IL-4. It can be used for WB assays with tag free, in the background of Transfected.
CREB1; Cyclic AMP-responsive element-binding protein 1; CREB-1; cAMP-responsive element-binding protein 1
WB, IHC-P, IP
Human, Rat
Phospho-CREB (Ser133) Antibody (YA209) is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Phospho-CREB (Ser133). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.
STAT1; Signal transducer and activator of transcription 1-alpha/beta; Transcription factor ISGF-3 components p91/p84
WB, IHC-P
Human, Mouse, Rat
Phospho-STAT1 (Ser727) Antibody (YA149) is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Phospho-STAT1 (Ser727). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
PPARA; NR1C1; PPAR; Peroxisome proliferator-activated receptor alpha; PPAR-alpha; Nuclear receptor subfamily 1 group C member 1
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
PPAR alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to PPAR alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
S100 alpha6; Protein S100-A6; Calcyclin; MLN 4; PRA; CACY; CABP; 5B10
WB
Human
S100A6 Antibody (YA674) is a non-conjugated and Mouse origined monoclonal antibody about 10 kDa, targeting to S100A6 (3E11). It can be used for WB assays with tag free, in the background of Human.
TBK1 Antibody (YA040) is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to TBK1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Hamster.
LIAS Antibody is an unconjugated, rabbit-derived, anti-LIAS polyclonal antibody. LIAS Antibody can be used for: ELISA, IHC-P, ICC, IF, expriments in mouse and predicted: human, rat, chicken, dog, pig, cow, horse, rabbit, sheep background without labeling.
CYP2E1 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting CYP2E1, with a predicted molecular weight of 57 kDa. CYP2E1 Antibody can be used for WB, ICC/IF, IHC-P experiments in human, mouse, rat backgrounds.
MonoMethyl-Histone H3 Antibody (YA997) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA997), targeting MonoMethyl-Histone H3, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). MonoMethyl-Histone H3 Antibody (YA997) can be used for WB, IHC-P experiment in human, mouse, rat background.
CD82 Antibody (YA1133) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1133), targeting CD82. CD82 Antibody (YA1133) can be used for IHC-P experiment in human background.
CDC73; C1orf28, HRPT2; Parafibromin; Cell division cycle protein 73 homolog; Hyperparathyroidism 2 protein
IHC-P
Human
HRPT2/Parafibromin Antibody (YA1200) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1200), targeting HRPT2/Parafibromin. HRPT2/Parafibromin Antibody (YA1200) can be used for IHC-P experiment in human background.
DMT1; DMRT1; DM domain expressed in testis protein 1; Doublesex- and mab-3-related transcription factor 1
IHC-P
Human
DMRT1 Antibody (YA1226) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1226), targeting DMRT1. DMRT1 Antibody (YA1226) can be used for IHC-P experiment in human background.
IL-5 Receptor alpha Antibody (YA1228) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1228), targeting IL-5 Receptor alpha. IL-5 Receptor alpha Antibody (YA1228) can be used for IHC-P experiment in human background.
CD103 Antibody (YA1243) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1243), targeting CD103. CD103 Antibody (YA1243) can be used for IHC-P experiment in human background.
FABP1; FABPL; Fatty acid-binding protein, liver; Fatty acid-binding protein 1; Liver-type fatty acid-binding protein (L-FABP)
IHC-P
Human
liver FABP Antibody (YA1268) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1268), targeting liver FABP. liver FABP Antibody (YA1268) can be used for IHC-P experiment in human background.
CD7 Antibody (YA1405) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1405), targeting CD7. CD7 Antibody (YA1405) can be used for FC, ELISA experiment in human background.
XBP1; TREB5; XBP2; X-box-binding protein 1; XBP-1; Tax-responsive element-binding protein 5
WB, IP
Human, Mouse
XBP1 Antibody (YA1424) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1424), targeting XBP1, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). XBP1 Antibody (YA1424) can be used for WB, IP experiment in human, mouse background.
P4HB Antibody (YA1503) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1503), targeting P4HB, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). P4HB Antibody (YA1503) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
ELOVL FA elongase 5; Fatty acid elongase 1; hELO1; Very long chain 3-ketoacyl-CoA synthase 5
WB, ICC/IF
Human
ELOVL5 Antibody (YA1558) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1558), targeting ELOVL5, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). ELOVL5 Antibody (YA1558) can be used for WB, ICC/IF experiment in human background.
CDKN2A/p14ARF Antibody (YA1563) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1563), targeting CDKN2A/p14ARF, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). CDKN2A/p14ARF Antibody (YA1563) can be used for WB, ICC/IF, IP, FC experiment in human background.
beta Defensin 1 Antibody (YA1655) is a biotin-conjugated non-conjugated IgG antibody, targeting beta Defensin 1, with a predicted molecular weight of 7 kDa (observed band size: 7 kDa). beta Defensin 1 Antibody (YA1655) can be used for WB experiment in human background.
p164 ROCK 2; Rho kinase 2; ROCK 2; Rock II; Rock2m; ROK alpha; ROKalpha
WB, ICC/IF
Human, Rat
ROCK2 Antibody (YA1667) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1667), targeting ROCK2, with a predicted molecular weight of 161 kDa (observed band size: 161 kDa). ROCK2 Antibody (YA1667) can be used for WB, ICC/IF experiment in human, rat background.
PGR; NR3C3; Progesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3
WB, IHC-F, IHC-P, ICC/IF, IP
Human
Phospho-Progesterone Receptor (Ser190) Antibody (YA1736) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1736), targeting Phospho-Progesterone Receptor (Ser190), with a predicted molecular weight of 99 kDa (observed band size: 90/118 kDa). Phospho-Progesterone Receptor (Ser190) Antibody (YA1736) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
PTP1B Antibody (YA1776) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1776), targeting PTP1B, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). PTP1B Antibody (YA1776) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
AMF Antibody (YA1777) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1777), targeting AMF, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). AMF Antibody (YA1777) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
eIF4A3 Antibody (YA1822) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1822), targeting eIF4A3, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). eIF4A3 Antibody (YA1822) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Phospho-DNA PKcs (Ser2056) Antibody (YA1823) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1823), targeting Phospho-DNA PKcs (Ser2056), with a predicted molecular weight of 469 kDa (observed band size: 469 kDa). Phospho-DNA PKcs (Ser2056) Antibody (YA1823) can be used for WB, IHC-P, ICC/IF experiment in human background.
Neuropilin 1 Antibody (YA1831) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1831), targeting Neuropilin 1, with a predicted molecular weight of 103 kDa (observed band size: 125-135 kDa). Neuropilin 1 Antibody (YA1831) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
ATP-binding cassette transporter 8; White protein homolog; ABC8; WHT1; ABCG1; ABC transporter 8; WHITE1
WB
Human
ABCG1 Antibody (YA1841) is a biotin-conjugated non-conjugated IgG antibody, targeting ABCG1, with a predicted molecular weight of 76 kDa (observed band size: 100 kDa). ABCG1 Antibody (YA1841) can be used for WB experiment in human background.
RKIP Antibody (YA1869) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1869), targeting RKIP, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). RKIP Antibody (YA1869) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
SC35 Antibody (YA1905) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1905), targeting SC35, with a predicted molecular weight of 25 kDa (observed band size: 35 kDa). SC35 Antibody (YA1905) can be used for WB, IHC-P, IP experiment in human, rat background.
YWHAB; 14-3-3 protein beta/alpha; Protein 1054; Protein kinase C inhibitor protein 1; KCIP-1
WB
Human, Rat
14-3-3 Antibody (YA1949) is a biotin-conjugated non-conjugated IgG antibody, with a predicted molecular weight of 28 kDa (observed band size: 27-29 kDa). 14-3-3 Antibody (YA1949) can be used for WB experiment in human, rat background.
BAG4; SODD; BAG family molecular chaperone regulator 4; BAG-4; Bcl-2-associated athanogene 4; Silencer of death domains
WB, IHC-F, IHC-P, ICC/IF
Human
SODD Antibody (YA1958) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1958), targeting SODD, with a predicted molecular weight of 50 kDa (observed band size: 70 kDa). SODD Antibody (YA1958) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
ADAMTS13 Antibody (YA2002) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2002), targeting ADAMTS13, with a predicted molecular weight of 154 kDa (observed band size: 154 kDa). ADAMTS13 Antibody (YA2002) can be used for WB, FC experiment in human background.
MT ND1 Antibody (YA2089) is a biotin-conjugated non-conjugated IgG antibody, targeting MT ND1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). MT ND1 Antibody (YA2089) can be used for WB experiment in human, mouse, rat background.
p95; p95vav; Protein vav 1; Protein vav 2; Protein vav 3; VAV; vav-T
WB, ICC/IF, IP, FC
Human
VAV1 Antibody (YA2161) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2161), targeting VAV1, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). VAV1 Antibody (YA2161) can be used for WB, ICC/IF, IP, FC experiment in human background.
Cpn10 Antibody (YA2190) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2190), targeting Cpn10, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). Cpn10 Antibody (YA2190) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
BMP4; BMP2B; DVR4; Bone morphogenetic protein 4; BMP-4; Bone morphogenetic protein 2B; BMP-2B
WB, ICC/IF, IP
Human
BMP4 Antibody (YA2285) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2285), targeting BMP4, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). BMP4 Antibody (YA2285) can be used for WB, ICC/IF, IP experiment in human background.
HsT17016; LS-B8340; SNAP23A; SNAP23B; Synaptosomal associated protein 23; Vesicle membrane fusion protein SNAP23
WB
Human, Mouse, Rat
SNAP23 Antibody (YA2427) is a biotin-conjugated non-conjugated IgG antibody, targeting SNAP23, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). SNAP23 Antibody (YA2427) can be used for WB experiment in human, mouse, rat background.
Lysosome Membrane Protein 2 Antibody (YA2567) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2567), targeting Lysosome Membrane Protein 2, with a predicted molecular weight of 54 kDa (observed band size: 77 kDa). Lysosome Membrane Protein 2 Antibody (YA2567) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
Thyroid Hormone Receptor alpha Antibody (YA2573) is a biotin-conjugated non-conjugated IgG antibody, targeting Thyroid Hormone Receptor alpha, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). Thyroid Hormone Receptor alpha Antibody (YA2573) can be used for WB experiment in human background.
Phospho-E Cadherin (Ser838/Ser840) Antibody (YA2579) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2579), targeting Phospho-E Cadherin (Ser838/Ser840), with a predicted molecular weight of 97 kDa (observed band size: 135 kDa). Phospho-E Cadherin (Ser838/Ser840) Antibody (YA2579) can be used for WB, IHC-P, IP experiment in human, mouse background.
NR3C1; GRL; Glucocorticoid receptor; GR; Nuclear receptor subfamily 3 group C member 1
WB, IHC-P
Human, Rat
Phospho-Glucocorticoid Receptor (Ser226) Antibody (YA2595) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2595), targeting Phospho-Glucocorticoid Receptor (Ser226), with a predicted molecular weight of 86 kDa (observed band size: 94 kDa). Phospho-Glucocorticoid Receptor (Ser226) Antibody (YA2595) can be used for WB, IHC-P experiment in human, rat background.
DAPK2; Death-associated protein kinase 2; DAP kinase 2; DAP-kinase-related protein 1; DRP-1
WB, IHC-P
Rat
DAPK2 Antibody (YA2643) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2643), targeting DAPK2, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). DAPK2 Antibody (YA2643) can be used for WB, IHC-P experiment in rat background.
FABP2 Antibody (YA2788) is a biotin-conjugated non-conjugated IgG antibody, targeting FABP2, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). FABP2 Antibody (YA2788) can be used for WB experiment in human, mouse, rat background.
IFITM3; Interferon-induced transmembrane protein 3; Dispanin subfamily A member 2b; DSPA2b; Interferon-inducible protein 1-8U
WB, IHC-F, IHC-P, ICC/IF
Human
Fragilis Antibody (YA2860) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2860), targeting Fragilis, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). Fragilis Antibody (YA2860) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
IL-32; IL 32alpha; IL 32beta; IL 32delta; IL 32gamma; IL32; NK4; TAIF; TAIFa; TAIFb; TAIFc; TAIFd
WB
Human
IL-32 Antibody (YA2911) is a biotin-conjugated non-conjugated IgG antibody, targeting IL-32, with a predicted molecular weight of 27 kDa (observed band size: 23 kDa). IL-32 Antibody (YA2911) can be used for WB experiment in human background.
Plectin Antibody (YA2915) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2915), targeting Plectin, with a predicted molecular weight of 532 kDa (observed band size: 532 kDa). Plectin Antibody (YA2915) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
p57 Kip2 Antibody (YA2954) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2954), targeting p57 Kip2, with a predicted molecular weight of 32 kDa (observed band size: 57 kDa). p57 Kip2 Antibody (YA2954) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
TAF1 Antibody (YA2956) is a biotin-conjugated non-conjugated IgG antibody, targeting TAF1, with a predicted molecular weight of 213 kDa (observed band size: 300 kDa). TAF1 Antibody (YA2956) can be used for WB experiment in human, mouse, rat background.
ING1 Antibody (YA3018) is a biotin-conjugated non-conjugated IgG antibody, targeting ING1, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). ING1 Antibody (YA3018) can be used for WB experiment in human, mouse, rat background.
NBN; NBS; NBS1; P95; Nibrin; Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1
WB, ICC/IF, IP
Human
Phospho-p95 (Ser343) Antibody (YA3103) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-p95 (Ser343), with a predicted molecular weight of 85 kDa. Phospho-p95 (Ser343) Antibody (YA3103) can be used for WB, ICC/IF, IP experiment in human background.
Integrin Linked ILK Antibody (YA3111) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3111), targeting Integrin Linked ILK, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Integrin Linked ILK Antibody (YA3111) can be used for WB, IP experiment in human, mouse, rat background.
Peroxiredoxin 6 Antibody (YA3154) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3154), targeting Peroxiredoxin 6, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). Peroxiredoxin 6 Antibody (YA3154) can be used for WB, IP experiment in human background.
Toll-Like Receptor 5 Antibody (YA3265) is a biotin-conjugated non-conjugated IgG antibody, targeting Toll-Like Receptor 5, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). Toll-Like Receptor 5 Antibody (YA3265) can be used for WB experiment in human, mouse, rat background.
Rhodopsin Antibody (YA3269) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3269), targeting Rhodopsin, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). Rhodopsin Antibody (YA3269) can be used for WB, IHC-P experiment in human, rat background.
NCE2; NEDD8 carrier protein UBE2F; NEDD8 protein ligase UBE2F; NEDD8-conjugating enzyme 2
WB, IHC-F, IHC-P, ICC/IF
Human
NCE2 Antibody (YA3291) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3291), targeting NCE2, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). NCE2 Antibody (YA3291) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
RPE65 Antibody (YA3310) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3310), targeting RPE65, with a predicted molecular weight of 61 kDa (observed band size: 61 kDa). RPE65 Antibody (YA3310) can be used for WB, IP experiment in human, mouse, rat background.
Reptin Antibody (YA3348) is a biotin-conjugated non-conjugated IgG antibody, targeting Reptin, with a predicted molecular weight of 51 kDa (observed band size: 48 kDa). Reptin Antibody (YA3348) can be used for WB experiment in human, mouse background.
IL-23R Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting IL-23R, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). IL-23R Antibody can be used for WB, IHC-P experiment in human background.
CSNK2B; CK2N; G5A; Casein kinase II subunit beta; CK II beta; Phosvitin; Protein G5a
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
Casein Kinase 2 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to Casein Kinase 2 beta. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
CD8 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD8 alpha. It can be used for WB,IHC-P assays with tag free, in the background of Human, Hamster.
DiMethyl-Histone H3 Antibody (YA783) is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to DiMethyl-Histone H3 (Lys27) (5F6). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
eIF4A1 Antibody (YA774) is a non-conjugated and Mouse origined monoclonal antibody about 46 kDa, targeting to eIF4A1 (6D7). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Estrogen Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to Estrogen Receptor alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human.
FTH1; FTH; FTHL6; OK/SW-cl.84; PIG15; Ferritin heavy chain; Ferritin H subunit; Cell proliferation-inducing gene 15 protein
WB, ICC/IF
Human, Mouse, Rat, Hamster
Ferritin Heavy Chain Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Ferritin Heavy Chain. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Hamster.
GRB2; ASH; Growth factor receptor-bound protein 2; Adapter protein GRB2; Protein Ash; SH2/SH3 adapter GRB2
WB
Human, Mouse, Rat
GRB2 Antibody (YA748) is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2 (5G3). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Mitofusin 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 86 kDa, targeting to Mitofusin 2. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
PERK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 125 kDa, targeting to PERK. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
MET; Hepatocyte growth factor receptor; HGF receptor; HGF/SF receptor; Proto-oncogene c-Met; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met
WB, IP
Human
Phospho-c-Met (Tyr1349) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Phospho-c-Met (Tyr1349). It can be used for WB,IP assays with tag free, in the background of Human.
TriMethyl-Histone H3 (Lys27) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to TriMethyl-Histone H3 (Lys27). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Rat.
VCAM1; L1CAM; Vascular cell adhesion protein 1; V-CAM 1; VCAM-1; INCAM-100; CD antigen CD106
WB, IHC-P, IP
Human, Mouse, Rat
VCAM1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to VCAM1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
PLK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to PLK1. It can be used for WB, ICC/IF, IP assays with tag free, in the background of Human, Rat.
Pan Cytokeratin Antibody is an unconjugated, approximately 42-64 kDa, rabbit-derived, anti-Pan Cytokeratin polyclonal antibody. Pan Cytokeratin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, cow, and predicted: chicken, dog, pig, horse, rabbit background without labeling.
FOXA1 Antibody (YA1102) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1102), targeting FOXA1. FOXA1 Antibody (YA1102) can be used for IHC-P experiment in human background.
RON Antibody (YA1129) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1129), targeting RON. RON Antibody (YA1129) can be used for IHC-P experiment in human background.
CD97 Antibody (YA1144) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1144), targeting CD97. CD97 Antibody (YA1144) can be used for IHC-P experiment in human background.
SA2 Antibody (YA1147) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1147), targeting SA2. SA2 Antibody (YA1147) can be used for IHC-P experiment in human background.
TAGLN; Transgelin; SM22; WS3-10; 22 kDa actin-binding protein; Protein WS3-10; Smooth muscle protein 22-alpha (SM22-alpha)
IHC-P
Human
TAGLN/Transgelin Antibody (YA1206) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1206), targeting TAGLN/Transgelin. TAGLN/Transgelin Antibody (YA1206) can be used for IHC-P experiment in human background.
CD10 Antibody (YA1313) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1313), targeting CD10, with a predicted molecular weight of 86 kDa (observed band size: 100 kDa). CD10 Antibody (YA1313) can be used for WB, IHC-P ，IP experiment in human, rat background.
NDUFB10 Antibody (YA1330) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1330), targeting NDUFB10, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). NDUFB10 Antibody (YA1330) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
CD171 Antibody (YA1370) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1370), targeting CD171. CD171 Antibody (YA1370) can be used for FC, ELISA experiment in human background.
IL-17RA Antibody (YA1379) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1379), targeting IL-17RA. IL-17RA Antibody (YA1379) can be used for FC, ELISA experiment in human background.
NFIB Antibody (YA1392) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1392), targeting NFIB, with a predicted molecular weight of 47 kDa (observed band size: 47,55 kDa). NFIB Antibody (YA1392) can be used for WB, IP experiment in human, rat background.
G0/G1 switch regulatory protein 3; G0S3; Protein fosB; GOSB; Oncogene FOSB; Activator protein 1
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Fos B Antibody (YA1498) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1498), targeting Fos B, with a predicted molecular weight of 36 kDa. Fos B Antibody (YA1498) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
EEC3; KET; LMS; SHFM4; TA p63 alpha; TP63; p51; p73H; p73L; tumor protein p63
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
p63 Antibody (YA1531) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1531), targeting p63, with a predicted molecular weight of 77 kDa . p63 Antibody (YA1531) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
PML; MYL; RNF71; TRIM19; Protein PML; Promyelocytic leukemia protein; RING finger protein 71; Tripartite motif-containing protein 19
WB, IHC-F, IHC-P, ICC/IF, IP
Human
PML Protein Antibody (YA1678) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1678), targeting PML Protein, with a predicted molecular weight of 98 kDa (observed band size: 98/117 kDa). PML Protein Antibody (YA1678) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Hsc70 Interacting Protein HIP Antibody (YA1738) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1738), targeting Hsc70 Interacting Protein HIP, with a predicted molecular weight of 41 kDa (observed band size: 47 kDa). Hsc70 Interacting Protein HIP Antibody (YA1738) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
GABA A Receptor beta 2 Antibody (YA1758) is a biotin-conjugated non-conjugated IgG antibody, targeting GABA A Receptor beta 2, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). GABA A Receptor beta 2 Antibody (YA1758) can be used for WB experiment in human, mouse, rat background.
SAE1 Antibody (YA1847) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1847), targeting SAE1, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). SAE1 Antibody (YA1847) can be used for WB, ICC/IF, IP, FC experiment in human, rat background.
KHSRP; FUBP2; Far upstream element-binding protein 2; FUSE-binding protein 2; KH type-splicing regulatory protein; KSRP; p75
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
KHSRP Antibody (YA2143) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2143), targeting KHSRP, with a predicted molecular weight of 73 kDa (observed band size: 82 kDa). KHSRP Antibody (YA2143) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
TRIB3 Antibody (YA2174) is a biotin-conjugated non-conjugated IgG antibody, targeting TRIB3, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). TRIB3 Antibody (YA2174) can be used for WB experiment in human background.
ATP5F1A Antibody (YA2306) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2306), targeting ATP5F1A, with a predicted molecular weight of 60 kDa (observed band size: 55 kDa). ATP5F1A Antibody (YA2306) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CAV2; Caveolae protein 20 Kd; Caveolin 2; Caveolin 2 isoform a and b; Caveolin-2
WB, IHC-F, IHC-P, ICC/IF, IP
Human
Caveolin 2 Antibody (YA2387) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2387), targeting Caveolin 2, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). Caveolin 2 Antibody (YA2387) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Fibulin 5 Antibody (YA2448) is a biotin-conjugated non-conjugated IgG antibody, targeting Fibulin 5, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Fibulin 5 Antibody (YA2448) can be used for WB experiment in human, mouse background.
KIF22; KID; KNSL4; Kinesin-like protein KIF22; Kinesin-like DNA-binding protein; Kinesin-like protein 4
WB
Human
Phospho-KIF22 (Ser427) Antibody (YA2498) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-KIF22 (Ser427), with a predicted molecular weight of 73 kDa (observed band size: 73 kDa). Phospho-KIF22 (Ser427) Antibody (YA2498) can be used for WB experiment in human background.
PPP1R1B; DARPP32; Protein phosphatase 1 regulatory subunit 1B; DARPP-32; Dopamine- and cAMP-regulated neuronal phosphoprotein
WB, IHC-P, IP
Human, Mouse, Rat
DARPP32 Antibody (YA2644) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2644), targeting DARPP32, with a predicted molecular weight of 23 kDa (observed band size: 32 kDa). DARPP32 Antibody (YA2644) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
A RAF Antibody (YA2673) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2673), targeting A RAF, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). A RAF Antibody (YA2673) can be used for WB, IHC-P experiment in human background.
E2F2 Antibody (YA2674) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2674), targeting E2F2, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). E2F2 Antibody (YA2674) can be used for WB, FC experiment in human, mouse, rat background.
DPS1 Antibody (YA2721) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2721), targeting DPS1, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). DPS1 Antibody (YA2721) can be used for WB, IP experiment in human background.
Collagen XVII alpha 1 Antibody (YA2759) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2759), targeting Collagen XVII alpha 1, with a predicted molecular weight of 150 kDa (observed band size: 130,180 kDa). Collagen XVII alpha 1 Antibody (YA2759) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Hyaluronan and proteoglycan link protein 1; Cartilage-linking protein 1; Cartilage-link protein; Proteoglycan link protein; HAPLN1; CRTL1
WB, IHC-P, ICC/IF
Human, Mouse, Rat
HAPLN1 Antibody (YA2805) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2805), targeting HAPLN1, with a predicted molecular weight of 40 kDa (observed band size: 48 kDa). HAPLN1 Antibody (YA2805) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
SPAK Antibody (YA2827) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2827), targeting SPAK, with a predicted molecular weight of 59 kDa (observed band size: 68 kDa). SPAK Antibody (YA2827) can be used for WB, IHC-P, FC experiment in human background.
Ephrin Receptor B4 Antibody (YA2892) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2892), targeting Ephrin Receptor B4, with a predicted molecular weight of 108 kDa (observed band size: 135 kDa). Ephrin Receptor B4 Antibody (YA2892) can be used for WB, IHC-P experiment in human, mouse, rat background.
AMS2; MAT 2; MAT 2A; MAT II; Mat2a; MATA2; MATII; SAMS 2; SAMS2
WB, ICC/IF
Human, Mouse, Rat
MAT2A Antibody (YA2926) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2926), targeting MAT2A, with a predicted molecular weight of 44 kDa (observed band size: 48 kDa). MAT2A Antibody (YA2926) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MAD2L1BP; CMT2; KIAA0110; MAD2L1-binding protein; Caught by MAD2 protein
WB, IHC-P, ICC/IF
Human, Mouse, Rat
MAD2L1 Binding Protein Antibody (YA3063) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3063), targeting MAD2L1 Binding Protein, with a predicted molecular weight of 31 kDa (observed band size: 34 kDa). MAD2L1 Binding Protein Antibody (YA3063) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
ATF1 Antibody (YA3136) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3136), targeting ATF1, with a predicted molecular weight of 29 kDa (observed band size: 36 kDa). ATF1 Antibody (YA3136) can be used for WB, ICC/IF, IP experiment in human background.
HSPA4; APG2; Heat shock 70 kDa protein 4; HSP70RY; Heat shock 70-related protein APG-2
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
HspA4 Antibody (YA3172) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3172), targeting HspA4, with a predicted molecular weight of 94 kDa (observed band size: 110 kDa). HspA4 Antibody (YA3172) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
T Box Brain Protein 1 Antibody (YA3217) is a biotin-conjugated non-conjugated IgG antibody, targeting T Box Brain Protein 1, with a predicted molecular weight of 74 kDa (observed band size: 74 kDa). T Box Brain Protein 1 Antibody (YA3217) can be used for WB experiment in human, mouse, rat background.
MRPS26 Antibody (YA3245) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3245), targeting MRPS26, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). MRPS26 Antibody (YA3245) can be used for WB, ICC/IF experiment in human background.
Myelin Protein Zero Antibody (YA3278) is a biotin-conjugated non-conjugated IgG antibody, targeting Myelin Protein Zero, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). Myelin Protein Zero Antibody (YA3278) can be used for WB experiment in rat background.
Integrin beta 4 Antibody (YA3280) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3280), targeting Integrin beta 4, with a predicted molecular weight of 202 kDa (observed band size: 210 kDa). Integrin beta 4 Antibody (YA3280) can be used for WB, IHC-P experiment in human, mouse background.
ERp57; ERp60; ERp61; Glucose Regulated Protein 58 Kd; HsT17083; p58; PDIA3; Phospholipase C alpha; PI PLC
WB, IHC-P, IP
Human
ERp57 Antibody (YA3300) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3300), targeting ERp57, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). ERp57 Antibody (YA3300) can be used for WB, IHC-P, IP experiment in human background.
USP14 Antibody (YA3328) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3328), targeting USP14, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). USP14 Antibody (YA3328) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Lymphotoxin alpha Antibody (YA3334) is a biotin-conjugated non-conjugated IgG antibody, targeting Lymphotoxin alpha, with a predicted molecular weight of 22 kDa (observed band size: 18 kDa). Lymphotoxin alpha Antibody (YA3334) can be used for WB experiment in human background.
Ah receptor; Aromatic hydrocarbon receptor; Aryl hydrocarbon receptor; Aryl hydrocarbon receptor precursor; BHLHE76; Class E basic helix loop helix protein 76; HGNC:348; AHR_HUMAN.
WB, ICC/IF
Human
Aryl hydrocarbon Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to Aryl hydrocarbon Receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human.
Bak Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 23 kDa, targeting to Bak. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.
CD11 antigen-like family member B; CR-3 alpha chain; Cell surface glycoprotein MAC-1 subunit alpha; CD11b; Leukocyte adhesion receptor MO1
WB, IP
Mouse
CD11b Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 127 kDa, targeting to CD11b. It can be used for WB,IP assays with tag free, in the background of Mouse.
CD19 Antibody (YA807) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD19 (3G7). It can be used for ICC/IF,FC assays with tag free, in the background of Human.
CD3D; T3D; T-cell surface glycoprotein CD3 delta chain; T-cell receptor T3 delta chain; CD antigen CD3d
WB, IHC-F, IHC-P, ICC/IF, IP
Human
CD3D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 19 kDa, targeting to CD3D. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
MYC; BHLHE39; Myc proto-oncogene protein; Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64
WB, ICC/IF, IP
Human, Mouse, Rat
c-Myc Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to c-Myc. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
ErbB 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 148 kDa, targeting to ErbB 3. It can be used for WB assays with tag free, in the background of Human.
CBX3; Chromobox protein homolog 3; HECH; Heterochromatin protein 1 homolog gamma; HP1 gamma; Modifier 2 protein
WB, IHC-F, IHC-P, ICC/IF, IP
Mouse, Human, Monkey, Hamster, Rat
HP1 gamma Antibody (YA733) is a non-conjugated and Mouse origined monoclonal antibody about 21 kDa, targeting to HP1 gamma (5G10). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Mouse, Human, Monkey, Hamster, Rat.
NOS2; NOS2A; Nitric oxide synthase; inducible; Hepatocyte NOS; HEP-NOS; Inducible NO synthase; Inducible NOS; iNOS; NOS type II; Peptidyl-cysteine S-nitrosylase NOS2
WB, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
iNOS Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 131 kDa, targeting to iNOS. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
VEGF Receptor 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 151 kDa, targeting to VEGF Receptor 1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
Occludin Antibody is an unconjugated, approximately 59 kDa, rabbit-derived, anti-Occludin polyclonal antibody. Occludin Antibody can be used for: IHC-P, IHC-F, Flow-Cyt, IF, ELISA expriments in human, mouse, rat, and predicted: dog, pig, cow, sheep background without labeling.
Acetyl-Histone H4 Antibody (YA926) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA926), targeting Acetyl-Histone H4, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). Acetyl-Histone H4 Antibody (YA926) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CBX5; HP1A; Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
HP1 alpha Antibody (YA981) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA981), targeting HP1 alpha, with a predicted molecular weight of 22 kDa (observed band size: 26 kDa). HP1 alpha Antibody (YA981) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
CBX5; HP1A; Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha
WB, IHC-P
Human, Rat, Mouse
HP1 alpha Antibody (YA982) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA982), targeting HP1 alpha, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). HP1 alpha Antibody (YA982) can be used for WB, IHC-P experiment in human, rat, mouse background.
CBX5; HP1A; Chromobox protein homolog 5; Antigen p25; Heterochromatin protein 1 homolog alpha; HP1 alpha
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
HP1 alpha Antibody (YA983) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA983), targeting HP1 alpha, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). HP1 alpha Antibody (YA983) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Phospho-delta 1 Catenin (Tyr228) Antibody (YA1018) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1018), targeting Phospho-delta 1 Catenin (Tyr228), with a predicted molecular weight of 108 kDa (observed band size: 95,100 kDa). Phospho-delta 1 Catenin (Tyr228) Antibody (YA1018) can be used for WB, ICC/IF, IP experiment in rat, hamster background.
Phospho-delta 1 Catenin (Ser268) Antibody (YA1019) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-delta 1 Catenin (Ser268), with a predicted molecular weight of 108 kDa (observed band size: 100 kDa). Phospho-delta 1 Catenin (Ser268) Antibody (YA1019) can be used for WB experiment in human, mouse background.
Phospho-delta 1 Catenin (Thr916) Antibody (YA1020) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1020), targeting Phospho-delta 1 Catenin (Thr916), with a predicted molecular weight of 108 kDa (observed band size: 100 kDa). Phospho-delta 1 Catenin (Thr916) Antibody (YA1020) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse background.
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Phospho-LAT (Tyr191) Antibody (YA1021) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1021), targeting Phospho-LAT (Tyr191), with a predicted molecular weight of 28 kDa (observed band size: 38 kDa). Phospho-LAT (Tyr191) Antibody (YA1021) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
WB
Human
Phospho-LAT (Tyr200) Antibody (YA1022) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-LAT (Tyr200), with a predicted molecular weight of 28 kDa (observed band size: 36-38 kDa). Phospho-LAT (Tyr200) Antibody (YA1022) can be used for WB experiment in human background.
FOXC1; FKHL7, FREAC3; Forkhead box protein C1; Forkhead-related protein FKHL7; Forkhead-related transcription factor 3 (FREAC-3)
IHC-P
Human
FOXC1 Antibody (YA1104) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1104), targeting FOXC1. FOXC1 Antibody (YA1104) can be used for IHC-P experiment in human background.
B7H4 Antibody (YA1172) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1172), targeting B7H4. B7H4 Antibody (YA1172) can be used for IHC-P experiment in human background.
SSTR2; somatostatin receptor 2; SS 2 R; SS2R; SRIF 1; SS2 R
IHC-P
Human
Somatostatin Receptor 2 Antibody (YA1197) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1197), targeting Somatostatin Receptor 2. Somatostatin Receptor 2 Antibody (YA1197) can be used for IHC-P experiment in human background.
BAP31 Antibody (YA1320) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1320), targeting BAP31, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). BAP31 Antibody (YA1320) can be used for WB, ICC/IF, IHC-P, FC experiment in human, mouse background.
NEAS Antibody (YA1355) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1355), targeting NEAS, with a predicted molecular weight of 285 kDa (observed band size: 285 kDa). NEAS Antibody (YA1355) can be used for WB, ICC/IF experiment in human, mouse, rat background.
BCL2L1; BCL2L; BCLX; Bcl-2-like protein 1; Bcl2-L-1; Apoptosis regulator Bcl-X
FC, ELISA
Human
BCL2L1 Antibody (YA1359) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1359), targeting BCL2L1. BCL2L1 Antibody (YA1359) can be used for FC, ELISA experiment in human background.
PAK1 Antibody (YA1363) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1363), targeting PAK1, with a predicted molecular weight of 61 kDa (observed band size: 66 kDa). PAK1 Antibody (YA1363) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Nesprin1 Antibody (YA1369) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1369), targeting Nesprin1, with a predicted molecular weight of 1011 kDa (observed band size: 112 kDa). Nesprin1 Antibody (YA1369) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
TOMM20 Antibody (YA1380) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1380), targeting TOMM20, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). TOMM20 Antibody (YA1380) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, hamster background.
GCLM Antibody (YA1407) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1407), targeting GCLM, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). GCLM Antibody (YA1407) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
KPNA2 Antibody (YA1415) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1415), targeting KPNA2, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). KPNA2 Antibody (YA1415) can be used for WB, FC experiment in human, mouse, rat background.
MELK; KIAA0175; Maternal embryonic leucine zipper kinase; hMELK; Protein kinase Eg3; pEg3 kinase; Protein kinase PK38; hPK38; Tyrosine-protein kinase MELK
WB
Human
MELK Antibody (YA1423) is a biotin-conjugated non-conjugated IgG antibody, targeting MELK, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). MELK Antibody (YA1423) can be used for WB experiment in human background.
Flotillin 2 Antibody (YA1439) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1439), targeting Flotillin 2, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). Flotillin 2 Antibody (YA1439) can be used for WB, IP experiment in human, mouse, rat background.
SNCA; NACP; PARK1; Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
WB, ICC/IF
Human, Mouse, Rat
Phospho-alpha Synuclein (Ser129) Antibody (YA1484) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1484), targeting Phospho-alpha Synuclein (Ser129), with a predicted molecular weight of 14 kDa. Phospho-alpha Synuclein (Ser129) Antibody (YA1484) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Mast Cell Tryptase Antibody (YA1533) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1533), targeting Mast Cell Tryptase, with a predicted molecular weight of 31 kDa. Mast Cell Tryptase Antibody (YA1533) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
IGFBP2; BP2; IBP2; Insulin-like growth factor-binding protein 2; IBP-2; IGF-binding protein 2; IGFBP-2
WB, IHC-P
Human
IGFBP2 Antibody (YA1589) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1589), targeting IGFBP2, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). IGFBP2 Antibody (YA1589) can be used for WB, IHC-P experiment in human background.
Peroxiredoxin 5 Antibody (YA1591) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1591), targeting Peroxiredoxin 5, with a predicted molecular weight of 22 kDa (observed band size: 17 kDa). Peroxiredoxin 5 Antibody (YA1591) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
LOXL2 Antibody (YA1606) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1606), targeting LOXL2, with a predicted molecular weight of 87 kDa. LOXL2 Antibody (YA1606) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
PRKD1; PKD; PKD1; PRKCM; Serine/threonine-protein kinase D1; Protein kinase C mu type; Protein kinase D; nPKC-D1; nPKC-mu
WB
Human, Rat
PKD1 Antibody (YA1659) is a biotin-conjugated non-conjugated IgG antibody, targeting PKD1, with a predicted molecular weight of 102 kDa (observed band size: 102 kDa). PKD1 Antibody (YA1659) can be used for WB experiment in human, rat background.
Prostaglandin E Synthase Antibody (YA1741) is a biotin-conjugated non-conjugated IgG antibody, targeting Prostaglandin E Synthase, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Prostaglandin E Synthase Antibody (YA1741) can be used for WB experiment in human, mouse, rat background.
RAP1GAP; KIAA0474; RAP1GA1; Rap1 GTPase-activating protein 1; Rap1GAP; Rap1GAP1
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
RAP1GAP Antibody (YA1826) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1826), targeting RAP1GAP, with a predicted molecular weight of 73 kDa (observed band size: 95 kDa). RAP1GAP Antibody (YA1826) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
ESR2; ESTRB; NR3A2; Estrogen receptor beta; ER-beta; Nuclear receptor subfamily 3 group A member 2
WB, IHC-P
Human
Estrogen Receptor beta Antibody (YA1892) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1892), targeting Estrogen Receptor beta, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Estrogen Receptor beta Antibody (YA1892) can be used for WB, IHC-P experiment in human background.
CLOCK; BHLHE8; KIAA0334; Circadian locomoter output cycles protein kaput; hCLOCK; Class E basic helix-loop-helix protein 8; bHLHe8
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
KAT13D Antibody (YA1920) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1920), targeting KAT13D, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). KAT13D Antibody (YA1920) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
GLI3; Transcriptional activator GLI3; GLI3 form of 190 kDa; GLI3-190; GLI3 full length protein; GLI3FL
WB, ICC/IF
Human
GLI3 Antibody (YA1956) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1956), targeting GLI3, with a predicted molecular weight of 170 kDa (observed band size: 190 kDa). GLI3 Antibody (YA1956) can be used for WB, ICC/IF experiment in human background.
67kDa Laminin Receptor Antibody (YA1959) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1959), targeting 67kDa Laminin Receptor, with a predicted molecular weight of 33 kDa (observed band size: 40 kDa). 67kDa Laminin Receptor Antibody (YA1959) can be used for WB, IP experiment in human, mouse, rat background.
ATF5 Antibody (YA2184) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2184), targeting ATF5, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). ATF5 Antibody (YA2184) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
DFFA; DFF1; DFF45; H13; DNA fragmentation factor subunit alpha; DNA fragmentation factor 45 kDa subunit; DFF-45; Inhibitor of CAD; ICAD
WB, IHC-P, ICC/IF, IP, FC
Human
ICAD Antibody (YA2262) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2262), targeting ICAD, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). ICAD Antibody (YA2262) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
PSMA3 Antibody (YA2386) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2386), targeting PSMA3, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). PSMA3 Antibody (YA2386) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CENP E; Centromere associated protein E; Centromere protein E 312kDa; KIF10; Kinesin family member 10; Kinesin related protein; PPP1R61
WB
Human
CENPE Antibody (YA2483) is a biotin-conjugated non-conjugated IgG antibody, targeting CENPE, with a predicted molecular weight of 316 kDa (observed band size: 316 kDa). CENPE Antibody (YA2483) can be used for WB experiment in human background.
Hsp110 Antibody (YA2613) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2613), targeting Hsp110, with a predicted molecular weight of 97 kDa (observed band size: 105 kDa). Hsp110 Antibody (YA2613) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Phospho-Rad17 (Ser656) Antibody (YA2640) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2640), targeting Phospho-Rad17 (Ser656), with a predicted molecular weight of 77 kDa (observed band size: 80 kDa). Phospho-Rad17 (Ser656) Antibody (YA2640) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
IL-17 Receptor A Antibody (YA2645) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2645), targeting IL-17 Receptor A, with a predicted molecular weight of 96 kDa (observed band size: 160 kDa). IL-17 Receptor A Antibody (YA2645) can be used for WB, IP experiment in human background.
AKAP8; AKAP95; A-kinase anchor protein 8; AKAP-8; A-kinase anchor protein 95 kDa; AKAP 95
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
AKAP95 Antibody (YA2696) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2696), targeting AKAP95, with a predicted molecular weight of 76 kDa (observed band size: 95 kDa). AKAP95 Antibody (YA2696) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Dynactin Subunit 3 Antibody (YA2762) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2762), targeting Dynactin Subunit 3, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Dynactin Subunit 3 Antibody (YA2762) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
CEP55; C10orf3; URCC6; Centrosomal protein of 55 kDa; Cep55; Up-regulated in colon cancer 6
WB, ICC/IF
Human, Rat
CEP55 Antibody (YA2797) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2797), targeting CEP55, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). CEP55 Antibody (YA2797) can be used for WB, ICC/IF experiment in human, rat background.
Desmoglein-1; Desmosomal glycoprotein 1; DG1; DGI; Pemphigus foliaceus antigen; Cadherin family member 4; DSG1; CDHF4
WB, IHC-P, ICC/IF
Human, Mouse, Rat
Desmoglein 1 Antibody (YA2873) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2873), targeting Desmoglein 1, with a predicted molecular weight of 114 kDa (observed band size: 114 kDa). Desmoglein 1 Antibody (YA2873) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
gemin2; SIP 1; SIP1; SIP1 delta; SMN interacting protein 1; Survival interacting protein 1
WB, IP
Human, Mouse, Rat
Gemin 2 Antibody (YA2906) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2906), targeting Gemin 2, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Gemin 2 Antibody (YA2906) can be used for WB, IP experiment in human, mouse, rat background.
GNAI2 Antibody (YA2944) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2944), targeting GNAI2, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). GNAI2 Antibody (YA2944) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Tyrosine Protein Kinase HCK Antibody (YA2963) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2963), targeting Tyrosine Protein Kinase HCK, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). Tyrosine Protein Kinase HCK Antibody (YA2963) can be used for WB, ICC/IF, IP experiment in human background.
MLANA; MART1; Melanoma antigen recognized by T-cells 1; MART-1; Antigen LB39-AA; Antigen SK29-AA; Protein Melan-A
WB, IHC-P, ICC/IF, FC
Human
MelanA Antibody (YA3040) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3040), targeting MelanA, with a predicted molecular weight of 13 kDa (observed band size: 20 kDa). MelanA Antibody (YA3040) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
MonoMethyl-Histone H4 Antibody (YA3046) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3046), targeting MonoMethyl-Histone H4, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). MonoMethyl-Histone H4 Antibody (YA3046) can be used for WB, ICC/IF experiment in human, mouse background.
Activator protein 1; AP 1; Jun D; jun D proto oncogene; Jund; JunD FL isoform; Transcription factor jun D
WB, IP
Human, Mouse, Rat
Phospho-JunD (Ser255) Antibody (YA3087) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3087), targeting Phospho-JunD (Ser255), with a predicted molecular weight of 35 kDa (observed band size: 38,42 kDa). Phospho-JunD (Ser255) Antibody (YA3087) can be used for WB, IP experiment in human, mouse, rat background.
L1CAM Antibody (YA3149) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3149), targeting L1CAM, with a predicted molecular weight of 140 kDa (observed band size: 140 kDa). L1CAM Antibody (YA3149) can be used for WB, IHC-P experiment in human background.
MYH6; MYH7; MYHC; MYHCA; MYHCB; Myosin heavy chain 6; Myosin heavy chain; Myosin-6; Myosin heavy chain; cardiac muscle alpha isoform
WB, IHC-P
Human, Mouse, Rat
MYH6 Antibody (YA3200) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3200), targeting MYH6, with a predicted molecular weight of 224 kDa. MYH6 Antibody (YA3200) can be used for WB, IHC-P experiment in human, mouse, rat background.
CD86 is an 80 kD immunoglobulin superfamily member also known as B7-2, B70, and Ly-58. CD86 is expressed on activated B and T cells, macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is a ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce co-stimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.
Neutrophil Elastase Antibody is an unconjugated, approximately 26 kDa, rabbit-derived, anti-Neutrophil Elastase monoclonal antibody. Neutrophil Elastase Antibody can be used for: WB,IHC-P,ICC/IF,FC expriments in human background without labeling.
AKT 1; AKT; AKT1; AKT1_HUMAN ; MGC99656; PKB; PKB-ALPHA; PRKBA; Protein Kinase B Alpha ; Proto-oncogene c-Akt; RAC Alpha;
IHC-P, IHC-F, ICC/IF, IP, FC
Human, Mouse
AKT1 Antibody (YA634) is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
CD3 epsilon Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 23 kDa, targeting to CD3 epsilon. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.
Estrogen Receptor alpha Antibody (YA768) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to Estrogen Receptor alpha (6F11). It can be used for WB assays with tag free, in the background of Transfected.
Fascin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 55 kDa, targeting to Fascin. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Macrophage scavenger receptor types I and II; Macrophage acetylated LDL receptor I and II; Scavenger receptor class A member 1; CD204; MSR1; SCARA1
WB
Human, Mouse, Rat
MSR1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 50 kDa, targeting to MSR1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
NADPH Oxidase 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 67 kDa, targeting to NADPH Oxidase 4. It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Phospho-BRAF (Thr401) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-BRAF (Thr401). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
IGF1R; Insulin-like growth factor 1 receptor; Insulin-like growth factor I receptor; IGF-I receptor; CD antigen CD221
WB, IP
Human, Mouse, Rat
Phospho-IGF1 Receptor (Tyr1166) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 155 kDa, targeting to Phospho-IGF1 Receptor (Tyr1166). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3
WB
Human, Mouse
Phospho-IKB alpha (Ser36) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha (Ser36). It can be used for WB assays with tag free, in the background of Human, Mouse.
Phospho-JNK (Thr183) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Phospho-JNK (Thr183). It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
TRAF6; RNF85; TNF receptor-associated factor 6; E3 ubiquitin-protein ligase TRAF6; Interleukin-1 signal transducer; RING finger protein 85
WB
Human, Rat
TRAF6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to TRAF6. It can be used for WB assays with tag free, in the background of Human, Rat.
HSF1 Antibody (YA896) is an unconjugated, approximately 57-80 kDa, rabbit-derived, anti-HSF1 (YA896) monoclonal antibody. HSF1 Antibody (YA896) can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human background without labeling.
Phospho-PTP1B (Ser352) Antibody (YA1027) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1027), targeting Phospho-PTP1B (Ser352), with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Phospho-PTP1B (Ser352) Antibody (YA1027) can be used for WB, ICC/IF, IP experiment in human background.
Phospho-PTP1B (Ser378) Antibody (YA1028) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1028), targeting Phospho-PTP1B (Ser378), with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Phospho-PTP1B (Ser378) Antibody (YA1028) can be used for WB, IHC-P experiment in human background.
AQP1; CHIP28; Aquaporin-1; AQP-1; Aquaporin-CHIP; Urine water channel; Water channel protein for red blood cells and kidney proximal tubule
IHC-P
Human
Aquaporin 1 Antibody (YA1149) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1149), targeting Aquaporin 1. Aquaporin 1 Antibody (YA1149) can be used for IHC-P experiment in human background.
Amyloid fibril protein AA; Amyloid fibrils; Amyloid protein A; Fibrils; PIG4; SAA 1; SAA 2; Serum amyloid A protein precursor
IHC-P
Human
Serum Amyloid A Antibody (YA1168) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1168), targeting Serum Amyloid A. Serum Amyloid A Antibody (YA1168) can be used for IHC-P experiment in human background.
T bet; T box 21; T PET; TBET; TBLYM; Tbx21; TPET; Transcription factor TBLYM; T Box Protein 21
IHC-P
Human
T-bet / Tbx21 Antibody (YA1217) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1217), targeting T-bet / Tbx21. T-bet / Tbx21 Antibody (YA1217) can be used for IHC-P experiment in human background.
CD134/OX40L Recepter Antibody (YA1254) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1254), targeting CD134/OX40L Recepter. CD134/OX40L Recepter Antibody (YA1254) can be used for IHC-P experiment in human background.
FBXW7; FBW7 ; FBX30; SEL10 ; F-box/WD repeat-containing protein 7; F-box protein FBX30; SEL-10; hCDc4
IHC-P
Human
Fbxw7 Antibody (YA1270) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1270), targeting Fbxw7. Fbxw7 Antibody (YA1270) can be used for IHC-P experiment in human background.
CD74; DHLAG; HLA class II histocompatibility antigen gamma chain; HLA-DR antigens-associated invariant chain; Ia antigen-associated invariant chain; Ii; p33; CD74
IHC-P
Human
CD74 Antibody (YA1282) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1282), targeting CD74. CD74 Antibody (YA1282) can be used for IHC-P experiment in human background.
CD15 Antibody (YA1327) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1327), targeting CD15. CD15 Antibody (YA1327) can be used for IHC-P experiment in human background.
PAK3 Antibody (YA1367) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1367), targeting PAK3, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). PAK3 Antibody (YA1367) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Laminin alpha 3 Antibody (YA1548) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1548), targeting Laminin alpha 3, with a predicted molecular weight of 367 kDa (observed band size: 367 kDa). Laminin alpha 3 Antibody (YA1548) can be used for WB, ICC/IF experiment in human background.
PP2A alpha/beta Antibody (YA1693) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1693), targeting PP2A alpha/beta, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). PP2A alpha/beta Antibody (YA1693) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat, hamster background.
Band 3 Antibody (YA1819) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1819), targeting Band 3, with a predicted molecular weight of 102 kDa (observed band size: 102 kDa). Band 3 Antibody (YA1819) can be used for WB, IHC-P, ICC/IF experiment in human background.
Securin Antibody (YA1917) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1917), targeting Securin, with a predicted molecular weight of 22 kDa (observed band size: 25 kDa). Securin Antibody (YA1917) can be used for WB, IHC-P, IP experiment in human, mouse background.
p60 CAF1 Antibody (YA1999) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1999), targeting p60 CAF1, with a predicted molecular weight of 61 kDa (observed band size: 70 kDa). p60 CAF1 Antibody (YA1999) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
AHSA1; C14orf3; HSPC322; Activator of 90 kDa heat shock protein ATPase homolog 1; AHA1; p38
WB, IP
Human, Mouse, Rat
AHA1 Antibody (YA2023) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2023), targeting AHA1, with a predicted molecular weight of 38 kDa (observed band size: 42 kDa). AHA1 Antibody (YA2023) can be used for WB, IP experiment in human, mouse, rat background.
Cytochrome P450 2C9 Antibody (YA2166) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2166), targeting Cytochrome P450 2C9, with a predicted molecular weight of 56 kDa (observed band size: 50 kDa). Cytochrome P450 2C9 Antibody (YA2166) can be used for WB, ICC/IF, FC experiment in human background.
ATP6V1A Antibody (YA2211) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2211), targeting ATP6V1A, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). ATP6V1A Antibody (YA2211) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Hsf2 Antibody (YA2235) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2235), targeting Hsf2, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). Hsf2 Antibody (YA2235) can be used for WB, ICC/IF, FC experiment in human background.
DDX58 Antibody (YA2318) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2318), targeting DDX58, with a predicted molecular weight of 107 kDa (observed band size: 107 kDa). DDX58 Antibody (YA2318) can be used for WB, IP experiment in human background.
ULK3 Antibody (YA2355) is a biotin-conjugated non-conjugated IgG antibody, targeting ULK3, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). ULK3 Antibody (YA2355) can be used for WB experiment in human background.
VCP Antibody (YA2375) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2375), targeting VCP, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). VCP Antibody (YA2375) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
HB9; HLXB9; Homeobox HB9; Homeobox protein HB9; HOXHB9; MNX1; Motor neuron and pancreas homeobox protein 1; SCRA1
WB, IP
Human, Mouse
HB9 Antibody (YA2415) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2415), targeting HB9, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). HB9 Antibody (YA2415) can be used for WB, IP experiment in human, mouse background.
Calcineurin A Antibody (YA2508) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2508), targeting Calcineurin A, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Calcineurin A Antibody (YA2508) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Toll-Like Receptor 7 Antibody (YA2514) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2514), targeting Toll-Like Receptor 7, with a predicted molecular weight of 121 kDa (observed band size: 140 kDa). Toll-Like Receptor 7 Antibody (YA2514) can be used for WB, IHC-P experiment in human background.
CITED2 Antibody (YA2596) is a biotin-conjugated non-conjugated IgG antibody, targeting CITED2, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). CITED2 Antibody (YA2596) can be used for WB experiment in human, mouse background.
ITCH Antibody (YA2623) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2623), targeting ITCH, with a predicted molecular weight of 103 kDa (observed band size: 103 kDa). ITCH Antibody (YA2623) can be used for WB, IHC-P experiment in human, mouse, rat background.
ATF7 Antibody (YA2651) is a biotin-conjugated non-conjugated IgG antibody, targeting ATF7, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). ATF7 Antibody (YA2651) can be used for WB experiment in human, mouse, rat background.
DDX5; G17P1; HELR; HLR1; Probable ATP-dependent RNA helicase DDX5; DEAD box protein 5; RNA helicase p68
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
DDX5 Antibody (YA2666) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2666), targeting DDX5, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). DDX5 Antibody (YA2666) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Keratin; type I cytoskeletal 13; Krt1-13; Cytokeratin 13; CK13; Keratin 13; KRT13; WSN2
WB, IHC-P, ICC/IF
Human, Mouse
Cytokeratin 13 Antibody (YA2695) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2695), targeting Cytokeratin 13, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Cytokeratin 13 Antibody (YA2695) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
ABCF1 Antibody (YA2712) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2712), targeting ABCF1, with a predicted molecular weight of 96 kDa (observed band size: 96 kDa). ABCF1 Antibody (YA2712) can be used for WB, IHC-P, ICC/IF experiment in human, rat background.
DP1 Antibody (YA2766) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2766), targeting DP1, with a predicted molecular weight of 45 kDa (observed band size: 50 kDa). DP1 Antibody (YA2766) can be used for WB, FC experiment in human, mouse, rat background.
ABI2 Antibody (YA2840) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2840), targeting ABI2, with a predicted molecular weight of 56 kDa (observed band size: 75 kDa). ABI2 Antibody (YA2840) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Histone H3-K4 methyltransferase SETD7; Lysine N-methyltransferase 7; SET domain-containing protein 7; SET7; SET9
WB, IP
Human, Mouse, Rat
SETD7 Antibody (YA2896) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2896), targeting SETD7, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). SETD7 Antibody (YA2896) can be used for WB, IP experiment in human, mouse, rat background.
KRT8; CYK8; Keratin; type II cytoskeletal 8; Cytokeratin-8; CK-8; Keratin-8; K8; Type-II keratin Kb8
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse
Cytokeratin 8 Antibody (YA3005) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3005), targeting Cytokeratin 8, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Cytokeratin 8 Antibody (YA3005) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse background.
E3 ubiquitin-protein ligase RAD18; hHR18; hRAD18; RAD18; RAD18; S. cerevisiae; homolog; RING finger protein 73; RNF73
WB, FC
Human, Mouse, Rat
Rad18 Antibody (YA3067) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3067), targeting Rad18, with a predicted molecular weight of 56 kDa (observed band size: 70 kDa). Rad18 Antibody (YA3067) can be used for WB, FC experiment in human, mouse, rat background.
IGF2BP1 Antibody (YA3071) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3071), targeting IGF2BP1, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). IGF2BP1 Antibody (YA3071) can be used for WB, IHC-P, IP experiment in human, mouse background.
A-kinase anchor protein 14; A-kinase anchor protein 14; A-kinase anchor protein 28 kDa; AKAP14; AKAP28
WB, ICC/IF, IP
Human, Mouse, Rat
AKAP14 Antibody (YA3078) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3078), targeting AKAP14, with a predicted molecular weight of 23 kDa (observed band size: 23 kDa). AKAP14 Antibody (YA3078) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Indoleamine 2,3-dioxygenase Antibody (YA3100) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3100), targeting Indoleamine 2,3-dioxygenase, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). Indoleamine 2,3-dioxygenase Antibody (YA3100) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
NEUROD1; BHLHA3; NEUROD; Neurogenic differentiation factor 1; NeuroD; NeuroD1; Class A basic helix-loop-helix protein 3; bHLHa3
WB, IP
Human, Mouse, Rat
NeuroD1 Antibody (YA3281) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3281), targeting NeuroD1, with a predicted molecular weight of 40 kDa (observed band size: 47 kDa). NeuroD1 Antibody (YA3281) can be used for WB, IP experiment in human, mouse, rat background.
alpha Fodrin Antibody (YA3347) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3347), targeting alpha Fodrin, with a predicted molecular weight of 285 kDa (observed band size: 150,285 kDa). alpha Fodrin Antibody (YA3347) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
cIAP2 Antibody (YA795) is a non-conjugated and Mouse origined monoclonal antibody about 68 kDa, targeting to cIAP2 (1F12). It can be used for WB assays with tag free, in the background of Human, Monkey.
MCM2; BM28; CCNL1; CDCL1; KIAA0030; DNA replication licensing factor MCM2; Minichromosome maintenance protein 2 homolog; Nuclear protein BM28
WB, IHC-F, IHC-P, ICC/IF, FC, IP
Human, Mouse
MCM2 Antibody (YA705) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to MCM2 (2B5). It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse.
AKT1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
ICC/IF, WB, IHC-F, IHC-P, ELISA
Human, Mouse, Rat
Phospho-AKT (Thr308) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 56 kDa, targeting to Phospho-AKT (Thr308). It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
FOXO3; FKHRL1; FOXO3A; Forkhead box protein O3; AF6q21 protein; Forkhead in rhabdomyosarcoma-like 1
WB
Human, Mouse, Rat
Phospho-FOXO3A (Ser253) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to Phospho-FOXO3A (Ser253). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
PI3 Kinase p110 gamma Antibody (YA690) is a non-conjugated and Mouse origined monoclonal antibody about 126 kDa, targeting to PI3 Kinase p110 gamma (2D10). It can be used for WB assays with tag free, in the background of Human.
S100A10 Antibody (YA675) is a non-conjugated and Mouse origined monoclonal antibody about 11 kDa, targeting to S100A10 (6F4). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
PRDX3; AOP1; Thioredoxin-dependent peroxide reductase; mitochondrial; Antioxidant protein 1; AOP-1; HBC189; Peroxiredoxin III; Prx-III; Peroxiredoxin-3; Protein MER5 homolog
WB, ICC/IF, IHC-P, FC, IP
Human
PRDX3 Antibody (YA909) is an unconjugated, approximately 28 kDa, human-derived, anti-PRDX3 (YA909) monoclonal antibody. PRDX3 Antibody (YA909) can be used for: WB, IF-Cell, IHC-P, FC, IP expriments in human background without labeling.
IFNG; IFG; IFI; IFN Gamma; IFN Immune; IFN-gamma; IFNG; IFNG_HUMAN; Immune Interferon; Interferon gamma; Interferon Gamma Precursor; Macrophage Activating Factor; MAF; T Cell Interferon; Type II Interferon.
WB, ICC/IF, FC
Human, Mouse, Rat
IFN gamma Antibody is an unconjugated, approximately 19 kDa, rabbit-derived, anti-IFN gamma monoclonal antibody. IFN gamma Antibody can be used for: WB,ICC/IF,FC expriments in human, mouse,rat background without labeling.
ox-LDL: LDL (Copper oxidized); Cu2SO4 oxidized low density lipoprotein; oxidized low density lipoprotein; Low density lipoprotein; MDA oxidized LDL; MDA oxidized low density lipoprotein. 氧化型低密度脂蛋白；
ELISA, IHC-P, IHC-F, FC, ICC/IF
Human
ox-LDL Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-ox-LDL polyclonal antibody. ox-LDL Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, background without labeling.
MTDH; AEG1; LYRIC; Protein LYRIC; 3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein
WB, IHC-P, FC
Human
LYRIC Antibody (YA995) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA995), targeting LYRIC, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). LYRIC Antibody (YA995) can be used for WB, IHC-P, FC experiment in human background.
MTDH; AEG1; LYRIC; Protein LYRIC; 3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein
WB, IHC-F, IHC-P, ICC/IF, IP
Human
LYRIC Antibody (YA996) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA996), targeting LYRIC, with a predicted molecular weight of 64 kDa (observed band size: 75 kDa). LYRIC Antibody (YA996) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
PHLPP2; KIAA0931, PHLPPL; PH domain leucine-rich repeat-containing protein phosphatase 2; PH domain leucine-rich repeat-containing protein phosphatase-like (PHLPP-like)
IHC-P
Human
PHLPP2 Antibody (YA1093) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1093), targeting PHLPP2. PHLPP2 Antibody (YA1093) can be used for IHC-P experiment in human background.
PCANAP6; PRST; Slc45a3; Solute carrier family 45 member 3; Prostate cancer-associated protein 6; Prostein
IHC-P
Human
SLC45A3 Antibody (YA1110) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1110), targeting SLC45A3. SLC45A3 Antibody (YA1110) can be used for IHC-P experiment in human background.
CD48 Antibody (YA1111) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1111), targeting CD48. CD48 Antibody (YA1111) can be used for IHC-P experiment in human background.
ROC1; RNF75; RBX1; E3 ubiquitin-protein ligase RBX1; RING finger protein 75; RING-box protein 1 (Rbx1)
IHC-P
Human
RBX1 Antibody (YA1124) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1124), targeting RBX1. RBX1 Antibody (YA1124) can be used for IHC-P experiment in human background.
Obestatin Antibody (YA1227) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1227), targeting Obestatin. Obestatin Antibody (YA1227) can be used for IHC-P experiment in human background.
Glutaminase interacting protein 3; Tax interaction protein 1; Tax1 binding protein 3; Tax1bp3; TIP1
WB, IHC-P, FC
Human, Mouse, Rat
TAX1BP3 Antibody (YA1345) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1345), targeting TAX1BP3, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). TAX1BP3 Antibody (YA1345) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
NDUFS3 Antibody (YA1346) is a biotin-conjugated non-conjugated IgG antibody, targeting NDUFS3, with a predicted molecular weight of 30 kDa (observed band size: 26 kDa). NDUFS3 Antibody (YA1346) can be used for WB experiment in human, mouse background.
BDKRB2 Antibody (YA1467) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1467), targeting BDKRB2, with a predicted molecular weight of 44 kDa (observed band size: 78 kDa). BDKRB2 Antibody (YA1467) can be used for WB, IP experiment in human, mouse background.
TNFSF12; APO3L; DR3LG; Tumor necrosis factor ligand superfamily member 12; APO3 ligand; TNF-related weak inducer of apoptosis; TWEAK
FC, ELISA
Human
TNFSF12 Antibody (YA1507) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1507), targeting TNFSF12. TNFSF12 Antibody (YA1507) can be used for FC, ELISA experiment in human background.
GATA1 Antibody (YA1587) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1587), targeting GATA1, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). GATA1 Antibody (YA1587) can be used for WB, ICC/IF, IP, ChIP experiment in human background.
Anti TCL1A; P14 TCL1; T cell leukemia 1; TCL1; TCL1 PEN; Tcl1a
WB, IHC-P, ICC/IF, FC
Human
T Cell Leukemia/Lymphoma Protein 1A Antibody (YA1704) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1704), targeting T Cell Leukemia/Lymphoma Protein 1A, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). T Cell Leukemia/Lymphoma Protein 1A Antibody (YA1704) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
PRKAR1A; PKR1; PRKAR1; TSE1; cAMP-dependent protein kinase type I-alpha regulatory subunit; Tissue-specific extinguisher 1; TSE1
WB
Human, Rat
PKA RI alpha Antibody (YA1751) is a biotin-conjugated non-conjugated IgG antibody, targeting PKA RI alpha, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). PKA RI alpha Antibody (YA1751) can be used for WB experiment in human, rat background.
Cenexin1 Antibody (YA1805) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1805), targeting Cenexin1, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). Cenexin1 Antibody (YA1805) can be used for WB, FC experiment in human background.
SEC61A Antibody (YA1825) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1825), targeting SEC61A, with a predicted molecular weight of 52 kDa (observed band size: 48 kDa). SEC61A Antibody (YA1825) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
TNPO3 Antibody (YA1986) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1986), targeting TNPO3, with a predicted molecular weight of 104 kDa (observed band size: 100 kDa). TNPO3 Antibody (YA1986) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
COPS3 Antibody (YA2191) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2191), targeting COPS3, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). COPS3 Antibody (YA2191) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
BOB 1; BOB-1; OBF 1; OBF1; OCA B; OCA-B; OCAB; OCT binding factor 1; Pou2af1
WB, IHC-P, ICC/IF, FC
Human
BOB1 Antibody (YA2212) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2212), targeting BOB1, with a predicted molecular weight of 27 kDa (observed band size: 35 kDa). BOB1 Antibody (YA2212) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Cytochrome P450 2E1 Antibody (YA2302) is a biotin-conjugated non-conjugated IgG antibody, targeting Cytochrome P450 2E1, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). Cytochrome P450 2E1 Antibody (YA2302) can be used for WB experiment in human, mouse, rat background.
GSTM1 Antibody (YA2308) is a biotin-conjugated non-conjugated IgG antibody, targeting GSTM1, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). GSTM1 Antibody (YA2308) can be used for WB experiment in human, mouse, rat background.
Ubiquitin Conjugating Enzyme E2 D3 Antibody (YA2333) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2333), targeting Ubiquitin Conjugating Enzyme E2 D3, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Ubiquitin Conjugating Enzyme E2 D3 Antibody (YA2333) can be used for WB, IP experiment in human, mouse, rat background.
Homeo box protein Meis1; Leukemogenic homolog protein; MEIS 1; Meis homeo box 1; Meis1; Meis1 mouse homolog; MEIS1 protein
WB, IP, FC
Human, Mouse, Rat
MEIS1 Antibody (YA2438) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2438), targeting MEIS1, with a predicted molecular weight of 43 kDa (observed band size: 47 kDa). MEIS1 Antibody (YA2438) can be used for WB, IP, FC experiment in human, mouse, rat background.
PML; MYL; RNF71; TRIM19; Protein PML; Promyelocytic leukemia protein; RING finger protein 71; Tripartite motif-containing protein 19
WB, IHC-P
Human
Phospho-PML Protein (Ser518) Antibody (YA2632) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2632), targeting Phospho-PML Protein (Ser518), with a predicted molecular weight of 98 kDa (observed band size: 98/117 kDa). Phospho-PML Protein (Ser518) Antibody (YA2632) can be used for WB, IHC-P experiment in human background.
CD266 antigen; FGF inducible 14; Fibroblast growth factor inducible immediate early response protein 14; FN14; TNFRSF 12A; Tweak receptor; TweakR
WB, IHC-P, IP
Human, Mouse, Rat
CD266 Antibody (YA2676) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2676), targeting CD266, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). CD266 Antibody (YA2676) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
RuvB Like 1 Antibody (YA2685) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2685), targeting RuvB Like 1, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). RuvB Like 1 Antibody (YA2685) can be used for WB, FC experiment in human, mouse, rat background.
DLX4; BP1; DLX7; DLX8; DLX9; Homeobox protein DLX-4; Beta protein 1; Homeobox protein DLX-7; Homeobox protein DLX-8
WB, ICC/IF, IP
Human, Rat
DLX4 Antibody (YA2697) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2697), targeting DLX4, with a predicted molecular weight of 26 kDa (observed band size: 35 kDa). DLX4 Antibody (YA2697) can be used for WB, ICC/IF, IP experiment in human, rat background.
DAXX; BING2; DAP6; Death domain-associated protein 6; Daxx; hDaxx; ETS1-associated protein 1; EAP1; Fas death domain-associated protein
WB, ICC/IF
Human
Daxx Antibody (YA2854) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2854), targeting Daxx, with a predicted molecular weight of 81 kDa (observed band size: 110 kDa). Daxx Antibody (YA2854) can be used for WB, ICC/IF experiment in human background.
Phospho-PP2A alpha (Tyr307) Antibody (YA2856) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2856), targeting Phospho-PP2A alpha (Tyr307), with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Phospho-PP2A alpha (Tyr307) Antibody (YA2856) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
Aw-68; HLA class I histocompatibility antigen; A-28 alpha chain; MHC class I antigen A*68; HLA-A; MHC class I antigen HLA A heavy chain
WB, IHC-P, ICC/IF, IP, FC
Human
HLA A Antibody (YA2940) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2940), targeting HLA A, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). HLA A Antibody (YA2940) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
Wolf Hirschhorn syndrome candidate 1 like 1; WHSC1L1; NSD3; pp14328; Histone-lysine N-methyltransferase NSD3; Protein whistle
WB, FC
Human, Mouse, Rat
NSD3 Antibody (YA3074) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3074), targeting NSD3, with a predicted molecular weight of 162 kDa (observed band size: 162 kDa). NSD3 Antibody (YA3074) can be used for WB, FC experiment in human, mouse, rat background.
IL-11 Receptor alpha Antibody (YA3092) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3092), targeting IL-11 Receptor alpha, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). IL-11 Receptor alpha Antibody (YA3092) can be used for WB, IHC-P experiment in human background.
ORAI1 Antibody (YA3157) is a biotin-conjugated non-conjugated IgG antibody, targeting ORAI1, with a predicted molecular weight of 33 kDa. ORAI1 Antibody (YA3157) can be used for WB experiment in human background.
CDC40 Antibody (YA3168) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3168), targeting CDC40, with a predicted molecular weight of 66 kDa (observed band size: 74 kDa). CDC40 Antibody (YA3168) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Protein CASP Antibody (YA3184) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3184), targeting Protein CASP, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). Protein CASP Antibody (YA3184) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
TPX2 Antibody (YA3285) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3285), targeting TPX2, with a predicted molecular weight of 86 kDa (observed band size: 100 kDa). TPX2 Antibody (YA3285) can be used for WB, ICC/IF experiment in human background.
Frizzled related protein 1; FRP1; FrzA; SARP2; Secreted apoptosis related protein 2; Secreted frizzled related protein 1; SFRP1
WB, IHC-P, ICC/IF
Human
SFRP1 Antibody (YA3311) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3311), targeting SFRP1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). SFRP1 Antibody (YA3311) can be used for WB, IHC-P, ICC/IF experiment in human background.
DAZ homolog; DAZ like autosomal; DAZH; DAZL; DAZL1; DAZLA; Deleted in azoospermia like 1; Germline specific RNA binding protein; SPGY like autosomal; SPGYLA; Tpx2
WB
Human
DAZL Antibody (YA3337) is a biotin-conjugated non-conjugated IgG antibody, targeting DAZL, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). DAZL Antibody (YA3337) can be used for WB experiment in human background.
ORM2 Antibody (YA3354) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3354), targeting ORM2, with a predicted molecular weight of 24 kDa (observed band size: 47 kDa). ORM2 Antibody (YA3354) can be used for WB, IHC-P experiment in human background.
CRMP2 Antibody (YA3370) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3370), targeting CRMP2, with a predicted molecular weight of 62 kDa. CRMP2 Antibody (YA3370) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
CD11 antigen-like family member B; CR-3 alpha chain; Cell surface glycoprotein MAC-1 subunit alpha; CD11b; Leukocyte adhesion receptor MO1
WB, IHC-P, ICC/IF, IP, FC
Human
CD11b Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 127 kDa, targeting to CD11b. It can be used for WB,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human.
CD144/VE Cadherin Antibody is an unconjugated, approximately 88 kDa, rabbit-derived, anti-CD144/VE Cadherin monoclonal antibody. CD144/VE Cadherin Antibody can be used for: WB, IF-Cell, FC expriments in human, mouse, rat, background without labeling.
Vitamin D3 receptor; 125 dihydroxyvitamin D3 receptor; 1 Antibody 1,25-@dihydroxyvitamin D3 receptor; 125 dihydroxyvitamin D3 receptor; 25-dihydroxyvitamin D3 receptor; NR1I1; Nuclear receptor subfamily 1 group I member 1; VDR; VDR_HUMAN; Vitamin D (1,25- dihydroxyvitamin D3) receptor; Vitamin D hormone receptor; Vitamin D receptor; Vitamin D3 receptor,
IHC-P, IHC-F, ICC/IF
Human, Rat
Vitamin D Receptor Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-Vitamin D Receptor polyclonal antibody. Vitamin D Receptor Antibody can be used for: IHC-P, IHC-F, ICC, IF expriments in human, rat, and predicted: mouse, chicken, pig, cow, horse, rabbit background without labeling.
LAMP2; Lysosome-associated membrane glycoprotein 2; LAMP-2; Lysosome-associated membrane protein 2; CD107 antigen-like family member B; CD107b
WB, IHC-P
Human
LAMP2 Antibody (YA310) is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP2. It can be used for WB,IHC-P assays with tag free, in the background of Human.
LYN; JTK8; Tyrosine-protein kinase Lyn; Lck/Yes-related novel protein tyrosine kinase; V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; p53Lyn; p56Lyn
WB
Human
Lyn Antibody (YA707) is a non-conjugated and Mouse origined monoclonal antibody about 59 kDa, targeting to Lyn (1C8). It can be used for WB assays with tag free, in the background of Human.
AKT1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
WB
Human, Mouse, Rat
Phospho-AKT1 (Ser473) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Phospho-AKT (Ser473). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Phospho-c-Jun (Ser243) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser243). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Phospho-c-Jun (Ser63) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser63). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Phospho-c-Jun (Ser73) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser73). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
MYC; BHLHE39; Myc proto-oncogene protein; Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64
WB, ICC/IF, IP
Mouse, Rat
Phospho-c-Myc (Ser62) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to Phospho-c-Myc (Ser62). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Mouse, Rat.
NFKBIA; IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3
WB, IP
Human, Mouse
Phospho-IKB alpha (Ser32) Antibody (YA185) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha (Ser32). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.
Toll-Like Receptor 3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 105 kDa, targeting to Toll-Like Receptor 3 . It can be used for WB, IHC-P, IHC-F, IF, ELISA assays with tag free, in the background of Human, Mouse, Rat.
CDKN2C Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-CDKN2C monoclonal antibody. CDKN2C Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in background without labeling.
AFP Antibody (YA914) is an unconjugated, approximately 65 kDa, mouse-derived, anti-AFP (YA914) monoclonal antibody. AFP Antibody (YA914) can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, background without labeling.
AFP Antibody (YA915) is an unconjugated, approximately 69 kDa, rabbit-derived, anti-AFP (YA915) monoclonal antibody. AFP Antibody (YA915) can be used for: WB,IHC-P,ICC/IF,FC expriments in human background without labeling.
CHD4 Antibody (YA946) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA946), targeting CHD4, with a predicted molecular weight of 218 kDa (observed band size: 260 kDa). CHD4 Antibody (YA946) can be used for WB, IP experiment in human background.
CHD4 Antibody (YA947) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA947), targeting CHD4, with a predicted molecular weight of 218 kDa (observed band size: 260 kDa). CHD4 Antibody (YA947) can be used for WB, ICC/IF, FC experiment in human background.
MAGEA1 Antibody (YA1105) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1105), targeting MAGEA1. MAGEA1 Antibody (YA1105) can be used for IHC-P experiment in human background.
HLA DPA1; major histocompatibility complex; class II; DP alpha 1; PLT1; HLADP; HLASB; DP(W3); DP(W4); HLA-DP1A
IHC-P
Human
HLA-DP Antibody (YA1181) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1181), targeting HLA-DP. HLA-DP Antibody (YA1181) can be used for IHC-P experiment in human background.
Trefoil Factor 3 Antibody (YA1242) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1242), targeting Trefoil Factor 3. Trefoil Factor 3 Antibody (YA1242) can be used for IHC-P experiment in human background.
CLDN4; CPER; CPETR1; WBSCR8; Claudin-4; Clostridium perfringens enterotoxin receptor; CPE-R; CPE-receptor; Williams-Beuren syndrome chromosomal region 8 protein
WB, IHC-P, IP
Human
Claudin 4 Antibody (YA1351) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1351), targeting Claudin 4, with a predicted molecular weight of 22 kDa (observed band size: 18 kDa). Claudin 4 Antibody (YA1351) can be used for WB, IHC-P, IP experiment in human background.
FRS2 Antibody (YA1400) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1400), targeting FRS2, with a predicted molecular weight of 57 kDa (observed band size: 80-85 kDa). FRS2 Antibody (YA1400) can be used for WB, IP experiment in human background.
Phospho-p27 Kip 1 (Ser10) Antibody (YA1494) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1494), targeting Phospho-p27 Kip 1 (Ser10), with a predicted molecular weight of 22 kDa (observed band size: 27 kDa). Phospho-p27 Kip 1 (Ser10) Antibody (YA1494) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
PDLIM1; CLIM1; CLP36; PDZ and LIM domain protein 1; C-terminal LIM domain protein 1; Elfin; LIM domain protein CLP-36
WB, ICC/IF, IP
Human, Mouse, Rat
PDLIM1 Antibody (YA1565) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1565), targeting PDLIM1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). PDLIM1 Antibody (YA1565) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
CD2 Antibody (YA1640) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1640), targeting CD2, with a predicted molecular weight of 39 kDa (observed band size: 48 kDa). CD2 Antibody (YA1640) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
MSH6; GTBP; DNA mismatch repair protein Msh6; hMSH6; G/T mismatch-binding protein; GTBP; GTMBP; MutS-alpha 160 kDa subunit; p160
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
MSH6 Antibody (YA1756) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1756), targeting MSH6, with a predicted molecular weight of 153 kDa (observed band size: 163 kDa). MSH6 Antibody (YA1756) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
CEBPB Antibody (YA1835) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1835), targeting CEBPB, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). CEBPB Antibody (YA1835) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
RPL10A; NEDD6; 60S ribosomal protein L10a; CSA-19; Neural precursor cell expressed developmentally down-regulated protein 6; NEDD-6
WB
Human, Mouse, Rat
RPL10A Antibody (YA1880) is a biotin-conjugated non-conjugated IgG antibody, targeting RPL10A, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). RPL10A Antibody (YA1880) can be used for WB experiment in human, mouse, rat background.
KMT1B Antibody (YA1882) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1882), targeting KMT1B, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). KMT1B Antibody (YA1882) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
SMARCB1 Antibody (YA2018) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2018), targeting SMARCB1, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). SMARCB1 Antibody (YA2018) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
Interferon gamma Receptor 1 Antibody (YA2074) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2074), targeting Interferon gamma Receptor 1, with a predicted molecular weight of 54 kDa (observed band size: 45-100 kDa). Interferon gamma Receptor 1 Antibody (YA2074) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
cytochrome P450 family 4 subfamily A member 11; CP4Y; CYP4A2; CYP4AII; CYPIVA11
WB, IHC-P, IP
Human, Mouse, Rat
Cytochrome P450 4A Antibody (YA2087) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2087), targeting Cytochrome P450 4A, with a predicted molecular weight of 59 kDa (observed band size: 50 kDa). Cytochrome P450 4A Antibody (YA2087) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Transcriptional Enhancer Factor TEF Antibody (YA2122) is a biotin-conjugated non-conjugated IgG antibody, targeting Transcriptional Enhancer Factor TEF, with a predicted molecular weight of 48 kDa (observed band size: 54 kDa). Transcriptional Enhancer Factor TEF Antibody (YA2122) can be used for WB experiment in human background.
CLSTN1 Antibody (YA2247) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2247), targeting CLSTN1, with a predicted molecular weight of 110 kDa (observed band size: 150 kDa). CLSTN1 Antibody (YA2247) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
UBA2 Antibody (YA2329) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2329), targeting UBA2, with a predicted molecular weight of 71 kDa (observed band size: 90 kDa). UBA2 Antibody (YA2329) can be used for WB, ICC/IF, IP experiment in human, rat background.
Scramblase 1 Antibody (YA2419) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2419), targeting Scramblase 1, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). Scramblase 1 Antibody (YA2419) can be used for WB, ICC/IF, IP, FC experiment in human background.
Excitatory amino acid transporter 2; Glutamate/aspartate transporter II; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2
WB, IP
Human, Mouse, Rat
EAAT2 Antibody (YA2482) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2482), targeting EAAT2, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). EAAT2 Antibody (YA2482) can be used for WB, IP experiment in human, mouse, rat background.
cIAP1; C-IAP1; IAP homolog B; Inhibitor of apoptosis protein 2; IAP-2; hIAP-2; hIAP2; API1; IAP2; MIHB; RNF48
WB, ICC/IF
Human
cIAP1 Antibody (YA2500) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2500), targeting cIAP1, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). cIAP1 Antibody (YA2500) can be used for WB, ICC/IF experiment in human background.
CCL4 beta Antibody (YA2559) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2559), targeting CCL4 beta, with a predicted molecular weight of 10 kDa (observed band size: 10 kDa). CCL4 beta Antibody (YA2559) can be used for WB, ICC/IF, IP experiment in human, mouse background.
GPR37; Probable G-protein coupled receptor 37; Endothelin B receptor-like protein 1; ETBR-LP-1; Parkin-associated endothelin receptor-like receptor; PAELR
WB
Rat
GPR37 Antibody (YA2951) is a biotin-conjugated non-conjugated IgG antibody, targeting GPR37, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). GPR37 Antibody (YA2951) can be used for WB experiment in rat background.
KCNA1 Antibody (YA3075) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3075), targeting KCNA1, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). KCNA1 Antibody (YA3075) can be used for WB, IP experiment in human background.
Delta type opioid receptor; Delta type opioid receptor DOR1; DOR 1; mDOR; Nbor; Opioid receptor delta 1; OPRD 1
WB, FC
Human, Mouse, Rat
delta Opioid Receptor Antibody (YA3117) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3117), targeting delta Opioid Receptor, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). delta Opioid Receptor Antibody (YA3117) can be used for WB, FC experiment in human, mouse, rat background.
ABL2 Antibody (YA3203) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3203), targeting ABL2, with a predicted molecular weight of 128 kDa (observed band size: 128 kDa). ABL2 Antibody (YA3203) can be used for WB, FC experiment in human, mouse, rat background.
Sortilin Antibody (YA3243) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3243), targeting Sortilin, with a predicted molecular weight of 92 kDa (observed band size: 92 kDa). Sortilin Antibody (YA3243) can be used for WB, IHC-P experiment in human, rat background.
Aw-68; HLA class I histocompatibility antigen; A-28 alpha chain; MHC class I antigen A*68; HLA-A; MHC class I antigen HLA A heavy chain
WB, IHC-P
Human
MHC Class I Antibody (YA3322) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3322), targeting MHC Class I, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). MHC Class I Antibody (YA3322) can be used for WB, IHC-P experiment in human background.
KIF 3; KIF 3A; Kifl; Kinesin family member 3A; Kinesin like protein KIF 3A; Kinesin-like protein KIF3A; Kns3
WB, IP
Human, Mouse, Rat
KIF3A Antibody (YA3366) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3366), targeting KIF3A, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). KIF3A Antibody (YA3366) can be used for WB, IP experiment in human, mouse, rat background.
CD1a Antibody (YA3379) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3379), targeting CD1a, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). CD1a Antibody (YA3379) can be used for WB, IHC-P experiment in human background.
Cytochrome P450 2D6 Antibody (YA3384) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3384), targeting Cytochrome P450 2D6, with a predicted molecular weight of 56 kDa (observed band size: 50/55/80 kDa). Cytochrome P450 2D6 Antibody (YA3384) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
AMPK alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to AMPK alpha. It can be used for WB,IP assays with tag free, in the background of Human .
Annexin A1 Antibody (YA832) is a non-conjugated and Mouse origined monoclonal antibody about 39 kDa, targeting to Annexin A1 (5E4D8). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
CD127 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to CD127. It can be used for WB assays with tag free, in the background of Human.
Cleaved-Caspase 3 p12 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to Cleaved-Caspase 3 p12. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
ErbB 4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 147 kDa, targeting to ErbB 4. It can be used for WB assays with tag free, in the background of Human, Rat.
FEN1 Antibody (YA765) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to FEN1 (1E7). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
SLC2A4; GLUT4; Solute carrier family 2; facilitated glucose transporter member 4; Glucose transporter type 4; insulin-responsive; GLUT-4
WB, IHC-P, ELISA
Human, Mouse, Rat
Glucose Transporter GLUT4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 55 kDa, targeting to Glucose Transporter GLUT4. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
IL-6 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human.
GAB1; GRB2-associated-binding protein 1; GRB2-associated binder 1; Growth factor receptor bound protein 2-associated protein 1
WB, IHC-P, IHC-F, ICC/IF, ELISA
Human, Mouse, Rat
Phospho-GAB1 (Tyr627) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 77 kDa, targeting to Phospho-GAB1 (Tyr627). It can be used for WB、IHC-P、IHC-F、ICC、IF、ELISA assays with tag free, in the background of Human, Mouse and Rat.
Phospho-HSF1 (Ser303/Ser307) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-HSF1 (Ser303/Ser307). It can be used for WB,IHC-P assays with tag free, in the background of Human.
Phospho-Histone H2A.X (Ser139) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H2AX. It can be used for WB,ICC/IF assays with N-6*His-tag, in the background of Human, Mouse.
IBSP Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 35 kDa, targeting to IBSP. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse.
Phospho-HSF1 (Ser326) Antibody(YA894) is an unconjugated, approximately 57 kDa, rabbit-derived, anti-HSF1 (Ser326)(YA894) monoclonal antibody. Phospho-HSF1 (Ser326) Antibody(YA894) can be used for: WB, IF-Cell, IHC-P, IP, FC expriments in human background without labeling.
Casein Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-casein monoclonal antibody. Casein Antibody can be used for: WB,IP expriments in human background without labeling.
Acetyl-Histone H4 Antibody (YA927) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA927), targeting Acetyl-Histone H4, with a predicted molecular weight of 11 kDa. Acetyl-Histone H4 Antibody (YA927) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
ALDH3A2; ALDH10; FALDH; Fatty aldehyde dehydrogenase; Aldehyde dehydrogenase 10; Aldehyde dehydrogenase family 3 member A2; Microsomal aldehyde dehydrogenase
WB
Human
ALDH3A2 Antibody (YA1071) is a biotin-conjugated non-conjugated IgG2a antibody, targeting ALDH3A2, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). ALDH3A2 Antibody (YA1071) can be used for WB experiment in human background.
C1QA Antibody (YA1213) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1213), targeting C1QA. C1QA Antibody (YA1213) can be used for IHC-P experiment in human background.
Homeobox protein Nkx 2.2; NK 2 homolog B; NK2 homeobox 2; NKX2 2; NKX22; Nkx2b
IHC-P
Human
Nkx2.2 Antibody (YA1214) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1214), targeting Nkx2.2. Nkx2.2 Antibody (YA1214) can be used for IHC-P experiment in human background.
Nogo Antibody (YA1420) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1420), targeting Nogo, with a predicted molecular weight of 130 kDa (observed band size: 40-55 kDa). Nogo Antibody (YA1420) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
RARB; HAP; NR1B2; Retinoic acid receptor beta; RAR-beta; HBV-activated protein; Nuclear receptor subfamily 1 group B member 2; RAR-epsilon
WB, IHC-P, ICC/IF
Human
Retinoic Acid Receptor beta Antibody (YA1574) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1574), targeting Retinoic Acid Receptor beta, with a predicted molecular weight of 50 kDa (observed band size: 55 kDa). Retinoic Acid Receptor beta Antibody (YA1574) can be used for WB, IHC-P, ICC/IF experiment in human background.
RAN; ARA24; OK/SW-cl.81; GTP-binding nuclear protein Ran; Androgen receptor-associated protein 24; GTPase Ran; Ras-like protein TC4; Ras-related nuclear protein
WB, ICC/IF, IP
Human, Mouse, Monkey
Ran Antibody (YA1821) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1821), targeting Ran, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). Ran Antibody (YA1821) can be used for WB, ICC/IF, IP experiment in human, mouse, monkey background.
APPL1; APPL; DIP13A; KIAA1428; DCC-interacting protein 13-alpha; Dip13-alpha; Adapter protein containing PH domain; PTB domain and leucine zipper motif 1
WB, IHC-P
Human, Mouse, Rat
APPL Antibody (YA2135) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2135), targeting APPL, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). APPL Antibody (YA2135) can be used for WB, IHC-P experiment in human, mouse, rat background.
BAG3; BIS; BAG family molecular chaperone regulator 3; BAG-3; Bcl-2-associated athanogene 3; Bcl-2-binding protein Bis; Docking protein CAIR-1
WB
Human, Rat
BAG3 Antibody (YA2240) is a biotin-conjugated non-conjugated IgG antibody, targeting BAG3, with a predicted molecular weight of 62 kDa (observed band size: 80 kDa). BAG3 Antibody (YA2240) can be used for WB experiment in human, rat background.
BIN1; AMPHL; Myc box-dependent-interacting protein 1; Amphiphysin II; Amphiphysin-like protein; Box-dependent myc-interacting protein 1; Bridging integrator 1
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
BIN1 Antibody (YA2275) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2275), targeting BIN1, with a predicted molecular weight of 65 kDa (observed band size: 45-80 kDa). BIN1 Antibody (YA2275) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
CD239 Antibody (YA2376) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2376), targeting CD239, with a predicted molecular weight of 67 kDa (observed band size: 85 kDa). CD239 Antibody (YA2376) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.
Helicard; HlCD; IDDM19; IFIH1; MDA-5; RH116; RIG I like receptor 2; RLR 2; RNA helicase DEAD box protein 116
WB, ICC/IF
Human
MDA5 Antibody (YA2399) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2399), targeting MDA5, with a predicted molecular weight of 117 kDa (observed band size: 117 kDa). MDA5 Antibody (YA2399) can be used for WB, ICC/IF experiment in human background.
MAP3K7IP 3; NAP1; NFkB activating protein 1; Tab3; TAK1 binding protein 3
WB, ICC/IF
Human, Mouse
TAB3 Antibody (YA2401) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2401), targeting TAB3, with a predicted molecular weight of 79 kDa (observed band size: 90 kDa). TAB3 Antibody (YA2401) can be used for WB, ICC/IF experiment in human, mouse background.
Gamma 1 globin; Gamma 2 globin; Gamma A hemoglobin; Gamma globin; Hb F Agamma; Hb F Ggamma; HBG1; HBG2; HBGA; HBGR
WB
Human
Fetal Hemoglobin Antibody (YA2564) is a biotin-conjugated non-conjugated IgG antibody, targeting Fetal Hemoglobin, with a predicted molecular weight of 16 kDa (observed band size: 12 kDa). Fetal Hemoglobin Antibody (YA2564) can be used for WB experiment in human background.
Phospho-Filamin A/B (Ser2152/Ser2107) Antibody (YA2590) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2590), targeting Phospho-Filamin A/B (Ser2152/Ser2107), with a predicted molecular weight of 278 kDa (observed band size: 281 kDa). Phospho-Filamin A/B (Ser2152/Ser2107) Antibody (YA2590) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
CDC6; CDC18L; Cell division control protein 6 homolog; CDC6-related protein; CDc18-related protein; HsCDc18; p62(CDc6); HsCDC6
WB, IHC-P, ICC/IF
Human
CDC6 Antibody (YA2626) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2626), targeting CDC6, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). CDC6 Antibody (YA2626) can be used for WB, IHC-P, ICC/IF experiment in human background.
SLC22A3; EMTH; OCT3; Solute carrier family 22 member 3; Extraneuronal monoamine transporter; EMT; Organic cation transporter 3
WB, IHC-P, FC
Human
SLC22A3 Antibody (YA2830) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2830), targeting SLC22A3, with a predicted molecular weight of 61 kDa (observed band size: 75 kDa). SLC22A3 Antibody (YA2830) can be used for WB, IHC-P, FC experiment in human background.
NME2 Antibody (YA2968) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2968), targeting NME2, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). NME2 Antibody (YA2968) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
RAD21; HR21; KIAA0078; NXP1; Double-strand-break repair protein rad21 homolog; hHR21; Nuclear matrix protein 1; NXP-1; SCC1 homolog
WB, FC
Human, Mouse, Rat
Rad21 Antibody (YA2985) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2985), targeting Rad21, with a predicted molecular weight of 72 kDa (observed band size: 72,128 kDa). Rad21 Antibody (YA2985) can be used for WB, FC experiment in human, mouse, rat background.
COPS5; CSN5; JAB1; COP9 signalosome complex subunit 5; SGN5; Signalosome subunit 5; Jun activation domain-binding protein 1
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
JAB1 Antibody (YA3159) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3159), targeting JAB1, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). JAB1 Antibody (YA3159) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
ITK Antibody (YA3346) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3346), targeting ITK, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). ITK Antibody (YA3346) can be used for WB, IHC-P, FC experiment in human background.
beta Arrestin 1 Antibody (YA822) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to beta Arrestin 1 (6A1). It can be used for WB assays with tag free, in the background of Human.
Elongation Factor 1A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to Elongation Factor 1A1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
MTR1A_HUMAN; Melatonin receptor type 1A; Melatonin Receptor 1A; Mel-1A-R; Mel1a receptor; MT1; MT 1; Mel 1A R
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
MTNR1A Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-MTNR1A polyclonal antibody. MTNR1A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep, guinea pig background without labeling.
SAFB1 Antibody (YA1042) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1042), targeting SAFB1, with a predicted molecular weight of 103 kDa (observed band size: 130 kDa). SAFB1 Antibody (YA1042) can be used for WB, ICC/IF, ChIP experiment in human background.
SAFB1 Antibody (YA1043) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1043), targeting SAFB1, with a predicted molecular weight of 103 kDa (observed band size: 150 kDa). SAFB1 Antibody (YA1043) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse background.
Rad23B Antibody (YA1075) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1075), targeting Rad23B, with a predicted molecular weight of 43 kDa (observed band size: 58 kDa). Rad23B Antibody (YA1075) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat, monkey, hamster background.
Amyloid Precursor Protein Antibody (YA1130) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1130), targeting Amyloid Precursor Protein. Amyloid Precursor Protein Antibody (YA1130) can be used for IHC-P experiment in human background.
TARC/CCL17 Antibody (YA1211) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1211), targeting TARC/CCL17. TARC/CCL17 Antibody (YA1211) can be used for IHC-P experiment in human background.
CD13 Antibody (YA1253) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1253), targeting CD13. CD13 Antibody (YA1253) can be used for IHC-P experiment in human background.
FGF1 Antibody (YA1430) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1430), targeting FGF1, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). FGF1 Antibody (YA1430) can be used for WB, IHC-P experiment in human, mouse, rat background.
CD123 Antibody (YA1458) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1458), targeting CD123. CD123 Antibody (YA1458) can be used for FC, ELISA experiment in human background.
E1 Ubiquitin Activating Enzyme Antibody (YA1817) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1817), targeting E1 Ubiquitin Activating Enzyme, with a predicted molecular weight of 118 kDa (observed band size: 118 kDa). E1 Ubiquitin Activating Enzyme Antibody (YA1817) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SERPING1 Antibody (YA1980) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1980), targeting SERPING1, with a predicted molecular weight of 55 kDa (observed band size: 100 kDa). SERPING1 Antibody (YA1980) can be used for WB, IP experiment in human, mouse, rat background.
HLTF Antibody (YA2086) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2086), targeting HLTF, with a predicted molecular weight of 114 kDa (observed band size: 120 kDa). HLTF Antibody (YA2086) can be used for WB, IHC-P, ICC/IF experiment in human, rat background.
SRSF3 Antibody (YA2169) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2169), targeting SRSF3, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). SRSF3 Antibody (YA2169) can be used for WB, IHC-P, ICC/IF, FC experiment in mouse, rat, human background.
TAX1BP1 Antibody (YA2248) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2248), targeting TAX1BP1, with a predicted molecular weight of 91 kDa (observed band size: 91 kDa). TAX1BP1 Antibody (YA2248) can be used for WB, IHC-P experiment in human background.
CBL; CBL2; RNF55; E3 ubiquitin-protein ligase CBL; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; Signal transduction protein CBL
WB, ICC/IF, IP
Human
CBL Antibody (YA2392) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2392), targeting CBL, with a predicted molecular weight of 100 kDa (observed band size: 120 kDa). CBL Antibody (YA2392) can be used for WB, ICC/IF, IP experiment in human background.
IGFBP1; IBP1; Insulin-like growth factor-binding protein 1; IBP-1; IGF-binding protein 1; IGFBP-1; Placental protein 12; PP12
WB
Human, Mouse, Rat
IGFBP1 Antibody (YA2410) is a biotin-conjugated non-conjugated IgG antibody, targeting IGFBP1, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). IGFBP1 Antibody (YA2410) can be used for WB experiment in human, mouse, rat background.
HOXA13 Antibody (YA2561) is a biotin-conjugated non-conjugated IgG antibody, targeting HOXA13, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). HOXA13 Antibody (YA2561) can be used for WB experiment in human, mouse, rat background.
Phospho-NDRG1 (Ser330) Antibody (YA2618) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2618), targeting Phospho-NDRG1 (Ser330), with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). Phospho-NDRG1 (Ser330) Antibody (YA2618) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
KRT8; CYK8; Keratin; type II cytoskeletal 8; Cytokeratin-8; CK-8; Keratin-8; K8; Type-II keratin Kb8
WB, IHC-F, IHC-P, ICC/IF, IP
Human
Phospho-Cytokeratin 8 (Ser23) Antibody (YA2635) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2635), targeting Phospho-Cytokeratin 8 (Ser23), with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Phospho-Cytokeratin 8 (Ser23) Antibody (YA2635) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
Glucose Transporter GLUT2 Antibody (YA2669) is a biotin-conjugated non-conjugated IgG antibody, targeting Glucose Transporter GLUT2, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). Glucose Transporter GLUT2 Antibody (YA2669) can be used for WB experiment in human background.
Transcription Factor 7 Like 1 Antibody (YA2794) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2794), targeting Transcription Factor 7 Like 1, with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). Transcription Factor 7 Like 1 Antibody (YA2794) can be used for WB, FC experiment in human background.
Transcription Factor 4 Antibody (YA2809) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2809), targeting Transcription Factor 4, with a predicted molecular weight of 71 kDa (observed band size: 71/90 kDa). Transcription Factor 4 Antibody (YA2809) can be used for WB, IHC-P, FC, ChIP experiment in human background.
DNA-binding protein inhibitor ID-1; Class B basic helix-loop-helix protein 24; bHLHb24; Inhibitor of DNA binding 1; ID1; BHLHB24; ID
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
ID1 Antibody (YA2845) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2845), targeting ID1, with a predicted molecular weight of 16 kDa (observed band size: 22 kDa). ID1 Antibody (YA2845) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
PKN2 Antibody (YA2890) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2890), targeting PKN2, with a predicted molecular weight of 112 kDa (observed band size: 112 kDa). PKN2 Antibody (YA2890) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
SLC2A3; GLUT3; Solute carrier family 2; facilitated glucose transporter member 3; Glucose transporter type 3; brain; GLUT-3
WB
Human, Mouse, Rat
Glucose Transporter GLUT3 Antibody (YA2922) is a biotin-conjugated non-conjugated IgG antibody, targeting Glucose Transporter GLUT3, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). Glucose Transporter GLUT3 Antibody (YA2922) can be used for WB experiment in human, mouse, rat background.
HSPA14; HSP60; HSP70L1; Heat shock 70 kDa protein 14; HSP70-like protein 1; Heat shock protein HSP60
WB, ICC/IF, IP
Human, Mouse
HspA14 Antibody (YA3003) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3003), targeting HspA14, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). HspA14 Antibody (YA3003) can be used for WB, ICC/IF, IP experiment in human, mouse background.
PRPF19 Antibody (YA3058) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3058), targeting PRPF19, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). PRPF19 Antibody (YA3058) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
ICOS Ligand Antibody (YA3064) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3064), targeting ICOS Ligand, with a predicted molecular weight of 33 kDa (observed band size: 75 kDa). ICOS Ligand Antibody (YA3064) can be used for WB, IP experiment in human background.
I 1; I1; Inhibitor 1; IPP1; Ppp1r1a; Protein phosphatase 1 regulatory (inhibitor) subunit 1A
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
PPP1R1A Antibody (YA3109) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3109), targeting PPP1R1A, with a predicted molecular weight of 19 kDa (observed band size: 27 kDa). PPP1R1A Antibody (YA3109) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Macro H2A.1 Antibody (YA3186) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3186), targeting Macro H2A.1, with a predicted molecular weight of 40 kDa (observed band size: 40 kDa). Macro H2A.1 Antibody (YA3186) can be used for WB, ICC/IF experiment in mouse, rat background.
Rac Antibody (YA3290) is a biotin-conjugated non-conjugated IgG antibody, targeting Rac, with a predicted molecular weight of 21 kDa. Rac Antibody (YA3290) can be used for WB experiment in human, mouse, rat background.
21 kDa TBP-like protein; Second TBP of unique DNA protein; STUD; TATA box-binding protein-related factor 2; TBPL1; TLF; TLP; TLP21
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
TBP Like 1 Antibody (YA3345) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3345), targeting TBP Like 1, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). TBP Like 1 Antibody (YA3345) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
MGC119418; MGC119419; MGC119420; Protein Wnt 3a Precursor; Protein Wnt-3a; Wingless type MMTV integration site family member 3A; Wnt 3a; WNT3A protein.
WB, IHC-P, ICC/IF
Human
Wnt3a Antibody is a non-conjugated and Rabbit origined Polyclonal antibody about 39 kDa, targeting to Wnt3a . It can be used for WB, IHC-P, IF assays with tag free, in the background of Human.
Adenovirus E1B19k binding protein B5; BNIP3a; BNIP3H; BNIP3L; BNIP3L protein; NIP3 like protein X; NIP3L; NIX
WB, IHC-P
Human, Mouse, Rat
BNIP3L Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to BNIP3L. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Lck Antibody (YA712) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to Lck (3E5). It can be used for WB assays with tag free, in the background of Human.
PAK2 Antibody (YA695) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to PAK2 (7H3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Monkey.
Phospho-Chk2 (Thr68) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 61 kDa, targeting to Phospho-Chk2 (Thr68). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
Phospho-Histone H2A.X (Ser139) Antibody (YA191) is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Phospho-Histone H2A.X (Ser139). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
TAK1 Antibody (YA663) is a non-conjugated and Mouse origined monoclonal antibody about 67 kDa, targeting to TAK1 (3G1). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Cell Death Activator; Cell death activator CIDE-3; Cell death inducing DFFA like effector protein C; CIDE 3; CIDE C; CIDEC_HUMAN; FLJ20871; FPLD5; FSP27; CIDE-3
WB, ICC/IF, FC
Human
CIDEC Antibody (YA911) is an unconjugated, approximately 27 kDa, mouse-derived, anti-CIDEC (YA911) monoclonal antibody. CIDEC Antibody (YA911) can be used for: WB, ICC/IF, FC expriments in human background without labeling.
Cell Death Activator; Cell death activator CIDE-3; Cell death inducing DFFA like effector protein C; CIDE 3; CIDE C; CIDEC_HUMAN; FLJ20871; FPLD5; FSP27; CIDE-3
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat
CIDEC/FSP27 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CIDEC/FSP27 polyclonal antibody. CIDEC/FSP27 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: pig backgrounds without labeling.
MYOG_HUMAN; MYOG; BHLHC3; MYF4; Class C basic helix-loop-helix protein 3 (bHLHc3); Myogenic factor 4 (Myf-4); BHLHC3; MYF4; MYF 4
WB, IHC-P, FC
Human, Mouse, Rat
Myogenin Antibody is an unconjugated, approximately 25 kDa, rabbit-derived, anti-Myogenin monoclonal antibody. Myogenin Antibody can be used for: WB, IHC-P, FC expriments in human, mouse, rat background without labeling.
hnRNP U Antibody (YA979) is a biotin-conjugated non-conjugated IgG1 antibody, targeting hnRNP U, with a predicted molecular weight of 91 kDa (observed band size: 110 kDa). hnRNP U Antibody (YA979) can be used for WB experiment in human background.
hnRNP U Antibody (YA980) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA980), targeting hnRNP U, with a predicted molecular weight of 91 kDa (observed band size: 120 kDa). hnRNP U Antibody (YA980) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Folate Binding Protein Antibody (YA1099) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1099), targeting Folate Binding Protein. Folate Binding Protein Antibody (YA1099) can be used for IHC-P experiment in human background.
CD276 Antibody (YA1279) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1279), targeting CD276. CD276 Antibody (YA1279) can be used for IHC-P experiment in human background.
Phospho-NFAT2 (Ser237) Antibody (YA1389) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-NFAT2 (Ser237), with a predicted molecular weight of 101 kDa (observed band size: 101 kDa). Phospho-NFAT2 (Ser237) Antibody (YA1389) can be used for WB experiment in human, mouse background.
IL-2RA Antibody (YA1457) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1457), targeting IL-2RA. IL-2RA Antibody (YA1457) can be used for FC, ELISA experiment in human background.
Anterior gradient protein 2 homolog; AG-2; hAG-2; HPC8; Secreted cement gland protein XAG-2 homolog; AGR2; AG2; GOB4; XAG2
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Rat
Anterior Gradient 2 Antibody (YA1779) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1779), targeting Anterior Gradient 2, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Anterior Gradient 2 Antibody (YA1779) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, rat background.
Dip1; LVNC7; MIB; mib1; ZZANK2; ZZZ6; DAPK-interacting protein 1; Mind bomb homolog 1; RING-type E3 ubiquitin transferase MIB1
WB, IHC-P, ICC/IF
Human, Mouse
MIB1 Antibody (YA1891) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1891), targeting MIB1, with a predicted molecular weight of 110 kDa (observed band size: 110 kDa). MIB1 Antibody (YA1891) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
Toll-Like Receptor 2 Antibody (YA1932) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1932), targeting Toll-Like Receptor 2, with a predicted molecular weight of 89 kDa (observed band size: 89 kDa). Toll-Like Receptor 2 Antibody (YA1932) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in mouse background.
Aly Antibody (YA2079) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2079), targeting Aly, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). Aly Antibody (YA2079) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
ATP1B3 Antibody (YA2201) is a biotin-conjugated non-conjugated IgG antibody, targeting ATP1B3, with a predicted molecular weight of 32 kDa (observed band size: 40 kDa). ATP1B3 Antibody (YA2201) can be used for WB experiment in mouse, rat background.
Transglutaminase 2 Antibody (YA2255) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2255), targeting Transglutaminase 2, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). Transglutaminase 2 Antibody (YA2255) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
ERR alpha Antibody (YA2283) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2283), targeting ERR alpha, with a predicted molecular weight of 46 kDa (observed band size: 50 kDa). ERR alpha Antibody (YA2283) can be used for WB, IP, FC experiment in human, mouse, rat background.
CAM kinase 2 delta; CAM kinase II delta; CaM kinase II delta subunit; CaM kinase II subunit delta; CAMK 2d; CaMK-II delta subunit; CAMK2D; CAMKI
WB
Human, Rat
CaMKII delta Antibody (YA2337) is a biotin-conjugated non-conjugated IgG antibody, targeting CaMKII delta, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). CaMKII delta Antibody (YA2337) can be used for WB experiment in human, rat background.
Interferon Regulatory Factor 4 Antibody (YA2408) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2408), targeting Interferon Regulatory Factor 4, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Interferon Regulatory Factor 4 Antibody (YA2408) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
PA2G4; EBP1; Proliferation-associated protein 2G4; Cell cycle protein p38-2G4 homolog; hG4-1; ErbB3-binding protein 1
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
EBP1 Antibody (YA2509) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2509), targeting EBP1, with a predicted molecular weight of 44 kDa (observed band size: 48 kDa). EBP1 Antibody (YA2509) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
KDM4B; JHDM3B; JMJD2B; KIAA0876; Lysine-specific demethylase 4B; JmjC domain-containing histone demethylation protein 3B; Jumonji domain-containing protein 2B
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
KDM4B Antibody (YA2536) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2536), targeting KDM4B, with a predicted molecular weight of 122 kDa (observed band size: 150 kDa). KDM4B Antibody (YA2536) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
DBF4; ASK; DBF4A; ZDBF1; Protein DBF4 homolog A; Activator of S phase kinase; Chiffon homolog A; DBF4-type zinc finger-containing protein 1
WB
Human
DBF4 Antibody (YA2652) is a biotin-conjugated non-conjugated IgG antibody, targeting DBF4, with a predicted molecular weight of 77 kDa (observed band size: 77 kDa). DBF4 Antibody (YA2652) can be used for WB experiment in human background.
Phospholipase C beta 3 Antibody (YA2694) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2694), targeting Phospholipase C beta 3, with a predicted molecular weight of 139 kDa (observed band size: 150 kDa). Phospholipase C beta 3 Antibody (YA2694) can be used for WB, IHC-P experiment in human background.
PI 3 Kinase p150 Antibody (YA2823) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2823), targeting PI 3 Kinase p150, with a predicted molecular weight of 153 kDa (observed band size: 150 kDa). PI 3 Kinase p150 Antibody (YA2823) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
p23 Antibody (YA3131) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3131), targeting p23, with a predicted molecular weight of 19 kDa (observed band size: 23 kDa). p23 Antibody (YA3131) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
C-X-C motif chemokine 4; CXCL4; Iroplact; OncostatinA; PF4; Platelet factor 4; SCYB4; short form; Small inducible cytokine subfamily member 4
WB, IHC-P, IP
Human, Rat
PF4 Antibody (YA3156) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3156), targeting PF4, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). PF4 Antibody (YA3156) can be used for WB, IHC-P, IP experiment in human, rat background.
Steroidogenic Factor 1 Antibody (YA3166) is a biotin-conjugated non-conjugated IgG antibody, targeting Steroidogenic Factor 1, with a predicted molecular weight of 52 kDa. Steroidogenic Factor 1 Antibody (YA3166) can be used for WB experiment in human, mouse, rat background.
ITGA4; CD49D; Integrin alpha-4; CD49 antigen-like family member D; Integrin alpha-IV; VLA-4 subunit alpha; CD49d
WB
Human
Integrin alpha 4 Antibody (YA3201) is a biotin-conjugated non-conjugated IgG antibody, targeting Integrin alpha 4, with a predicted molecular weight of 115 kDa (observed band size: 150 kDa). Integrin alpha 4 Antibody (YA3201) can be used for WB experiment in human background.
RNF14; ARA54; HRIHFB2038; E3 ubiquitin-protein ligase RNF14; Androgen receptor-associated protein 54; HFB30; RING finger protein 14; Triad2 protein
WB
Human, Mouse, Rat
RNF14 Antibody (YA3216) is a biotin-conjugated non-conjugated IgG antibody, targeting RNF14, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). RNF14 Antibody (YA3216) can be used for WB experiment in human, mouse, rat background.
TATA Box Binding Protein Antibody (YA3260) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3260), targeting TATA Box Binding Protein, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). TATA Box Binding Protein Antibody (YA3260) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
S100A1; S100A; Protein S100-A1; S-100 protein alpha chain; S-100 protein subunit alpha; S100 calcium-binding protein A1
WB, IHC-P, IP, FC
Human, Mouse
S100A1 Antibody (YA3316) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3316), targeting S100A1, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). S100A1 Antibody (YA3316) can be used for WB, IHC-P, IP, FC experiment in human, mouse background.
DAPK3; ZIPK; Death-associated protein kinase 3; DAP kinase 3; DAP-like kinase; Dlk; MYPT1 kinase; Zipper-interacting protein kinase; ZIP-kinase
WB
Human
DAP kinase 3 Antibody (YA3319) is a biotin-conjugated non-conjugated IgG antibody, targeting DAP kinase 3, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). DAP kinase 3 Antibody (YA3319) can be used for WB experiment in human background.
CD86 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 38 kDa, targeting to CD86. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.
Phospho-TAK1 (Ser439) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 67 kDa, targeting to Phospho-TAK1 (Ser439). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
NTRK2; TRKB; BDNF/NT-3 growth factors receptor; GP145-TrkB; Trk-B; Neurotrophic tyrosine kinase receptor type 2; TrkB tyrosine kinase; Tropomyosin-related kinase B
WB
Human, Mouse, Rat
Phospho-TrkA/B (Tyr490/Tyr516) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to Phospho-TrkA/B (Tyr490/Tyr516). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
TERT Antibody is an unconjugated, approximately 125 kDa, rabbit-derived, anti-TERT polyclonal antibody. TERT Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.
B2MG; Beta 2 microglobin; Beta 2 microglobulin; Beta-2-microglobulin form pI 5.3; CDABP0092; Hdcma22p
ELISA
Human
beta 2 Microglobulin Antibody (YA934) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA934), targeting beta 2 Microglobulin. beta 2 Microglobulin Antibody (YA934) can be used for ELISA experiment in human background.
B2MG; Beta 2 microglobin; Beta 2 microglobulin; Beta-2-microglobulin form pI 5.3; CDABP0092; Hdcma22p
WB, IP
Human, Mouse, Rat
beta 2 Microglobulin Antibody (YA935) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA935), targeting beta 2 Microglobulin, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). beta 2 Microglobulin Antibody (YA935) can be used for WB, IP experiment in human, mouse, rat background.
CHD3 Antibody (YA944) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA944), targeting CHD3, with a predicted molecular weight of 227 kDa (observed band size: 260 kDa). CHD3 Antibody (YA944) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
CHD3 Antibody (YA945) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA945), targeting CHD3, with a predicted molecular weight of 227 kDa (observed band size: 260 kDa). CHD3 Antibody (YA945) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CDC6; CDC18L; Cell division control protein 6 homolog; CDC6-related protein; CDc18-related protein; HsCDc18; p62(CDc6); HsCDC6
WB
Human, Rat
Phospho-CDC6 (Ser106) Antibody (YA1016) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-CDC6 (Ser106), with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). Phospho-CDC6 (Ser106) Antibody (YA1016) can be used for WB experiment in human, rat background.
CDC6; CDC18L; Cell division control protein 6 homolog; CDC6-related protein; CDc18-related protein; HsCDc18; p62(CDc6); HsCDC6
WB, ICC/IF
Human
Phospho-CDC6 (Ser54) Antibody (YA1017) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1017), targeting Phospho-CDC6 (Ser54), with a predicted molecular weight of 63 kDa (observed band size: 63 kDa). Phospho-CDC6 (Ser54) Antibody (YA1017) can be used for WB, ICC/IF experiment in human background.
ARID1A Antibody (YA1158) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1158), targeting ARID1A. ARID1A Antibody (YA1158) can be used for IHC-P experiment in human background.
IL4I1; FIG1 ; UNQ636/PRO1265 ; L-amino-acid oxidase ; Interleukin-4-induced protein 1; hIL4I1 ; Protein Fig-1 ; LAAO; LAO
IHC-P
Human
IL-4I1/LAO Antibody (YA1225) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1225), targeting IL-4I1/LAO. IL-4I1/LAO Antibody (YA1225) can be used for IHC-P experiment in human background.
B7H2 Antibody (YA1451) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1451), targeting B7H2. B7H2 Antibody (YA1451) can be used for FC, ELISA experiment in human background.
PDGF B Antibody (YA1556) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1556), targeting PDGF B, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). PDGF B Antibody (YA1556) can be used for WB, IHC-P experiment in human, mouse, rat background.
AAT4; FAA4; MYH11; Myosin 11; Myosin heavy chain 11; Myosin heavy chain smooth muscle isoform; Myosin heavy polypeptide 11 smooth muscle; SMHC; SMMHC
WB, IHC-P
Human, Mouse
MYH11 Antibody (YA1620) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1620), targeting MYH11, with a predicted molecular weight of 227 kDa (observed band size: 250 kDa). MYH11 Antibody (YA1620) can be used for WB, IHC-P experiment in human, mouse background.
OXGR1 Antibody (YA1646) is a biotin-conjugated non-conjugated IgG antibody, targeting OXGR1, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). OXGR1 Antibody (YA1646) can be used for WB experiment in human, rat background.
SYNCRIP; HNRPQ; NSAP1; Heterogeneous nuclear ribonucleoprotein Q; hnRNP Q; Glycine- and tyrosine-rich RNA-binding protein; GRY-RBP; NS1-associated protein 1; Synaptotagmin-binding; cytoplasmic RNA-interacting protein
WB, IHC-P, ICC/IF
Human, Mouse, Rat
hnRNP Q Antibody (YA1838) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1838), targeting hnRNP Q, with a predicted molecular weight of 70 kDa (observed band size: 65-82 kDa). hnRNP Q Antibody (YA1838) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
MYL9 Antibody (YA2093) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2093), targeting MYL9, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). MYL9 Antibody (YA2093) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
TOMM22 Antibody (YA2111) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2111), targeting TOMM22, with a predicted molecular weight of 16 kDa (observed band size: 16 kDa). TOMM22 Antibody (YA2111) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
AP3M1 Antibody (YA2117) is a biotin-conjugated non-conjugated IgG antibody, targeting AP3M1, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). AP3M1 Antibody (YA2117) can be used for WB experiment in human, mouse, rat background.
TAF15 Antibody (YA2134) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2134), targeting TAF15, with a predicted molecular weight of 62 kDa (observed band size: 77 kDa). TAF15 Antibody (YA2134) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
IL-2 Receptor alpha Antibody (YA2361) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2361), targeting IL-2 Receptor alpha. IL-2 Receptor alpha Antibody (YA2361) can be used for IHC-P, ICC/IF experiment in human background.
CD247; CD3Z; T3Z; TCRZ; T-cell surface glycoprotein CD3 zeta chain; T-cell receptor T3 zeta chain; CD antigen CD247
WB, IP
Human
Phospho-CD3 zeta (Tyr142) Antibody (YA2425) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2425), targeting Phospho-CD3 zeta (Tyr142), with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Phospho-CD3 zeta (Tyr142) Antibody (YA2425) can be used for WB, IP experiment in human background.
ALK-1 Antibody (YA2457) is a biotin-conjugated non-conjugated IgG antibody, targeting ALK-1, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). ALK-1 Antibody (YA2457) can be used for WB experiment in human, mouse, rat background.
IP10 Antibody (YA2542) is a biotin-conjugated non-conjugated IgG antibody, targeting IP10, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). IP10 Antibody (YA2542) can be used for WB experiment in human background.
DPYSL4; CRMP3; ULIP4; Dihydropyrimidinase-related protein 4; DRP-4; Collapsin response mediator protein 3; CRMP-3; UNC33-like phosphoprotein 4; ULIP-4
WB
Rat
CRMP3 Antibody (YA2563) is a biotin-conjugated non-conjugated IgG antibody, targeting CRMP3, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). CRMP3 Antibody (YA2563) can be used for WB experiment in rat background.
EBI3 Antibody (YA2692) is a biotin-conjugated non-conjugated IgG antibody, targeting EBI3, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). EBI3 Antibody (YA2692) can be used for WB experiment in human, mouse, rat background.
IL-1 Receptor Antagonist Protein Antibody (YA3095) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3095), targeting IL-1 Receptor Antagonist Protein, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). IL-1 Receptor Antagonist Protein Antibody (YA3095) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
Cell division cycle-associated protein 3; Trigger of mitotic entry protein 1; TOME-1; Gene-rich cluster protein C8; CDCA3; C8; GRCC8; TOME1
WB, ICC/IF
Human, Mouse, Rat
CDCA3 Antibody (YA3176) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3176), targeting CDCA3, with a predicted molecular weight of 29 kDa (observed band size: 26 kDa). CDCA3 Antibody (YA3176) can be used for WB, ICC/IF experiment in human, mouse, rat background.
NCK2; GRB4; Cytoplasmic protein NCK2; Growth factor receptor-bound protein 4; NCK adaptor protein 2; Nck-2; SH2/SH3 adaptor protein NCK-beta
WB, ICC/IF
Human, Mouse, Rat
NCK2 Antibody (YA3293) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3293), targeting NCK2, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). NCK2 Antibody (YA3293) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MEK3/MEK6 Antibody (YA3323) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3323), targeting MEK3/MEK6, with a predicted molecular weight of 39,37 kDa (observed band size: 39,37 kDa). MEK3/MEK6 Antibody (YA3323) can be used for WB, ICC/IF, IP experiment in human, mouse background.
Antithrombin; Antithrombin III; AT 3; AT III; AT3; AT3D; ATIII; Heparin cofactor I; Serpin C1; Serpin family C member 1; SERPINC1; THPH7
WB, ICC/IF
Human
Antithrombin III Antibody (YA3352) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3352), targeting Antithrombin III, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). Antithrombin III Antibody (YA3352) can be used for WB, ICC/IF experiment in human background.
cytochrome P450 family 4 subfamily A member 11; CP4Y; CYP4A2; CYP4AII; CYPIVA11
WB, IHC-P, IP
Human, Mouse, Rat
CYP4A11 Antibody is an unconjugated, approximately 59 kDa, rabbit-derived, anti-CYP4A11 monoclonal antibody. CYP4A11 Antibody can be used for: WB,IHC-P,IP expriments in Human, Mouse,Rat background without labeling.
MGC119418; MGC119419; MGC119420; Protein Wnt 3a Precursor; Protein Wnt-3a; Wingless type MMTV integration site family member 3A; Wnt 3a; WNT3A protein.
WB, IHC-P, ICC/IF, FC
Human
Wnt3a Antibody is a non-conjugated and Mouse origined Monoclonal antibody about 39 kDa, targeting to Wnt3a . It can be used for WB, ICC, IHC-P, FC assays with tag free, in the background of Human.
SIRT1; SIR2L1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2; Sirtuin 1
WB, ICC/IF, IHC-P, IP
Human, Mouse
SIRT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to SIRT1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.
p-pg; PGP; ABCB1; MDR1; PGY1; Multidrug resistance protein 1; ATP-binding cassette sub-family B member 1; P-glycoprotein 1; CD antigen CD243
WB
Human
P Glycoprotein Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 141 kDa, targeting to P Glycoprotein. It can be used for WB assays with tag free, in the background of Human.
CD14 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CD14 monoclonal antibody. CD14 Antibody can be used for: WB,IHC-P, ICC/IF expriments in human background without labeling.
IL-10 Antibody is an unconjugated, approximately 18 kDa, rabbit-derived, anti-IL-10 monoclonal antibody. IL-10 Antibody can be used for: WB, ICC, FC expriments in human background without labeling.
CD166 Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-CD166 monoclonal antibody. CD166 Antibody can be used for: WB,IHC-F,IHC-P,ICC/IF,IP expriments in human, mouse, rat background without labeling.
4 Hydroxynonenal Antibody is an unconjugated, approximately 0.156 kDa, rabbit-derived, anti-4 Hydroxynonenal polyclonal antibody. 4 Hydroxynonenal Antibody can be used for: WB, ELISA, IHC-P, IF expriments in background without labeling.
CBL; CBL2; RNF55; E3 ubiquitin-protein ligase CBL; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; Signal transduction protein CBL
WB, IP
Human, Rat
Phospho-CBL (Tyr774) Antibody (YA1014) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1014), targeting Phospho-CBL (Tyr774), with a predicted molecular weight of 100 kDa (observed band size: 120 kDa). Phospho-CBL (Tyr774) Antibody (YA1014) can be used for WB, IP experiment in human, rat background.
CBL; CBL2; RNF55; E3 ubiquitin-protein ligase CBL; Casitas B-lineage lymphoma proto-oncogene; Proto-oncogene c-Cbl; RING finger protein 55; Signal transduction protein CBL
WB
Human
Phospho-CBL (Ser669) Antibody (YA1015) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-CBL (Ser669), with a predicted molecular weight of 100 kDa (observed band size: 120 kDa). Phospho-CBL (Ser669) Antibody (YA1015) can be used for WB experiment in human background.
ZEB1 Antibody (YA1153) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1153), targeting ZEB1. ZEB1 Antibody (YA1153) can be used for IHC-P experiment in human background.
CSF1R Antibody (YA1189) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1189), targeting CSF1R. CSF1R Antibody (YA1189) can be used for IHC-P experiment in human background.
LMO2; RBTN2, RBTNL1, RHOM2, TTG2; Rhombotin-2; Cysteine-rich protein TTG-2; LIM domain only protein 2 (LMO-2); T-cell translocation protein 2
IHC-P
Human
LMO2 Antibody (YA1273) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1273), targeting LMO2. LMO2 Antibody (YA1273) can be used for IHC-P experiment in human background.
OX40 Antibody (YA1504) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1504), targeting OX40. OX40 Antibody (YA1504) can be used for FC, ELISA experiment in human background.
IKK epsilon Antibody (YA1611) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1611), targeting IKK epsilon, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). IKK epsilon Antibody (YA1611) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
HNF 1 beta Antibody (YA1724) is a biotin-conjugated non-conjugated IgG antibody, targeting HNF 1 beta, with a predicted molecular weight of 61 kDa (observed band size: 70 kDa). HNF 1 beta Antibody (YA1724) can be used for WB experiment in human background.
CLASP1; KIAA0622; MAST1; CLIP-associating protein 1; Cytoplasmic linker-associated protein 1; Multiple asters homolog 1; Protein Orbit homolog 1; hOrbit1
WB, IHC-P, ICC/IF, FC
Mouse, Rat, Human
CLASP1 Antibody (YA2133) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2133), targeting CLASP1, with a predicted molecular weight of 169 kDa (observed band size: 169 kDa). CLASP1 Antibody (YA2133) can be used for WB, IHC-P, ICC/IF, FC experiment in mouse, rat, human background.
HLA-DQA1; CD; CELIAC1; DQ-A1; GSE; HLA-DQA; DQ alpha 1 chain; DC-1 alpha chain; DC-alpha; HLA-DCA; MHC class II DQA1
WB, IHC-P, IP
Human, Mouse, Rat
HLA DQA1 Antibody (YA2433) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2433), targeting HLA DQA1, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). HLA DQA1 Antibody (YA2433) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Phospho-Amyloid Precursor Protein (Thr743) Antibody (YA2568) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2568), targeting Phospho-Amyloid Precursor Protein (Thr743), with a predicted molecular weight of 87 kDa (observed band size: 100 kDa). Phospho-Amyloid Precursor Protein (Thr743) Antibody (YA2568) can be used for WB, ICC/IF, IP experiment in human, rat background.
Glutathione S Transferase mu 1 Antibody (YA2928) is a biotin-conjugated non-conjugated IgG antibody, targeting Glutathione S Transferase mu 1, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). Glutathione S Transferase mu 1 Antibody (YA2928) can be used for WB experiment in human, hamster background.
WASF2; WAVE2; Wiskott-Aldrich syndrome protein family member 2; WASP family protein member 2; Protein WAVE-2; Verprolin homology domain-containing protein 2
WB, IHC-P
Human, Mouse, Rat
WAVE 2 Antibody (YA3072) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3072), targeting WAVE 2, with a predicted molecular weight of 54 kDa (observed band size: 80 kDa). WAVE 2 Antibody (YA3072) can be used for WB, IHC-P experiment in human, mouse, rat background.
AGO3 Antibody (YA3124) is a biotin-conjugated non-conjugated IgG antibody, targeting AGO3, with a predicted molecular weight of 97 kDa (observed band size: 97 kDa). AGO3 Antibody (YA3124) can be used for WB experiment in human, mouse, rat background.
PAX8 Antibody (YA3178) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3178), targeting PAX8, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). PAX8 Antibody (YA3178) can be used for WB, IHC-P, ICC/IF experiment in human background.
MEKK2 Antibody (YA3215) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3215), targeting MEKK2, with a predicted molecular weight of 70 kDa (observed band size: 72 kDa). MEKK2 Antibody (YA3215) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
KDM4A; JHDM3A; JMJD2; JMJD2A; KIAA0677; Lysine-specific demethylase 4A; JmjC domain-containing histone demethylation protein 3A; Jumonji domain-containing protein 2A
WB, IP
Human
KDM4A Antibody (YA3331) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3331), targeting KDM4A, with a predicted molecular weight of 121 kDa (observed band size: 150 kDa). KDM4A Antibody (YA3331) can be used for WB, IP experiment in human background.
PYCARD; ASC; CARD5; TMS1; Apoptosis-associated speck-like protein containing a CARD; hASC; Caspase recruitment domain-containing protein 5; PYD and CARD domain-containing protein; Target of methylation-induced silencing 1
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
ASC Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to ASC. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Calumenin Antibody (YA813) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to Calumenin (4C6). It can be used for WB assays with tag free, in the background of Human, Mouse.
Caspase 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 45 kDa, targeting to Caspase 1. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
CD79a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD79a. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
NF-KB p105 Antibody (YA700) is a non-conjugated and Mouse origined monoclonal antibody about 105 kDa, targeting to NF-KB p105 (5E3). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Peroxiredoxin 1 Antibody (YA692) is a non-conjugated and Mouse origined monoclonal antibody about 22 kDa, targeting to Peroxiredoxin 1 (6A6). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-CD18 (Ser745) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Phospho-CD18 (Ser745). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
SOCS1; SSI1; TIP3; Suppressor of cytokine signaling 1; SOCS-1; JAK-binding protein; JAB; STAT-induced STAT inhibitor 1; SSI-1; Tec-interacting protein 3; TIP-3
ICC/IF, WB, IHC-F, IHC-P, ELISA
Human, Mouse, Rat
SOCS1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to SOCS1. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
Cathepsin K Antibody is an unconjugated, approximately 36 kDa, rabbit-derived, anti-Cathepsin K polyclonal antibody. Cathepsin K Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: human, mouse, dog, pig, cow, horse, guinea pig background without labeling.
NM23A Antibody (YA1002) is a biotin-conjugated non-conjugated IgG1 antibody, targeting NM23A, with a predicted molecular weight of 17 kDa (observed band size: 16,18 kDa). NM23A Antibody (YA1002) can be used for WB experiment in human, mouse, rat background.
NM23A Antibody (YA1003) is a biotin-conjugated non-conjugated IgG antibody, targeting NM23A, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). NM23A Antibody (YA1003) can be used for WB experiment in human background.
SIRT1; SIR2L1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2
WB, IHC-P, ICC/IF
Human
Phospho-SIRT1 (Ser47) Antibody (YA1036) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1036), targeting Phospho-SIRT1 (Ser47), with a predicted molecular weight of 82 kDa (observed band size: 110 kDa). Phospho-SIRT1 (Ser47) Antibody (YA1036) can be used for WB, IHC-P, ICC/IF experiment in human background.
SIRT1; SIR2L1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; Regulatory protein SIR2 homolog 1; SIR2-like protein 1; hSIR2
WB
Human
Phospho-SIRT1 (Thr530) Antibody (YA1037) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-SIRT1 (Thr530), with a predicted molecular weight of 82 kDa (observed band size: 120 kDa). Phospho-SIRT1 (Thr530) Antibody (YA1037) can be used for WB experiment in human background.
TBL1X; TBL1; F-box-like/WD repeat-containing protein TBL1X; SMAP55; Transducin beta-like protein 1X; Transducin-beta-like protein 1; X-linked
WB, ICC/IF
Human
TBL1X Antibody (YA1065) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA1065), targeting TBL1X, with a predicted molecular weight of 62 kDa (observed band size: 58 kDa). TBL1X Antibody (YA1065) can be used for WB, ICC/IF experiment in human background.
5T4 Antibody (YA1097) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1097), targeting 5T4. 5T4 Antibody (YA1097) can be used for IHC-P experiment in human background.
AKR1B10; AKR1B11; Aldo-keto reductase family 1 member B10; ARL-1; Aldose reductase-like; Aldose reductase-related protein (ARP; hARP); Small intestine reductase (SI reductase)
IHC-P
Human
AKR1B10 Antibody (YA1113) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1113), targeting AKR1B10. AKR1B10 Antibody (YA1113) can be used for IHC-P experiment in human background.
ASCL1; ASH1, BHLHA46; HASH1; Achaete-scute homolog 1; ASH-1; hASH1 ; Class A basic helix-loop-helix protein 46
IHC-P
Human
MASH1/Achaete-scute homolog 1 Antibody (YA1126) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1126), targeting MASH1/Achaete-scute homolog 1. MASH1/Achaete-scute homolog 1 Antibody (YA1126) can be used for IHC-P experiment in human background.
LRE1; L1RE1; LINE-1 retrotransposable element ORF1 protein; L1ORF1p; LINE retrotransposable element 1; LINE1 retrotransposable element 1
IHC-P
Human
LINE-1 ORF1p Antibody (YA1263) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1263), targeting LINE-1 ORF1p. LINE-1 ORF1p Antibody (YA1263) can be used for IHC-P experiment in human background.
NR1D1; EAR1; HREV; THRAL; Nuclear receptor subfamily 1 group D member 1; Rev-erbA-alpha; V-erbA-related protein 1; EAR-1
WB, ICC/IF
Human, Mouse, Rat
NR1D1 Antibody (YA1426) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1426), targeting NR1D1, with a predicted molecular weight of 67 kDa (observed band size: 67 kDa). NR1D1 Antibody (YA1426) can be used for WB, ICC/IF experiment in human, mouse, rat background.
Death domain containing protein p84N5; HPR1; hTREX84; Nuclear matrix protein p84; p84N5; THO complex 1; Tho1; Thoc1
WB, ICC/IF
Human
THO Complex Subunit 1 Antibody (YA1437) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1437), targeting THO Complex Subunit 1, with a predicted molecular weight of 76 kDa (observed band size: 84 kDa). THO Complex Subunit 1 Antibody (YA1437) can be used for WB, ICC/IF experiment in human background.
PTH1R; PTHR; PTHR1; Parathyroid hormone/parathyroid hormone-related peptide receptor; PTH/PTHrP type I receptor; PTH/PTHr receptor; Parathyroid hormone 1 receptor; PTH1 receptor
WB, IP
Human
Parathyroid Hormone Receptor 1 Antibody (YA1452) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1452), targeting Parathyroid Hormone Receptor 1, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). Parathyroid Hormone Receptor 1 Antibody (YA1452) can be used for WB, IP experiment in human background.
OX40L Antibody (YA1475) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1475), targeting OX40L. OX40L Antibody (YA1475) can be used for FC, ELISA experiment in human background.
APAF1 Antibody (YA1481) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1481), targeting APAF1, with a predicted molecular weight of 142 kDa (observed band size: 135 kDa). APAF1 Antibody (YA1481) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.
MYOD1; BHLHC1; MYF3; MYOD; Myoblast determination protein 1; Class C basic helix-loop-helix protein 1; bHLHc1; Myogenic factor 3; Myf-3
WB, IHC-P
Human
MyoD1/Myf3 Antibody (YA1491) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1491), targeting MyoD1/Myf3, with a predicted molecular weight of 35 kDa (observed band size: 45 kDa). MyoD1/Myf3 Antibody (YA1491) can be used for WB, IHC-P experiment in human background.
Peroxiredoxin 2 Antibody (YA1585) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1585), targeting Peroxiredoxin 2, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). Peroxiredoxin 2 Antibody (YA1585) can be used for WB, IHC-P experiment in human, mouse, rat background.
MAD2L1; MAD2; Mitotic spindle assembly checkpoint protein MAD2A; HsMAD2; Mitotic arrest deficient 2-like protein 1; MAD2-like protein 1
WB
Human
MAD2L1 Antibody (YA1692) is a biotin-conjugated non-conjugated IgG antibody, targeting MAD2L1, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). MAD2L1 Antibody (YA1692) can be used for WB experiment in human background.
COUP-TF1; EAR3; ERBAL3; NR2F1; NR2F2; Nuclear receptor subfamily 2 group F member 1; SVP44; TCFCOUP1; TFCOUP1
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
COUP TF1 Antibody (YA2322) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2322), targeting COUP TF1, with a predicted molecular weight of 46 kDa (observed band size: 46 kDa). COUP TF1 Antibody (YA2322) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
GGT1 Antibody (YA2634) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2634), targeting GGT1, with a predicted molecular weight of 61 kDa (observed band size: 50-60 kDa). GGT1 Antibody (YA2634) can be used for WB, IHC-P experiment in human background.
Guanylyl Cyclase alpha 1 Antibody (YA2937) is a biotin-conjugated non-conjugated IgG antibody, targeting Guanylyl Cyclase alpha 1, with a predicted molecular weight of 77 kDa (observed band size: 73 kDa). Guanylyl Cyclase alpha 1 Antibody (YA2937) can be used for WB experiment in human background.
Acetyl-Histone H2A Antibody (YA3044) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3044), targeting Acetyl-Histone H2A, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). Acetyl-Histone H2A Antibody (YA3044) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
HSPA2; Heat shock 70kD protein 2; HSP70-2; HSP70-3; Heat shock 70 kDa protein 2; Heat shock 70kDa protein 2
WB, IHC-P
Human, Mouse, Rat
HspA2 Antibody (YA3056) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3056), targeting HspA2, with a predicted molecular weight of 70 kDa (observed band size: 70 kDa). HspA2 Antibody (YA3056) can be used for WB, IHC-P experiment in human, mouse, rat background.
ITGA2; CD49B; Integrin alpha-2; CD49 antigen-like family member B; Collagen receptor; Platelet membrane glycoprotein Ia; GPIa; VLA-2 subunit alpha; CD49b
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
Integrin alpha 2 Antibody (YA3107) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3107), targeting Integrin alpha 2, with a predicted molecular weight of 129 kDa (observed band size: 150 kDa). Integrin alpha 2 Antibody (YA3107) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Metabotropic Glutamate Receptor 2 Antibody (YA3218) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3218), targeting Metabotropic Glutamate Receptor 2, with a predicted molecular weight of 96 kDa (observed band size: 99 kDa). Metabotropic Glutamate Receptor 2 Antibody (YA3218) can be used for WB, IHC-P experiment in human, mouse background.
Cytochrome P450 3A4 Antibody (YA3365) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3365), targeting Cytochrome P450 3A4, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). Cytochrome P450 3A4 Antibody (YA3365) can be used for WB, IHC-P, IP experiment in human background.
Myelin Protein Zero Rabbit pAb; peripheral myelin prothein Zero; MPZ; MPP; Myelin P0 protein; CHM; CMT1; CMT1B; DSS; MYELIN GLYCOPROTEIN P-ZERO; MYELIN PROTEIN PERIPHERAL; Myelin protein zero; P0; MYP0_HUMAN.
WB
Rat
MPZ Antibody is a rabbit-derived non-conjugated IgG antibody, targeting MPZ, with a predicted molecular weight of 28 kDa (observed band size: 28 kDa). MPZ Antibody can be used for WB experiments in rat backgrounds.
TERT Antibody is an unconjugated, approximately 125 kDa, rabbit-derived, anti-TERT monoclonal antibody. TERT Antibody can be used for: WB, IHC-P, Flow-Cyt expriments in human background without labeling.
PYCARD; ASC; CARD5; TMS1; Apoptosis-associated speck-like protein containing a CARD; hASC; Caspase recruitment domain-containing protein 5; PYD and CARD domain-containing protein; Target of methylation-induced silencing 1
WB, ICC/IF, FC
Human
TMS1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to TMS1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.
ALDH1A1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to ALDH1A1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.
AMPK alpha 2 Antibody (YA623) is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to AMPK alpha 2. It can be used for WB,IP assays with tag free, in the background of Human, Rat.
Aurora A Antibody (YA827) is a non-conjugated and Mouse origined monoclonal antibody about 46 kDa, targeting to Aurora A (2E3). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.
Cleaved-Caspase 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 45 kDa, targeting to Cleaved-Caspase 1. It can be used for WB,ICC/IF,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse.
AIFM2; AMID; PRG3; Apoptosis-inducing factor 2; Apoptosis-inducing factor homologous mitochondrion-associated inducer of death; Apoptosis-inducing factor-like mitochondrion-associated inducer of death; p53-responsive gene 3 protein
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Monkey
FSP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to FSP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Monkey.
HDAC4 Antibody (YA741) is a non-conjugated and Mouse origined monoclonal antibody about 119 kDa, targeting to HDAC4 (4A3). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat, Monkey.
ARNT; BHLHE2; Aryl hydrocarbon receptor nuclear translocator; ARNT protein; Class E basic helix-loop-helix protein 2; bHLHe2; Dioxin receptor; nuclear translocator; Hypoxia-inducible factor 1-beta; HIF-1-beta; HIF1-beta
WB, IHC-P
Human, Mouse, Rat, Hamster
HIF1 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to HIF1 beta. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat, Hamster.
KDM1A; AOF2; KDM1; KIAA0601; LSD1; Lysine-specific histone demethylase 1A; BRAF35-HDAC complex protein BHC110; Flavin-containing amine oxidase domain-containing protein 2
WB
Human, Mouse, Monkey
KDM1A Antibody (YA718) is a non-conjugated and Mouse origined monoclonal antibody about 93 kDa, targeting to KDM1A (1B2). It can be used for WB assays with tag free, in the background of Human, Mouse, Monkey.
CSDD1; FLJ12457; LIN 28; Lin-28A; LIN28; LIN28A; LN28A_HUMAN; Protein lin-28 homolog A; ZCCHC1; Zinc finger CCHC domain-containing protein 1.
WB
Human, Mouse
LIN28A Antibody (YA711) is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to LIN28A (2C1). It can be used for WB assays with tag free, in the background of Human, Mouse.
PGC1 alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 91 kDa, targeting to PGC1 alpha. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Phospho-AMPK alpha 2 (Thr172) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 62 kDa, targeting to Phospho-AMPK alpha 2 (Thr172). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Phospho-IRE1 (Ser724) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 110 kDa, targeting to Phospho-IRE1 (Ser724). It can be used for WB,IP assays with tag free, in the background of Human.
SREBF1; BHLHD1; SREBP1; Sterol regulatory element-binding protein 1; SREBP-1; Class D basic helix-loop-helix protein 1; bHLHd1; Sterol regulatory element-binding transcription factor 1
WB, ELISA
Human, Mouse, Rat
SREBP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 122 kDa, targeting to SREBP1. It can be used for WB,ELISA assays with tag free, in the background of Human, Mouse, Rat.
ACAN Antibody is an unconjugated, rabbit-derived, anti-ACAN monoclonal antibody. ACAN Antibody can be used for:IHC-P expriments in human background without labeling.
MMP7 Antibody is an unconjugated, approximately 30 kDa, rabbit-derived, anti-MMP7 polyclonal antibody. MMP7 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
SCF Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-SCF monoclonal antibody. SCF Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human background without labeling.
APOA1 Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-APOA1 monoclonal antibody. APOA1 Antibody can be used for: WB,IHC-P,ICC/IF,IP expriments in human, mouse background without labeling.
K1C18_HUMAN; Keratin, type I cytoskeletal 18; KRT18; CYK18; Cell proliferation-inducing gene 46 protein; Cytokeratin-18 (CK-18); Keratin-18 (K18); PIG46; Keratin 18
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat
CK18 Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-CK18 polyclonal antibody. CK18 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit background without labeling.
Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.
ELISA
Human
Ferritin Light Chain Antibody (YA971) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA971), targeting Ferritin Light Chain. Ferritin Light Chain Antibody (YA971) can be used for ELISA experiment in human background.
Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.
ELISA
Human
Ferritin Light Chain Antibody (YA972) is a mouse-derived non-conjugated IgG2a antibody (Clone NO.: YA972), targeting Ferritin Light Chain. Ferritin Light Chain Antibody (YA972) can be used for ELISA experiment in human background.
SHP1 Antibody (YA1044) is a mouse-derived non-conjugated IgG2a antibody (Clone NO.: YA1044), targeting SHP1, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). SHP1 Antibody (YA1044) can be used for WB, IP experiment in human background.
SHP1 Antibody (YA1045) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1045), targeting SHP1, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). SHP1 Antibody (YA1045) can be used for WB, IHC-P experiment in human background.
CD39 Antibody (YA1094) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1094), targeting CD39. CD39 Antibody (YA1094) can be used for IHC-P experiment in human background.
Ionotropic Glutamate Receptor 2 Antibody (YA1143) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1143), targeting Ionotropic Glutamate Receptor 2. Ionotropic Glutamate Receptor 2 Antibody (YA1143) can be used for IHC-P experiment in human background.
VIPR1 Antibody (YA1269) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1269), targeting VIPR1. VIPR1 Antibody (YA1269) can be used for IHC-P experiment in human background.
DPP4/CD26 Antibody (YA1274) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1274), targeting DPP4/CD26. DPP4/CD26 Antibody (YA1274) can be used for IHC-P experiment in human background.
OTUB1 Antibody (YA1483) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1483), targeting OTUB1, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). OTUB1 Antibody (YA1483) can be used for WB, IP experiment in human, mouse, rat background.
NTRK1; MTC; TRK; TRKA; High affinity nerve growth factor receptor; Neurotrophic tyrosine kinase receptor type 1; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor; Tyrosine kinase receptor A
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
Trk A Antibody (YA1489) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1489), targeting Trk A, with a predicted molecular weight of 87 kDa. Trk A Antibody (YA1489) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
CK-15; CK15; cytokeratin15; K15; K1C15; K1CO; keratin 15; Keratin-15; keratin-15; beta; KRT15; KRTB; type I cytoskeletal 15
WB, IHC-P, ICC/IF, FC
Human, Mouse
Cytokeratin 15 Antibody (YA1493) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1493), targeting Cytokeratin 15, with a predicted molecular weight of 49 kDa. Cytokeratin 15 Antibody (YA1493) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse background.
Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1530), targeting Phospho-PAK1/2/3 (Ser144/Ser141/Ser154), with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
MMP17 Antibody (YA1728) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1728), targeting MMP17, with a predicted molecular weight of 67 kDa (observed band size: 58 kDa). MMP17 Antibody (YA1728) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
RENT1 Antibody (YA1858) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1858), targeting RENT1, with a predicted molecular weight of 124 kDa (observed band size: 124 kDa). RENT1 Antibody (YA1858) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
EGR2; KROX20; E3 SUMO-protein ligase EGR2; AT591; E3 SUMO-protein transferase ERG2 Curated; Early growth response protein 2 (EGR-2); Zinc finger protein Krox-20;
WB
Human, Mouse, Rat
EGR2 Antibody (YA1926) is a biotin-conjugated non-conjugated IgG antibody, targeting EGR2, with a predicted molecular weight of 50 kDa (observed band size: 53 kDa). EGR2 Antibody (YA1926) can be used for WB experiment in human, mouse, rat background.
SLC27A4; ACSVL4; FATP4; Long-chain fatty acid transport protein 4; FATP-4; Fatty acid transport protein 4; Solute carrier family 27 member 4
WB, ICC/IF, IP
Human
SLC27A4 Antibody (YA1988) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1988), targeting SLC27A4, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). SLC27A4 Antibody (YA1988) can be used for WB, ICC/IF, IP experiment in human background.
CXCR5 Antibody (YA2106) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2106), targeting CXCR5, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). CXCR5 Antibody (YA2106) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
Cytochrome P450 24A1 Antibody (YA2121) is a biotin-conjugated non-conjugated IgG antibody, targeting Cytochrome P450 24A1, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Cytochrome P450 24A1 Antibody (YA2121) can be used for WB experiment in human background.
CASP10; MCH4; Caspase-10; CASP-10; Apoptotic protease Mch-4; FAS-associated death domain protein interleukin-1B-converting enzyme 2; FLICE2; ICE-like apoptotic protease 4
WB, IHC-P, IP
Human
Caspase 10 Antibody (YA2366) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2366), targeting Caspase 10, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Caspase 10 Antibody (YA2366) can be used for WB, IHC-P, IP experiment in human background.
SHC1; SHC; SHCA; SHC-transforming protein 1; SHC-transforming protein 3; SHC-transforming protein A; Src homology 2 domain-containing-transforming protein C1; SH2 domain protein C1
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
SHC Antibody (YA2394) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2394), targeting SHC, with a predicted molecular weight of 63 kDa (observed band size: 46, 52, 66 kDa). SHC Antibody (YA2394) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
Y14 Antibody (YA2439) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2439), targeting Y14, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). Y14 Antibody (YA2439) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
DDX39B Antibody (YA2470) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2470), targeting DDX39B, with a predicted molecular weight of 49 kDa (observed band size: 45 kDa). DDX39B Antibody (YA2470) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
SLC1A3; EAAT1; GLAST; GLAST1; Excitatory amino acid transporter 1; Sodium-dependent glutamate/aspartate transporter 1; GLAST-1; Solute carrier family 1 member 3
WB, IHC-P
Human, Mouse, Rat
EAAT1 Antibody (YA2479) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2479), targeting EAAT1, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). EAAT1 Antibody (YA2479) can be used for WB, IHC-P experiment in human, mouse, rat background.
CD26 Antibody (YA2511) is a biotin-conjugated non-conjugated IgG antibody, targeting CD26, with a predicted molecular weight of 88 kDa (observed band size: 110 kDa). CD26 Antibody (YA2511) can be used for WB experiment in human, mouse, rat background.
DCI Antibody (YA2658) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2658), targeting DCI, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). DCI Antibody (YA2658) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Cleaved-Caspase 2 Antibody (YA2772) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2772), targeting Cleaved-Caspase 2, with a predicted molecular weight of 51 kDa (observed band size: 48,30,12 kDa). Cleaved-Caspase 2 Antibody (YA2772) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CDC34 Antibody (YA2786) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2786), targeting CDC34, with a predicted molecular weight of 27 kDa (observed band size: 32 kDa). CDC34 Antibody (YA2786) can be used for WB, IP experiment in human, mouse, rat background.
HINT1; HINT; PKCI1; PRKCNH1; Histidine triad nucleotide-binding protein 1; Adenosine 5'-monophosphoramidase; Protein kinase C inhibitor 1; Protein kinase C-interacting protein 1; PKCI-1
WB, ICC/IF, IP
Human
HINT1 Antibody (YA2983) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2983), targeting HINT1, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). HINT1 Antibody (YA2983) can be used for WB, ICC/IF, IP experiment in human background.
NFKBIB; IKBB; TRIP9; NF-kappa-B inhibitor beta; NF-kappa-BIB; I-kappa-B-beta; IkB-B; IkB-beta; IkappaBbeta; Thyroid receptor-interacting protein 9; TR-interacting protein 9; TRIP-9
WB, IHC-P, IP
Human, Mouse
IKB beta Antibody (YA3088) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3088), targeting IKB beta, with a predicted molecular weight of 38 kDa (observed band size: 48 kDa). IKB beta Antibody (YA3088) can be used for WB, IHC-P, IP experiment in human, mouse background.
P2Y12 Antibody (YA3135) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3135), targeting P2Y12, with a predicted molecular weight of 39 kDa (observed band size: 52 kDa). P2Y12 Antibody (YA3135) can be used for WB, IP experiment in human background.
MLK3 Antibody (YA3237) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3237), targeting MLK3, with a predicted molecular weight of 93 kDa (observed band size: 93 kDa). MLK3 Antibody (YA3237) can be used for WB, ICC/IF experiment in human background.
BCL2 adenovirus E1B 19kD interacting protein 1; BNIP1; Nip1; sec20; SEC20L; Transformation-related gene 8 protein; TRG8; Vesicle transport protein SEC20
WB, IHC-P
Human, Mouse, Rat
BNIP1 Antibody (YA3329) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3329), targeting BNIP1, with a predicted molecular weight of 26 kDa (observed band size: 26 kDa). BNIP1 Antibody (YA3329) can be used for WB, IHC-P experiment in human, mouse, rat background.
Prostaglandin E Receptor EP2 Antibody (YA3342) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3342), targeting Prostaglandin E Receptor EP2, with a predicted molecular weight of 40 kDa (observed band size: 52 kDa). Prostaglandin E Receptor EP2 Antibody (YA3342) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat, cow background.
Mata1l1; Metastasis associated gene 1 like 1; Metastasis associated gene family member 2; Mmta2; MTA1L1; p53 target protein in deacetylase complex; PID
WB, IHC-P, ICC/IF, FC
Human
MTA2 Antibody (YA3344) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3344), targeting MTA2, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). MTA2 Antibody (YA3344) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.
Factor H Antibody (YA3361) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3361), targeting Factor H, with a predicted molecular weight of 139 kDa (observed band size: 180 kDa). Factor H Antibody (YA3361) can be used for WB, ICC/IF experiment in human background.
HT-7; CD147; EMMPRIN; AI115436; AI325119; BSG; Basigin; 5F7; EMMPRIN; Leukocyte activation antigen M6; OK blood group antigen; Tumor cell-derived collagenase stimulatory factor; TCSF; CD antigen CD147
WB, IHC-P, IHC-F, ICC/IF
Human
CD147 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to CD147. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
ZO1_HUMAN; Tight junction protein ZO-1; TJP1; ZO1; Tight junction protein 1; Zona occludens protein 1; Zonula occludens protein 1; ZO1 tight junction protein
WB, IHC-P, ICC/IF
Human, Mouse, Rat, Monkey
ZO-1/TJP1 Antibody is an unconjugated, approximately 191 kDa, rabbit-derived, anti-ZO-1/TJP1 monoclonal antibody. ZO-1/TJP1 Antibody can be used for: WB, IF-Cell, IHC-P expriments in Human, Mouse, Rat, Monkey background without labeling.
alpha 1 Sodium Potassium ATPase Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 113 kDa, targeting to alpha 1 Sodium Potassium ATPase. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
AMPK alpha 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to AMPK alpha 1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
AMPK beta 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 30 kDa, targeting to AMPK beta 1. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
CD44 Antibody (YA801) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to CD44 (2H12). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
CDK1; CDC2; CDC28A; CDKN1; P34CDC2; Cyclin-dependent kinase 1; CDK1; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase
WB, IP
Human
CDK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CDK1. It can be used for WB,IP assays with tag free, in the background of Human.
HSPA5; GRP78; 78 kDa glucose-regulated protein; GRP-78; Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78; Heat shock 70 kDa protein 5; Immunoglobulin heavy chain-binding protein; BiP
WB, ICC/IF, IP
Human, Mouse, Rat
GRP78 BiP Antibody (YA746) is a non-conjugated and Mouse origined monoclonal antibody about 72 kDa, targeting to GRP78 BiP (4F11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
IKK beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to IKK beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic tar
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
mTOR Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 289 kDa, targeting to mTOR. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
Phospho-eIF2A (Ser51) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-eIF2A (Ser51). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
Phospho-eIF4E (Ser209) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to Phospho-eIF4E (Ser209). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
CEA Antibody (YA917) is an unconjugated, approximately 150-200 kDa, rabbit-derived, anti-CEA (YA917) monoclonal antibody. CEA Antibody (YA917) can be used for: WB,IHC-P,ICC/IF expriments in human, background without labeling.
CXCR4 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CXCR4 polyclonal antibody. CXCR4 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: cow, rabbit background without labeling.
Choline O acetyltransferase; Choline O acetyltransferase; Acetyl CoA choline O acetyltransferase; Acetyl CoA:choline O acetyltransferase; ChAT; CHOACTase; Choline acetylase; choline acetyltransferase; CMS1A; CMS1A2; EC 2.3.1.6; OTTHUMP00000019583; OTTHUMP00000019584; CLAT_HUMAN.
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
ChAT Antibody is an unconjugated, approximately 82 kDa, rabbit-derived, anti-ChAT monoclonal antibody. ChAT Antibody can be used for: WB,IHC-P,ICC/IF,FC,IPexpriments in human, mouse, rat background without labeling.
SNAI1_HUMAN; Zinc finger protein SNAI1; SNAI1; SNAH; SNAI 1; SNA; SNAIL1; dJ710H13.1; Protein snail homolog 1 (Protein sna); Protein snail homolog 1; Protein sna
WB, IHC-P, ICC/IF, ELISA
Human, Mouse
SNAI1 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-SNAI1 polyclonal antibody. SNAI1 Antibody can be used for: WB,IHC-P,ICC/IF,ELISA expriments in human,and mouse background without labeling.
Scavenger receptor cysteine-rich type 1 protein M130; CD 163; CD163 antigen; CD163 molecule; Hemoglobin Scavenger Receptor; M130; M130 antigen precursor; Macrophage associated antigen; MM130; C163A_HUMAN.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse
CD163 Antibody is an unconjugated, approximately 130 kDa, rabbit-derived, anti-CD163 polyclonal antibody. CD163 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, and predicted: rat, dog, pig, horse background without labeling.
Calcium/calmodulin dependent protein kinase beta; Calcium/calmodulin dependent protein kinase kinase 2; Calcium/calmodulin dependent protein kinase kinase beta; CaM kinase kinase beta; CaM KK beta; CAMKK 2; CAMKK; CaMKK beta; CAMKK beta protein; CAMKKB.
WB, IHC-P, IHC-F, FC,
Human, Mouse, Rat, Sheep
CAMKK2 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CAMKK2 polyclonal antibody. CAMKK2 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, expriments in human, mouse, rat, sheep, and predicted: pig, cow, horse background without labeling.
Osteocalcin Propeptide; Gamma-carboxyglutamic acid-containing protein; Bone Gla-protein; BGLAP; Bone gamma carboxyglutamate protein; BGLAP; BGP; Bone gamma carboxyglutamate gla protein osteocalcin; Bone gamma carboxyglutamate protein; Bone Gla protein; Gamma carboxyglutamic acid containing protein; OC; PMF1; OSTCN_HUMAN.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse
Osteocalcin Antibody is an unconjugated, approximately 11 kDa, rabbit-derived, anti-Osteocalcin polyclonal antibody. Osteocalcin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.
F2 Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting F2, with a predicted molecular weight of 70 kDa (observed band size: 76 kDa). F2 Antibody can be used for WB, IP experiment in human background.
ALB; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.
ELISA
Human
Human Serum Albumin Antibody (YA984) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA984), targeting Human Serum Albumin. Human Serum Albumin Antibody (YA984) can be used for ELISA experiment in human background.
ALB; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.
WB, ELISA
Human
Human Serum Albumin Antibody (YA985) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA985), targeting Human Serum Albumin, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). Human Serum Albumin Antibody (YA985) can be used for WB, ELISA experiment in human background.
ALB; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.
WB, ELISA
Human
Human Serum Albumin Antibody (YA986) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA986), targeting Human Serum Albumin, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). Human Serum Albumin Antibody (YA986) can be used for WB, ELISA experiment in human background.
HNF 4 alpha Antibody (YA1190) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1190), targeting HNF 4 alpha. HNF 4 alpha Antibody (YA1190) can be used for IHC-P experiment in human background.
Nectin 2 Antibody (YA1196) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1196), targeting Nectin 2. Nectin 2 Antibody (YA1196) can be used for IHC-P experiment in human background.
PBK; TOPK; Lymphokine-activated killer T-cell-originated protein kinase; Cancer/testis antigen 84; CT84; MAPKK-like protein kinase; Nori-3; PDZ-binding kinase; Spermatogenesis-related protein kinase; SPK; T-LAK cell-originated protein kinas
IHC-P
Human
PBK Antibody (YA1256) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1256), targeting PBK. PBK Antibody (YA1256) can be used for IHC-P experiment in human background.
LILRB1; ILT2; LIR1 ; MIR7; Leukocyte immunoglobulin-like receptor subfamily B member 1; LIR-1 ; Leukocyte immunoglobulin-like receptor 1; CD85j ; CD85 antigen-like family member J
IHC-P
Human
LILRB1 Antibody (YA1261) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1261), targeting LILRB1. LILRB1 Antibody (YA1261) can be used for IHC-P experiment in human background.
CD22 Antibody (YA1267) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1267), targeting CD22. CD22 Antibody (YA1267) can be used for IHC-P experiment in human background.
SKP2; FBXL1; S-phase kinase-associated protein 2; Cyclin-A/CDK2-associated protein p45; F-box protein Skp2; F-box/LRR-repeat protein 1; p45skp2
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
SKP2 Antibody (YA1332) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1332), targeting SKP2, with a predicted molecular weight of 48 kDa (observed band size: 48 kDa). SKP2 Antibody (YA1332) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
NDUFB9 Antibody (YA1340) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1340), targeting NDUFB9, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). NDUFB9 Antibody (YA1340) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CD244; 2B4; Natural killer cell receptor 2B4; NK cell activation-inducing ligand; NAIL; NK cell type I receptor protein 2B4; NKR2B4; h2B4; CD244
ICC/IF, FC, ELISA
Human
2B4 Antibody (YA1382) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA1382), targeting 2B4. 2B4 Antibody (YA1382) can be used for ICC/IF, FC, ELISA experiment in human background.
VEGFR2 Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting VEGFR2, with a predicted molecular weight of 152 kDa. VEGFR2 Antibody (YA1388) can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA experiment in human, mouse background.
B7-1 Antibody (YA1413) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1413), targeting B7-1. B7-1 Antibody (YA1413) can be used for FC, ELISA experiment in human background.
ALDH1A2; RALDH2; Retinal dehydrogenase 2; RALDH 2; RalDH2; Aldehyde dehydrogenase family 1 member A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II)
WB
Human, Mouse, Rat
ALDH1A2 Antibody (YA1469) is a biotin-conjugated non-conjugated IgG antibody, targeting ALDH1A2, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). ALDH1A2 Antibody (YA1469) can be used for WB experiment in human, mouse, rat background.
CD36 Antibody (YA1538) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1538), targeting CD36, with a predicted molecular weight of 53 kDa (observed band size: 70-100 kDa). CD36 Antibody (YA1538) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Annexin IV Antibody (YA1921) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1921), targeting Annexin IV, with a predicted molecular weight of 36 kDa (observed band size: 30 kDa). Annexin IV Antibody (YA1921) can be used for WB, ICC/IF, FC experiment in human background.
PDGFR beta Antibody (YA1925) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1925), targeting PDGFR beta, with a predicted molecular weight of 124 kDa (observed band size: 190 kDa). PDGFR beta Antibody (YA1925) can be used for WB, IP experiment in human, mouse, rat background.
TEAD1; TCF13; TEF1; Transcriptional enhancer factor TEF-1; NTEF-1; Protein GT-IIC; TEA domain family member 1; TEAD-1; Transcription factor 13; TCF-13
WB, IHC-P, IP
Human, Mouse, Rat
Transcriptional Enhancer Factor TEF 1 Antibody (YA1954) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1954), targeting Transcriptional Enhancer Factor TEF 1, with a predicted molecular weight of 48 kDa (observed band size: 52 kDa). Transcriptional Enhancer Factor TEF 1 Antibody (YA1954) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
FMO3 Antibody (YA1992) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1992), targeting FMO3, with a predicted molecular weight of 60 kDa (observed band size: 56 kDa). FMO3 Antibody (YA1992) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
alpha 1a Adrenergic Receptor Antibody (YA2059) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2059), targeting alpha 1a Adrenergic Receptor, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). alpha 1a Adrenergic Receptor Antibody (YA2059) can be used for WB, IHC-P experiment in rat background.
APE1 Antibody (YA2120) is a biotin-conjugated non-conjugated IgG antibody, targeting APE1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). APE1 Antibody (YA2120) can be used for WB experiment in human, mouse, rat background.
Guanylyl Cyclase beta 1 Antibody (YA2147) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2147), targeting Guanylyl Cyclase beta 1, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). Guanylyl Cyclase beta 1 Antibody (YA2147) can be used for WB, IHC-P experiment in human, mouse, rat background.
ERAP1 Antibody (YA2159) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2159), targeting ERAP1, with a predicted molecular weight of 107 kDa (observed band size: 107 kDa). ERAP1 Antibody (YA2159) can be used for WB, IHC-P experiment in human, rat background.
PIAS1; DDXBP1; E3 SUMO-protein ligase PIAS1; DEAD/H box-binding protein 1; Gu-binding protein; GBP; Protein inhibitor of activated STAT protein 1; RNA helicase II-binding protein
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
PIAS1 Antibody (YA2217) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2217), targeting PIAS1, with a predicted molecular weight of 72 kDa (observed band size: 76 kDa). PIAS1 Antibody (YA2217) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
TGFBI Antibody (YA2268) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2268), targeting TGFBI, with a predicted molecular weight of 75 kDa (observed band size: 68 kDa). TGFBI Antibody (YA2268) can be used for WB, IHC-P experiment in human, mouse, rat background.
Integrin alpha L Antibody (YA2398) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2398), targeting Integrin alpha L, with a predicted molecular weight of 129 kDa (observed band size: 150 kDa). Integrin alpha L Antibody (YA2398) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
G3BP1; G3BP; Ras GTPase-activating protein-binding protein 1; G3BP-1; ATP-dependent DNA helicase VIII; hDH VIII; GAP SH3 domain-binding protein 1
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
G3BP Antibody (YA2432) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2432), targeting G3BP, with a predicted molecular weight of 52 kDa (observed band size: 68 kDa). G3BP Antibody (YA2432) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Phospho-Jun/JunD (Ser73/Ser100) Antibody (YA2606) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2606), targeting Phospho-Jun/JunD (Ser73/Ser100), with a predicted molecular weight of 36 kDa (observed band size: 38,42,48 kDa). Phospho-Jun/JunD (Ser73/Ser100) Antibody (YA2606) can be used for WB, IP experiment in human, mouse, rat background.
Collagen VI alpha 1/2/3 Antibody (YA2637) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2637), targeting Collagen VI alpha 1/2/3, with a predicted molecular weight of 109 kDa (observed band size: 147 kDa). Collagen VI alpha 1/2/3 Antibody (YA2637) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
BUB1B; BUBR1; MAD3L; SSK1; Mitotic checkpoint serine/threonine-protein kinase BUB1 beta; MAD3/BUB1-related protein kinase; hBUBR1; Mitotic checkpoint kinase MAD3L; Protein SSK1
WB, ICC/IF, IP
Human
BUBR1 Antibody (YA2757) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2757), targeting BUBR1, with a predicted molecular weight of 120 kDa (observed band size: 120 kDa). BUBR1 Antibody (YA2757) can be used for WB, ICC/IF, IP experiment in human background.
DAK1; DAP K1; DAP kinase 1; DAPK 1; DAPK; DAPK1; DAPK1_HUMAN; Death Associated Protein Kinase 1; Death-associated protein kinase 1
WB, IHC-P, ICC/IF
Human, Mouse, Rat
DAP Kinase 1 Antibody (YA2798) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2798), targeting DAP Kinase 1, with a predicted molecular weight of 160 kDa (observed band size: 160 kDa). DAP Kinase 1 Antibody (YA2798) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
ACO1; IREB1; Cytoplasmic aconitate hydratase; Aconitase; Citrate hydro-lyase; Ferritin repressor protein; Iron regulatory protein 1; IRP1; Iron-responsive element-binding protein 1; IRE-BP 1
WB, ICC/IF
Human, Mouse, Rat
Aconitase 1 Antibody (YA2850) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2850), targeting Aconitase 1, with a predicted molecular weight of 98 kDa (observed band size: 98 kDa). Aconitase 1 Antibody (YA2850) can be used for WB, ICC/IF experiment in human, mouse, rat background.
HDAC9 Antibody (YA2967) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2967), targeting HDAC9, with a predicted molecular weight of 111 kDa (observed band size: 150 kDa). HDAC9 Antibody (YA2967) can be used for WB, IHC-P experiment in human background.
Junctional Adhesion Molecule 1 Antibody (YA3025) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3025), targeting Junctional Adhesion Molecule 1, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Junctional Adhesion Molecule 1 Antibody (YA3025) can be used for WB, ICC/IF, IP experiment in human background.
MAPKAPK3; MAP kinase-activated protein kinase 3; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAP-K3; MAPKAPK-3; MK-3; Chromosome 3p kinase; 3pK
WB, IP
Human
MAPKAP Kinase 3 Antibody (YA3070) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3070), targeting MAPKAP Kinase 3, with a predicted molecular weight of 43 kDa (observed band size: 43 kDa). MAPKAP Kinase 3 Antibody (YA3070) can be used for WB, IP experiment in human background.
IL-1 receptor-associated kinase 4; Interleukin 1 receptor associated kinase 4 mutant form 1; IPD1; IRAK4; LOC 51135; NY REN 64; REN64
WB, IHC-F, IHC-P, ICC/IF
Human
IRAK4 Antibody (YA3115) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3115), targeting IRAK4, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). IRAK4 Antibody (YA3115) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
GRP75 Antibody (YA3155) is a biotin-conjugated non-conjugated IgG antibody, targeting GRP75, with a predicted molecular weight of 74 kDa. GRP75 Antibody (YA3155) can be used for WB experiment in human, mouse, rat background.
protein tyrosine phosphatase type IVA; member 2; HH13; OV-1; PRL2; HH7-2; PRL-2; PTP4A; HU-PP-1; PTPCAAX2; ptp-IV1a; ptp-IV1b
WB, IP
Human
PTP4A2 Antibody (YA3193) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3193), targeting PTP4A2, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). PTP4A2 Antibody (YA3193) can be used for WB, IP experiment in human background.
Toll-Like Receptor 9; CD289; TLR9; Toll like receptor 9; Toll like receptor 9 isoform A precursor; Toll like receptor 9 isoform B
WB
Human
Toll-Like Receptor 9 Antibody (YA3321) is a biotin-conjugated non-conjugated IgG antibody, targeting Toll-Like Receptor 9, with a predicted molecular weight of 116 kDa (observed band size: 130 kDa). Toll-Like Receptor 9 Antibody (YA3321) can be used for WB experiment in human background.
CD209; CLEC4L; CD209 antigen; C-type lectin domain family 4 member L; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN; DC-SIGN1; CD209
WB
Human
CD209 Antibody (YA3359) is a biotin-conjugated non-conjugated IgG antibody, targeting CD209, with a predicted molecular weight of 46 kDa (observed band size: 50 kDa). CD209 Antibody (YA3359) can be used for WB experiment in human background.
ITGAX Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting ITGAX, with a predicted molecular weight of 128 kDa (observed band size: 140 kDa). ITGAX Antibody can be used for WB, IHC-P, ICC/IF, IP experiment in human background.
CD19 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to CD19. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.
APG 5L; APG5; APG5 autophagy 5 like; APG5 like; APG5-like; Apoptosis specific protein; ASP; ATG 5; ATG5 autophagy related 5 homolog; Autophagy protein 5; hAPG5
WB, ICC/IF, IP
Human, Mouse, Rat
APG5L Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to APG5L. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
ATG4A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to ATG4A. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human .
ATG4C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to ATG4C. It can be used for WB,IHC-P assays with tag free, in the background of Human.
CD9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to CD9. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
HSPD1; HSP60; 60 kDa heat shock protein; mitochondrial; 60 kDa chaperonin; Chaperonin 60; CPN60; Heat shock protein 60; HSP-60; Hsp60; HuCHA60; Mitochondrial matrix protein P1; P60 lymphocyte protein
WB, ICC/IF, IP
Human, Mouse, Rat
Hsp60 Antibody (YA730) is a non-conjugated and Mouse origined monoclonal antibody about 61 kDa, targeting to Hsp60 (6C8). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
p21 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 18 kDa, targeting to p21. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic tar
WB
Human, Mouse, Rat
Phospho-mTOR (Ser2481) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 289 kDa, targeting to Phospho-mTOR (Ser2481). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
USP7 Antibody (YA657) is a non-conjugated and Mouse origined monoclonal antibody about 128 kDa, targeting to USP7 (3E4). It can be used for WB assays with tag free, in the background of Human.
StARD1; Cholesterol trafficker; Luteinizing hormone induced protein; Mitochondrial steroid acute regulatory protein; StAR related lipid transfer (START) domain containing 1; StARD1; START domain containing protein 1; Steroidogenic Acute Regulatory Protein; Steroidogenic acute regulatory protein mitochondrial; STAR_HUMAN.
WB
Human, Mouse
StAR Antibody is an unconjugated, approximately 32 kDa, rabbit-derived, anti-StAR monoclonal antibody. StAR Antibody can be used for: WB expriments in human, mouse background without labeling.
SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1
WB
Human
Syntenin 1 Antibody (YA1050) is a biotin-conjugated non-conjugated IgG2b antibody, targeting Syntenin 1, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Syntenin 1 Antibody (YA1050) can be used for WB experiment in human background.
SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1
WB, IHC-P, ICC/IF, IP, FC
Human
Syntenin 1 Antibody (YA1051) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1051), targeting Syntenin 1, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Syntenin 1 Antibody (YA1051) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
General transcription factor IIB; General transcription factor TFIIB; gtf2b; RNA polymerase II transcription factor IIB; S300 II; S300-II; TF IIB; TF2B; TF2B_HUMAN; TFIIB; Transcription initiation factor IIB.
WB
Human, Mouse, Monkey
Transcription Initiation Factor IIB Antibody (YA1054) is a biotin-conjugated non-conjugated IgG2b antibody, targeting Transcription Initiation Factor IIB, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). Transcription Initiation Factor IIB Antibody (YA1054) can be used for WB experiment in human, mouse, monkey background.
General transcription factor IIB; General transcription factor TFIIB; gtf2b; RNA polymerase II transcription factor IIB; S300 II; S300-II; TF IIB; TF2B; TF2B_HUMAN; TFIIB; Transcription initiation factor IIB.
WB, IP
Human, Mouse, Rat
Transcription Initiation Factor IIB Antibody (YA1055) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1055), targeting Transcription Initiation Factor IIB, with a predicted molecular weight of 35 kDa (observed band size: 31 kDa). Transcription Initiation Factor IIB Antibody (YA1055) can be used for WB, IP experiment in human, mouse, rat background.
JMJD6; KIAA0585; PTDSR; Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6; Histone arginine demethylase JMJD6; JmjC domain-containing protein 6; Jumonji domain-containing protein 6; Lysyl-hydroxylase JMJD6; Peptide-lysine 5-diox
WB, ICC/IF
Human
JMJD6 Antibody (YA1064) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1064), targeting JMJD6, with a predicted molecular weight of 46 kDa (observed band size: 62 kDa). JMJD6 Antibody (YA1064) can be used for WB, ICC/IF experiment in human background.
THO Complex Subunit 1; Death domain containing protein p84N5; HPR1; hTREX84; Nuclear matrix protein p84; p84N5; THO complex 1; Tho1; Thoc1
IHC-P
Human
Nuclear Matrix Protein p84 Antibody (YA1224) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1224), targeting Nuclear Matrix Protein p84. Nuclear Matrix Protein p84 Antibody (YA1224) can be used for IHC-P experiment in human background.
p75 NGF Receptor Antibody (YA1245) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1245), targeting p75 NGF Receptor. p75 NGF Receptor Antibody (YA1245) can be used for IHC-P experiment in human background.
VIP2R; VIPR2; Vasoactive intestinal polypeptide receptor 2; VIP-R-2; Helodermin-preferring VIP receptor; Pituitary adenylate cyclase-activating polypeptide type III receptor (PACAP type III receptor; PACAP-R-3; PACAP-R3); VPAC2
IHC-P
Human
VPAC2 Antibody (YA1271) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1271), targeting VPAC2. VPAC2 Antibody (YA1271) can be used for IHC-P experiment in human background.
CA9 Antibody (YA1368) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1368), targeting CA9. CA9 Antibody (YA1368) can be used for FC, ELISA experiment in human background.
SELP; GMRP; GRMP; P-selectin; CD62 antigen-like family member P; Granule membrane protein 140; GMP-140; Leukocyte-endothelial cell adhesion molecule 3; LECAM3; Platelet activation dependent granule-external membrane protein; PADGEM; CD62P
FC, ELISA
Human
SELP Antibody (YA1482) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1482), targeting SELP. SELP Antibody (YA1482) can be used for FC, ELISA experiment in human background.
IP3 Receptor Antibody (YA1596) is a biotin-conjugated non-conjugated IgG antibody, targeting IP3 Receptor, with a predicted molecular weight of 314 kDa. IP3 Receptor Antibody (YA1596) can be used for WB experiment in human, mouse, rat background.
Activin A Receptor Type IB Antibody (YA1989) is a biotin-conjugated non-conjugated IgG antibody, targeting Activin A Receptor Type IB, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). Activin A Receptor Type IB Antibody (YA1989) can be used for WB experiment in human, mouse, rat background.
CBFB Antibody (YA2006) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2006), targeting CBFB, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). CBFB Antibody (YA2006) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
TNFAIP3; OTUD7C; Tumor necrosis factor alpha-induced protein 3; TNF alpha-induced protein 3; OTU domain-containing protein 7C; Putative DNA-binding protein A20; Zinc finger protein A20
WB, IHC-F, IHC-P, ICC/IF
Human
TNFAIP3 Antibody (YA2231) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2231), targeting TNFAIP3, with a predicted molecular weight of 90 kDa (observed band size: 82 kDa). TNFAIP3 Antibody (YA2231) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Liver Carboxylesterase 1 Antibody (YA2328) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2328), targeting Liver Carboxylesterase 1, with a predicted molecular weight of 63 kDa (observed band size: 55 kDa). Liver Carboxylesterase 1 Antibody (YA2328) can be used for WB, IP, FC experiment in human, mouse, rat background.
Carbonic Anhydrase 9Rabbit mAb Antibody (YA2443) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA2443), targeting Carbonic Anhydrase 9. Carbonic Anhydrase 9 Antibody (YA2443) can be used for WB,IHC-P,FC experiment in human background.
MEKK3 Antibody (YA2633) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2633), targeting MEKK3, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). MEKK3 Antibody (YA2633) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Cytokeratin 1 Antibody (YA2665) is a biotin-conjugated non-conjugated IgG antibody, targeting Cytokeratin 1, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). Cytokeratin 1 Antibody (YA2665) can be used for WB experiment in human, mouse, rat background.
Annexin 4 Antibody (YA2714) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2714), targeting Annexin 4, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Annexin 4 Antibody (YA2714) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat, hamster background.
IL-12 beta Antibody (YA2753) is a biotin-conjugated non-conjugated IgG antibody, targeting IL-12 beta, with a predicted molecular weight of 37 kDa (observed band size: 40 kDa). IL-12 beta Antibody (YA2753) can be used for WB experiment in human background.
AGTR2; Angiotensin ii receptor type 2; Angiotensin II type-2 receptor; AT2 receptor; AT2; At2r; MRX88; Angiotensin ii at2; Angiotensin receptor 2; Type-2 angiotensin II receptor; ATGR2
WB, IP
Human, Mouse, Rat
AGTR2 Antibody (YA3090) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3090), targeting AGTR2, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). AGTR2 Antibody (YA3090) can be used for WB, IP experiment in human, mouse, rat background.
AP-2 complex subunit mu; AP-2 mu chain; Adapter-related protein complex 2 subunit mu; Adaptin-mu2; Clathrin assembly protein complex 2 mu medium chain; Clathrin coat assembly protein AP50
WB
Human, Mouse, Rat
AP2M1 Antibody (YA3106) is a biotin-conjugated non-conjugated IgG antibody, targeting AP2M1, with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). AP2M1 Antibody (YA3106) can be used for WB experiment in human, mouse, rat background.
MEK5 Antibody (YA3140) is a biotin-conjugated non-conjugated IgG antibody, targeting MEK5, with a predicted molecular weight of 50 kDa. MEK5 Antibody (YA3140) can be used for WB, ICC/IF experiment in human background.
FCGR2A; CD32; FCG2; FCGR2A1; IGFR2; Low affinity immunoglobulin gamma Fc region receptor II-a; IgG Fc receptor II-a; CDw32; Fc-gamma RII-a; Fc-gamma-RIIa; FcRII-a; CD32
WB, IHC-P
Human
CD32 Antibody (YA3250) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3250), targeting CD32, with a predicted molecular weight of 35 kDa (observed band size: 43 kDa). CD32 Antibody (YA3250) can be used for WB, IHC-P experiment in human background.
SUMO Conjugating Enzyme UBC9 Antibody (YA3301) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3301), targeting SUMO Conjugating Enzyme UBC9, with a predicted molecular weight of 18 kDa (observed band size: 18 kDa). SUMO Conjugating Enzyme UBC9 Antibody (YA3301) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B; Type-1 angiotensin II receptor; AT1AR; AT1BR; Angiotensin II type-1 receptor; AT1
WB
Human
Angiotensin II Type 1 Receptor Antibody (YA3358) is a biotin-conjugated non-conjugated IgG antibody, targeting Angiotensin II Type 1 Receptor, with a predicted molecular weight of 41 kDa (observed band size: 41 kDa). Angiotensin II Type 1 Receptor Antibody (YA3358) can be used for WB experiment in human background.
Thyroid Transcription Factor 1 Antibody (YA2297) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2297), targeting Thyroid Transcription Factor 1, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). Thyroid Transcription Factor 1 Antibody (YA2297) can be used for WB, ICC/IF experiment in human, hamster background.
Aquaporin 4 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Aquaporin 4, with a predicted molecular weight of 36 kDa (observed band size: 34 kDa). Aquaporin 4 Antibody can be used for WB, IHC-P, IHC-F, FC, ICC/IF experiments in human, mouse, rat, pig, cow, rabbit, sheep backgrounds.
ACDCR1; ADIPO R1; Adiponectin receptor protein 1; ADIPOR 1; ADIPOR1; CGI-45; CGI-45 protein; FLJ25385; PAQR1; Progestin and adipoQ receptor family member I; TESBP1A; ADR1_HUMAN.
ICC/IF, IHC-P, FC
Human, Mouse
Adiponectin receptor protein 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Adiponectin receptor protein 1. It can be used for ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.
14-3-3 protein eta; 1433F_HUMAN; Brain protein 14-3-3; eta isoform; HGNC:12853; Protein AS1; Tyrosine 3/tryptophan 5 monooxygenase activation protein eta polypeptide; YWHA 1; YWHA1; Ywhah.
WB
Human, Mouse, Rat
14-3-3 eta Antibody (YA838) is a non-conjugated and Mouse origined monoclonal antibody about 28 kDa, targeting to 14-3-3 eta (5F2). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
EIF4EBP1; Eukaryotic translation initiation factor 4E-binding protein 1; 4E-BP1; eIF4E-binding protein 1; Phosphorylated heat- and acid-stable protein regulated by insulin 1; PHAS-I
WB, IHC-P, IP
Human, Mouse, Rat, Hamster
4E BP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to 4E BP1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
ASK1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 155 kDa, targeting to ASK1. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse.
CBR1 Antibody (YA810) is a non-conjugated and Mouse origined monoclonal antibody about 30 kDa, targeting to CBR1 (2C9). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
c-Kit Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 110 kDa, targeting to c-Kit. It can be used for WB,IHC-P assays with tag free, in the background of Human.
Cleaved-PARP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to Cleaved-PARP1. It can be used for WB assays with tag free, in the background of Human.
DUSP1; CL100; MKP1; PTPN10; VH1; Dual specificity protein phosphatase 1; Dual specificity protein phosphatase hVH1; Mitogen-activated protein kinase phosphatase 1; MAP kinase phosphatase 1; MKP-1; Protein-tyrosine phosphatase CL100
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
DUSP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 39 kDa, targeting to DUSP1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
alpha pal; alpha palindromic binding protein; Alpha palindromic-binding protein; Alpha-pal; locus control region factor 1; NFE2 related factor 1; NRF-1; Nrf1; NRF1_HUMAN; Nuclear respiratory factor 1; transcription factor 11.
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Nrf1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Nrf1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
p21 Antibody (YA254) is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to p21. It can be used for WB assays with tag free, in the background of Human, Mouse.
PARP1 Antibody (YA245) is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to PARP1. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-AMPK alpha 1 (Ser496) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (Ser496). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-ATF2 (Thr71) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Phospho-ATF2 (Thr71). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
CDK1; CDC2; CDC28A; CDKN1; P34CDC2; Cyclin-dependent kinase 1; CDK1; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase
WB
Human, Mouse, Rat
Phospho-CDK1 (Tyr15) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 34 kDa, targeting to Phospho-CDK1 (Tyr15). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; Serine/threonine-protein kinase mTOR; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic tar
WB, IHC-P
Human, Mouse
Phospho-mTOR (Ser2448) Antibody (YA171) is a non-conjugated and Rabbit origined monoclonal antibody about 289 kDa, targeting to Phospho-mTOR (Ser2448). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.
TNF Receptor 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to TNF Receptor 2. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat.
Calponin 1 Antibody is an unconjugated, approximately 33 kDa, rabbit-derived, anti-Calponin 1 monoclonal antibody. Calponin 1 Antibody can be used for: WB,IHC-P,ICC/IF expriments in human, mouse, rat, and predicted: dog, pig background without labeling.
Myogenic differentiation 1; AI503393; bHLHc1; MD1; MGC156574; MYF3; MYOD; MYOD1; PUM; MYOD1_HUMAN; Class C basic helix-loop-helix protein 1; bHLHc1; Myogenic factor 3; Myf-3.
WB, ELISA
Human, Mouse, Rat, Chicken
MyoD1/Myf3 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-MyoD1/Myf3 polyclonal antibody. MyoD1/Myf3 Antibody can be used for: WB, ELISA expriments in human, mouse, rat, and chicken background without labeling.
Adhesion related kinase; AI323647; Ark; Axl; AXL oncogene; AXL receptor tyrosine kinase; AXL transforming gene; AXL transforming sequence/gene; EC 2.7.10.1; JTK11; Oncogene AXL; Tyro7; Tyrosine protein kinase receptor UFO; Tyrosine-protein kinase receptor UFO; UFO; UFO_HUMAN.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse
AXL Antibody is an unconjugated, approximately 95 kDa, rabbit-derived, anti-AXL polyclonal antibody. AXL Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, horse, rabbit background without labeling.
FLJ36922; FLJ55954; OTTHUMP00000165834; PP-T; PP5; PPP5; PPP5_HUMAN; PPP5C; PPT; Protein phosphatase 5; catalytic subunit; Protein phosphatase T; Serine/threonine protein phosphatase 5; Serine/threonine-protein phosphatase 5.
WB
Human
PPP5C Antibody (YA1069) is a biotin-conjugated non-conjugated IgG2a antibody, targeting PPP5C, with a predicted molecular weight of 57 kDa (observed band size: 57 kDa). PPP5C Antibody (YA1069) can be used for WB experiment in human background.
4-bisphosphate 4-phosphatase; Inositol polyphosphate 4 phosphatase type II 105kDa; Inositol polyphosphate 4-phosphatase type II; Inpp4b; MGC132014; Type II inositol 3; 4 bisphosphate 4 phosphatase; Type II inositol-3
IHC-P
Human
INPP4B Antibody (YA1236) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1236), targeting INPP4B. INPP4B Antibody (YA1236) can be used for IHC-P experiment in human background.
VISTA Antibody (YA1276) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1276), targeting VISTA. VISTA Antibody (YA1276) can be used for IHC-P experiment in human background.
TROP2 Antibody (YA1496) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA1496), targeting TROP2. TROP2 Antibody (YA1496) can be used for WB,IHC-P,FC,ELISA experiment in human background.
SHP2 Antibody (YA1643) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1643), targeting SHP2, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). SHP2 Antibody (YA1643) can be used for WB, IHC-P, IP experiment in human background.
DKC1; NOLA4; H/ACA ribonucleoprotein complex subunit 4; CBF5 homolog; Dyskerin; Nopp140-associated protein of 57 kDa; Nucleolar protein NAP57; Nucleolar protein family A member 4; snoRNP protein DKC1
WB, IHC-P, ICC/IF
Human, Mouse, Rat
DKC1 Antibody (YA1750) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1750), targeting DKC1, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). DKC1 Antibody (YA1750) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Phospho-Glutamate Receptor 1 (AMPA Subtype) (Ser845) Antibody (YA2081) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-Glutamate Receptor 1 (AMPA Subtype) (Ser845), with a predicted molecular weight of 102 kDa (observed band size: 102 kDa). Phospho-Glutamate Receptor 1 (AMPA Subtype) (Ser845) Antibody (YA2081) can be used for WB experiment in human, rat background.
AP-2 complex subunit mu; AP-2 mu chain; Adapter-related protein complex 2 subunit mu; Adaptin-mu2; Clathrin assembly protein complex 2 mu medium chain; Clathrin coat assembly protein AP50
WB
Human
Phospho-AP2M1 (Thr156) Antibody (YA2113) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-AP2M1 (Thr156), with a predicted molecular weight of 50 kDa (observed band size: 50 kDa). Phospho-AP2M1 (Thr156) Antibody (YA2113) can be used for WB experiment in human background.
TROP2 Antibody (YA2130) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2130), targeting TROP2, with a predicted molecular weight of 36 kDa (observed band size: 45-65 kDa). TROP2 Antibody (YA2130) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
SORL1; C11orf32; Sortilin-related receptor; Low-density lipoprotein receptor relative with 11 ligand-binding repeats; LDLR relative with 11 ligand-binding repeats; LR11; SorLA-1; Sorting protein-related receptor containing LDLR class A repe
WB, IHC-P
Human, Mouse, Rat
SorLA Antibody (YA2310) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2310), targeting SorLA, with a predicted molecular weight of 248 kDa (observed band size: 270 kDa). SorLA Antibody (YA2310) can be used for WB, IHC-P experiment in human, mouse, rat background.
CAMK2B; CAM2; CAMK2; CAMKB; Calcium/calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta; CAMK2G; CAMK; CAMK-II; CAMKG; Calcium/calmodulin-dependent protein kinase type II subunit gamma
WB
Mouse
CaMKII beta Antibody (YA2344) is a biotin-conjugated non-conjugated IgG antibody, targeting CaMKII beta, with a predicted molecular weight of 73 kDa (observed band size: 54 kDa). CaMKII beta Antibody (YA2344) can be used for WB experiment in mouse background.
GABA B Receptor 1 Antibody (YA2418) is a biotin-conjugated non-conjugated IgG antibody, targeting GABA B Receptor 1, with a predicted molecular weight of 108 kDa (observed band size: 108 kDa). GABA B Receptor 1 Antibody (YA2418) can be used for WB experiment in human, mouse, rat background.
Cyclooxygenase 1 Antibody (YA2537) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2537), targeting Cyclooxygenase 1, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). Cyclooxygenase 1 Antibody (YA2537) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
STXBP1; UNC18A; Syntaxin-binding protein 1; MUNC18-1; N-Sec1; Protein unc-18 homolog 1; Unc18-1; Protein unc-18 homolog A; Unc-18A; p67
WB, IHC-P, ICC/IF
Human, Mouse, Rat
Syntaxin Binding Protein 1 Antibody (YA2620) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2620), targeting Syntaxin Binding Protein 1, with a predicted molecular weight of 68 kDa (observed band size: 65 kDa). Syntaxin Binding Protein 1 Antibody (YA2620) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Phospho-PDGFR beta (Tyr740) Antibody (YA3062) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3062), targeting Phospho-PDGFR beta (Tyr740), with a predicted molecular weight of 124 kDa (observed band size: 190 kDa). Phospho-PDGFR beta (Tyr740) Antibody (YA3062) can be used for WB, ICC/IF experiment in mouse, rat background.
IGFBP7 Antibody (YA3079) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3079), targeting IGFBP7, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). IGFBP7 Antibody (YA3079) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
MUC1; PUM; Mucin-1; MUC-1; Breast carcinoma-associated antigen DF3; Carcinoma-associated mucin; Episialin; H23AG; Krebs von den Lungen-6; KL-6; PEMT; Peanut-reactive urinary mucin; PUM; Polymorphic epithelial mucin; PEM; Tumor-associated ep
WB, IHC-P, ICC/IF, IP, FC
Human
Mucin 1 Antibody (YA3086) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3086), targeting Mucin 1, with a predicted molecular weight of 122 kDa (observed band size: 18-25 kDa). Mucin 1 Antibody (YA3086) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human background.
BAD; BBC6; BCL2L8; Bcl2 antagonist of cell death; BAD; Bcl-2-binding component 6; Bcl-2-like protein 8; Bcl2-L-8; Bcl-XL/Bcl-2-associated death promoter
WB, IP
Human, Mouse, Rat
Phospho-Bad (Ser112) Antibody (YA3099) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3099), targeting Phospho-Bad (Ser112), with a predicted molecular weight of 18 kDa (observed band size: 23 kDa). Phospho-Bad (Ser112) Antibody (YA3099) can be used for WB, IP experiment in human, mouse, rat background.
FA D2; FA4; FAC D2; FACD 2; FACD; FACD2; FAD; FAD2; FANCD 2; FANCD; FANCD2; Fanconi anemia group D2 protein; FLJ23826; Protein FACD2; Type 4 Fanconi pancytopenia
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
FANCD2 Antibody (YA3102) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3102), targeting FANCD2, with a predicted molecular weight of 164 kDa (observed band size: 164 kDa). FANCD2 Antibody (YA3102) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
SUZ12; CHET9; JJAZ1; KIAA0160; Polycomb protein SUZ12; Chromatin precipitated E2F target 9 protein; ChET 9 protein; Joined to JAZF1 protein; Suppressor of zeste 12 protein homolog
WB, ICC/IF, IP
Human, Mouse, Rat
Polycomb Protein SUZ12 Antibody (YA3185) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3185), targeting Polycomb Protein SUZ12, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). Polycomb Protein SUZ12 Antibody (YA3185) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
SDF1 Antibody (YA3188) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3188), targeting SDF1, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). SDF1 Antibody (YA3188) can be used for WB, ICC/IF experiment in human background.
SELP; GMRP; GRMP; P-selectin; CD62 antigen-like family member P; Granule membrane protein 140; GMP-140; Leukocyte-endothelial cell adhesion molecule 3; LECAM3; Platelet activation dependent granule-external membrane protein; PADGEM; CD62P
WB, IHC-P
Human
CD62P Antibody (YA3274) is a biotin-conjugated non-conjugated IgG antibody, targeting CD62P, with a predicted molecular weight of 91 kDa. CD62P Antibody (YA3274) can be used for WB, IHC-P experiment in human background.
Alpha-2-Macroglobulin; A2m; Alpha 2M; Alpha-2-macroglobulin; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5; CPAMD5; FWP007; S863 7
WB, IHC-P
Human
Alpha-2-Macroglobulin Antibody (YA3305) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3305), targeting Alpha-2-Macroglobulin, with a predicted molecular weight of 163 kDa (observed band size: 163 kDa). Alpha-2-Macroglobulin Antibody (YA3305) can be used for WB, IHC-P experiment in human background.
ATG4C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to ATG4C. It can be used for WB,IP assays with tag free, in the background of Human,Rat,Mouse.
Cleaved-Caspase 8 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to Cleaved-Caspase 8. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
DNM1L; DLP1; DRP1; Dynamin-1-like protein; Dnm1p/Vps1p-like protein; DVLP; Dynamin family member proline-rich carboxyl-terminal domain less; Dymple; Dynamin-like protein; Dynamin-like protein 4; Dynamin-like protein IV; HdynIV; Dynamin-rela
WB, IHC-P
Human, Mouse, Rat
DRP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 82 kDa, targeting to DRP1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
EpCAM Antibody (YA458) is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to EpCAM. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
Endothelial Kruppel like zinc finger protein; Epithelial zinc finger protein EZF; EZF; GKLF; Gut-enriched krueppel-like factor; KLF; KLF4; KLF4_HUMAN; Krueppel-like factor 4; Kruppel like factor 4; Epithelial zinc finger protein EZF; Gut enriched Krueppel
WB
Human, Mouse, Rat
KLF4 Antibody (YA716) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to KLF4 (3B3). It can be used for WB assays with tag free, in the background of Transfected.
LC3A/B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 14 kDa, targeting to LC3A/B. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
EIF4EBP1; Eukaryotic translation initiation factor 4E-binding protein 1; 4E-BP1; eIF4E-binding protein 1; Phosphorylated heat- and acid-stable protein regulated by insulin 1; PHAS-I
WB, IHC-P, IP
Human, Mouse, Rat
Phospho-4E BP1 (Thr46) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to Phospho-4E BP1 (Thr46). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.
PPAR gamma Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 58 kDa, targeting to PPAR gamma. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.
ANM 1; ANM1; ANM1_HUMAN; complete CDs; HCP 1; HCP1; Heterogeneous nuclear ribonucleoprotein methyltransferase 1 like 2; Heterogeneous nuclear ribonucleoproteins methyltransferase like 2; Heterogeneous nuclear ribonucleoproteins methyltransferase like2; Hi
WB
Human
PRMT1 Antibody (YA686) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to PRMT1 (4E9). It can be used for WB assays with tag free, in the background of Human.
PYK2 Antibody (YA682) is a non-conjugated and Mouse origined monoclonal antibody about 116 kDa, targeting to PYK2 (4B4). It can be used for WB,IHC-P assays with tag free, in the background of Human.
POLR2A; POLR2; DNA-directed RNA polymerase II subunit RPB1; RNA polymerase II subunit B1; DNA-directed RNA polymerase II subunit A; DNA-directed RNA polymerase III largest subunit; RNA-directed RNA polymerase II subunit RPB1
WB, IHC-F, IHC-P, ICC/IF, IP
Human
RNA Polymerase II Subunit B1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 217 kDa, targeting to RNA Polymerase II Subunit B1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.
Nrf2 Antibody(YA895) is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Nrf2(YA895) monoclonal antibody. Nrf2 Antibody(YA895) can be used for: WB, IHC-P, ICC/IF, IP, ChIP expriments in human, mouse background without labeling.
CPT1A Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CPT1A polyclonal antibody. CPT1A Antibody can be used for: WB, ELISA expriments in mouse, and predicted: human, rat background without labeling.
C5b-9 Antibody is an unconjugated, rabbit-derived, anti-C5b-9 polyclonal antibody. C5b-9 Antibody can be used for: WB, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse background without labeling.
BRICD4; BRICHOS domain containing 4; CHM1 LIKE; CHM1L; Chondromodulin I like; Chondromodulin I like protein; Chondromodulin-1-like protein; Chondromodulin-I-like protein; hChM1L; hTeM; Myodulin; TEM; Tendin; Tenomodulin; Tenomodulin protein; TNMD; TNMD_HUMAN; UNQ771/PRO1565.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
TNMD Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-TNMD polyclonal antibody. TNMD Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.
Cytokeratin pan Antibody (YA953) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Cytokeratin pan, with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). Cytokeratin pan Antibody (YA953) can be used for WB experiment in human, mouse, rat background.
Cytokeratin pan Antibody (YA954) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA954), targeting Cytokeratin pan. Cytokeratin pan Antibody (YA954) can be used for IHC-P, ICC/IF experiment in human background.
SUMO2; HSMT3; SMT3 homolog 2; SMT3A; Sentrin 2; Smt3B; SMT3H2; SUMO-2; SUMO-3; Sentrin-2; Ubiquitin-like protein SMT3A; Ubiquitin-like protein SMT3B
WB
Human
SUMO2/3 Antibody (YA1048) is a biotin-conjugated non-conjugated IgG2b antibody, targeting SUMO2/3, with a predicted molecular weight of 11 kDa. SUMO2/3 Antibody (YA1048) can be used for WB experiment in human background.
SUMO2; HSMT3; SMT3 homolog 2; SMT3A; Sentrin 2; Smt3B; SMT3H2; SUMO-2; SUMO-3; Sentrin-2; Ubiquitin-like protein SMT3A; Ubiquitin-like protein SMT3B
WB, IHC-P, ICC/IF
Human, Mouse, Rat
SUMO2/3 Antibody (YA1049) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1049), targeting SUMO2/3, with a predicted molecular weight of 11 kDa (observed band size: 16 kDa). SUMO2/3 Antibody (YA1049) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
p150 CAF1 Antibody (YA1488) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1488), targeting p150 CAF1, with a predicted molecular weight of 107 kDa (observed band size: 150 kDa). p150 CAF1 Antibody (YA1488) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
RCHY1; ARNIP; CHIMP; PIRH2; RNF199; ZNF363; RING finger and CHY zinc finger domain-containing protein 1; Androgen receptor N-terminal-interacting protein; CH-rich-interacting match with PLAG1; E3 ubiquitin-protein ligase Pirh2; RING finger
WB
Human
Pirh2 Antibody (YA1743) is a biotin-conjugated non-conjugated IgG antibody, targeting Pirh2, with a predicted molecular weight of 30 kDa (observed band size: 30 kDa). Pirh2 Antibody (YA1743) can be used for WB experiment in human background.
Syntaxin 1B Antibody (YA1840) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1840), targeting Syntaxin 1B, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). Syntaxin 1B Antibody (YA1840) can be used for WB, IP experiment in human, mouse, rat background.
Transcription Factor 7 Like 2 Antibody (YA2167) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2167), targeting Transcription Factor 7 Like 2, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). Transcription Factor 7 Like 2 Antibody (YA2167) can be used for WB, IHC-P, IP experiment in human background.
WNK1; HSN2; KDP; KIAA0344; PRKWNK1; Serine/threonine-protein kinase WNK1; Erythrocyte 65 kDa protein; p65; Kinase deficient protein; Protein kinase lysine-deficient 1; Protein kinase with no lysine 1; hWNK1
WB, IHC-P
Human, Mouse, Rat
WNK1 Antibody (YA2213) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2213), targeting WNK1, with a predicted molecular weight of 251 kDa (observed band size: 251 kDa). WNK1 Antibody (YA2213) can be used for WB, IHC-P experiment in human, mouse, rat background.
SF3B1; SAP155; Splicing factor 3B subunit 1; Pre-mRNA-splicing factor SF3b 155 kDa subunit; SF3b155; Spliceosome-associated protein 155; SAP 155
WB, IHC-P, ICC/IF, FC
Human, Mouse, Rat
SF3B1 Antibody (YA2256) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2256), targeting SF3B1, with a predicted molecular weight of 146 kDa (observed band size: 155 kDa). SF3B1 Antibody (YA2256) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
EDG3 Antibody (YA2359) is a biotin-conjugated non-conjugated IgG antibody, targeting EDG3, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). EDG3 Antibody (YA2359) can be used for WB experiment in human, mouse, rat background.
SLC1A1; EAAC1; EAAT3; Excitatory amino acid transporter 3; Excitatory amino-acid carrier 1; Neuronal and epithelial glutamate transporter; Sodium-dependent glutamate/aspartate transporter 3; Solute carrier family 1 member 1
WB, IHC-P, ICC/IF
Human, Mouse, Rat
EAAT3 Antibody (YA2365) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2365), targeting EAAT3, with a predicted molecular weight of 57 kDa (observed band size: 70 kDa). EAAT3 Antibody (YA2365) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
ATG4B Antibody (YA2468) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2468), targeting ATG4B, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). ATG4B Antibody (YA2468) can be used for WB, FC experiment in human, mouse, rat background.
HSPB8; CRYAC; E2IG1; HSP22; PP1629; Heat shock protein beta-8; HspB8; Alpha-crystallin C chain; E2-induced gene 1 protein; Protein kinase H11; Small stress protein-like protein HSP22
WB, IHC-P, ICC/IF
Human, Mouse, Rat
HspB8 Antibody (YA2617) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2617), targeting HspB8, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). HspB8 Antibody (YA2617) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
Ephrin Receptor B3 Antibody (YA2877) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2877), targeting Ephrin Receptor B3, with a predicted molecular weight of 110 kDa (observed band size: 110 kDa). Ephrin Receptor B3 Antibody (YA2877) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
JNK3 Antibody (YA3150) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3150), targeting JNK3, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). JNK3 Antibody (YA3150) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.
HTR2C Antibody (YA3364) is a biotin-conjugated non-conjugated IgG antibody, targeting HTR2C, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). HTR2C Antibody (YA3364) can be used for WB experiment in human, mouse, rat background.
Phospho-Nrf2 (Ser40) Antibody (YA168) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-Nrf2(S40). It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
KIF11; EG5; KNSL1; TRIP5; Kinesin-like protein KIF11; Kinesin-like protein 1; Kinesin-like spindle protein HKSP; Kinesin-related motor protein Eg5; Thyroid receptor-interacting protein 5; TR-interacting protein 5; TRIP-5
WB, ICC/IF, IP
Human
Eg5 Antibody (YA776) is a non-conjugated and Mouse origined monoclonal antibody about 119 kDa, targeting to Eg5 (4H3). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.
Hsp27 Antibody (YA732) is a non-conjugated and Mouse origined monoclonal antibody about 23 kDa, targeting to Hsp27 (7E5). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.
DNAJB1; DNAJ1; HDJ1; HSPF1; DnaJ homolog subfamily B member 1; DnaJ protein homolog 1; Heat shock 40 kDa protein 1; HSP40; Heat shock protein 40; Human DnaJ protein 1; hDj-1
WB
Human
Hsp40 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 38 kDa, targeting to Hsp40. It can be used for WB assays with tag free, in the background of Human.
p38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to p38. It can be used for WB,IP assays with tag free, in the background of Human.
Phospho-ASK1 (Ser966) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 155 kDa, targeting to Phospho-ASK1 (Ser966). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
RPS6KA5; MSK1; Ribosomal protein S6 kinase alpha-5; S6K-alpha-5; 90 kDa ribosomal protein S6 kinase 5; Nuclear mitogen- and stress-activated protein kinase 1; RSK-like protein kinase; RSKL
WB, ICC/IF, IP
Human, Mouse, Rat, Hamster
Phospho-MSK1 (Ser360) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 90 kDa, targeting to Phospho-MSK1 (Ser360). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
RPS6KA5; MSK1; Ribosomal protein S6 kinase alpha-5; S6K-alpha-5; 90 kDa ribosomal protein S6 kinase 5; Nuclear mitogen- and stress-activated protein kinase 1; RSK-like protein kinase; RSKL
WB, IHC-P, IP
Human, Rat
Phospho-MSK1 (Ser376) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 90 kDa, targeting to Phospho-MSK1 (Ser376). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.
Phospho-Nrf2 (Ser40) Antibody (YA169) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-Nrf2 (Ser40). It can be used for WB,IHC-P assays with tag free, in the background of Human.
SMAD3; MADH3; Mothers against decapentaplegic homolog 3; MAD homolog 3; Mad3; Mothers against DPP homolog 3; hMAD-3; JV15-2; SMAD family member 3; SMAD 3; Smad3; hSMAD3
WB, IHC-P, ICC/IF
Human, Mouse
Phospho-Smad3 (Ser423/425) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Phospho-Smad3 (Ser423/425). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.
PI3 Kinase p55 gamma Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to PI3 Kinase p55 gamma. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
PKM2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 58 kDa, targeting to PKM2. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.
YBX1; NSEP1; YB1; Nuclease-sensitive element-binding protein 1; CCAAT-binding transcription factor I subunit A; CBF-A; DNA-binding protein B; DBPB; Enhancer factor I subunit A; EFI-A; Y-box transcription factor; Y-box-binding protein 1; YB-
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
YB1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to YB1. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
MAP4K4/NIK Antibody (YA1123) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1123), targeting MAP4K4/NIK. MAP4K4/NIK Antibody (YA1123) can be used for IHC-P experiment in human background.
Laminin gamma 1 Antibody (YA1255) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1255), targeting Laminin gamma 1. Laminin gamma 1 Antibody (YA1255) can be used for IHC-P experiment in human background.
SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP; Tyrosine-protein phosphatase non-receptor type substrate 1; SHP substrate 1; SHPS-1; Brain Ig-like molecule with tyrosine-based activation motifs; Bit; CD172 antigen-like family member A; Inhibito
WB, FC
Human
SIRP alpha Antibody (YA1361) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1361), targeting SIRP alpha. SIRP alpha Antibody (YA1361) can be used for FC,WB experiment in human background.
POU2F2; OCT2; OTF2; POU domain; class 2; transcription factor 2; Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2; Octamer-binding protein 2; Oct-2; Octamer-binding transcription factor 2; OTF-2
WB, ICC/IF, IP, FC
Human, Mouse, Rat
Oct-2 Antibody (YA1527) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1527), with a predicted molecular weight of 51 kDa (observed band size: 58 kDa). Oct-2 Antibody (YA1527) can be used for WB, ICC/IF, IP, FC experiment in human, mouse, rat background.
POMC Antibody (YA1619) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1619), targeting POMC, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). POMC Antibody (YA1619) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
PTN Antibody (YA1773) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1773), targeting PTN, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). PTN Antibody (YA1773) can be used for WB, IP experiment in human, rat background.
TRIM25; EFP; RNF147; ZNF147; E3 ubiquitin/ISG15 ligase TRIM25; Estrogen-responsive finger protein; RING finger protein 147; Tripartite motif-containing protein 25; Ubiquitin/ISG15-conjugating enzyme TRIM25; Zinc finger protein 147
WB, ICC/IF, IP
Human, Rat
TRIM25 Antibody (YA2278) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2278), targeting TRIM25, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). TRIM25 Antibody (YA2278) can be used for WB, ICC/IF, IP experiment in human, rat background.
BLNK; BASH; SLP65; B-cell linker protein; B-cell adapter containing a SH2 domain protein; B-cell adapter containing a Src homology 2 domain protein; Cytoplasmic adapter protein; Src homology 2 domain-containing leukocyte protein of 65 kDa
WB, IP
Human, Mouse, Rat
BLNK Antibody (YA2282) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2282), targeting BLNK, with a predicted molecular weight of 50 kDa (observed band size: 70 kDa). BLNK Antibody (YA2282) can be used for WB, IP experiment in human, mouse, rat background.
ACTL6A; BAF53; BAF53A; INO80K; Actin-like protein 6A; 53 kDa BRG1-associated factor A; Actin-related protein Baf53a; ArpNbeta; BRG1-associated factor 53A; BAF53A; INO80 complex subunit K
WB, ICC/IF, IP
Human
ACTL6A Antibody (YA2684) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2684), targeting ACTL6A, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). ACTL6A Antibody (YA2684) can be used for WB, ICC/IF, IP experiment in human background.
ANXA2; ANX2; ANX2L4; CAL1H; LPC2D; Annexin A2; Annexin II; Annexin-2; Calpactin I heavy chain; Calpactin-1 heavy chain; Chromobindin-8; Lipocortin II; Placental anticoagulant protein IV; PAP-IV; Protein I; p36
WB, IP
Human
Annexin 2 Antibody (YA2711) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2711), targeting Annexin 2, with a predicted molecular weight of 39 kDa (observed band size: 39 kDa). Annexin 2 Antibody (YA2711) can be used for WB, IP experiment in human background.
TRAF4; CART1; MLN62; RNF83; TNF receptor-associated factor 4; Cysteine-rich domain associated with RING and Traf domains protein 1; Metastatic lymph node gene 62 protein; MLN 62; RING finger protein 83
WB, ICC/IF, FC
Human, Mouse
TRAF4 Antibody (YA2808) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2808), targeting TRAF4, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). TRAF4 Antibody (YA2808) can be used for WB, ICC/IF, FC experiment in human, mouse background.
Int 1 related protein; INT1L 1; INT1L1; IRP; IRP protein; ONCOGENE INT1 LIKE 1; Protein Wnt-2; Secreted growth factor; Wingless type MMTV integration site family member 2; WNT2
WB
Human, Mouse, Rat
Wnt2 Antibody (YA2973) is a biotin-conjugated non-conjugated IgG antibody, targeting Wnt2, with a predicted molecular weight of 40 kDa (observed band size: 34 kDa). Wnt2 Antibody (YA2973) can be used for WB experiment in human, mouse, rat background.
MEK2 Antibody (YA3059) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3059), targeting MEK2, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). MEK2 Antibody (YA3059) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse background.
ATG9A; APG9-like 1; Autophagy 9-like 1 protein; Autophagy-related protein 9A; MGD3208; MATG9; APG9 autophagy 9-like 1; APG9L1; Autophagy related 9A
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat
ATG9A Antibody (YA3081) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3081), targeting ATG9A, with a predicted molecular weight of 94 kDa. ATG9A Antibody (YA3081) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
GTF2I; BAP135; WBSCR6; General transcription factor II-I; GTFII-I; TFII-I; Bruton tyrosine kinase-associated protein 135; BAP-135; BTK-associated protein 135; SRF-Phox1-interacting protein; SPIN; Williams-Beuren syndrome chromosomal region
WB, IHC-F, IHC-P, ICC/IF
Human
General Transcription Factor II I Antibody (YA3268) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3268), targeting General Transcription Factor II I, with a predicted molecular weight of 112 kDa (observed band size: 135/138 kDa). General Transcription Factor II I Antibody (YA3268) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
DDR2; NTRKR3; TKT; TYRO10; Discoidin domain-containing receptor 2; Discoidin domain receptor 2; CD167 antigen-like family member B; Discoidin domain-containing receptor tyrosine kinase 2; Neurotrophic tyrosine kinase; receptor-related 3; Re
WB
Human, Mouse, Rat
DDR2 Antibody (YA3367) is a biotin-conjugated non-conjugated IgG antibody, targeting DDR2, with a predicted molecular weight of 97 kDa (observed band size: 97 kDa). DDR2 Antibody (YA3367) can be used for WB experiment in human, mouse, rat background.
Metalloproteinase inhibitor 2 precursor; Tissue inhibitor of metalloproteinases 2; Collagenase inhibitor; CSC 21K; CSC21K; TIMP2; TIMP 2; TIMP 2; TIMP metallopeptidase inhibitor 2; TIMP2_HUMAN; Metalloproteinase inhibitor 2; CSC-21K; TIMP-2.
WB, IHC-P, FC
Human
TIMP2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to TIMP2. It can be used for WB, IHC-P,Flow-Cytassays with tag free, in the background of Human.
High temperature requirement protein A2; HTRA 2; HtrA like serine protease; HtrA serine peptidase 2; HtrA; E. coli; homolog of; 2; HtrA2; HTRA2_HUMAN; mitochondrial; Omi stress regulated endoprotease; Omi stress-regulated endoprotease; PARK 13; PARK13; Pr
WB, IP
Human
HtrA2 Antibody (YA726) is a non-conjugated and Mouse origined monoclonal antibody about 49 kDa, targeting to HtrA2 (8G11). It can be used for WB,IP assays with tag free, in the background of Human.
NF-KB p100 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to NF-KB p100. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
p38 Antibody (YA696) is a non-conjugated and Mouse origined monoclonal antibody about 41 kDa, targeting to p38 (5A1). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Phospho-FAK (Tyr576) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to Phospho-FAK (Tyr576). It can be used for WB assays with tag free, in the background of Human, Mouse.
Phospho-Hsp27 (Ser78) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 23 kDa, targeting to Phospho-Hsp27 (Ser78). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.
Phospho-Hsp27 (Ser82) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 23 kDa, targeting to Phospho-Hsp27 (Ser82). It can be used for WB,IHC-P assays with tag free, in the background of Human.
Phospho-MEK1 (Ser298) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Phospho-MEK1 (Ser298). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Phospho-MEK1 (Thr292) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Phospho-MEK1 (Thr292). It can be used for WB assays with tag free, in the background of Mouse, Rat.
Thioredoxin Reductase 2 Antibody (YA661) is a non-conjugated and Mouse origined monoclonal antibody about 57 kDa, targeting to Thioredoxin Reductase 2 (3F2). It can be used for WB assays with tag free, in the background of Human.
OPGL; CD254; hRANKL2; ODF; OPGL; Osteoclast differentiation factor; Osteoprotegerin ligand; RANKL; Receptor activator of nuclear factor kappa B ligand; sOdf; SOFA; TNF related activation induced cytokine; TNFSF 11; TNFSF11; TRANCE; Tumor necrosis factor ligand superfamily member 11; Osteoprotegerin Ligand; TNF11_HUMAN.
WB, IHC-P, ELISA
Human, Mouse, Rat
RANKL/CD254 Antibody is an unconjugated, approximately 35 kDa, rabbit-derived, anti-RANKL/CD254 polyclonal antibody. RANKL/CD254 Antibody can be used for: WB, IHC-P, ELISA expriments in human, mouse, rat background without labeling.
CD11c Antibody is an unconjugated, approximately 126 kDa, rabbit-derived, anti-CD11c polyclonal antibody. CD11c Antibody can be used for: ELISA, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, dog background without labeling.
EIF2AK2; PKR; PRKR; Interferon-induced; double-stranded RNA-activated protein kinase; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2; Interferon-inducible RNA-dependent protein kinase; P1/eIF-2A protein k
WB
Human
Phospho-PKR (Thr451) Antibody (YA1025) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-PKR (Thr451), with a predicted molecular weight of 62 kDa (observed band size: 74 kDa). Phospho-PKR (Thr451) Antibody (YA1025) can be used for WB experiment in human background.
EIF2AK2; PKR; PRKR; Interferon-induced; double-stranded RNA-activated protein kinase; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2; Interferon-inducible RNA-dependent protein kinase; P1/eIF-2A protein k
WB, IHC-P, IP, ChIP
Human
Phospho-PKR (Thr446) Antibody (YA1026) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1026), targeting Phospho-PKR (Thr446), with a predicted molecular weight of 62 kDa (observed band size: 62 kDa). Phospho-PKR (Thr446) Antibody (YA1026) can be used for WB, IHC-P, IP, ChIP experiment in human background.
SF3B3 Antibody (YA1171) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1171), targeting SF3B3. SF3B3 Antibody (YA1171) can be used for IHC-P experiment in human background.
CLEC4C; BDCA2, CLECSF11, CLECSF7, DLEC, HECL; UNQ9361/PRO34150; C-type lectin domain family 4 member C; CD303; Blood dendritic cell antigen 2 (BDCA-2); C-type lectin superfamily member 7; Dendritic lectin
IHC-P
Human
CLEC4C Antibody (YA1174) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1174), targeting CLEC4C. CLEC4C Antibody (YA1174) can be used for IHC-P experiment in human background.
SLC34A2; Sodium-dependent phosphate transport protein 2B; Sodium-phosphate transport protein 2B; Na(+)-dependent phosphate cotransporter 2B; NaPi3b; Sodium/phosphate cotransporter 2B (Na(+)/Pi cotransporter 2B; NaPi-2b); Solute carrier family 34 member 2
IHC-P
Human
SLC34A2 Antibody (YA1182) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1182), targeting SLC34A2. SLC34A2 Antibody (YA1182) can be used for IHC-P experiment in human background.
Bcl10 Antibody (YA1188) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1188), targeting Bcl10. Bcl10 Antibody (YA1188) can be used for IHC-P experiment in human background.
NR2F2; ARP1; TFCOUP2; COUP transcription factor 2; COUP-TF2; Apolipoprotein A-I regulatory protein 1; ARP-1; COUP transcription factor II; COUP-TF II; Nuclear receptor subfamily 2 group F member 2
IHC-P
Human
NR2F2 Antibody (YA1223) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1223), targeting NR2F2. NR2F2 Antibody (YA1223) can be used for IHC-P experiment in human background.
BCL6; BCL5; LAZ3; ZBTB27; ZNF51; B-cell lymphoma 6 protein; BCL-6; B-cell lymphoma 5 protein; BCL-5; Protein LAZ-3; Zinc finger and BTB domain-containing protein 27; Zinc finger protein 51
IHC-P
Human
Bcl6 Antibody (YA1281) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1281), targeting Bcl6. Bcl6 Antibody (YA1281) can be used for IHC-P experiment in human background.
BAFF Antibody (YA1510) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1510), targeting BAFF. BAFF Antibody (YA1510) can be used for FC, ELISA experiment in human background.
EPHA3 Antibody (YA1517) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1517), targeting EPHA3. EPHA3 Antibody (YA1517) can be used for FC, ELISA experiment in human background.
GABA B Receptor 2 Antibody (YA1733) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1733), targeting GABA B Receptor 2, with a predicted molecular weight of 106 kDa (observed band size: 106 kDa). GABA B Receptor 2 Antibody (YA1733) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
IKK alpha/beta Antibody (YA1871) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1871), targeting IKK alpha/beta, with a predicted molecular weight of 85 kDa (observed band size: 75,87 kDa). IKK alpha/beta Antibody (YA1871) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
Cytochrome P450 27A1 Antibody (YA2163) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2163), targeting Cytochrome P450 27A1, with a predicted molecular weight of 60 kDa (observed band size: 50 kDa). Cytochrome P450 27A1 Antibody (YA2163) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
PTX3; TNFAIP5; TSG14; Pentraxin-related protein PTX3; Pentaxin-related protein PTX3; Tumor necrosis factor alpha-induced protein 5; TNF alpha-induced protein 5; Tumor necrosis factor-inducible gene 14 protein; TSG-14
WB, FC
Human, Mouse
Pentraxin 3 Antibody (YA2173) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2173), targeting Pentraxin 3, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). Pentraxin 3 Antibody (YA2173) can be used for WB, FC experiment in human, mouse background.
Ephrin Receptor B1 Antibody (YA2176) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2176), targeting Ephrin Receptor B1, with a predicted molecular weight of 110 kDa (observed band size: 120 kDa). Ephrin Receptor B1 Antibody (YA2176) can be used for WB, IP experiment in human, mouse, rat background.
Ly6A/E Antibody (YA2518) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2518), targeting Ly6A/E, with a predicted molecular weight of 14 kDa (observed band size: 18 kDa). Ly6A/E Antibody (YA2518) can be used for WB, IHC-P experiment in mouse background.
TNFRSF10D; DCR2; TRAILR4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; Decoy receptor 2; DcR2; TNF-related apoptosis-inducing ligand receptor 4; TRAIL receptor 4; TRAIL-R4; TRAIL receptor with a truncated death domain; CD
WB, IHC-P, ICC/IF
Human
DcR2 Antibody (YA2588) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2588), targeting DcR2, with a predicted molecular weight of 42 kDa (observed band size: 36 kDa). DcR2 Antibody (YA2588) can be used for WB, IHC-P, ICC/IF experiment in human background.
BCL2A1; ACC-1; ACC-2; Bcl-2-like protein 5; Bcl-2-related protein A1; BCL2-related protein A1; BFL1; Bcl2-L-5; BCL2L5; GRS; HBPA1; Protein BFL-1; Protein GRS
WB, IHC-P, FC
Human, Mouse, Rat
Bcl2 A1 Antibody (YA2743) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2743), targeting Bcl2 A1, with a predicted molecular weight of 20 kDa (observed band size: 27 kDa). Bcl2 A1 Antibody (YA2743) can be used for WB, IHC-P, FC experiment in human, mouse, rat background.
GDF15 Antibody (YA2903) is a biotin-conjugated non-conjugated IgG antibody, targeting GDF15, with a predicted molecular weight of 34 kDa (observed band size: 34 kDa). GDF15 Antibody (YA2903) can be used for WB experiment in human background.
ERAB Antibody (YA3343) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3343), targeting ERAB, with a predicted molecular weight of 27 kDa (observed band size: 27 kDa). ERAB Antibody (YA3343) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.
CDk 5; CDk5; CDK5_HUMAN; Cell division protein kinase 5; Crk6; Cyclin dependent kinase 5; Cyclin-dependent kinase 5; Protein kinase CDK5 splicing; PSSALRE; Serine threonine protein kinase PSSALRE; Serine/threonine-protein kinase PSSALRE; Tau protein kinas
WB, ICC/IF
Human, Mouse, Rat, Monkey
CDK5 Antibody (YA796) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to CDK5 (2E8). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Monkey.
HER2 Antibody (YA771) is a non-conjugated and Mouse origined monoclonal antibody about 138 kDa, targeting to HER2. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
TRIM28; KAP1; RNF96; TIF1B; Transcription intermediary factor 1-beta; TIF1-beta; E3 SUMO-protein ligase TRIM28; KRAB-associated protein 1; KAP-1; KRAB-interacting protein 1; KRIP-1; Nuclear corepressor KAP-1; RING finger protein 96; Tripart
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse, Rat
KAP1 Antibody (YA719) is a non-conjugated and Rabbit origined monoclonal antibody about 89 kDa, targeting to KAP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human,Mouse,Rat.
Proteasome beta 8 Antibody (YA684) is a non-conjugated and Mouse origined monoclonal antibody about 30 kDa, targeting to Proteasome beta 8 (3G3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.
SMAD2; MADH2; MADR2; Mothers against decapentaplegic homolog 2; MAD homolog 2; Mothers against DPP homolog 2; JV18-1; Mad-related protein 2; hMAD-2; SMAD family member 2; SMAD 2; Smad2; hSMAD2
WB, ICC/IF, FC, IP, ChIP
Human, Mouse, Rat
Smad2/3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 52 kDa, targeting to Smad2/3. It can be used for WB,ICC/IF,FC,IP,ChIP assays with tag free, in the background of Human, Mouse, Rat.
ADRB2 Antibody is an unconjugated, approximately 46 kDa, rabbit-derived, anti-ADRB2 polyclonal antibody. ADRB2 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, rabbit background without labeling.
8-OHdG (DNA/RNA Damage) Antibody is an unconjugated, approximately 0.283 kDa, rabbit-derived, anti-8-OHdG (DNA/RNA Damage) polyclonal antibody. 8-OHdG (DNA/RNA Damage) Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.
GPR43 Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-GPR43 polyclonal antibody. GPR43 Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat background without labeling.
PRDM1/Blimp1 Antibody (YA1101) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1101), targeting PRDM1/Blimp1. PRDM1/Blimp1 Antibody (YA1101) can be used for IHC-P experiment in human background.
FCRL4; FCRH4, IFGP2, IRTA1; Fc receptor-like protein 4; CD307d; FcR-like protein 4; FcRL4; Fc receptor homolog 4 (FcRH4); IFGP family protein 2 (hIFGP2); Immune receptor translocation-associated protein 1
IHC-P
Human
FCRL4 Antibody (YA1272) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1272), targeting FCRL4. FCRL4 Antibody (YA1272) can be used for IHC-P experiment in human background.
NR4A1; GFRP1; HMR; NAK1; Nuclear receptor subfamily 4 group A member 1; Early response protein NAK1; Nuclear hormone receptor NUR/77; Nur77; Orphan nuclear receptor HMR; Orphan nuclear receptor TR3; ST-59; Testicular receptor 3
WB
Rat
NUR77 Antibody (YA1462) is a biotin-conjugated non-conjugated IgG antibody, targeting NUR77, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). NUR77 Antibody (YA1462) can be used for WB experiment in rat background.
GC1q R Antibody (YA2311) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2311), targeting GC1q R, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). GC1q R Antibody (YA2311) can be used for WB, IP experiment in human, mouse, rat background.
NR5A2 Antibody (YA2472) is a biotin-conjugated non-conjugated IgG antibody, targeting NR5A2, with a predicted molecular weight of 61 kDa (observed band size: 65 kDa). NR5A2 Antibody (YA2472) can be used for WB experiment in human, mouse, rat background.
DNAJA1; DNAJ2; HDJ2; HSJ2; HSPF4; DnaJ homolog subfamily A member 1; DnaJ protein homolog 2; HSDJ; Heat shock 40 kDa protein 4; Heat shock protein J2; HSJ-2; Human DnaJ protein 2; hDj-2
WB, IP, FC
Human, Mouse, Rat
DNAJA1 Antibody (YA2748) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2748), targeting DNAJA1, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). DNAJA1 Antibody (YA2748) can be used for WB, IP, FC experiment in human, mouse, rat background.
Acetyl-Histone H3 (Lys14) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys14). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Rat.
Acetyl-Histone H3 (Lys27) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys27). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human.
Acetyl-Histone H3 (Lys4) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
SMARCA4; BAF190A; BRG1; SNF2B; SNF2L4; Transcription activator BRG1; ATP-dependent helicase SMARCA4; BRG1-associated factor 190A; BAF190A; Mitotic growth and transcription activator; Protein BRG-1; Protein brahma homolog 1; SNF2-beta; SWI/S
WB, ICC/IF, IP
Human, Mouse
BRG1 Antibody (YA817) is a non-conjugated and Mouse origined monoclonal antibody about 185 kDa, targeting to BRG1 (6D7). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.
Phospho-p38 (Thr180/Tyr182) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 41 kDa, targeting to Phospho-p38 (Thr180/Tyr182). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
SMAD2; MADH2; MADR2; Mothers against decapentaplegic homolog 2; MAD homolog 2; Mothers against DPP homolog 2; JV18-1; Mad-related protein 2; hMAD-2; SMAD family member 2; SMAD 2; Smad2; hSMAD2
WB
Human, Mouse, Rat, Hamster
Phospho-Smad2 (Ser250) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Phospho-Smad2 (Ser250). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Hamster.
PI3 Kinase p85 alpha Antibody (YA689) is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to PI3 Kinase p85 alpha (1C8). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
PI3 Kinase p85 beta Antibody (YA688) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to PI3 Kinase p85 beta (8D9). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.
mitochondrial; ODPA_HUMAN; PDH; PDHA; PDHA1; PDHCE1A; PDHE1 A type I; PDHE1-A type I; PHE1A; Pyruvate Dehydrogenase (lipoamide) alpha 1; Pyruvate dehydrogenase complex; E1 alpha polypeptide 1; Pyruvate Dehydrogenase E1 alpha; Pyruvate dehydrogenase E1 com
WB, ICC/IF
Human, Mouse
Pyruvate Dehydrogenase E1 alpha Antibody (YA681) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to Pyruvate Dehydrogenase E1 alpha (3H2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
NEF; Protein S100 B; Protein S100-B; S 100 calcium binding protein beta chain; S 100 protein beta chain; S-100 protein beta chain; S-100 protein subunit beta; S100; S100 calcium binding protein beta (neural); S100 calcium-binding protein B; S100 protein b
WB, IHC-P, ICC/IF, IP
Human, Mouse, Rat, Goat
S100B Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 11 kDa, targeting to S100B. It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Goat.
Chromosome segregation protein SmcB; DXS423E; KIAA0178; MGC138332; Sb1.8; Segregation of mitotic chromosomes 1; SMC protein 1A; SMC-1-alpha; SMC-1A; SMC1 (structural maintenance of chromosomes 1 yeast) like 1; SMC1; SMC1 structural maintenance of chromoso
WB, ICC/IF
Human
SMC1A Antibody (YA673) is a non-conjugated and Mouse origined monoclonal antibody about 143 kDa, targeting to SMC1A (4C5). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
Fas like protein; Apoptosis inducing protein TRICK2A/2B; Apoptosis inducing receptor TRAIL R2; CD 262; CD262; CD262 antigen; Cytotoxic TRAIL receptor 2; Death domain containing receptor for TRAIL/Apo 2L; Death domain containing receptor for TRAIL/Apo2L; D
WB, ICC/IF
Human, Mouse
TNFRSF10B Antibody (YA660) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to TNFRSF10B (7F4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.
Substance P Antibody is an unconjugated, approximately 1.4/13 kDa, rabbit-derived, anti-Substance P polyclonal antibody. Substance P Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, guinea pig, and predicted: pig, cow, horse, rabbit, sheep background without labeling.
CD16 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CD16 polyclonal antibody. CD16 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: pig, cow, rabbit, sheep background without labeling.
FABP 1; FABP1; FABP1; FABPL; FABPL_HUMAN; Fatty Acid Binding Protein 1; Fatty acid binding protein 1 liver; Fatty Acid Binding Protein; Fatty acid-binding protein 1; Fatty acid-binding protein; Fatty acid-binding protein liver; L FABP; L-FABP; liver; Liver-type fatty acid-binding protein.
ELISA
Human
FABP1 Antibody (YA965) is a biotin-conjugated non-conjugated IgG1 antibody, targeting FABP1, with a predicted molecular weight of 14 kDa. FABP1 Antibody (YA965) can be used for ELISA experiment in human background.
FABP 1; FABP1; FABP1; FABPL; FABPL_HUMAN; Fatty Acid Binding Protein 1; Fatty acid binding protein 1 liver; Fatty Acid Binding Protein; Fatty acid-binding protein 1; Fatty acid-binding protein; Fatty acid-binding protein liver; L FABP; L-FABP; liver; Liver-type fatty acid-binding protein.
WB, IHC-F, IHC-P, ICC/IF
Mouse
FABP1 Antibody (YA967) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA967), targeting FABP1, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). FABP1 Antibody (YA967) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in mouse background.
NUP98 Antibody (YA1010) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1010), targeting NUP98, with a predicted molecular weight of 198 kDa (observed band size: 98 kDa). NUP98 Antibody (YA1010) can be used for WB, IP experiment in human background.
NUP98 Antibody (YA1011) is a biotin-conjugated non-conjugated IgG antibody, targeting NUP98, with a predicted molecular weight of 198 kDa (observed band size: 98 kDa). NUP98 Antibody (YA1011) can be used for WB experiment in human background.
SLC1A5 ; ASCT2; M7V1, RDR, RDRC; Neutral amino acid transporter B(0); ATB(0); Baboon M7 virus receptor; RD114/simian type D retrovirus receptor; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5
IHC-P
Human
SLC1A5/ASCT2 Antibody (YA1180) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1180), targeting SLC1A5/ASCT2. SLC1A5/ASCT2 Antibody (YA1180) can be used for IHC-P experiment in human background.
CCL19 Antibody (YA1670) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1670), targeting CCL19, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). CCL19 Antibody (YA1670) can be used for WB, FC experiment in human background.
BACE1 Antibody (YA1914) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1914), targeting BACE1, with a predicted molecular weight of 56 kDa (observed band size: 68 kDa). BACE1 Antibody (YA1914) can be used for WB, IP experiment in human, mouse, rat background.
SERCA2 ATPase Antibody (YA1931) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1931), targeting SERCA2 ATPase, with a predicted molecular weight of 115 kDa (observed band size: 115 kDa). SERCA2 ATPase Antibody (YA1931) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
SKP1; EMC19; OCP2; SKP1A; TCEB1L; S-phase kinase-associated protein 1; Cyclin-A/CDK2-associated protein p19; Organ of Corti protein 2; OCP-2; Organ of Corti protein II; OCP-II; RNA polymerase II elongation factor-like protein; SIII; Transcr
WB, ICC/IF
Human, Mouse, Rat
SKP1 Antibody (YA1974) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1974), targeting SKP1, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). SKP1 Antibody (YA1974) can be used for WB, ICC/IF experiment in human, mouse, rat background.
IGF2BP2; IMP2; VICKZ2; Insulin-like growth factor 2 mRNA-binding protein 2; IGF2 mRNA-binding protein 2; IMP-2; Hepatocellular carcinoma autoantigen p62; IGF-II mRNA-binding protein 2; VICKZ family member 2
WB, IHC-P, ICC/IF
Human, Mouse, Rat
IGF2BP2 Antibody (YA2033) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2033), targeting IGF2BP2, with a predicted molecular weight of 66 kDa (observed band size: 66,62 kDa). IGF2BP2 Antibody (YA2033) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
SHIP1 Antibody (YA2832) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2832), targeting SHIP1, with a predicted molecular weight of 133 kDa (observed band size: 140 kDa). SHIP1 Antibody (YA2832) can be used for WB, IHC-P, IP, FC experiment in human background.
CCL19 beta Antibody (YA2923) is a biotin-conjugated non-conjugated IgG antibody, targeting CCL19 beta, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). CCL19 beta Antibody (YA2923) can be used for WB experiment in human background.
MGC1490; Rab 11; Rab 11A; Rab-11; RAB11 A; RAB11; Rab11a; RAB11A member RAS oncogene family; Ras related protein Rab 11A; Ras related protein Rab11A; Ras-related protein Rab-11A; RB11A; YL 8; YL8
WB, IP
Human, Mouse, Rat
Rab11A Antibody (YA2976) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2976), targeting Rab11A, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). Rab11A Antibody (YA2976) can be used for WB, IP experiment in human, mouse, rat background.
CD59 Antibody (YA3251) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3251), targeting CD59, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). CD59 Antibody (YA3251) can be used for WB, ICC/IF, IP, FC experiment in human background.
Aurora B Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Aurora B. It can be used for WB,IP assays with tag free, in the background of Human.
Histone H2B Antibody (YA737) is a non-conjugated and Mouse origined monoclonal antibody about 14 kDa, targeting to Histone H2B (7E2). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
XRCC6; G22P1; X-ray repair cross-complementing protein 6; 5'-deoxyribose-5-phosphate lyase Ku70; 5'-dRP lyase Ku70; 70 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 1; ATP-dependent DNA helicase II 70 kDa subunit; CTC box-
WB, IHC-F, IHC-P, ICC/IF
Human
Ku70 Antibody (YA319) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.
XRCC5; G22P2; X-ray repair cross-complementing protein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair pr
WB, ICC/IF, IP, ChIP
Human, Monkey
Ku80 Antibody (YA714) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to Ku80 (8H1). It can be used for WB,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Monkey.
UCHL1 / PGP9.5; UCHL1; B220; CD 45; CD45; CD45 antigen; ec3.1.3.48; GP 180; GP180; Human homolog of severe combined immunodeficiency due to PTPRC deficiency; L CA; L-CA; lca; Leukocyte common antigen; LY 5; LY5; Protein tyrosine phosphatase receptor type
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
PGP9.5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to PGP9.5. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 84 kDa, targeting to Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199). It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.
Phospho-RSK4 (Ser232) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-RSK4 (Ser232). It can be used for WB,ICC/IF assays with tag free, in the background of Human.
SUMO1; SMT3C; SMT3H3; UBL1; OK/SW-cl.43; Small ubiquitin-related modifier 1; SUMO-1; GAP-modifying protein 1; GMP1; SMT3 homolog 3; Sentrin; Ubiquitin-homology domain protein PIC1; Ubiquitin-like protein SMT3C; Smt3C; Ubiquitin-like protein
WB, IHC-P
Human, Mouse, Rat
SUMO1 Antibody (YA047) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to SUMO1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
IL17A Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-IL17A polyclonal antibody. IL17A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, background without labeling.
Sonic hedgehog; Vhh-1; Sonic hedgehog protein; SHH; HHG 1; HHG1; HLP 3; HLP3; Holoprosencephaly 3; HPE 3; HPE3; MCOPCB5; SMMC I; SMMCI; Sonic Hedgehog (Drosophila) homolog; sonic hedgehog homolog (Drosophila); Sonic hedgehog homolog; Sonic hedgehog protein; TPT; TPTPS; Sonic hedgehog protein N-product; SHH_HUMAN.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
Shh Antibody is an unconjugated, approximately 19/47 kDa, rabbit-derived, anti-Shh polyclonal antibody. Shh Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, cow, horse, rabbit background without labeling.
Ferroportin 1; Ferroportin-1; FPN1; HFE4; IREG1; Iron regulated transporter 1; Iron-regulated transporter 1; MTP1; S40A1_HUMAN; SLC40A1; Solute carrier family 40 member 1; MST079; MSTP079; MTP1; SLC11A3.
WB, ELISA
Human
SLC40A1 Antibody is an unconjugated, approximately 63 kDa, rabbit-derived, anti-SLC40A1 polyclonal antibody. SLC40A1 Antibody can be used for: WB, ELISA expriments in human, and predicted: mouse, rat, dog, pig, rabbit background without labeling.
Basic domain helix loop helix protein class B 1; Basic helix loop helix protein class B 1; BHLHB; bHLHB1; bHLHe19; Class B basic helix loop helix protein 1; Class B basic helix-loop-helix protein 1; class E basic helix loop helix protein 19
WB
Human, Mouse, Rat
Olig2 Antibody (YA1012) is a biotin-conjugated non-conjugated IgG1 antibody, targeting Olig2, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Olig2 Antibody (YA1012) can be used for WB experiment in human, mouse, rat background.
Basic domain helix loop helix protein class B 1; Basic helix loop helix protein class B 1; BHLHB; bHLHB1; bHLHe19; Class B basic helix loop helix protein 1; Class B basic helix-loop-helix protein 1; class E basic helix loop helix protein 19
WB, IHC-P
Human, Mouse, Rat
Olig2 Antibody (YA1013) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1013), targeting Olig2, with a predicted molecular weight of 32 kDa (observed band size: 32 kDa). Olig2 Antibody (YA1013) can be used for WB, IHC-P experiment in human, mouse, rat background.
SLC7A5; CD98LC, LAT1; MPE16; Large neutral amino acids transporter small subunit 1; 4F2 light chain (4F2 LC; 4F2LC); CD98 light chain; Integral membrane protein E16; Solute carrier family 7 member 5
IHC-P
Human
SLC7A5/LAT1 Antibody (YA1193) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1193), targeting SLC7A5/LAT1. SLC7A5/LAT1 Antibody (YA1193) can be used for IHC-P experiment in human background.
IL-13RA1 Antibody (YA1377) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1377), targeting IL-13RA1. IL-13RA1 Antibody (YA1377) can be used for FC, ELISA experiment in human background.
CELF1; BRUNOL2; CUGBP; CUGBP1; NAB50; CUGBP Elav-like family member 1; CELF-1; 50 kDa nuclear polyadenylated RNA-binding protein; Bruno-like protein 2; CUG triplet repeat RNA-binding protein 1; CUG-BP1; CUG-BP- and ETR-3-like factor 1; Dead
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse, Rat
CUG BP1 Antibody (YA2806) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2806), targeting CUG BP1, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). CUG BP1 Antibody (YA2806) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Phospho-SHIP1 (Tyr1020) Antibody (YA3089) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3089), targeting Phospho-SHIP1 (Tyr1020), with a predicted molecular weight of 133 kDa (observed band size: 145 kDa). Phospho-SHIP1 (Tyr1020) Antibody (YA3089) can be used for WB, ICC/IF, IP experiment in human background.
IFNAR1; IFNAR; Interferon alpha/beta receptor 1; IFN-R-1; IFN-alpha/beta receptor 1; Cytokine receptor class-II member 1; Cytokine receptor family 2 member 1; CRF2-1; Type I interferon receptor 1
WB, IP
Human
Interferon alpha/beta Receptor 1 Antibody (YA3112) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3112), targeting Interferon alpha/beta Receptor 1, with a predicted molecular weight of 64 kDa (observed band size: 110-130 kDa). Interferon alpha/beta Receptor 1 Antibody (YA3112) can be used for WB, IP experiment in human background.
SMARCA2; BAF190B; BRM; SNF2A; SNF2L2; Probable global transcription activator SNF2L2; ATP-dependent helicase SMARCA2; BRG1-associated factor 190B; BAF190B; Protein brahma homolog; hBRM; SNF2-alpha; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2
WB, IHC-F, IHC-P, ICC/IF
Human
SMARCA2 Antibody (YA3241) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3241), targeting SMARCA2, with a predicted molecular weight of 181 kDa (observed band size: 190 kDa). SMARCA2 Antibody (YA3241) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Programmed cell death protein 1; CD279; CD279 antigen; hPD 1; hPD-1; hSLE1; PD 1; PD1; PDCD 1; PDCD1; PDCD1_HUMAN; Programmed cell death 1; Protein PD 1; Protein PD-1; SLEB2; Systemic lupus erythematosus susceptibility 2.
WB, IHC-P, ICC/IF, FC
Human
PD-1 Antibody is an unconjugated, approximately 32 kDa, rabbit-derived, anti-PD-1 monoclonal antibody. PD-1 Antibody can be used for: WB, IHC-P, Flow-Cyt, IF/ICC expriments in human background without labeling.
SMAD1; BSP1; MADH1; MADR1; Mothers against decapentaplegic homolog 1; MAD homolog 1; Mothers against DPP homolog 1; JV4-1; Mad-related protein 1; SMAD family member 1; SMAD 1; Smad1; hSMAD1; Transforming growth factor-beta-signaling protein
WB, IP
Human, Rat
Phospho-Smad1 (Ser463/Ser465) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Phospho-Smad1 (Ser463/Ser465). It can be used for WB,IP assays with tag free, in the background of Human, Rat.
NK1R Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-NK1R polyclonal antibody. NK1R Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, guinea pig, and predicted: mouse, dog, pig, cow, horse background without labeling.
Muscarinic Acetylcholine receptor M3 Antibody is an unconjugated, approximately 66 kDa, rabbit-derived, anti-Muscarinic Acetylcholine receptor M3 monoclonal antibody. Muscarinic Acetylcholine receptor M3 Antibody can be used for: WB expriments in human background without labeling.
GLP-1R Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-GLP-1R polyclonal antibody. GLP-1R Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.
GADD153; CHOP; Growth arrest and DNA damage-inducible 153; C/EBP homologous protein; C/EBP Homology Protein; CEBPZ; CHOP10; DDIT 3; DNA Damage Inducible Transcript 3; GADD 153; Growth Arrest and DNA Damage Inducible Protein 153; Growth arrest and DNA damage inducible protein GADD153; MGC4154; DDIT3_HUMAN.
WB, IHC-P, ICC/IF
Human, Mouse, Rat
DDIT3 Antibody is an unconjugated, approximately 19 kDa, rabbit-derived, anti-DDIT3 polyclonal antibody. DDIT3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.
CK 7; CK-7; ck7; Cytokeratin 7; Cytokeratin-7; Cytokeratin7; D15Wsu77e; K2C7; K2C7_HUMAN; K7; Keratin 55k type ii cytoskeletal; Keratin 7; Keratin simple epithelial type 1 k7; Keratin type II cytoskeletal 7
WB, ICC/IF
Human
Cytokeratin 7 Antibody (YA950) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA950), targeting Cytokeratin 7, with a predicted molecular weight of 51 kDa (observed band size: 55 kDa). Cytokeratin 7 Antibody (YA950) can be used for WB, ICC/IF experiment in human background.
CK 7; CK-7; ck7; Cytokeratin 7; Cytokeratin-7; Cytokeratin7; D15Wsu77e; K2C7; K2C7_HUMAN; K7; Keratin 55k type ii cytoskeletal; Keratin 7; Keratin simple epithelial type 1 k7; Keratin type II cytoskeletal 7
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Mouse, Rat
Cytokeratin 7 Antibody (YA951) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA951), targeting Cytokeratin 7, with a predicted molecular weight of 51 kDa (observed band size: 54 kDa). Cytokeratin 7 Antibody (YA951) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
CK 7; CK-7; ck7; Cytokeratin 7; Cytokeratin-7; Cytokeratin7; D15Wsu77e; K2C7; K2C7_HUMAN; K7; Keratin 55k type ii cytoskeletal; Keratin 7; Keratin simple epithelial type 1 k7; Keratin type II cytoskeletal 7
WB, ICC/IF, IP
Human
Cytokeratin 7 Antibody (YA952) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA952), targeting Cytokeratin 7, with a predicted molecular weight of 51 kDa (observed band size: 51 kDa). Cytokeratin 7 Antibody (YA952) can be used for WB, ICC/IF, IP experiment in human background.
MAP2K6 Antibody (YA1088) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1088), targeting MAP2K6, with a predicted molecular weight of 37 kDa (observed band size: 40 kDa). MAP2K6 Antibody (YA1088) can be used for WB, IP experiment in human, rat background.
FOXM1 Antibody (YA1112) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1112), targeting FOXM1. FOXM1 Antibody (YA1112) can be used for IHC-P experiment in human background.
TCF3 / E2A Antibody (YA1220) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1220), targeting TCF3 / E2A. TCF3 / E2A Antibody (YA1220) can be used for IHC-P experiment in human background.
IGF2R Antibody (YA1499) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1499), targeting IGF2R, with a predicted molecular weight of 274 kDa (observed band size: 274 kDa). IGF2R Antibody (YA1499) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
IL-13 Receptor alpha 1 Antibody (YA1624) is a biotin-conjugated non-conjugated IgG antibody, targeting IL-13 Receptor alpha 1, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). IL-13 Receptor alpha 1 Antibody (YA1624) can be used for WB experiment in human background.
CK 6A; CK 6B; CK 6C; CK 6D; CK 6E; CK-6C; CK-6E; K6a keratin; K6b keratin; K6C; K6c keratin; K6d keratin; K6e keratin; Keratin; KRT6A; KRT6B; KRT6C; KRT6D; KRT6E
WB, IHC-P, ICC/IF
Human
Cytokeratin 6 Antibody (YA1701) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1701), targeting Cytokeratin 6, with a predicted molecular weight of 60 kDa (observed band size: 60 kDa). Cytokeratin 6 Antibody (YA1701) can be used for WB, IHC-P, ICC/IF experiment in human background.
ILF3; DRBF; MPHOSPH4; NF90; Interleukin enhancer-binding factor 3; Double-stranded RNA-binding protein 76; DRBP76; M-phase phosphoprotein 4; MPP4; Nuclear factor associated with dsRNA; NFAR; Nuclear factor of activated T-cells 90 kDa; NF-AT-90; Translational control protein 80; TCP80
WB, IHC-P, ICC/IF, IP, FC
Human, Mouse
ILF3 Antibody (YA1904) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1904), targeting ILF3, with a predicted molecular weight of 95 kDa (observed band size: 95 kDa). ILF3 Antibody (YA1904) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse background.
Phosphatidylinositol 3-kinase catalytic subunit type 3 (EC:2.7.1.137); PI3-kinase type 3; PI3K type 3; PtdIns-3-kinase type 3; Phosphatidylinositol 3-kinase p100 subunit; Phosphoinositide-3-kinase class 3; hVps34; VPS34 AntibodyPIK3C3；
WB, IHC-P
Human, Mouse, Rat
PIK3C3 Antibody (YA2789) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2789), targeting PIK3C3, with a predicted molecular weight of 102 kDa (observed band size: 102 kDa). PIK3C3 Antibody (YA2789) can be used for WB, IHC-P experiment in human, mouse, rat background.
CD16a/b; CD32; CD32A/B; Fc fragment of IgG low affinity IIa/b receptor; Fc fragment of IgG low affinity IIIa/b receptor; Fc fragment of IgG low affinity IIIb receptor; Fc gamma receptor III A/B; FCG2A; FcGR; FCGR2A/BFCGR3; FCGR3A/B; Fc gamma RIIa/b
30 kDa adipocyte complement related protein; ACDC; ACRP 30; ACRP30; ADIPO_HUMAN; Adipocyte; AdipoQ; Adipose most abundant gene transcript 1; Adipose specific collagen like factor; ADIPQTL1; ADPN; APM 1; apM-1; ApM1; C1q and collagen domain-containing protein; GBP 28; GBP28; Gelatin binding protein; Gelatin binding protein 28; Gelatin-binding protein.
WB, ICC/IF, IHC-P
Mouse
Adiponectin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to Adiponectin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Mouse.
Cdk7 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Cdk7. It can be used for WB assays with tag free, in the background of Human.
MGC22487; Oct 3; Oct 4; Oct-3; Oct-4; OCT3; Oct4; Octamer binding protein 3; Octamer binding protein 4; Octamer binding transcription factor 3; Octamer-binding protein 3; Octamer-binding protein 4; Octamer-binding transcription factor 3; OTF 3; OTF 4; OTF
WB, ICC/IF
Human, Mouse
Oct-4 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 39 kDa, targeting to POU5F1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.
Connexin 43; Connexin-43; Cx 43; Cx43; CXA1_HUMAN; DFNB38; Gap junction 43 kDa heart protein; Gap junction alpha-1 protein; Gap junction protein alpha 1 43kDa (connexin 43); Gap junction protein alpha 1 43kDa; Gap junction protein alpha like; GJA 1; Gja1
WB, IHC-F, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
Connexin 43 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 43 kDa, targeting to Connexin 43. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.
MGC22487; Oct 3; Oct 4; Oct-3; Oct-4; OCT3; Oct4; Octamer binding protein 3; Octamer binding protein 4; Octamer binding transcription factor 3; Octamer-binding protein 3; Octamer-binding protein 4; Octamer-binding transcription factor 3; OTF 3; OTF 4; OTF
WB, IHC-P, ICC/IF, IP, ChIP
Human, Mouse
Oct-4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 39 kDa, targeting to POU5F1. It can be used for WB,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Mouse.
Phospho-MEK4 (Ser80) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Phospho-MEK4 (Ser80). It can be used for WB,IP assays with tag free, in the background of Human.
RPS6KA3; ISPK1; MAPKAPK1B; RSK2; Ribosomal protein S6 kinase alpha-3; S6K-alpha-3; 90 kDa ribosomal protein S6 kinase 3; p90-RSK 3; p90RSK3; Insulin-stimulated protein kinase 1; ISPK-1; MAP kinase-activated protein kinase 1b; MAPK-activated
WB, IP
Human, Mouse, Rat
Phospho-RSK2 (Ser227) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-RSK2 (Ser227). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
RPS6KA2; MAPKAPK1C; RSK3; Ribosomal protein S6 kinase alpha-2; S6K-alpha-2; 90 kDa ribosomal protein S6 kinase 2; p90-RSK 2; p90RSK2; MAP kinase-activated protein kinase 1c; MAPK-activated protein kinase 1c; MAPKAP kinase 1c; MAPKAPK-1c; Ri
WB, IHC-F, IHC-P, ICC/IF, IP
Human, Hamster
RSK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK3. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Hamster.
Advanced glycosylation end product specific receptor; Advanced glycosylation end product-specific receptor; AGER; EC 2.7.11.22; LE 9211 A antigen; LE-9211-A antigen; MGC22357; MOK; RAGE 1; RAGE1; MOK protein kinase; Receptor for advanced glycation endproducts; Renal tumor antigen 1; Renal tumor antigen; Renal cell carcinoma antigen (MOK protein kinase); Renal tumor antigen 1; RAGE_HUMAN.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat,
RAGE Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-RAGE polyclonal antibody. RAGE Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
Clgi; Collagenase inhibitor; EPA; EPO; Erythroid Potentiating Activity; Fibroblast collagenase inhibitor; FLJ90373; HC; Human Collagenase Inhibitor; Metalloproteinase inhibitor 1; Metalloproteinase inhibitor 1 precursor; OTTHUMP00000023214; TIMP 1; TIMP; TIMP metallopeptidase inhibitor 1; TIMP1 protein; Tissue Inhibitor of Metalloproteinase 1; Tissue inhibitor of metalloproteinases; Ttissue inhibitor of metalloproteinase 1 erythroid potentiating activity collagenase inhibitor.
WB, IHC-P, ICC/IF
Human
TIMP-1 Antibody is an unconjugated, approximately 21 kDa, rabbit-derived, anti-TIMP-1 monoclonal antibody. TIMP-1 Antibody can be used for: WB, IHC-P, ICC/IF expriments in human background without labeling.
GPR30 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-GPR30 polyclonal antibody. GPR30 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: chicken, cow, horse, rabbit background without labeling.
CXC-chemokine receptor 2; CD 182; CD182; CD182 antigen; CDw128b; Chemokine (CXC) receptor 2; CMKAR2; CXCR 2; CXC R2; CXC-R2; CXCR2_HUMAN; C-X-C chemokine receptor type 2; CXCR-2; GRO/MGSA receptor; High affinity interleukin-8 receptor B; IL-8R B; IL-8 receptor type 2.
WB, IHC-P, ELISA
Human
CXCR2 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-CXCR2 polyclonal antibody. CXCR2 Antibody can be used for: WB,IHC-P ELISA expriments in human background without labeling.
Phospho-PERK (Thr980) Antibody is an unconjugated, approximately 119 kDa, rabbit-derived, anti-PERK (Thr980) polyclonal antibody. Phospho-PERK (Thr980) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit background without labeling.
GSDMD Antibody is an unconjugated, approximately 53 kDa, rabbit-derived, anti-GSDMD polyclonal antibody. GSDMD Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, and predicted: mouse, rat background without labeling.
Caspase-5 subunit p20; Apoptosis related cysteine protease; CASP 5; CASP5; Caspase-5; Caspase5; Caspase 5 apoptosis related cysteine peptidase; caspase 5 apoptosis related cysteine protease; ICE; ICE(rel) III; ICE(rel)III; ICEREL III; ICERELIII; ICH 3; ICH 3 protease; ICH3; ICH3 protease; MGC141966; TY; TY protease.
WB, IHC-P, IHC-F, ICC/IF, ELISA
Human, Mouse
Caspase-5 p20 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Caspase-5 p20, with a predicted molecular weight of 48 kDa. Caspase-5 p20 Antibody can be used for WB, IHC-P, IHC-F, ICC/IF, ELISA experiments in human, mouse backgrounds.
C4A Antibody (YA1505) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1505), targeting C4A, with a predicted molecular weight of 193 kDa (observed band size: 193 kDa). C4A Antibody (YA1505) can be used for WB, IHC-P, FC experiment in human background.
PI3 Kinase p110 delta Antibody (YA1617) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1617), targeting PI3 Kinase p110 delta, with a predicted molecular weight of 119 kDa (observed band size: 119 kDa). PI3 Kinase p110 delta Antibody (YA1617) can be used for WB, ICC/IF experiment in human, mouse, rat background.
MEK7 Antibody (YA2647) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2647), targeting MEK7, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). MEK7 Antibody (YA2647) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.
Hsp90 alpha/beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Hsp90 alpha/beta. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.
Cancer/testis antigen 98; CT98; DKFZp686F1078; hKOC; IF2B3_HUMAN; IGF II mRNA binding protein 3; IGF-II mRNA-binding protein 3; IGF2 mRNA binding protein 3; IGF2 mRNA-binding protein 3; IGF2BP3; IMP 3; IMP-3; Insulin like growth factor 2 mRNA binding prot
WB, ICC/IF, IP, FC
Human, Mouse, Rat
IMP3 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to IMP3. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.
RPS6KA1; MAPKAPK1A; RSK1; Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAP
WB, ICC/IF, IP
Human, Rat, Mouse
Phospho-RSK1 p90 (Ser380) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Phospho-RSK1 p90 (Ser380). It can be used for WB, ICC/IF, IP assays with tag free, in the background of Human, Mouse and Rat.
RPS6KA1; MAPKAPK1A; RSK1; Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAP
WB, IP
Human, Mouse, Monkey
RSK1 p90 Antibody (YA676) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to RSK1 p90 (6B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Monkey.
IGF 1 Antibody is an unconjugated, approximately 7.7/21 kDa, rabbit-derived, anti-IGF 1 polyclonal antibody. IGF 1 Antibody can be used for: WB, IHC-P, IHC-F, IF, ELISA expriments in human, mouse, rat, dog, and predicted: pig, cow, rabbit, sheep background without labeling.
CD8 antigen, alpha polypeptide (p32); CD8a; CD8a antigen; CD8a molecule; CD8A_MOUSE; CD8A_HUMAN; Leu2; Leu2 T lymphocyte antigen; MAL; OKT8 T cell antigen; p32; T cell antigen Leu2; T cell co receptor; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; T8 T cell antigen.
WB, IHC-P, ICC/IF
Mouse
CD8 Antibody is an unconjugated, approximately 27 kDa, rabbit-derived, anti-CD8 polyclonal antibody. CD8 Antibody can be used for: WB, IHC-P, IHC-F, IF expriments in human, mouse, background without labeling.
CEBP-alpha Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CEBP-alpha polyclonal antibody. CEBP-alpha Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, rat, and predicted: mouse, dog, pig, cow, rabbit, sheep, goat background without labeling.
ACS3; B-HLH DNA binding protein; bHLHa38; BPES2; BPES3; Class A basic helix-loop-helix protein 38; CRS1; H-twist; OTTHUMP00000116043; SCS; Twist basic helix loop helix transcription factor 1; Twist homolog 1 (Drosophila); Twist homolog 1; TWIST homolog of drosophila; Twist related protein 1; Twist-related protein 1; Twist1; TWST1_HUMAN.
WB, IHC-P, ICC/IF, FC
Human, Mouse
TWIST Antibody is an unconjugated, approximately 23 kDa, mouse-derived, anti-TWIST monoclonal antibody. TWIST Antibody can be used for: WB, IHC-P, ICC/IF, FC expriments in human, mouse background without labeling.
interleukin-1 alpha; Hematopoietin 1; IL 1 alpha; IL1 alpha; IL 1; IL 1A; Il-1a; IL1; IL1A; IL1F1; ilia; Interleukin 1 alpha; Interleukin 1 alpha precursor; Interleukin1 alpha; Preinterleukin 1 alpha; Pro interleukin 1 alpha; Prointerleukin 1 alpha; IL1A_HUMAN.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse
IL-1 alpha Antibody is a rabbit-derived non-conjugated IgG antibody, targeting IL-1 alpha, with a predicted molecular weight of 31 kDa. IL-1 alpha Antibody can be used for WB, ELISA, IHC-P, IHC-F, FC, ICC/IF experiments in human, mouse backgrounds.
422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3
ELISA
Human
FABP3 Antibody (YA968) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA968), targeting FABP3. FABP3 Antibody (YA968) can be used for ELISA experiment in human background.
422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3
ELISA
Human
FABP3 Antibody (YA969) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA969), targeting FABP3. FABP3 Antibody (YA969) can be used for ELISA experiment in human background.
422 protein; Cardiac Fatty Acid Binding Protein; FABP 11; FABP 3; FABP11; FABP3; FABPH_HUMAN; fatty acid binding protein 11; Fatty acid binding protein 3; Fatty acid binding protein 3 muscle and heart; Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor; Fatty acid binding protein 3 muscle; Fatty acid binding protein 3
WB, IHC-P
Human, Mouse, Rat
FABP3 Antibody (YA970) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA970), targeting FABP3, with a predicted molecular weight of 15 kDa (observed band size: 15 kDa). FABP3 Antibody (YA970) can be used for WB, IHC-P experiment in human, mouse, rat background.
GSDMD Antibody is an unconjugated, approximately 53 kDa, rabbit-derived, anti-GSDMD monoclonal antibody. GSDMD Antibody can be used for: WB expriments in human background without labeling.
Phospho-BTK(Y223) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to Phospho-BTK(Y223). It can be used for WB, IP assays with tag free, in the background of Human.
RPS6KA1; MAPKAPK1A; RSK1; Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; p90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAP
WB, IP
Human, Mouse, Rat
Phospho-RSK1 p90 (Thr359/Ser363) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Phospho-RSK1 p90 (Thr359/Ser363). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.
Fbx32; 4833442G10Rik; AI430017; Atrogin 1; Atrogin-1; ATROGIN1; Atrophy gene 1; F box only protein 32; F-box only protein 32; F-box protein 32; FBX32_HUMAN; fbxo25; FBXO32; FLJ32424; MAFbx; MGC108443; MGC137646; MGC33610; Muscle atrophy F box; Muscle atrophy F box protein; Muscle atrophy F-box protein.
WB; ICC/IF
Human, Mouse, Rat
Fbx32 Antibody (YA919) is an unconjugated, approximately 42 kDa, rabbit-derived, anti-Fbx32 (YA919) monoclonal antibody. Fbx32 Antibody (YA919) can be used for: WB, IF-Cell expriments in mouse, rat, and human background without labeling.
DA transporter; DAT 1; DAT; DAT1; SC6A3_HUMAN; SLC6A3; Sodium dependent dopamine transporter; Sodium-dependent dopamine transporter; Solute carrier family 6 (neurotransmitter transporter dopamine), member 3; Solute carrier family 6 member 3; Variable number tandem repeat (VNTR); dopamine transporter; ADAT 1; Adenosine deaminase tRNA specific 1; HADAT1; tRNA specific adenosine deaminase 1.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse, Rat
Dopamine Transporter Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Dopamine Transporter polyclonal antibody. Dopamine Transporter Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog, cow background without labeling.
LOX 1 Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-LOX 1 polyclonal antibody. LOX 1 Antibody can be used for: WB, IF-Cell, IHC-P, FC expriments in human, mouse background without labeling.
40 kDa keratin intermediate filament; CK 19; ck19; CK19; CK-19; KRT19; Cytokeratin19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin-19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; K1C19_HUMAN; Keratin, type I cytoskeletal 19; Keratin, type I, 40 kd.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human
Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 19 polyclonal antibody. Cytokeratin 19 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human and predicted: mouse, rat, chicken, dog, pig, cow, horse, rabbit background without labeling.
HAVCR; HAVCR 1; HA; Vcr-1; hepatitis A virus cellular receptor 1; HKIM-1; Kidney Injury Molecule1; KIM1; KIM 1; KIM-1; TIM-1; TIMD 1; TIMD1; KM-1; TIMD1_HUMAN; T cell immunoglobin domain and mucin domain protein 1; T-cell immunoglobulin and mucin domain-containing protein 1; T-cell membrane protein 1. 肾脏损伤分子1
WB
Human, Mouse, Rat
TIM 1 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-TIM 1 monoclonal antibody. TIM 1 Antibody can be used for: WB expriments in human, mouse, and rat background without labeling.
Mannose Receptor; C-type lectin domain family 13 member D; CD 206; CD206; CD206 antigen; CLEC13D; CLEC13DL; Macrophage mannose receptor; Mannose receptor C type 1; MMR; MRC 1; MRC-1; MRC1_HUMAN; Macrophage mannose receptor 1; MRC1L1; C-type lectin domain family 13 member D-like; Macrophage mannose receptor 1-like protein 1.
WB
Human, Rat
MRC1 Antibody is an unconjugated, approximately 160 kDa, rabbit-derived, anti-MRC1 monoclonal antibody. MRC1 Antibody can be used for: WB expriments in human and rat background without labeling.
AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8
WB, IP
Human, Mouse, Rat, Hamster
JNK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to JNK. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.
CD90/Thy-1 Antibody is an unconjugated, approximately 18 kDa, rabbit-derived, anti-CD90/Thy-1 monoclonal antibody. CD90/Thy-1 Antibody can be used for: WB,IHC-P,ICC/IF expriments in human background without labeling.
Alpha-ENaC Antibody is an unconjugated, approximately 76 kDa, rabbit-derived, anti-Alpha-ENaC polyclonal antibody. Alpha-ENaC Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, sheep background without labeling.
DGAT1 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting DGAT1, with a predicted molecular weight of 55 kDa (observed band size: 55 kDa). DGAT1 Antibody can be used for WB,IHC-P,IP experiments in human backgrounds.
40 kDa keratin intermediate filament; CK 19; ck19; CK19; CK-19; KRT19; Cytokeratin19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin-19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; K1C19_HUMAN; Keratin, type I cytoskeletal 19; Keratin, type I, 40 kd
WB, IHC-P, IHC-F, ICC/IF
Human
Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, mouse-derived, anti-Cytokeratin 19 monoclonal antibody. Cytokeratin 19 Antibody can be used for: WB,IHC-F,IHC-P,ICC/IF expriments in human background without labeling.
Alpha isoform serine threonine protein phosphatase PP1alpha 1 catalytic subunit; Catalytic subunit; PP1A; PP1A_HUMAN; PP1alpha; PP2C ALPHA; PP2CA; Ppp1ca; Protein Phosphatase 2C Alpha Isoform; Serine threonine protein phosphatase PP1 alpha catalytic subunit; Serine threonine protein phosphatase PP1 alpha catalytic subunit protein phosphatase 1; Serine/threonine-protein phosphatase PP1-alpha catalytic subunit.
WB, IHC-F, IHC-P, ICC/IF
Human
PP1C alpha Antibody (YA1040) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1040), targeting PP1C alpha, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). PP1C alpha Antibody (YA1040) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
Alpha isoform serine threonine protein phosphatase PP1alpha 1 catalytic subunit; Catalytic subunit; PP1A; PP1A_HUMAN; PP1alpha; PP2C ALPHA; PP2CA; Ppp1ca; Protein Phosphatase 2C Alpha Isoform; Serine threonine protein phosphatase PP1 alpha catalytic subunit; Serine threonine protein phosphatase PP1 alpha catalytic subunit protein phosphatase 1; Serine/threonine-protein phosphatase PP1-alpha catalytic subunit.
WB, ICC/IF
Human
PP1C alpha Antibody (YA1041) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1041), targeting PP1C alpha, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). PP1C alpha Antibody (YA1041) can be used for WB, ICC/IF experiment in human background.
Hydroxyl-Histone H2A Antibody (YA3332) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3332), targeting Hydroxyl-Histone H2A, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). Hydroxyl-Histone H2A Antibody (YA3332) can be used for WB, IHC-P experiment in human, mouse background.
40 kDa keratin intermediate filament; CK 19; ck19; CK19; CK-19; KRT19; Cytokeratin19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin-19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; K1C19_HUMAN; Keratin, type I cytoskeletal 19; Keratin, type I, 40 kd.
WB, IHC-P, IHC-F, ICC/IF, FC, ELISA
Human, Mouse
Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 19 polyclonal antibody. Cytokeratin 19 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.
ACE2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to ACE2. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Hamster.
AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8
WB, ICC/IF
Human, Mouse, Rat
JNK1 (1A4) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to JNK1 (1A4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.
Toll-like receptor 2; Toll like receptor 2; Toll like receptor 2 precursor; Toll-like receptor 2; TLR 2; TLR-2; Toll/interleukin-1 receptor-like protein 4; CD282 antigen; CD282; TIL 4; TIL4; TLR2_HUMAN; Toll/interleukin 1 receptor like 4; Toll/interleukin 1 receptor like protein 4; Toll/interleukin receptor like protein 4.
WB, ICC/IF, FC
Human, Mouse, Rat
TLR2 Antibody is an unconjugated, approximately 84 kDa, rabbit-derived, anti-TLR2 monoclonal antibody. TLR2 Antibody can be used for: WB, FC, IF-Cell expriments in human, mouse, rat background without labeling.
PP 1G; PP-1G; PP1G; PP1G_HUMAN; PP1gamma; PPP 1G; PPP1CC; PPP1CC protein; PPP1G; Protein phosphatase 1 catalytic subunit gamma isoform; Protein phosphatase 1C catalytic subunit; Protein phosphatase 1C subunit; Protein phosphatase 2C gamma isoform; Serine/threonine phosphatase 1 gamma; Serine/threonine protein phosphatase PP1 gamma catalytic subunit; Serine/threonine-protein phosphatase PP1-gamma catalytic subunit.
WB
Human
PP1C gamma Antibody (YA1068) is a biotin-conjugated non-conjugated IgG2b antibody, targeting PP1C gamma, with a predicted molecular weight of 37 kDa (observed band size: 37 kDa). PP1C gamma Antibody (YA1068) can be used for WB experiment in human background.
KIR2DL3 Antibody (YA1246) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1246), targeting KIR2DL3. KIR2DL3 Antibody (YA1246) can be used for IHC-P experiment in human background.
S6K2 Antibody (YA1514) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1514), targeting S6K2, with a predicted molecular weight of 53 kDa (observed band size: 53 kDa). S6K2 Antibody (YA1514) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.
Alpha isoform serine threonine protein phosphatase PP1alpha 1 catalytic subunit; Catalytic subunit; PP1A; PP1A_HUMAN; PP1alpha; PP2C ALPHA; PP2CA; Ppp1ca; Protein Phosphatase 2C Alpha Isoform; Serine threonine protein phosphatase PP1 alpha catalytic subunit; Serine threonine protein phosphatase PP1 alpha catalytic subunit protein phosphatase 1; Serine/threonine-protein phosphatase PP1-alpha catalytic subunit.
WB, IHC-P, IP
Human, Mouse, Rat
PP1C alpha/beta Antibody (YA1700) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1700), targeting PP1C alpha/beta, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). PP1C alpha/beta Antibody (YA1700) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.
Phospho-S6K2 (Ser371) Antibody (YA1890) is a biotin-conjugated non-conjugated IgG antibody, targeting Phospho-S6K2 (Ser371), with a predicted molecular weight of 53 kDa (observed band size: 60 kDa). Phospho-S6K2 (Ser371) Antibody (YA1890) can be used for WB experiment in human, mouse, rat background.
COX2/Cyclooxygenase 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to COX2/Cyclooxygenase 2. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Rat.
AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8
WB, IP
Human, Rat
Phospho-JNK1 (Thr183/Tyr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-JNK1 (Thr183/Tyr185). It can be used for WB,IP assays with tag free, in the background of Human, Rat.
Cytokeratin 5 Antibody is an unconjugated, approximately 62 kDa, rabbit-derived, anti-Cytokeratin 5 monoclonal antibody. Cytokeratin 5 Antibody can be used for: WB, IHC-P, IF-Tissue, IF-Cell, FC expriments in human, mouse, rat background without labeling.
2-oxoglutarate dehydrogenase complex component E2; Dihydrolipoamide S succinyltransferase (E2 component of 2 oxo glutarate complex); Dihydrolipoamide S succinyltransferase; Dihydrolipoamide succinyltransferase component of 2 oxoglutarate dehydrogenase complex; Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex; Dihydrolipoyllysine residue succinyltransferase component of 2 oxoglutarate dehydrogenase complex; Dihydrolipoyllysine residue succinyltransferase component of 2 oxoglutarate dehydrogenase complex mitochondrial; Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex; Dlst; DLTS; E2; E2K; mitochondrial; ODO2_HUMAN; OGDC-E2.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse
DLST Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-DLST polyclonal antibody. DLST Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF, expriments in mouse and predicted: human, rat, dog, pig, cow, horse, rabbit, sheep background without labeling.
IL-8/CXCL8 Antibody is an unconjugated, approximately 8/9 kDa, rabbit-derived, anti-IL-8/CXCL8 polyclonal antibody. IL-8/CXCL8 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, rabbit, and predicted: pig, cow, sheep background without labeling.
troponin I type 3 (cardiac); Cardiac troponin I; Troponin I, cardiac muscle; Cardiomyopathy, familial hypertrophic, 7, included; CMD1FF; CMD2A; CMH7; cTnI; Familial hypertrophic cardiomyopathy 7; MGC116817; RCM1; Tn1; Tni; TNN I3; TNNC 1; TNNC-1; TNNC1; TNNI3; Troponin I cardiac; Troponin I cardiac muscle; Troponin I cardiac muscle isoform; Troponin I type 3 cardiac; troponin I, cardiac 3; TroponinI; Troponin I; TNNI3_HUMAN.
WB, IHC-P, ICC/IF, IP
Human
Cardiac Troponin I/TNNC1 Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-Cardiac Troponin I/TNNC1 monoclonal antibody. Cardiac Troponin I/TNNC1 Antibody can be used for:WB,IHC-P,ICC/IF,IP expriments in human background without labeling.
AMCFII; C-X-C motif chemokine 5; Cxcl5; CXCL5_HUMAN; ENA-78(1-78); ENA-78(9-78); ENA78; Epithelial derived neutrophil activating peptide 78; Epithelial derived neutrophil activating protein 78; Epithelial-derived neutrophil-activating protein 78; GCP2; LIX; Neutrophil activating peptide ENA 78; Neutrophil-activating peptide ENA-78; SCYB5; Scyb6; Small inducible cytokine B5; Small inducible cytokine subfamily B member 5; Small-inducible cytokine B5.
WB, ICC/IF, IP
Human
CXCL5 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL5 monoclonal antibody. CXCL5 Antibody can be used for: WB,ICC/IF,IP expriments in human background without labeling.
CD80 Antibody is an unconjugated, approximately 30 kDa, mouse-derived, anti-CD80 monoclonal antibody. CD80 Antibody can be used for: WB, IHC-P,FC ICC expriments in mouse,human, and predicted: rat background without labeling.
Phospho-eNOS (Ser1177) Antibody is an unconjugated, approximately 133 kDa, rabbit-derived, anti-eNOS (Ser1177) polyclonal antibody. Phospho-eNOS (Ser1177) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit, sheep, guinea pig background without labeling.
A disintegrin and metalloproteinase with thrombospondin motifs 5; A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 5; A Disintigrin And Metalloproteinase with ThromboSpondin motif-5; ADAM metallopeptidase with thrombospondin type 1 motif 5; ADAM TS 11; ADAM TS 5; ADAM TS5; ADAMTS 11; ADAMTS 5; ADAMTS11; ADMP 2; ADMP2; Aggrecanase 2; aggrecanase-2; FLJ36738; Implantin; ThromboSpondin motif-5.
WB, ICC/IF, FC
Human, Mouse, Rat
ADAMTS5 Antibody is an unconjugated, approximately 102 kDa, rabbit-derived, anti-ADAMTS5 monoclonal antibody. ADAMTS5 Antibody can be used for: WB, IF-Cell, FC expriments in human, mouse, rat background without labeling.
NOX2 Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-NOX2 polyclonal antibody. NOX2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, rabbit background without labeling.
Collagen type I; Alpha 1 type I collagen; Alpha 2 type I collagen; COL1A1; COL1A2; Collagen I alpha 1 polypeptide; Collagen I alpha 2 polypeptide; Collagen Of Skin Tendon And Bone; Collagen Type 1; Collagen type I alpha 1; Collagen type I alpha 2; OI4; Osteogenesis Imperfecta Type IV; Pro alpha 1(I) collagen; Type I procollagen; CO1A1_HUMAN.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat, Rabbit
Collagen I Antibody is an unconjugated, approximately 130 kDa, rabbit-derived, anti-Collagen I polyclonal antibody. Collagen I Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, rabbit, and predicted: chicken, dog, cow, sheep background without labeling.
CLL associated antigen KW 6; DNA-binding protein Ikaros; hIk 1; hIk-1; Hs.54452; IK1; Ikaros (zinc finger protein); IKAROS; IKAROS family zinc finger 1 (Ikaros); Ikaros family zinc finger protein 1; Ikzf1; IKZF1_HUMAN; LYF1; Lymphoid transcription factor LyF-1; PRO0758; Zinc finger protein subfamily 1A 1 (Ikaros); zinc finger protein subfamily 1A 1; Zinc finger protein; subfamily 1A; member 1; ZNFN1A1.
WB, IP
Human
Ikaros Antibody (YA987) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA987), targeting Ikaros, with a predicted molecular weight of 58 kDa (observed band size: 58 kDa). Ikaros Antibody (YA987) can be used for WB, IP experiment in human background.
CLL associated antigen KW 6; DNA-binding protein Ikaros; hIk 1; hIk-1; Hs.54452; IK1; Ikaros (zinc finger protein); IKAROS; IKAROS family zinc finger 1 (Ikaros); Ikaros family zinc finger protein 1; Ikzf1; IKZF1_HUMAN; LYF1; Lymphoid transcription factor LyF-1; PRO0758; Zinc finger protein subfamily 1A 1 (Ikaros); zinc finger protein subfamily 1A 1; Zinc finger protein; subfamily 1A; member 1; ZNFN1A1.
IHC-P
Human
Ikaros Antibody (YA988) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA988), targeting Ikaros. Ikaros Antibody (YA988) can be used for IHC-P experiment in human background.
B cell antigen receptor Ig beta associated protein 1; BPM 90; BPM L; BPM-L; BPM90; BPML; IBAP 1; Imp 9; Importin 9; Novel centrosomal protein RanBPM; RAN binding protein 9; Ran binding protein centrosomal; Ran Binding Protein in the Microtubule organizing center; Ran binding protein M; Ran BP9; Ran-binding protein 9; Ran-binding protein M; RANB9_HUMAN; RanBP 7; RANBP 9; RanBP7; RanBP9; RanBPM.
WB, ICC/IF
Human, Mouse, Rat
RanBP9 Antibody (YA1995) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1995), targeting RanBP9, with a predicted molecular weight of 78 kDa (observed band size: 91 kDa). RanBP9 Antibody (YA1995) can be used for WB, ICC/IF experiment in human, mouse, rat background.
COL 3A1; COL3A1; Collagen alpha 1(III) chain; Collagen III alpha 1 chain precursor; Collagen III alpha 1 polypeptide; Collagen type III alpha 1 (Ehlers Danlos syndrome type IV autosomal dominant); Collagen type III alpha 1; Collagen type III alpha; EDS4A; Ehlers Danlos syndrome type IV, autosomal dominant; Fetal collagen; Type III collagen; CO3A1_HUMAN; Collagen alpha-1(III) chain; Type III collagen; type III preprocollagen alpha 1 chain.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Dog, Rabbit
Collagen III Antibody is an unconjugated, approximately 117 kDa, rabbit-derived, anti-Collagen III polyclonal antibody. Collagen III Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, dog, rabbit, and predicted: mouse, rat, chicken, cow background without labeling.
CCN 2; CCN-2; CCN2; Connective Tissue Growth Factor; Hcs 24; Hcs24; Hypertrophic chondrocyte specific protein 24; Hypertrophic chondrocyte-specific gene product 24; Insulin-like Growth Factor-Binding Protein 8; MGC102839; NOV 2; NOV2; Connective tissue growth factor; CCN family member 2; Hypertrophic chondrocyte-specific protein 24; Insulin-like growth-binding protein 8; IBP-8; IGF-binding protein 8; IGFBP8; IGFBP-8; connective tissue growth factor precursor; CTGF_HUMAN.
WB, ELISA
Mouse, Rat
CTGF Antibody is an unconjugated, approximately 36 kDa, rabbit-derived, anti-CTGF polyclonal antibody. CTGF Antibody can be used for: WB, ELISA expriments in mouse, rat, and predicted: human,chicken, dog, pig, cow background without labeling.
TGF beta Receptor II Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-TGF beta Receptor II polyclonal antibody. TGF beta Receptor II Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, cow, and predicted: chicken, pig, horse, rabbit, sheep background without labeling.
CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC Motif Receptor 3; Chemokine CXC Motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.
WB
Human, Mouse, Rat
CXCR3 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CXCR3 polyclonal antibody. CXCR3 Antibody can be used for: WB expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit, guinea pig background without labeling.
LATS1 +LATS2 (phospho T1079 + T1041); Serine/threonine protein kinase LATS2; KPM; Large tumor supressor, homolog 1; LATS, large tumor suppressor, homolog 1 (Drosophila); LATS, large tumor suppressor, homolog 2 (Drosophila); LATS1 +LATS2 (phospho T1079 + T1041); p-LATS1 +LATS2(Thr1079 +Thr1041); RGD1564085; Serine/threonine protein kinase LATS1; WARTS; WARTS protein kinase; wts; 4932411G09Rik; AV277261; AW208599; AW228608; FLJ13161; LATS1_HUMAN.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse
phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody is an unconjugated, approximately 124 kDa, rabbit-derived, anti-phospho-LATS1+LATS2 (Thr1079 +Thr1041) polyclonal antibody. phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.
CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC Motif Receptor 3; Chemokine CXC Motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.
WB, ICC/IF, IP
Human
CXCR3 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-CXCR3 monoclonal antibody. CXCR3 Antibody can be used for: WB expriments in human background without labeling.
Collagen II alpha 1; COL2A1; COL2A1 protein; collagen, type II, alpha 1; collagen alpha-1(II); type II collagen; alpha-1 type II collagen; alpha1 type II collagen; Col2a1; AOM; Cartilage collagen; Chondrocalcin; COL11A3; Collagen alpha 1(II) chain precursor; Collagen II alpha 1 polypeptide; Collagen type II alpha 1 (primary osteoarthritis spondyloepiphyseal dysplasia congenital); MGC131516; SEDC; Collagen alpha-1(II) chain; Alpha-1 type II collagen; CO2A1_HUMAN.; CollagenII;
WB, ELISA, IHC-P, ICC/IF
Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Guinea Pig
Collagen II Antibody is an unconjugated, approximately 117 KDa, rabbit-derived, anti-Collagen II polyclonal antibody. Collagen II Antibody can be used for: WB, ELISA, IHC-P, IF expriments in human, mouse, rat, chicken, dog, pig, cow, rabbit, guinea pig background without labeling.
Phospho-NFKB1 p105/p50 (Ser337) Antibody is an unconjugated, approximately 50&120 kDa, rabbit-derived, anti-NFKB1 p105/p50 (Ser337) polyclonal antibody. Phospho-NFKB1 p105/p50 (Ser337) Antibody can be used for: WB, IHC-P, ICC/IF expriments in human, mouse, rat background without labeling.
CD 152; CD152; CD152 antigen; Celiac disease 3; CELIAC3; CTLA 4; CTLA-4; Cytotoxic T cell associated 4; Cytotoxic T lymphocyte associated 4; Cytotoxic T lymphocyte associated antigen 4; Cytotoxic T lymphocyte associated protein 4; Cytotoxic T lymphocyte associated serine esterase 4; Cytotoxic T lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; Cytotoxic T-lymphocyte-associated protein 4; GSE; IDDM12; CD152 isoform; CTLA4_HUMAN; GRD4; ICOS; Ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4.
WB, ICC/IF
Human, Mouse, Rat
CTLA4 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting CTLA4, with a predicted molecular weight of 25 kDa. CTLA4 Antibody can be used for WB,ICC/IF experiments in human, mouse, rat backgrounds.
ACE Antibody is an unconjugated, approximately 150 kDa, rabbit-derived, anti-ACE monoclonal antibody. ACE Antibody can be used for: WB,IHC-P,FC expriments in human, mouse background without labeling.
phospho-ERK1 + 2 (Thr183/Tyr185) Antibody is an unconjugated, approximately 42/44 kDa, rabbit-derived, anti-phospho-ERK1 + 2 (Thr183/Tyr185) polyclonal antibody. phospho-ERK1 + 2 (Thr183/Tyr185) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, cow, horse, rabbit, guinea pig background without labeling.
CYP1A2 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting CYP1A2, with a predicted molecular weight of 58 kDa. CYP1A2 Antibody can be used for WB,ICC/IF,FC experiments in human backgrounds.
CASP4 Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting CASP4, with a predicted molecular weight of 43 kDa. CASP4 Antibody can be used for WB, ELISA experiment in human and rat background.
C21; DC42; F box like/WD repeat containing protein TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1; FLJ12894; IRA1; Nuclear receptor corepressor/HDAC3 complex subunit; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1 related protein 1; TBL1-related protein 1; TBL1R_HUMAN; TBL1XR1; Transducin (beta) like 1 X linked receptor 1; Transducin beta like 1X related protein 1; Transducin beta-like 1X-related protein 1.
WB, IHC-F, IHC-P, ICC/IF
Human, Mouse
TBL1XR1 Antibody (YA1052) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1052), targeting TBL1XR1, with a predicted molecular weight of 56 kDa (observed band size: 60 kDa). TBL1XR1 Antibody (YA1052) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse background.
C21; DC42; F box like/WD repeat containing protein TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1; FLJ12894; IRA1; Nuclear receptor corepressor/HDAC3 complex subunit; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1 related protein 1; TBL1-related protein 1; TBL1R_HUMAN; TBL1XR1; Transducin (beta) like 1 X linked receptor 1; Transducin beta like 1X related protein 1; Transducin beta-like 1X-related protein 1.
WB, IHC-P, ICC/IF
Human, Mouse, Rat
TBL1XR1 Antibody (YA1053) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1053), targeting TBL1XR1, with a predicted molecular weight of 56 kDa (observed band size: 56 kDa). TBL1XR1 Antibody (YA1053) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
C21; DC42; F box like/WD repeat containing protein TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1; FLJ12894; IRA1; Nuclear receptor corepressor/HDAC3 complex subunit; Nuclear receptor corepressor/HDAC3 complex subunit TBLR1; TBL1 related protein 1; TBL1-related protein 1; TBL1R_HUMAN; TBL1XR1; Transducin (beta) like 1 X linked receptor 1; Transducin beta like 1X related protein 1; Transducin beta-like 1X-related protein 1.
WB, IHC-P, ICC/IF
Human, Monkey
TBLR1 Antibody (YA1084) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1084), targeting TBLR1, with a predicted molecular weight of 56 kDa (observed band size: 60 kDa). TBLR1 Antibody (YA1084) can be used for WB, IHC-P, ICC/IF experiment in human, monkey background.
DKFZp781C1895; DKFZp781O1323; Dwfc; hSmad 5; hSmad5; JV5 1; JV5-1; MAD homolog 5; MAD mothers against decapentaplegic homolog 5; MAD; mothers against decapentaplegic homolog 5; MADH 5; MADH5; Mothers against decapentaplegic homolog 5; Mothers against DPP homolog 5; MusMLP; SMA and MAD related protein 5; SMAD 5; SMAD family member 5; SMAD mothers against DPP homolog 5; Smad5; Smad5; SMAD5_HUMAN.
WB, IHC-P, ICC/IF
Human, Mouse, Rat
Phospho-Smad5 (Ser463/465) Antibody (YA2838) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2838), targeting Phospho-Smad5 (Ser463/465), with a predicted molecular weight of 52 kDa (observed band size: 58 kDa). Phospho-Smad5 (Ser463/465) Antibody (YA2838) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.
10 kDa interferon gamma induced protein; C7; Chemokine (C X C motif) ligand 10; Chemokine CXC motif ligand 10; Crg 2; CRG2; CXCL 10; CXCL10; Gamma IP10; gIP 10; GIP10; IFI 10; IFI10; INP 10; INP10; Interferon activated gene 10; Interferon gamma induced cell line; Interferon inducible cytokine IP 10; MOB1; SCYB 10; SCYB10; Small inducible cytokine B10; Small inducible cytokine B10 precursor; Small inducible cytokine subfamily B (Cys X Cys) member 10; Gamma-IP-10.
ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat,
CXCL10/IP10 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL10/IP10 polyclonal antibody. CXCL10/IP10 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
HSD3B1 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-HSD3B1 monoclonal antibody. HSD3B1 Antibody can be used for: WB,ICC/IF expriments in human background without labeling.
Arresten; Canstatin; COL4A1; HANAC; ICH; POREN1; Collagen Alpha 1(IV) Chain; Collagen IV Alpha 1 Polypeptide; Collagen Of Basement Membrane Alpha 1 Chain; Collagen Of Basement Membrane Alpha 2 Chain; Collagen Type IV Alpha 1; DKFZp686I14213; FLJ22259; collagen alpha-1(IV) chain preproprotein; collagen alpha-1(IV) chain preproprotein; Col4a1 protein; collagen of basement membrane, alpha-1 chain; collagen IV, alpha-1 polypeptide; collagen alpha-1(IV) chain; COL4A1 NC1 domain; CO4A1_HUMAN; Collagen Ⅳ; Collagen Type Ⅳ.
ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat
Collagen IV Antibody is an unconjugated, approximately 165 kDa, rabbit-derived, anti-Collagen IV polyclonal antibody. Collagen IV Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, rabbit background without labeling.
Caspase-1 p20 Antibody is an unconjugated, approximately 20/46 kDa, rabbit-derived, anti-Caspase-1 p20 polyclonal antibody. Caspase-1 p20 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.
KRT2; KRT76; KRT3; KRT5; KRT6A; KRT6B; KRT6C; KRT71; KRT72; KRT73; KRT74; KRT75; KRT79; KRT8; KRT84; Keratin; type II cytoskeletal 2 epidermal; Keratin; type II cytoskeletal 2 oral; Keratin; type II cytoskeletal 3; Keratin; type II cytoskeletal 5; Keratin; type II cytoskeletal 6A; Keratin; type II cytoskeletal 6B; Keratin; type II cytoskeletal 6C; Keratin; type II cytoskeletal 71; Keratin; type II cytoskeletal 72; Keratin; type II cytoskeletal 73; Keratin; type II cytoskeletal 74
WB, IHC-P
Human
Cytokeratin 2e Antibody (YA2671) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2671), targeting Cytokeratin 2e, with a predicted molecular weight of 65 kDa (observed band size: 65 kDa). Cytokeratin 2e Antibody (YA2671) can be used for WB, IHC-P experiment in human background.
Alpha CaMKII; Calcium calmodulin dependent protein kinase II; Calcium/calmodulin dependent protein kinase II alpha B subunit; Calcium/calmodulin dependent protein kinase type II alpha chain; Calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha; Calcium/calmodulin-dependent protein kinase II alpha; Calcium/calmodulin-dependent protein kinase II-alpha; Calcium/calmodulin-dependent protein kinase type II subunit alpha; Calcium/calmodulin-dependent protein kinase type IIA; CaM kinase II alpha chain; CaM kinase II alpha subunit; CaM kinase II subunit alpha; CaMK II alpha subunit; CaMK-II subunit alpha; Camk2a; CAMKA; CaMKII; CaMKIINalpha; EC2.7.11.17; KCC2A_HUMAN; KIAA0968; MGC123320; MGC139375; MGC155201; mKIAA0968; PK2CDD; PKCCD; R74975; zgc:112538; zgc:123320;
WB, IP, FC, IHC-P
Human, Mouse, Rat
CaMKII alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to CaMKII alpha. It can be used for WB,IP,FC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
F4/80 (mouse); Adhesion G protein-coupled receptor E1; Cell surface glycoprotein EMR1; Cell surface glycoprotein F4/80; DD7A5 7; Egf like module containing mucin like hormone receptor like 1; Egf like module containing mucin like hormone receptor like sequence 1; EGF like module receptor 1; EGF TM7; EGF-like module receptor 1; EGF-like module-containing mucin-like hormone receptor-like 1; EGFTM7; EMR 1; EMR1; EMR-1; EMR1 hormone receptor; EMR1_HUMAN; AGRE1_HUMAN; Gpf480; Ly71; Lymphocyte antigen 71; TM7LN3.
WB, IHC-P, IHC-F, ICC/IF
Mouse, Rat
ADGRE1 (F4/80) Antibody (YA920) is an unconjugated, approximately 102 kDa, rabbit-derived, anti-ADGRE1 (F4/80) (YA920) monoclonal antibody. ADGRE1 (F4/80) Antibody (YA920) can be used for: WB, IHC-P, IF-Tissue, IHC-Fr expriments in mouse, rat background without labeling.
Galectin 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Galectin 3. It can be used for WB,ICC/IF,FC,IHC-P assays with tag free, in the background of Human, Mouse.
PRKACA/PRKACB; PRKACA + PRKACB; PKA alpha + beta; PKA alpha; PKA beta; cAMP dependent protein kinase alpha catalytic subunit; cAMP dependent protein kinase beta catalytic subunit; cAMP dependent protein kinase catalytic subunit alpha; cAMP dependent protein kinase catalytic subunit beta; DKFZp781I2452; MGC102831; MGC41879; MGC48865; MGC9320; PKA C alpha; PKA C beta; PKACA; PKACB; PRKACA; PRKACB; Protein kinase A catalytic subunit alpha; Protein kinase A catalytic subunit; Protein kinase A catalytic subunit beta; Protein kinase cAMP dependent catalytic alpha; Protein kinase cAMP dependent catalytic beta; cAMP dependent protein kinase catalytic subunit alpha isoform 1; cAMP-dependent protein kinase catalytic subunit alpha; KAPCA_HUMAN; KAPCB_HUMAN; PKA C alpha; PKA C-alpha; PKACA; PRKACA; Protein kinase A catalytic subunit; Protein kinase cAMP dependent catalytic alpha.
WB, ELISA, IHC-P, IHC-F, ICC/IF
Human, Mouse
PKA alpha + beta Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-PKA alpha + beta polyclonal antibody. PKA alpha + beta Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat background without labeling.
CCR7_HUMAN; BLR 2; BLR2; C C chemokine receptor type 7; C C CKR 7; CC chemokine receptor 7; CC chemokine receptor type 7; CC CKR 7; CCCKR7; CCR 7; CD 197; CD197; CD197 antigen; CDW197; Chemokine C C motif receptor 7; Chemokine C C receptor 7; Chemokine receptor 7-like protein; EBI 1; EBI1; Ebi1h; EBV Induced G Protein Coupled Receptor 1; Epstein Barr virus induced G protein coupled receptor; Epstein Barr virus induced gene 1; EVI 1; EVI1; Lymphocyte Specific G Protein Coupled Peptide Receptor; MGC108519; MIP 3 beta receptor; MIP3 Beta Receptor.
WB, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
CCR7 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-CCR7 polyclonal antibody. CCR7 Antibody can be used for: WB, ELISA, IHC-P, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.
Basic helix loop helix PAS protein MOP2; Basic-helix-loop-helix-PAS protein MOP2; bHLHe73; Class E basic helix-loop-helix protein 73; ECYT4; Endothelial PAS domain containing protein 1; Endothelial pas domain protein 1; Endothelial PAS domain-containing protein 1; EPAS 1; EPAS-1; EPAS1; EPAS1_HUMAN; HIF 1 alpha like factor; HIF-1-alpha-like factor; HIF-2-alpha; HIF2-alpha; HIF2A; HLF; Hypoxia inducible factor 2 alpha; Hypoxia inducible factor 2 alpha subunit; Hypoxia-inducible factor 2-alpha; Member of PAS protein 2; Member of pas superfamily 2; MOP 2; MOP2; PAS domain-containing protein 2; PASD2.
WB, IHC-P, FC
Human, Mouse, Rat
HIF 2 alpha Antibody is an unconjugated, approximately 96 kDa, rabbit-derived, anti-HIF 2 alpha monoclonal antibody. HIF 2 alpha Antibody can be used for:WB, IHC-P, FC expriments in human, mouse, rat background without labeling.
PIK3CA Antibody is an unconjugated, approximately 110 kDa, rabbit-derived, anti-PIK3CA monoclonal antibody. PIK3CA Antibody can be used for: WB, ICC/IF, IP expriments in human, mouse, rat background without labeling.
alpha smooth muscle ActinAntibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to alpha smooth muscle Actin. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.
MCP-1/CCL2; C-C motif chemokine 2; CCL 2; CCL2; CCL2_HUMAN; Chemokine (C C motif) ligand 2; Chemokine C C motif ligand 2; Chemokine CC Motif Ligand 2; GDCF 2; GDCF 2 HC11; GDCF-2; GDCF2; HC11; HSMCR30; HSMCR30; JE; MCAF; MCP 1; MCP-1; MGC9434; Monocyte chemoattractant protein 1; Monocyte chemotactic and activating factor; Monocyte chemotactic protein 1; Monocyte secretory protein JE; SCYA2; Small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig je); Small inducible cytokine A2; Small inducible cytokine subfamily A (Cys Cys), member 2; Small inducible cytokine subfamily A Cys Cys member 2; Small-inducible cytokine A2; SMC CF; SMC-CF; SMCCF.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Rat
MCP1 Antibody is an unconjugated, approximately 11 kDa, rabbit-derived, anti-MCP1 polyclonal antibody. MCP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, dog, pig, horse, rabbit background without labeling.
Phospho-PKM2(Tyr105)Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Phospho-PKM2(Tyr105)Antibody, with a predicted molecular weight of 58 kDa. Phospho-PKM2(Tyr105)Antibody can be used for IHC-P, IHC-F, ICC/IF, FC, ELISA experiments in human, rat backgrounds.
Histone H3 (tri methyl K9) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (tri methyl K9). It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.
phospho-PI3 Kinase p110 beta (Ser1070) Antibody is an unconjugated, approximately 110-123 kDa, rabbit-derived, anti-phospho-PI3 Kinase p110 beta (Ser1070) polyclonal antibody. phospho-PI3 Kinase p110 beta (Ser1070) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, guinea pig background without labeling.
NF-kB p65 (phospho S536); p-NF-κB p65(Phospho-Ser536); RELA(phospho S536); NF kB P65; NF-kB p65; NFKBp65; NF-κBp65; p65 NF kappaB; p65 NFkB; NFKBp65; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells; TF65_HUMAN. NFκB-p65; NFκB p65; NF κB-p65; NFκBp65
WB, IHC-P, FC
Human, Mouse, Rat
Phospho-NF-κB p65 (Ser536) Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Phospho-NF-κB p65 (Ser536), with a predicted molecular weight of 61 kDa. Phospho-NF-κB p65 (Ser536) Antibody can be used for WB, IHC-P, FC experiments in human, mouse, rat backgrounds.
60S acidic ribosomal protein P1; AA409079; AI325195; AU020965; HSSB; ik:tdsubc_2g1; M(2)21C; MGC137236; OTTHUMP00000004008; p32; p34; RCJMB04_6d17 replication protein A2; 32kDa; REPA 2; REPA1; REPA2; Replication factor A protein 2; Replication protein A 32 kDa subunit; Replication protein A 32kDa subunit; Replication protein A 34 kDa subunit; Replication protein A; replication protein A1 (70kD); Replication Protein A2 (32kDa); Replication protein A2 32kD; Replication protein A2 32kDa; Replication protein A2; Replication protein A2; 32kDa; RF A; RF-A protein 2; Rf-A2; RFA; RFA2_HUMAN; RP A; RP-A p32; RP-A p34; RP21C; RPA 2; RPA 32; RPA; RPA2; RPA32; RPA34; RPA70; RpLP1; RpP2; xx:tdsubc_2g1; zgc:109822.
WB, IP
Human, Mouse, Rat
Phospho-RPA2 (Thr21) Antibody (YA2720) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2720), targeting Phospho-RPA2 (Thr21), with a predicted molecular weight of 29 kDa (observed band size: 32 kDa). Phospho-RPA2 (Thr21) Antibody (YA2720) can be used for WB, IP experiment in human, mouse, rat background.
MEK3 Antibody (YA3214) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3214), targeting MEK3, with a predicted molecular weight of 39 kDa (observed band size: 38-40 kDa). MEK3 Antibody (YA3214) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
p38 (phospho T180 + Y182); p-p38 (phospho T180 + Y182); p38 (phospho T180/Y182); CSAID Binding Protein 1; CSAID binding protein; CSAID-binding protein; Csaids binding protein; CSBP 1; CSBP 2; CSBP; CSBP1; CSBP2; CSPB 1; CSPB1; Cytokine suppressive anti inflammatory drug binding protein; Cytokine suppressive anti-inflammatory drug-binding protein; EXIP; MAP kinase 14; MAP kinase MXI2; MAP kinase p38 alpha; MAPK 14; MAPK14; MAX interacting protein 2; MAX-interacting protein 2; Mitogen Activated Protein Kinase 14; Mitogen activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; Mitogen-activated protein kinase p38 alpha; MK14_HUMAN; Mxi 2; Mxi2; p38 ALPHA; p38; p38 MAP kinase; p38 MAPK; p38 mitogen activated protein kinase; p38ALPHA; p38alpha Exip; PRKM14; PRKM15; RK; SAPK 2A; SAPK2A; Stress Activated Protein Kinase 2A.
WB, IHC-P, FC, ICC/IF, ELISA
Human, Mouse
Phospho-p38 (Thr180+Tyr182) Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Phospho-p38 (Thr180+Tyr182), with a predicted molecular weight of 41 kDa . Phospho-p38 (Thr180+Tyr182) Antibody can be used for WB, IHC-P, FC, ICC/IF, ELISA experiments in human, mouse backgrounds.
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs) . Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Fmoc-DAP-N3 is a click chemistry reagent containing an azide group. Fmoc-DAP-N3 is a short, linear spacer molecule with Fmoc protected amino function. Fmoc-DAP-N3 can be used in click conjugation and amid bond formation either with small molecules or for bioconjugation with proteins and antibodies . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
Mal-AMCHC-N-Propargylamide is a click chemistry reagent containing an azide group. Mal-AMCHC-N-Propargylamide can be a bio-conjugation reagent for antibody-agent-conjugate synthesis using Click-Chemistry .
DM1-(PEG)4-DBCO is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DM1-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-Ahx-DM1 is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DBCO-PEG4-Ahx-DM1 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG4-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
TCO-PEG12-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG12-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DNP-PEG2-NHCO-C2-DBCO is a clickable hapten that bears a dinitrophenyl (DNP) moiety as the antibody‐recruiting motif at one end, a polyethylene glycol chain as a spacer and a dibenzocyclooctene at the other end for the SPAAC chemistry .
DBCO-Maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-NHS ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fluorescein-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-Maleimide is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-NHS ester (sodium) is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Mal-Sulfo-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-Sulfo-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-SS-aldehyde is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-aldehyde is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-SS-NHS is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-S-S-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-S-S-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
TCO-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-SS-amine is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Tetrazine-Ph-OPSS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-OPSS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-SS-Biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
PVP-037.2 is a TLR7/8 agonist. PVP-037.2 can serve as an adjuvant to enhance vaccine-induced TH1 type immune responses, increasing the production of antigen-specific antibodies IgG1 and IgG2c .
Propargyl-C1-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-C2-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC). Propargyl-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-Sulfo-Link-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Sulfo-Link-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-Ph-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-Ph-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-Val-Cit-PABC-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-OH is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-Val-Cit-PABC-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-NHCO-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-CONH-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-CONH-S-S-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG3-acid is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG3-acid contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
Propargyl-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG1-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-PEG4-Maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCOT-PEF3-OPFP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCOT-PEF3-OPFP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Aminooxy-PEG2-BCN is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
PTAD-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
APN-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
APN-PEG4-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
endo-BCN-PEG4-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . endo-BCN-PEG4-acid is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-HyNic is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-HyNic is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
HyNic-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . HyNic-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Bocaminooxyacetamide-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
bisSP1 is an antibody agent conjugates linker . bisSP1 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DBCO-NHS ester 2 is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 2 is a derivative of Dibenzylcyclooctyne (DBCO) used in copper-free click chemistry . DBCO-NHS ester 2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
PC DBCO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC DBCO-PEG3-biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Diazo Biotin-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Diazo Biotin-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG1-SS-alcohol is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-alcohol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
bis-PEG2-endo-BCN is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . bis-PEG2-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
PC Alkyne-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Alkyne-PEG4-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
PC Biotin-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BCN-PEG3-VC-PFP ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-VC-PFP ester is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-SS-PEG4-Biotin is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG4-oxyamine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-oxyamine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
TCO-PEG3-Biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-Biotin is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Tetrazine-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-PEG4-oxyamine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-oxyamine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG4-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-PEG3-SS-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-SS-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG3-Biotin is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-Biotin is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG4-OH is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
BCN-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG3-oxyamine is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG4-hydrazide is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-hydrazide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-oxyamine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-alkyne is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BCN-PEG4-Ts is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG4-Ts is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Amino-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG4-amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Methyltetrazine-PEG4-aldehyde is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-aldehyde is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
TCO-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Amino-bis-PEG3-BCN is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG6-amine (hydrochloride) is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG6-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Mal-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG3 acetic-EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3 acetic-EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG7-amine hydrochloride is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG7-amine (hydrochloride) is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-C6-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-C6-acid can be used in the synthesis of carmaphycin analogues . DBCO- C6- acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Gly-Gly-Gly-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Gly-Gly-Gly-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG4-SS-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-NHS is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
BCN-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Tetrazine-PEG5-SS-amine is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG5-SS-amine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-PEG4-SS-Py is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-PEG4-SS-Py is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Amino-bis-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-bis-PEG3-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
DBCO-PEG4-SS-TCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-SS-TCO is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Methyltetrazine-PEG4-SS-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-NHS ester is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Aminooxy-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Methyltetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-SS-PEG4-Biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Tetrazine-diazo-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Tetrazine-diazo-PEG4-biotin is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
DBCO-PEG3-propionic EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-propionic EVCit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Cy7-YNE is a fluorescence labeling agent (Ex=700-770 nm，Em=790 nm). Cyanine dyes are used to label proteins, antibodies, and peptides. Cy7-YNE is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Ald-Ph-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-amido-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Boc-aminooxy-amide-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-aminooxy-amide-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
BCN-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . BCN-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
DBCO-PEG4-Propionic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Propionic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-acetic-Val-Cit-PAB is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-NHCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-amine is a cleavable ADC linker used to conjugate MMAE (HY-15162) and antibody (e.g., DBCO-VCpAB−MMAE and DBCO-TRX−MMAE with EC50s of 280 nM and 22 nM in SKBR3 cells, respectively) .
Propargyl-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG6-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azidoethyl-SS-ethylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-PEG1-SS-PEG1-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azidoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azidoethyl-SS-ethylazide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-ethylazide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . endo-BCN-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
TCO-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
NH2-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Sulfo-Cy7.5 DBCO is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) bearing a DBCO group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Sulfo-Cy7.5 DBCO can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples .
6-O-2-Propyn-1-yl-D-galactose is a nonclaevable glycolinker for the functionalization of cytotoxic agents and applications in antibody-agent conjugation. 6-O-2-Propyn-1-yl-D-galactose is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-NHS ester 3 (Compound 12) is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 3 is a derivative of Dibenzylcyclooctyne (DBCO) obtained by activation of N-hydroxysuccinimide by the carboxylic acid moiety of both methyl-oxanorbornadiene (MeOND) and dibenzoazacyclooctyne (DIBAC) . DBCO-NHS ester 3 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG1-SS-PEG1-propargyl is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG1-SS-PEG1-PFP ester is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-PFP ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azidoethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azidoethyl-SS-propionic NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Methyltetrazine-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Alkyne-PEG4-SS-PEG4-alkyne is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Alkyne-PEG4-SS-PEG4-alkyne is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Amino-PEG4-bis-PEG3-propargyl is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Mal-PEG4-bis-PEG3-DBCO is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Mal-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Mal-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
TCO-PEG3-CH2-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG3-CH2-aldehyde is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Acid-PEG1-bis-PEG3-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Acid-PEG1-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Aminooxy-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-bis-PEG3-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
6-Azido-hexylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 6-Azido-hexylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
BCN-HS-PEG2-VA-PABC-SG3199 (Compound 4) is a pyrrolobenzodiazepine that can be used as a agent linker of antibody-drug conjugates (ADC) . BCN-HS-PEG2-VA-PABC-SG3199 is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-Ph-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DBCO-Amide-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-Amide-PEG5-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG5-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG5-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG9-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG9-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG9-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG8-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-bromide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-bromide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-Br is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Br is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-thiol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-thiol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG2-NHBoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-NHBoc is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-NHBoc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG4-Tos is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Mal-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Propargyl-NH-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-NH-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Ald-Ph-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Amino-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Propargyl-C8-amido-PEG2-NHS ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-C8-amido-PEG2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG2-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-NHCO-PEG4-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG5-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG3-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG3-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG3-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG8-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG7-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG6-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG5-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG5-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG2-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Propargyl-PEG2-amine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
m-PEG6-azide is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG5-Tos is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG5-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SSPy is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
Bocaminooxyacetamide-PEG2-Azido is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Bocaminooxyacetamide-PEG2-Azido is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biotin-PEG1-azide is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG1-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-C6-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C6-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-C2-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Bis-sulfone-PEG3-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bis-sulfone-PEG3-Azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biotin-PEG4-SS-azide is a cleavable, biotin-labeled, ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Biotin-PEG4-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
APN-PEG36-tetrazine is an analogue of APN-PEG4-tetrazine. APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . APN-PEG36-tetrazine is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
N3-D-Orn(Boc)-OH is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
N3-D-Orn(Boc)-OH (CHA) is a Boc-protected pentanoic amino acid derivative, can be used as a click chemistry reagent and has been used to synthesis antibody-drug conjugates (ADC) . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
4-N3Pfp-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . 4-N3Pfp-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C3-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C3-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C4-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C4-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-C5-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-O-C1-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-O-C1-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC). Propargyl-O-C1-amido-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
DBCO-NHCO-PEG4-NH-Boc is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NH-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHCO-PEG4-NH-Boc is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). The ADCs can be used in bacterial infections caused by Gram-negative bacteria . Propargyl-PEG8-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
PC Biotin-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC Biotin-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biotin-PEG3-SS-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Biotin-PEG3-SS-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-SS-NHS is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-SS-NHS is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
PTAD-PEG4-N3 is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PTAD-PEG4-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Hynic-PEG3-N3 is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Hynic-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Aminoxyacetamide-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminoxyacetamide-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Gly-Gly-Gly-PEG4-azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Gly-Gly-Gly-PEG4-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Cy3 alkyne chloride is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing a sulfonate ion and an alkyne functional group. Cy3 is a fluorescent dye with a fluorescence spectrum typically in the green to orange wavelength range. The alkyne functional group of Cy3 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy3 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
DBCO-(PEG2-VC-PAB-MMAE)2 is made by MMAE conjugated to the cleavable DBCO-(PEG2-VC-PAB)2 linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody agent conjugate . DBCO-(PEG2-VC-PAB-MMAE)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-(PEG2-Val-Cit-PAB)2 is a dual cleavable ADC linker for antibody-drug conjugates (ADCs). DBCO-(PEG2-Val-Cit-PAB)2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. DBCO-(PEG2-Val-Cit-PAB)2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Propargyl-PEG8-NH2 (compound 3b) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NH2 is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG8-NH2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azide-C2-SS-C2-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-C2-SS-C2-biotin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-Val-Cit-PAB-OH is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-Ala-Ala-Asn-PAB is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Boc-gly-PEG3-endo-BCN is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Boc-gly-PEG3-endo-BCN is also a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Boc-gly-PEG3-endo-BCN is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N3-PEG5-aldehyde is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG5-aldehyde is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DBCO-PEG3-TCO is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG3-TCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. DBCO-PEG3-TCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Azido-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG1-Val-Cit-PABC-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG1-Val-Cit-PABC-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
(R)-8-Azido-2-(Fmoc-amino)octanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . (R)-8-Azido-2-(Fmoc-amino)octanoic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-O-C1-amido-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-O-C1-amido-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Propargyl-PEG5-acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Azido-PEG9-acid is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Azido-PEG9-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
PC-Biotin-PEG4-PEG3-azide is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . PC-Biotin-PEG4-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-CH2-PEG5-azide is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-CH2-PEG5-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG4-amido-Lys(Fmoc)-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG4-amido-Lys(Fmoc)-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Methyltetrazine-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Methyltetrazine-PEG4-hydrazone-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Methyltetrazine-PEG4-hydrazone-DBCO also contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups.
β-D-tetraacetylgalactopyranoside-PEG1-N3 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . β-D-tetraacetylgalactopyranoside-PEG1-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-PEG4-Val-Cit-PAB-MMAF is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
N3-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG2-C2-PFP ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG2-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-C2-PFP ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-C2-PFP ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG4-C2-Pfp ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-Pfp ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG4-C2-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG9-amine is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG9-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG7-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG7-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG8-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-C2-SS-PEG2-C2-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-C2-SS-PEG2-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Amino-PEG6-amido-bis-PEG5-N3 is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG6-amido-bis-PEG5-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-Ph-PEG4-bis-PEG3-N3 is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Ald-Ph-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Amino-PEG4-bis-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Amino-PEG4-bis-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG4-VC-PAB-Doxorubicin is a agent-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody agent conjugate (ADC) . Azide-PEG4-VC-PAB-Doxorubicin is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
DIBAC-GGFG-NH2CH2-Dxd (compound LP4), a Camptothecin (HY-16560) derivative, is a linker-payload of protein-agent conjugates . Dxd (HY-13631D) can be used as a payload for the antibody-coupling drug ADC (DS-8201a).DIBAC-GGFG-NH2CH2-Dxd is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups .
Cy7.5 alkyne chloride is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functional group of Cy7.5 alkyne chloride can react with molecules containing the azide functional group to form covalent bonds. Cy7.5 alkyne chloride can bind to biological molecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
DBCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG4-amine can be used in the synthesis of FPM-PEG4-DBCO (a homobifunctional azide-to-azide cross-linker) . DBCO-PEG4-amine is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-PEG2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG8-NHS ester is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG8-NHS ester is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG8-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG5-alcohol is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-NHS ester is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG6-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-alcohol is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-alcohol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azide-PEG3-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azide-PEG3-Tos is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azide-PEG3-Tos is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG6-amine is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG6-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
TCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . TCO-PEG4-DBCO is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. TCO-PEG4-DBCO also contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Azido-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs, such as the conjugate CPT-APO (CPT: Camptothecin (HY-16560)). Azido-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG5-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Aminooxy-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Aminooxy-C2-PEG3-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Aminooxy-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Propargyl-PEG1-SS-PEG1-C2-Boc is a Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG1-SS-PEG1-C2-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Propargyl-PEG1-SS-PEG1-C2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Sulfo-Cy7.5 alkyne is a dye derivative of Cyanine 7.5 (Cy7.5) (HY-D0926) containing a sulfonate ion and an alkyne functional group. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The alkyne functionality of Sulfo-Cy7.5 alkyne can react with molecules containing the azide functionality to form covalent bonds. Sulfo-Cy7.5 alkyne can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples.
Azido-PEG4-C2-acid a PEG-based PROTAC linker can be used in the synthesis of vRucaparib-TP4. Azido-PEG4-C2-acid is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-Val-Cit-PAB-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-Val-Cit-PAB-OH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG3-Val-Cit-PAB-PNP is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG3-Val-Cit-PAB-PNP is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG3-Val-Cit-PAB-PNP is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Ald-CH2-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Ald-CH2-PEG3-azide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . Ald-CH2-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Bromo-PEG2-C2-azide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bromo-PEG2-C2-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Bromo-PEG2-C2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent containing an azide group. TCO-PEG2-Sulfo-NHS ester is a PEG linker containing a TCO moiety and a sulfo-NHS ester moiety. The sulfo group makes this molecule soluble in waqueous buffer. This reagent can be used to label antibodies, proteins and other primary amine-containing macromolecules with TCO moiety. Reagent grade, for research use only . TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
Azido-PEG4-CH2-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG4-CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG4-CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG5-CH2CO2H is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG5-CH2CO2H is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG5-CH2CO2H is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-CH2CH2COOH a PEG-based PROTAC linker can be used in the synthesis of BI-3663 (HY-111546), BI-4216 and BI-0319. Azido-PEG3-acid is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-CH2CH2COOH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
N3-PEG3-CH2CH2-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . N3-PEG3-CH2CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs . N3-PEG3-CH2CH2-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . Azido-PEG2-C2-amine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Sulfo-Cy7.5 azide is a Cyanine 7.5 (Cy7.5) (HY-D0926) dye derivative with azide and sulfonate functional groups. The sulfonate ion increases the water solubility of the compound, making it suitable for use in aqueous solutions. Cy7.5 is a near-infrared fluorescent dye commonly used for biolabeling and cell imaging. The azide group of Sulfo-Cy7.5 azide can react chemically with molecules containing alkyne functionality, such as alkyne or cyclooctyne, to form covalent bonds. Therefore, Sulfo-Cy7.5 azide can bind to biomolecules such as proteins and antibodies to track their location and dynamic changes in biological samples. It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) containing mRNA encoding COVID-19 Spike Protein , suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 Spike Protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 Spike Protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 Spike Protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
C12-TLRa is an adjuvant lipidoid. C12-TLRa acts as a structural component of LNP to enhance mRNA delivery. C12-TLRa substitution can increase antigen-specific antibody responses and B cell responses of clinically relevant mRNA-LNP vaccines .
CD19 CAR mRNA (Mouse) will express mouse CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
PLAUR Human Pre-designed siRNA Set A contains three designed siRNAs for PLAUR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Phospholipid-PEG-Biotin (MW 1000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 3400) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 10000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
Phospholipid-PEG-Biotin (MW 20000) is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG-Biotin (MW 3400) can interact with avidinylated antibodies. Phospholipid-PEG-Biotin (MW 3400) can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation .
16:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
16:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:0 mPEG5000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG750 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
14:0 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
CD19 CAR mRNA (Human) will express Human CD19 CAR protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 CAR is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.
Incomplete Freund's adjuvant (IFA) (Montanide ISA-51) is an immunoadjuvant emulsified with antigen by its discoverer Jules T. Freund. Incomplete Freund's adjuvant (IFA) does not contain inactivated tuberculosis bacilli and consists of petroleum jelly containing lanolin. Incomplete Freund's adjuvant (IFA) induces high antibody titers and long-lasting effector T cell responses with no long-term effects on collagen disease, tumors, or death. Complete Freund's adjuvant (CFA) (HY-153808) is another type of Freund's Adjuvant that stimulates a stronger immune response .
COVID-19 Spike Protein mRNA will express COVID-19 spike protein, and suitable for detection of RNA delivery, translation efficiency, cell viability, etc. COVID-19 spike protein is the novel coronavirus pneumonia spike protein located on the membrane surface. COVID-19 spike protein undertakes the functions of virus binding to host cell membrane receptors and membrane fusion, thereby mediating the entry of COVID-19 virus into cells. COVID-19 spike protein is an important site of action for host neutralizing antibodies and a key target for vaccine design .
CD19 car mRNA (Mouse)-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .
Inquiry Online
Your information is safe with us. * Required Fields.
![Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine](http://file.medchemexpress.eu/product_pic/hy-21577.gif)
![NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT](http://file.medchemexpress.eu/product_pic/hy-148819.gif)
![Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT](http://file.medchemexpress.eu/product_pic/hy-148820.gif)
![NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride](http://file.medchemexpress.eu/product_pic/hy-148819a.gif)
